Province, Autonomous City and Community of hospitalization	Main diagnosis (ICD-9-CM) reduced list	Sex	Total
TOTAL NATIONAL	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	4.719.667
TOTAL NATIONAL	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	2.223.772
TOTAL NATIONAL	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	2.495.895
TOTAL NATIONAL	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	98.875
TOTAL NATIONAL	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	54.718
TOTAL NATIONAL	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	44.157
TOTAL NATIONAL	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	15.065
TOTAL NATIONAL	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	7.883
TOTAL NATIONAL	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	7.182
TOTAL NATIONAL	Group 0102 Imprecise intestinal infections 009	Both sexes	8.245
TOTAL NATIONAL	Group 0102 Imprecise intestinal infections 009	Men	3.980
TOTAL NATIONAL	Group 0102 Imprecise intestinal infections 009	Women	4.266
TOTAL NATIONAL	Group 0103 Tuberculosis 010-018, 137	Both sexes	3.711
TOTAL NATIONAL	Group 0103 Tuberculosis 010-018, 137	Men	2.374
TOTAL NATIONAL	Group 0103 Tuberculosis 010-018, 137	Women	1.337
TOTAL NATIONAL	Group 0104 Septicaemia  038	Both sexes	38.149
TOTAL NATIONAL	Group 0104 Septicaemia  038	Men	20.525
TOTAL NATIONAL	Group 0104 Septicaemia  038	Women	17.623
TOTAL NATIONAL	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	3.022
TOTAL NATIONAL	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	2.205
TOTAL NATIONAL	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	817
TOTAL NATIONAL	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	30.683
TOTAL NATIONAL	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	17.751
TOTAL NATIONAL	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	12.932
TOTAL NATIONAL	Group 0200 Neoplasms  140-239	Both sexes	453.632
TOTAL NATIONAL	Group 0200 Neoplasms  140-239	Men	238.329
TOTAL NATIONAL	Group 0200 Neoplasms  140-239	Women	215.302
TOTAL NATIONAL	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	46.296
TOTAL NATIONAL	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	27.941
TOTAL NATIONAL	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	18.355
TOTAL NATIONAL	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	34.201
TOTAL NATIONAL	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	27.060
TOTAL NATIONAL	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7.141
TOTAL NATIONAL	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	8.741
TOTAL NATIONAL	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	5.055
TOTAL NATIONAL	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	3.686
TOTAL NATIONAL	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	34.831
TOTAL NATIONAL	Group 0204 Malignant neoplasm of breast  174-175	Men	295
TOTAL NATIONAL	Group 0204 Malignant neoplasm of breast  174-175	Women	34.535
TOTAL NATIONAL	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	9.185
TOTAL NATIONAL	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
TOTAL NATIONAL	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	9.185
TOTAL NATIONAL	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	5.041
TOTAL NATIONAL	Group 0206 Malignant neoplasm of ovary  1830	Men	..
TOTAL NATIONAL	Group 0206 Malignant neoplasm of ovary  1830	Women	5.041
TOTAL NATIONAL	Group 0207 Malignant neoplasm of prostate  185	Both sexes	17.477
TOTAL NATIONAL	Group 0207 Malignant neoplasm of prostate  185	Men	17.477
TOTAL NATIONAL	Group 0207 Malignant neoplasm of prostate  185	Women	..
TOTAL NATIONAL	Group 0208 Malignant neoplasm of bladder  188	Both sexes	41.509
TOTAL NATIONAL	Group 0208 Malignant neoplasm of bladder  188	Men	34.767
TOTAL NATIONAL	Group 0208 Malignant neoplasm of bladder  188	Women	6.742
TOTAL NATIONAL	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	159.368
TOTAL NATIONAL	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	93.231
TOTAL NATIONAL	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	66.137
TOTAL NATIONAL	Group 0210 Carcinoma in situ  230-234	Both sexes	7.579
TOTAL NATIONAL	Group 0210 Carcinoma in situ  230-234	Men	2.757
TOTAL NATIONAL	Group 0210 Carcinoma in situ  230-234	Women	4.822
TOTAL NATIONAL	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	5.268
TOTAL NATIONAL	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	3.196
TOTAL NATIONAL	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	2.072
TOTAL NATIONAL	Grupo 0212 Leiomyoma of uterus  218	Both sexes	22.395
TOTAL NATIONAL	Grupo 0212 Leiomyoma of uterus  218	Men	..
TOTAL NATIONAL	Grupo 0212 Leiomyoma of uterus  218	Women	22.395
TOTAL NATIONAL	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	61.742
TOTAL NATIONAL	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	26.549
TOTAL NATIONAL	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	35.193
TOTAL NATIONAL	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	42.532
TOTAL NATIONAL	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	20.959
TOTAL NATIONAL	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	21.573
TOTAL NATIONAL	Group 0301 Anaemias 280-285	Both sexes	24.892
TOTAL NATIONAL	Group 0301 Anaemias 280-285	Men	11.898
TOTAL NATIONAL	Group 0301 Anaemias 280-285	Women	12.994
TOTAL NATIONAL	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	17.640
TOTAL NATIONAL	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	9.061
TOTAL NATIONAL	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	8.579
TOTAL NATIONAL	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	85.507
TOTAL NATIONAL	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	33.875
TOTAL NATIONAL	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	51.631
TOTAL NATIONAL	Group 0401 Diabetes mellitus  249-250	Both sexes	26.681
TOTAL NATIONAL	Group 0401 Diabetes mellitus  249-250	Men	15.382
TOTAL NATIONAL	Group 0401 Diabetes mellitus  249-250	Women	11.299
TOTAL NATIONAL	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	58.826
TOTAL NATIONAL	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	18.494
TOTAL NATIONAL	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	40.332
TOTAL NATIONAL	Group 0500 Mental disorders  290-319	Both sexes	117.965
TOTAL NATIONAL	Group 0500 Mental disorders  290-319	Men	60.939
TOTAL NATIONAL	Group 0500 Mental disorders  290-319	Women	57.027
TOTAL NATIONAL	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	4.560
TOTAL NATIONAL	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	1.996
TOTAL NATIONAL	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	2.564
TOTAL NATIONAL	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	8.578
TOTAL NATIONAL	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	6.374
TOTAL NATIONAL	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	2.204
TOTAL NATIONAL	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	7.169
TOTAL NATIONAL	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	5.273
TOTAL NATIONAL	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1.896
TOTAL NATIONAL	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	33.780
TOTAL NATIONAL	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	20.818
TOTAL NATIONAL	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	12.961
TOTAL NATIONAL	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	27.351
TOTAL NATIONAL	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	10.671
TOTAL NATIONAL	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	16.680
TOTAL NATIONAL	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	36.527
TOTAL NATIONAL	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	15.806
TOTAL NATIONAL	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	20.721
TOTAL NATIONAL	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	107.107
TOTAL NATIONAL	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	54.020
TOTAL NATIONAL	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	53.087
TOTAL NATIONAL	Group 0601 Alzheimer's disease  3310	Both sexes	3.373
TOTAL NATIONAL	Group 0601 Alzheimer's disease  3310	Men	1.150
TOTAL NATIONAL	Group 0601 Alzheimer's disease  3310	Women	2.223
TOTAL NATIONAL	Group 0602 Multiple sclerosis 340	Both sexes	2.454
TOTAL NATIONAL	Group 0602 Multiple sclerosis 340	Men	800
TOTAL NATIONAL	Group 0602 Multiple sclerosis 340	Women	1.655
TOTAL NATIONAL	Group 0603 Epilepsy  345	Both sexes	17.969
TOTAL NATIONAL	Group 0603 Epilepsy  345	Men	9.604
TOTAL NATIONAL	Group 0603 Epilepsy  345	Women	8.364
TOTAL NATIONAL	Group 0604 Transient cerebral ischemia 435	Both sexes	16.026
TOTAL NATIONAL	Group 0604 Transient cerebral ischemia 435	Men	8.037
TOTAL NATIONAL	Group 0604 Transient cerebral ischemia 435	Women	7.989
TOTAL NATIONAL	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	67.285
TOTAL NATIONAL	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	34.429
TOTAL NATIONAL	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	32.856
TOTAL NATIONAL	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	29.505
TOTAL NATIONAL	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	15.256
TOTAL NATIONAL	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	14.250
TOTAL NATIONAL	Grupo 0701 Cataract  366	Both sexes	5.815
TOTAL NATIONAL	Grupo 0701 Cataract  366	Men	2.772
TOTAL NATIONAL	Grupo 0701 Cataract  366	Women	3.043
TOTAL NATIONAL	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	23.690
TOTAL NATIONAL	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	12.483
TOTAL NATIONAL	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	11.207
TOTAL NATIONAL	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	23.375
TOTAL NATIONAL	Group 0800 Diseases of the ear and the mastoid  380-389	Men	11.325
TOTAL NATIONAL	Group 0800 Diseases of the ear and the mastoid  380-389	Women	12.049
TOTAL NATIONAL	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	607.575
TOTAL NATIONAL	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	339.103
TOTAL NATIONAL	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	268.472
TOTAL NATIONAL	Group 0901 Hypertensive disease  401-405	Both sexes	31.523
TOTAL NATIONAL	Group 0901 Hypertensive disease  401-405	Men	13.434
TOTAL NATIONAL	Group 0901 Hypertensive disease  401-405	Women	18.090
TOTAL NATIONAL	Group 0902 Angina pectoris  4111, 413	Both sexes	25.804
TOTAL NATIONAL	Group 0902 Angina pectoris  4111, 413	Men	16.103
TOTAL NATIONAL	Group 0902 Angina pectoris  4111, 413	Women	9.701
TOTAL NATIONAL	Group 0903 Acute myocardial infarction  410	Both sexes	53.435
TOTAL NATIONAL	Group 0903 Acute myocardial infarction  410	Men	37.750
TOTAL NATIONAL	Group 0903 Acute myocardial infarction  410	Women	15.685
TOTAL NATIONAL	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	42.666
TOTAL NATIONAL	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	32.460
TOTAL NATIONAL	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	10.207
TOTAL NATIONAL	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	19.577
TOTAL NATIONAL	Group 0905 Diseases of the lungs circulation 415-417	Men	8.885
TOTAL NATIONAL	Group 0905 Diseases of the lungs circulation 415-417	Women	10.692
TOTAL NATIONAL	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	77.626
TOTAL NATIONAL	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	42.215
TOTAL NATIONAL	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	35.411
TOTAL NATIONAL	Grupo 0907 Heart failure  428	Both sexes	121.240
TOTAL NATIONAL	Grupo 0907 Heart failure  428	Men	56.432
TOTAL NATIONAL	Grupo 0907 Heart failure  428	Women	64.807
TOTAL NATIONAL	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	102.120
TOTAL NATIONAL	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	54.689
TOTAL NATIONAL	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	47.431
TOTAL NATIONAL	Grupo 0909 Atherosclerosis  440	Both sexes	20.630
TOTAL NATIONAL	Grupo 0909 Atherosclerosis  440	Men	15.244
TOTAL NATIONAL	Grupo 0909 Atherosclerosis  440	Women	5.386
TOTAL NATIONAL	Group 0910 Varicose veins of lower extremities 454	Both sexes	16.762
TOTAL NATIONAL	Group 0910 Varicose veins of lower extremities 454	Men	6.008
TOTAL NATIONAL	Group 0910 Varicose veins of lower extremities 454	Women	10.754
TOTAL NATIONAL	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	96.192
TOTAL NATIONAL	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	55.883
TOTAL NATIONAL	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	40.308
TOTAL NATIONAL	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	531.141
TOTAL NATIONAL	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	302.411
TOTAL NATIONAL	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	228.729
TOTAL NATIONAL	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	25.520
TOTAL NATIONAL	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	13.528
TOTAL NATIONAL	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	11.992
TOTAL NATIONAL	Group 1002 Pneumonia 480-486	Both sexes	115.723
TOTAL NATIONAL	Group 1002 Pneumonia 480-486	Men	68.055
TOTAL NATIONAL	Group 1002 Pneumonia 480-486	Women	47.668
TOTAL NATIONAL	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	49.336
TOTAL NATIONAL	Group 1003 Acute bronchitis and bronchiolitis  466	Men	24.068
TOTAL NATIONAL	Group 1003 Acute bronchitis and bronchiolitis  466	Women	25.269
TOTAL NATIONAL	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	26.813
TOTAL NATIONAL	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	14.135
TOTAL NATIONAL	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	12.678
TOTAL NATIONAL	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	42.159
TOTAL NATIONAL	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	26.132
TOTAL NATIONAL	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	16.028
TOTAL NATIONAL	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	84.780
TOTAL NATIONAL	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	64.338
TOTAL NATIONAL	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	20.442
TOTAL NATIONAL	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	21.616
TOTAL NATIONAL	Group 1007 Asthma 4930-4931,4938-4939	Men	6.855
TOTAL NATIONAL	Group 1007 Asthma 4930-4931,4938-4939	Women	14.761
TOTAL NATIONAL	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	165.193
TOTAL NATIONAL	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	85.301
TOTAL NATIONAL	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	79.891
TOTAL NATIONAL	Group 1100 Diseases of the digestive system  520-579	Both sexes	576.156
TOTAL NATIONAL	Group 1100 Diseases of the digestive system  520-579	Men	320.174
TOTAL NATIONAL	Group 1100 Diseases of the digestive system  520-579	Women	255.981
TOTAL NATIONAL	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	9.794
TOTAL NATIONAL	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	4.535
TOTAL NATIONAL	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	5.259
TOTAL NATIONAL	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	8.146
TOTAL NATIONAL	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	4.497
TOTAL NATIONAL	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	3.649
TOTAL NATIONAL	Group 1103 Diseases of the esophagus 530	Both sexes	11.041
TOTAL NATIONAL	Group 1103 Diseases of the esophagus 530	Men	6.598
TOTAL NATIONAL	Group 1103 Diseases of the esophagus 530	Women	4.443
TOTAL NATIONAL	Group 1104 Peptic ulcer 531-534	Both sexes	10.967
TOTAL NATIONAL	Group 1104 Peptic ulcer 531-534	Men	7.630
TOTAL NATIONAL	Group 1104 Peptic ulcer 531-534	Women	3.337
TOTAL NATIONAL	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	14.177
TOTAL NATIONAL	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	6.926
TOTAL NATIONAL	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	7.251
TOTAL NATIONAL	Group 1106 Appendicitis  540-543	Both sexes	48.585
TOTAL NATIONAL	Group 1106 Appendicitis  540-543	Men	27.594
TOTAL NATIONAL	Group 1106 Appendicitis  540-543	Women	20.991
TOTAL NATIONAL	Group 1107 Inguinal hernia  550	Both sexes	59.881
TOTAL NATIONAL	Group 1107 Inguinal hernia  550	Men	53.098
TOTAL NATIONAL	Group 1107 Inguinal hernia  550	Women	6.784
TOTAL NATIONAL	Group 1108 Other abdominal hernia  551-553	Both sexes	47.490
TOTAL NATIONAL	Group 1108 Other abdominal hernia  551-553	Men	22.499
TOTAL NATIONAL	Group 1108 Other abdominal hernia  551-553	Women	24.992
TOTAL NATIONAL	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	11.251
TOTAL NATIONAL	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	5.709
TOTAL NATIONAL	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	5.543
TOTAL NATIONAL	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	31.749
TOTAL NATIONAL	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	14.934
TOTAL NATIONAL	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	16.815
TOTAL NATIONAL	Group 1111 Intestinal obstruction without hernia 560	Both sexes	27.247
TOTAL NATIONAL	Group 1111 Intestinal obstruction without hernia 560	Men	13.806
TOTAL NATIONAL	Group 1111 Intestinal obstruction without hernia 560	Women	13.441
TOTAL NATIONAL	Group 1112 Intestinal diverticulosis 562	Both sexes	23.978
TOTAL NATIONAL	Group 1112 Intestinal diverticulosis 562	Men	11.898
TOTAL NATIONAL	Group 1112 Intestinal diverticulosis 562	Women	12.079
TOTAL NATIONAL	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	33.783
TOTAL NATIONAL	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	21.596
TOTAL NATIONAL	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	12.187
TOTAL NATIONAL	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	19.160
TOTAL NATIONAL	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	8.722
TOTAL NATIONAL	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	10.438
TOTAL NATIONAL	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	10.017
TOTAL NATIONAL	Group 1115 Alcoholic hepatitis 5710-5713	Men	8.503
TOTAL NATIONAL	Group 1115 Alcoholic hepatitis 5710-5713	Women	1.514
TOTAL NATIONAL	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	20.224
TOTAL NATIONAL	Group 1116 Other diseases of the liver 570,5714-573	Men	12.168
TOTAL NATIONAL	Group 1116 Other diseases of the liver 570,5714-573	Women	8.055
TOTAL NATIONAL	Group 1117 Cholelithiasis  574	Both sexes	105.339
TOTAL NATIONAL	Group 1117 Cholelithiasis  574	Men	44.013
TOTAL NATIONAL	Group 1117 Cholelithiasis  574	Women	61.326
TOTAL NATIONAL	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	28.016
TOTAL NATIONAL	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	14.994
TOTAL NATIONAL	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	13.021
TOTAL NATIONAL	Group 1119 Pancreatic diseases 577	Both sexes	31.711
TOTAL NATIONAL	Group 1119 Pancreatic diseases 577	Men	17.587
TOTAL NATIONAL	Group 1119 Pancreatic diseases 577	Women	14.125
TOTAL NATIONAL	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	23.599
TOTAL NATIONAL	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	12.867
TOTAL NATIONAL	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	10.732
TOTAL NATIONAL	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	48.303
TOTAL NATIONAL	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	26.145
TOTAL NATIONAL	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	22.158
TOTAL NATIONAL	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	30.158
TOTAL NATIONAL	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	17.760
TOTAL NATIONAL	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	12.398
TOTAL NATIONAL	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	2.234
TOTAL NATIONAL	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	1.161
TOTAL NATIONAL	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	1.073
TOTAL NATIONAL	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	15.911
TOTAL NATIONAL	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	7.224
TOTAL NATIONAL	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	8.688
TOTAL NATIONAL	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	352.112
TOTAL NATIONAL	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	167.441
TOTAL NATIONAL	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	184.670
TOTAL NATIONAL	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
TOTAL NATIONAL	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
TOTAL NATIONAL	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
TOTAL NATIONAL	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
TOTAL NATIONAL	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
TOTAL NATIONAL	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
TOTAL NATIONAL	Group 1303 Internal derangement of knee 717	Both sexes	48.791
TOTAL NATIONAL	Group 1303 Internal derangement of knee 717	Men	32.911
TOTAL NATIONAL	Group 1303 Internal derangement of knee 717	Women	15.880
TOTAL NATIONAL	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	129.913
TOTAL NATIONAL	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	54.955
TOTAL NATIONAL	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	74.959
TOTAL NATIONAL	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	6.210
TOTAL NATIONAL	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	2.205
TOTAL NATIONAL	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	4.005
TOTAL NATIONAL	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	17.730
TOTAL NATIONAL	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	8.502
TOTAL NATIONAL	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	9.228
TOTAL NATIONAL	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	32.883
TOTAL NATIONAL	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	17.520
TOTAL NATIONAL	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	15.363
TOTAL NATIONAL	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	8.855
TOTAL NATIONAL	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	3.932
TOTAL NATIONAL	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	4.922
TOTAL NATIONAL	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	52.302
TOTAL NATIONAL	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	26.830
TOTAL NATIONAL	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	25.473
TOTAL NATIONAL	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	55.428
TOTAL NATIONAL	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	20.586
TOTAL NATIONAL	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	34.841
TOTAL NATIONAL	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	311.049
TOTAL NATIONAL	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	142.809
TOTAL NATIONAL	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	168.239
TOTAL NATIONAL	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	31.944
TOTAL NATIONAL	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	11.393
TOTAL NATIONAL	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	20.551
TOTAL NATIONAL	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	27.306
TOTAL NATIONAL	Group 1402 Renal failure  5836-5837, 584-586	Men	15.696
TOTAL NATIONAL	Group 1402 Renal failure  5836-5837, 584-586	Women	11.610
TOTAL NATIONAL	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	40.254
TOTAL NATIONAL	Group 1403 Urolithiasis  592, 594, 7880	Men	23.951
TOTAL NATIONAL	Group 1403 Urolithiasis  592, 594, 7880	Women	16.303
TOTAL NATIONAL	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	82.896
TOTAL NATIONAL	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	40.380
TOTAL NATIONAL	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	42.517
TOTAL NATIONAL	Group 1405 Prostatic hyperplasia  600	Both sexes	26.555
TOTAL NATIONAL	Group 1405 Prostatic hyperplasia  600	Men	26.555
TOTAL NATIONAL	Group 1405 Prostatic hyperplasia  600	Women	..
TOTAL NATIONAL	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	22.323
TOTAL NATIONAL	Group 1406 Other diseases of the male genital organs    601-608	Men	22.323
TOTAL NATIONAL	Group 1406 Other diseases of the male genital organs    601-608	Women	..
TOTAL NATIONAL	Group 1407 Disorders of breast  610-612	Both sexes	20.396
TOTAL NATIONAL	Group 1407 Disorders of breast  610-612	Men	1.809
TOTAL NATIONAL	Group 1407 Disorders of breast  610-612	Women	18.587
TOTAL NATIONAL	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	8.251
TOTAL NATIONAL	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
TOTAL NATIONAL	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	8.251
TOTAL NATIONAL	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	4.016
TOTAL NATIONAL	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
TOTAL NATIONAL	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	4.016
TOTAL NATIONAL	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	47.107
TOTAL NATIONAL	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	702
TOTAL NATIONAL	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	46.405
TOTAL NATIONAL	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	492.723
TOTAL NATIONAL	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
TOTAL NATIONAL	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	492.723
TOTAL NATIONAL	Group 1501 Legally induced abortion  635	Both sexes	2.098
TOTAL NATIONAL	Group 1501 Legally induced abortion  635	Men	..
TOTAL NATIONAL	Group 1501 Legally induced abortion  635	Women	2.098
TOTAL NATIONAL	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	27.798
TOTAL NATIONAL	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
TOTAL NATIONAL	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	27.798
TOTAL NATIONAL	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	292.630
TOTAL NATIONAL	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
TOTAL NATIONAL	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	292.630
TOTAL NATIONAL	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	83.868
TOTAL NATIONAL	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
TOTAL NATIONAL	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	83.868
TOTAL NATIONAL	Group 1505 Single spontaneous delivery  650	Both sexes	31.864
TOTAL NATIONAL	Group 1505 Single spontaneous delivery  650	Men	..
TOTAL NATIONAL	Group 1505 Single spontaneous delivery  650	Women	31.864
TOTAL NATIONAL	Group 1506 Other deliveries  6695-6697	Both sexes	15.948
TOTAL NATIONAL	Group 1506 Other deliveries  6695-6697	Men	..
TOTAL NATIONAL	Group 1506 Other deliveries  6695-6697	Women	15.948
TOTAL NATIONAL	Group 1507 Complications related to the puerperium  670-676	Both sexes	3.955
TOTAL NATIONAL	Group 1507 Complications related to the puerperium  670-676	Men	..
TOTAL NATIONAL	Group 1507 Complications related to the puerperium  670-676	Women	3.955
TOTAL NATIONAL	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	34.561
TOTAL NATIONAL	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
TOTAL NATIONAL	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	34.561
TOTAL NATIONAL	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	64.181
TOTAL NATIONAL	Group 1600 Some disorders originating in the perinatal period  760-779	Men	35.382
TOTAL NATIONAL	Group 1600 Some disorders originating in the perinatal period  760-779	Women	28.799
TOTAL NATIONAL	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	17.752
TOTAL NATIONAL	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	9.410
TOTAL NATIONAL	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	8.343
TOTAL NATIONAL	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	46.429
TOTAL NATIONAL	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	25.972
TOTAL NATIONAL	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	20.457
TOTAL NATIONAL	Grupo 1700 Congenital abnormalities  740-759	Both sexes	38.190
TOTAL NATIONAL	Grupo 1700 Congenital abnormalities  740-759	Men	21.328
TOTAL NATIONAL	Grupo 1700 Congenital abnormalities  740-759	Women	16.863
TOTAL NATIONAL	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	224.060
TOTAL NATIONAL	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	119.692
TOTAL NATIONAL	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	104.368
TOTAL NATIONAL	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	26.454
TOTAL NATIONAL	Group 1801 Pain in throat and chest 7841, 7865	Men	15.037
TOTAL NATIONAL	Group 1801 Pain in throat and chest 7841, 7865	Women	11.417
TOTAL NATIONAL	Group 1802 Abdominal pain   7890	Both sexes	24.628
TOTAL NATIONAL	Group 1802 Abdominal pain   7890	Men	9.684
TOTAL NATIONAL	Group 1802 Abdominal pain   7890	Women	14.944
TOTAL NATIONAL	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	27.392
TOTAL NATIONAL	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	13.766
TOTAL NATIONAL	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	13.626
TOTAL NATIONAL	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	145.586
TOTAL NATIONAL	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	81.205
TOTAL NATIONAL	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	64.381
TOTAL NATIONAL	Group 1900 Injuries and poisoning  800-999	Both sexes	418.002
TOTAL NATIONAL	Group 1900 Injuries and poisoning  800-999	Men	212.051
TOTAL NATIONAL	Group 1900 Injuries and poisoning  800-999	Women	205.951
TOTAL NATIONAL	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	23.073
TOTAL NATIONAL	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	13.225
TOTAL NATIONAL	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	9.848
TOTAL NATIONAL	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	11.222
TOTAL NATIONAL	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	7.849
TOTAL NATIONAL	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3.372
TOTAL NATIONAL	Group 1903 Radius and ulna fracture 813	Both sexes	25.409
TOTAL NATIONAL	Group 1903 Radius and ulna fracture 813	Men	11.772
TOTAL NATIONAL	Group 1903 Radius and ulna fracture 813	Women	13.637
TOTAL NATIONAL	Group 1904 Femur fracture  820-821	Both sexes	68.328
TOTAL NATIONAL	Group 1904 Femur fracture  820-821	Men	19.059
TOTAL NATIONAL	Group 1904 Femur fracture  820-821	Women	49.270
TOTAL NATIONAL	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	30.220
TOTAL NATIONAL	Group 1905 Leg fracture, including the ankle 823-824	Men	15.269
TOTAL NATIONAL	Group 1905 Leg fracture, including the ankle 823-824	Women	14.950
TOTAL NATIONAL	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	120.926
TOTAL NATIONAL	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	71.576
TOTAL NATIONAL	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	49.351
TOTAL NATIONAL	Group 1907 Burns  940-949	Both sexes	3.350
TOTAL NATIONAL	Group 1907 Burns  940-949	Men	2.041
TOTAL NATIONAL	Group 1907 Burns  940-949	Women	1.309
TOTAL NATIONAL	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	11.852
TOTAL NATIONAL	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	5.426
TOTAL NATIONAL	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	6.426
TOTAL NATIONAL	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	110.400
TOTAL NATIONAL	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	58.752
TOTAL NATIONAL	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	51.648
TOTAL NATIONAL	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1.207
TOTAL NATIONAL	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	748
TOTAL NATIONAL	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	459
TOTAL NATIONAL	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	12.015
TOTAL NATIONAL	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	6.334
TOTAL NATIONAL	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	5.681
TOTAL NATIONAL	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	97.679
TOTAL NATIONAL	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	47.814
TOTAL NATIONAL	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	49.865
TOTAL NATIONAL	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	4.850
TOTAL NATIONAL	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	2.816
TOTAL NATIONAL	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2.034
TOTAL NATIONAL	Group 2102 Contraceptive management  V25	Both sexes	1.677
TOTAL NATIONAL	Group 2102 Contraceptive management  V25	Men	114
TOTAL NATIONAL	Group 2102 Contraceptive management  V25	Women	1.563
TOTAL NATIONAL	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
TOTAL NATIONAL	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
TOTAL NATIONAL	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
TOTAL NATIONAL	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	31.802
TOTAL NATIONAL	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	19.260
TOTAL NATIONAL	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	12.542
TOTAL NATIONAL	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	59.350
TOTAL NATIONAL	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	25.624
TOTAL NATIONAL	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	33.726
ANDALUC═A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	694.141
ANDALUC═A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	310.756
ANDALUC═A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	383.385
ANDALUC═A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	16.129
ANDALUC═A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	9.147
ANDALUC═A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	6.982
ANDALUC═A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.732
ANDALUC═A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	945
ANDALUC═A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	787
ANDALUC═A	Group 0102 Imprecise intestinal infections 009	Both sexes	1.655
ANDALUC═A	Group 0102 Imprecise intestinal infections 009	Men	784
ANDALUC═A	Group 0102 Imprecise intestinal infections 009	Women	870
ANDALUC═A	Group 0103 Tuberculosis 010-018, 137	Both sexes	550
ANDALUC═A	Group 0103 Tuberculosis 010-018, 137	Men	367
ANDALUC═A	Group 0103 Tuberculosis 010-018, 137	Women	183
ANDALUC═A	Group 0104 Septicaemia  038	Both sexes	6.690
ANDALUC═A	Group 0104 Septicaemia  038	Men	3.621
ANDALUC═A	Group 0104 Septicaemia  038	Women	3.068
ANDALUC═A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	669
ANDALUC═A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	533
ANDALUC═A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	137
ANDALUC═A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	4.834
ANDALUC═A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.897
ANDALUC═A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	1.937
ANDALUC═A	Group 0200 Neoplasms  140-239	Both sexes	64.625
ANDALUC═A	Group 0200 Neoplasms  140-239	Men	33.237
ANDALUC═A	Group 0200 Neoplasms  140-239	Women	31.388
ANDALUC═A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	6.599
ANDALUC═A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	4.046
ANDALUC═A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.553
ANDALUC═A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	4.575
ANDALUC═A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.788
ANDALUC═A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	787
ANDALUC═A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1.643
ANDALUC═A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	1.005
ANDALUC═A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	638
ANDALUC═A	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	5.514
ANDALUC═A	Group 0204 Malignant neoplasm of breast  174-175	Men	55
ANDALUC═A	Group 0204 Malignant neoplasm of breast  174-175	Women	5.460
ANDALUC═A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.421
ANDALUC═A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
ANDALUC═A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.421
ANDALUC═A	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	774
ANDALUC═A	Group 0206 Malignant neoplasm of ovary  1830	Men	..
ANDALUC═A	Group 0206 Malignant neoplasm of ovary  1830	Women	774
ANDALUC═A	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.856
ANDALUC═A	Group 0207 Malignant neoplasm of prostate  185	Men	1.856
ANDALUC═A	Group 0207 Malignant neoplasm of prostate  185	Women	..
ANDALUC═A	Group 0208 Malignant neoplasm of bladder  188	Both sexes	5.970
ANDALUC═A	Group 0208 Malignant neoplasm of bladder  188	Men	5.024
ANDALUC═A	Group 0208 Malignant neoplasm of bladder  188	Women	947
ANDALUC═A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	22.145
ANDALUC═A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	13.073
ANDALUC═A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	9.072
ANDALUC═A	Group 0210 Carcinoma in situ  230-234	Both sexes	813
ANDALUC═A	Group 0210 Carcinoma in situ  230-234	Men	268
ANDALUC═A	Group 0210 Carcinoma in situ  230-234	Women	544
ANDALUC═A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	533
ANDALUC═A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	286
ANDALUC═A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	247
ANDALUC═A	Grupo 0212 Leiomyoma of uterus  218	Both sexes	3.635
ANDALUC═A	Grupo 0212 Leiomyoma of uterus  218	Men	..
ANDALUC═A	Grupo 0212 Leiomyoma of uterus  218	Women	3.635
ANDALUC═A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	9.147
ANDALUC═A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.836
ANDALUC═A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	5.312
ANDALUC═A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	6.306
ANDALUC═A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	3.092
ANDALUC═A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	3.214
ANDALUC═A	Group 0301 Anaemias 280-285	Both sexes	3.427
ANDALUC═A	Group 0301 Anaemias 280-285	Men	1.673
ANDALUC═A	Group 0301 Anaemias 280-285	Women	1.754
ANDALUC═A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.879
ANDALUC═A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.419
ANDALUC═A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.461
ANDALUC═A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	12.245
ANDALUC═A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.805
ANDALUC═A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	7.440
ANDALUC═A	Group 0401 Diabetes mellitus  249-250	Both sexes	3.711
ANDALUC═A	Group 0401 Diabetes mellitus  249-250	Men	2.175
ANDALUC═A	Group 0401 Diabetes mellitus  249-250	Women	1.536
ANDALUC═A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	8.535
ANDALUC═A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.631
ANDALUC═A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	5.904
ANDALUC═A	Group 0500 Mental disorders  290-319	Both sexes	13.178
ANDALUC═A	Group 0500 Mental disorders  290-319	Men	7.222
ANDALUC═A	Group 0500 Mental disorders  290-319	Women	5.956
ANDALUC═A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	271
ANDALUC═A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	120
ANDALUC═A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	150
ANDALUC═A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	552
ANDALUC═A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	431
ANDALUC═A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	121
ANDALUC═A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	761
ANDALUC═A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	592
ANDALUC═A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	169
ANDALUC═A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	4.158
ANDALUC═A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	2.763
ANDALUC═A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	1.395
ANDALUC═A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	3.075
ANDALUC═A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	1.316
ANDALUC═A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.759
ANDALUC═A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	4.361
ANDALUC═A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	1.999
ANDALUC═A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	2.362
ANDALUC═A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	13.630
ANDALUC═A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	6.530
ANDALUC═A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	7.100
ANDALUC═A	Group 0601 Alzheimer's disease  3310	Both sexes	301
ANDALUC═A	Group 0601 Alzheimer's disease  3310	Men	104
ANDALUC═A	Group 0601 Alzheimer's disease  3310	Women	197
ANDALUC═A	Group 0602 Multiple sclerosis 340	Both sexes	318
ANDALUC═A	Group 0602 Multiple sclerosis 340	Men	97
ANDALUC═A	Group 0602 Multiple sclerosis 340	Women	221
ANDALUC═A	Group 0603 Epilepsy  345	Both sexes	2.456
ANDALUC═A	Group 0603 Epilepsy  345	Men	1.285
ANDALUC═A	Group 0603 Epilepsy  345	Women	1.171
ANDALUC═A	Group 0604 Transient cerebral ischemia 435	Both sexes	2.458
ANDALUC═A	Group 0604 Transient cerebral ischemia 435	Men	1.245
ANDALUC═A	Group 0604 Transient cerebral ischemia 435	Women	1.213
ANDALUC═A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	8.098
ANDALUC═A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	3.800
ANDALUC═A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	4.298
ANDALUC═A	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	5.517
ANDALUC═A	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.981
ANDALUC═A	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.536
ANDALUC═A	Grupo 0701 Cataract  366	Both sexes	940
ANDALUC═A	Grupo 0701 Cataract  366	Men	497
ANDALUC═A	Grupo 0701 Cataract  366	Women	443
ANDALUC═A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	4.577
ANDALUC═A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	2.484
ANDALUC═A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	2.093
ANDALUC═A	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	3.329
ANDALUC═A	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.636
ANDALUC═A	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.694
ANDALUC═A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	92.429
ANDALUC═A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	52.714
ANDALUC═A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	39.716
ANDALUC═A	Group 0901 Hypertensive disease  401-405	Both sexes	6.137
ANDALUC═A	Group 0901 Hypertensive disease  401-405	Men	2.537
ANDALUC═A	Group 0901 Hypertensive disease  401-405	Women	3.600
ANDALUC═A	Group 0902 Angina pectoris  4111, 413	Both sexes	5.723
ANDALUC═A	Group 0902 Angina pectoris  4111, 413	Men	3.476
ANDALUC═A	Group 0902 Angina pectoris  4111, 413	Women	2.247
ANDALUC═A	Group 0903 Acute myocardial infarction  410	Both sexes	9.951
ANDALUC═A	Group 0903 Acute myocardial infarction  410	Men	6.850
ANDALUC═A	Group 0903 Acute myocardial infarction  410	Women	3.101
ANDALUC═A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	7.682
ANDALUC═A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	5.661
ANDALUC═A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	2.021
ANDALUC═A	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.495
ANDALUC═A	Group 0905 Diseases of the lungs circulation 415-417	Men	1.181
ANDALUC═A	Group 0905 Diseases of the lungs circulation 415-417	Women	1.314
ANDALUC═A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	10.977
ANDALUC═A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	6.074
ANDALUC═A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	4.904
ANDALUC═A	Grupo 0907 Heart failure  428	Both sexes	15.172
ANDALUC═A	Grupo 0907 Heart failure  428	Men	7.237
ANDALUC═A	Grupo 0907 Heart failure  428	Women	7.935
ANDALUC═A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	15.626
ANDALUC═A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	8.705
ANDALUC═A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	6.921
ANDALUC═A	Grupo 0909 Atherosclerosis  440	Both sexes	3.069
ANDALUC═A	Grupo 0909 Atherosclerosis  440	Men	2.295
ANDALUC═A	Grupo 0909 Atherosclerosis  440	Women	774
ANDALUC═A	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.809
ANDALUC═A	Group 0910 Varicose veins of lower extremities 454	Men	692
ANDALUC═A	Group 0910 Varicose veins of lower extremities 454	Women	1.117
ANDALUC═A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	13.789
ANDALUC═A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	8.006
ANDALUC═A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	5.783
ANDALUC═A	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	63.274
ANDALUC═A	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	36.728
ANDALUC═A	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	26.546
ANDALUC═A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	4.118
ANDALUC═A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	2.213
ANDALUC═A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.905
ANDALUC═A	Group 1002 Pneumonia 480-486	Both sexes	13.435
ANDALUC═A	Group 1002 Pneumonia 480-486	Men	7.910
ANDALUC═A	Group 1002 Pneumonia 480-486	Women	5.525
ANDALUC═A	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	5.878
ANDALUC═A	Group 1003 Acute bronchitis and bronchiolitis  466	Men	3.087
ANDALUC═A	Group 1003 Acute bronchitis and bronchiolitis  466	Women	2.791
ANDALUC═A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	2.926
ANDALUC═A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.482
ANDALUC═A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.444
ANDALUC═A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	6.228
ANDALUC═A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	3.796
ANDALUC═A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.432
ANDALUC═A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	7.390
ANDALUC═A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	5.874
ANDALUC═A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.516
ANDALUC═A	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.890
ANDALUC═A	Group 1007 Asthma 4930-4931,4938-4939	Men	609
ANDALUC═A	Group 1007 Asthma 4930-4931,4938-4939	Women	1.282
ANDALUC═A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	21.408
ANDALUC═A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	11.757
ANDALUC═A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	9.651
ANDALUC═A	Group 1100 Diseases of the digestive system  520-579	Both sexes	87.738
ANDALUC═A	Group 1100 Diseases of the digestive system  520-579	Men	47.433
ANDALUC═A	Group 1100 Diseases of the digestive system  520-579	Women	40.305
ANDALUC═A	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	1.455
ANDALUC═A	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	684
ANDALUC═A	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	771
ANDALUC═A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1.382
ANDALUC═A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	729
ANDALUC═A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	653
ANDALUC═A	Group 1103 Diseases of the esophagus 530	Both sexes	1.931
ANDALUC═A	Group 1103 Diseases of the esophagus 530	Men	1.115
ANDALUC═A	Group 1103 Diseases of the esophagus 530	Women	816
ANDALUC═A	Group 1104 Peptic ulcer 531-534	Both sexes	1.779
ANDALUC═A	Group 1104 Peptic ulcer 531-534	Men	1.258
ANDALUC═A	Group 1104 Peptic ulcer 531-534	Women	520
ANDALUC═A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	2.289
ANDALUC═A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	1.119
ANDALUC═A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	1.170
ANDALUC═A	Group 1106 Appendicitis  540-543	Both sexes	7.836
ANDALUC═A	Group 1106 Appendicitis  540-543	Men	4.435
ANDALUC═A	Group 1106 Appendicitis  540-543	Women	3.401
ANDALUC═A	Group 1107 Inguinal hernia  550	Both sexes	6.951
ANDALUC═A	Group 1107 Inguinal hernia  550	Men	6.079
ANDALUC═A	Group 1107 Inguinal hernia  550	Women	871
ANDALUC═A	Group 1108 Other abdominal hernia  551-553	Both sexes	7.141
ANDALUC═A	Group 1108 Other abdominal hernia  551-553	Men	3.147
ANDALUC═A	Group 1108 Other abdominal hernia  551-553	Women	3.995
ANDALUC═A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	2.201
ANDALUC═A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	1.087
ANDALUC═A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	1.114
ANDALUC═A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	4.363
ANDALUC═A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	2.038
ANDALUC═A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.325
ANDALUC═A	Group 1111 Intestinal obstruction without hernia 560	Both sexes	3.576
ANDALUC═A	Group 1111 Intestinal obstruction without hernia 560	Men	1.791
ANDALUC═A	Group 1111 Intestinal obstruction without hernia 560	Women	1.785
ANDALUC═A	Group 1112 Intestinal diverticulosis 562	Both sexes	3.213
ANDALUC═A	Group 1112 Intestinal diverticulosis 562	Men	1.690
ANDALUC═A	Group 1112 Intestinal diverticulosis 562	Women	1.523
ANDALUC═A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	5.412
ANDALUC═A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	3.416
ANDALUC═A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.996
ANDALUC═A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.525
ANDALUC═A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.228
ANDALUC═A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.296
ANDALUC═A	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.659
ANDALUC═A	Group 1115 Alcoholic hepatitis 5710-5713	Men	1.415
ANDALUC═A	Group 1115 Alcoholic hepatitis 5710-5713	Women	244
ANDALUC═A	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	2.945
ANDALUC═A	Group 1116 Other diseases of the liver 570,5714-573	Men	1.843
ANDALUC═A	Group 1116 Other diseases of the liver 570,5714-573	Women	1.101
ANDALUC═A	Group 1117 Cholelithiasis  574	Both sexes	17.451
ANDALUC═A	Group 1117 Cholelithiasis  574	Men	7.073
ANDALUC═A	Group 1117 Cholelithiasis  574	Women	10.378
ANDALUC═A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	4.013
ANDALUC═A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.059
ANDALUC═A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.954
ANDALUC═A	Group 1119 Pancreatic diseases 577	Both sexes	6.054
ANDALUC═A	Group 1119 Pancreatic diseases 577	Men	3.241
ANDALUC═A	Group 1119 Pancreatic diseases 577	Women	2.813
ANDALUC═A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.563
ANDALUC═A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.985
ANDALUC═A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.578
ANDALUC═A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	6.411
ANDALUC═A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	3.481
ANDALUC═A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	2.930
ANDALUC═A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	3.782
ANDALUC═A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	2.290
ANDALUC═A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.492
ANDALUC═A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	328
ANDALUC═A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	181
ANDALUC═A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	147
ANDALUC═A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.301
ANDALUC═A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.011
ANDALUC═A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.290
ANDALUC═A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	45.191
ANDALUC═A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	20.612
ANDALUC═A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	24.579
ANDALUC═A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
ANDALUC═A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
ANDALUC═A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
ANDALUC═A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
ANDALUC═A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
ANDALUC═A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
ANDALUC═A	Group 1303 Internal derangement of knee 717	Both sexes	4.682
ANDALUC═A	Group 1303 Internal derangement of knee 717	Men	3.192
ANDALUC═A	Group 1303 Internal derangement of knee 717	Women	1.490
ANDALUC═A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	19.118
ANDALUC═A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	7.682
ANDALUC═A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	11.436
ANDALUC═A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	939
ANDALUC═A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	326
ANDALUC═A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	613
ANDALUC═A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.354
ANDALUC═A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.137
ANDALUC═A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.217
ANDALUC═A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	4.358
ANDALUC═A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	2.158
ANDALUC═A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	2.200
ANDALUC═A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1.197
ANDALUC═A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	472
ANDALUC═A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	725
ANDALUC═A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	5.820
ANDALUC═A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	2.910
ANDALUC═A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	2.910
ANDALUC═A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	6.724
ANDALUC═A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	2.736
ANDALUC═A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	3.988
ANDALUC═A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	42.145
ANDALUC═A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	18.108
ANDALUC═A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	24.038
ANDALUC═A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	4.785
ANDALUC═A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.940
ANDALUC═A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	2.845
ANDALUC═A	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	4.350
ANDALUC═A	Group 1402 Renal failure  5836-5837, 584-586	Men	2.468
ANDALUC═A	Group 1402 Renal failure  5836-5837, 584-586	Women	1.882
ANDALUC═A	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	5.848
ANDALUC═A	Group 1403 Urolithiasis  592, 594, 7880	Men	3.378
ANDALUC═A	Group 1403 Urolithiasis  592, 594, 7880	Women	2.470
ANDALUC═A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	8.524
ANDALUC═A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	4.153
ANDALUC═A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	4.371
ANDALUC═A	Group 1405 Prostatic hyperplasia  600	Both sexes	2.904
ANDALUC═A	Group 1405 Prostatic hyperplasia  600	Men	2.904
ANDALUC═A	Group 1405 Prostatic hyperplasia  600	Women	..
ANDALUC═A	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	2.922
ANDALUC═A	Group 1406 Other diseases of the male genital organs    601-608	Men	2.922
ANDALUC═A	Group 1406 Other diseases of the male genital organs    601-608	Women	..
ANDALUC═A	Group 1407 Disorders of breast  610-612	Both sexes	3.222
ANDALUC═A	Group 1407 Disorders of breast  610-612	Men	283
ANDALUC═A	Group 1407 Disorders of breast  610-612	Women	2.939
ANDALUC═A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1.540
ANDALUC═A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
ANDALUC═A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1.540
ANDALUC═A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	751
ANDALUC═A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
ANDALUC═A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	751
ANDALUC═A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	7.299
ANDALUC═A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	60
ANDALUC═A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	7.240
ANDALUC═A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	97.891
ANDALUC═A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
ANDALUC═A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	97.891
ANDALUC═A	Group 1501 Legally induced abortion  635	Both sexes	162
ANDALUC═A	Group 1501 Legally induced abortion  635	Men	..
ANDALUC═A	Group 1501 Legally induced abortion  635	Women	162
ANDALUC═A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	6.269
ANDALUC═A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
ANDALUC═A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	6.269
ANDALUC═A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	61.217
ANDALUC═A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
ANDALUC═A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	61.217
ANDALUC═A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	13.323
ANDALUC═A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
ANDALUC═A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	13.323
ANDALUC═A	Group 1505 Single spontaneous delivery  650	Both sexes	6.164
ANDALUC═A	Group 1505 Single spontaneous delivery  650	Men	..
ANDALUC═A	Group 1505 Single spontaneous delivery  650	Women	6.164
ANDALUC═A	Group 1506 Other deliveries  6695-6697	Both sexes	4.002
ANDALUC═A	Group 1506 Other deliveries  6695-6697	Men	..
ANDALUC═A	Group 1506 Other deliveries  6695-6697	Women	4.002
ANDALUC═A	Group 1507 Complications related to the puerperium  670-676	Both sexes	671
ANDALUC═A	Group 1507 Complications related to the puerperium  670-676	Men	..
ANDALUC═A	Group 1507 Complications related to the puerperium  670-676	Women	671
ANDALUC═A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	6.084
ANDALUC═A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
ANDALUC═A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	6.084
ANDALUC═A	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	9.805
ANDALUC═A	Group 1600 Some disorders originating in the perinatal period  760-779	Men	5.295
ANDALUC═A	Group 1600 Some disorders originating in the perinatal period  760-779	Women	4.510
ANDALUC═A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	3.465
ANDALUC═A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.783
ANDALUC═A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.683
ANDALUC═A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	6.340
ANDALUC═A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	3.512
ANDALUC═A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	2.827
ANDALUC═A	Grupo 1700 Congenital abnormalities  740-759	Both sexes	6.518
ANDALUC═A	Grupo 1700 Congenital abnormalities  740-759	Men	3.562
ANDALUC═A	Grupo 1700 Congenital abnormalities  740-759	Women	2.955
ANDALUC═A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	35.586
ANDALUC═A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	18.290
ANDALUC═A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	17.296
ANDALUC═A	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	5.059
ANDALUC═A	Group 1801 Pain in throat and chest 7841, 7865	Men	2.723
ANDALUC═A	Group 1801 Pain in throat and chest 7841, 7865	Women	2.337
ANDALUC═A	Group 1802 Abdominal pain   7890	Both sexes	4.650
ANDALUC═A	Group 1802 Abdominal pain   7890	Men	1.707
ANDALUC═A	Group 1802 Abdominal pain   7890	Women	2.944
ANDALUC═A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	4.634
ANDALUC═A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	2.164
ANDALUC═A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	2.470
ANDALUC═A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	21.242
ANDALUC═A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	11.697
ANDALUC═A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	9.546
ANDALUC═A	Group 1900 Injuries and poisoning  800-999	Both sexes	61.111
ANDALUC═A	Group 1900 Injuries and poisoning  800-999	Men	30.805
ANDALUC═A	Group 1900 Injuries and poisoning  800-999	Women	30.306
ANDALUC═A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	2.722
ANDALUC═A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.662
ANDALUC═A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.060
ANDALUC═A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.788
ANDALUC═A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	1.282
ANDALUC═A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	506
ANDALUC═A	Group 1903 Radius and ulna fracture 813	Both sexes	4.366
ANDALUC═A	Group 1903 Radius and ulna fracture 813	Men	2.129
ANDALUC═A	Group 1903 Radius and ulna fracture 813	Women	2.236
ANDALUC═A	Group 1904 Femur fracture  820-821	Both sexes	10.168
ANDALUC═A	Group 1904 Femur fracture  820-821	Men	2.932
ANDALUC═A	Group 1904 Femur fracture  820-821	Women	7.235
ANDALUC═A	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	5.088
ANDALUC═A	Group 1905 Leg fracture, including the ankle 823-824	Men	2.577
ANDALUC═A	Group 1905 Leg fracture, including the ankle 823-824	Women	2.510
ANDALUC═A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	16.734
ANDALUC═A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	9.591
ANDALUC═A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	7.143
ANDALUC═A	Group 1907 Burns  940-949	Both sexes	568
ANDALUC═A	Group 1907 Burns  940-949	Men	311
ANDALUC═A	Group 1907 Burns  940-949	Women	257
ANDALUC═A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	2.003
ANDALUC═A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	975
ANDALUC═A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	1.028
ANDALUC═A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	16.205
ANDALUC═A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	8.521
ANDALUC═A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	7.684
ANDALUC═A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	226
ANDALUC═A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	134
ANDALUC═A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	92
ANDALUC═A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.244
ANDALUC═A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	690
ANDALUC═A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	553
ANDALUC═A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	11.081
ANDALUC═A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	5.079
ANDALUC═A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	6.002
ANDALUC═A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	684
ANDALUC═A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	382
ANDALUC═A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	302
ANDALUC═A	Group 2102 Contraceptive management  V25	Both sexes	157
ANDALUC═A	Group 2102 Contraceptive management  V25	Men	25
ANDALUC═A	Group 2102 Contraceptive management  V25	Women	132
ANDALUC═A	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
ANDALUC═A	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
ANDALUC═A	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
ANDALUC═A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	3.892
ANDALUC═A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2.488
ANDALUC═A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.404
ANDALUC═A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	6.349
ANDALUC═A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	2.184
ANDALUC═A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	4.165
AlmerÝa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	52.541
AlmerÝa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	23.299
AlmerÝa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	29.242
AlmerÝa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.312
AlmerÝa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	799
AlmerÝa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	513
AlmerÝa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	195
AlmerÝa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	119
AlmerÝa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	76
AlmerÝa	Group 0102 Imprecise intestinal infections 009	Both sexes	197
AlmerÝa	Group 0102 Imprecise intestinal infections 009	Men	98
AlmerÝa	Group 0102 Imprecise intestinal infections 009	Women	99
AlmerÝa	Group 0103 Tuberculosis 010-018, 137	Both sexes	80
AlmerÝa	Group 0103 Tuberculosis 010-018, 137	Men	57
AlmerÝa	Group 0103 Tuberculosis 010-018, 137	Women	23
AlmerÝa	Group 0104 Septicaemia  038	Both sexes	389
AlmerÝa	Group 0104 Septicaemia  038	Men	208
AlmerÝa	Group 0104 Septicaemia  038	Women	181
AlmerÝa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	47
AlmerÝa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	43
AlmerÝa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	4
AlmerÝa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	404
AlmerÝa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	274
AlmerÝa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	130
AlmerÝa	Group 0200 Neoplasms  140-239	Both sexes	4.285
AlmerÝa	Group 0200 Neoplasms  140-239	Men	2.268
AlmerÝa	Group 0200 Neoplasms  140-239	Women	2.017
AlmerÝa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	408
AlmerÝa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	258
AlmerÝa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	150
AlmerÝa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	402
AlmerÝa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	343
AlmerÝa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	59
AlmerÝa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	27
AlmerÝa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	19
AlmerÝa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	8
AlmerÝa	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	345
AlmerÝa	Group 0204 Malignant neoplasm of breast  174-175	Men	3
AlmerÝa	Group 0204 Malignant neoplasm of breast  174-175	Women	342
AlmerÝa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	99
AlmerÝa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
AlmerÝa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	99
AlmerÝa	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	45
AlmerÝa	Group 0206 Malignant neoplasm of ovary  1830	Men	..
AlmerÝa	Group 0206 Malignant neoplasm of ovary  1830	Women	45
AlmerÝa	Group 0207 Malignant neoplasm of prostate  185	Both sexes	110
AlmerÝa	Group 0207 Malignant neoplasm of prostate  185	Men	110
AlmerÝa	Group 0207 Malignant neoplasm of prostate  185	Women	..
AlmerÝa	Group 0208 Malignant neoplasm of bladder  188	Both sexes	471
AlmerÝa	Group 0208 Malignant neoplasm of bladder  188	Men	421
AlmerÝa	Group 0208 Malignant neoplasm of bladder  188	Women	50
AlmerÝa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.393
AlmerÝa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	819
AlmerÝa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	574
AlmerÝa	Group 0210 Carcinoma in situ  230-234	Both sexes	32
AlmerÝa	Group 0210 Carcinoma in situ  230-234	Men	10
AlmerÝa	Group 0210 Carcinoma in situ  230-234	Women	22
AlmerÝa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	28
AlmerÝa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	11
AlmerÝa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	17
AlmerÝa	Grupo 0212 Leiomyoma of uterus  218	Both sexes	324
AlmerÝa	Grupo 0212 Leiomyoma of uterus  218	Men	..
AlmerÝa	Grupo 0212 Leiomyoma of uterus  218	Women	324
AlmerÝa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	601
AlmerÝa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	274
AlmerÝa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	327
AlmerÝa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	452
AlmerÝa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	239
AlmerÝa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	213
AlmerÝa	Group 0301 Anaemias 280-285	Both sexes	266
AlmerÝa	Group 0301 Anaemias 280-285	Men	151
AlmerÝa	Group 0301 Anaemias 280-285	Women	115
AlmerÝa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	186
AlmerÝa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	88
AlmerÝa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	98
AlmerÝa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	832
AlmerÝa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	384
AlmerÝa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	448
AlmerÝa	Group 0401 Diabetes mellitus  249-250	Both sexes	315
AlmerÝa	Group 0401 Diabetes mellitus  249-250	Men	202
AlmerÝa	Group 0401 Diabetes mellitus  249-250	Women	113
AlmerÝa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	517
AlmerÝa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	182
AlmerÝa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	335
AlmerÝa	Group 0500 Mental disorders  290-319	Both sexes	960
AlmerÝa	Group 0500 Mental disorders  290-319	Men	547
AlmerÝa	Group 0500 Mental disorders  290-319	Women	413
AlmerÝa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	14
AlmerÝa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	6
AlmerÝa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	8
AlmerÝa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	24
AlmerÝa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	18
AlmerÝa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	6
AlmerÝa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	60
AlmerÝa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	49
AlmerÝa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	11
AlmerÝa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	343
AlmerÝa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	230
AlmerÝa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	113
AlmerÝa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	173
AlmerÝa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	90
AlmerÝa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	83
AlmerÝa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	346
AlmerÝa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	154
AlmerÝa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	192
AlmerÝa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	818
AlmerÝa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	394
AlmerÝa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	424
AlmerÝa	Group 0601 Alzheimer's disease  3310	Both sexes	35
AlmerÝa	Group 0601 Alzheimer's disease  3310	Men	9
AlmerÝa	Group 0601 Alzheimer's disease  3310	Women	26
AlmerÝa	Group 0602 Multiple sclerosis 340	Both sexes	11
AlmerÝa	Group 0602 Multiple sclerosis 340	Men	4
AlmerÝa	Group 0602 Multiple sclerosis 340	Women	7
AlmerÝa	Group 0603 Epilepsy  345	Both sexes	133
AlmerÝa	Group 0603 Epilepsy  345	Men	65
AlmerÝa	Group 0603 Epilepsy  345	Women	68
AlmerÝa	Group 0604 Transient cerebral ischemia 435	Both sexes	197
AlmerÝa	Group 0604 Transient cerebral ischemia 435	Men	100
AlmerÝa	Group 0604 Transient cerebral ischemia 435	Women	97
AlmerÝa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	442
AlmerÝa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	216
AlmerÝa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	226
AlmerÝa	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	377
AlmerÝa	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	216
AlmerÝa	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	161
AlmerÝa	Grupo 0701 Cataract  366	Both sexes	24
AlmerÝa	Grupo 0701 Cataract  366	Men	10
AlmerÝa	Grupo 0701 Cataract  366	Women	14
AlmerÝa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	353
AlmerÝa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	206
AlmerÝa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	147
AlmerÝa	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	272
AlmerÝa	Group 0800 Diseases of the ear and the mastoid  380-389	Men	135
AlmerÝa	Group 0800 Diseases of the ear and the mastoid  380-389	Women	137
AlmerÝa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.841
AlmerÝa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.395
AlmerÝa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.446
AlmerÝa	Group 0901 Hypertensive disease  401-405	Both sexes	397
AlmerÝa	Group 0901 Hypertensive disease  401-405	Men	144
AlmerÝa	Group 0901 Hypertensive disease  401-405	Women	253
AlmerÝa	Group 0902 Angina pectoris  4111, 413	Both sexes	259
AlmerÝa	Group 0902 Angina pectoris  4111, 413	Men	158
AlmerÝa	Group 0902 Angina pectoris  4111, 413	Women	101
AlmerÝa	Group 0903 Acute myocardial infarction  410	Both sexes	815
AlmerÝa	Group 0903 Acute myocardial infarction  410	Men	599
AlmerÝa	Group 0903 Acute myocardial infarction  410	Women	216
AlmerÝa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	397
AlmerÝa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	303
AlmerÝa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	94
AlmerÝa	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	176
AlmerÝa	Group 0905 Diseases of the lungs circulation 415-417	Men	87
AlmerÝa	Group 0905 Diseases of the lungs circulation 415-417	Women	89
AlmerÝa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	637
AlmerÝa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	375
AlmerÝa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	262
AlmerÝa	Grupo 0907 Heart failure  428	Both sexes	1.146
AlmerÝa	Grupo 0907 Heart failure  428	Men	540
AlmerÝa	Grupo 0907 Heart failure  428	Women	606
AlmerÝa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.175
AlmerÝa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	663
AlmerÝa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	512
AlmerÝa	Grupo 0909 Atherosclerosis  440	Both sexes	226
AlmerÝa	Grupo 0909 Atherosclerosis  440	Men	163
AlmerÝa	Grupo 0909 Atherosclerosis  440	Women	63
AlmerÝa	Group 0910 Varicose veins of lower extremities 454	Both sexes	9
AlmerÝa	Group 0910 Varicose veins of lower extremities 454	Men	4
AlmerÝa	Group 0910 Varicose veins of lower extremities 454	Women	5
AlmerÝa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	604
AlmerÝa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	359
AlmerÝa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	245
AlmerÝa	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.267
AlmerÝa	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.641
AlmerÝa	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.626
AlmerÝa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	358
AlmerÝa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	196
AlmerÝa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	162
AlmerÝa	Group 1002 Pneumonia 480-486	Both sexes	1.523
AlmerÝa	Group 1002 Pneumonia 480-486	Men	907
AlmerÝa	Group 1002 Pneumonia 480-486	Women	616
AlmerÝa	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.017
AlmerÝa	Group 1003 Acute bronchitis and bronchiolitis  466	Men	475
AlmerÝa	Group 1003 Acute bronchitis and bronchiolitis  466	Women	542
AlmerÝa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	229
AlmerÝa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	109
AlmerÝa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	120
AlmerÝa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	434
AlmerÝa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	309
AlmerÝa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	125
AlmerÝa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	897
AlmerÝa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	754
AlmerÝa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	143
AlmerÝa	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	251
AlmerÝa	Group 1007 Asthma 4930-4931,4938-4939	Men	107
AlmerÝa	Group 1007 Asthma 4930-4931,4938-4939	Women	144
AlmerÝa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.558
AlmerÝa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	784
AlmerÝa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	774
AlmerÝa	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.237
AlmerÝa	Group 1100 Diseases of the digestive system  520-579	Men	3.436
AlmerÝa	Group 1100 Diseases of the digestive system  520-579	Women	2.801
AlmerÝa	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	92
AlmerÝa	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	55
AlmerÝa	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	37
AlmerÝa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	140
AlmerÝa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	69
AlmerÝa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	71
AlmerÝa	Group 1103 Diseases of the esophagus 530	Both sexes	137
AlmerÝa	Group 1103 Diseases of the esophagus 530	Men	88
AlmerÝa	Group 1103 Diseases of the esophagus 530	Women	49
AlmerÝa	Group 1104 Peptic ulcer 531-534	Both sexes	139
AlmerÝa	Group 1104 Peptic ulcer 531-534	Men	107
AlmerÝa	Group 1104 Peptic ulcer 531-534	Women	32
AlmerÝa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	143
AlmerÝa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	74
AlmerÝa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	69
AlmerÝa	Group 1106 Appendicitis  540-543	Both sexes	736
AlmerÝa	Group 1106 Appendicitis  540-543	Men	424
AlmerÝa	Group 1106 Appendicitis  540-543	Women	312
AlmerÝa	Group 1107 Inguinal hernia  550	Both sexes	312
AlmerÝa	Group 1107 Inguinal hernia  550	Men	286
AlmerÝa	Group 1107 Inguinal hernia  550	Women	26
AlmerÝa	Group 1108 Other abdominal hernia  551-553	Both sexes	346
AlmerÝa	Group 1108 Other abdominal hernia  551-553	Men	162
AlmerÝa	Group 1108 Other abdominal hernia  551-553	Women	184
AlmerÝa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	155
AlmerÝa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	81
AlmerÝa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	74
AlmerÝa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	327
AlmerÝa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	151
AlmerÝa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	176
AlmerÝa	Group 1111 Intestinal obstruction without hernia 560	Both sexes	317
AlmerÝa	Group 1111 Intestinal obstruction without hernia 560	Men	160
AlmerÝa	Group 1111 Intestinal obstruction without hernia 560	Women	157
AlmerÝa	Group 1112 Intestinal diverticulosis 562	Both sexes	318
AlmerÝa	Group 1112 Intestinal diverticulosis 562	Men	159
AlmerÝa	Group 1112 Intestinal diverticulosis 562	Women	159
AlmerÝa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	285
AlmerÝa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	181
AlmerÝa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	104
AlmerÝa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	141
AlmerÝa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	75
AlmerÝa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	66
AlmerÝa	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	126
AlmerÝa	Group 1115 Alcoholic hepatitis 5710-5713	Men	111
AlmerÝa	Group 1115 Alcoholic hepatitis 5710-5713	Women	15
AlmerÝa	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	227
AlmerÝa	Group 1116 Other diseases of the liver 570,5714-573	Men	139
AlmerÝa	Group 1116 Other diseases of the liver 570,5714-573	Women	88
AlmerÝa	Group 1117 Cholelithiasis  574	Both sexes	1.314
AlmerÝa	Group 1117 Cholelithiasis  574	Men	568
AlmerÝa	Group 1117 Cholelithiasis  574	Women	746
AlmerÝa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	256
AlmerÝa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	133
AlmerÝa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	123
AlmerÝa	Group 1119 Pancreatic diseases 577	Both sexes	515
AlmerÝa	Group 1119 Pancreatic diseases 577	Men	288
AlmerÝa	Group 1119 Pancreatic diseases 577	Women	227
AlmerÝa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	211
AlmerÝa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	125
AlmerÝa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	86
AlmerÝa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	448
AlmerÝa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	259
AlmerÝa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	189
AlmerÝa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	310
AlmerÝa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	194
AlmerÝa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	116
AlmerÝa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	17
AlmerÝa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	9
AlmerÝa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	8
AlmerÝa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	121
AlmerÝa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	56
AlmerÝa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	65
AlmerÝa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.363
AlmerÝa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.627
AlmerÝa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.736
AlmerÝa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
AlmerÝa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
AlmerÝa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
AlmerÝa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
AlmerÝa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
AlmerÝa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
AlmerÝa	Group 1303 Internal derangement of knee 717	Both sexes	444
AlmerÝa	Group 1303 Internal derangement of knee 717	Men	304
AlmerÝa	Group 1303 Internal derangement of knee 717	Women	140
AlmerÝa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.253
AlmerÝa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	496
AlmerÝa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	757
AlmerÝa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	60
AlmerÝa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	33
AlmerÝa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	27
AlmerÝa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	140
AlmerÝa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	71
AlmerÝa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	69
AlmerÝa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	300
AlmerÝa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	160
AlmerÝa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	140
AlmerÝa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	68
AlmerÝa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	35
AlmerÝa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	33
AlmerÝa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	571
AlmerÝa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	293
AlmerÝa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	278
AlmerÝa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	527
AlmerÝa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	235
AlmerÝa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	292
AlmerÝa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.215
AlmerÝa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.406
AlmerÝa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.809
AlmerÝa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	438
AlmerÝa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	191
AlmerÝa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	247
AlmerÝa	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	331
AlmerÝa	Group 1402 Renal failure  5836-5837, 584-586	Men	188
AlmerÝa	Group 1402 Renal failure  5836-5837, 584-586	Women	143
AlmerÝa	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	315
AlmerÝa	Group 1403 Urolithiasis  592, 594, 7880	Men	217
AlmerÝa	Group 1403 Urolithiasis  592, 594, 7880	Women	98
AlmerÝa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	717
AlmerÝa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	370
AlmerÝa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	347
AlmerÝa	Group 1405 Prostatic hyperplasia  600	Both sexes	216
AlmerÝa	Group 1405 Prostatic hyperplasia  600	Men	216
AlmerÝa	Group 1405 Prostatic hyperplasia  600	Women	..
AlmerÝa	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	204
AlmerÝa	Group 1406 Other diseases of the male genital organs    601-608	Men	204
AlmerÝa	Group 1406 Other diseases of the male genital organs    601-608	Women	..
AlmerÝa	Group 1407 Disorders of breast  610-612	Both sexes	269
AlmerÝa	Group 1407 Disorders of breast  610-612	Men	20
AlmerÝa	Group 1407 Disorders of breast  610-612	Women	249
AlmerÝa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	154
AlmerÝa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
AlmerÝa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	154
AlmerÝa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	47
AlmerÝa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
AlmerÝa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	47
AlmerÝa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	524
AlmerÝa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
AlmerÝa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	524
AlmerÝa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.635
AlmerÝa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
AlmerÝa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.635
AlmerÝa	Group 1501 Legally induced abortion  635	Both sexes	12
AlmerÝa	Group 1501 Legally induced abortion  635	Men	..
AlmerÝa	Group 1501 Legally induced abortion  635	Women	12
AlmerÝa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	734
AlmerÝa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
AlmerÝa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	734
AlmerÝa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.451
AlmerÝa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
AlmerÝa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.451
AlmerÝa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	961
AlmerÝa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
AlmerÝa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	961
AlmerÝa	Group 1505 Single spontaneous delivery  650	Both sexes	481
AlmerÝa	Group 1505 Single spontaneous delivery  650	Men	..
AlmerÝa	Group 1505 Single spontaneous delivery  650	Women	481
AlmerÝa	Group 1506 Other deliveries  6695-6697	Both sexes	347
AlmerÝa	Group 1506 Other deliveries  6695-6697	Men	..
AlmerÝa	Group 1506 Other deliveries  6695-6697	Women	347
AlmerÝa	Group 1507 Complications related to the puerperium  670-676	Both sexes	21
AlmerÝa	Group 1507 Complications related to the puerperium  670-676	Men	..
AlmerÝa	Group 1507 Complications related to the puerperium  670-676	Women	21
AlmerÝa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	628
AlmerÝa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
AlmerÝa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	628
AlmerÝa	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	855
AlmerÝa	Group 1600 Some disorders originating in the perinatal period  760-779	Men	471
AlmerÝa	Group 1600 Some disorders originating in the perinatal period  760-779	Women	384
AlmerÝa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	323
AlmerÝa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	177
AlmerÝa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	146
AlmerÝa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	532
AlmerÝa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	294
AlmerÝa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	238
AlmerÝa	Grupo 1700 Congenital abnormalities  740-759	Both sexes	438
AlmerÝa	Grupo 1700 Congenital abnormalities  740-759	Men	270
AlmerÝa	Grupo 1700 Congenital abnormalities  740-759	Women	168
AlmerÝa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.060
AlmerÝa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.105
AlmerÝa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	955
AlmerÝa	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	225
AlmerÝa	Group 1801 Pain in throat and chest 7841, 7865	Men	132
AlmerÝa	Group 1801 Pain in throat and chest 7841, 7865	Women	93
AlmerÝa	Group 1802 Abdominal pain   7890	Both sexes	241
AlmerÝa	Group 1802 Abdominal pain   7890	Men	72
AlmerÝa	Group 1802 Abdominal pain   7890	Women	169
AlmerÝa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	130
AlmerÝa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	58
AlmerÝa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	72
AlmerÝa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.464
AlmerÝa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	843
AlmerÝa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	621
AlmerÝa	Group 1900 Injuries and poisoning  800-999	Both sexes	4.185
AlmerÝa	Group 1900 Injuries and poisoning  800-999	Men	2.302
AlmerÝa	Group 1900 Injuries and poisoning  800-999	Women	1.883
AlmerÝa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	185
AlmerÝa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	119
AlmerÝa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	66
AlmerÝa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	155
AlmerÝa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	115
AlmerÝa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	40
AlmerÝa	Group 1903 Radius and ulna fracture 813	Both sexes	366
AlmerÝa	Group 1903 Radius and ulna fracture 813	Men	206
AlmerÝa	Group 1903 Radius and ulna fracture 813	Women	160
AlmerÝa	Group 1904 Femur fracture  820-821	Both sexes	726
AlmerÝa	Group 1904 Femur fracture  820-821	Men	226
AlmerÝa	Group 1904 Femur fracture  820-821	Women	500
AlmerÝa	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	387
AlmerÝa	Group 1905 Leg fracture, including the ankle 823-824	Men	219
AlmerÝa	Group 1905 Leg fracture, including the ankle 823-824	Women	168
AlmerÝa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.181
AlmerÝa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	786
AlmerÝa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	395
AlmerÝa	Group 1907 Burns  940-949	Both sexes	44
AlmerÝa	Group 1907 Burns  940-949	Men	21
AlmerÝa	Group 1907 Burns  940-949	Women	23
AlmerÝa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	139
AlmerÝa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	84
AlmerÝa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	55
AlmerÝa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	890
AlmerÝa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	463
AlmerÝa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	427
AlmerÝa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
AlmerÝa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
AlmerÝa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
AlmerÝa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	99
AlmerÝa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	55
AlmerÝa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	44
AlmerÝa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	689
AlmerÝa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	405
AlmerÝa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	284
AlmerÝa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	20
AlmerÝa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	10
AlmerÝa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	10
AlmerÝa	Group 2102 Contraceptive management  V25	Both sexes	7
AlmerÝa	Group 2102 Contraceptive management  V25	Men	..
AlmerÝa	Group 2102 Contraceptive management  V25	Women	7
AlmerÝa	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
AlmerÝa	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
AlmerÝa	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
AlmerÝa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	310
AlmerÝa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	203
AlmerÝa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	107
AlmerÝa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	352
AlmerÝa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	192
AlmerÝa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	160
Cßdiz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	103.366
Cßdiz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	46.961
Cßdiz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	56.405
Cßdiz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.891
Cßdiz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.157
Cßdiz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.734
Cßdiz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	282
Cßdiz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	145
Cßdiz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	137
Cßdiz	Group 0102 Imprecise intestinal infections 009	Both sexes	548
Cßdiz	Group 0102 Imprecise intestinal infections 009	Men	274
Cßdiz	Group 0102 Imprecise intestinal infections 009	Women	274
Cßdiz	Group 0103 Tuberculosis 010-018, 137	Both sexes	64
Cßdiz	Group 0103 Tuberculosis 010-018, 137	Men	46
Cßdiz	Group 0103 Tuberculosis 010-018, 137	Women	18
Cßdiz	Group 0104 Septicaemia  038	Both sexes	1.872
Cßdiz	Group 0104 Septicaemia  038	Men	1.018
Cßdiz	Group 0104 Septicaemia  038	Women	854
Cßdiz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	127
Cßdiz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	98
Cßdiz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	28
Cßdiz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	998
Cßdiz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	575
Cßdiz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	423
Cßdiz	Group 0200 Neoplasms  140-239	Both sexes	8.924
Cßdiz	Group 0200 Neoplasms  140-239	Men	4.867
Cßdiz	Group 0200 Neoplasms  140-239	Women	4.057
Cßdiz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.026
Cßdiz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	619
Cßdiz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	407
Cßdiz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	686
Cßdiz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	572
Cßdiz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	114
Cßdiz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	178
Cßdiz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	107
Cßdiz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	71
Cßdiz	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	797
Cßdiz	Group 0204 Malignant neoplasm of breast  174-175	Men	12
Cßdiz	Group 0204 Malignant neoplasm of breast  174-175	Women	786
Cßdiz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	200
Cßdiz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Cßdiz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	200
Cßdiz	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	121
Cßdiz	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Cßdiz	Group 0206 Malignant neoplasm of ovary  1830	Women	121
Cßdiz	Group 0207 Malignant neoplasm of prostate  185	Both sexes	281
Cßdiz	Group 0207 Malignant neoplasm of prostate  185	Men	281
Cßdiz	Group 0207 Malignant neoplasm of prostate  185	Women	..
Cßdiz	Group 0208 Malignant neoplasm of bladder  188	Both sexes	878
Cßdiz	Group 0208 Malignant neoplasm of bladder  188	Men	757
Cßdiz	Group 0208 Malignant neoplasm of bladder  188	Women	120
Cßdiz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.032
Cßdiz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.912
Cßdiz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.119
Cßdiz	Group 0210 Carcinoma in situ  230-234	Both sexes	140
Cßdiz	Group 0210 Carcinoma in situ  230-234	Men	90
Cßdiz	Group 0210 Carcinoma in situ  230-234	Women	50
Cßdiz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	63
Cßdiz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	30
Cßdiz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	32
Cßdiz	Grupo 0212 Leiomyoma of uterus  218	Both sexes	439
Cßdiz	Grupo 0212 Leiomyoma of uterus  218	Men	..
Cßdiz	Grupo 0212 Leiomyoma of uterus  218	Women	439
Cßdiz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.082
Cßdiz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	485
Cßdiz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	596
Cßdiz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.154
Cßdiz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	551
Cßdiz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	603
Cßdiz	Group 0301 Anaemias 280-285	Both sexes	702
Cßdiz	Group 0301 Anaemias 280-285	Men	332
Cßdiz	Group 0301 Anaemias 280-285	Women	370
Cßdiz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	452
Cßdiz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	220
Cßdiz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	232
Cßdiz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.807
Cßdiz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	685
Cßdiz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.122
Cßdiz	Group 0401 Diabetes mellitus  249-250	Both sexes	562
Cßdiz	Group 0401 Diabetes mellitus  249-250	Men	300
Cßdiz	Group 0401 Diabetes mellitus  249-250	Women	262
Cßdiz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.245
Cßdiz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	385
Cßdiz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	860
Cßdiz	Group 0500 Mental disorders  290-319	Both sexes	1.807
Cßdiz	Group 0500 Mental disorders  290-319	Men	1.076
Cßdiz	Group 0500 Mental disorders  290-319	Women	731
Cßdiz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	76
Cßdiz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	29
Cßdiz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	47
Cßdiz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	101
Cßdiz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	85
Cßdiz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	17
Cßdiz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	129
Cßdiz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	91
Cßdiz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	38
Cßdiz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	587
Cßdiz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	433
Cßdiz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	154
Cßdiz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	359
Cßdiz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	171
Cßdiz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	188
Cßdiz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	555
Cßdiz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	267
Cßdiz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	288
Cßdiz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.296
Cßdiz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.070
Cßdiz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.226
Cßdiz	Group 0601 Alzheimer's disease  3310	Both sexes	56
Cßdiz	Group 0601 Alzheimer's disease  3310	Men	23
Cßdiz	Group 0601 Alzheimer's disease  3310	Women	33
Cßdiz	Group 0602 Multiple sclerosis 340	Both sexes	64
Cßdiz	Group 0602 Multiple sclerosis 340	Men	14
Cßdiz	Group 0602 Multiple sclerosis 340	Women	50
Cßdiz	Group 0603 Epilepsy  345	Both sexes	409
Cßdiz	Group 0603 Epilepsy  345	Men	221
Cßdiz	Group 0603 Epilepsy  345	Women	188
Cßdiz	Group 0604 Transient cerebral ischemia 435	Both sexes	544
Cßdiz	Group 0604 Transient cerebral ischemia 435	Men	247
Cßdiz	Group 0604 Transient cerebral ischemia 435	Women	297
Cßdiz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.223
Cßdiz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	566
Cßdiz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	657
Cßdiz	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	822
Cßdiz	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	412
Cßdiz	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	410
Cßdiz	Grupo 0701 Cataract  366	Both sexes	181
Cßdiz	Grupo 0701 Cataract  366	Men	96
Cßdiz	Grupo 0701 Cataract  366	Women	85
Cßdiz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	641
Cßdiz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	316
Cßdiz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	325
Cßdiz	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	420
Cßdiz	Group 0800 Diseases of the ear and the mastoid  380-389	Men	231
Cßdiz	Group 0800 Diseases of the ear and the mastoid  380-389	Women	188
Cßdiz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	14.653
Cßdiz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	8.209
Cßdiz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	6.445
Cßdiz	Group 0901 Hypertensive disease  401-405	Both sexes	785
Cßdiz	Group 0901 Hypertensive disease  401-405	Men	342
Cßdiz	Group 0901 Hypertensive disease  401-405	Women	443
Cßdiz	Group 0902 Angina pectoris  4111, 413	Both sexes	966
Cßdiz	Group 0902 Angina pectoris  4111, 413	Men	561
Cßdiz	Group 0902 Angina pectoris  4111, 413	Women	405
Cßdiz	Group 0903 Acute myocardial infarction  410	Both sexes	1.368
Cßdiz	Group 0903 Acute myocardial infarction  410	Men	920
Cßdiz	Group 0903 Acute myocardial infarction  410	Women	449
Cßdiz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.567
Cßdiz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.088
Cßdiz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	479
Cßdiz	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	297
Cßdiz	Group 0905 Diseases of the lungs circulation 415-417	Men	131
Cßdiz	Group 0905 Diseases of the lungs circulation 415-417	Women	166
Cßdiz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.825
Cßdiz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	955
Cßdiz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	869
Cßdiz	Grupo 0907 Heart failure  428	Both sexes	2.606
Cßdiz	Grupo 0907 Heart failure  428	Men	1.163
Cßdiz	Grupo 0907 Heart failure  428	Women	1.443
Cßdiz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.549
Cßdiz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.447
Cßdiz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.102
Cßdiz	Grupo 0909 Atherosclerosis  440	Both sexes	425
Cßdiz	Grupo 0909 Atherosclerosis  440	Men	307
Cßdiz	Grupo 0909 Atherosclerosis  440	Women	118
Cßdiz	Group 0910 Varicose veins of lower extremities 454	Both sexes	139
Cßdiz	Group 0910 Varicose veins of lower extremities 454	Men	60
Cßdiz	Group 0910 Varicose veins of lower extremities 454	Women	80
Cßdiz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.127
Cßdiz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.236
Cßdiz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	891
Cßdiz	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	9.603
Cßdiz	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.462
Cßdiz	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.141
Cßdiz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	701
Cßdiz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	381
Cßdiz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	320
Cßdiz	Group 1002 Pneumonia 480-486	Both sexes	1.854
Cßdiz	Group 1002 Pneumonia 480-486	Men	1.040
Cßdiz	Group 1002 Pneumonia 480-486	Women	814
Cßdiz	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.214
Cßdiz	Group 1003 Acute bronchitis and bronchiolitis  466	Men	652
Cßdiz	Group 1003 Acute bronchitis and bronchiolitis  466	Women	562
Cßdiz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	361
Cßdiz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	183
Cßdiz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	178
Cßdiz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	837
Cßdiz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	525
Cßdiz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	312
Cßdiz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.143
Cßdiz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	861
Cßdiz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	282
Cßdiz	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	321
Cßdiz	Group 1007 Asthma 4930-4931,4938-4939	Men	107
Cßdiz	Group 1007 Asthma 4930-4931,4938-4939	Women	214
Cßdiz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.172
Cßdiz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.714
Cßdiz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.458
Cßdiz	Group 1100 Diseases of the digestive system  520-579	Both sexes	12.725
Cßdiz	Group 1100 Diseases of the digestive system  520-579	Men	6.857
Cßdiz	Group 1100 Diseases of the digestive system  520-579	Women	5.868
Cßdiz	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	150
Cßdiz	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	72
Cßdiz	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	77
Cßdiz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	176
Cßdiz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	95
Cßdiz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	81
Cßdiz	Group 1103 Diseases of the esophagus 530	Both sexes	207
Cßdiz	Group 1103 Diseases of the esophagus 530	Men	119
Cßdiz	Group 1103 Diseases of the esophagus 530	Women	88
Cßdiz	Group 1104 Peptic ulcer 531-534	Both sexes	280
Cßdiz	Group 1104 Peptic ulcer 531-534	Men	203
Cßdiz	Group 1104 Peptic ulcer 531-534	Women	77
Cßdiz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	498
Cßdiz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	222
Cßdiz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	276
Cßdiz	Group 1106 Appendicitis  540-543	Both sexes	1.087
Cßdiz	Group 1106 Appendicitis  540-543	Men	590
Cßdiz	Group 1106 Appendicitis  540-543	Women	497
Cßdiz	Group 1107 Inguinal hernia  550	Both sexes	1.079
Cßdiz	Group 1107 Inguinal hernia  550	Men	961
Cßdiz	Group 1107 Inguinal hernia  550	Women	117
Cßdiz	Group 1108 Other abdominal hernia  551-553	Both sexes	942
Cßdiz	Group 1108 Other abdominal hernia  551-553	Men	438
Cßdiz	Group 1108 Other abdominal hernia  551-553	Women	503
Cßdiz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	402
Cßdiz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	194
Cßdiz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	208
Cßdiz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	703
Cßdiz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	310
Cßdiz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	393
Cßdiz	Group 1111 Intestinal obstruction without hernia 560	Both sexes	549
Cßdiz	Group 1111 Intestinal obstruction without hernia 560	Men	290
Cßdiz	Group 1111 Intestinal obstruction without hernia 560	Women	259
Cßdiz	Group 1112 Intestinal diverticulosis 562	Both sexes	429
Cßdiz	Group 1112 Intestinal diverticulosis 562	Men	213
Cßdiz	Group 1112 Intestinal diverticulosis 562	Women	216
Cßdiz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	703
Cßdiz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	444
Cßdiz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	259
Cßdiz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	404
Cßdiz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	180
Cßdiz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	224
Cßdiz	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	317
Cßdiz	Group 1115 Alcoholic hepatitis 5710-5713	Men	277
Cßdiz	Group 1115 Alcoholic hepatitis 5710-5713	Women	40
Cßdiz	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	426
Cßdiz	Group 1116 Other diseases of the liver 570,5714-573	Men	272
Cßdiz	Group 1116 Other diseases of the liver 570,5714-573	Women	154
Cßdiz	Group 1117 Cholelithiasis  574	Both sexes	2.376
Cßdiz	Group 1117 Cholelithiasis  574	Men	903
Cßdiz	Group 1117 Cholelithiasis  574	Women	1.473
Cßdiz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	596
Cßdiz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	300
Cßdiz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	296
Cßdiz	Group 1119 Pancreatic diseases 577	Both sexes	800
Cßdiz	Group 1119 Pancreatic diseases 577	Men	429
Cßdiz	Group 1119 Pancreatic diseases 577	Women	371
Cßdiz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	602
Cßdiz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	344
Cßdiz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	257
Cßdiz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.239
Cßdiz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	657
Cßdiz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	582
Cßdiz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	661
Cßdiz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	404
Cßdiz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	257
Cßdiz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	97
Cßdiz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	50
Cßdiz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	47
Cßdiz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	480
Cßdiz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	203
Cßdiz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	277
Cßdiz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.751
Cßdiz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.627
Cßdiz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.124
Cßdiz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Cßdiz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Cßdiz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Cßdiz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Cßdiz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Cßdiz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Cßdiz	Group 1303 Internal derangement of knee 717	Both sexes	594
Cßdiz	Group 1303 Internal derangement of knee 717	Men	426
Cßdiz	Group 1303 Internal derangement of knee 717	Women	168
Cßdiz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.473
Cßdiz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.027
Cßdiz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.446
Cßdiz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	149
Cßdiz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	54
Cßdiz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	94
Cßdiz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	231
Cßdiz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	120
Cßdiz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	111
Cßdiz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	485
Cßdiz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	252
Cßdiz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	233
Cßdiz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	240
Cßdiz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	91
Cßdiz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	149
Cßdiz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	567
Cßdiz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	301
Cßdiz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	266
Cßdiz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.012
Cßdiz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	355
Cßdiz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	657
Cßdiz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.261
Cßdiz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.073
Cßdiz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.188
Cßdiz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	719
Cßdiz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	294
Cßdiz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	425
Cßdiz	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	594
Cßdiz	Group 1402 Renal failure  5836-5837, 584-586	Men	319
Cßdiz	Group 1402 Renal failure  5836-5837, 584-586	Women	275
Cßdiz	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.220
Cßdiz	Group 1403 Urolithiasis  592, 594, 7880	Men	681
Cßdiz	Group 1403 Urolithiasis  592, 594, 7880	Women	539
Cßdiz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.832
Cßdiz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	879
Cßdiz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	953
Cßdiz	Group 1405 Prostatic hyperplasia  600	Both sexes	425
Cßdiz	Group 1405 Prostatic hyperplasia  600	Men	425
Cßdiz	Group 1405 Prostatic hyperplasia  600	Women	..
Cßdiz	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	416
Cßdiz	Group 1406 Other diseases of the male genital organs    601-608	Men	416
Cßdiz	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Cßdiz	Group 1407 Disorders of breast  610-612	Both sexes	452
Cßdiz	Group 1407 Disorders of breast  610-612	Men	47
Cßdiz	Group 1407 Disorders of breast  610-612	Women	405
Cßdiz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	248
Cßdiz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Cßdiz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	248
Cßdiz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	225
Cßdiz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Cßdiz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	225
Cßdiz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.130
Cßdiz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	12
Cßdiz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.118
Cßdiz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	13.523
Cßdiz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Cßdiz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	13.523
Cßdiz	Group 1501 Legally induced abortion  635	Both sexes	29
Cßdiz	Group 1501 Legally induced abortion  635	Men	..
Cßdiz	Group 1501 Legally induced abortion  635	Women	29
Cßdiz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	920
Cßdiz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Cßdiz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	920
Cßdiz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	7.645
Cßdiz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Cßdiz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	7.645
Cßdiz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.575
Cßdiz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Cßdiz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.575
Cßdiz	Group 1505 Single spontaneous delivery  650	Both sexes	1.407
Cßdiz	Group 1505 Single spontaneous delivery  650	Men	..
Cßdiz	Group 1505 Single spontaneous delivery  650	Women	1.407
Cßdiz	Group 1506 Other deliveries  6695-6697	Both sexes	1.219
Cßdiz	Group 1506 Other deliveries  6695-6697	Men	..
Cßdiz	Group 1506 Other deliveries  6695-6697	Women	1.219
Cßdiz	Group 1507 Complications related to the puerperium  670-676	Both sexes	58
Cßdiz	Group 1507 Complications related to the puerperium  670-676	Men	..
Cßdiz	Group 1507 Complications related to the puerperium  670-676	Women	58
Cßdiz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	672
Cßdiz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Cßdiz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	672
Cßdiz	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.511
Cßdiz	Group 1600 Some disorders originating in the perinatal period  760-779	Men	811
Cßdiz	Group 1600 Some disorders originating in the perinatal period  760-779	Women	700
Cßdiz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	509
Cßdiz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	251
Cßdiz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	258
Cßdiz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.001
Cßdiz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	560
Cßdiz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	441
Cßdiz	Grupo 1700 Congenital abnormalities  740-759	Both sexes	863
Cßdiz	Grupo 1700 Congenital abnormalities  740-759	Men	488
Cßdiz	Grupo 1700 Congenital abnormalities  740-759	Women	376
Cßdiz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.235
Cßdiz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.238
Cßdiz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.997
Cßdiz	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	886
Cßdiz	Group 1801 Pain in throat and chest 7841, 7865	Men	462
Cßdiz	Group 1801 Pain in throat and chest 7841, 7865	Women	424
Cßdiz	Group 1802 Abdominal pain   7890	Both sexes	1.149
Cßdiz	Group 1802 Abdominal pain   7890	Men	441
Cßdiz	Group 1802 Abdominal pain   7890	Women	707
Cßdiz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	233
Cßdiz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	124
Cßdiz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	109
Cßdiz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	3.967
Cßdiz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.210
Cßdiz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.758
Cßdiz	Group 1900 Injuries and poisoning  800-999	Both sexes	7.588
Cßdiz	Group 1900 Injuries and poisoning  800-999	Men	3.865
Cßdiz	Group 1900 Injuries and poisoning  800-999	Women	3.723
Cßdiz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	523
Cßdiz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	308
Cßdiz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	216
Cßdiz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	236
Cßdiz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	183
Cßdiz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	53
Cßdiz	Group 1903 Radius and ulna fracture 813	Both sexes	441
Cßdiz	Group 1903 Radius and ulna fracture 813	Men	219
Cßdiz	Group 1903 Radius and ulna fracture 813	Women	223
Cßdiz	Group 1904 Femur fracture  820-821	Both sexes	1.290
Cßdiz	Group 1904 Femur fracture  820-821	Men	372
Cßdiz	Group 1904 Femur fracture  820-821	Women	918
Cßdiz	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	639
Cßdiz	Group 1905 Leg fracture, including the ankle 823-824	Men	332
Cßdiz	Group 1905 Leg fracture, including the ankle 823-824	Women	308
Cßdiz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.964
Cßdiz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.171
Cßdiz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	793
Cßdiz	Group 1907 Burns  940-949	Both sexes	29
Cßdiz	Group 1907 Burns  940-949	Men	16
Cßdiz	Group 1907 Burns  940-949	Women	14
Cßdiz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	379
Cßdiz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	186
Cßdiz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	193
Cßdiz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.857
Cßdiz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	953
Cßdiz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	904
Cßdiz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	49
Cßdiz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	28
Cßdiz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	21
Cßdiz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	180
Cßdiz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	97
Cßdiz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	83
Cßdiz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.293
Cßdiz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	626
Cßdiz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	667
Cßdiz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	32
Cßdiz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	20
Cßdiz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	13
Cßdiz	Group 2102 Contraceptive management  V25	Both sexes	17
Cßdiz	Group 2102 Contraceptive management  V25	Men	2
Cßdiz	Group 2102 Contraceptive management  V25	Women	15
Cßdiz	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Cßdiz	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Cßdiz	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Cßdiz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	465
Cßdiz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	323
Cßdiz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	141
Cßdiz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	779
Cßdiz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	280
Cßdiz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	499
C¾rdoba	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	70.697
C¾rdoba	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	33.117
C¾rdoba	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	37.580
C¾rdoba	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.061
C¾rdoba	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	624
C¾rdoba	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	437
C¾rdoba	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	108
C¾rdoba	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	61
C¾rdoba	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	47
C¾rdoba	Group 0102 Imprecise intestinal infections 009	Both sexes	29
C¾rdoba	Group 0102 Imprecise intestinal infections 009	Men	16
C¾rdoba	Group 0102 Imprecise intestinal infections 009	Women	13
C¾rdoba	Group 0103 Tuberculosis 010-018, 137	Both sexes	46
C¾rdoba	Group 0103 Tuberculosis 010-018, 137	Men	26
C¾rdoba	Group 0103 Tuberculosis 010-018, 137	Women	20
C¾rdoba	Group 0104 Septicaemia  038	Both sexes	369
C¾rdoba	Group 0104 Septicaemia  038	Men	200
C¾rdoba	Group 0104 Septicaemia  038	Women	169
C¾rdoba	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	60
C¾rdoba	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	48
C¾rdoba	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	12
C¾rdoba	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	449
C¾rdoba	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	273
C¾rdoba	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	176
C¾rdoba	Group 0200 Neoplasms  140-239	Both sexes	7.039
C¾rdoba	Group 0200 Neoplasms  140-239	Men	3.729
C¾rdoba	Group 0200 Neoplasms  140-239	Women	3.310
C¾rdoba	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	695
C¾rdoba	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	457
C¾rdoba	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	238
C¾rdoba	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	428
C¾rdoba	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	353
C¾rdoba	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	75
C¾rdoba	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	287
C¾rdoba	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	175
C¾rdoba	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	112
C¾rdoba	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	537
C¾rdoba	Group 0204 Malignant neoplasm of breast  174-175	Men	4
C¾rdoba	Group 0204 Malignant neoplasm of breast  174-175	Women	533
C¾rdoba	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	160
C¾rdoba	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
C¾rdoba	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	160
C¾rdoba	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	73
C¾rdoba	Group 0206 Malignant neoplasm of ovary  1830	Men	..
C¾rdoba	Group 0206 Malignant neoplasm of ovary  1830	Women	73
C¾rdoba	Group 0207 Malignant neoplasm of prostate  185	Both sexes	211
C¾rdoba	Group 0207 Malignant neoplasm of prostate  185	Men	211
C¾rdoba	Group 0207 Malignant neoplasm of prostate  185	Women	..
C¾rdoba	Group 0208 Malignant neoplasm of bladder  188	Both sexes	589
C¾rdoba	Group 0208 Malignant neoplasm of bladder  188	Men	468
C¾rdoba	Group 0208 Malignant neoplasm of bladder  188	Women	121
C¾rdoba	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.467
C¾rdoba	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.478
C¾rdoba	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	989
C¾rdoba	Group 0210 Carcinoma in situ  230-234	Both sexes	77
C¾rdoba	Group 0210 Carcinoma in situ  230-234	Men	13
C¾rdoba	Group 0210 Carcinoma in situ  230-234	Women	64
C¾rdoba	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	76
C¾rdoba	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	39
C¾rdoba	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	37
C¾rdoba	Grupo 0212 Leiomyoma of uterus  218	Both sexes	234
C¾rdoba	Grupo 0212 Leiomyoma of uterus  218	Men	..
C¾rdoba	Grupo 0212 Leiomyoma of uterus  218	Women	234
C¾rdoba	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.205
C¾rdoba	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	531
C¾rdoba	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	674
C¾rdoba	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	688
C¾rdoba	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	335
C¾rdoba	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	353
C¾rdoba	Group 0301 Anaemias 280-285	Both sexes	451
C¾rdoba	Group 0301 Anaemias 280-285	Men	230
C¾rdoba	Group 0301 Anaemias 280-285	Women	221
C¾rdoba	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	237
C¾rdoba	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	105
C¾rdoba	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	132
C¾rdoba	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.123
C¾rdoba	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	448
C¾rdoba	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	675
C¾rdoba	Group 0401 Diabetes mellitus  249-250	Both sexes	261
C¾rdoba	Group 0401 Diabetes mellitus  249-250	Men	133
C¾rdoba	Group 0401 Diabetes mellitus  249-250	Women	128
C¾rdoba	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	862
C¾rdoba	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	315
C¾rdoba	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	547
C¾rdoba	Group 0500 Mental disorders  290-319	Both sexes	1.034
C¾rdoba	Group 0500 Mental disorders  290-319	Men	552
C¾rdoba	Group 0500 Mental disorders  290-319	Women	482
C¾rdoba	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	25
C¾rdoba	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	15
C¾rdoba	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	10
C¾rdoba	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	34
C¾rdoba	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	31
C¾rdoba	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	3
C¾rdoba	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	71
C¾rdoba	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	52
C¾rdoba	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	19
C¾rdoba	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	281
C¾rdoba	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	185
C¾rdoba	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	96
C¾rdoba	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	272
C¾rdoba	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	118
C¾rdoba	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	154
C¾rdoba	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	351
C¾rdoba	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	151
C¾rdoba	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	200
C¾rdoba	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.257
C¾rdoba	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	610
C¾rdoba	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	647
C¾rdoba	Group 0601 Alzheimer's disease  3310	Both sexes	17
C¾rdoba	Group 0601 Alzheimer's disease  3310	Men	9
C¾rdoba	Group 0601 Alzheimer's disease  3310	Women	8
C¾rdoba	Group 0602 Multiple sclerosis 340	Both sexes	21
C¾rdoba	Group 0602 Multiple sclerosis 340	Men	6
C¾rdoba	Group 0602 Multiple sclerosis 340	Women	15
C¾rdoba	Group 0603 Epilepsy  345	Both sexes	175
C¾rdoba	Group 0603 Epilepsy  345	Men	98
C¾rdoba	Group 0603 Epilepsy  345	Women	77
C¾rdoba	Group 0604 Transient cerebral ischemia 435	Both sexes	211
C¾rdoba	Group 0604 Transient cerebral ischemia 435	Men	105
C¾rdoba	Group 0604 Transient cerebral ischemia 435	Women	106
C¾rdoba	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	833
C¾rdoba	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	392
C¾rdoba	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	441
C¾rdoba	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	937
C¾rdoba	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	565
C¾rdoba	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	372
C¾rdoba	Grupo 0701 Cataract  366	Both sexes	166
C¾rdoba	Grupo 0701 Cataract  366	Men	98
C¾rdoba	Grupo 0701 Cataract  366	Women	68
C¾rdoba	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	771
C¾rdoba	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	467
C¾rdoba	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	304
C¾rdoba	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	236
C¾rdoba	Group 0800 Diseases of the ear and the mastoid  380-389	Men	115
C¾rdoba	Group 0800 Diseases of the ear and the mastoid  380-389	Women	121
C¾rdoba	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	10.051
C¾rdoba	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.863
C¾rdoba	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.188
C¾rdoba	Group 0901 Hypertensive disease  401-405	Both sexes	401
C¾rdoba	Group 0901 Hypertensive disease  401-405	Men	188
C¾rdoba	Group 0901 Hypertensive disease  401-405	Women	213
C¾rdoba	Group 0902 Angina pectoris  4111, 413	Both sexes	693
C¾rdoba	Group 0902 Angina pectoris  4111, 413	Men	477
C¾rdoba	Group 0902 Angina pectoris  4111, 413	Women	216
C¾rdoba	Group 0903 Acute myocardial infarction  410	Both sexes	771
C¾rdoba	Group 0903 Acute myocardial infarction  410	Men	565
C¾rdoba	Group 0903 Acute myocardial infarction  410	Women	206
C¾rdoba	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	753
C¾rdoba	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	582
C¾rdoba	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	171
C¾rdoba	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	331
C¾rdoba	Group 0905 Diseases of the lungs circulation 415-417	Men	145
C¾rdoba	Group 0905 Diseases of the lungs circulation 415-417	Women	186
C¾rdoba	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.205
C¾rdoba	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	720
C¾rdoba	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	485
C¾rdoba	Grupo 0907 Heart failure  428	Both sexes	1.853
C¾rdoba	Grupo 0907 Heart failure  428	Men	868
C¾rdoba	Grupo 0907 Heart failure  428	Women	985
C¾rdoba	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.690
C¾rdoba	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	922
C¾rdoba	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	768
C¾rdoba	Grupo 0909 Atherosclerosis  440	Both sexes	277
C¾rdoba	Grupo 0909 Atherosclerosis  440	Men	218
C¾rdoba	Grupo 0909 Atherosclerosis  440	Women	59
C¾rdoba	Group 0910 Varicose veins of lower extremities 454	Both sexes	206
C¾rdoba	Group 0910 Varicose veins of lower extremities 454	Men	79
C¾rdoba	Group 0910 Varicose veins of lower extremities 454	Women	127
C¾rdoba	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.871
C¾rdoba	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.099
C¾rdoba	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	772
C¾rdoba	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.378
C¾rdoba	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.290
C¾rdoba	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.088
C¾rdoba	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	357
C¾rdoba	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	188
C¾rdoba	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	169
C¾rdoba	Group 1002 Pneumonia 480-486	Both sexes	1.771
C¾rdoba	Group 1002 Pneumonia 480-486	Men	1.046
C¾rdoba	Group 1002 Pneumonia 480-486	Women	725
C¾rdoba	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	277
C¾rdoba	Group 1003 Acute bronchitis and bronchiolitis  466	Men	176
C¾rdoba	Group 1003 Acute bronchitis and bronchiolitis  466	Women	101
C¾rdoba	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	108
C¾rdoba	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	54
C¾rdoba	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	54
C¾rdoba	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	407
C¾rdoba	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	251
C¾rdoba	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	156
C¾rdoba	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.188
C¾rdoba	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	963
C¾rdoba	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	225
C¾rdoba	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	137
C¾rdoba	Group 1007 Asthma 4930-4931,4938-4939	Men	27
C¾rdoba	Group 1007 Asthma 4930-4931,4938-4939	Women	110
C¾rdoba	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.133
C¾rdoba	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.585
C¾rdoba	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.548
C¾rdoba	Group 1100 Diseases of the digestive system  520-579	Both sexes	10.457
C¾rdoba	Group 1100 Diseases of the digestive system  520-579	Men	5.781
C¾rdoba	Group 1100 Diseases of the digestive system  520-579	Women	4.676
C¾rdoba	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	190
C¾rdoba	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	93
C¾rdoba	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	97
C¾rdoba	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	185
C¾rdoba	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	105
C¾rdoba	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	80
C¾rdoba	Group 1103 Diseases of the esophagus 530	Both sexes	235
C¾rdoba	Group 1103 Diseases of the esophagus 530	Men	130
C¾rdoba	Group 1103 Diseases of the esophagus 530	Women	105
C¾rdoba	Group 1104 Peptic ulcer 531-534	Both sexes	179
C¾rdoba	Group 1104 Peptic ulcer 531-534	Men	123
C¾rdoba	Group 1104 Peptic ulcer 531-534	Women	56
C¾rdoba	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	149
C¾rdoba	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	79
C¾rdoba	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	70
C¾rdoba	Group 1106 Appendicitis  540-543	Both sexes	795
C¾rdoba	Group 1106 Appendicitis  540-543	Men	463
C¾rdoba	Group 1106 Appendicitis  540-543	Women	332
C¾rdoba	Group 1107 Inguinal hernia  550	Both sexes	999
C¾rdoba	Group 1107 Inguinal hernia  550	Men	887
C¾rdoba	Group 1107 Inguinal hernia  550	Women	112
C¾rdoba	Group 1108 Other abdominal hernia  551-553	Both sexes	1.094
C¾rdoba	Group 1108 Other abdominal hernia  551-553	Men	498
C¾rdoba	Group 1108 Other abdominal hernia  551-553	Women	596
C¾rdoba	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	196
C¾rdoba	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	107
C¾rdoba	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	89
C¾rdoba	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	438
C¾rdoba	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	209
C¾rdoba	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	229
C¾rdoba	Group 1111 Intestinal obstruction without hernia 560	Both sexes	554
C¾rdoba	Group 1111 Intestinal obstruction without hernia 560	Men	294
C¾rdoba	Group 1111 Intestinal obstruction without hernia 560	Women	260
C¾rdoba	Group 1112 Intestinal diverticulosis 562	Both sexes	395
C¾rdoba	Group 1112 Intestinal diverticulosis 562	Men	223
C¾rdoba	Group 1112 Intestinal diverticulosis 562	Women	172
C¾rdoba	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	593
C¾rdoba	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	364
C¾rdoba	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	229
C¾rdoba	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	265
C¾rdoba	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	126
C¾rdoba	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	139
C¾rdoba	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	193
C¾rdoba	Group 1115 Alcoholic hepatitis 5710-5713	Men	167
C¾rdoba	Group 1115 Alcoholic hepatitis 5710-5713	Women	26
C¾rdoba	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	393
C¾rdoba	Group 1116 Other diseases of the liver 570,5714-573	Men	240
C¾rdoba	Group 1116 Other diseases of the liver 570,5714-573	Women	153
C¾rdoba	Group 1117 Cholelithiasis  574	Both sexes	2.146
C¾rdoba	Group 1117 Cholelithiasis  574	Men	885
C¾rdoba	Group 1117 Cholelithiasis  574	Women	1.261
C¾rdoba	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	355
C¾rdoba	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	194
C¾rdoba	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	161
C¾rdoba	Group 1119 Pancreatic diseases 577	Both sexes	669
C¾rdoba	Group 1119 Pancreatic diseases 577	Men	344
C¾rdoba	Group 1119 Pancreatic diseases 577	Women	325
C¾rdoba	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	434
C¾rdoba	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	250
C¾rdoba	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	184
C¾rdoba	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	689
C¾rdoba	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	392
C¾rdoba	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	297
C¾rdoba	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	398
C¾rdoba	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	252
C¾rdoba	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	146
C¾rdoba	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	25
C¾rdoba	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
C¾rdoba	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
C¾rdoba	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	266
C¾rdoba	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	128
C¾rdoba	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	138
C¾rdoba	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.135
C¾rdoba	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.088
C¾rdoba	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.047
C¾rdoba	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
C¾rdoba	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
C¾rdoba	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
C¾rdoba	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
C¾rdoba	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
C¾rdoba	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
C¾rdoba	Group 1303 Internal derangement of knee 717	Both sexes	359
C¾rdoba	Group 1303 Internal derangement of knee 717	Men	256
C¾rdoba	Group 1303 Internal derangement of knee 717	Women	103
C¾rdoba	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.301
C¾rdoba	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	851
C¾rdoba	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.450
C¾rdoba	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	82
C¾rdoba	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	25
C¾rdoba	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	57
C¾rdoba	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	337
C¾rdoba	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	147
C¾rdoba	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	190
C¾rdoba	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	372
C¾rdoba	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	171
C¾rdoba	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	201
C¾rdoba	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	46
C¾rdoba	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	21
C¾rdoba	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	25
C¾rdoba	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	578
C¾rdoba	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	279
C¾rdoba	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	299
C¾rdoba	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.060
C¾rdoba	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	338
C¾rdoba	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	722
C¾rdoba	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.655
C¾rdoba	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.705
C¾rdoba	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.950
C¾rdoba	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	401
C¾rdoba	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	159
C¾rdoba	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	242
C¾rdoba	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	541
C¾rdoba	Group 1402 Renal failure  5836-5837, 584-586	Men	316
C¾rdoba	Group 1402 Renal failure  5836-5837, 584-586	Women	225
C¾rdoba	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	456
C¾rdoba	Group 1403 Urolithiasis  592, 594, 7880	Men	251
C¾rdoba	Group 1403 Urolithiasis  592, 594, 7880	Women	205
C¾rdoba	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	646
C¾rdoba	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	337
C¾rdoba	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	309
C¾rdoba	Group 1405 Prostatic hyperplasia  600	Both sexes	271
C¾rdoba	Group 1405 Prostatic hyperplasia  600	Men	271
C¾rdoba	Group 1405 Prostatic hyperplasia  600	Women	..
C¾rdoba	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	325
C¾rdoba	Group 1406 Other diseases of the male genital organs    601-608	Men	325
C¾rdoba	Group 1406 Other diseases of the male genital organs    601-608	Women	..
C¾rdoba	Group 1407 Disorders of breast  610-612	Both sexes	299
C¾rdoba	Group 1407 Disorders of breast  610-612	Men	43
C¾rdoba	Group 1407 Disorders of breast  610-612	Women	256
C¾rdoba	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	132
C¾rdoba	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
C¾rdoba	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	132
C¾rdoba	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	31
C¾rdoba	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
C¾rdoba	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	31
C¾rdoba	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	553
C¾rdoba	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
C¾rdoba	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	550
C¾rdoba	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	8.387
C¾rdoba	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
C¾rdoba	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	8.387
C¾rdoba	Group 1501 Legally induced abortion  635	Both sexes	3
C¾rdoba	Group 1501 Legally induced abortion  635	Men	..
C¾rdoba	Group 1501 Legally induced abortion  635	Women	3
C¾rdoba	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	339
C¾rdoba	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
C¾rdoba	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	339
C¾rdoba	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.021
C¾rdoba	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
C¾rdoba	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.021
C¾rdoba	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.061
C¾rdoba	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
C¾rdoba	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.061
C¾rdoba	Group 1505 Single spontaneous delivery  650	Both sexes	817
C¾rdoba	Group 1505 Single spontaneous delivery  650	Men	..
C¾rdoba	Group 1505 Single spontaneous delivery  650	Women	817
C¾rdoba	Group 1506 Other deliveries  6695-6697	Both sexes	551
C¾rdoba	Group 1506 Other deliveries  6695-6697	Men	..
C¾rdoba	Group 1506 Other deliveries  6695-6697	Women	551
C¾rdoba	Group 1507 Complications related to the puerperium  670-676	Both sexes	35
C¾rdoba	Group 1507 Complications related to the puerperium  670-676	Men	..
C¾rdoba	Group 1507 Complications related to the puerperium  670-676	Women	35
C¾rdoba	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	560
C¾rdoba	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
C¾rdoba	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	560
C¾rdoba	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	988
C¾rdoba	Group 1600 Some disorders originating in the perinatal period  760-779	Men	545
C¾rdoba	Group 1600 Some disorders originating in the perinatal period  760-779	Women	443
C¾rdoba	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	311
C¾rdoba	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	152
C¾rdoba	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	159
C¾rdoba	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	677
C¾rdoba	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	393
C¾rdoba	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	284
C¾rdoba	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.071
C¾rdoba	Grupo 1700 Congenital abnormalities  740-759	Men	481
C¾rdoba	Grupo 1700 Congenital abnormalities  740-759	Women	590
C¾rdoba	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.727
C¾rdoba	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.459
C¾rdoba	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.268
C¾rdoba	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	452
C¾rdoba	Group 1801 Pain in throat and chest 7841, 7865	Men	255
C¾rdoba	Group 1801 Pain in throat and chest 7841, 7865	Women	197
C¾rdoba	Group 1802 Abdominal pain   7890	Both sexes	521
C¾rdoba	Group 1802 Abdominal pain   7890	Men	192
C¾rdoba	Group 1802 Abdominal pain   7890	Women	329
C¾rdoba	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	25
C¾rdoba	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	16
C¾rdoba	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	9
C¾rdoba	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.729
C¾rdoba	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	996
C¾rdoba	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	733
C¾rdoba	Group 1900 Injuries and poisoning  800-999	Both sexes	5.985
C¾rdoba	Group 1900 Injuries and poisoning  800-999	Men	3.018
C¾rdoba	Group 1900 Injuries and poisoning  800-999	Women	2.967
C¾rdoba	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	345
C¾rdoba	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	209
C¾rdoba	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	136
C¾rdoba	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	225
C¾rdoba	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	148
C¾rdoba	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	77
C¾rdoba	Group 1903 Radius and ulna fracture 813	Both sexes	325
C¾rdoba	Group 1903 Radius and ulna fracture 813	Men	157
C¾rdoba	Group 1903 Radius and ulna fracture 813	Women	168
C¾rdoba	Group 1904 Femur fracture  820-821	Both sexes	1.134
C¾rdoba	Group 1904 Femur fracture  820-821	Men	337
C¾rdoba	Group 1904 Femur fracture  820-821	Women	797
C¾rdoba	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	385
C¾rdoba	Group 1905 Leg fracture, including the ankle 823-824	Men	199
C¾rdoba	Group 1905 Leg fracture, including the ankle 823-824	Women	186
C¾rdoba	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.205
C¾rdoba	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	721
C¾rdoba	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	484
C¾rdoba	Group 1907 Burns  940-949	Both sexes	72
C¾rdoba	Group 1907 Burns  940-949	Men	40
C¾rdoba	Group 1907 Burns  940-949	Women	32
C¾rdoba	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	211
C¾rdoba	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	87
C¾rdoba	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	124
C¾rdoba	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.938
C¾rdoba	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.032
C¾rdoba	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	906
C¾rdoba	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
C¾rdoba	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
C¾rdoba	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
C¾rdoba	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	143
C¾rdoba	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	88
C¾rdoba	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	55
C¾rdoba	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	799
C¾rdoba	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	517
C¾rdoba	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	282
C¾rdoba	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	78
C¾rdoba	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	38
C¾rdoba	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	40
C¾rdoba	Group 2102 Contraceptive management  V25	Both sexes	8
C¾rdoba	Group 2102 Contraceptive management  V25	Men	2
C¾rdoba	Group 2102 Contraceptive management  V25	Women	6
C¾rdoba	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
C¾rdoba	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
C¾rdoba	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
C¾rdoba	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	465
C¾rdoba	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	343
C¾rdoba	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	122
C¾rdoba	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	248
C¾rdoba	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	134
C¾rdoba	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	114
Granada	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	73.980
Granada	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	33.336
Granada	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	40.644
Granada	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.733
Granada	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.016
Granada	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	717
Granada	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	166
Granada	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	100
Granada	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	66
Granada	Group 0102 Imprecise intestinal infections 009	Both sexes	58
Granada	Group 0102 Imprecise intestinal infections 009	Men	29
Granada	Group 0102 Imprecise intestinal infections 009	Women	29
Granada	Group 0103 Tuberculosis 010-018, 137	Both sexes	53
Granada	Group 0103 Tuberculosis 010-018, 137	Men	36
Granada	Group 0103 Tuberculosis 010-018, 137	Women	17
Granada	Group 0104 Septicaemia  038	Both sexes	893
Granada	Group 0104 Septicaemia  038	Men	490
Granada	Group 0104 Septicaemia  038	Women	403
Granada	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	50
Granada	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	40
Granada	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	10
Granada	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	513
Granada	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	321
Granada	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	192
Granada	Group 0200 Neoplasms  140-239	Both sexes	7.502
Granada	Group 0200 Neoplasms  140-239	Men	3.843
Granada	Group 0200 Neoplasms  140-239	Women	3.659
Granada	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	698
Granada	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	418
Granada	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	280
Granada	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	551
Granada	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	449
Granada	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	102
Granada	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	327
Granada	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	202
Granada	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	125
Granada	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	637
Granada	Group 0204 Malignant neoplasm of breast  174-175	Men	5
Granada	Group 0204 Malignant neoplasm of breast  174-175	Women	632
Granada	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	174
Granada	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Granada	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	174
Granada	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	79
Granada	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Granada	Group 0206 Malignant neoplasm of ovary  1830	Women	79
Granada	Group 0207 Malignant neoplasm of prostate  185	Both sexes	231
Granada	Group 0207 Malignant neoplasm of prostate  185	Men	231
Granada	Group 0207 Malignant neoplasm of prostate  185	Women	..
Granada	Group 0208 Malignant neoplasm of bladder  188	Both sexes	704
Granada	Group 0208 Malignant neoplasm of bladder  188	Men	578
Granada	Group 0208 Malignant neoplasm of bladder  188	Women	126
Granada	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.471
Granada	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.465
Granada	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.006
Granada	Group 0210 Carcinoma in situ  230-234	Both sexes	77
Granada	Group 0210 Carcinoma in situ  230-234	Men	20
Granada	Group 0210 Carcinoma in situ  230-234	Women	57
Granada	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	37
Granada	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	21
Granada	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	16
Granada	Grupo 0212 Leiomyoma of uterus  218	Both sexes	433
Granada	Grupo 0212 Leiomyoma of uterus  218	Men	..
Granada	Grupo 0212 Leiomyoma of uterus  218	Women	433
Granada	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.083
Granada	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	454
Granada	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	629
Granada	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	545
Granada	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	262
Granada	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	283
Granada	Group 0301 Anaemias 280-285	Both sexes	189
Granada	Group 0301 Anaemias 280-285	Men	82
Granada	Group 0301 Anaemias 280-285	Women	107
Granada	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	356
Granada	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	180
Granada	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	176
Granada	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.496
Granada	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	546
Granada	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	950
Granada	Group 0401 Diabetes mellitus  249-250	Both sexes	481
Granada	Group 0401 Diabetes mellitus  249-250	Men	262
Granada	Group 0401 Diabetes mellitus  249-250	Women	219
Granada	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.015
Granada	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	284
Granada	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	731
Granada	Group 0500 Mental disorders  290-319	Both sexes	1.245
Granada	Group 0500 Mental disorders  290-319	Men	668
Granada	Group 0500 Mental disorders  290-319	Women	577
Granada	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	8
Granada	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	2
Granada	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	6
Granada	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	93
Granada	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	64
Granada	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	29
Granada	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	90
Granada	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	74
Granada	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	16
Granada	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	445
Granada	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	275
Granada	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	170
Granada	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	273
Granada	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	115
Granada	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	158
Granada	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	336
Granada	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	138
Granada	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	198
Granada	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.560
Granada	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	761
Granada	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	799
Granada	Group 0601 Alzheimer's disease  3310	Both sexes	11
Granada	Group 0601 Alzheimer's disease  3310	Men	6
Granada	Group 0601 Alzheimer's disease  3310	Women	5
Granada	Group 0602 Multiple sclerosis 340	Both sexes	26
Granada	Group 0602 Multiple sclerosis 340	Men	10
Granada	Group 0602 Multiple sclerosis 340	Women	16
Granada	Group 0603 Epilepsy  345	Both sexes	246
Granada	Group 0603 Epilepsy  345	Men	120
Granada	Group 0603 Epilepsy  345	Women	126
Granada	Group 0604 Transient cerebral ischemia 435	Both sexes	197
Granada	Group 0604 Transient cerebral ischemia 435	Men	104
Granada	Group 0604 Transient cerebral ischemia 435	Women	93
Granada	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.080
Granada	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	521
Granada	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	559
Granada	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	737
Granada	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	380
Granada	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	357
Granada	Grupo 0701 Cataract  366	Both sexes	142
Granada	Grupo 0701 Cataract  366	Men	75
Granada	Grupo 0701 Cataract  366	Women	67
Granada	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	595
Granada	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	305
Granada	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	290
Granada	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	375
Granada	Group 0800 Diseases of the ear and the mastoid  380-389	Men	197
Granada	Group 0800 Diseases of the ear and the mastoid  380-389	Women	178
Granada	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	9.394
Granada	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.396
Granada	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.998
Granada	Group 0901 Hypertensive disease  401-405	Both sexes	503
Granada	Group 0901 Hypertensive disease  401-405	Men	197
Granada	Group 0901 Hypertensive disease  401-405	Women	306
Granada	Group 0902 Angina pectoris  4111, 413	Both sexes	527
Granada	Group 0902 Angina pectoris  4111, 413	Men	335
Granada	Group 0902 Angina pectoris  4111, 413	Women	192
Granada	Group 0903 Acute myocardial infarction  410	Both sexes	1.094
Granada	Group 0903 Acute myocardial infarction  410	Men	767
Granada	Group 0903 Acute myocardial infarction  410	Women	327
Granada	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	596
Granada	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	439
Granada	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	157
Granada	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	429
Granada	Group 0905 Diseases of the lungs circulation 415-417	Men	207
Granada	Group 0905 Diseases of the lungs circulation 415-417	Women	222
Granada	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.006
Granada	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	596
Granada	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	410
Granada	Grupo 0907 Heart failure  428	Both sexes	1.580
Granada	Grupo 0907 Heart failure  428	Men	773
Granada	Grupo 0907 Heart failure  428	Women	807
Granada	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.892
Granada	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	997
Granada	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	895
Granada	Grupo 0909 Atherosclerosis  440	Both sexes	312
Granada	Grupo 0909 Atherosclerosis  440	Men	228
Granada	Grupo 0909 Atherosclerosis  440	Women	84
Granada	Group 0910 Varicose veins of lower extremities 454	Both sexes	65
Granada	Group 0910 Varicose veins of lower extremities 454	Men	31
Granada	Group 0910 Varicose veins of lower extremities 454	Women	34
Granada	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.390
Granada	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	826
Granada	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	564
Granada	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.742
Granada	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.025
Granada	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.717
Granada	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	479
Granada	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	282
Granada	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	197
Granada	Group 1002 Pneumonia 480-486	Both sexes	1.580
Granada	Group 1002 Pneumonia 480-486	Men	978
Granada	Group 1002 Pneumonia 480-486	Women	602
Granada	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	593
Granada	Group 1003 Acute bronchitis and bronchiolitis  466	Men	307
Granada	Group 1003 Acute bronchitis and bronchiolitis  466	Women	286
Granada	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	327
Granada	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	166
Granada	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	161
Granada	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	578
Granada	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	380
Granada	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	198
Granada	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	717
Granada	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	633
Granada	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	84
Granada	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	356
Granada	Group 1007 Asthma 4930-4931,4938-4939	Men	111
Granada	Group 1007 Asthma 4930-4931,4938-4939	Women	245
Granada	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.112
Granada	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.168
Granada	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	944
Granada	Group 1100 Diseases of the digestive system  520-579	Both sexes	9.581
Granada	Group 1100 Diseases of the digestive system  520-579	Men	5.190
Granada	Group 1100 Diseases of the digestive system  520-579	Women	4.391
Granada	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	331
Granada	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	144
Granada	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	187
Granada	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	201
Granada	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	115
Granada	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	86
Granada	Group 1103 Diseases of the esophagus 530	Both sexes	139
Granada	Group 1103 Diseases of the esophagus 530	Men	87
Granada	Group 1103 Diseases of the esophagus 530	Women	52
Granada	Group 1104 Peptic ulcer 531-534	Both sexes	187
Granada	Group 1104 Peptic ulcer 531-534	Men	129
Granada	Group 1104 Peptic ulcer 531-534	Women	58
Granada	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	189
Granada	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	100
Granada	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	89
Granada	Group 1106 Appendicitis  540-543	Both sexes	983
Granada	Group 1106 Appendicitis  540-543	Men	554
Granada	Group 1106 Appendicitis  540-543	Women	429
Granada	Group 1107 Inguinal hernia  550	Both sexes	610
Granada	Group 1107 Inguinal hernia  550	Men	541
Granada	Group 1107 Inguinal hernia  550	Women	69
Granada	Group 1108 Other abdominal hernia  551-553	Both sexes	849
Granada	Group 1108 Other abdominal hernia  551-553	Men	357
Granada	Group 1108 Other abdominal hernia  551-553	Women	492
Granada	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	159
Granada	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	87
Granada	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	72
Granada	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	338
Granada	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	187
Granada	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	151
Granada	Group 1111 Intestinal obstruction without hernia 560	Both sexes	380
Granada	Group 1111 Intestinal obstruction without hernia 560	Men	191
Granada	Group 1111 Intestinal obstruction without hernia 560	Women	189
Granada	Group 1112 Intestinal diverticulosis 562	Both sexes	241
Granada	Group 1112 Intestinal diverticulosis 562	Men	129
Granada	Group 1112 Intestinal diverticulosis 562	Women	112
Granada	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	721
Granada	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	480
Granada	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	241
Granada	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	249
Granada	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	127
Granada	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	122
Granada	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	154
Granada	Group 1115 Alcoholic hepatitis 5710-5713	Men	130
Granada	Group 1115 Alcoholic hepatitis 5710-5713	Women	24
Granada	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	388
Granada	Group 1116 Other diseases of the liver 570,5714-573	Men	260
Granada	Group 1116 Other diseases of the liver 570,5714-573	Women	128
Granada	Group 1117 Cholelithiasis  574	Both sexes	1.934
Granada	Group 1117 Cholelithiasis  574	Men	765
Granada	Group 1117 Cholelithiasis  574	Women	1.169
Granada	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	496
Granada	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	237
Granada	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	259
Granada	Group 1119 Pancreatic diseases 577	Both sexes	711
Granada	Group 1119 Pancreatic diseases 577	Men	391
Granada	Group 1119 Pancreatic diseases 577	Women	320
Granada	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	321
Granada	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	179
Granada	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	142
Granada	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	617
Granada	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	340
Granada	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	277
Granada	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	350
Granada	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	208
Granada	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	142
Granada	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	28
Granada	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	13
Granada	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	15
Granada	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	239
Granada	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	119
Granada	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	120
Granada	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.179
Granada	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.954
Granada	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.225
Granada	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Granada	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Granada	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Granada	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Granada	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Granada	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Granada	Group 1303 Internal derangement of knee 717	Both sexes	193
Granada	Group 1303 Internal derangement of knee 717	Men	134
Granada	Group 1303 Internal derangement of knee 717	Women	59
Granada	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.138
Granada	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	872
Granada	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.266
Granada	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	149
Granada	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	39
Granada	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	110
Granada	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	378
Granada	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	183
Granada	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	195
Granada	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	292
Granada	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	174
Granada	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	118
Granada	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	30
Granada	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	14
Granada	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	16
Granada	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	458
Granada	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	256
Granada	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	202
Granada	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	541
Granada	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	282
Granada	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	259
Granada	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.116
Granada	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.788
Granada	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.328
Granada	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	589
Granada	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	277
Granada	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	312
Granada	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	598
Granada	Group 1402 Renal failure  5836-5837, 584-586	Men	368
Granada	Group 1402 Renal failure  5836-5837, 584-586	Women	230
Granada	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	343
Granada	Group 1403 Urolithiasis  592, 594, 7880	Men	191
Granada	Group 1403 Urolithiasis  592, 594, 7880	Women	152
Granada	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	718
Granada	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	395
Granada	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	323
Granada	Group 1405 Prostatic hyperplasia  600	Both sexes	281
Granada	Group 1405 Prostatic hyperplasia  600	Men	281
Granada	Group 1405 Prostatic hyperplasia  600	Women	..
Granada	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	255
Granada	Group 1406 Other diseases of the male genital organs    601-608	Men	255
Granada	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Granada	Group 1407 Disorders of breast  610-612	Both sexes	226
Granada	Group 1407 Disorders of breast  610-612	Men	20
Granada	Group 1407 Disorders of breast  610-612	Women	206
Granada	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	186
Granada	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Granada	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	186
Granada	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	70
Granada	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Granada	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	70
Granada	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	850
Granada	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Granada	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	849
Granada	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	10.570
Granada	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Granada	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	10.570
Granada	Group 1501 Legally induced abortion  635	Both sexes	3
Granada	Group 1501 Legally induced abortion  635	Men	..
Granada	Group 1501 Legally induced abortion  635	Women	3
Granada	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	990
Granada	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Granada	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	990
Granada	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.558
Granada	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Granada	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.558
Granada	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.121
Granada	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Granada	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.121
Granada	Group 1505 Single spontaneous delivery  650	Both sexes	546
Granada	Group 1505 Single spontaneous delivery  650	Men	..
Granada	Group 1505 Single spontaneous delivery  650	Women	546
Granada	Group 1506 Other deliveries  6695-6697	Both sexes	528
Granada	Group 1506 Other deliveries  6695-6697	Men	..
Granada	Group 1506 Other deliveries  6695-6697	Women	528
Granada	Group 1507 Complications related to the puerperium  670-676	Both sexes	72
Granada	Group 1507 Complications related to the puerperium  670-676	Men	..
Granada	Group 1507 Complications related to the puerperium  670-676	Women	72
Granada	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	752
Granada	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Granada	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	752
Granada	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	948
Granada	Group 1600 Some disorders originating in the perinatal period  760-779	Men	524
Granada	Group 1600 Some disorders originating in the perinatal period  760-779	Women	424
Granada	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	358
Granada	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	205
Granada	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	153
Granada	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	590
Granada	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	319
Granada	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	271
Granada	Grupo 1700 Congenital abnormalities  740-759	Both sexes	582
Granada	Grupo 1700 Congenital abnormalities  740-759	Men	354
Granada	Grupo 1700 Congenital abnormalities  740-759	Women	228
Granada	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.055
Granada	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.575
Granada	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.480
Granada	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	249
Granada	Group 1801 Pain in throat and chest 7841, 7865	Men	130
Granada	Group 1801 Pain in throat and chest 7841, 7865	Women	119
Granada	Group 1802 Abdominal pain   7890	Both sexes	201
Granada	Group 1802 Abdominal pain   7890	Men	77
Granada	Group 1802 Abdominal pain   7890	Women	124
Granada	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.338
Granada	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	681
Granada	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	657
Granada	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.267
Granada	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	687
Granada	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	580
Granada	Group 1900 Injuries and poisoning  800-999	Both sexes	7.810
Granada	Group 1900 Injuries and poisoning  800-999	Men	3.980
Granada	Group 1900 Injuries and poisoning  800-999	Women	3.830
Granada	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	258
Granada	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	163
Granada	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	95
Granada	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	236
Granada	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	177
Granada	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	59
Granada	Group 1903 Radius and ulna fracture 813	Both sexes	743
Granada	Group 1903 Radius and ulna fracture 813	Men	330
Granada	Group 1903 Radius and ulna fracture 813	Women	413
Granada	Group 1904 Femur fracture  820-821	Both sexes	1.245
Granada	Group 1904 Femur fracture  820-821	Men	352
Granada	Group 1904 Femur fracture  820-821	Women	893
Granada	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	677
Granada	Group 1905 Leg fracture, including the ankle 823-824	Men	362
Granada	Group 1905 Leg fracture, including the ankle 823-824	Women	315
Granada	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.278
Granada	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.416
Granada	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	862
Granada	Group 1907 Burns  940-949	Both sexes	85
Granada	Group 1907 Burns  940-949	Men	46
Granada	Group 1907 Burns  940-949	Women	39
Granada	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	216
Granada	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	99
Granada	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	117
Granada	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.872
Granada	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	923
Granada	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	949
Granada	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	30
Granada	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	21
Granada	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	9
Granada	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	170
Granada	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	91
Granada	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	79
Granada	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.193
Granada	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	537
Granada	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	656
Granada	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	37
Granada	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	25
Granada	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	12
Granada	Group 2102 Contraceptive management  V25	Both sexes	6
Granada	Group 2102 Contraceptive management  V25	Men	1
Granada	Group 2102 Contraceptive management  V25	Women	5
Granada	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Granada	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Granada	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Granada	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	389
Granada	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	231
Granada	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	158
Granada	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	761
Granada	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	280
Granada	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	481
Huelva	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	40.505
Huelva	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.156
Huelva	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	22.349
Huelva	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	741
Huelva	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	412
Huelva	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	329
Huelva	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	101
Huelva	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	47
Huelva	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	54
Huelva	Group 0102 Imprecise intestinal infections 009	Both sexes	83
Huelva	Group 0102 Imprecise intestinal infections 009	Men	31
Huelva	Group 0102 Imprecise intestinal infections 009	Women	52
Huelva	Group 0103 Tuberculosis 010-018, 137	Both sexes	54
Huelva	Group 0103 Tuberculosis 010-018, 137	Men	35
Huelva	Group 0103 Tuberculosis 010-018, 137	Women	19
Huelva	Group 0104 Septicaemia  038	Both sexes	209
Huelva	Group 0104 Septicaemia  038	Men	113
Huelva	Group 0104 Septicaemia  038	Women	96
Huelva	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	45
Huelva	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	36
Huelva	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	9
Huelva	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	249
Huelva	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	150
Huelva	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	99
Huelva	Group 0200 Neoplasms  140-239	Both sexes	3.161
Huelva	Group 0200 Neoplasms  140-239	Men	1.698
Huelva	Group 0200 Neoplasms  140-239	Women	1.463
Huelva	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	466
Huelva	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	266
Huelva	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	200
Huelva	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	210
Huelva	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	175
Huelva	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	35
Huelva	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	15
Huelva	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	9
Huelva	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	6
Huelva	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	279
Huelva	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Huelva	Group 0204 Malignant neoplasm of breast  174-175	Women	276
Huelva	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	70
Huelva	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Huelva	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	70
Huelva	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	39
Huelva	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Huelva	Group 0206 Malignant neoplasm of ovary  1830	Women	39
Huelva	Group 0207 Malignant neoplasm of prostate  185	Both sexes	104
Huelva	Group 0207 Malignant neoplasm of prostate  185	Men	104
Huelva	Group 0207 Malignant neoplasm of prostate  185	Women	..
Huelva	Group 0208 Malignant neoplasm of bladder  188	Both sexes	351
Huelva	Group 0208 Malignant neoplasm of bladder  188	Men	301
Huelva	Group 0208 Malignant neoplasm of bladder  188	Women	50
Huelva	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.012
Huelva	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	639
Huelva	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	373
Huelva	Group 0210 Carcinoma in situ  230-234	Both sexes	30
Huelva	Group 0210 Carcinoma in situ  230-234	Men	13
Huelva	Group 0210 Carcinoma in situ  230-234	Women	17
Huelva	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	36
Huelva	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	23
Huelva	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	13
Huelva	Grupo 0212 Leiomyoma of uterus  218	Both sexes	186
Huelva	Grupo 0212 Leiomyoma of uterus  218	Men	..
Huelva	Grupo 0212 Leiomyoma of uterus  218	Women	186
Huelva	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	363
Huelva	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	165
Huelva	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	198
Huelva	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	569
Huelva	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	267
Huelva	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	302
Huelva	Group 0301 Anaemias 280-285	Both sexes	361
Huelva	Group 0301 Anaemias 280-285	Men	170
Huelva	Group 0301 Anaemias 280-285	Women	191
Huelva	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	208
Huelva	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	97
Huelva	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	111
Huelva	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	669
Huelva	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	303
Huelva	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	366
Huelva	Group 0401 Diabetes mellitus  249-250	Both sexes	264
Huelva	Group 0401 Diabetes mellitus  249-250	Men	160
Huelva	Group 0401 Diabetes mellitus  249-250	Women	104
Huelva	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	405
Huelva	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	143
Huelva	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	262
Huelva	Group 0500 Mental disorders  290-319	Both sexes	893
Huelva	Group 0500 Mental disorders  290-319	Men	440
Huelva	Group 0500 Mental disorders  290-319	Women	453
Huelva	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	22
Huelva	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	18
Huelva	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	4
Huelva	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	31
Huelva	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	25
Huelva	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	6
Huelva	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	30
Huelva	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	25
Huelva	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
Huelva	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	296
Huelva	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	181
Huelva	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	115
Huelva	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	191
Huelva	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	67
Huelva	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	124
Huelva	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	323
Huelva	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	124
Huelva	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	199
Huelva	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	959
Huelva	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	479
Huelva	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	480
Huelva	Group 0601 Alzheimer's disease  3310	Both sexes	35
Huelva	Group 0601 Alzheimer's disease  3310	Men	12
Huelva	Group 0601 Alzheimer's disease  3310	Women	23
Huelva	Group 0602 Multiple sclerosis 340	Both sexes	17
Huelva	Group 0602 Multiple sclerosis 340	Men	5
Huelva	Group 0602 Multiple sclerosis 340	Women	12
Huelva	Group 0603 Epilepsy  345	Both sexes	180
Huelva	Group 0603 Epilepsy  345	Men	95
Huelva	Group 0603 Epilepsy  345	Women	85
Huelva	Group 0604 Transient cerebral ischemia 435	Both sexes	240
Huelva	Group 0604 Transient cerebral ischemia 435	Men	131
Huelva	Group 0604 Transient cerebral ischemia 435	Women	109
Huelva	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	487
Huelva	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	236
Huelva	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	251
Huelva	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	157
Huelva	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	83
Huelva	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	74
Huelva	Grupo 0701 Cataract  366	Both sexes	7
Huelva	Grupo 0701 Cataract  366	Men	4
Huelva	Grupo 0701 Cataract  366	Women	3
Huelva	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	150
Huelva	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	79
Huelva	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	71
Huelva	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	318
Huelva	Group 0800 Diseases of the ear and the mastoid  380-389	Men	140
Huelva	Group 0800 Diseases of the ear and the mastoid  380-389	Women	178
Huelva	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.066
Huelva	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.414
Huelva	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.652
Huelva	Group 0901 Hypertensive disease  401-405	Both sexes	515
Huelva	Group 0901 Hypertensive disease  401-405	Men	203
Huelva	Group 0901 Hypertensive disease  401-405	Women	312
Huelva	Group 0902 Angina pectoris  4111, 413	Both sexes	557
Huelva	Group 0902 Angina pectoris  4111, 413	Men	321
Huelva	Group 0902 Angina pectoris  4111, 413	Women	236
Huelva	Group 0903 Acute myocardial infarction  410	Both sexes	464
Huelva	Group 0903 Acute myocardial infarction  410	Men	332
Huelva	Group 0903 Acute myocardial infarction  410	Women	132
Huelva	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	391
Huelva	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	277
Huelva	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	114
Huelva	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	137
Huelva	Group 0905 Diseases of the lungs circulation 415-417	Men	70
Huelva	Group 0905 Diseases of the lungs circulation 415-417	Women	67
Huelva	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	928
Huelva	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	496
Huelva	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	432
Huelva	Grupo 0907 Heart failure  428	Both sexes	979
Huelva	Grupo 0907 Heart failure  428	Men	492
Huelva	Grupo 0907 Heart failure  428	Women	487
Huelva	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.005
Huelva	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	585
Huelva	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	420
Huelva	Grupo 0909 Atherosclerosis  440	Both sexes	151
Huelva	Grupo 0909 Atherosclerosis  440	Men	105
Huelva	Grupo 0909 Atherosclerosis  440	Women	46
Huelva	Group 0910 Varicose veins of lower extremities 454	Both sexes	132
Huelva	Group 0910 Varicose veins of lower extremities 454	Men	62
Huelva	Group 0910 Varicose veins of lower extremities 454	Women	70
Huelva	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	807
Huelva	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	471
Huelva	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	336
Huelva	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	3.472
Huelva	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.961
Huelva	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.511
Huelva	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	231
Huelva	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	120
Huelva	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	111
Huelva	Group 1002 Pneumonia 480-486	Both sexes	698
Huelva	Group 1002 Pneumonia 480-486	Men	414
Huelva	Group 1002 Pneumonia 480-486	Women	284
Huelva	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	349
Huelva	Group 1003 Acute bronchitis and bronchiolitis  466	Men	158
Huelva	Group 1003 Acute bronchitis and bronchiolitis  466	Women	191
Huelva	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	247
Huelva	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	123
Huelva	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	124
Huelva	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	409
Huelva	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	268
Huelva	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	141
Huelva	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	434
Huelva	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	336
Huelva	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	98
Huelva	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	104
Huelva	Group 1007 Asthma 4930-4931,4938-4939	Men	19
Huelva	Group 1007 Asthma 4930-4931,4938-4939	Women	85
Huelva	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.000
Huelva	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	523
Huelva	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	477
Huelva	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.111
Huelva	Group 1100 Diseases of the digestive system  520-579	Men	2.842
Huelva	Group 1100 Diseases of the digestive system  520-579	Women	2.269
Huelva	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	18
Huelva	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	10
Huelva	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	8
Huelva	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	56
Huelva	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	30
Huelva	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	26
Huelva	Group 1103 Diseases of the esophagus 530	Both sexes	122
Huelva	Group 1103 Diseases of the esophagus 530	Men	68
Huelva	Group 1103 Diseases of the esophagus 530	Women	54
Huelva	Group 1104 Peptic ulcer 531-534	Both sexes	137
Huelva	Group 1104 Peptic ulcer 531-534	Men	93
Huelva	Group 1104 Peptic ulcer 531-534	Women	44
Huelva	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	175
Huelva	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	100
Huelva	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	75
Huelva	Group 1106 Appendicitis  540-543	Both sexes	404
Huelva	Group 1106 Appendicitis  540-543	Men	235
Huelva	Group 1106 Appendicitis  540-543	Women	169
Huelva	Group 1107 Inguinal hernia  550	Both sexes	413
Huelva	Group 1107 Inguinal hernia  550	Men	368
Huelva	Group 1107 Inguinal hernia  550	Women	45
Huelva	Group 1108 Other abdominal hernia  551-553	Both sexes	363
Huelva	Group 1108 Other abdominal hernia  551-553	Men	177
Huelva	Group 1108 Other abdominal hernia  551-553	Women	186
Huelva	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	135
Huelva	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	77
Huelva	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	58
Huelva	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	287
Huelva	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	145
Huelva	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	142
Huelva	Group 1111 Intestinal obstruction without hernia 560	Both sexes	190
Huelva	Group 1111 Intestinal obstruction without hernia 560	Men	82
Huelva	Group 1111 Intestinal obstruction without hernia 560	Women	108
Huelva	Group 1112 Intestinal diverticulosis 562	Both sexes	149
Huelva	Group 1112 Intestinal diverticulosis 562	Men	70
Huelva	Group 1112 Intestinal diverticulosis 562	Women	79
Huelva	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	467
Huelva	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	301
Huelva	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	166
Huelva	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	187
Huelva	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	90
Huelva	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	97
Huelva	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	100
Huelva	Group 1115 Alcoholic hepatitis 5710-5713	Men	95
Huelva	Group 1115 Alcoholic hepatitis 5710-5713	Women	5
Huelva	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	164
Huelva	Group 1116 Other diseases of the liver 570,5714-573	Men	95
Huelva	Group 1116 Other diseases of the liver 570,5714-573	Women	69
Huelva	Group 1117 Cholelithiasis  574	Both sexes	946
Huelva	Group 1117 Cholelithiasis  574	Men	399
Huelva	Group 1117 Cholelithiasis  574	Women	547
Huelva	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	222
Huelva	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	113
Huelva	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	109
Huelva	Group 1119 Pancreatic diseases 577	Both sexes	340
Huelva	Group 1119 Pancreatic diseases 577	Men	185
Huelva	Group 1119 Pancreatic diseases 577	Women	155
Huelva	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	236
Huelva	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	109
Huelva	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	127
Huelva	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	369
Huelva	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	206
Huelva	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	163
Huelva	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	217
Huelva	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	133
Huelva	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	84
Huelva	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	26
Huelva	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
Huelva	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	14
Huelva	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	126
Huelva	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	61
Huelva	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	65
Huelva	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.428
Huelva	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.101
Huelva	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.327
Huelva	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Huelva	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Huelva	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Huelva	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Huelva	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Huelva	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Huelva	Group 1303 Internal derangement of knee 717	Both sexes	162
Huelva	Group 1303 Internal derangement of knee 717	Men	118
Huelva	Group 1303 Internal derangement of knee 717	Women	44
Huelva	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.053
Huelva	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	421
Huelva	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	632
Huelva	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	50
Huelva	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	24
Huelva	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	26
Huelva	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	105
Huelva	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	50
Huelva	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	55
Huelva	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	237
Huelva	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	99
Huelva	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	138
Huelva	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	123
Huelva	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	54
Huelva	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	69
Huelva	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	334
Huelva	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	190
Huelva	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	144
Huelva	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	364
Huelva	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	145
Huelva	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	219
Huelva	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.209
Huelva	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	921
Huelva	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.288
Huelva	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	233
Huelva	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	90
Huelva	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	143
Huelva	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	219
Huelva	Group 1402 Renal failure  5836-5837, 584-586	Men	122
Huelva	Group 1402 Renal failure  5836-5837, 584-586	Women	97
Huelva	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	422
Huelva	Group 1403 Urolithiasis  592, 594, 7880	Men	246
Huelva	Group 1403 Urolithiasis  592, 594, 7880	Women	176
Huelva	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	552
Huelva	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	210
Huelva	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	342
Huelva	Group 1405 Prostatic hyperplasia  600	Both sexes	124
Huelva	Group 1405 Prostatic hyperplasia  600	Men	124
Huelva	Group 1405 Prostatic hyperplasia  600	Women	..
Huelva	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	112
Huelva	Group 1406 Other diseases of the male genital organs    601-608	Men	112
Huelva	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Huelva	Group 1407 Disorders of breast  610-612	Both sexes	63
Huelva	Group 1407 Disorders of breast  610-612	Men	17
Huelva	Group 1407 Disorders of breast  610-612	Women	46
Huelva	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	71
Huelva	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Huelva	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	71
Huelva	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	33
Huelva	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Huelva	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	33
Huelva	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	380
Huelva	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Huelva	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	380
Huelva	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.900
Huelva	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Huelva	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.900
Huelva	Group 1501 Legally induced abortion  635	Both sexes	18
Huelva	Group 1501 Legally induced abortion  635	Men	..
Huelva	Group 1501 Legally induced abortion  635	Women	18
Huelva	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	433
Huelva	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Huelva	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	433
Huelva	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.022
Huelva	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Huelva	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.022
Huelva	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	396
Huelva	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Huelva	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	396
Huelva	Group 1505 Single spontaneous delivery  650	Both sexes	392
Huelva	Group 1505 Single spontaneous delivery  650	Men	..
Huelva	Group 1505 Single spontaneous delivery  650	Women	392
Huelva	Group 1506 Other deliveries  6695-6697	Both sexes	115
Huelva	Group 1506 Other deliveries  6695-6697	Men	..
Huelva	Group 1506 Other deliveries  6695-6697	Women	115
Huelva	Group 1507 Complications related to the puerperium  670-676	Both sexes	59
Huelva	Group 1507 Complications related to the puerperium  670-676	Men	..
Huelva	Group 1507 Complications related to the puerperium  670-676	Women	59
Huelva	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	465
Huelva	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Huelva	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	465
Huelva	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	464
Huelva	Group 1600 Some disorders originating in the perinatal period  760-779	Men	239
Huelva	Group 1600 Some disorders originating in the perinatal period  760-779	Women	225
Huelva	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	177
Huelva	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	78
Huelva	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	99
Huelva	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	287
Huelva	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	161
Huelva	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	126
Huelva	Grupo 1700 Congenital abnormalities  740-759	Both sexes	159
Huelva	Grupo 1700 Congenital abnormalities  740-759	Men	87
Huelva	Grupo 1700 Congenital abnormalities  740-759	Women	72
Huelva	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.074
Huelva	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.639
Huelva	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.435
Huelva	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	615
Huelva	Group 1801 Pain in throat and chest 7841, 7865	Men	351
Huelva	Group 1801 Pain in throat and chest 7841, 7865	Women	264
Huelva	Group 1802 Abdominal pain   7890	Both sexes	415
Huelva	Group 1802 Abdominal pain   7890	Men	174
Huelva	Group 1802 Abdominal pain   7890	Women	241
Huelva	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	243
Huelva	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	127
Huelva	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	116
Huelva	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.801
Huelva	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	987
Huelva	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	814
Huelva	Group 1900 Injuries and poisoning  800-999	Both sexes	3.282
Huelva	Group 1900 Injuries and poisoning  800-999	Men	1.645
Huelva	Group 1900 Injuries and poisoning  800-999	Women	1.637
Huelva	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	142
Huelva	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	81
Huelva	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	61
Huelva	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	74
Huelva	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	50
Huelva	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	24
Huelva	Group 1903 Radius and ulna fracture 813	Both sexes	284
Huelva	Group 1903 Radius and ulna fracture 813	Men	141
Huelva	Group 1903 Radius and ulna fracture 813	Women	143
Huelva	Group 1904 Femur fracture  820-821	Both sexes	530
Huelva	Group 1904 Femur fracture  820-821	Men	151
Huelva	Group 1904 Femur fracture  820-821	Women	379
Huelva	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	242
Huelva	Group 1905 Leg fracture, including the ankle 823-824	Men	123
Huelva	Group 1905 Leg fracture, including the ankle 823-824	Women	119
Huelva	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	970
Huelva	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	562
Huelva	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	408
Huelva	Group 1907 Burns  940-949	Both sexes	4
Huelva	Group 1907 Burns  940-949	Men	1
Huelva	Group 1907 Burns  940-949	Women	3
Huelva	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	149
Huelva	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	74
Huelva	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	75
Huelva	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	800
Huelva	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	410
Huelva	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	390
Huelva	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	15
Huelva	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
Huelva	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	7
Huelva	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	72
Huelva	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	44
Huelva	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	28
Huelva	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	504
Huelva	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	279
Huelva	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	225
Huelva	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	11
Huelva	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	6
Huelva	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
Huelva	Group 2102 Contraceptive management  V25	Both sexes	8
Huelva	Group 2102 Contraceptive management  V25	Men	..
Huelva	Group 2102 Contraceptive management  V25	Women	8
Huelva	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Huelva	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Huelva	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Huelva	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	163
Huelva	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	114
Huelva	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	49
Huelva	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	322
Huelva	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	159
Huelva	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	163
JaÚn	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	48.370
JaÚn	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	22.066
JaÚn	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	26.304
JaÚn	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	767
JaÚn	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	417
JaÚn	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	350
JaÚn	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	98
JaÚn	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	53
JaÚn	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	45
JaÚn	Group 0102 Imprecise intestinal infections 009	Both sexes	23
JaÚn	Group 0102 Imprecise intestinal infections 009	Men	2
JaÚn	Group 0102 Imprecise intestinal infections 009	Women	21
JaÚn	Group 0103 Tuberculosis 010-018, 137	Both sexes	18
JaÚn	Group 0103 Tuberculosis 010-018, 137	Men	12
JaÚn	Group 0103 Tuberculosis 010-018, 137	Women	6
JaÚn	Group 0104 Septicaemia  038	Both sexes	276
JaÚn	Group 0104 Septicaemia  038	Men	135
JaÚn	Group 0104 Septicaemia  038	Women	141
JaÚn	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	46
JaÚn	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	31
JaÚn	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	15
JaÚn	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	306
JaÚn	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	184
JaÚn	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	122
JaÚn	Group 0200 Neoplasms  140-239	Both sexes	3.768
JaÚn	Group 0200 Neoplasms  140-239	Men	1.923
JaÚn	Group 0200 Neoplasms  140-239	Women	1.845
JaÚn	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	486
JaÚn	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	296
JaÚn	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	190
JaÚn	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	273
JaÚn	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	236
JaÚn	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	37
JaÚn	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	47
JaÚn	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	30
JaÚn	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	17
JaÚn	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	358
JaÚn	Group 0204 Malignant neoplasm of breast  174-175	Men	3
JaÚn	Group 0204 Malignant neoplasm of breast  174-175	Women	355
JaÚn	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	96
JaÚn	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
JaÚn	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	96
JaÚn	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	47
JaÚn	Group 0206 Malignant neoplasm of ovary  1830	Men	..
JaÚn	Group 0206 Malignant neoplasm of ovary  1830	Women	47
JaÚn	Group 0207 Malignant neoplasm of prostate  185	Both sexes	58
JaÚn	Group 0207 Malignant neoplasm of prostate  185	Men	58
JaÚn	Group 0207 Malignant neoplasm of prostate  185	Women	..
JaÚn	Group 0208 Malignant neoplasm of bladder  188	Both sexes	429
JaÚn	Group 0208 Malignant neoplasm of bladder  188	Men	360
JaÚn	Group 0208 Malignant neoplasm of bladder  188	Women	69
JaÚn	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.204
JaÚn	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	729
JaÚn	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	475
JaÚn	Group 0210 Carcinoma in situ  230-234	Both sexes	54
JaÚn	Group 0210 Carcinoma in situ  230-234	Men	25
JaÚn	Group 0210 Carcinoma in situ  230-234	Women	29
JaÚn	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	46
JaÚn	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	22
JaÚn	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	24
JaÚn	Grupo 0212 Leiomyoma of uterus  218	Both sexes	233
JaÚn	Grupo 0212 Leiomyoma of uterus  218	Men	..
JaÚn	Grupo 0212 Leiomyoma of uterus  218	Women	233
JaÚn	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	437
JaÚn	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	164
JaÚn	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	273
JaÚn	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	472
JaÚn	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	258
JaÚn	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	214
JaÚn	Group 0301 Anaemias 280-285	Both sexes	247
JaÚn	Group 0301 Anaemias 280-285	Men	134
JaÚn	Group 0301 Anaemias 280-285	Women	113
JaÚn	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	225
JaÚn	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	124
JaÚn	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	101
JaÚn	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	967
JaÚn	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	465
JaÚn	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	502
JaÚn	Group 0401 Diabetes mellitus  249-250	Both sexes	380
JaÚn	Group 0401 Diabetes mellitus  249-250	Men	249
JaÚn	Group 0401 Diabetes mellitus  249-250	Women	131
JaÚn	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	587
JaÚn	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	216
JaÚn	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	371
JaÚn	Group 0500 Mental disorders  290-319	Both sexes	1.130
JaÚn	Group 0500 Mental disorders  290-319	Men	584
JaÚn	Group 0500 Mental disorders  290-319	Women	546
JaÚn	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	28
JaÚn	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	10
JaÚn	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	18
JaÚn	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	38
JaÚn	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	31
JaÚn	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	7
JaÚn	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	32
JaÚn	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	26
JaÚn	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	6
JaÚn	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	282
JaÚn	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	188
JaÚn	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	94
JaÚn	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	305
JaÚn	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	128
JaÚn	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	177
JaÚn	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	445
JaÚn	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	201
JaÚn	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	244
JaÚn	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.106
JaÚn	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	523
JaÚn	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	583
JaÚn	Group 0601 Alzheimer's disease  3310	Both sexes	41
JaÚn	Group 0601 Alzheimer's disease  3310	Men	16
JaÚn	Group 0601 Alzheimer's disease  3310	Women	25
JaÚn	Group 0602 Multiple sclerosis 340	Both sexes	44
JaÚn	Group 0602 Multiple sclerosis 340	Men	13
JaÚn	Group 0602 Multiple sclerosis 340	Women	31
JaÚn	Group 0603 Epilepsy  345	Both sexes	218
JaÚn	Group 0603 Epilepsy  345	Men	117
JaÚn	Group 0603 Epilepsy  345	Women	101
JaÚn	Group 0604 Transient cerebral ischemia 435	Both sexes	237
JaÚn	Group 0604 Transient cerebral ischemia 435	Men	124
JaÚn	Group 0604 Transient cerebral ischemia 435	Women	113
JaÚn	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	566
JaÚn	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	253
JaÚn	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	313
JaÚn	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	621
JaÚn	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	347
JaÚn	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	274
JaÚn	Grupo 0701 Cataract  366	Both sexes	99
JaÚn	Grupo 0701 Cataract  366	Men	58
JaÚn	Grupo 0701 Cataract  366	Women	41
JaÚn	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	522
JaÚn	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	289
JaÚn	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	233
JaÚn	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	131
JaÚn	Group 0800 Diseases of the ear and the mastoid  380-389	Men	50
JaÚn	Group 0800 Diseases of the ear and the mastoid  380-389	Women	81
JaÚn	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.461
JaÚn	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.678
JaÚn	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.783
JaÚn	Group 0901 Hypertensive disease  401-405	Both sexes	457
JaÚn	Group 0901 Hypertensive disease  401-405	Men	169
JaÚn	Group 0901 Hypertensive disease  401-405	Women	288
JaÚn	Group 0902 Angina pectoris  4111, 413	Both sexes	426
JaÚn	Group 0902 Angina pectoris  4111, 413	Men	277
JaÚn	Group 0902 Angina pectoris  4111, 413	Women	149
JaÚn	Group 0903 Acute myocardial infarction  410	Both sexes	938
JaÚn	Group 0903 Acute myocardial infarction  410	Men	651
JaÚn	Group 0903 Acute myocardial infarction  410	Women	287
JaÚn	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	268
JaÚn	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	193
JaÚn	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	75
JaÚn	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	194
JaÚn	Group 0905 Diseases of the lungs circulation 415-417	Men	94
JaÚn	Group 0905 Diseases of the lungs circulation 415-417	Women	100
JaÚn	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	744
JaÚn	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	384
JaÚn	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	360
JaÚn	Grupo 0907 Heart failure  428	Both sexes	1.101
JaÚn	Grupo 0907 Heart failure  428	Men	533
JaÚn	Grupo 0907 Heart failure  428	Women	568
JaÚn	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.227
JaÚn	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	700
JaÚn	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	527
JaÚn	Grupo 0909 Atherosclerosis  440	Both sexes	135
JaÚn	Grupo 0909 Atherosclerosis  440	Men	112
JaÚn	Grupo 0909 Atherosclerosis  440	Women	23
JaÚn	Group 0910 Varicose veins of lower extremities 454	Both sexes	67
JaÚn	Group 0910 Varicose veins of lower extremities 454	Men	27
JaÚn	Group 0910 Varicose veins of lower extremities 454	Women	40
JaÚn	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	904
JaÚn	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	538
JaÚn	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	366
JaÚn	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.539
JaÚn	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.314
JaÚn	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.225
JaÚn	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	385
JaÚn	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	212
JaÚn	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	173
JaÚn	Group 1002 Pneumonia 480-486	Both sexes	1.246
JaÚn	Group 1002 Pneumonia 480-486	Men	715
JaÚn	Group 1002 Pneumonia 480-486	Women	531
JaÚn	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	407
JaÚn	Group 1003 Acute bronchitis and bronchiolitis  466	Men	220
JaÚn	Group 1003 Acute bronchitis and bronchiolitis  466	Women	187
JaÚn	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	106
JaÚn	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	58
JaÚn	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	48
JaÚn	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	330
JaÚn	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	221
JaÚn	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	109
JaÚn	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	595
JaÚn	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	513
JaÚn	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	82
JaÚn	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	108
JaÚn	Group 1007 Asthma 4930-4931,4938-4939	Men	49
JaÚn	Group 1007 Asthma 4930-4931,4938-4939	Women	59
JaÚn	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.362
JaÚn	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.326
JaÚn	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.036
JaÚn	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.113
JaÚn	Group 1100 Diseases of the digestive system  520-579	Men	3.393
JaÚn	Group 1100 Diseases of the digestive system  520-579	Women	2.720
JaÚn	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	63
JaÚn	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	36
JaÚn	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	27
JaÚn	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	90
JaÚn	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	41
JaÚn	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	49
JaÚn	Group 1103 Diseases of the esophagus 530	Both sexes	75
JaÚn	Group 1103 Diseases of the esophagus 530	Men	53
JaÚn	Group 1103 Diseases of the esophagus 530	Women	22
JaÚn	Group 1104 Peptic ulcer 531-534	Both sexes	178
JaÚn	Group 1104 Peptic ulcer 531-534	Men	135
JaÚn	Group 1104 Peptic ulcer 531-534	Women	43
JaÚn	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	147
JaÚn	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	73
JaÚn	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	74
JaÚn	Group 1106 Appendicitis  540-543	Both sexes	441
JaÚn	Group 1106 Appendicitis  540-543	Men	251
JaÚn	Group 1106 Appendicitis  540-543	Women	190
JaÚn	Group 1107 Inguinal hernia  550	Both sexes	374
JaÚn	Group 1107 Inguinal hernia  550	Men	328
JaÚn	Group 1107 Inguinal hernia  550	Women	46
JaÚn	Group 1108 Other abdominal hernia  551-553	Both sexes	398
JaÚn	Group 1108 Other abdominal hernia  551-553	Men	158
JaÚn	Group 1108 Other abdominal hernia  551-553	Women	240
JaÚn	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	174
JaÚn	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	106
JaÚn	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	68
JaÚn	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	268
JaÚn	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	132
JaÚn	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	136
JaÚn	Group 1111 Intestinal obstruction without hernia 560	Both sexes	256
JaÚn	Group 1111 Intestinal obstruction without hernia 560	Men	135
JaÚn	Group 1111 Intestinal obstruction without hernia 560	Women	121
JaÚn	Group 1112 Intestinal diverticulosis 562	Both sexes	190
JaÚn	Group 1112 Intestinal diverticulosis 562	Men	116
JaÚn	Group 1112 Intestinal diverticulosis 562	Women	74
JaÚn	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	518
JaÚn	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	336
JaÚn	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	182
JaÚn	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	153
JaÚn	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	75
JaÚn	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	78
JaÚn	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	134
JaÚn	Group 1115 Alcoholic hepatitis 5710-5713	Men	116
JaÚn	Group 1115 Alcoholic hepatitis 5710-5713	Women	18
JaÚn	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	207
JaÚn	Group 1116 Other diseases of the liver 570,5714-573	Men	134
JaÚn	Group 1116 Other diseases of the liver 570,5714-573	Women	73
JaÚn	Group 1117 Cholelithiasis  574	Both sexes	1.316
JaÚn	Group 1117 Cholelithiasis  574	Men	550
JaÚn	Group 1117 Cholelithiasis  574	Women	766
JaÚn	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	253
JaÚn	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	144
JaÚn	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	109
JaÚn	Group 1119 Pancreatic diseases 577	Both sexes	575
JaÚn	Group 1119 Pancreatic diseases 577	Men	307
JaÚn	Group 1119 Pancreatic diseases 577	Women	268
JaÚn	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	303
JaÚn	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	167
JaÚn	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	136
JaÚn	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	316
JaÚn	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	187
JaÚn	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	129
JaÚn	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	219
JaÚn	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	139
JaÚn	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	80
JaÚn	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	14
JaÚn	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	8
JaÚn	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	6
JaÚn	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	83
JaÚn	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	40
JaÚn	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	43
JaÚn	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.678
JaÚn	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.252
JaÚn	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.426
JaÚn	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
JaÚn	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
JaÚn	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
JaÚn	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
JaÚn	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
JaÚn	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
JaÚn	Group 1303 Internal derangement of knee 717	Both sexes	242
JaÚn	Group 1303 Internal derangement of knee 717	Men	187
JaÚn	Group 1303 Internal derangement of knee 717	Women	55
JaÚn	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.467
JaÚn	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	581
JaÚn	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	886
JaÚn	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	90
JaÚn	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	26
JaÚn	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	64
JaÚn	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	129
JaÚn	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	74
JaÚn	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	55
JaÚn	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	170
JaÚn	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	93
JaÚn	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	77
JaÚn	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	25
JaÚn	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	11
JaÚn	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	14
JaÚn	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	294
JaÚn	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	148
JaÚn	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	146
JaÚn	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	261
JaÚn	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	132
JaÚn	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	129
JaÚn	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.698
JaÚn	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.152
JaÚn	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.546
JaÚn	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	295
JaÚn	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	121
JaÚn	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	174
JaÚn	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	480
JaÚn	Group 1402 Renal failure  5836-5837, 584-586	Men	276
JaÚn	Group 1402 Renal failure  5836-5837, 584-586	Women	204
JaÚn	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	322
JaÚn	Group 1403 Urolithiasis  592, 594, 7880	Men	170
JaÚn	Group 1403 Urolithiasis  592, 594, 7880	Women	152
JaÚn	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	462
JaÚn	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	203
JaÚn	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	259
JaÚn	Group 1405 Prostatic hyperplasia  600	Both sexes	152
JaÚn	Group 1405 Prostatic hyperplasia  600	Men	152
JaÚn	Group 1405 Prostatic hyperplasia  600	Women	..
JaÚn	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	214
JaÚn	Group 1406 Other diseases of the male genital organs    601-608	Men	214
JaÚn	Group 1406 Other diseases of the male genital organs    601-608	Women	..
JaÚn	Group 1407 Disorders of breast  610-612	Both sexes	92
JaÚn	Group 1407 Disorders of breast  610-612	Men	15
JaÚn	Group 1407 Disorders of breast  610-612	Women	77
JaÚn	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	83
JaÚn	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
JaÚn	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	83
JaÚn	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	45
JaÚn	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
JaÚn	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	45
JaÚn	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	553
JaÚn	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
JaÚn	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	552
JaÚn	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	6.608
JaÚn	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
JaÚn	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	6.608
JaÚn	Group 1501 Legally induced abortion  635	Both sexes	4
JaÚn	Group 1501 Legally induced abortion  635	Men	..
JaÚn	Group 1501 Legally induced abortion  635	Women	4
JaÚn	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	383
JaÚn	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
JaÚn	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	383
JaÚn	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.014
JaÚn	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
JaÚn	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.014
JaÚn	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.250
JaÚn	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
JaÚn	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.250
JaÚn	Group 1505 Single spontaneous delivery  650	Both sexes	290
JaÚn	Group 1505 Single spontaneous delivery  650	Men	..
JaÚn	Group 1505 Single spontaneous delivery  650	Women	290
JaÚn	Group 1506 Other deliveries  6695-6697	Both sexes	273
JaÚn	Group 1506 Other deliveries  6695-6697	Men	..
JaÚn	Group 1506 Other deliveries  6695-6697	Women	273
JaÚn	Group 1507 Complications related to the puerperium  670-676	Both sexes	42
JaÚn	Group 1507 Complications related to the puerperium  670-676	Men	..
JaÚn	Group 1507 Complications related to the puerperium  670-676	Women	42
JaÚn	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	352
JaÚn	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
JaÚn	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	352
JaÚn	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	716
JaÚn	Group 1600 Some disorders originating in the perinatal period  760-779	Men	394
JaÚn	Group 1600 Some disorders originating in the perinatal period  760-779	Women	322
JaÚn	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	230
JaÚn	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	111
JaÚn	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	119
JaÚn	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	486
JaÚn	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	283
JaÚn	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	203
JaÚn	Grupo 1700 Congenital abnormalities  740-759	Both sexes	157
JaÚn	Grupo 1700 Congenital abnormalities  740-759	Men	79
JaÚn	Grupo 1700 Congenital abnormalities  740-759	Women	78
JaÚn	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.981
JaÚn	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.521
JaÚn	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.460
JaÚn	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	356
JaÚn	Group 1801 Pain in throat and chest 7841, 7865	Men	185
JaÚn	Group 1801 Pain in throat and chest 7841, 7865	Women	171
JaÚn	Group 1802 Abdominal pain   7890	Both sexes	243
JaÚn	Group 1802 Abdominal pain   7890	Men	92
JaÚn	Group 1802 Abdominal pain   7890	Women	151
JaÚn	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.108
JaÚn	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	551
JaÚn	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	557
JaÚn	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.274
JaÚn	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	693
JaÚn	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	581
JaÚn	Group 1900 Injuries and poisoning  800-999	Both sexes	4.290
JaÚn	Group 1900 Injuries and poisoning  800-999	Men	2.160
JaÚn	Group 1900 Injuries and poisoning  800-999	Women	2.130
JaÚn	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	188
JaÚn	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	107
JaÚn	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	81
JaÚn	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	112
JaÚn	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	86
JaÚn	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	26
JaÚn	Group 1903 Radius and ulna fracture 813	Both sexes	337
JaÚn	Group 1903 Radius and ulna fracture 813	Men	183
JaÚn	Group 1903 Radius and ulna fracture 813	Women	154
JaÚn	Group 1904 Femur fracture  820-821	Both sexes	930
JaÚn	Group 1904 Femur fracture  820-821	Men	257
JaÚn	Group 1904 Femur fracture  820-821	Women	673
JaÚn	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	372
JaÚn	Group 1905 Leg fracture, including the ankle 823-824	Men	196
JaÚn	Group 1905 Leg fracture, including the ankle 823-824	Women	176
JaÚn	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.168
JaÚn	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	729
JaÚn	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	439
JaÚn	Group 1907 Burns  940-949	Both sexes	11
JaÚn	Group 1907 Burns  940-949	Men	6
JaÚn	Group 1907 Burns  940-949	Women	5
JaÚn	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	143
JaÚn	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	69
JaÚn	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	74
JaÚn	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	923
JaÚn	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	467
JaÚn	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	456
JaÚn	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	6
JaÚn	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
JaÚn	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
JaÚn	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	100
JaÚn	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	59
JaÚn	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	41
JaÚn	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	851
JaÚn	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	369
JaÚn	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	482
JaÚn	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	45
JaÚn	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	28
JaÚn	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	17
JaÚn	Group 2102 Contraceptive management  V25	Both sexes	15
JaÚn	Group 2102 Contraceptive management  V25	Men	..
JaÚn	Group 2102 Contraceptive management  V25	Women	15
JaÚn	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
JaÚn	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
JaÚn	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
JaÚn	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	393
JaÚn	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	228
JaÚn	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	165
JaÚn	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	398
JaÚn	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	113
JaÚn	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	285
Mßlaga	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	137.716
Mßlaga	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	61.100
Mßlaga	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	76.616
Mßlaga	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.929
Mßlaga	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.627
Mßlaga	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.303
Mßlaga	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	324
Mßlaga	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	158
Mßlaga	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	167
Mßlaga	Group 0102 Imprecise intestinal infections 009	Both sexes	414
Mßlaga	Group 0102 Imprecise intestinal infections 009	Men	178
Mßlaga	Group 0102 Imprecise intestinal infections 009	Women	235
Mßlaga	Group 0103 Tuberculosis 010-018, 137	Both sexes	119
Mßlaga	Group 0103 Tuberculosis 010-018, 137	Men	82
Mßlaga	Group 0103 Tuberculosis 010-018, 137	Women	37
Mßlaga	Group 0104 Septicaemia  038	Both sexes	1.029
Mßlaga	Group 0104 Septicaemia  038	Men	561
Mßlaga	Group 0104 Septicaemia  038	Women	468
Mßlaga	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	167
Mßlaga	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	134
Mßlaga	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	32
Mßlaga	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	877
Mßlaga	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	513
Mßlaga	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	363
Mßlaga	Group 0200 Neoplasms  140-239	Both sexes	13.582
Mßlaga	Group 0200 Neoplasms  140-239	Men	6.680
Mßlaga	Group 0200 Neoplasms  140-239	Women	6.902
Mßlaga	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.238
Mßlaga	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	775
Mßlaga	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	463
Mßlaga	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	934
Mßlaga	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	733
Mßlaga	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	201
Mßlaga	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	396
Mßlaga	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	251
Mßlaga	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	144
Mßlaga	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.226
Mßlaga	Group 0204 Malignant neoplasm of breast  174-175	Men	13
Mßlaga	Group 0204 Malignant neoplasm of breast  174-175	Women	1.213
Mßlaga	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	271
Mßlaga	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Mßlaga	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	271
Mßlaga	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	155
Mßlaga	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Mßlaga	Group 0206 Malignant neoplasm of ovary  1830	Women	155
Mßlaga	Group 0207 Malignant neoplasm of prostate  185	Both sexes	396
Mßlaga	Group 0207 Malignant neoplasm of prostate  185	Men	396
Mßlaga	Group 0207 Malignant neoplasm of prostate  185	Women	..
Mßlaga	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.006
Mßlaga	Group 0208 Malignant neoplasm of bladder  188	Men	859
Mßlaga	Group 0208 Malignant neoplasm of bladder  188	Women	146
Mßlaga	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.788
Mßlaga	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.720
Mßlaga	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.069
Mßlaga	Group 0210 Carcinoma in situ  230-234	Both sexes	247
Mßlaga	Group 0210 Carcinoma in situ  230-234	Men	55
Mßlaga	Group 0210 Carcinoma in situ  230-234	Women	192
Mßlaga	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	93
Mßlaga	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	54
Mßlaga	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	39
Mßlaga	Grupo 0212 Leiomyoma of uterus  218	Both sexes	878
Mßlaga	Grupo 0212 Leiomyoma of uterus  218	Men	..
Mßlaga	Grupo 0212 Leiomyoma of uterus  218	Women	878
Mßlaga	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.955
Mßlaga	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	824
Mßlaga	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.130
Mßlaga	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.088
Mßlaga	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	517
Mßlaga	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	572
Mßlaga	Group 0301 Anaemias 280-285	Both sexes	444
Mßlaga	Group 0301 Anaemias 280-285	Men	213
Mßlaga	Group 0301 Anaemias 280-285	Women	231
Mßlaga	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	644
Mßlaga	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	304
Mßlaga	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	340
Mßlaga	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.314
Mßlaga	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	882
Mßlaga	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.431
Mßlaga	Group 0401 Diabetes mellitus  249-250	Both sexes	599
Mßlaga	Group 0401 Diabetes mellitus  249-250	Men	368
Mßlaga	Group 0401 Diabetes mellitus  249-250	Women	231
Mßlaga	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.715
Mßlaga	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	515
Mßlaga	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.200
Mßlaga	Group 0500 Mental disorders  290-319	Both sexes	2.595
Mßlaga	Group 0500 Mental disorders  290-319	Men	1.389
Mßlaga	Group 0500 Mental disorders  290-319	Women	1.206
Mßlaga	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	40
Mßlaga	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	17
Mßlaga	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	23
Mßlaga	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	98
Mßlaga	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	73
Mßlaga	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	25
Mßlaga	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	161
Mßlaga	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	124
Mßlaga	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	37
Mßlaga	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	807
Mßlaga	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	526
Mßlaga	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	280
Mßlaga	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	681
Mßlaga	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	280
Mßlaga	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	402
Mßlaga	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	808
Mßlaga	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	369
Mßlaga	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	438
Mßlaga	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.475
Mßlaga	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.165
Mßlaga	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.310
Mßlaga	Group 0601 Alzheimer's disease  3310	Both sexes	43
Mßlaga	Group 0601 Alzheimer's disease  3310	Men	10
Mßlaga	Group 0601 Alzheimer's disease  3310	Women	33
Mßlaga	Group 0602 Multiple sclerosis 340	Both sexes	92
Mßlaga	Group 0602 Multiple sclerosis 340	Men	30
Mßlaga	Group 0602 Multiple sclerosis 340	Women	62
Mßlaga	Group 0603 Epilepsy  345	Both sexes	416
Mßlaga	Group 0603 Epilepsy  345	Men	221
Mßlaga	Group 0603 Epilepsy  345	Women	195
Mßlaga	Group 0604 Transient cerebral ischemia 435	Both sexes	402
Mßlaga	Group 0604 Transient cerebral ischemia 435	Men	217
Mßlaga	Group 0604 Transient cerebral ischemia 435	Women	185
Mßlaga	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.522
Mßlaga	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	687
Mßlaga	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	835
Mßlaga	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	881
Mßlaga	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	452
Mßlaga	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	429
Mßlaga	Grupo 0701 Cataract  366	Both sexes	249
Mßlaga	Grupo 0701 Cataract  366	Men	118
Mßlaga	Grupo 0701 Cataract  366	Women	131
Mßlaga	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	631
Mßlaga	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	334
Mßlaga	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	298
Mßlaga	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	736
Mßlaga	Group 0800 Diseases of the ear and the mastoid  380-389	Men	356
Mßlaga	Group 0800 Diseases of the ear and the mastoid  380-389	Women	379
Mßlaga	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	17.829
Mßlaga	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.469
Mßlaga	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.360
Mßlaga	Group 0901 Hypertensive disease  401-405	Both sexes	1.092
Mßlaga	Group 0901 Hypertensive disease  401-405	Men	449
Mßlaga	Group 0901 Hypertensive disease  401-405	Women	643
Mßlaga	Group 0902 Angina pectoris  4111, 413	Both sexes	964
Mßlaga	Group 0902 Angina pectoris  4111, 413	Men	587
Mßlaga	Group 0902 Angina pectoris  4111, 413	Women	377
Mßlaga	Group 0903 Acute myocardial infarction  410	Both sexes	2.118
Mßlaga	Group 0903 Acute myocardial infarction  410	Men	1.501
Mßlaga	Group 0903 Acute myocardial infarction  410	Women	617
Mßlaga	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.976
Mßlaga	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.464
Mßlaga	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	512
Mßlaga	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	400
Mßlaga	Group 0905 Diseases of the lungs circulation 415-417	Men	213
Mßlaga	Group 0905 Diseases of the lungs circulation 415-417	Women	187
Mßlaga	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.705
Mßlaga	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	973
Mßlaga	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	731
Mßlaga	Grupo 0907 Heart failure  428	Both sexes	2.378
Mßlaga	Grupo 0907 Heart failure  428	Men	1.192
Mßlaga	Grupo 0907 Heart failure  428	Women	1.186
Mßlaga	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.761
Mßlaga	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.599
Mßlaga	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.162
Mßlaga	Grupo 0909 Atherosclerosis  440	Both sexes	606
Mßlaga	Grupo 0909 Atherosclerosis  440	Men	450
Mßlaga	Grupo 0909 Atherosclerosis  440	Women	155
Mßlaga	Group 0910 Varicose veins of lower extremities 454	Both sexes	665
Mßlaga	Group 0910 Varicose veins of lower extremities 454	Men	232
Mßlaga	Group 0910 Varicose veins of lower extremities 454	Women	432
Mßlaga	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.165
Mßlaga	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.809
Mßlaga	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.357
Mßlaga	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	11.611
Mßlaga	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	6.609
Mßlaga	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.002
Mßlaga	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	823
Mßlaga	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	401
Mßlaga	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	422
Mßlaga	Group 1002 Pneumonia 480-486	Both sexes	2.421
Mßlaga	Group 1002 Pneumonia 480-486	Men	1.465
Mßlaga	Group 1002 Pneumonia 480-486	Women	956
Mßlaga	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	683
Mßlaga	Group 1003 Acute bronchitis and bronchiolitis  466	Men	357
Mßlaga	Group 1003 Acute bronchitis and bronchiolitis  466	Women	326
Mßlaga	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	816
Mßlaga	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	421
Mßlaga	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	395
Mßlaga	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.677
Mßlaga	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	942
Mßlaga	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	735
Mßlaga	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.191
Mßlaga	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	829
Mßlaga	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	362
Mßlaga	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	316
Mßlaga	Group 1007 Asthma 4930-4931,4938-4939	Men	82
Mßlaga	Group 1007 Asthma 4930-4931,4938-4939	Women	234
Mßlaga	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.683
Mßlaga	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.111
Mßlaga	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.572
Mßlaga	Group 1100 Diseases of the digestive system  520-579	Both sexes	17.333
Mßlaga	Group 1100 Diseases of the digestive system  520-579	Men	9.338
Mßlaga	Group 1100 Diseases of the digestive system  520-579	Women	7.995
Mßlaga	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	250
Mßlaga	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	111
Mßlaga	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	139
Mßlaga	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	228
Mßlaga	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	124
Mßlaga	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	104
Mßlaga	Group 1103 Diseases of the esophagus 530	Both sexes	269
Mßlaga	Group 1103 Diseases of the esophagus 530	Men	143
Mßlaga	Group 1103 Diseases of the esophagus 530	Women	126
Mßlaga	Group 1104 Peptic ulcer 531-534	Both sexes	335
Mßlaga	Group 1104 Peptic ulcer 531-534	Men	231
Mßlaga	Group 1104 Peptic ulcer 531-534	Women	104
Mßlaga	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	434
Mßlaga	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	220
Mßlaga	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	214
Mßlaga	Group 1106 Appendicitis  540-543	Both sexes	1.647
Mßlaga	Group 1106 Appendicitis  540-543	Men	940
Mßlaga	Group 1106 Appendicitis  540-543	Women	707
Mßlaga	Group 1107 Inguinal hernia  550	Both sexes	1.573
Mßlaga	Group 1107 Inguinal hernia  550	Men	1.412
Mßlaga	Group 1107 Inguinal hernia  550	Women	161
Mßlaga	Group 1108 Other abdominal hernia  551-553	Both sexes	1.466
Mßlaga	Group 1108 Other abdominal hernia  551-553	Men	647
Mßlaga	Group 1108 Other abdominal hernia  551-553	Women	818
Mßlaga	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	435
Mßlaga	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	193
Mßlaga	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	242
Mßlaga	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.015
Mßlaga	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	454
Mßlaga	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	560
Mßlaga	Group 1111 Intestinal obstruction without hernia 560	Both sexes	609
Mßlaga	Group 1111 Intestinal obstruction without hernia 560	Men	292
Mßlaga	Group 1111 Intestinal obstruction without hernia 560	Women	316
Mßlaga	Group 1112 Intestinal diverticulosis 562	Both sexes	853
Mßlaga	Group 1112 Intestinal diverticulosis 562	Men	451
Mßlaga	Group 1112 Intestinal diverticulosis 562	Women	402
Mßlaga	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.035
Mßlaga	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	669
Mßlaga	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	366
Mßlaga	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	468
Mßlaga	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	216
Mßlaga	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	252
Mßlaga	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	222
Mßlaga	Group 1115 Alcoholic hepatitis 5710-5713	Men	176
Mßlaga	Group 1115 Alcoholic hepatitis 5710-5713	Women	45
Mßlaga	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	474
Mßlaga	Group 1116 Other diseases of the liver 570,5714-573	Men	310
Mßlaga	Group 1116 Other diseases of the liver 570,5714-573	Women	164
Mßlaga	Group 1117 Cholelithiasis  574	Both sexes	3.580
Mßlaga	Group 1117 Cholelithiasis  574	Men	1.430
Mßlaga	Group 1117 Cholelithiasis  574	Women	2.150
Mßlaga	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	764
Mßlaga	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	408
Mßlaga	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	356
Mßlaga	Group 1119 Pancreatic diseases 577	Both sexes	1.059
Mßlaga	Group 1119 Pancreatic diseases 577	Men	561
Mßlaga	Group 1119 Pancreatic diseases 577	Women	499
Mßlaga	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	619
Mßlaga	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	349
Mßlaga	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	270
Mßlaga	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.292
Mßlaga	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	688
Mßlaga	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	604
Mßlaga	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	830
Mßlaga	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	502
Mßlaga	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	328
Mßlaga	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	49
Mßlaga	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	25
Mßlaga	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	24
Mßlaga	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	414
Mßlaga	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	162
Mßlaga	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	252
Mßlaga	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	8.587
Mßlaga	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.175
Mßlaga	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.412
Mßlaga	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Mßlaga	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Mßlaga	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Mßlaga	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Mßlaga	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Mßlaga	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Mßlaga	Group 1303 Internal derangement of knee 717	Both sexes	1.016
Mßlaga	Group 1303 Internal derangement of knee 717	Men	688
Mßlaga	Group 1303 Internal derangement of knee 717	Women	327
Mßlaga	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.296
Mßlaga	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.450
Mßlaga	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.845
Mßlaga	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	159
Mßlaga	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	67
Mßlaga	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	93
Mßlaga	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	368
Mßlaga	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	174
Mßlaga	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	194
Mßlaga	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	960
Mßlaga	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	473
Mßlaga	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	487
Mßlaga	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	290
Mßlaga	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	120
Mßlaga	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	170
Mßlaga	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.322
Mßlaga	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	693
Mßlaga	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	629
Mßlaga	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.175
Mßlaga	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	510
Mßlaga	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	665
Mßlaga	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	9.634
Mßlaga	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.091
Mßlaga	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.543
Mßlaga	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.109
Mßlaga	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	429
Mßlaga	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	679
Mßlaga	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	781
Mßlaga	Group 1402 Renal failure  5836-5837, 584-586	Men	440
Mßlaga	Group 1402 Renal failure  5836-5837, 584-586	Women	341
Mßlaga	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.400
Mßlaga	Group 1403 Urolithiasis  592, 594, 7880	Men	849
Mßlaga	Group 1403 Urolithiasis  592, 594, 7880	Women	552
Mßlaga	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.774
Mßlaga	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	883
Mßlaga	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	891
Mßlaga	Group 1405 Prostatic hyperplasia  600	Both sexes	745
Mßlaga	Group 1405 Prostatic hyperplasia  600	Men	745
Mßlaga	Group 1405 Prostatic hyperplasia  600	Women	..
Mßlaga	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	676
Mßlaga	Group 1406 Other diseases of the male genital organs    601-608	Men	676
Mßlaga	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Mßlaga	Group 1407 Disorders of breast  610-612	Both sexes	1.044
Mßlaga	Group 1407 Disorders of breast  610-612	Men	56
Mßlaga	Group 1407 Disorders of breast  610-612	Women	988
Mßlaga	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	355
Mßlaga	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Mßlaga	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	355
Mßlaga	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	156
Mßlaga	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Mßlaga	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	156
Mßlaga	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.594
Mßlaga	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	13
Mßlaga	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.581
Mßlaga	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.453
Mßlaga	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Mßlaga	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.453
Mßlaga	Group 1501 Legally induced abortion  635	Both sexes	59
Mßlaga	Group 1501 Legally induced abortion  635	Men	..
Mßlaga	Group 1501 Legally induced abortion  635	Women	59
Mßlaga	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.322
Mßlaga	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Mßlaga	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.322
Mßlaga	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.538
Mßlaga	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Mßlaga	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.538
Mßlaga	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.034
Mßlaga	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Mßlaga	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.034
Mßlaga	Group 1505 Single spontaneous delivery  650	Both sexes	710
Mßlaga	Group 1505 Single spontaneous delivery  650	Men	..
Mßlaga	Group 1505 Single spontaneous delivery  650	Women	710
Mßlaga	Group 1506 Other deliveries  6695-6697	Both sexes	447
Mßlaga	Group 1506 Other deliveries  6695-6697	Men	..
Mßlaga	Group 1506 Other deliveries  6695-6697	Women	447
Mßlaga	Group 1507 Complications related to the puerperium  670-676	Both sexes	159
Mßlaga	Group 1507 Complications related to the puerperium  670-676	Men	..
Mßlaga	Group 1507 Complications related to the puerperium  670-676	Women	159
Mßlaga	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.184
Mßlaga	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Mßlaga	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.184
Mßlaga	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.074
Mßlaga	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.082
Mßlaga	Group 1600 Some disorders originating in the perinatal period  760-779	Women	992
Mßlaga	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	693
Mßlaga	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	357
Mßlaga	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	336
Mßlaga	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.381
Mßlaga	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	726
Mßlaga	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	656
Mßlaga	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.120
Mßlaga	Grupo 1700 Congenital abnormalities  740-759	Men	608
Mßlaga	Grupo 1700 Congenital abnormalities  740-759	Women	513
Mßlaga	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.820
Mßlaga	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.488
Mßlaga	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.332
Mßlaga	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	617
Mßlaga	Group 1801 Pain in throat and chest 7841, 7865	Men	352
Mßlaga	Group 1801 Pain in throat and chest 7841, 7865	Women	265
Mßlaga	Group 1802 Abdominal pain   7890	Both sexes	619
Mßlaga	Group 1802 Abdominal pain   7890	Men	205
Mßlaga	Group 1802 Abdominal pain   7890	Women	413
Mßlaga	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.337
Mßlaga	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	516
Mßlaga	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	821
Mßlaga	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.247
Mßlaga	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.414
Mßlaga	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.833
Mßlaga	Group 1900 Injuries and poisoning  800-999	Both sexes	12.712
Mßlaga	Group 1900 Injuries and poisoning  800-999	Men	6.553
Mßlaga	Group 1900 Injuries and poisoning  800-999	Women	6.159
Mßlaga	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	521
Mßlaga	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	332
Mßlaga	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	188
Mßlaga	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	367
Mßlaga	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	256
Mßlaga	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	112
Mßlaga	Group 1903 Radius and ulna fracture 813	Both sexes	772
Mßlaga	Group 1903 Radius and ulna fracture 813	Men	362
Mßlaga	Group 1903 Radius and ulna fracture 813	Women	410
Mßlaga	Group 1904 Femur fracture  820-821	Both sexes	2.117
Mßlaga	Group 1904 Femur fracture  820-821	Men	649
Mßlaga	Group 1904 Femur fracture  820-821	Women	1.468
Mßlaga	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.133
Mßlaga	Group 1905 Leg fracture, including the ankle 823-824	Men	582
Mßlaga	Group 1905 Leg fracture, including the ankle 823-824	Women	552
Mßlaga	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.607
Mßlaga	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.127
Mßlaga	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.479
Mßlaga	Group 1907 Burns  940-949	Both sexes	165
Mßlaga	Group 1907 Burns  940-949	Men	83
Mßlaga	Group 1907 Burns  940-949	Women	82
Mßlaga	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	375
Mßlaga	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	185
Mßlaga	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	189
Mßlaga	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.347
Mßlaga	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.804
Mßlaga	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.543
Mßlaga	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	57
Mßlaga	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	39
Mßlaga	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	18
Mßlaga	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	251
Mßlaga	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	134
Mßlaga	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	117
Mßlaga	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.650
Mßlaga	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	931
Mßlaga	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.719
Mßlaga	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	132
Mßlaga	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	81
Mßlaga	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	51
Mßlaga	Group 2102 Contraceptive management  V25	Both sexes	61
Mßlaga	Group 2102 Contraceptive management  V25	Men	16
Mßlaga	Group 2102 Contraceptive management  V25	Women	45
Mßlaga	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Mßlaga	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Mßlaga	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Mßlaga	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	648
Mßlaga	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	371
Mßlaga	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	278
Mßlaga	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.809
Mßlaga	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	464
Mßlaga	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.345
Sevilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	166.966
Sevilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	72.721
Sevilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	94.245
Sevilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.695
Sevilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.095
Sevilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.600
Sevilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	457
Sevilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	262
Sevilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	195
Sevilla	Group 0102 Imprecise intestinal infections 009	Both sexes	303
Sevilla	Group 0102 Imprecise intestinal infections 009	Men	156
Sevilla	Group 0102 Imprecise intestinal infections 009	Women	147
Sevilla	Group 0103 Tuberculosis 010-018, 137	Both sexes	116
Sevilla	Group 0103 Tuberculosis 010-018, 137	Men	73
Sevilla	Group 0103 Tuberculosis 010-018, 137	Women	43
Sevilla	Group 0104 Septicaemia  038	Both sexes	1.653
Sevilla	Group 0104 Septicaemia  038	Men	896
Sevilla	Group 0104 Septicaemia  038	Women	757
Sevilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	128
Sevilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	102
Sevilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	26
Sevilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.038
Sevilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	606
Sevilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	432
Sevilla	Group 0200 Neoplasms  140-239	Both sexes	16.364
Sevilla	Group 0200 Neoplasms  140-239	Men	8.229
Sevilla	Group 0200 Neoplasms  140-239	Women	8.135
Sevilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.581
Sevilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	956
Sevilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	625
Sevilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.091
Sevilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	927
Sevilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	164
Sevilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	366
Sevilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	212
Sevilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	154
Sevilla	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.335
Sevilla	Group 0204 Malignant neoplasm of breast  174-175	Men	12
Sevilla	Group 0204 Malignant neoplasm of breast  174-175	Women	1.323
Sevilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	351
Sevilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Sevilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	351
Sevilla	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	214
Sevilla	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Sevilla	Group 0206 Malignant neoplasm of ovary  1830	Women	214
Sevilla	Group 0207 Malignant neoplasm of prostate  185	Both sexes	465
Sevilla	Group 0207 Malignant neoplasm of prostate  185	Men	465
Sevilla	Group 0207 Malignant neoplasm of prostate  185	Women	..
Sevilla	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.543
Sevilla	Group 0208 Malignant neoplasm of bladder  188	Men	1.279
Sevilla	Group 0208 Malignant neoplasm of bladder  188	Women	264
Sevilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.778
Sevilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.311
Sevilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.467
Sevilla	Group 0210 Carcinoma in situ  230-234	Both sexes	156
Sevilla	Group 0210 Carcinoma in situ  230-234	Men	43
Sevilla	Group 0210 Carcinoma in situ  230-234	Women	113
Sevilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	154
Sevilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	86
Sevilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	68
Sevilla	Grupo 0212 Leiomyoma of uterus  218	Both sexes	908
Sevilla	Grupo 0212 Leiomyoma of uterus  218	Men	..
Sevilla	Grupo 0212 Leiomyoma of uterus  218	Women	908
Sevilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.422
Sevilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	938
Sevilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.484
Sevilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.338
Sevilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	663
Sevilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	675
Sevilla	Group 0301 Anaemias 280-285	Both sexes	767
Sevilla	Group 0301 Anaemias 280-285	Men	362
Sevilla	Group 0301 Anaemias 280-285	Women	405
Sevilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	571
Sevilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	301
Sevilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	270
Sevilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.038
Sevilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.092
Sevilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.946
Sevilla	Group 0401 Diabetes mellitus  249-250	Both sexes	849
Sevilla	Group 0401 Diabetes mellitus  249-250	Men	501
Sevilla	Group 0401 Diabetes mellitus  249-250	Women	348
Sevilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.189
Sevilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	591
Sevilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.598
Sevilla	Group 0500 Mental disorders  290-319	Both sexes	3.514
Sevilla	Group 0500 Mental disorders  290-319	Men	1.966
Sevilla	Group 0500 Mental disorders  290-319	Women	1.548
Sevilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	57
Sevilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	23
Sevilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	34
Sevilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	133
Sevilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	105
Sevilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	28
Sevilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	188
Sevilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	151
Sevilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	37
Sevilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.117
Sevilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	744
Sevilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	373
Sevilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	821
Sevilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	348
Sevilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	473
Sevilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.198
Sevilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	595
Sevilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	603
Sevilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.159
Sevilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.528
Sevilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.631
Sevilla	Group 0601 Alzheimer's disease  3310	Both sexes	62
Sevilla	Group 0601 Alzheimer's disease  3310	Men	19
Sevilla	Group 0601 Alzheimer's disease  3310	Women	43
Sevilla	Group 0602 Multiple sclerosis 340	Both sexes	43
Sevilla	Group 0602 Multiple sclerosis 340	Men	15
Sevilla	Group 0602 Multiple sclerosis 340	Women	28
Sevilla	Group 0603 Epilepsy  345	Both sexes	679
Sevilla	Group 0603 Epilepsy  345	Men	348
Sevilla	Group 0603 Epilepsy  345	Women	331
Sevilla	Group 0604 Transient cerebral ischemia 435	Both sexes	430
Sevilla	Group 0604 Transient cerebral ischemia 435	Men	217
Sevilla	Group 0604 Transient cerebral ischemia 435	Women	213
Sevilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.945
Sevilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	929
Sevilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.016
Sevilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	985
Sevilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	526
Sevilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	459
Sevilla	Grupo 0701 Cataract  366	Both sexes	72
Sevilla	Grupo 0701 Cataract  366	Men	38
Sevilla	Grupo 0701 Cataract  366	Women	34
Sevilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	913
Sevilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	488
Sevilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	425
Sevilla	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	842
Sevilla	Group 0800 Diseases of the ear and the mastoid  380-389	Men	411
Sevilla	Group 0800 Diseases of the ear and the mastoid  380-389	Women	431
Sevilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	22.134
Sevilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	12.290
Sevilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	9.844
Sevilla	Group 0901 Hypertensive disease  401-405	Both sexes	1.987
Sevilla	Group 0901 Hypertensive disease  401-405	Men	845
Sevilla	Group 0901 Hypertensive disease  401-405	Women	1.142
Sevilla	Group 0902 Angina pectoris  4111, 413	Both sexes	1.331
Sevilla	Group 0902 Angina pectoris  4111, 413	Men	760
Sevilla	Group 0902 Angina pectoris  4111, 413	Women	571
Sevilla	Group 0903 Acute myocardial infarction  410	Both sexes	2.383
Sevilla	Group 0903 Acute myocardial infarction  410	Men	1.516
Sevilla	Group 0903 Acute myocardial infarction  410	Women	867
Sevilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.734
Sevilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.315
Sevilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	419
Sevilla	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	531
Sevilla	Group 0905 Diseases of the lungs circulation 415-417	Men	234
Sevilla	Group 0905 Diseases of the lungs circulation 415-417	Women	297
Sevilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.928
Sevilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.574
Sevilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.354
Sevilla	Grupo 0907 Heart failure  428	Both sexes	3.529
Sevilla	Grupo 0907 Heart failure  428	Men	1.676
Sevilla	Grupo 0907 Heart failure  428	Women	1.853
Sevilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.327
Sevilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.792
Sevilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.535
Sevilla	Grupo 0909 Atherosclerosis  440	Both sexes	937
Sevilla	Grupo 0909 Atherosclerosis  440	Men	712
Sevilla	Grupo 0909 Atherosclerosis  440	Women	225
Sevilla	Group 0910 Varicose veins of lower extremities 454	Both sexes	526
Sevilla	Group 0910 Varicose veins of lower extremities 454	Men	197
Sevilla	Group 0910 Varicose veins of lower extremities 454	Women	329
Sevilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.921
Sevilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.669
Sevilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.252
Sevilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	12.662
Sevilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.426
Sevilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.236
Sevilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	784
Sevilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	433
Sevilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	351
Sevilla	Group 1002 Pneumonia 480-486	Both sexes	2.342
Sevilla	Group 1002 Pneumonia 480-486	Men	1.345
Sevilla	Group 1002 Pneumonia 480-486	Women	997
Sevilla	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.338
Sevilla	Group 1003 Acute bronchitis and bronchiolitis  466	Men	742
Sevilla	Group 1003 Acute bronchitis and bronchiolitis  466	Women	596
Sevilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	732
Sevilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	368
Sevilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	364
Sevilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.556
Sevilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	900
Sevilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	656
Sevilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.225
Sevilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	985
Sevilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	240
Sevilla	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	297
Sevilla	Group 1007 Asthma 4930-4931,4938-4939	Men	107
Sevilla	Group 1007 Asthma 4930-4931,4938-4939	Women	190
Sevilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.388
Sevilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.546
Sevilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.842
Sevilla	Group 1100 Diseases of the digestive system  520-579	Both sexes	20.181
Sevilla	Group 1100 Diseases of the digestive system  520-579	Men	10.596
Sevilla	Group 1100 Diseases of the digestive system  520-579	Women	9.585
Sevilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	362
Sevilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	163
Sevilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	199
Sevilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	307
Sevilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	150
Sevilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	157
Sevilla	Group 1103 Diseases of the esophagus 530	Both sexes	747
Sevilla	Group 1103 Diseases of the esophagus 530	Men	427
Sevilla	Group 1103 Diseases of the esophagus 530	Women	320
Sevilla	Group 1104 Peptic ulcer 531-534	Both sexes	343
Sevilla	Group 1104 Peptic ulcer 531-534	Men	237
Sevilla	Group 1104 Peptic ulcer 531-534	Women	106
Sevilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	554
Sevilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	251
Sevilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	303
Sevilla	Group 1106 Appendicitis  540-543	Both sexes	1.743
Sevilla	Group 1106 Appendicitis  540-543	Men	978
Sevilla	Group 1106 Appendicitis  540-543	Women	765
Sevilla	Group 1107 Inguinal hernia  550	Both sexes	1.591
Sevilla	Group 1107 Inguinal hernia  550	Men	1.296
Sevilla	Group 1107 Inguinal hernia  550	Women	295
Sevilla	Group 1108 Other abdominal hernia  551-553	Both sexes	1.684
Sevilla	Group 1108 Other abdominal hernia  551-553	Men	709
Sevilla	Group 1108 Other abdominal hernia  551-553	Women	975
Sevilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	545
Sevilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	243
Sevilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	302
Sevilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	987
Sevilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	450
Sevilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	537
Sevilla	Group 1111 Intestinal obstruction without hernia 560	Both sexes	721
Sevilla	Group 1111 Intestinal obstruction without hernia 560	Men	347
Sevilla	Group 1111 Intestinal obstruction without hernia 560	Women	374
Sevilla	Group 1112 Intestinal diverticulosis 562	Both sexes	638
Sevilla	Group 1112 Intestinal diverticulosis 562	Men	328
Sevilla	Group 1112 Intestinal diverticulosis 562	Women	310
Sevilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.090
Sevilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	642
Sevilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	448
Sevilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	658
Sevilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	339
Sevilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	319
Sevilla	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	413
Sevilla	Group 1115 Alcoholic hepatitis 5710-5713	Men	342
Sevilla	Group 1115 Alcoholic hepatitis 5710-5713	Women	71
Sevilla	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	666
Sevilla	Group 1116 Other diseases of the liver 570,5714-573	Men	393
Sevilla	Group 1116 Other diseases of the liver 570,5714-573	Women	273
Sevilla	Group 1117 Cholelithiasis  574	Both sexes	3.839
Sevilla	Group 1117 Cholelithiasis  574	Men	1.573
Sevilla	Group 1117 Cholelithiasis  574	Women	2.266
Sevilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.071
Sevilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	530
Sevilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	541
Sevilla	Group 1119 Pancreatic diseases 577	Both sexes	1.384
Sevilla	Group 1119 Pancreatic diseases 577	Men	736
Sevilla	Group 1119 Pancreatic diseases 577	Women	648
Sevilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	838
Sevilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	462
Sevilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	376
Sevilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.441
Sevilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	752
Sevilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	689
Sevilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	797
Sevilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	458
Sevilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	339
Sevilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	72
Sevilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	52
Sevilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	20
Sevilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	572
Sevilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	242
Sevilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	330
Sevilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	13.070
Sevilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.788
Sevilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	7.282
Sevilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Sevilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Sevilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Sevilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Sevilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Sevilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Sevilla	Group 1303 Internal derangement of knee 717	Both sexes	1.672
Sevilla	Group 1303 Internal derangement of knee 717	Men	1.079
Sevilla	Group 1303 Internal derangement of knee 717	Women	593
Sevilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	5.137
Sevilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.983
Sevilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	3.154
Sevilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	200
Sevilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	58
Sevilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	142
Sevilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	665
Sevilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	317
Sevilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	348
Sevilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.541
Sevilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	736
Sevilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	805
Sevilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	375
Sevilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	126
Sevilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	249
Sevilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.696
Sevilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	750
Sevilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	946
Sevilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.784
Sevilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	739
Sevilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.045
Sevilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	9.358
Sevilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.972
Sevilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.386
Sevilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.002
Sevilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	379
Sevilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	623
Sevilla	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	806
Sevilla	Group 1402 Renal failure  5836-5837, 584-586	Men	439
Sevilla	Group 1402 Renal failure  5836-5837, 584-586	Women	367
Sevilla	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.370
Sevilla	Group 1403 Urolithiasis  592, 594, 7880	Men	773
Sevilla	Group 1403 Urolithiasis  592, 594, 7880	Women	597
Sevilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.823
Sevilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	876
Sevilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	947
Sevilla	Group 1405 Prostatic hyperplasia  600	Both sexes	690
Sevilla	Group 1405 Prostatic hyperplasia  600	Men	690
Sevilla	Group 1405 Prostatic hyperplasia  600	Women	..
Sevilla	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	720
Sevilla	Group 1406 Other diseases of the male genital organs    601-608	Men	720
Sevilla	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Sevilla	Group 1407 Disorders of breast  610-612	Both sexes	777
Sevilla	Group 1407 Disorders of breast  610-612	Men	65
Sevilla	Group 1407 Disorders of breast  610-612	Women	712
Sevilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	311
Sevilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Sevilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	311
Sevilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	144
Sevilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Sevilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	144
Sevilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.715
Sevilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	30
Sevilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.685
Sevilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	23.815
Sevilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Sevilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	23.815
Sevilla	Group 1501 Legally induced abortion  635	Both sexes	34
Sevilla	Group 1501 Legally induced abortion  635	Men	..
Sevilla	Group 1501 Legally induced abortion  635	Women	34
Sevilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.148
Sevilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Sevilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.148
Sevilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	14.968
Sevilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Sevilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	14.968
Sevilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.925
Sevilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Sevilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.925
Sevilla	Group 1505 Single spontaneous delivery  650	Both sexes	1.520
Sevilla	Group 1505 Single spontaneous delivery  650	Men	..
Sevilla	Group 1505 Single spontaneous delivery  650	Women	1.520
Sevilla	Group 1506 Other deliveries  6695-6697	Both sexes	522
Sevilla	Group 1506 Other deliveries  6695-6697	Men	..
Sevilla	Group 1506 Other deliveries  6695-6697	Women	522
Sevilla	Group 1507 Complications related to the puerperium  670-676	Both sexes	226
Sevilla	Group 1507 Complications related to the puerperium  670-676	Men	..
Sevilla	Group 1507 Complications related to the puerperium  670-676	Women	226
Sevilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.472
Sevilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Sevilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.472
Sevilla	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.249
Sevilla	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.229
Sevilla	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.020
Sevilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	864
Sevilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	452
Sevilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	412
Sevilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.385
Sevilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	777
Sevilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	608
Sevilla	Grupo 1700 Congenital abnormalities  740-759	Both sexes	2.127
Sevilla	Grupo 1700 Congenital abnormalities  740-759	Men	1.196
Sevilla	Grupo 1700 Congenital abnormalities  740-759	Women	931
Sevilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	8.633
Sevilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.265
Sevilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	4.368
Sevilla	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.659
Sevilla	Group 1801 Pain in throat and chest 7841, 7865	Men	855
Sevilla	Group 1801 Pain in throat and chest 7841, 7865	Women	804
Sevilla	Group 1802 Abdominal pain   7890	Both sexes	1.262
Sevilla	Group 1802 Abdominal pain   7890	Men	453
Sevilla	Group 1802 Abdominal pain   7890	Women	809
Sevilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	219
Sevilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	90
Sevilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	129
Sevilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.493
Sevilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.867
Sevilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.626
Sevilla	Group 1900 Injuries and poisoning  800-999	Both sexes	15.259
Sevilla	Group 1900 Injuries and poisoning  800-999	Men	7.282
Sevilla	Group 1900 Injuries and poisoning  800-999	Women	7.977
Sevilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	560
Sevilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	343
Sevilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	217
Sevilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	382
Sevilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	267
Sevilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	115
Sevilla	Group 1903 Radius and ulna fracture 813	Both sexes	1.097
Sevilla	Group 1903 Radius and ulna fracture 813	Men	532
Sevilla	Group 1903 Radius and ulna fracture 813	Women	565
Sevilla	Group 1904 Femur fracture  820-821	Both sexes	2.196
Sevilla	Group 1904 Femur fracture  820-821	Men	588
Sevilla	Group 1904 Femur fracture  820-821	Women	1.608
Sevilla	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.252
Sevilla	Group 1905 Leg fracture, including the ankle 823-824	Men	565
Sevilla	Group 1905 Leg fracture, including the ankle 823-824	Women	687
Sevilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.362
Sevilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.079
Sevilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.283
Sevilla	Group 1907 Burns  940-949	Both sexes	158
Sevilla	Group 1907 Burns  940-949	Men	98
Sevilla	Group 1907 Burns  940-949	Women	60
Sevilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	391
Sevilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	190
Sevilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	201
Sevilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	4.578
Sevilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.469
Sevilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.109
Sevilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	54
Sevilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	29
Sevilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	25
Sevilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	229
Sevilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	122
Sevilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	107
Sevilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.102
Sevilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.415
Sevilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.687
Sevilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	328
Sevilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	174
Sevilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	154
Sevilla	Group 2102 Contraceptive management  V25	Both sexes	35
Sevilla	Group 2102 Contraceptive management  V25	Men	4
Sevilla	Group 2102 Contraceptive management  V25	Women	31
Sevilla	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Sevilla	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Sevilla	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Sevilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.059
Sevilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	675
Sevilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	384
Sevilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.680
Sevilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	562
Sevilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.118
ARAGËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	155.285
ARAGËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	75.756
ARAGËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	79.529
ARAGËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.045
ARAGËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.672
ARAGËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.373
ARAGËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	575
ARAGËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	293
ARAGËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	282
ARAGËN	Group 0102 Imprecise intestinal infections 009	Both sexes	216
ARAGËN	Group 0102 Imprecise intestinal infections 009	Men	103
ARAGËN	Group 0102 Imprecise intestinal infections 009	Women	113
ARAGËN	Group 0103 Tuberculosis 010-018, 137	Both sexes	177
ARAGËN	Group 0103 Tuberculosis 010-018, 137	Men	110
ARAGËN	Group 0103 Tuberculosis 010-018, 137	Women	67
ARAGËN	Group 0104 Septicaemia  038	Both sexes	1.141
ARAGËN	Group 0104 Septicaemia  038	Men	603
ARAGËN	Group 0104 Septicaemia  038	Women	538
ARAGËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	59
ARAGËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	44
ARAGËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	15
ARAGËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	876
ARAGËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	518
ARAGËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	358
ARAGËN	Group 0200 Neoplasms  140-239	Both sexes	14.171
ARAGËN	Group 0200 Neoplasms  140-239	Men	7.326
ARAGËN	Group 0200 Neoplasms  140-239	Women	6.845
ARAGËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.293
ARAGËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	804
ARAGËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	489
ARAGËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	996
ARAGËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	811
ARAGËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	185
ARAGËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	550
ARAGËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	328
ARAGËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	222
ARAGËN	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	978
ARAGËN	Group 0204 Malignant neoplasm of breast  174-175	Men	10
ARAGËN	Group 0204 Malignant neoplasm of breast  174-175	Women	968
ARAGËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	243
ARAGËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
ARAGËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	243
ARAGËN	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	137
ARAGËN	Group 0206 Malignant neoplasm of ovary  1830	Men	..
ARAGËN	Group 0206 Malignant neoplasm of ovary  1830	Women	137
ARAGËN	Group 0207 Malignant neoplasm of prostate  185	Both sexes	536
ARAGËN	Group 0207 Malignant neoplasm of prostate  185	Men	536
ARAGËN	Group 0207 Malignant neoplasm of prostate  185	Women	..
ARAGËN	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.083
ARAGËN	Group 0208 Malignant neoplasm of bladder  188	Men	868
ARAGËN	Group 0208 Malignant neoplasm of bladder  188	Women	215
ARAGËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.650
ARAGËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.733
ARAGËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.917
ARAGËN	Group 0210 Carcinoma in situ  230-234	Both sexes	701
ARAGËN	Group 0210 Carcinoma in situ  230-234	Men	242
ARAGËN	Group 0210 Carcinoma in situ  230-234	Women	459
ARAGËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	136
ARAGËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	77
ARAGËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	59
ARAGËN	Grupo 0212 Leiomyoma of uterus  218	Both sexes	721
ARAGËN	Grupo 0212 Leiomyoma of uterus  218	Men	..
ARAGËN	Grupo 0212 Leiomyoma of uterus  218	Women	721
ARAGËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.147
ARAGËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	917
ARAGËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.230
ARAGËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.432
ARAGËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	710
ARAGËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	722
ARAGËN	Group 0301 Anaemias 280-285	Both sexes	957
ARAGËN	Group 0301 Anaemias 280-285	Men	466
ARAGËN	Group 0301 Anaemias 280-285	Women	491
ARAGËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	475
ARAGËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	244
ARAGËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	231
ARAGËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.040
ARAGËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.302
ARAGËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.739
ARAGËN	Group 0401 Diabetes mellitus  249-250	Both sexes	881
ARAGËN	Group 0401 Diabetes mellitus  249-250	Men	508
ARAGËN	Group 0401 Diabetes mellitus  249-250	Women	372
ARAGËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.160
ARAGËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	793
ARAGËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.366
ARAGËN	Group 0500 Mental disorders  290-319	Both sexes	3.343
ARAGËN	Group 0500 Mental disorders  290-319	Men	1.609
ARAGËN	Group 0500 Mental disorders  290-319	Women	1.734
ARAGËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	162
ARAGËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	73
ARAGËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	90
ARAGËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	219
ARAGËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	170
ARAGËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	49
ARAGËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	115
ARAGËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	82
ARAGËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	33
ARAGËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	771
ARAGËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	456
ARAGËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	315
ARAGËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	784
ARAGËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	278
ARAGËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	505
ARAGËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.292
ARAGËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	550
ARAGËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	743
ARAGËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	4.109
ARAGËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.048
ARAGËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.061
ARAGËN	Group 0601 Alzheimer's disease  3310	Both sexes	101
ARAGËN	Group 0601 Alzheimer's disease  3310	Men	45
ARAGËN	Group 0601 Alzheimer's disease  3310	Women	56
ARAGËN	Group 0602 Multiple sclerosis 340	Both sexes	69
ARAGËN	Group 0602 Multiple sclerosis 340	Men	25
ARAGËN	Group 0602 Multiple sclerosis 340	Women	44
ARAGËN	Group 0603 Epilepsy  345	Both sexes	367
ARAGËN	Group 0603 Epilepsy  345	Men	176
ARAGËN	Group 0603 Epilepsy  345	Women	190
ARAGËN	Group 0604 Transient cerebral ischemia 435	Both sexes	502
ARAGËN	Group 0604 Transient cerebral ischemia 435	Men	249
ARAGËN	Group 0604 Transient cerebral ischemia 435	Women	254
ARAGËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.071
ARAGËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.554
ARAGËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.517
ARAGËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.159
ARAGËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	593
ARAGËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	566
ARAGËN	Grupo 0701 Cataract  366	Both sexes	343
ARAGËN	Grupo 0701 Cataract  366	Men	176
ARAGËN	Grupo 0701 Cataract  366	Women	167
ARAGËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	816
ARAGËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	417
ARAGËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	399
ARAGËN	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	676
ARAGËN	Group 0800 Diseases of the ear and the mastoid  380-389	Men	300
ARAGËN	Group 0800 Diseases of the ear and the mastoid  380-389	Women	376
ARAGËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	18.121
ARAGËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	9.946
ARAGËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	8.175
ARAGËN	Group 0901 Hypertensive disease  401-405	Both sexes	546
ARAGËN	Group 0901 Hypertensive disease  401-405	Men	255
ARAGËN	Group 0901 Hypertensive disease  401-405	Women	291
ARAGËN	Group 0902 Angina pectoris  4111, 413	Both sexes	773
ARAGËN	Group 0902 Angina pectoris  4111, 413	Men	503
ARAGËN	Group 0902 Angina pectoris  4111, 413	Women	270
ARAGËN	Group 0903 Acute myocardial infarction  410	Both sexes	1.330
ARAGËN	Group 0903 Acute myocardial infarction  410	Men	944
ARAGËN	Group 0903 Acute myocardial infarction  410	Women	386
ARAGËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.155
ARAGËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	871
ARAGËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	284
ARAGËN	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	595
ARAGËN	Group 0905 Diseases of the lungs circulation 415-417	Men	272
ARAGËN	Group 0905 Diseases of the lungs circulation 415-417	Women	323
ARAGËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.348
ARAGËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.263
ARAGËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.085
ARAGËN	Grupo 0907 Heart failure  428	Both sexes	4.265
ARAGËN	Grupo 0907 Heart failure  428	Men	2.014
ARAGËN	Grupo 0907 Heart failure  428	Women	2.252
ARAGËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.803
ARAGËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.473
ARAGËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.330
ARAGËN	Grupo 0909 Atherosclerosis  440	Both sexes	519
ARAGËN	Grupo 0909 Atherosclerosis  440	Men	383
ARAGËN	Grupo 0909 Atherosclerosis  440	Women	136
ARAGËN	Group 0910 Varicose veins of lower extremities 454	Both sexes	852
ARAGËN	Group 0910 Varicose veins of lower extremities 454	Men	294
ARAGËN	Group 0910 Varicose veins of lower extremities 454	Women	558
ARAGËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.935
ARAGËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.675
ARAGËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.260
ARAGËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	15.587
ARAGËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	9.106
ARAGËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.481
ARAGËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	960
ARAGËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	512
ARAGËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	448
ARAGËN	Group 1002 Pneumonia 480-486	Both sexes	3.313
ARAGËN	Group 1002 Pneumonia 480-486	Men	1.946
ARAGËN	Group 1002 Pneumonia 480-486	Women	1.367
ARAGËN	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.386
ARAGËN	Group 1003 Acute bronchitis and bronchiolitis  466	Men	691
ARAGËN	Group 1003 Acute bronchitis and bronchiolitis  466	Women	696
ARAGËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	594
ARAGËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	337
ARAGËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	257
ARAGËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.712
ARAGËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.093
ARAGËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	619
ARAGËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.624
ARAGËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.079
ARAGËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	544
ARAGËN	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	466
ARAGËN	Group 1007 Asthma 4930-4931,4938-4939	Men	125
ARAGËN	Group 1007 Asthma 4930-4931,4938-4939	Women	341
ARAGËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.531
ARAGËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.322
ARAGËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.209
ARAGËN	Group 1100 Diseases of the digestive system  520-579	Both sexes	18.035
ARAGËN	Group 1100 Diseases of the digestive system  520-579	Men	10.378
ARAGËN	Group 1100 Diseases of the digestive system  520-579	Women	7.658
ARAGËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	251
ARAGËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	113
ARAGËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	138
ARAGËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	226
ARAGËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	130
ARAGËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	96
ARAGËN	Group 1103 Diseases of the esophagus 530	Both sexes	304
ARAGËN	Group 1103 Diseases of the esophagus 530	Men	176
ARAGËN	Group 1103 Diseases of the esophagus 530	Women	128
ARAGËN	Group 1104 Peptic ulcer 531-534	Both sexes	403
ARAGËN	Group 1104 Peptic ulcer 531-534	Men	277
ARAGËN	Group 1104 Peptic ulcer 531-534	Women	126
ARAGËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	404
ARAGËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	183
ARAGËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	221
ARAGËN	Group 1106 Appendicitis  540-543	Both sexes	1.241
ARAGËN	Group 1106 Appendicitis  540-543	Men	705
ARAGËN	Group 1106 Appendicitis  540-543	Women	536
ARAGËN	Group 1107 Inguinal hernia  550	Both sexes	2.650
ARAGËN	Group 1107 Inguinal hernia  550	Men	2.324
ARAGËN	Group 1107 Inguinal hernia  550	Women	326
ARAGËN	Group 1108 Other abdominal hernia  551-553	Both sexes	1.596
ARAGËN	Group 1108 Other abdominal hernia  551-553	Men	783
ARAGËN	Group 1108 Other abdominal hernia  551-553	Women	813
ARAGËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	281
ARAGËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	165
ARAGËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	116
ARAGËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	937
ARAGËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	438
ARAGËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	499
ARAGËN	Group 1111 Intestinal obstruction without hernia 560	Both sexes	857
ARAGËN	Group 1111 Intestinal obstruction without hernia 560	Men	428
ARAGËN	Group 1111 Intestinal obstruction without hernia 560	Women	429
ARAGËN	Group 1112 Intestinal diverticulosis 562	Both sexes	753
ARAGËN	Group 1112 Intestinal diverticulosis 562	Men	369
ARAGËN	Group 1112 Intestinal diverticulosis 562	Women	384
ARAGËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.110
ARAGËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	681
ARAGËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	429
ARAGËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	635
ARAGËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	279
ARAGËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	356
ARAGËN	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	303
ARAGËN	Group 1115 Alcoholic hepatitis 5710-5713	Men	263
ARAGËN	Group 1115 Alcoholic hepatitis 5710-5713	Women	40
ARAGËN	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	597
ARAGËN	Group 1116 Other diseases of the liver 570,5714-573	Men	368
ARAGËN	Group 1116 Other diseases of the liver 570,5714-573	Women	229
ARAGËN	Group 1117 Cholelithiasis  574	Both sexes	3.233
ARAGËN	Group 1117 Cholelithiasis  574	Men	1.442
ARAGËN	Group 1117 Cholelithiasis  574	Women	1.791
ARAGËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	750
ARAGËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	412
ARAGËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	338
ARAGËN	Group 1119 Pancreatic diseases 577	Both sexes	788
ARAGËN	Group 1119 Pancreatic diseases 577	Men	470
ARAGËN	Group 1119 Pancreatic diseases 577	Women	318
ARAGËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	715
ARAGËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	371
ARAGËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	344
ARAGËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.576
ARAGËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	877
ARAGËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	700
ARAGËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	894
ARAGËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	545
ARAGËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	348
ARAGËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	87
ARAGËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	53
ARAGËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	34
ARAGËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	596
ARAGËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	278
ARAGËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	317
ARAGËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	12.036
ARAGËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.917
ARAGËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	6.119
ARAGËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
ARAGËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
ARAGËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
ARAGËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
ARAGËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
ARAGËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
ARAGËN	Group 1303 Internal derangement of knee 717	Both sexes	1.833
ARAGËN	Group 1303 Internal derangement of knee 717	Men	1.165
ARAGËN	Group 1303 Internal derangement of knee 717	Women	668
ARAGËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.769
ARAGËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.721
ARAGËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.048
ARAGËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	192
ARAGËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	68
ARAGËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	124
ARAGËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	486
ARAGËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	255
ARAGËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	231
ARAGËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.225
ARAGËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	677
ARAGËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	548
ARAGËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	379
ARAGËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	172
ARAGËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	207
ARAGËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	2.052
ARAGËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.134
ARAGËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	918
ARAGËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.100
ARAGËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	725
ARAGËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.375
ARAGËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	9.792
ARAGËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.664
ARAGËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.129
ARAGËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	641
ARAGËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	247
ARAGËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	394
ARAGËN	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	795
ARAGËN	Group 1402 Renal failure  5836-5837, 584-586	Men	449
ARAGËN	Group 1402 Renal failure  5836-5837, 584-586	Women	346
ARAGËN	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.546
ARAGËN	Group 1403 Urolithiasis  592, 594, 7880	Men	922
ARAGËN	Group 1403 Urolithiasis  592, 594, 7880	Women	624
ARAGËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.258
ARAGËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.135
ARAGËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.123
ARAGËN	Group 1405 Prostatic hyperplasia  600	Both sexes	1.098
ARAGËN	Group 1405 Prostatic hyperplasia  600	Men	1.098
ARAGËN	Group 1405 Prostatic hyperplasia  600	Women	..
ARAGËN	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	717
ARAGËN	Group 1406 Other diseases of the male genital organs    601-608	Men	717
ARAGËN	Group 1406 Other diseases of the male genital organs    601-608	Women	..
ARAGËN	Group 1407 Disorders of breast  610-612	Both sexes	613
ARAGËN	Group 1407 Disorders of breast  610-612	Men	85
ARAGËN	Group 1407 Disorders of breast  610-612	Women	528
ARAGËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	240
ARAGËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
ARAGËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	240
ARAGËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	160
ARAGËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
ARAGËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	160
ARAGËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.724
ARAGËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	11
ARAGËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.713
ARAGËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	12.879
ARAGËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
ARAGËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	12.879
ARAGËN	Group 1501 Legally induced abortion  635	Both sexes	5
ARAGËN	Group 1501 Legally induced abortion  635	Men	..
ARAGËN	Group 1501 Legally induced abortion  635	Women	5
ARAGËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	865
ARAGËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
ARAGËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	865
ARAGËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.371
ARAGËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
ARAGËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.371
ARAGËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.011
ARAGËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
ARAGËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.011
ARAGËN	Group 1505 Single spontaneous delivery  650	Both sexes	1.201
ARAGËN	Group 1505 Single spontaneous delivery  650	Men	..
ARAGËN	Group 1505 Single spontaneous delivery  650	Women	1.201
ARAGËN	Group 1506 Other deliveries  6695-6697	Both sexes	347
ARAGËN	Group 1506 Other deliveries  6695-6697	Men	..
ARAGËN	Group 1506 Other deliveries  6695-6697	Women	347
ARAGËN	Group 1507 Complications related to the puerperium  670-676	Both sexes	118
ARAGËN	Group 1507 Complications related to the puerperium  670-676	Men	..
ARAGËN	Group 1507 Complications related to the puerperium  670-676	Women	118
ARAGËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	961
ARAGËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
ARAGËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	961
ARAGËN	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.087
ARAGËN	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.161
ARAGËN	Group 1600 Some disorders originating in the perinatal period  760-779	Women	926
ARAGËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	369
ARAGËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	202
ARAGËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	167
ARAGËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.718
ARAGËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	959
ARAGËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	759
ARAGËN	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.330
ARAGËN	Grupo 1700 Congenital abnormalities  740-759	Men	708
ARAGËN	Grupo 1700 Congenital abnormalities  740-759	Women	622
ARAGËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	15.179
ARAGËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	7.872
ARAGËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	7.307
ARAGËN	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.042
ARAGËN	Group 1801 Pain in throat and chest 7841, 7865	Men	615
ARAGËN	Group 1801 Pain in throat and chest 7841, 7865	Women	427
ARAGËN	Group 1802 Abdominal pain   7890	Both sexes	882
ARAGËN	Group 1802 Abdominal pain   7890	Men	381
ARAGËN	Group 1802 Abdominal pain   7890	Women	501
ARAGËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	8.059
ARAGËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	3.944
ARAGËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	4.115
ARAGËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.196
ARAGËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.932
ARAGËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.264
ARAGËN	Group 1900 Injuries and poisoning  800-999	Both sexes	13.725
ARAGËN	Group 1900 Injuries and poisoning  800-999	Men	7.348
ARAGËN	Group 1900 Injuries and poisoning  800-999	Women	6.377
ARAGËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	705
ARAGËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	409
ARAGËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	296
ARAGËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	366
ARAGËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	260
ARAGËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	106
ARAGËN	Group 1903 Radius and ulna fracture 813	Both sexes	771
ARAGËN	Group 1903 Radius and ulna fracture 813	Men	343
ARAGËN	Group 1903 Radius and ulna fracture 813	Women	428
ARAGËN	Group 1904 Femur fracture  820-821	Both sexes	2.297
ARAGËN	Group 1904 Femur fracture  820-821	Men	650
ARAGËN	Group 1904 Femur fracture  820-821	Women	1.647
ARAGËN	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	810
ARAGËN	Group 1905 Leg fracture, including the ankle 823-824	Men	424
ARAGËN	Group 1905 Leg fracture, including the ankle 823-824	Women	386
ARAGËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.914
ARAGËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.164
ARAGËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.750
ARAGËN	Group 1907 Burns  940-949	Both sexes	95
ARAGËN	Group 1907 Burns  940-949	Men	64
ARAGËN	Group 1907 Burns  940-949	Women	31
ARAGËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	272
ARAGËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	134
ARAGËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	138
ARAGËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.084
ARAGËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.665
ARAGËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.419
ARAGËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	20
ARAGËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	13
ARAGËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	7
ARAGËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	390
ARAGËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	221
ARAGËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	169
ARAGËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	3.961
ARAGËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	2.219
ARAGËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.742
ARAGËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	241
ARAGËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	161
ARAGËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	80
ARAGËN	Group 2102 Contraceptive management  V25	Both sexes	60
ARAGËN	Group 2102 Contraceptive management  V25	Men	4
ARAGËN	Group 2102 Contraceptive management  V25	Women	56
ARAGËN	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
ARAGËN	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
ARAGËN	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
ARAGËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.049
ARAGËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	644
ARAGËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	405
ARAGËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.611
ARAGËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.410
ARAGËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.201
Huesca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	21.395
Huesca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	10.461
Huesca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	10.934
Huesca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	684
Huesca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	373
Huesca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	311
Huesca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	114
Huesca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	63
Huesca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	51
Huesca	Group 0102 Imprecise intestinal infections 009	Both sexes	114
Huesca	Group 0102 Imprecise intestinal infections 009	Men	56
Huesca	Group 0102 Imprecise intestinal infections 009	Women	58
Huesca	Group 0103 Tuberculosis 010-018, 137	Both sexes	28
Huesca	Group 0103 Tuberculosis 010-018, 137	Men	18
Huesca	Group 0103 Tuberculosis 010-018, 137	Women	10
Huesca	Group 0104 Septicaemia  038	Both sexes	286
Huesca	Group 0104 Septicaemia  038	Men	163
Huesca	Group 0104 Septicaemia  038	Women	123
Huesca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	13
Huesca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	11
Huesca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
Huesca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	129
Huesca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	62
Huesca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	67
Huesca	Group 0200 Neoplasms  140-239	Both sexes	1.654
Huesca	Group 0200 Neoplasms  140-239	Men	850
Huesca	Group 0200 Neoplasms  140-239	Women	804
Huesca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	209
Huesca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	129
Huesca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	80
Huesca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	138
Huesca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	108
Huesca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	30
Huesca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	19
Huesca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	10
Huesca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	9
Huesca	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	153
Huesca	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Huesca	Group 0204 Malignant neoplasm of breast  174-175	Women	150
Huesca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	33
Huesca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Huesca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	33
Huesca	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	18
Huesca	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Huesca	Group 0206 Malignant neoplasm of ovary  1830	Women	18
Huesca	Group 0207 Malignant neoplasm of prostate  185	Both sexes	74
Huesca	Group 0207 Malignant neoplasm of prostate  185	Men	74
Huesca	Group 0207 Malignant neoplasm of prostate  185	Women	..
Huesca	Group 0208 Malignant neoplasm of bladder  188	Both sexes	138
Huesca	Group 0208 Malignant neoplasm of bladder  188	Men	120
Huesca	Group 0208 Malignant neoplasm of bladder  188	Women	18
Huesca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	507
Huesca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	306
Huesca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	201
Huesca	Group 0210 Carcinoma in situ  230-234	Both sexes	45
Huesca	Group 0210 Carcinoma in situ  230-234	Men	17
Huesca	Group 0210 Carcinoma in situ  230-234	Women	28
Huesca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	15
Huesca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	7
Huesca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	8
Huesca	Grupo 0212 Leiomyoma of uterus  218	Both sexes	88
Huesca	Grupo 0212 Leiomyoma of uterus  218	Men	..
Huesca	Grupo 0212 Leiomyoma of uterus  218	Women	88
Huesca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	217
Huesca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	76
Huesca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	141
Huesca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	225
Huesca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	119
Huesca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	106
Huesca	Group 0301 Anaemias 280-285	Both sexes	173
Huesca	Group 0301 Anaemias 280-285	Men	90
Huesca	Group 0301 Anaemias 280-285	Women	83
Huesca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	52
Huesca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	29
Huesca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	23
Huesca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	348
Huesca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	175
Huesca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	173
Huesca	Group 0401 Diabetes mellitus  249-250	Both sexes	148
Huesca	Group 0401 Diabetes mellitus  249-250	Men	90
Huesca	Group 0401 Diabetes mellitus  249-250	Women	58
Huesca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	200
Huesca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	85
Huesca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	115
Huesca	Group 0500 Mental disorders  290-319	Both sexes	767
Huesca	Group 0500 Mental disorders  290-319	Men	402
Huesca	Group 0500 Mental disorders  290-319	Women	365
Huesca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	39
Huesca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	21
Huesca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	18
Huesca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	40
Huesca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	30
Huesca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	10
Huesca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	25
Huesca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	22
Huesca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Huesca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	183
Huesca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	112
Huesca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	71
Huesca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	242
Huesca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	94
Huesca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	148
Huesca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	238
Huesca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	123
Huesca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	115
Huesca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	511
Huesca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	229
Huesca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	282
Huesca	Group 0601 Alzheimer's disease  3310	Both sexes	17
Huesca	Group 0601 Alzheimer's disease  3310	Men	11
Huesca	Group 0601 Alzheimer's disease  3310	Women	6
Huesca	Group 0602 Multiple sclerosis 340	Both sexes	5
Huesca	Group 0602 Multiple sclerosis 340	Men	4
Huesca	Group 0602 Multiple sclerosis 340	Women	1
Huesca	Group 0603 Epilepsy  345	Both sexes	75
Huesca	Group 0603 Epilepsy  345	Men	40
Huesca	Group 0603 Epilepsy  345	Women	35
Huesca	Group 0604 Transient cerebral ischemia 435	Both sexes	98
Huesca	Group 0604 Transient cerebral ischemia 435	Men	45
Huesca	Group 0604 Transient cerebral ischemia 435	Women	53
Huesca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	316
Huesca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	129
Huesca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	187
Huesca	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	232
Huesca	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	107
Huesca	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	125
Huesca	Grupo 0701 Cataract  366	Both sexes	166
Huesca	Grupo 0701 Cataract  366	Men	77
Huesca	Grupo 0701 Cataract  366	Women	89
Huesca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	66
Huesca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	30
Huesca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	36
Huesca	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	88
Huesca	Group 0800 Diseases of the ear and the mastoid  380-389	Men	40
Huesca	Group 0800 Diseases of the ear and the mastoid  380-389	Women	48
Huesca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.643
Huesca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.403
Huesca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.240
Huesca	Group 0901 Hypertensive disease  401-405	Both sexes	122
Huesca	Group 0901 Hypertensive disease  401-405	Men	52
Huesca	Group 0901 Hypertensive disease  401-405	Women	70
Huesca	Group 0902 Angina pectoris  4111, 413	Both sexes	107
Huesca	Group 0902 Angina pectoris  4111, 413	Men	69
Huesca	Group 0902 Angina pectoris  4111, 413	Women	38
Huesca	Group 0903 Acute myocardial infarction  410	Both sexes	135
Huesca	Group 0903 Acute myocardial infarction  410	Men	90
Huesca	Group 0903 Acute myocardial infarction  410	Women	45
Huesca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	64
Huesca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	49
Huesca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	15
Huesca	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	77
Huesca	Group 0905 Diseases of the lungs circulation 415-417	Men	38
Huesca	Group 0905 Diseases of the lungs circulation 415-417	Women	39
Huesca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	414
Huesca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	222
Huesca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	192
Huesca	Grupo 0907 Heart failure  428	Both sexes	706
Huesca	Grupo 0907 Heart failure  428	Men	348
Huesca	Grupo 0907 Heart failure  428	Women	358
Huesca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	448
Huesca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	247
Huesca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	201
Huesca	Grupo 0909 Atherosclerosis  440	Both sexes	60
Huesca	Grupo 0909 Atherosclerosis  440	Men	50
Huesca	Grupo 0909 Atherosclerosis  440	Women	10
Huesca	Group 0910 Varicose veins of lower extremities 454	Both sexes	179
Huesca	Group 0910 Varicose veins of lower extremities 454	Men	64
Huesca	Group 0910 Varicose veins of lower extremities 454	Women	115
Huesca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	331
Huesca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	174
Huesca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	157
Huesca	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.641
Huesca	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.575
Huesca	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.066
Huesca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	156
Huesca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	83
Huesca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	73
Huesca	Group 1002 Pneumonia 480-486	Both sexes	517
Huesca	Group 1002 Pneumonia 480-486	Men	304
Huesca	Group 1002 Pneumonia 480-486	Women	213
Huesca	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	340
Huesca	Group 1003 Acute bronchitis and bronchiolitis  466	Men	156
Huesca	Group 1003 Acute bronchitis and bronchiolitis  466	Women	184
Huesca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	50
Huesca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	26
Huesca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	24
Huesca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	210
Huesca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	156
Huesca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	54
Huesca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	447
Huesca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	383
Huesca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	64
Huesca	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	70
Huesca	Group 1007 Asthma 4930-4931,4938-4939	Men	25
Huesca	Group 1007 Asthma 4930-4931,4938-4939	Women	45
Huesca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	851
Huesca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	442
Huesca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	409
Huesca	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.894
Huesca	Group 1100 Diseases of the digestive system  520-579	Men	1.686
Huesca	Group 1100 Diseases of the digestive system  520-579	Women	1.208
Huesca	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	21
Huesca	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	8
Huesca	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	13
Huesca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	27
Huesca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	14
Huesca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	13
Huesca	Group 1103 Diseases of the esophagus 530	Both sexes	27
Huesca	Group 1103 Diseases of the esophagus 530	Men	15
Huesca	Group 1103 Diseases of the esophagus 530	Women	12
Huesca	Group 1104 Peptic ulcer 531-534	Both sexes	84
Huesca	Group 1104 Peptic ulcer 531-534	Men	60
Huesca	Group 1104 Peptic ulcer 531-534	Women	24
Huesca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	87
Huesca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	34
Huesca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	53
Huesca	Group 1106 Appendicitis  540-543	Both sexes	193
Huesca	Group 1106 Appendicitis  540-543	Men	119
Huesca	Group 1106 Appendicitis  540-543	Women	74
Huesca	Group 1107 Inguinal hernia  550	Both sexes	430
Huesca	Group 1107 Inguinal hernia  550	Men	374
Huesca	Group 1107 Inguinal hernia  550	Women	56
Huesca	Group 1108 Other abdominal hernia  551-553	Both sexes	224
Huesca	Group 1108 Other abdominal hernia  551-553	Men	110
Huesca	Group 1108 Other abdominal hernia  551-553	Women	114
Huesca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	40
Huesca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	21
Huesca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	19
Huesca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	162
Huesca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	73
Huesca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	89
Huesca	Group 1111 Intestinal obstruction without hernia 560	Both sexes	138
Huesca	Group 1111 Intestinal obstruction without hernia 560	Men	69
Huesca	Group 1111 Intestinal obstruction without hernia 560	Women	69
Huesca	Group 1112 Intestinal diverticulosis 562	Both sexes	102
Huesca	Group 1112 Intestinal diverticulosis 562	Men	56
Huesca	Group 1112 Intestinal diverticulosis 562	Women	46
Huesca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	156
Huesca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	97
Huesca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	59
Huesca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	153
Huesca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	69
Huesca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	84
Huesca	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	52
Huesca	Group 1115 Alcoholic hepatitis 5710-5713	Men	46
Huesca	Group 1115 Alcoholic hepatitis 5710-5713	Women	6
Huesca	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	113
Huesca	Group 1116 Other diseases of the liver 570,5714-573	Men	71
Huesca	Group 1116 Other diseases of the liver 570,5714-573	Women	42
Huesca	Group 1117 Cholelithiasis  574	Both sexes	558
Huesca	Group 1117 Cholelithiasis  574	Men	266
Huesca	Group 1117 Cholelithiasis  574	Women	292
Huesca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	140
Huesca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	80
Huesca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	60
Huesca	Group 1119 Pancreatic diseases 577	Both sexes	94
Huesca	Group 1119 Pancreatic diseases 577	Men	51
Huesca	Group 1119 Pancreatic diseases 577	Women	43
Huesca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	93
Huesca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	53
Huesca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	40
Huesca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	268
Huesca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	140
Huesca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	128
Huesca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	178
Huesca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	104
Huesca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	74
Huesca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	10
Huesca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	8
Huesca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Huesca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	80
Huesca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	28
Huesca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	52
Huesca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.287
Huesca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	629
Huesca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	658
Huesca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Huesca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Huesca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Huesca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Huesca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Huesca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Huesca	Group 1303 Internal derangement of knee 717	Both sexes	241
Huesca	Group 1303 Internal derangement of knee 717	Men	154
Huesca	Group 1303 Internal derangement of knee 717	Women	87
Huesca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	456
Huesca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	224
Huesca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	232
Huesca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	24
Huesca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	11
Huesca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	13
Huesca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	16
Huesca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	10
Huesca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	6
Huesca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	59
Huesca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	31
Huesca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	28
Huesca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	70
Huesca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	21
Huesca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	49
Huesca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	192
Huesca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	102
Huesca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	90
Huesca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	229
Huesca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	76
Huesca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	153
Huesca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.379
Huesca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	677
Huesca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	702
Huesca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	105
Huesca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	33
Huesca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	72
Huesca	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	156
Huesca	Group 1402 Renal failure  5836-5837, 584-586	Men	101
Huesca	Group 1402 Renal failure  5836-5837, 584-586	Women	55
Huesca	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	198
Huesca	Group 1403 Urolithiasis  592, 594, 7880	Men	117
Huesca	Group 1403 Urolithiasis  592, 594, 7880	Women	81
Huesca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	436
Huesca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	226
Huesca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	210
Huesca	Group 1405 Prostatic hyperplasia  600	Both sexes	122
Huesca	Group 1405 Prostatic hyperplasia  600	Men	122
Huesca	Group 1405 Prostatic hyperplasia  600	Women	..
Huesca	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	70
Huesca	Group 1406 Other diseases of the male genital organs    601-608	Men	70
Huesca	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Huesca	Group 1407 Disorders of breast  610-612	Both sexes	49
Huesca	Group 1407 Disorders of breast  610-612	Men	5
Huesca	Group 1407 Disorders of breast  610-612	Women	44
Huesca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	28
Huesca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Huesca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	28
Huesca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	21
Huesca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Huesca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	21
Huesca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	194
Huesca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
Huesca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	191
Huesca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.755
Huesca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Huesca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.755
Huesca	Group 1501 Legally induced abortion  635	Both sexes	..
Huesca	Group 1501 Legally induced abortion  635	Men	..
Huesca	Group 1501 Legally induced abortion  635	Women	..
Huesca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	128
Huesca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Huesca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	128
Huesca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	946
Huesca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Huesca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	946
Huesca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	335
Huesca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Huesca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	335
Huesca	Group 1505 Single spontaneous delivery  650	Both sexes	85
Huesca	Group 1505 Single spontaneous delivery  650	Men	..
Huesca	Group 1505 Single spontaneous delivery  650	Women	85
Huesca	Group 1506 Other deliveries  6695-6697	Both sexes	39
Huesca	Group 1506 Other deliveries  6695-6697	Men	..
Huesca	Group 1506 Other deliveries  6695-6697	Women	39
Huesca	Group 1507 Complications related to the puerperium  670-676	Both sexes	24
Huesca	Group 1507 Complications related to the puerperium  670-676	Men	..
Huesca	Group 1507 Complications related to the puerperium  670-676	Women	24
Huesca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	198
Huesca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Huesca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	198
Huesca	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	266
Huesca	Group 1600 Some disorders originating in the perinatal period  760-779	Men	150
Huesca	Group 1600 Some disorders originating in the perinatal period  760-779	Women	116
Huesca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	61
Huesca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	37
Huesca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	24
Huesca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	205
Huesca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	113
Huesca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	92
Huesca	Grupo 1700 Congenital abnormalities  740-759	Both sexes	33
Huesca	Grupo 1700 Congenital abnormalities  740-759	Men	17
Huesca	Grupo 1700 Congenital abnormalities  740-759	Women	16
Huesca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.265
Huesca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	664
Huesca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	601
Huesca	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	137
Huesca	Group 1801 Pain in throat and chest 7841, 7865	Men	79
Huesca	Group 1801 Pain in throat and chest 7841, 7865	Women	58
Huesca	Group 1802 Abdominal pain   7890	Both sexes	210
Huesca	Group 1802 Abdominal pain   7890	Men	82
Huesca	Group 1802 Abdominal pain   7890	Women	128
Huesca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	..
Huesca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Huesca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Huesca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	918
Huesca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	503
Huesca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	415
Huesca	Group 1900 Injuries and poisoning  800-999	Both sexes	1.788
Huesca	Group 1900 Injuries and poisoning  800-999	Men	873
Huesca	Group 1900 Injuries and poisoning  800-999	Women	915
Huesca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	126
Huesca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	69
Huesca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	57
Huesca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	28
Huesca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	17
Huesca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	11
Huesca	Group 1903 Radius and ulna fracture 813	Both sexes	71
Huesca	Group 1903 Radius and ulna fracture 813	Men	26
Huesca	Group 1903 Radius and ulna fracture 813	Women	45
Huesca	Group 1904 Femur fracture  820-821	Both sexes	392
Huesca	Group 1904 Femur fracture  820-821	Men	118
Huesca	Group 1904 Femur fracture  820-821	Women	274
Huesca	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	139
Huesca	Group 1905 Leg fracture, including the ankle 823-824	Men	58
Huesca	Group 1905 Leg fracture, including the ankle 823-824	Women	81
Huesca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	519
Huesca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	298
Huesca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	221
Huesca	Group 1907 Burns  940-949	Both sexes	3
Huesca	Group 1907 Burns  940-949	Men	..
Huesca	Group 1907 Burns  940-949	Women	3
Huesca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	74
Huesca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	41
Huesca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	33
Huesca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	393
Huesca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	218
Huesca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	175
Huesca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Huesca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Huesca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Huesca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	43
Huesca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	28
Huesca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	15
Huesca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	667
Huesca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	352
Huesca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	315
Huesca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	27
Huesca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	20
Huesca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	7
Huesca	Group 2102 Contraceptive management  V25	Both sexes	12
Huesca	Group 2102 Contraceptive management  V25	Men	..
Huesca	Group 2102 Contraceptive management  V25	Women	12
Huesca	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Huesca	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Huesca	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Huesca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	107
Huesca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	57
Huesca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	50
Huesca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	521
Huesca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	275
Huesca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	246
Teruel	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	14.161
Teruel	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	6.970
Teruel	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	7.191
Teruel	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	258
Teruel	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	147
Teruel	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	111
Teruel	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	113
Teruel	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	60
Teruel	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	53
Teruel	Group 0102 Imprecise intestinal infections 009	Both sexes	9
Teruel	Group 0102 Imprecise intestinal infections 009	Men	5
Teruel	Group 0102 Imprecise intestinal infections 009	Women	4
Teruel	Group 0103 Tuberculosis 010-018, 137	Both sexes	8
Teruel	Group 0103 Tuberculosis 010-018, 137	Men	4
Teruel	Group 0103 Tuberculosis 010-018, 137	Women	4
Teruel	Group 0104 Septicaemia  038	Both sexes	38
Teruel	Group 0104 Septicaemia  038	Men	25
Teruel	Group 0104 Septicaemia  038	Women	13
Teruel	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	5
Teruel	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	4
Teruel	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Teruel	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	84
Teruel	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	48
Teruel	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	36
Teruel	Group 0200 Neoplasms  140-239	Both sexes	968
Teruel	Group 0200 Neoplasms  140-239	Men	514
Teruel	Group 0200 Neoplasms  140-239	Women	454
Teruel	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	156
Teruel	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	102
Teruel	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	54
Teruel	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	72
Teruel	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	56
Teruel	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	16
Teruel	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	5
Teruel	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	4
Teruel	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	1
Teruel	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	75
Teruel	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Teruel	Group 0204 Malignant neoplasm of breast  174-175	Women	75
Teruel	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	15
Teruel	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Teruel	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	15
Teruel	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	19
Teruel	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Teruel	Group 0206 Malignant neoplasm of ovary  1830	Women	19
Teruel	Group 0207 Malignant neoplasm of prostate  185	Both sexes	29
Teruel	Group 0207 Malignant neoplasm of prostate  185	Men	29
Teruel	Group 0207 Malignant neoplasm of prostate  185	Women	..
Teruel	Group 0208 Malignant neoplasm of bladder  188	Both sexes	130
Teruel	Group 0208 Malignant neoplasm of bladder  188	Men	99
Teruel	Group 0208 Malignant neoplasm of bladder  188	Women	31
Teruel	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	313
Teruel	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	174
Teruel	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	139
Teruel	Group 0210 Carcinoma in situ  230-234	Both sexes	13
Teruel	Group 0210 Carcinoma in situ  230-234	Men	5
Teruel	Group 0210 Carcinoma in situ  230-234	Women	8
Teruel	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	13
Teruel	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	8
Teruel	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	5
Teruel	Grupo 0212 Leiomyoma of uterus  218	Both sexes	30
Teruel	Grupo 0212 Leiomyoma of uterus  218	Men	..
Teruel	Grupo 0212 Leiomyoma of uterus  218	Women	30
Teruel	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	98
Teruel	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	37
Teruel	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	61
Teruel	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	127
Teruel	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	54
Teruel	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	73
Teruel	Group 0301 Anaemias 280-285	Both sexes	85
Teruel	Group 0301 Anaemias 280-285	Men	40
Teruel	Group 0301 Anaemias 280-285	Women	45
Teruel	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	42
Teruel	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	14
Teruel	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	28
Teruel	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	159
Teruel	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	75
Teruel	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	85
Teruel	Group 0401 Diabetes mellitus  249-250	Both sexes	75
Teruel	Group 0401 Diabetes mellitus  249-250	Men	43
Teruel	Group 0401 Diabetes mellitus  249-250	Women	31
Teruel	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	85
Teruel	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	31
Teruel	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	53
Teruel	Group 0500 Mental disorders  290-319	Both sexes	341
Teruel	Group 0500 Mental disorders  290-319	Men	179
Teruel	Group 0500 Mental disorders  290-319	Women	162
Teruel	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	39
Teruel	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	19
Teruel	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	21
Teruel	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	26
Teruel	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	21
Teruel	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	5
Teruel	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	12
Teruel	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	7
Teruel	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
Teruel	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	98
Teruel	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	58
Teruel	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	40
Teruel	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	55
Teruel	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	22
Teruel	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	33
Teruel	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	111
Teruel	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	53
Teruel	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	58
Teruel	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	266
Teruel	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	131
Teruel	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	135
Teruel	Group 0601 Alzheimer's disease  3310	Both sexes	11
Teruel	Group 0601 Alzheimer's disease  3310	Men	1
Teruel	Group 0601 Alzheimer's disease  3310	Women	10
Teruel	Group 0602 Multiple sclerosis 340	Both sexes	3
Teruel	Group 0602 Multiple sclerosis 340	Men	..
Teruel	Group 0602 Multiple sclerosis 340	Women	3
Teruel	Group 0603 Epilepsy  345	Both sexes	48
Teruel	Group 0603 Epilepsy  345	Men	12
Teruel	Group 0603 Epilepsy  345	Women	35
Teruel	Group 0604 Transient cerebral ischemia 435	Both sexes	86
Teruel	Group 0604 Transient cerebral ischemia 435	Men	47
Teruel	Group 0604 Transient cerebral ischemia 435	Women	40
Teruel	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	119
Teruel	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	72
Teruel	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	47
Teruel	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	34
Teruel	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	18
Teruel	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	16
Teruel	Grupo 0701 Cataract  366	Both sexes	9
Teruel	Grupo 0701 Cataract  366	Men	5
Teruel	Grupo 0701 Cataract  366	Women	4
Teruel	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	25
Teruel	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	13
Teruel	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	12
Teruel	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	44
Teruel	Group 0800 Diseases of the ear and the mastoid  380-389	Men	22
Teruel	Group 0800 Diseases of the ear and the mastoid  380-389	Women	22
Teruel	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.712
Teruel	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	926
Teruel	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	786
Teruel	Group 0901 Hypertensive disease  401-405	Both sexes	39
Teruel	Group 0901 Hypertensive disease  401-405	Men	18
Teruel	Group 0901 Hypertensive disease  401-405	Women	21
Teruel	Group 0902 Angina pectoris  4111, 413	Both sexes	138
Teruel	Group 0902 Angina pectoris  4111, 413	Men	102
Teruel	Group 0902 Angina pectoris  4111, 413	Women	36
Teruel	Group 0903 Acute myocardial infarction  410	Both sexes	85
Teruel	Group 0903 Acute myocardial infarction  410	Men	58
Teruel	Group 0903 Acute myocardial infarction  410	Women	27
Teruel	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	49
Teruel	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	33
Teruel	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	16
Teruel	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	80
Teruel	Group 0905 Diseases of the lungs circulation 415-417	Men	39
Teruel	Group 0905 Diseases of the lungs circulation 415-417	Women	41
Teruel	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	219
Teruel	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	122
Teruel	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	97
Teruel	Grupo 0907 Heart failure  428	Both sexes	544
Teruel	Grupo 0907 Heart failure  428	Men	284
Teruel	Grupo 0907 Heart failure  428	Women	261
Teruel	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	256
Teruel	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	124
Teruel	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	132
Teruel	Grupo 0909 Atherosclerosis  440	Both sexes	19
Teruel	Grupo 0909 Atherosclerosis  440	Men	13
Teruel	Grupo 0909 Atherosclerosis  440	Women	6
Teruel	Group 0910 Varicose veins of lower extremities 454	Both sexes	41
Teruel	Group 0910 Varicose veins of lower extremities 454	Men	9
Teruel	Group 0910 Varicose veins of lower extremities 454	Women	32
Teruel	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	242
Teruel	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	125
Teruel	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	117
Teruel	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.893
Teruel	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.186
Teruel	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	707
Teruel	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	135
Teruel	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	81
Teruel	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	54
Teruel	Group 1002 Pneumonia 480-486	Both sexes	404
Teruel	Group 1002 Pneumonia 480-486	Men	252
Teruel	Group 1002 Pneumonia 480-486	Women	152
Teruel	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	215
Teruel	Group 1003 Acute bronchitis and bronchiolitis  466	Men	100
Teruel	Group 1003 Acute bronchitis and bronchiolitis  466	Women	116
Teruel	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	35
Teruel	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	22
Teruel	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	13
Teruel	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	126
Teruel	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	82
Teruel	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	44
Teruel	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	363
Teruel	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	309
Teruel	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	53
Teruel	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	59
Teruel	Group 1007 Asthma 4930-4931,4938-4939	Men	16
Teruel	Group 1007 Asthma 4930-4931,4938-4939	Women	43
Teruel	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	555
Teruel	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	323
Teruel	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	232
Teruel	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.110
Teruel	Group 1100 Diseases of the digestive system  520-579	Men	1.245
Teruel	Group 1100 Diseases of the digestive system  520-579	Women	866
Teruel	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	5
Teruel	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	2
Teruel	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	3
Teruel	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	17
Teruel	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	10
Teruel	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	7
Teruel	Group 1103 Diseases of the esophagus 530	Both sexes	32
Teruel	Group 1103 Diseases of the esophagus 530	Men	21
Teruel	Group 1103 Diseases of the esophagus 530	Women	11
Teruel	Group 1104 Peptic ulcer 531-534	Both sexes	52
Teruel	Group 1104 Peptic ulcer 531-534	Men	32
Teruel	Group 1104 Peptic ulcer 531-534	Women	20
Teruel	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	49
Teruel	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	16
Teruel	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	33
Teruel	Group 1106 Appendicitis  540-543	Both sexes	142
Teruel	Group 1106 Appendicitis  540-543	Men	80
Teruel	Group 1106 Appendicitis  540-543	Women	62
Teruel	Group 1107 Inguinal hernia  550	Both sexes	352
Teruel	Group 1107 Inguinal hernia  550	Men	321
Teruel	Group 1107 Inguinal hernia  550	Women	31
Teruel	Group 1108 Other abdominal hernia  551-553	Both sexes	187
Teruel	Group 1108 Other abdominal hernia  551-553	Men	92
Teruel	Group 1108 Other abdominal hernia  551-553	Women	95
Teruel	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	30
Teruel	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	19
Teruel	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	11
Teruel	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	126
Teruel	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	58
Teruel	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	68
Teruel	Group 1111 Intestinal obstruction without hernia 560	Both sexes	109
Teruel	Group 1111 Intestinal obstruction without hernia 560	Men	59
Teruel	Group 1111 Intestinal obstruction without hernia 560	Women	50
Teruel	Group 1112 Intestinal diverticulosis 562	Both sexes	86
Teruel	Group 1112 Intestinal diverticulosis 562	Men	49
Teruel	Group 1112 Intestinal diverticulosis 562	Women	37
Teruel	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	86
Teruel	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	50
Teruel	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	36
Teruel	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	57
Teruel	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	20
Teruel	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	37
Teruel	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	21
Teruel	Group 1115 Alcoholic hepatitis 5710-5713	Men	17
Teruel	Group 1115 Alcoholic hepatitis 5710-5713	Women	4
Teruel	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	68
Teruel	Group 1116 Other diseases of the liver 570,5714-573	Men	42
Teruel	Group 1116 Other diseases of the liver 570,5714-573	Women	26
Teruel	Group 1117 Cholelithiasis  574	Both sexes	395
Teruel	Group 1117 Cholelithiasis  574	Men	198
Teruel	Group 1117 Cholelithiasis  574	Women	197
Teruel	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	113
Teruel	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	61
Teruel	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	52
Teruel	Group 1119 Pancreatic diseases 577	Both sexes	99
Teruel	Group 1119 Pancreatic diseases 577	Men	56
Teruel	Group 1119 Pancreatic diseases 577	Women	43
Teruel	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	83
Teruel	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	41
Teruel	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	42
Teruel	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	136
Teruel	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	72
Teruel	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	65
Teruel	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	91
Teruel	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	53
Teruel	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	37
Teruel	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	4
Teruel	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	2
Teruel	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Teruel	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	42
Teruel	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	16
Teruel	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	25
Teruel	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	738
Teruel	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	347
Teruel	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	391
Teruel	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Teruel	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Teruel	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Teruel	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Teruel	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Teruel	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Teruel	Group 1303 Internal derangement of knee 717	Both sexes	109
Teruel	Group 1303 Internal derangement of knee 717	Men	66
Teruel	Group 1303 Internal derangement of knee 717	Women	43
Teruel	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	322
Teruel	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	162
Teruel	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	160
Teruel	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	21
Teruel	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	7
Teruel	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	14
Teruel	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	5
Teruel	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	2
Teruel	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	3
Teruel	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	20
Teruel	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	13
Teruel	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	7
Teruel	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	13
Teruel	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	6
Teruel	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	7
Teruel	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	115
Teruel	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	56
Teruel	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	59
Teruel	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	133
Teruel	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	35
Teruel	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	98
Teruel	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	724
Teruel	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	391
Teruel	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	334
Teruel	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	51
Teruel	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	19
Teruel	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	32
Teruel	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	91
Teruel	Group 1402 Renal failure  5836-5837, 584-586	Men	57
Teruel	Group 1402 Renal failure  5836-5837, 584-586	Women	34
Teruel	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	101
Teruel	Group 1403 Urolithiasis  592, 594, 7880	Men	64
Teruel	Group 1403 Urolithiasis  592, 594, 7880	Women	37
Teruel	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	148
Teruel	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	68
Teruel	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	80
Teruel	Group 1405 Prostatic hyperplasia  600	Both sexes	106
Teruel	Group 1405 Prostatic hyperplasia  600	Men	106
Teruel	Group 1405 Prostatic hyperplasia  600	Women	..
Teruel	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	71
Teruel	Group 1406 Other diseases of the male genital organs    601-608	Men	71
Teruel	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Teruel	Group 1407 Disorders of breast  610-612	Both sexes	20
Teruel	Group 1407 Disorders of breast  610-612	Men	6
Teruel	Group 1407 Disorders of breast  610-612	Women	14
Teruel	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	26
Teruel	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Teruel	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	26
Teruel	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	7
Teruel	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Teruel	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	7
Teruel	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	103
Teruel	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Teruel	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	103
Teruel	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.227
Teruel	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Teruel	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.227
Teruel	Group 1501 Legally induced abortion  635	Both sexes	1
Teruel	Group 1501 Legally induced abortion  635	Men	..
Teruel	Group 1501 Legally induced abortion  635	Women	1
Teruel	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	99
Teruel	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Teruel	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	99
Teruel	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	608
Teruel	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Teruel	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	608
Teruel	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	248
Teruel	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Teruel	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	248
Teruel	Group 1505 Single spontaneous delivery  650	Both sexes	150
Teruel	Group 1505 Single spontaneous delivery  650	Men	..
Teruel	Group 1505 Single spontaneous delivery  650	Women	150
Teruel	Group 1506 Other deliveries  6695-6697	Both sexes	16
Teruel	Group 1506 Other deliveries  6695-6697	Men	..
Teruel	Group 1506 Other deliveries  6695-6697	Women	16
Teruel	Group 1507 Complications related to the puerperium  670-676	Both sexes	12
Teruel	Group 1507 Complications related to the puerperium  670-676	Men	..
Teruel	Group 1507 Complications related to the puerperium  670-676	Women	12
Teruel	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	93
Teruel	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Teruel	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	93
Teruel	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	534
Teruel	Group 1600 Some disorders originating in the perinatal period  760-779	Men	267
Teruel	Group 1600 Some disorders originating in the perinatal period  760-779	Women	267
Teruel	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	23
Teruel	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	15
Teruel	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	8
Teruel	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	511
Teruel	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	252
Teruel	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	259
Teruel	Grupo 1700 Congenital abnormalities  740-759	Both sexes	27
Teruel	Grupo 1700 Congenital abnormalities  740-759	Men	8
Teruel	Grupo 1700 Congenital abnormalities  740-759	Women	19
Teruel	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.405
Teruel	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	751
Teruel	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	654
Teruel	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	75
Teruel	Group 1801 Pain in throat and chest 7841, 7865	Men	49
Teruel	Group 1801 Pain in throat and chest 7841, 7865	Women	26
Teruel	Group 1802 Abdominal pain   7890	Both sexes	92
Teruel	Group 1802 Abdominal pain   7890	Men	54
Teruel	Group 1802 Abdominal pain   7890	Women	38
Teruel	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	728
Teruel	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	350
Teruel	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	378
Teruel	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	510
Teruel	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	298
Teruel	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	212
Teruel	Group 1900 Injuries and poisoning  800-999	Both sexes	1.142
Teruel	Group 1900 Injuries and poisoning  800-999	Men	494
Teruel	Group 1900 Injuries and poisoning  800-999	Women	648
Teruel	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	71
Teruel	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	35
Teruel	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	36
Teruel	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	12
Teruel	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	9
Teruel	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3
Teruel	Group 1903 Radius and ulna fracture 813	Both sexes	59
Teruel	Group 1903 Radius and ulna fracture 813	Men	25
Teruel	Group 1903 Radius and ulna fracture 813	Women	34
Teruel	Group 1904 Femur fracture  820-821	Both sexes	324
Teruel	Group 1904 Femur fracture  820-821	Men	76
Teruel	Group 1904 Femur fracture  820-821	Women	248
Teruel	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	72
Teruel	Group 1905 Leg fracture, including the ankle 823-824	Men	33
Teruel	Group 1905 Leg fracture, including the ankle 823-824	Women	39
Teruel	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	247
Teruel	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	148
Teruel	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	99
Teruel	Group 1907 Burns  940-949	Both sexes	2
Teruel	Group 1907 Burns  940-949	Men	1
Teruel	Group 1907 Burns  940-949	Women	1
Teruel	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	26
Teruel	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	8
Teruel	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	18
Teruel	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	219
Teruel	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	98
Teruel	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	121
Teruel	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	5
Teruel	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Teruel	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
Teruel	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	104
Teruel	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	57
Teruel	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	47
Teruel	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	314
Teruel	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	142
Teruel	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	172
Teruel	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	30
Teruel	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	21
Teruel	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	9
Teruel	Group 2102 Contraceptive management  V25	Both sexes	6
Teruel	Group 2102 Contraceptive management  V25	Men	..
Teruel	Group 2102 Contraceptive management  V25	Women	6
Teruel	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Teruel	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Teruel	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Teruel	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	39
Teruel	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	23
Teruel	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	16
Teruel	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	239
Teruel	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	98
Teruel	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	141
Zaragoza	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	119.729
Zaragoza	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	58.325
Zaragoza	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	61.404
Zaragoza	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.103
Zaragoza	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.152
Zaragoza	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	951
Zaragoza	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	348
Zaragoza	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	170
Zaragoza	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	178
Zaragoza	Group 0102 Imprecise intestinal infections 009	Both sexes	93
Zaragoza	Group 0102 Imprecise intestinal infections 009	Men	42
Zaragoza	Group 0102 Imprecise intestinal infections 009	Women	51
Zaragoza	Group 0103 Tuberculosis 010-018, 137	Both sexes	141
Zaragoza	Group 0103 Tuberculosis 010-018, 137	Men	88
Zaragoza	Group 0103 Tuberculosis 010-018, 137	Women	53
Zaragoza	Group 0104 Septicaemia  038	Both sexes	817
Zaragoza	Group 0104 Septicaemia  038	Men	415
Zaragoza	Group 0104 Septicaemia  038	Women	402
Zaragoza	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	41
Zaragoza	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	29
Zaragoza	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	12
Zaragoza	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	663
Zaragoza	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	408
Zaragoza	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	255
Zaragoza	Group 0200 Neoplasms  140-239	Both sexes	11.549
Zaragoza	Group 0200 Neoplasms  140-239	Men	5.962
Zaragoza	Group 0200 Neoplasms  140-239	Women	5.587
Zaragoza	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	928
Zaragoza	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	573
Zaragoza	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	355
Zaragoza	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	786
Zaragoza	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	647
Zaragoza	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	139
Zaragoza	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	526
Zaragoza	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	314
Zaragoza	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	212
Zaragoza	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	750
Zaragoza	Group 0204 Malignant neoplasm of breast  174-175	Men	7
Zaragoza	Group 0204 Malignant neoplasm of breast  174-175	Women	743
Zaragoza	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	195
Zaragoza	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Zaragoza	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	195
Zaragoza	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	100
Zaragoza	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Zaragoza	Group 0206 Malignant neoplasm of ovary  1830	Women	100
Zaragoza	Group 0207 Malignant neoplasm of prostate  185	Both sexes	433
Zaragoza	Group 0207 Malignant neoplasm of prostate  185	Men	433
Zaragoza	Group 0207 Malignant neoplasm of prostate  185	Women	..
Zaragoza	Group 0208 Malignant neoplasm of bladder  188	Both sexes	815
Zaragoza	Group 0208 Malignant neoplasm of bladder  188	Men	649
Zaragoza	Group 0208 Malignant neoplasm of bladder  188	Women	166
Zaragoza	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.830
Zaragoza	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.253
Zaragoza	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.577
Zaragoza	Group 0210 Carcinoma in situ  230-234	Both sexes	643
Zaragoza	Group 0210 Carcinoma in situ  230-234	Men	220
Zaragoza	Group 0210 Carcinoma in situ  230-234	Women	423
Zaragoza	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	108
Zaragoza	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	62
Zaragoza	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	46
Zaragoza	Grupo 0212 Leiomyoma of uterus  218	Both sexes	603
Zaragoza	Grupo 0212 Leiomyoma of uterus  218	Men	..
Zaragoza	Grupo 0212 Leiomyoma of uterus  218	Women	603
Zaragoza	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.832
Zaragoza	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	804
Zaragoza	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.028
Zaragoza	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.080
Zaragoza	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	537
Zaragoza	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	543
Zaragoza	Group 0301 Anaemias 280-285	Both sexes	699
Zaragoza	Group 0301 Anaemias 280-285	Men	336
Zaragoza	Group 0301 Anaemias 280-285	Women	363
Zaragoza	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	381
Zaragoza	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	201
Zaragoza	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	180
Zaragoza	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.533
Zaragoza	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.052
Zaragoza	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.481
Zaragoza	Group 0401 Diabetes mellitus  249-250	Both sexes	658
Zaragoza	Group 0401 Diabetes mellitus  249-250	Men	375
Zaragoza	Group 0401 Diabetes mellitus  249-250	Women	283
Zaragoza	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.875
Zaragoza	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	677
Zaragoza	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.198
Zaragoza	Group 0500 Mental disorders  290-319	Both sexes	2.235
Zaragoza	Group 0500 Mental disorders  290-319	Men	1.027
Zaragoza	Group 0500 Mental disorders  290-319	Women	1.208
Zaragoza	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	84
Zaragoza	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	33
Zaragoza	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	51
Zaragoza	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	153
Zaragoza	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	119
Zaragoza	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	34
Zaragoza	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	78
Zaragoza	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	53
Zaragoza	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	25
Zaragoza	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	490
Zaragoza	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	286
Zaragoza	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	204
Zaragoza	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	487
Zaragoza	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	162
Zaragoza	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	324
Zaragoza	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	943
Zaragoza	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	374
Zaragoza	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	570
Zaragoza	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.332
Zaragoza	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.688
Zaragoza	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.644
Zaragoza	Group 0601 Alzheimer's disease  3310	Both sexes	73
Zaragoza	Group 0601 Alzheimer's disease  3310	Men	33
Zaragoza	Group 0601 Alzheimer's disease  3310	Women	40
Zaragoza	Group 0602 Multiple sclerosis 340	Both sexes	61
Zaragoza	Group 0602 Multiple sclerosis 340	Men	21
Zaragoza	Group 0602 Multiple sclerosis 340	Women	40
Zaragoza	Group 0603 Epilepsy  345	Both sexes	244
Zaragoza	Group 0603 Epilepsy  345	Men	124
Zaragoza	Group 0603 Epilepsy  345	Women	120
Zaragoza	Group 0604 Transient cerebral ischemia 435	Both sexes	318
Zaragoza	Group 0604 Transient cerebral ischemia 435	Men	157
Zaragoza	Group 0604 Transient cerebral ischemia 435	Women	161
Zaragoza	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.636
Zaragoza	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.353
Zaragoza	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.283
Zaragoza	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	893
Zaragoza	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	468
Zaragoza	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	425
Zaragoza	Grupo 0701 Cataract  366	Both sexes	168
Zaragoza	Grupo 0701 Cataract  366	Men	94
Zaragoza	Grupo 0701 Cataract  366	Women	74
Zaragoza	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	725
Zaragoza	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	374
Zaragoza	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	351
Zaragoza	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	544
Zaragoza	Group 0800 Diseases of the ear and the mastoid  380-389	Men	238
Zaragoza	Group 0800 Diseases of the ear and the mastoid  380-389	Women	306
Zaragoza	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	13.766
Zaragoza	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	7.617
Zaragoza	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	6.149
Zaragoza	Group 0901 Hypertensive disease  401-405	Both sexes	385
Zaragoza	Group 0901 Hypertensive disease  401-405	Men	185
Zaragoza	Group 0901 Hypertensive disease  401-405	Women	200
Zaragoza	Group 0902 Angina pectoris  4111, 413	Both sexes	528
Zaragoza	Group 0902 Angina pectoris  4111, 413	Men	332
Zaragoza	Group 0902 Angina pectoris  4111, 413	Women	196
Zaragoza	Group 0903 Acute myocardial infarction  410	Both sexes	1.110
Zaragoza	Group 0903 Acute myocardial infarction  410	Men	796
Zaragoza	Group 0903 Acute myocardial infarction  410	Women	314
Zaragoza	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.042
Zaragoza	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	789
Zaragoza	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	253
Zaragoza	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	438
Zaragoza	Group 0905 Diseases of the lungs circulation 415-417	Men	195
Zaragoza	Group 0905 Diseases of the lungs circulation 415-417	Women	243
Zaragoza	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.715
Zaragoza	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	919
Zaragoza	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	796
Zaragoza	Grupo 0907 Heart failure  428	Both sexes	3.015
Zaragoza	Grupo 0907 Heart failure  428	Men	1.382
Zaragoza	Grupo 0907 Heart failure  428	Women	1.633
Zaragoza	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.099
Zaragoza	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.102
Zaragoza	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	997
Zaragoza	Grupo 0909 Atherosclerosis  440	Both sexes	440
Zaragoza	Grupo 0909 Atherosclerosis  440	Men	320
Zaragoza	Grupo 0909 Atherosclerosis  440	Women	120
Zaragoza	Group 0910 Varicose veins of lower extremities 454	Both sexes	632
Zaragoza	Group 0910 Varicose veins of lower extremities 454	Men	221
Zaragoza	Group 0910 Varicose veins of lower extremities 454	Women	411
Zaragoza	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.362
Zaragoza	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.376
Zaragoza	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	986
Zaragoza	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	11.053
Zaragoza	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	6.345
Zaragoza	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.708
Zaragoza	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	669
Zaragoza	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	348
Zaragoza	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	321
Zaragoza	Group 1002 Pneumonia 480-486	Both sexes	2.392
Zaragoza	Group 1002 Pneumonia 480-486	Men	1.390
Zaragoza	Group 1002 Pneumonia 480-486	Women	1.002
Zaragoza	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	831
Zaragoza	Group 1003 Acute bronchitis and bronchiolitis  466	Men	435
Zaragoza	Group 1003 Acute bronchitis and bronchiolitis  466	Women	396
Zaragoza	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	509
Zaragoza	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	289
Zaragoza	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	220
Zaragoza	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.376
Zaragoza	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	855
Zaragoza	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	521
Zaragoza	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.814
Zaragoza	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.387
Zaragoza	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	427
Zaragoza	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	337
Zaragoza	Group 1007 Asthma 4930-4931,4938-4939	Men	84
Zaragoza	Group 1007 Asthma 4930-4931,4938-4939	Women	253
Zaragoza	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.125
Zaragoza	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.557
Zaragoza	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.568
Zaragoza	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.031
Zaragoza	Group 1100 Diseases of the digestive system  520-579	Men	7.447
Zaragoza	Group 1100 Diseases of the digestive system  520-579	Women	5.584
Zaragoza	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	225
Zaragoza	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	103
Zaragoza	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	122
Zaragoza	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	182
Zaragoza	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	106
Zaragoza	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	76
Zaragoza	Group 1103 Diseases of the esophagus 530	Both sexes	245
Zaragoza	Group 1103 Diseases of the esophagus 530	Men	140
Zaragoza	Group 1103 Diseases of the esophagus 530	Women	105
Zaragoza	Group 1104 Peptic ulcer 531-534	Both sexes	267
Zaragoza	Group 1104 Peptic ulcer 531-534	Men	185
Zaragoza	Group 1104 Peptic ulcer 531-534	Women	82
Zaragoza	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	268
Zaragoza	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	133
Zaragoza	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	135
Zaragoza	Group 1106 Appendicitis  540-543	Both sexes	906
Zaragoza	Group 1106 Appendicitis  540-543	Men	506
Zaragoza	Group 1106 Appendicitis  540-543	Women	400
Zaragoza	Group 1107 Inguinal hernia  550	Both sexes	1.868
Zaragoza	Group 1107 Inguinal hernia  550	Men	1.629
Zaragoza	Group 1107 Inguinal hernia  550	Women	239
Zaragoza	Group 1108 Other abdominal hernia  551-553	Both sexes	1.185
Zaragoza	Group 1108 Other abdominal hernia  551-553	Men	581
Zaragoza	Group 1108 Other abdominal hernia  551-553	Women	604
Zaragoza	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	211
Zaragoza	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	125
Zaragoza	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	86
Zaragoza	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	649
Zaragoza	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	307
Zaragoza	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	342
Zaragoza	Group 1111 Intestinal obstruction without hernia 560	Both sexes	610
Zaragoza	Group 1111 Intestinal obstruction without hernia 560	Men	300
Zaragoza	Group 1111 Intestinal obstruction without hernia 560	Women	310
Zaragoza	Group 1112 Intestinal diverticulosis 562	Both sexes	565
Zaragoza	Group 1112 Intestinal diverticulosis 562	Men	264
Zaragoza	Group 1112 Intestinal diverticulosis 562	Women	301
Zaragoza	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	868
Zaragoza	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	534
Zaragoza	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	334
Zaragoza	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	425
Zaragoza	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	190
Zaragoza	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	235
Zaragoza	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	230
Zaragoza	Group 1115 Alcoholic hepatitis 5710-5713	Men	200
Zaragoza	Group 1115 Alcoholic hepatitis 5710-5713	Women	30
Zaragoza	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	416
Zaragoza	Group 1116 Other diseases of the liver 570,5714-573	Men	255
Zaragoza	Group 1116 Other diseases of the liver 570,5714-573	Women	161
Zaragoza	Group 1117 Cholelithiasis  574	Both sexes	2.280
Zaragoza	Group 1117 Cholelithiasis  574	Men	978
Zaragoza	Group 1117 Cholelithiasis  574	Women	1.302
Zaragoza	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	497
Zaragoza	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	271
Zaragoza	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	226
Zaragoza	Group 1119 Pancreatic diseases 577	Both sexes	595
Zaragoza	Group 1119 Pancreatic diseases 577	Men	363
Zaragoza	Group 1119 Pancreatic diseases 577	Women	232
Zaragoza	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	539
Zaragoza	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	277
Zaragoza	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	262
Zaragoza	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.172
Zaragoza	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	665
Zaragoza	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	507
Zaragoza	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	625
Zaragoza	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	388
Zaragoza	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	237
Zaragoza	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	73
Zaragoza	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	43
Zaragoza	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	30
Zaragoza	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	474
Zaragoza	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	234
Zaragoza	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	240
Zaragoza	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	10.011
Zaragoza	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.941
Zaragoza	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.070
Zaragoza	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Zaragoza	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Zaragoza	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Zaragoza	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Zaragoza	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Zaragoza	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Zaragoza	Group 1303 Internal derangement of knee 717	Both sexes	1.483
Zaragoza	Group 1303 Internal derangement of knee 717	Men	945
Zaragoza	Group 1303 Internal derangement of knee 717	Women	538
Zaragoza	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.991
Zaragoza	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.335
Zaragoza	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.656
Zaragoza	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	147
Zaragoza	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	50
Zaragoza	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	97
Zaragoza	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	465
Zaragoza	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	243
Zaragoza	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	222
Zaragoza	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.146
Zaragoza	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	633
Zaragoza	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	513
Zaragoza	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	296
Zaragoza	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	145
Zaragoza	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	151
Zaragoza	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.745
Zaragoza	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	976
Zaragoza	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	769
Zaragoza	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.738
Zaragoza	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	614
Zaragoza	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.124
Zaragoza	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.689
Zaragoza	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.596
Zaragoza	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.093
Zaragoza	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	485
Zaragoza	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	195
Zaragoza	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	290
Zaragoza	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	548
Zaragoza	Group 1402 Renal failure  5836-5837, 584-586	Men	291
Zaragoza	Group 1402 Renal failure  5836-5837, 584-586	Women	257
Zaragoza	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.247
Zaragoza	Group 1403 Urolithiasis  592, 594, 7880	Men	741
Zaragoza	Group 1403 Urolithiasis  592, 594, 7880	Women	506
Zaragoza	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.674
Zaragoza	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	841
Zaragoza	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	833
Zaragoza	Group 1405 Prostatic hyperplasia  600	Both sexes	870
Zaragoza	Group 1405 Prostatic hyperplasia  600	Men	870
Zaragoza	Group 1405 Prostatic hyperplasia  600	Women	..
Zaragoza	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	576
Zaragoza	Group 1406 Other diseases of the male genital organs    601-608	Men	576
Zaragoza	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Zaragoza	Group 1407 Disorders of breast  610-612	Both sexes	544
Zaragoza	Group 1407 Disorders of breast  610-612	Men	74
Zaragoza	Group 1407 Disorders of breast  610-612	Women	470
Zaragoza	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	186
Zaragoza	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Zaragoza	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	186
Zaragoza	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	132
Zaragoza	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Zaragoza	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	132
Zaragoza	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.427
Zaragoza	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	8
Zaragoza	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.419
Zaragoza	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.897
Zaragoza	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Zaragoza	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.897
Zaragoza	Group 1501 Legally induced abortion  635	Both sexes	4
Zaragoza	Group 1501 Legally induced abortion  635	Men	..
Zaragoza	Group 1501 Legally induced abortion  635	Women	4
Zaragoza	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	638
Zaragoza	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Zaragoza	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	638
Zaragoza	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.817
Zaragoza	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Zaragoza	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.817
Zaragoza	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.428
Zaragoza	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Zaragoza	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.428
Zaragoza	Group 1505 Single spontaneous delivery  650	Both sexes	966
Zaragoza	Group 1505 Single spontaneous delivery  650	Men	..
Zaragoza	Group 1505 Single spontaneous delivery  650	Women	966
Zaragoza	Group 1506 Other deliveries  6695-6697	Both sexes	292
Zaragoza	Group 1506 Other deliveries  6695-6697	Men	..
Zaragoza	Group 1506 Other deliveries  6695-6697	Women	292
Zaragoza	Group 1507 Complications related to the puerperium  670-676	Both sexes	82
Zaragoza	Group 1507 Complications related to the puerperium  670-676	Men	..
Zaragoza	Group 1507 Complications related to the puerperium  670-676	Women	82
Zaragoza	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	670
Zaragoza	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Zaragoza	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	670
Zaragoza	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.287
Zaragoza	Group 1600 Some disorders originating in the perinatal period  760-779	Men	744
Zaragoza	Group 1600 Some disorders originating in the perinatal period  760-779	Women	543
Zaragoza	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	285
Zaragoza	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	150
Zaragoza	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	135
Zaragoza	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.002
Zaragoza	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	594
Zaragoza	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	408
Zaragoza	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.270
Zaragoza	Grupo 1700 Congenital abnormalities  740-759	Men	683
Zaragoza	Grupo 1700 Congenital abnormalities  740-759	Women	587
Zaragoza	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	12.509
Zaragoza	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	6.457
Zaragoza	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	6.052
Zaragoza	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	830
Zaragoza	Group 1801 Pain in throat and chest 7841, 7865	Men	487
Zaragoza	Group 1801 Pain in throat and chest 7841, 7865	Women	343
Zaragoza	Group 1802 Abdominal pain   7890	Both sexes	580
Zaragoza	Group 1802 Abdominal pain   7890	Men	245
Zaragoza	Group 1802 Abdominal pain   7890	Women	335
Zaragoza	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	7.331
Zaragoza	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	3.594
Zaragoza	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	3.737
Zaragoza	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	3.768
Zaragoza	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.131
Zaragoza	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.637
Zaragoza	Group 1900 Injuries and poisoning  800-999	Both sexes	10.795
Zaragoza	Group 1900 Injuries and poisoning  800-999	Men	5.981
Zaragoza	Group 1900 Injuries and poisoning  800-999	Women	4.814
Zaragoza	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	508
Zaragoza	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	305
Zaragoza	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	203
Zaragoza	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	326
Zaragoza	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	234
Zaragoza	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	92
Zaragoza	Group 1903 Radius and ulna fracture 813	Both sexes	641
Zaragoza	Group 1903 Radius and ulna fracture 813	Men	292
Zaragoza	Group 1903 Radius and ulna fracture 813	Women	349
Zaragoza	Group 1904 Femur fracture  820-821	Both sexes	1.581
Zaragoza	Group 1904 Femur fracture  820-821	Men	456
Zaragoza	Group 1904 Femur fracture  820-821	Women	1.125
Zaragoza	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	599
Zaragoza	Group 1905 Leg fracture, including the ankle 823-824	Men	333
Zaragoza	Group 1905 Leg fracture, including the ankle 823-824	Women	266
Zaragoza	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.148
Zaragoza	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.718
Zaragoza	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.430
Zaragoza	Group 1907 Burns  940-949	Both sexes	90
Zaragoza	Group 1907 Burns  940-949	Men	63
Zaragoza	Group 1907 Burns  940-949	Women	27
Zaragoza	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	172
Zaragoza	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	85
Zaragoza	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	87
Zaragoza	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.472
Zaragoza	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.349
Zaragoza	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.123
Zaragoza	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	15
Zaragoza	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	10
Zaragoza	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
Zaragoza	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	243
Zaragoza	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	136
Zaragoza	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	107
Zaragoza	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.980
Zaragoza	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.725
Zaragoza	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.255
Zaragoza	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	184
Zaragoza	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	120
Zaragoza	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	64
Zaragoza	Group 2102 Contraceptive management  V25	Both sexes	42
Zaragoza	Group 2102 Contraceptive management  V25	Men	4
Zaragoza	Group 2102 Contraceptive management  V25	Women	38
Zaragoza	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Zaragoza	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Zaragoza	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Zaragoza	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	903
Zaragoza	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	564
Zaragoza	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	339
Zaragoza	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.851
Zaragoza	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.037
Zaragoza	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	814
ASTURIAS, PRINCIPADO DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	116.616
ASTURIAS, PRINCIPADO DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	57.073
ASTURIAS, PRINCIPADO DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	59.543
ASTURIAS, PRINCIPADO DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.098
ASTURIAS, PRINCIPADO DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.101
ASTURIAS, PRINCIPADO DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	997
ASTURIAS, PRINCIPADO DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	311
ASTURIAS, PRINCIPADO DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	151
ASTURIAS, PRINCIPADO DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	160
ASTURIAS, PRINCIPADO DE	Group 0102 Imprecise intestinal infections 009	Both sexes	131
ASTURIAS, PRINCIPADO DE	Group 0102 Imprecise intestinal infections 009	Men	71
ASTURIAS, PRINCIPADO DE	Group 0102 Imprecise intestinal infections 009	Women	60
ASTURIAS, PRINCIPADO DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	110
ASTURIAS, PRINCIPADO DE	Group 0103 Tuberculosis 010-018, 137	Men	69
ASTURIAS, PRINCIPADO DE	Group 0103 Tuberculosis 010-018, 137	Women	41
ASTURIAS, PRINCIPADO DE	Group 0104 Septicaemia  038	Both sexes	906
ASTURIAS, PRINCIPADO DE	Group 0104 Septicaemia  038	Men	457
ASTURIAS, PRINCIPADO DE	Group 0104 Septicaemia  038	Women	449
ASTURIAS, PRINCIPADO DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	40
ASTURIAS, PRINCIPADO DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	28
ASTURIAS, PRINCIPADO DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	12
ASTURIAS, PRINCIPADO DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	600
ASTURIAS, PRINCIPADO DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	325
ASTURIAS, PRINCIPADO DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	275
ASTURIAS, PRINCIPADO DE	Group 0200 Neoplasms  140-239	Both sexes	11.019
ASTURIAS, PRINCIPADO DE	Group 0200 Neoplasms  140-239	Men	6.070
ASTURIAS, PRINCIPADO DE	Group 0200 Neoplasms  140-239	Women	4.949
ASTURIAS, PRINCIPADO DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.208
ASTURIAS, PRINCIPADO DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	724
ASTURIAS, PRINCIPADO DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	484
ASTURIAS, PRINCIPADO DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.095
ASTURIAS, PRINCIPADO DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	855
ASTURIAS, PRINCIPADO DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	240
ASTURIAS, PRINCIPADO DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	182
ASTURIAS, PRINCIPADO DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	96
ASTURIAS, PRINCIPADO DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	86
ASTURIAS, PRINCIPADO DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	685
ASTURIAS, PRINCIPADO DE	Group 0204 Malignant neoplasm of breast  174-175	Men	8
ASTURIAS, PRINCIPADO DE	Group 0204 Malignant neoplasm of breast  174-175	Women	677
ASTURIAS, PRINCIPADO DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	226
ASTURIAS, PRINCIPADO DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
ASTURIAS, PRINCIPADO DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	226
ASTURIAS, PRINCIPADO DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	117
ASTURIAS, PRINCIPADO DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
ASTURIAS, PRINCIPADO DE	Group 0206 Malignant neoplasm of ovary  1830	Women	117
ASTURIAS, PRINCIPADO DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	548
ASTURIAS, PRINCIPADO DE	Group 0207 Malignant neoplasm of prostate  185	Men	548
ASTURIAS, PRINCIPADO DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
ASTURIAS, PRINCIPADO DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	869
ASTURIAS, PRINCIPADO DE	Group 0208 Malignant neoplasm of bladder  188	Men	741
ASTURIAS, PRINCIPADO DE	Group 0208 Malignant neoplasm of bladder  188	Women	128
ASTURIAS, PRINCIPADO DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.921
ASTURIAS, PRINCIPADO DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.307
ASTURIAS, PRINCIPADO DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.614
ASTURIAS, PRINCIPADO DE	Group 0210 Carcinoma in situ  230-234	Both sexes	351
ASTURIAS, PRINCIPADO DE	Group 0210 Carcinoma in situ  230-234	Men	234
ASTURIAS, PRINCIPADO DE	Group 0210 Carcinoma in situ  230-234	Women	117
ASTURIAS, PRINCIPADO DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	92
ASTURIAS, PRINCIPADO DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	55
ASTURIAS, PRINCIPADO DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	37
ASTURIAS, PRINCIPADO DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	522
ASTURIAS, PRINCIPADO DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
ASTURIAS, PRINCIPADO DE	Grupo 0212 Leiomyoma of uterus  218	Women	522
ASTURIAS, PRINCIPADO DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.203
ASTURIAS, PRINCIPADO DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	502
ASTURIAS, PRINCIPADO DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	701
ASTURIAS, PRINCIPADO DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	998
ASTURIAS, PRINCIPADO DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	474
ASTURIAS, PRINCIPADO DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	524
ASTURIAS, PRINCIPADO DE	Group 0301 Anaemias 280-285	Both sexes	750
ASTURIAS, PRINCIPADO DE	Group 0301 Anaemias 280-285	Men	339
ASTURIAS, PRINCIPADO DE	Group 0301 Anaemias 280-285	Women	411
ASTURIAS, PRINCIPADO DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	248
ASTURIAS, PRINCIPADO DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	135
ASTURIAS, PRINCIPADO DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	113
ASTURIAS, PRINCIPADO DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.790
ASTURIAS, PRINCIPADO DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	746
ASTURIAS, PRINCIPADO DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.044
ASTURIAS, PRINCIPADO DE	Group 0401 Diabetes mellitus  249-250	Both sexes	812
ASTURIAS, PRINCIPADO DE	Group 0401 Diabetes mellitus  249-250	Men	448
ASTURIAS, PRINCIPADO DE	Group 0401 Diabetes mellitus  249-250	Women	364
ASTURIAS, PRINCIPADO DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	978
ASTURIAS, PRINCIPADO DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	298
ASTURIAS, PRINCIPADO DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	680
ASTURIAS, PRINCIPADO DE	Group 0500 Mental disorders  290-319	Both sexes	3.073
ASTURIAS, PRINCIPADO DE	Group 0500 Mental disorders  290-319	Men	1.525
ASTURIAS, PRINCIPADO DE	Group 0500 Mental disorders  290-319	Women	1.548
ASTURIAS, PRINCIPADO DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	80
ASTURIAS, PRINCIPADO DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	36
ASTURIAS, PRINCIPADO DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	44
ASTURIAS, PRINCIPADO DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	242
ASTURIAS, PRINCIPADO DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	182
ASTURIAS, PRINCIPADO DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	60
ASTURIAS, PRINCIPADO DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	175
ASTURIAS, PRINCIPADO DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	132
ASTURIAS, PRINCIPADO DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	43
ASTURIAS, PRINCIPADO DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	728
ASTURIAS, PRINCIPADO DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	452
ASTURIAS, PRINCIPADO DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	276
ASTURIAS, PRINCIPADO DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	713
ASTURIAS, PRINCIPADO DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	227
ASTURIAS, PRINCIPADO DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	486
ASTURIAS, PRINCIPADO DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.135
ASTURIAS, PRINCIPADO DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	496
ASTURIAS, PRINCIPADO DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	639
ASTURIAS, PRINCIPADO DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.442
ASTURIAS, PRINCIPADO DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.248
ASTURIAS, PRINCIPADO DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.194
ASTURIAS, PRINCIPADO DE	Group 0601 Alzheimer's disease  3310	Both sexes	37
ASTURIAS, PRINCIPADO DE	Group 0601 Alzheimer's disease  3310	Men	16
ASTURIAS, PRINCIPADO DE	Group 0601 Alzheimer's disease  3310	Women	21
ASTURIAS, PRINCIPADO DE	Group 0602 Multiple sclerosis 340	Both sexes	105
ASTURIAS, PRINCIPADO DE	Group 0602 Multiple sclerosis 340	Men	41
ASTURIAS, PRINCIPADO DE	Group 0602 Multiple sclerosis 340	Women	64
ASTURIAS, PRINCIPADO DE	Group 0603 Epilepsy  345	Both sexes	448
ASTURIAS, PRINCIPADO DE	Group 0603 Epilepsy  345	Men	242
ASTURIAS, PRINCIPADO DE	Group 0603 Epilepsy  345	Women	206
ASTURIAS, PRINCIPADO DE	Group 0604 Transient cerebral ischemia 435	Both sexes	547
ASTURIAS, PRINCIPADO DE	Group 0604 Transient cerebral ischemia 435	Men	259
ASTURIAS, PRINCIPADO DE	Group 0604 Transient cerebral ischemia 435	Women	288
ASTURIAS, PRINCIPADO DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.305
ASTURIAS, PRINCIPADO DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	690
ASTURIAS, PRINCIPADO DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	615
ASTURIAS, PRINCIPADO DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	639
ASTURIAS, PRINCIPADO DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	278
ASTURIAS, PRINCIPADO DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	361
ASTURIAS, PRINCIPADO DE	Grupo 0701 Cataract  366	Both sexes	279
ASTURIAS, PRINCIPADO DE	Grupo 0701 Cataract  366	Men	113
ASTURIAS, PRINCIPADO DE	Grupo 0701 Cataract  366	Women	166
ASTURIAS, PRINCIPADO DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	360
ASTURIAS, PRINCIPADO DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	165
ASTURIAS, PRINCIPADO DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	195
ASTURIAS, PRINCIPADO DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	401
ASTURIAS, PRINCIPADO DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	191
ASTURIAS, PRINCIPADO DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	210
ASTURIAS, PRINCIPADO DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	20.059
ASTURIAS, PRINCIPADO DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.766
ASTURIAS, PRINCIPADO DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	9.293
ASTURIAS, PRINCIPADO DE	Group 0901 Hypertensive disease  401-405	Both sexes	1.504
ASTURIAS, PRINCIPADO DE	Group 0901 Hypertensive disease  401-405	Men	601
ASTURIAS, PRINCIPADO DE	Group 0901 Hypertensive disease  401-405	Women	903
ASTURIAS, PRINCIPADO DE	Group 0902 Angina pectoris  4111, 413	Both sexes	1.170
ASTURIAS, PRINCIPADO DE	Group 0902 Angina pectoris  4111, 413	Men	729
ASTURIAS, PRINCIPADO DE	Group 0902 Angina pectoris  4111, 413	Women	441
ASTURIAS, PRINCIPADO DE	Group 0903 Acute myocardial infarction  410	Both sexes	1.760
ASTURIAS, PRINCIPADO DE	Group 0903 Acute myocardial infarction  410	Men	1.182
ASTURIAS, PRINCIPADO DE	Group 0903 Acute myocardial infarction  410	Women	578
ASTURIAS, PRINCIPADO DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	991
ASTURIAS, PRINCIPADO DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	732
ASTURIAS, PRINCIPADO DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	259
ASTURIAS, PRINCIPADO DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	734
ASTURIAS, PRINCIPADO DE	Group 0905 Diseases of the lungs circulation 415-417	Men	318
ASTURIAS, PRINCIPADO DE	Group 0905 Diseases of the lungs circulation 415-417	Women	416
ASTURIAS, PRINCIPADO DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.242
ASTURIAS, PRINCIPADO DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.194
ASTURIAS, PRINCIPADO DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.048
ASTURIAS, PRINCIPADO DE	Grupo 0907 Heart failure  428	Both sexes	3.477
ASTURIAS, PRINCIPADO DE	Grupo 0907 Heart failure  428	Men	1.727
ASTURIAS, PRINCIPADO DE	Grupo 0907 Heart failure  428	Women	1.750
ASTURIAS, PRINCIPADO DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.389
ASTURIAS, PRINCIPADO DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.754
ASTURIAS, PRINCIPADO DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.635
ASTURIAS, PRINCIPADO DE	Grupo 0909 Atherosclerosis  440	Both sexes	685
ASTURIAS, PRINCIPADO DE	Grupo 0909 Atherosclerosis  440	Men	465
ASTURIAS, PRINCIPADO DE	Grupo 0909 Atherosclerosis  440	Women	220
ASTURIAS, PRINCIPADO DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.479
ASTURIAS, PRINCIPADO DE	Group 0910 Varicose veins of lower extremities 454	Men	519
ASTURIAS, PRINCIPADO DE	Group 0910 Varicose veins of lower extremities 454	Women	960
ASTURIAS, PRINCIPADO DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.628
ASTURIAS, PRINCIPADO DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.545
ASTURIAS, PRINCIPADO DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.083
ASTURIAS, PRINCIPADO DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	15.456
ASTURIAS, PRINCIPADO DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.820
ASTURIAS, PRINCIPADO DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.636
ASTURIAS, PRINCIPADO DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	738
ASTURIAS, PRINCIPADO DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	398
ASTURIAS, PRINCIPADO DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	340
ASTURIAS, PRINCIPADO DE	Group 1002 Pneumonia 480-486	Both sexes	3.377
ASTURIAS, PRINCIPADO DE	Group 1002 Pneumonia 480-486	Men	2.069
ASTURIAS, PRINCIPADO DE	Group 1002 Pneumonia 480-486	Women	1.308
ASTURIAS, PRINCIPADO DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	740
ASTURIAS, PRINCIPADO DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	377
ASTURIAS, PRINCIPADO DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	363
ASTURIAS, PRINCIPADO DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	224
ASTURIAS, PRINCIPADO DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	87
ASTURIAS, PRINCIPADO DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	137
ASTURIAS, PRINCIPADO DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	786
ASTURIAS, PRINCIPADO DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	477
ASTURIAS, PRINCIPADO DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	309
ASTURIAS, PRINCIPADO DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.054
ASTURIAS, PRINCIPADO DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.412
ASTURIAS, PRINCIPADO DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	642
ASTURIAS, PRINCIPADO DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.533
ASTURIAS, PRINCIPADO DE	Group 1007 Asthma 4930-4931,4938-4939	Men	556
ASTURIAS, PRINCIPADO DE	Group 1007 Asthma 4930-4931,4938-4939	Women	977
ASTURIAS, PRINCIPADO DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.004
ASTURIAS, PRINCIPADO DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.444
ASTURIAS, PRINCIPADO DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.560
ASTURIAS, PRINCIPADO DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.768
ASTURIAS, PRINCIPADO DE	Group 1100 Diseases of the digestive system  520-579	Men	7.800
ASTURIAS, PRINCIPADO DE	Group 1100 Diseases of the digestive system  520-579	Women	5.968
ASTURIAS, PRINCIPADO DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	111
ASTURIAS, PRINCIPADO DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	61
ASTURIAS, PRINCIPADO DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	50
ASTURIAS, PRINCIPADO DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	161
ASTURIAS, PRINCIPADO DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	81
ASTURIAS, PRINCIPADO DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	80
ASTURIAS, PRINCIPADO DE	Group 1103 Diseases of the esophagus 530	Both sexes	224
ASTURIAS, PRINCIPADO DE	Group 1103 Diseases of the esophagus 530	Men	132
ASTURIAS, PRINCIPADO DE	Group 1103 Diseases of the esophagus 530	Women	92
ASTURIAS, PRINCIPADO DE	Group 1104 Peptic ulcer 531-534	Both sexes	215
ASTURIAS, PRINCIPADO DE	Group 1104 Peptic ulcer 531-534	Men	139
ASTURIAS, PRINCIPADO DE	Group 1104 Peptic ulcer 531-534	Women	76
ASTURIAS, PRINCIPADO DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	301
ASTURIAS, PRINCIPADO DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	180
ASTURIAS, PRINCIPADO DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	121
ASTURIAS, PRINCIPADO DE	Group 1106 Appendicitis  540-543	Both sexes	1.036
ASTURIAS, PRINCIPADO DE	Group 1106 Appendicitis  540-543	Men	589
ASTURIAS, PRINCIPADO DE	Group 1106 Appendicitis  540-543	Women	447
ASTURIAS, PRINCIPADO DE	Group 1107 Inguinal hernia  550	Both sexes	1.476
ASTURIAS, PRINCIPADO DE	Group 1107 Inguinal hernia  550	Men	1.353
ASTURIAS, PRINCIPADO DE	Group 1107 Inguinal hernia  550	Women	123
ASTURIAS, PRINCIPADO DE	Group 1108 Other abdominal hernia  551-553	Both sexes	975
ASTURIAS, PRINCIPADO DE	Group 1108 Other abdominal hernia  551-553	Men	488
ASTURIAS, PRINCIPADO DE	Group 1108 Other abdominal hernia  551-553	Women	487
ASTURIAS, PRINCIPADO DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	344
ASTURIAS, PRINCIPADO DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	185
ASTURIAS, PRINCIPADO DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	159
ASTURIAS, PRINCIPADO DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	776
ASTURIAS, PRINCIPADO DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	367
ASTURIAS, PRINCIPADO DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	409
ASTURIAS, PRINCIPADO DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	965
ASTURIAS, PRINCIPADO DE	Group 1111 Intestinal obstruction without hernia 560	Men	452
ASTURIAS, PRINCIPADO DE	Group 1111 Intestinal obstruction without hernia 560	Women	513
ASTURIAS, PRINCIPADO DE	Group 1112 Intestinal diverticulosis 562	Both sexes	675
ASTURIAS, PRINCIPADO DE	Group 1112 Intestinal diverticulosis 562	Men	321
ASTURIAS, PRINCIPADO DE	Group 1112 Intestinal diverticulosis 562	Women	354
ASTURIAS, PRINCIPADO DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	674
ASTURIAS, PRINCIPADO DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	416
ASTURIAS, PRINCIPADO DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	258
ASTURIAS, PRINCIPADO DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	537
ASTURIAS, PRINCIPADO DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	226
ASTURIAS, PRINCIPADO DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	311
ASTURIAS, PRINCIPADO DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	319
ASTURIAS, PRINCIPADO DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	286
ASTURIAS, PRINCIPADO DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	33
ASTURIAS, PRINCIPADO DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	458
ASTURIAS, PRINCIPADO DE	Group 1116 Other diseases of the liver 570,5714-573	Men	294
ASTURIAS, PRINCIPADO DE	Group 1116 Other diseases of the liver 570,5714-573	Women	164
ASTURIAS, PRINCIPADO DE	Group 1117 Cholelithiasis  574	Both sexes	2.341
ASTURIAS, PRINCIPADO DE	Group 1117 Cholelithiasis  574	Men	1.016
ASTURIAS, PRINCIPADO DE	Group 1117 Cholelithiasis  574	Women	1.325
ASTURIAS, PRINCIPADO DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	846
ASTURIAS, PRINCIPADO DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	470
ASTURIAS, PRINCIPADO DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	376
ASTURIAS, PRINCIPADO DE	Group 1119 Pancreatic diseases 577	Both sexes	774
ASTURIAS, PRINCIPADO DE	Group 1119 Pancreatic diseases 577	Men	448
ASTURIAS, PRINCIPADO DE	Group 1119 Pancreatic diseases 577	Women	326
ASTURIAS, PRINCIPADO DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	560
ASTURIAS, PRINCIPADO DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	296
ASTURIAS, PRINCIPADO DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	264
ASTURIAS, PRINCIPADO DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.119
ASTURIAS, PRINCIPADO DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	613
ASTURIAS, PRINCIPADO DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	506
ASTURIAS, PRINCIPADO DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	727
ASTURIAS, PRINCIPADO DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	429
ASTURIAS, PRINCIPADO DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	298
ASTURIAS, PRINCIPADO DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	45
ASTURIAS, PRINCIPADO DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	26
ASTURIAS, PRINCIPADO DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	19
ASTURIAS, PRINCIPADO DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	347
ASTURIAS, PRINCIPADO DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	158
ASTURIAS, PRINCIPADO DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	189
ASTURIAS, PRINCIPADO DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	8.619
ASTURIAS, PRINCIPADO DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.189
ASTURIAS, PRINCIPADO DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.430
ASTURIAS, PRINCIPADO DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
ASTURIAS, PRINCIPADO DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
ASTURIAS, PRINCIPADO DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
ASTURIAS, PRINCIPADO DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
ASTURIAS, PRINCIPADO DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
ASTURIAS, PRINCIPADO DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
ASTURIAS, PRINCIPADO DE	Group 1303 Internal derangement of knee 717	Both sexes	873
ASTURIAS, PRINCIPADO DE	Group 1303 Internal derangement of knee 717	Men	554
ASTURIAS, PRINCIPADO DE	Group 1303 Internal derangement of knee 717	Women	319
ASTURIAS, PRINCIPADO DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.351
ASTURIAS, PRINCIPADO DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	2.013
ASTURIAS, PRINCIPADO DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.338
ASTURIAS, PRINCIPADO DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	127
ASTURIAS, PRINCIPADO DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	46
ASTURIAS, PRINCIPADO DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	81
ASTURIAS, PRINCIPADO DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	366
ASTURIAS, PRINCIPADO DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	171
ASTURIAS, PRINCIPADO DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	195
ASTURIAS, PRINCIPADO DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	793
ASTURIAS, PRINCIPADO DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	416
ASTURIAS, PRINCIPADO DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	377
ASTURIAS, PRINCIPADO DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	258
ASTURIAS, PRINCIPADO DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	131
ASTURIAS, PRINCIPADO DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	127
ASTURIAS, PRINCIPADO DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	901
ASTURIAS, PRINCIPADO DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	473
ASTURIAS, PRINCIPADO DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	428
ASTURIAS, PRINCIPADO DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	950
ASTURIAS, PRINCIPADO DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	385
ASTURIAS, PRINCIPADO DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	565
ASTURIAS, PRINCIPADO DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	6.922
ASTURIAS, PRINCIPADO DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.231
ASTURIAS, PRINCIPADO DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.691
ASTURIAS, PRINCIPADO DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	512
ASTURIAS, PRINCIPADO DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	222
ASTURIAS, PRINCIPADO DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	290
ASTURIAS, PRINCIPADO DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	619
ASTURIAS, PRINCIPADO DE	Group 1402 Renal failure  5836-5837, 584-586	Men	343
ASTURIAS, PRINCIPADO DE	Group 1402 Renal failure  5836-5837, 584-586	Women	276
ASTURIAS, PRINCIPADO DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	927
ASTURIAS, PRINCIPADO DE	Group 1403 Urolithiasis  592, 594, 7880	Men	547
ASTURIAS, PRINCIPADO DE	Group 1403 Urolithiasis  592, 594, 7880	Women	380
ASTURIAS, PRINCIPADO DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.420
ASTURIAS, PRINCIPADO DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.037
ASTURIAS, PRINCIPADO DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.383
ASTURIAS, PRINCIPADO DE	Group 1405 Prostatic hyperplasia  600	Both sexes	560
ASTURIAS, PRINCIPADO DE	Group 1405 Prostatic hyperplasia  600	Men	560
ASTURIAS, PRINCIPADO DE	Group 1405 Prostatic hyperplasia  600	Women	..
ASTURIAS, PRINCIPADO DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	477
ASTURIAS, PRINCIPADO DE	Group 1406 Other diseases of the male genital organs    601-608	Men	477
ASTURIAS, PRINCIPADO DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
ASTURIAS, PRINCIPADO DE	Group 1407 Disorders of breast  610-612	Both sexes	305
ASTURIAS, PRINCIPADO DE	Group 1407 Disorders of breast  610-612	Men	34
ASTURIAS, PRINCIPADO DE	Group 1407 Disorders of breast  610-612	Women	271
ASTURIAS, PRINCIPADO DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	142
ASTURIAS, PRINCIPADO DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
ASTURIAS, PRINCIPADO DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	142
ASTURIAS, PRINCIPADO DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	50
ASTURIAS, PRINCIPADO DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
ASTURIAS, PRINCIPADO DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	50
ASTURIAS, PRINCIPADO DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	910
ASTURIAS, PRINCIPADO DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	11
ASTURIAS, PRINCIPADO DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	899
ASTURIAS, PRINCIPADO DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.848
ASTURIAS, PRINCIPADO DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
ASTURIAS, PRINCIPADO DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.848
ASTURIAS, PRINCIPADO DE	Group 1501 Legally induced abortion  635	Both sexes	55
ASTURIAS, PRINCIPADO DE	Group 1501 Legally induced abortion  635	Men	..
ASTURIAS, PRINCIPADO DE	Group 1501 Legally induced abortion  635	Women	55
ASTURIAS, PRINCIPADO DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	340
ASTURIAS, PRINCIPADO DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
ASTURIAS, PRINCIPADO DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	340
ASTURIAS, PRINCIPADO DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.813
ASTURIAS, PRINCIPADO DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
ASTURIAS, PRINCIPADO DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.813
ASTURIAS, PRINCIPADO DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.036
ASTURIAS, PRINCIPADO DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
ASTURIAS, PRINCIPADO DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.036
ASTURIAS, PRINCIPADO DE	Group 1505 Single spontaneous delivery  650	Both sexes	718
ASTURIAS, PRINCIPADO DE	Group 1505 Single spontaneous delivery  650	Men	..
ASTURIAS, PRINCIPADO DE	Group 1505 Single spontaneous delivery  650	Women	718
ASTURIAS, PRINCIPADO DE	Group 1506 Other deliveries  6695-6697	Both sexes	426
ASTURIAS, PRINCIPADO DE	Group 1506 Other deliveries  6695-6697	Men	..
ASTURIAS, PRINCIPADO DE	Group 1506 Other deliveries  6695-6697	Women	426
ASTURIAS, PRINCIPADO DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	92
ASTURIAS, PRINCIPADO DE	Group 1507 Complications related to the puerperium  670-676	Men	..
ASTURIAS, PRINCIPADO DE	Group 1507 Complications related to the puerperium  670-676	Women	92
ASTURIAS, PRINCIPADO DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	368
ASTURIAS, PRINCIPADO DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
ASTURIAS, PRINCIPADO DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	368
ASTURIAS, PRINCIPADO DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.041
ASTURIAS, PRINCIPADO DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	603
ASTURIAS, PRINCIPADO DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	438
ASTURIAS, PRINCIPADO DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	272
ASTURIAS, PRINCIPADO DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	149
ASTURIAS, PRINCIPADO DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	123
ASTURIAS, PRINCIPADO DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	769
ASTURIAS, PRINCIPADO DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	454
ASTURIAS, PRINCIPADO DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	315
ASTURIAS, PRINCIPADO DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	568
ASTURIAS, PRINCIPADO DE	Grupo 1700 Congenital abnormalities  740-759	Men	307
ASTURIAS, PRINCIPADO DE	Grupo 1700 Congenital abnormalities  740-759	Women	261
ASTURIAS, PRINCIPADO DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.849
ASTURIAS, PRINCIPADO DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.444
ASTURIAS, PRINCIPADO DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.405
ASTURIAS, PRINCIPADO DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	670
ASTURIAS, PRINCIPADO DE	Group 1801 Pain in throat and chest 7841, 7865	Men	352
ASTURIAS, PRINCIPADO DE	Group 1801 Pain in throat and chest 7841, 7865	Women	318
ASTURIAS, PRINCIPADO DE	Group 1802 Abdominal pain   7890	Both sexes	736
ASTURIAS, PRINCIPADO DE	Group 1802 Abdominal pain   7890	Men	314
ASTURIAS, PRINCIPADO DE	Group 1802 Abdominal pain   7890	Women	422
ASTURIAS, PRINCIPADO DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	374
ASTURIAS, PRINCIPADO DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	209
ASTURIAS, PRINCIPADO DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	165
ASTURIAS, PRINCIPADO DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.069
ASTURIAS, PRINCIPADO DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.569
ASTURIAS, PRINCIPADO DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.500
ASTURIAS, PRINCIPADO DE	Group 1900 Injuries and poisoning  800-999	Both sexes	10.263
ASTURIAS, PRINCIPADO DE	Group 1900 Injuries and poisoning  800-999	Men	4.801
ASTURIAS, PRINCIPADO DE	Group 1900 Injuries and poisoning  800-999	Women	5.462
ASTURIAS, PRINCIPADO DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	408
ASTURIAS, PRINCIPADO DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	220
ASTURIAS, PRINCIPADO DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	188
ASTURIAS, PRINCIPADO DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	249
ASTURIAS, PRINCIPADO DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	175
ASTURIAS, PRINCIPADO DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	74
ASTURIAS, PRINCIPADO DE	Group 1903 Radius and ulna fracture 813	Both sexes	390
ASTURIAS, PRINCIPADO DE	Group 1903 Radius and ulna fracture 813	Men	162
ASTURIAS, PRINCIPADO DE	Group 1903 Radius and ulna fracture 813	Women	228
ASTURIAS, PRINCIPADO DE	Group 1904 Femur fracture  820-821	Both sexes	2.076
ASTURIAS, PRINCIPADO DE	Group 1904 Femur fracture  820-821	Men	502
ASTURIAS, PRINCIPADO DE	Group 1904 Femur fracture  820-821	Women	1.574
ASTURIAS, PRINCIPADO DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	754
ASTURIAS, PRINCIPADO DE	Group 1905 Leg fracture, including the ankle 823-824	Men	372
ASTURIAS, PRINCIPADO DE	Group 1905 Leg fracture, including the ankle 823-824	Women	382
ASTURIAS, PRINCIPADO DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.947
ASTURIAS, PRINCIPADO DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.637
ASTURIAS, PRINCIPADO DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.310
ASTURIAS, PRINCIPADO DE	Group 1907 Burns  940-949	Both sexes	76
ASTURIAS, PRINCIPADO DE	Group 1907 Burns  940-949	Men	40
ASTURIAS, PRINCIPADO DE	Group 1907 Burns  940-949	Women	36
ASTURIAS, PRINCIPADO DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	393
ASTURIAS, PRINCIPADO DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	175
ASTURIAS, PRINCIPADO DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	218
ASTURIAS, PRINCIPADO DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.724
ASTURIAS, PRINCIPADO DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.400
ASTURIAS, PRINCIPADO DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.324
ASTURIAS, PRINCIPADO DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	21
ASTURIAS, PRINCIPADO DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	10
ASTURIAS, PRINCIPADO DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	11
ASTURIAS, PRINCIPADO DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	225
ASTURIAS, PRINCIPADO DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	108
ASTURIAS, PRINCIPADO DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	117
ASTURIAS, PRINCIPADO DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.644
ASTURIAS, PRINCIPADO DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	866
ASTURIAS, PRINCIPADO DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	778
ASTURIAS, PRINCIPADO DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	67
ASTURIAS, PRINCIPADO DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	47
ASTURIAS, PRINCIPADO DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	20
ASTURIAS, PRINCIPADO DE	Group 2102 Contraceptive management  V25	Both sexes	26
ASTURIAS, PRINCIPADO DE	Group 2102 Contraceptive management  V25	Men	1
ASTURIAS, PRINCIPADO DE	Group 2102 Contraceptive management  V25	Women	25
ASTURIAS, PRINCIPADO DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
ASTURIAS, PRINCIPADO DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
ASTURIAS, PRINCIPADO DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
ASTURIAS, PRINCIPADO DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	850
ASTURIAS, PRINCIPADO DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	503
ASTURIAS, PRINCIPADO DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	347
ASTURIAS, PRINCIPADO DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	701
ASTURIAS, PRINCIPADO DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	315
ASTURIAS, PRINCIPADO DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	386
BALEARS, ILLES	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	123.621
BALEARS, ILLES	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	58.257
BALEARS, ILLES	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	65.364
BALEARS, ILLES	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.959
BALEARS, ILLES	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.615
BALEARS, ILLES	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.344
BALEARS, ILLES	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	546
BALEARS, ILLES	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	275
BALEARS, ILLES	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	270
BALEARS, ILLES	Group 0102 Imprecise intestinal infections 009	Both sexes	561
BALEARS, ILLES	Group 0102 Imprecise intestinal infections 009	Men	255
BALEARS, ILLES	Group 0102 Imprecise intestinal infections 009	Women	306
BALEARS, ILLES	Group 0103 Tuberculosis 010-018, 137	Both sexes	102
BALEARS, ILLES	Group 0103 Tuberculosis 010-018, 137	Men	79
BALEARS, ILLES	Group 0103 Tuberculosis 010-018, 137	Women	23
BALEARS, ILLES	Group 0104 Septicaemia  038	Both sexes	846
BALEARS, ILLES	Group 0104 Septicaemia  038	Men	498
BALEARS, ILLES	Group 0104 Septicaemia  038	Women	348
BALEARS, ILLES	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	82
BALEARS, ILLES	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	55
BALEARS, ILLES	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	27
BALEARS, ILLES	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	821
BALEARS, ILLES	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	451
BALEARS, ILLES	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	370
BALEARS, ILLES	Group 0200 Neoplasms  140-239	Both sexes	8.057
BALEARS, ILLES	Group 0200 Neoplasms  140-239	Men	4.021
BALEARS, ILLES	Group 0200 Neoplasms  140-239	Women	4.036
BALEARS, ILLES	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	777
BALEARS, ILLES	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	464
BALEARS, ILLES	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	312
BALEARS, ILLES	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	675
BALEARS, ILLES	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	521
BALEARS, ILLES	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	154
BALEARS, ILLES	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	138
BALEARS, ILLES	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	83
BALEARS, ILLES	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	54
BALEARS, ILLES	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	859
BALEARS, ILLES	Group 0204 Malignant neoplasm of breast  174-175	Men	7
BALEARS, ILLES	Group 0204 Malignant neoplasm of breast  174-175	Women	852
BALEARS, ILLES	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	161
BALEARS, ILLES	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
BALEARS, ILLES	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	161
BALEARS, ILLES	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	89
BALEARS, ILLES	Group 0206 Malignant neoplasm of ovary  1830	Men	..
BALEARS, ILLES	Group 0206 Malignant neoplasm of ovary  1830	Women	89
BALEARS, ILLES	Group 0207 Malignant neoplasm of prostate  185	Both sexes	293
BALEARS, ILLES	Group 0207 Malignant neoplasm of prostate  185	Men	293
BALEARS, ILLES	Group 0207 Malignant neoplasm of prostate  185	Women	..
BALEARS, ILLES	Group 0208 Malignant neoplasm of bladder  188	Both sexes	643
BALEARS, ILLES	Group 0208 Malignant neoplasm of bladder  188	Men	515
BALEARS, ILLES	Group 0208 Malignant neoplasm of bladder  188	Women	128
BALEARS, ILLES	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.475
BALEARS, ILLES	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.441
BALEARS, ILLES	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.034
BALEARS, ILLES	Group 0210 Carcinoma in situ  230-234	Both sexes	211
BALEARS, ILLES	Group 0210 Carcinoma in situ  230-234	Men	119
BALEARS, ILLES	Group 0210 Carcinoma in situ  230-234	Women	91
BALEARS, ILLES	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	112
BALEARS, ILLES	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	66
BALEARS, ILLES	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	45
BALEARS, ILLES	Grupo 0212 Leiomyoma of uterus  218	Both sexes	408
BALEARS, ILLES	Grupo 0212 Leiomyoma of uterus  218	Men	..
BALEARS, ILLES	Grupo 0212 Leiomyoma of uterus  218	Women	408
BALEARS, ILLES	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.217
BALEARS, ILLES	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	509
BALEARS, ILLES	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	707
BALEARS, ILLES	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	872
BALEARS, ILLES	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	396
BALEARS, ILLES	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	476
BALEARS, ILLES	Group 0301 Anaemias 280-285	Both sexes	601
BALEARS, ILLES	Group 0301 Anaemias 280-285	Men	261
BALEARS, ILLES	Group 0301 Anaemias 280-285	Women	340
BALEARS, ILLES	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	271
BALEARS, ILLES	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	135
BALEARS, ILLES	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	137
BALEARS, ILLES	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.967
BALEARS, ILLES	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	879
BALEARS, ILLES	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.088
BALEARS, ILLES	Group 0401 Diabetes mellitus  249-250	Both sexes	751
BALEARS, ILLES	Group 0401 Diabetes mellitus  249-250	Men	432
BALEARS, ILLES	Group 0401 Diabetes mellitus  249-250	Women	319
BALEARS, ILLES	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.217
BALEARS, ILLES	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	447
BALEARS, ILLES	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	770
BALEARS, ILLES	Group 0500 Mental disorders  290-319	Both sexes	3.168
BALEARS, ILLES	Group 0500 Mental disorders  290-319	Men	1.564
BALEARS, ILLES	Group 0500 Mental disorders  290-319	Women	1.604
BALEARS, ILLES	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	95
BALEARS, ILLES	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	47
BALEARS, ILLES	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	48
BALEARS, ILLES	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	435
BALEARS, ILLES	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	306
BALEARS, ILLES	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	128
BALEARS, ILLES	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	153
BALEARS, ILLES	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	108
BALEARS, ILLES	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	45
BALEARS, ILLES	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	784
BALEARS, ILLES	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	450
BALEARS, ILLES	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	334
BALEARS, ILLES	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	747
BALEARS, ILLES	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	286
BALEARS, ILLES	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	460
BALEARS, ILLES	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	956
BALEARS, ILLES	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	367
BALEARS, ILLES	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	589
BALEARS, ILLES	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	4.055
BALEARS, ILLES	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.147
BALEARS, ILLES	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.908
BALEARS, ILLES	Group 0601 Alzheimer's disease  3310	Both sexes	72
BALEARS, ILLES	Group 0601 Alzheimer's disease  3310	Men	27
BALEARS, ILLES	Group 0601 Alzheimer's disease  3310	Women	45
BALEARS, ILLES	Group 0602 Multiple sclerosis 340	Both sexes	45
BALEARS, ILLES	Group 0602 Multiple sclerosis 340	Men	12
BALEARS, ILLES	Group 0602 Multiple sclerosis 340	Women	33
BALEARS, ILLES	Group 0603 Epilepsy  345	Both sexes	520
BALEARS, ILLES	Group 0603 Epilepsy  345	Men	278
BALEARS, ILLES	Group 0603 Epilepsy  345	Women	241
BALEARS, ILLES	Group 0604 Transient cerebral ischemia 435	Both sexes	375
BALEARS, ILLES	Group 0604 Transient cerebral ischemia 435	Men	198
BALEARS, ILLES	Group 0604 Transient cerebral ischemia 435	Women	177
BALEARS, ILLES	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.043
BALEARS, ILLES	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.632
BALEARS, ILLES	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.412
BALEARS, ILLES	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	576
BALEARS, ILLES	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	292
BALEARS, ILLES	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	283
BALEARS, ILLES	Grupo 0701 Cataract  366	Both sexes	44
BALEARS, ILLES	Grupo 0701 Cataract  366	Men	22
BALEARS, ILLES	Grupo 0701 Cataract  366	Women	22
BALEARS, ILLES	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	532
BALEARS, ILLES	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	270
BALEARS, ILLES	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	261
BALEARS, ILLES	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	882
BALEARS, ILLES	Group 0800 Diseases of the ear and the mastoid  380-389	Men	428
BALEARS, ILLES	Group 0800 Diseases of the ear and the mastoid  380-389	Women	454
BALEARS, ILLES	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	13.344
BALEARS, ILLES	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	7.481
BALEARS, ILLES	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	5.863
BALEARS, ILLES	Group 0901 Hypertensive disease  401-405	Both sexes	766
BALEARS, ILLES	Group 0901 Hypertensive disease  401-405	Men	344
BALEARS, ILLES	Group 0901 Hypertensive disease  401-405	Women	422
BALEARS, ILLES	Group 0902 Angina pectoris  4111, 413	Both sexes	891
BALEARS, ILLES	Group 0902 Angina pectoris  4111, 413	Men	576
BALEARS, ILLES	Group 0902 Angina pectoris  4111, 413	Women	316
BALEARS, ILLES	Group 0903 Acute myocardial infarction  410	Both sexes	1.094
BALEARS, ILLES	Group 0903 Acute myocardial infarction  410	Men	785
BALEARS, ILLES	Group 0903 Acute myocardial infarction  410	Women	310
BALEARS, ILLES	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	686
BALEARS, ILLES	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	517
BALEARS, ILLES	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	170
BALEARS, ILLES	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	299
BALEARS, ILLES	Group 0905 Diseases of the lungs circulation 415-417	Men	143
BALEARS, ILLES	Group 0905 Diseases of the lungs circulation 415-417	Women	157
BALEARS, ILLES	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.948
BALEARS, ILLES	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.075
BALEARS, ILLES	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	872
BALEARS, ILLES	Grupo 0907 Heart failure  428	Both sexes	2.632
BALEARS, ILLES	Grupo 0907 Heart failure  428	Men	1.198
BALEARS, ILLES	Grupo 0907 Heart failure  428	Women	1.434
BALEARS, ILLES	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.154
BALEARS, ILLES	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.235
BALEARS, ILLES	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	919
BALEARS, ILLES	Grupo 0909 Atherosclerosis  440	Both sexes	306
BALEARS, ILLES	Grupo 0909 Atherosclerosis  440	Men	232
BALEARS, ILLES	Grupo 0909 Atherosclerosis  440	Women	74
BALEARS, ILLES	Group 0910 Varicose veins of lower extremities 454	Both sexes	482
BALEARS, ILLES	Group 0910 Varicose veins of lower extremities 454	Men	169
BALEARS, ILLES	Group 0910 Varicose veins of lower extremities 454	Women	314
BALEARS, ILLES	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.084
BALEARS, ILLES	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.209
BALEARS, ILLES	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	875
BALEARS, ILLES	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	14.767
BALEARS, ILLES	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.088
BALEARS, ILLES	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.679
BALEARS, ILLES	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	772
BALEARS, ILLES	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	407
BALEARS, ILLES	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	365
BALEARS, ILLES	Group 1002 Pneumonia 480-486	Both sexes	3.553
BALEARS, ILLES	Group 1002 Pneumonia 480-486	Men	2.011
BALEARS, ILLES	Group 1002 Pneumonia 480-486	Women	1.541
BALEARS, ILLES	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.715
BALEARS, ILLES	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.154
BALEARS, ILLES	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.561
BALEARS, ILLES	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	548
BALEARS, ILLES	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	277
BALEARS, ILLES	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	270
BALEARS, ILLES	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.135
BALEARS, ILLES	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	713
BALEARS, ILLES	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	422
BALEARS, ILLES	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.492
BALEARS, ILLES	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.778
BALEARS, ILLES	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	714
BALEARS, ILLES	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	591
BALEARS, ILLES	Group 1007 Asthma 4930-4931,4938-4939	Men	198
BALEARS, ILLES	Group 1007 Asthma 4930-4931,4938-4939	Women	393
BALEARS, ILLES	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.962
BALEARS, ILLES	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.550
BALEARS, ILLES	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.412
BALEARS, ILLES	Group 1100 Diseases of the digestive system  520-579	Both sexes	14.414
BALEARS, ILLES	Group 1100 Diseases of the digestive system  520-579	Men	7.827
BALEARS, ILLES	Group 1100 Diseases of the digestive system  520-579	Women	6.587
BALEARS, ILLES	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	183
BALEARS, ILLES	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	88
BALEARS, ILLES	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	94
BALEARS, ILLES	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	191
BALEARS, ILLES	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	106
BALEARS, ILLES	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	85
BALEARS, ILLES	Group 1103 Diseases of the esophagus 530	Both sexes	197
BALEARS, ILLES	Group 1103 Diseases of the esophagus 530	Men	123
BALEARS, ILLES	Group 1103 Diseases of the esophagus 530	Women	74
BALEARS, ILLES	Group 1104 Peptic ulcer 531-534	Both sexes	241
BALEARS, ILLES	Group 1104 Peptic ulcer 531-534	Men	175
BALEARS, ILLES	Group 1104 Peptic ulcer 531-534	Women	66
BALEARS, ILLES	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	578
BALEARS, ILLES	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	259
BALEARS, ILLES	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	319
BALEARS, ILLES	Group 1106 Appendicitis  540-543	Both sexes	1.294
BALEARS, ILLES	Group 1106 Appendicitis  540-543	Men	715
BALEARS, ILLES	Group 1106 Appendicitis  540-543	Women	580
BALEARS, ILLES	Group 1107 Inguinal hernia  550	Both sexes	1.296
BALEARS, ILLES	Group 1107 Inguinal hernia  550	Men	1.158
BALEARS, ILLES	Group 1107 Inguinal hernia  550	Women	139
BALEARS, ILLES	Group 1108 Other abdominal hernia  551-553	Both sexes	1.108
BALEARS, ILLES	Group 1108 Other abdominal hernia  551-553	Men	552
BALEARS, ILLES	Group 1108 Other abdominal hernia  551-553	Women	557
BALEARS, ILLES	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	286
BALEARS, ILLES	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	115
BALEARS, ILLES	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	172
BALEARS, ILLES	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.787
BALEARS, ILLES	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	757
BALEARS, ILLES	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	1.030
BALEARS, ILLES	Group 1111 Intestinal obstruction without hernia 560	Both sexes	640
BALEARS, ILLES	Group 1111 Intestinal obstruction without hernia 560	Men	307
BALEARS, ILLES	Group 1111 Intestinal obstruction without hernia 560	Women	334
BALEARS, ILLES	Group 1112 Intestinal diverticulosis 562	Both sexes	718
BALEARS, ILLES	Group 1112 Intestinal diverticulosis 562	Men	358
BALEARS, ILLES	Group 1112 Intestinal diverticulosis 562	Women	360
BALEARS, ILLES	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	741
BALEARS, ILLES	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	457
BALEARS, ILLES	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	283
BALEARS, ILLES	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	455
BALEARS, ILLES	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	206
BALEARS, ILLES	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	249
BALEARS, ILLES	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	148
BALEARS, ILLES	Group 1115 Alcoholic hepatitis 5710-5713	Men	112
BALEARS, ILLES	Group 1115 Alcoholic hepatitis 5710-5713	Women	36
BALEARS, ILLES	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	367
BALEARS, ILLES	Group 1116 Other diseases of the liver 570,5714-573	Men	225
BALEARS, ILLES	Group 1116 Other diseases of the liver 570,5714-573	Women	142
BALEARS, ILLES	Group 1117 Cholelithiasis  574	Both sexes	2.210
BALEARS, ILLES	Group 1117 Cholelithiasis  574	Men	1.018
BALEARS, ILLES	Group 1117 Cholelithiasis  574	Women	1.193
BALEARS, ILLES	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	739
BALEARS, ILLES	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	379
BALEARS, ILLES	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	360
BALEARS, ILLES	Group 1119 Pancreatic diseases 577	Both sexes	666
BALEARS, ILLES	Group 1119 Pancreatic diseases 577	Men	397
BALEARS, ILLES	Group 1119 Pancreatic diseases 577	Women	269
BALEARS, ILLES	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	569
BALEARS, ILLES	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	324
BALEARS, ILLES	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	245
BALEARS, ILLES	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.451
BALEARS, ILLES	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	782
BALEARS, ILLES	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	669
BALEARS, ILLES	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.052
BALEARS, ILLES	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	617
BALEARS, ILLES	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	435
BALEARS, ILLES	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	64
BALEARS, ILLES	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	34
BALEARS, ILLES	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	30
BALEARS, ILLES	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	335
BALEARS, ILLES	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	131
BALEARS, ILLES	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	204
BALEARS, ILLES	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	10.290
BALEARS, ILLES	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.964
BALEARS, ILLES	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.325
BALEARS, ILLES	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
BALEARS, ILLES	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
BALEARS, ILLES	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
BALEARS, ILLES	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
BALEARS, ILLES	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
BALEARS, ILLES	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
BALEARS, ILLES	Group 1303 Internal derangement of knee 717	Both sexes	1.291
BALEARS, ILLES	Group 1303 Internal derangement of knee 717	Men	867
BALEARS, ILLES	Group 1303 Internal derangement of knee 717	Women	424
BALEARS, ILLES	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.424
BALEARS, ILLES	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.523
BALEARS, ILLES	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.901
BALEARS, ILLES	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	134
BALEARS, ILLES	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	51
BALEARS, ILLES	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	82
BALEARS, ILLES	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	342
BALEARS, ILLES	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	162
BALEARS, ILLES	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	180
BALEARS, ILLES	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	873
BALEARS, ILLES	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	466
BALEARS, ILLES	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	407
BALEARS, ILLES	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	787
BALEARS, ILLES	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	326
BALEARS, ILLES	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	460
BALEARS, ILLES	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.844
BALEARS, ILLES	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	955
BALEARS, ILLES	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	888
BALEARS, ILLES	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.596
BALEARS, ILLES	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	613
BALEARS, ILLES	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	983
BALEARS, ILLES	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	8.616
BALEARS, ILLES	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.119
BALEARS, ILLES	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.497
BALEARS, ILLES	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	912
BALEARS, ILLES	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	245
BALEARS, ILLES	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	666
BALEARS, ILLES	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	459
BALEARS, ILLES	Group 1402 Renal failure  5836-5837, 584-586	Men	279
BALEARS, ILLES	Group 1402 Renal failure  5836-5837, 584-586	Women	180
BALEARS, ILLES	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.783
BALEARS, ILLES	Group 1403 Urolithiasis  592, 594, 7880	Men	1.082
BALEARS, ILLES	Group 1403 Urolithiasis  592, 594, 7880	Women	700
BALEARS, ILLES	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.403
BALEARS, ILLES	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.147
BALEARS, ILLES	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.256
BALEARS, ILLES	Group 1405 Prostatic hyperplasia  600	Both sexes	614
BALEARS, ILLES	Group 1405 Prostatic hyperplasia  600	Men	614
BALEARS, ILLES	Group 1405 Prostatic hyperplasia  600	Women	..
BALEARS, ILLES	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	666
BALEARS, ILLES	Group 1406 Other diseases of the male genital organs    601-608	Men	666
BALEARS, ILLES	Group 1406 Other diseases of the male genital organs    601-608	Women	..
BALEARS, ILLES	Group 1407 Disorders of breast  610-612	Both sexes	378
BALEARS, ILLES	Group 1407 Disorders of breast  610-612	Men	57
BALEARS, ILLES	Group 1407 Disorders of breast  610-612	Women	321
BALEARS, ILLES	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	224
BALEARS, ILLES	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
BALEARS, ILLES	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	224
BALEARS, ILLES	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	97
BALEARS, ILLES	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
BALEARS, ILLES	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	97
BALEARS, ILLES	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.079
BALEARS, ILLES	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	27
BALEARS, ILLES	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.052
BALEARS, ILLES	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	11.381
BALEARS, ILLES	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
BALEARS, ILLES	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	11.381
BALEARS, ILLES	Group 1501 Legally induced abortion  635	Both sexes	187
BALEARS, ILLES	Group 1501 Legally induced abortion  635	Men	..
BALEARS, ILLES	Group 1501 Legally induced abortion  635	Women	187
BALEARS, ILLES	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	524
BALEARS, ILLES	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
BALEARS, ILLES	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	524
BALEARS, ILLES	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.053
BALEARS, ILLES	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
BALEARS, ILLES	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.053
BALEARS, ILLES	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.831
BALEARS, ILLES	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
BALEARS, ILLES	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.831
BALEARS, ILLES	Group 1505 Single spontaneous delivery  650	Both sexes	1.655
BALEARS, ILLES	Group 1505 Single spontaneous delivery  650	Men	..
BALEARS, ILLES	Group 1505 Single spontaneous delivery  650	Women	1.655
BALEARS, ILLES	Group 1506 Other deliveries  6695-6697	Both sexes	508
BALEARS, ILLES	Group 1506 Other deliveries  6695-6697	Men	..
BALEARS, ILLES	Group 1506 Other deliveries  6695-6697	Women	508
BALEARS, ILLES	Group 1507 Complications related to the puerperium  670-676	Both sexes	83
BALEARS, ILLES	Group 1507 Complications related to the puerperium  670-676	Men	..
BALEARS, ILLES	Group 1507 Complications related to the puerperium  670-676	Women	83
BALEARS, ILLES	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	540
BALEARS, ILLES	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
BALEARS, ILLES	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	540
BALEARS, ILLES	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.582
BALEARS, ILLES	Group 1600 Some disorders originating in the perinatal period  760-779	Men	914
BALEARS, ILLES	Group 1600 Some disorders originating in the perinatal period  760-779	Women	668
BALEARS, ILLES	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	313
BALEARS, ILLES	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	188
BALEARS, ILLES	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	125
BALEARS, ILLES	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.269
BALEARS, ILLES	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	726
BALEARS, ILLES	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	544
BALEARS, ILLES	Grupo 1700 Congenital abnormalities  740-759	Both sexes	754
BALEARS, ILLES	Grupo 1700 Congenital abnormalities  740-759	Men	422
BALEARS, ILLES	Grupo 1700 Congenital abnormalities  740-759	Women	332
BALEARS, ILLES	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	9.763
BALEARS, ILLES	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.923
BALEARS, ILLES	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	4.840
BALEARS, ILLES	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.044
BALEARS, ILLES	Group 1801 Pain in throat and chest 7841, 7865	Men	586
BALEARS, ILLES	Group 1801 Pain in throat and chest 7841, 7865	Women	458
BALEARS, ILLES	Group 1802 Abdominal pain   7890	Both sexes	1.482
BALEARS, ILLES	Group 1802 Abdominal pain   7890	Men	545
BALEARS, ILLES	Group 1802 Abdominal pain   7890	Women	938
BALEARS, ILLES	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.425
BALEARS, ILLES	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	678
BALEARS, ILLES	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	747
BALEARS, ILLES	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.812
BALEARS, ILLES	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	3.114
BALEARS, ILLES	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.697
BALEARS, ILLES	Group 1900 Injuries and poisoning  800-999	Both sexes	12.547
BALEARS, ILLES	Group 1900 Injuries and poisoning  800-999	Men	6.486
BALEARS, ILLES	Group 1900 Injuries and poisoning  800-999	Women	6.062
BALEARS, ILLES	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.034
BALEARS, ILLES	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	586
BALEARS, ILLES	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	448
BALEARS, ILLES	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	405
BALEARS, ILLES	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	282
BALEARS, ILLES	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	123
BALEARS, ILLES	Group 1903 Radius and ulna fracture 813	Both sexes	809
BALEARS, ILLES	Group 1903 Radius and ulna fracture 813	Men	329
BALEARS, ILLES	Group 1903 Radius and ulna fracture 813	Women	480
BALEARS, ILLES	Group 1904 Femur fracture  820-821	Both sexes	1.634
BALEARS, ILLES	Group 1904 Femur fracture  820-821	Men	534
BALEARS, ILLES	Group 1904 Femur fracture  820-821	Women	1.100
BALEARS, ILLES	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	924
BALEARS, ILLES	Group 1905 Leg fracture, including the ankle 823-824	Men	433
BALEARS, ILLES	Group 1905 Leg fracture, including the ankle 823-824	Women	491
BALEARS, ILLES	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.955
BALEARS, ILLES	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.838
BALEARS, ILLES	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.117
BALEARS, ILLES	Group 1907 Burns  940-949	Both sexes	104
BALEARS, ILLES	Group 1907 Burns  940-949	Men	65
BALEARS, ILLES	Group 1907 Burns  940-949	Women	39
BALEARS, ILLES	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	371
BALEARS, ILLES	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	173
BALEARS, ILLES	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	198
BALEARS, ILLES	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.811
BALEARS, ILLES	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	965
BALEARS, ILLES	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	846
BALEARS, ILLES	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	9
BALEARS, ILLES	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
BALEARS, ILLES	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	8
BALEARS, ILLES	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	491
BALEARS, ILLES	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	280
BALEARS, ILLES	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	211
BALEARS, ILLES	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.176
BALEARS, ILLES	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	907
BALEARS, ILLES	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.269
BALEARS, ILLES	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	168
BALEARS, ILLES	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	71
BALEARS, ILLES	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	96
BALEARS, ILLES	Group 2102 Contraceptive management  V25	Both sexes	43
BALEARS, ILLES	Group 2102 Contraceptive management  V25	Men	5
BALEARS, ILLES	Group 2102 Contraceptive management  V25	Women	38
BALEARS, ILLES	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
BALEARS, ILLES	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
BALEARS, ILLES	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
BALEARS, ILLES	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	268
BALEARS, ILLES	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	164
BALEARS, ILLES	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	104
BALEARS, ILLES	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.696
BALEARS, ILLES	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	667
BALEARS, ILLES	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.030
CANARIAS	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	179.647
CANARIAS	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	83.329
CANARIAS	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	96.318
CANARIAS	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.532
CANARIAS	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.924
CANARIAS	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.607
CANARIAS	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	419
CANARIAS	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	206
CANARIAS	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	213
CANARIAS	Group 0102 Imprecise intestinal infections 009	Both sexes	189
CANARIAS	Group 0102 Imprecise intestinal infections 009	Men	75
CANARIAS	Group 0102 Imprecise intestinal infections 009	Women	114
CANARIAS	Group 0103 Tuberculosis 010-018, 137	Both sexes	84
CANARIAS	Group 0103 Tuberculosis 010-018, 137	Men	61
CANARIAS	Group 0103 Tuberculosis 010-018, 137	Women	23
CANARIAS	Group 0104 Septicaemia  038	Both sexes	1.588
CANARIAS	Group 0104 Septicaemia  038	Men	847
CANARIAS	Group 0104 Septicaemia  038	Women	740
CANARIAS	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	123
CANARIAS	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	102
CANARIAS	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	21
CANARIAS	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.129
CANARIAS	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	633
CANARIAS	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	496
CANARIAS	Group 0200 Neoplasms  140-239	Both sexes	16.655
CANARIAS	Group 0200 Neoplasms  140-239	Men	8.239
CANARIAS	Group 0200 Neoplasms  140-239	Women	8.416
CANARIAS	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.506
CANARIAS	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	888
CANARIAS	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	618
CANARIAS	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.165
CANARIAS	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	848
CANARIAS	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	317
CANARIAS	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	405
CANARIAS	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	221
CANARIAS	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	184
CANARIAS	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.370
CANARIAS	Group 0204 Malignant neoplasm of breast  174-175	Men	11
CANARIAS	Group 0204 Malignant neoplasm of breast  174-175	Women	1.359
CANARIAS	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	441
CANARIAS	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CANARIAS	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	441
CANARIAS	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	165
CANARIAS	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CANARIAS	Group 0206 Malignant neoplasm of ovary  1830	Women	165
CANARIAS	Group 0207 Malignant neoplasm of prostate  185	Both sexes	692
CANARIAS	Group 0207 Malignant neoplasm of prostate  185	Men	692
CANARIAS	Group 0207 Malignant neoplasm of prostate  185	Women	..
CANARIAS	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.143
CANARIAS	Group 0208 Malignant neoplasm of bladder  188	Men	960
CANARIAS	Group 0208 Malignant neoplasm of bladder  188	Women	183
CANARIAS	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.720
CANARIAS	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.241
CANARIAS	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.479
CANARIAS	Group 0210 Carcinoma in situ  230-234	Both sexes	365
CANARIAS	Group 0210 Carcinoma in situ  230-234	Men	115
CANARIAS	Group 0210 Carcinoma in situ  230-234	Women	250
CANARIAS	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	220
CANARIAS	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	131
CANARIAS	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	89
CANARIAS	Grupo 0212 Leiomyoma of uterus  218	Both sexes	926
CANARIAS	Grupo 0212 Leiomyoma of uterus  218	Men	..
CANARIAS	Grupo 0212 Leiomyoma of uterus  218	Women	926
CANARIAS	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.537
CANARIAS	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.132
CANARIAS	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.405
CANARIAS	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.285
CANARIAS	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	590
CANARIAS	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	695
CANARIAS	Group 0301 Anaemias 280-285	Both sexes	678
CANARIAS	Group 0301 Anaemias 280-285	Men	309
CANARIAS	Group 0301 Anaemias 280-285	Women	369
CANARIAS	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	607
CANARIAS	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	281
CANARIAS	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	326
CANARIAS	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	4.337
CANARIAS	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.707
CANARIAS	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.630
CANARIAS	Group 0401 Diabetes mellitus  249-250	Both sexes	1.240
CANARIAS	Group 0401 Diabetes mellitus  249-250	Men	707
CANARIAS	Group 0401 Diabetes mellitus  249-250	Women	533
CANARIAS	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.097
CANARIAS	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	1.000
CANARIAS	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.097
CANARIAS	Group 0500 Mental disorders  290-319	Both sexes	3.663
CANARIAS	Group 0500 Mental disorders  290-319	Men	2.016
CANARIAS	Group 0500 Mental disorders  290-319	Women	1.647
CANARIAS	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	80
CANARIAS	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	36
CANARIAS	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	44
CANARIAS	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	403
CANARIAS	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	330
CANARIAS	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	73
CANARIAS	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	429
CANARIAS	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	340
CANARIAS	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	89
CANARIAS	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.153
CANARIAS	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	669
CANARIAS	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	484
CANARIAS	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	855
CANARIAS	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	326
CANARIAS	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	529
CANARIAS	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	743
CANARIAS	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	315
CANARIAS	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	428
CANARIAS	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.983
CANARIAS	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.106
CANARIAS	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.876
CANARIAS	Group 0601 Alzheimer's disease  3310	Both sexes	60
CANARIAS	Group 0601 Alzheimer's disease  3310	Men	19
CANARIAS	Group 0601 Alzheimer's disease  3310	Women	41
CANARIAS	Group 0602 Multiple sclerosis 340	Both sexes	204
CANARIAS	Group 0602 Multiple sclerosis 340	Men	61
CANARIAS	Group 0602 Multiple sclerosis 340	Women	143
CANARIAS	Group 0603 Epilepsy  345	Both sexes	445
CANARIAS	Group 0603 Epilepsy  345	Men	222
CANARIAS	Group 0603 Epilepsy  345	Women	223
CANARIAS	Group 0604 Transient cerebral ischemia 435	Both sexes	456
CANARIAS	Group 0604 Transient cerebral ischemia 435	Men	245
CANARIAS	Group 0604 Transient cerebral ischemia 435	Women	211
CANARIAS	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.817
CANARIAS	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.559
CANARIAS	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.258
CANARIAS	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.148
CANARIAS	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	559
CANARIAS	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	589
CANARIAS	Grupo 0701 Cataract  366	Both sexes	132
CANARIAS	Grupo 0701 Cataract  366	Men	67
CANARIAS	Grupo 0701 Cataract  366	Women	65
CANARIAS	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.016
CANARIAS	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	492
CANARIAS	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	524
CANARIAS	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	996
CANARIAS	Group 0800 Diseases of the ear and the mastoid  380-389	Men	479
CANARIAS	Group 0800 Diseases of the ear and the mastoid  380-389	Women	517
CANARIAS	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	23.066
CANARIAS	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	13.118
CANARIAS	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	9.948
CANARIAS	Group 0901 Hypertensive disease  401-405	Both sexes	1.534
CANARIAS	Group 0901 Hypertensive disease  401-405	Men	688
CANARIAS	Group 0901 Hypertensive disease  401-405	Women	846
CANARIAS	Group 0902 Angina pectoris  4111, 413	Both sexes	830
CANARIAS	Group 0902 Angina pectoris  4111, 413	Men	508
CANARIAS	Group 0902 Angina pectoris  4111, 413	Women	322
CANARIAS	Group 0903 Acute myocardial infarction  410	Both sexes	2.686
CANARIAS	Group 0903 Acute myocardial infarction  410	Men	1.919
CANARIAS	Group 0903 Acute myocardial infarction  410	Women	767
CANARIAS	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.685
CANARIAS	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.245
CANARIAS	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	440
CANARIAS	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	528
CANARIAS	Group 0905 Diseases of the lungs circulation 415-417	Men	202
CANARIAS	Group 0905 Diseases of the lungs circulation 415-417	Women	326
CANARIAS	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.760
CANARIAS	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.595
CANARIAS	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.164
CANARIAS	Grupo 0907 Heart failure  428	Both sexes	3.390
CANARIAS	Grupo 0907 Heart failure  428	Men	1.671
CANARIAS	Grupo 0907 Heart failure  428	Women	1.719
CANARIAS	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.661
CANARIAS	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.019
CANARIAS	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.642
CANARIAS	Grupo 0909 Atherosclerosis  440	Both sexes	804
CANARIAS	Grupo 0909 Atherosclerosis  440	Men	574
CANARIAS	Grupo 0909 Atherosclerosis  440	Women	230
CANARIAS	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.185
CANARIAS	Group 0910 Varicose veins of lower extremities 454	Men	380
CANARIAS	Group 0910 Varicose veins of lower extremities 454	Women	805
CANARIAS	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	4.003
CANARIAS	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	2.316
CANARIAS	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.687
CANARIAS	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	19.271
CANARIAS	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	10.456
CANARIAS	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	8.816
CANARIAS	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	894
CANARIAS	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	476
CANARIAS	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	418
CANARIAS	Group 1002 Pneumonia 480-486	Both sexes	4.705
CANARIAS	Group 1002 Pneumonia 480-486	Men	2.581
CANARIAS	Group 1002 Pneumonia 480-486	Women	2.124
CANARIAS	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.159
CANARIAS	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.025
CANARIAS	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.134
CANARIAS	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.550
CANARIAS	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	791
CANARIAS	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	759
CANARIAS	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.852
CANARIAS	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.159
CANARIAS	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	693
CANARIAS	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.137
CANARIAS	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.441
CANARIAS	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	696
CANARIAS	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	788
CANARIAS	Group 1007 Asthma 4930-4931,4938-4939	Men	295
CANARIAS	Group 1007 Asthma 4930-4931,4938-4939	Women	493
CANARIAS	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.186
CANARIAS	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.687
CANARIAS	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.498
CANARIAS	Group 1100 Diseases of the digestive system  520-579	Both sexes	22.932
CANARIAS	Group 1100 Diseases of the digestive system  520-579	Men	12.858
CANARIAS	Group 1100 Diseases of the digestive system  520-579	Women	10.073
CANARIAS	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	485
CANARIAS	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	210
CANARIAS	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	275
CANARIAS	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	318
CANARIAS	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	170
CANARIAS	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	148
CANARIAS	Group 1103 Diseases of the esophagus 530	Both sexes	388
CANARIAS	Group 1103 Diseases of the esophagus 530	Men	215
CANARIAS	Group 1103 Diseases of the esophagus 530	Women	173
CANARIAS	Group 1104 Peptic ulcer 531-534	Both sexes	407
CANARIAS	Group 1104 Peptic ulcer 531-534	Men	298
CANARIAS	Group 1104 Peptic ulcer 531-534	Women	109
CANARIAS	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	600
CANARIAS	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	294
CANARIAS	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	306
CANARIAS	Group 1106 Appendicitis  540-543	Both sexes	1.788
CANARIAS	Group 1106 Appendicitis  540-543	Men	1.089
CANARIAS	Group 1106 Appendicitis  540-543	Women	699
CANARIAS	Group 1107 Inguinal hernia  550	Both sexes	2.768
CANARIAS	Group 1107 Inguinal hernia  550	Men	2.516
CANARIAS	Group 1107 Inguinal hernia  550	Women	252
CANARIAS	Group 1108 Other abdominal hernia  551-553	Both sexes	2.366
CANARIAS	Group 1108 Other abdominal hernia  551-553	Men	1.281
CANARIAS	Group 1108 Other abdominal hernia  551-553	Women	1.085
CANARIAS	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	454
CANARIAS	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	222
CANARIAS	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	232
CANARIAS	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.797
CANARIAS	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	818
CANARIAS	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	979
CANARIAS	Group 1111 Intestinal obstruction without hernia 560	Both sexes	827
CANARIAS	Group 1111 Intestinal obstruction without hernia 560	Men	419
CANARIAS	Group 1111 Intestinal obstruction without hernia 560	Women	408
CANARIAS	Group 1112 Intestinal diverticulosis 562	Both sexes	1.028
CANARIAS	Group 1112 Intestinal diverticulosis 562	Men	523
CANARIAS	Group 1112 Intestinal diverticulosis 562	Women	505
CANARIAS	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.122
CANARIAS	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	743
CANARIAS	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	379
CANARIAS	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	774
CANARIAS	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	349
CANARIAS	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	425
CANARIAS	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	616
CANARIAS	Group 1115 Alcoholic hepatitis 5710-5713	Men	528
CANARIAS	Group 1115 Alcoholic hepatitis 5710-5713	Women	88
CANARIAS	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	711
CANARIAS	Group 1116 Other diseases of the liver 570,5714-573	Men	399
CANARIAS	Group 1116 Other diseases of the liver 570,5714-573	Women	312
CANARIAS	Group 1117 Cholelithiasis  574	Both sexes	3.859
CANARIAS	Group 1117 Cholelithiasis  574	Men	1.415
CANARIAS	Group 1117 Cholelithiasis  574	Women	2.444
CANARIAS	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	948
CANARIAS	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	447
CANARIAS	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	501
CANARIAS	Group 1119 Pancreatic diseases 577	Both sexes	1.057
CANARIAS	Group 1119 Pancreatic diseases 577	Men	600
CANARIAS	Group 1119 Pancreatic diseases 577	Women	457
CANARIAS	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	618
CANARIAS	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	322
CANARIAS	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	296
CANARIAS	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.566
CANARIAS	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.405
CANARIAS	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.161
CANARIAS	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.737
CANARIAS	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.045
CANARIAS	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	692
CANARIAS	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	94
CANARIAS	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	45
CANARIAS	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	49
CANARIAS	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	735
CANARIAS	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	315
CANARIAS	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	420
CANARIAS	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	12.846
CANARIAS	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	6.235
CANARIAS	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	6.611
CANARIAS	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CANARIAS	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CANARIAS	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CANARIAS	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CANARIAS	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CANARIAS	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CANARIAS	Group 1303 Internal derangement of knee 717	Both sexes	1.948
CANARIAS	Group 1303 Internal derangement of knee 717	Men	1.338
CANARIAS	Group 1303 Internal derangement of knee 717	Women	610
CANARIAS	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.513
CANARIAS	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.793
CANARIAS	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.720
CANARIAS	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	297
CANARIAS	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	70
CANARIAS	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	227
CANARIAS	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	651
CANARIAS	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	336
CANARIAS	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	315
CANARIAS	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.725
CANARIAS	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	922
CANARIAS	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	803
CANARIAS	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	376
CANARIAS	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	168
CANARIAS	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	208
CANARIAS	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.746
CANARIAS	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	955
CANARIAS	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	791
CANARIAS	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.590
CANARIAS	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	653
CANARIAS	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	937
CANARIAS	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	10.772
CANARIAS	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.138
CANARIAS	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	6.633
CANARIAS	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	977
CANARIAS	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	373
CANARIAS	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	604
CANARIAS	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	634
CANARIAS	Group 1402 Renal failure  5836-5837, 584-586	Men	352
CANARIAS	Group 1402 Renal failure  5836-5837, 584-586	Women	282
CANARIAS	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.123
CANARIAS	Group 1403 Urolithiasis  592, 594, 7880	Men	630
CANARIAS	Group 1403 Urolithiasis  592, 594, 7880	Women	493
CANARIAS	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.884
CANARIAS	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.224
CANARIAS	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.660
CANARIAS	Group 1405 Prostatic hyperplasia  600	Both sexes	768
CANARIAS	Group 1405 Prostatic hyperplasia  600	Men	768
CANARIAS	Group 1405 Prostatic hyperplasia  600	Women	..
CANARIAS	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	647
CANARIAS	Group 1406 Other diseases of the male genital organs    601-608	Men	647
CANARIAS	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CANARIAS	Group 1407 Disorders of breast  610-612	Both sexes	1.131
CANARIAS	Group 1407 Disorders of breast  610-612	Men	127
CANARIAS	Group 1407 Disorders of breast  610-612	Women	1.004
CANARIAS	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	422
CANARIAS	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CANARIAS	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	422
CANARIAS	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	156
CANARIAS	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CANARIAS	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	156
CANARIAS	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.029
CANARIAS	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	17
CANARIAS	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.012
CANARIAS	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.133
CANARIAS	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CANARIAS	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.133
CANARIAS	Group 1501 Legally induced abortion  635	Both sexes	182
CANARIAS	Group 1501 Legally induced abortion  635	Men	..
CANARIAS	Group 1501 Legally induced abortion  635	Women	182
CANARIAS	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	958
CANARIAS	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CANARIAS	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	958
CANARIAS	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	13.150
CANARIAS	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CANARIAS	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	13.150
CANARIAS	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.085
CANARIAS	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CANARIAS	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.085
CANARIAS	Group 1505 Single spontaneous delivery  650	Both sexes	412
CANARIAS	Group 1505 Single spontaneous delivery  650	Men	..
CANARIAS	Group 1505 Single spontaneous delivery  650	Women	412
CANARIAS	Group 1506 Other deliveries  6695-6697	Both sexes	129
CANARIAS	Group 1506 Other deliveries  6695-6697	Men	..
CANARIAS	Group 1506 Other deliveries  6695-6697	Women	129
CANARIAS	Group 1507 Complications related to the puerperium  670-676	Both sexes	83
CANARIAS	Group 1507 Complications related to the puerperium  670-676	Men	..
CANARIAS	Group 1507 Complications related to the puerperium  670-676	Women	83
CANARIAS	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.134
CANARIAS	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CANARIAS	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.134
CANARIAS	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.600
CANARIAS	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.492
CANARIAS	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.108
CANARIAS	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	696
CANARIAS	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	364
CANARIAS	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	332
CANARIAS	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.904
CANARIAS	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.128
CANARIAS	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	776
CANARIAS	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.486
CANARIAS	Grupo 1700 Congenital abnormalities  740-759	Men	880
CANARIAS	Grupo 1700 Congenital abnormalities  740-759	Women	606
CANARIAS	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	8.052
CANARIAS	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.223
CANARIAS	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.829
CANARIAS	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	847
CANARIAS	Group 1801 Pain in throat and chest 7841, 7865	Men	485
CANARIAS	Group 1801 Pain in throat and chest 7841, 7865	Women	362
CANARIAS	Group 1802 Abdominal pain   7890	Both sexes	694
CANARIAS	Group 1802 Abdominal pain   7890	Men	268
CANARIAS	Group 1802 Abdominal pain   7890	Women	426
CANARIAS	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.400
CANARIAS	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	689
CANARIAS	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	711
CANARIAS	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.111
CANARIAS	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.781
CANARIAS	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.330
CANARIAS	Group 1900 Injuries and poisoning  800-999	Both sexes	17.029
CANARIAS	Group 1900 Injuries and poisoning  800-999	Men	9.066
CANARIAS	Group 1900 Injuries and poisoning  800-999	Women	7.963
CANARIAS	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.151
CANARIAS	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	672
CANARIAS	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	479
CANARIAS	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	684
CANARIAS	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	466
CANARIAS	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	218
CANARIAS	Group 1903 Radius and ulna fracture 813	Both sexes	1.281
CANARIAS	Group 1903 Radius and ulna fracture 813	Men	541
CANARIAS	Group 1903 Radius and ulna fracture 813	Women	740
CANARIAS	Group 1904 Femur fracture  820-821	Both sexes	2.006
CANARIAS	Group 1904 Femur fracture  820-821	Men	623
CANARIAS	Group 1904 Femur fracture  820-821	Women	1.383
CANARIAS	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.612
CANARIAS	Group 1905 Leg fracture, including the ankle 823-824	Men	767
CANARIAS	Group 1905 Leg fracture, including the ankle 823-824	Women	845
CANARIAS	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	4.807
CANARIAS	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.933
CANARIAS	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.874
CANARIAS	Group 1907 Burns  940-949	Both sexes	136
CANARIAS	Group 1907 Burns  940-949	Men	86
CANARIAS	Group 1907 Burns  940-949	Women	50
CANARIAS	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	311
CANARIAS	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	151
CANARIAS	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	160
CANARIAS	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	4.588
CANARIAS	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.584
CANARIAS	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.004
CANARIAS	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	29
CANARIAS	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	22
CANARIAS	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	7
CANARIAS	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	424
CANARIAS	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	221
CANARIAS	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	203
CANARIAS	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	4.294
CANARIAS	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.836
CANARIAS	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.458
CANARIAS	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	326
CANARIAS	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	169
CANARIAS	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	157
CANARIAS	Group 2102 Contraceptive management  V25	Both sexes	248
CANARIAS	Group 2102 Contraceptive management  V25	Men	5
CANARIAS	Group 2102 Contraceptive management  V25	Women	243
CANARIAS	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CANARIAS	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CANARIAS	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CANARIAS	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.402
CANARIAS	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	802
CANARIAS	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	600
CANARIAS	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.318
CANARIAS	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	860
CANARIAS	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.458
Palmas, Las	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	84.283
Palmas, Las	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	39.118
Palmas, Las	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	45.165
Palmas, Las	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.552
Palmas, Las	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	886
Palmas, Las	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	666
Palmas, Las	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	262
Palmas, Las	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	134
Palmas, Las	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	128
Palmas, Las	Group 0102 Imprecise intestinal infections 009	Both sexes	68
Palmas, Las	Group 0102 Imprecise intestinal infections 009	Men	26
Palmas, Las	Group 0102 Imprecise intestinal infections 009	Women	42
Palmas, Las	Group 0103 Tuberculosis 010-018, 137	Both sexes	60
Palmas, Las	Group 0103 Tuberculosis 010-018, 137	Men	48
Palmas, Las	Group 0103 Tuberculosis 010-018, 137	Women	12
Palmas, Las	Group 0104 Septicaemia  038	Both sexes	613
Palmas, Las	Group 0104 Septicaemia  038	Men	328
Palmas, Las	Group 0104 Septicaemia  038	Women	285
Palmas, Las	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	62
Palmas, Las	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	51
Palmas, Las	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	11
Palmas, Las	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	487
Palmas, Las	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	299
Palmas, Las	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	188
Palmas, Las	Group 0200 Neoplasms  140-239	Both sexes	7.869
Palmas, Las	Group 0200 Neoplasms  140-239	Men	3.905
Palmas, Las	Group 0200 Neoplasms  140-239	Women	3.964
Palmas, Las	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	693
Palmas, Las	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	408
Palmas, Las	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	285
Palmas, Las	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	596
Palmas, Las	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	435
Palmas, Las	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	161
Palmas, Las	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	159
Palmas, Las	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	97
Palmas, Las	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	62
Palmas, Las	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	596
Palmas, Las	Group 0204 Malignant neoplasm of breast  174-175	Men	5
Palmas, Las	Group 0204 Malignant neoplasm of breast  174-175	Women	591
Palmas, Las	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	252
Palmas, Las	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Palmas, Las	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	252
Palmas, Las	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	76
Palmas, Las	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Palmas, Las	Group 0206 Malignant neoplasm of ovary  1830	Women	76
Palmas, Las	Group 0207 Malignant neoplasm of prostate  185	Both sexes	235
Palmas, Las	Group 0207 Malignant neoplasm of prostate  185	Men	235
Palmas, Las	Group 0207 Malignant neoplasm of prostate  185	Women	..
Palmas, Las	Group 0208 Malignant neoplasm of bladder  188	Both sexes	495
Palmas, Las	Group 0208 Malignant neoplasm of bladder  188	Men	419
Palmas, Las	Group 0208 Malignant neoplasm of bladder  188	Women	76
Palmas, Las	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.712
Palmas, Las	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.543
Palmas, Las	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.169
Palmas, Las	Group 0210 Carcinoma in situ  230-234	Both sexes	200
Palmas, Las	Group 0210 Carcinoma in situ  230-234	Men	82
Palmas, Las	Group 0210 Carcinoma in situ  230-234	Women	118
Palmas, Las	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	109
Palmas, Las	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	69
Palmas, Las	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	40
Palmas, Las	Grupo 0212 Leiomyoma of uterus  218	Both sexes	448
Palmas, Las	Grupo 0212 Leiomyoma of uterus  218	Men	..
Palmas, Las	Grupo 0212 Leiomyoma of uterus  218	Women	448
Palmas, Las	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.298
Palmas, Las	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	612
Palmas, Las	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	686
Palmas, Las	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	520
Palmas, Las	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	233
Palmas, Las	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	287
Palmas, Las	Group 0301 Anaemias 280-285	Both sexes	262
Palmas, Las	Group 0301 Anaemias 280-285	Men	120
Palmas, Las	Group 0301 Anaemias 280-285	Women	142
Palmas, Las	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	258
Palmas, Las	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	113
Palmas, Las	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	145
Palmas, Las	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.056
Palmas, Las	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	867
Palmas, Las	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.189
Palmas, Las	Group 0401 Diabetes mellitus  249-250	Both sexes	681
Palmas, Las	Group 0401 Diabetes mellitus  249-250	Men	410
Palmas, Las	Group 0401 Diabetes mellitus  249-250	Women	271
Palmas, Las	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.375
Palmas, Las	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	457
Palmas, Las	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	918
Palmas, Las	Group 0500 Mental disorders  290-319	Both sexes	1.906
Palmas, Las	Group 0500 Mental disorders  290-319	Men	1.016
Palmas, Las	Group 0500 Mental disorders  290-319	Women	890
Palmas, Las	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	54
Palmas, Las	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	27
Palmas, Las	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	27
Palmas, Las	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	130
Palmas, Las	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	109
Palmas, Las	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	21
Palmas, Las	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	146
Palmas, Las	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	111
Palmas, Las	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	35
Palmas, Las	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	664
Palmas, Las	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	388
Palmas, Las	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	276
Palmas, Las	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	485
Palmas, Las	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	190
Palmas, Las	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	295
Palmas, Las	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	427
Palmas, Las	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	191
Palmas, Las	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	236
Palmas, Las	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.470
Palmas, Las	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	794
Palmas, Las	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	676
Palmas, Las	Group 0601 Alzheimer's disease  3310	Both sexes	20
Palmas, Las	Group 0601 Alzheimer's disease  3310	Men	10
Palmas, Las	Group 0601 Alzheimer's disease  3310	Women	10
Palmas, Las	Group 0602 Multiple sclerosis 340	Both sexes	29
Palmas, Las	Group 0602 Multiple sclerosis 340	Men	6
Palmas, Las	Group 0602 Multiple sclerosis 340	Women	23
Palmas, Las	Group 0603 Epilepsy  345	Both sexes	188
Palmas, Las	Group 0603 Epilepsy  345	Men	95
Palmas, Las	Group 0603 Epilepsy  345	Women	93
Palmas, Las	Group 0604 Transient cerebral ischemia 435	Both sexes	192
Palmas, Las	Group 0604 Transient cerebral ischemia 435	Men	107
Palmas, Las	Group 0604 Transient cerebral ischemia 435	Women	85
Palmas, Las	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.041
Palmas, Las	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	576
Palmas, Las	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	465
Palmas, Las	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	326
Palmas, Las	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	151
Palmas, Las	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	175
Palmas, Las	Grupo 0701 Cataract  366	Both sexes	25
Palmas, Las	Grupo 0701 Cataract  366	Men	16
Palmas, Las	Grupo 0701 Cataract  366	Women	9
Palmas, Las	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	301
Palmas, Las	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	135
Palmas, Las	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	166
Palmas, Las	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	521
Palmas, Las	Group 0800 Diseases of the ear and the mastoid  380-389	Men	249
Palmas, Las	Group 0800 Diseases of the ear and the mastoid  380-389	Women	272
Palmas, Las	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	11.152
Palmas, Las	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.334
Palmas, Las	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.818
Palmas, Las	Group 0901 Hypertensive disease  401-405	Both sexes	766
Palmas, Las	Group 0901 Hypertensive disease  401-405	Men	357
Palmas, Las	Group 0901 Hypertensive disease  401-405	Women	409
Palmas, Las	Group 0902 Angina pectoris  4111, 413	Both sexes	437
Palmas, Las	Group 0902 Angina pectoris  4111, 413	Men	262
Palmas, Las	Group 0902 Angina pectoris  4111, 413	Women	175
Palmas, Las	Group 0903 Acute myocardial infarction  410	Both sexes	1.582
Palmas, Las	Group 0903 Acute myocardial infarction  410	Men	1.134
Palmas, Las	Group 0903 Acute myocardial infarction  410	Women	448
Palmas, Las	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	757
Palmas, Las	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	555
Palmas, Las	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	202
Palmas, Las	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	275
Palmas, Las	Group 0905 Diseases of the lungs circulation 415-417	Men	100
Palmas, Las	Group 0905 Diseases of the lungs circulation 415-417	Women	175
Palmas, Las	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.228
Palmas, Las	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	686
Palmas, Las	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	542
Palmas, Las	Grupo 0907 Heart failure  428	Both sexes	1.675
Palmas, Las	Grupo 0907 Heart failure  428	Men	807
Palmas, Las	Grupo 0907 Heart failure  428	Women	868
Palmas, Las	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.683
Palmas, Las	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	954
Palmas, Las	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	729
Palmas, Las	Grupo 0909 Atherosclerosis  440	Both sexes	400
Palmas, Las	Grupo 0909 Atherosclerosis  440	Men	285
Palmas, Las	Grupo 0909 Atherosclerosis  440	Women	115
Palmas, Las	Group 0910 Varicose veins of lower extremities 454	Both sexes	576
Palmas, Las	Group 0910 Varicose veins of lower extremities 454	Men	179
Palmas, Las	Group 0910 Varicose veins of lower extremities 454	Women	397
Palmas, Las	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.773
Palmas, Las	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.015
Palmas, Las	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	758
Palmas, Las	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	8.389
Palmas, Las	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.654
Palmas, Las	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.735
Palmas, Las	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	374
Palmas, Las	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	199
Palmas, Las	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	175
Palmas, Las	Group 1002 Pneumonia 480-486	Both sexes	2.194
Palmas, Las	Group 1002 Pneumonia 480-486	Men	1.203
Palmas, Las	Group 1002 Pneumonia 480-486	Women	991
Palmas, Las	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	865
Palmas, Las	Group 1003 Acute bronchitis and bronchiolitis  466	Men	415
Palmas, Las	Group 1003 Acute bronchitis and bronchiolitis  466	Women	450
Palmas, Las	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	701
Palmas, Las	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	380
Palmas, Las	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	321
Palmas, Las	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	925
Palmas, Las	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	579
Palmas, Las	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	346
Palmas, Las	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	901
Palmas, Las	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	632
Palmas, Las	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	269
Palmas, Las	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	438
Palmas, Las	Group 1007 Asthma 4930-4931,4938-4939	Men	167
Palmas, Las	Group 1007 Asthma 4930-4931,4938-4939	Women	271
Palmas, Las	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.991
Palmas, Las	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.079
Palmas, Las	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	912
Palmas, Las	Group 1100 Diseases of the digestive system  520-579	Both sexes	10.332
Palmas, Las	Group 1100 Diseases of the digestive system  520-579	Men	5.921
Palmas, Las	Group 1100 Diseases of the digestive system  520-579	Women	4.411
Palmas, Las	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	167
Palmas, Las	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	83
Palmas, Las	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	84
Palmas, Las	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	119
Palmas, Las	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	61
Palmas, Las	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	58
Palmas, Las	Group 1103 Diseases of the esophagus 530	Both sexes	181
Palmas, Las	Group 1103 Diseases of the esophagus 530	Men	97
Palmas, Las	Group 1103 Diseases of the esophagus 530	Women	84
Palmas, Las	Group 1104 Peptic ulcer 531-534	Both sexes	195
Palmas, Las	Group 1104 Peptic ulcer 531-534	Men	147
Palmas, Las	Group 1104 Peptic ulcer 531-534	Women	48
Palmas, Las	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	204
Palmas, Las	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	110
Palmas, Las	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	94
Palmas, Las	Group 1106 Appendicitis  540-543	Both sexes	930
Palmas, Las	Group 1106 Appendicitis  540-543	Men	572
Palmas, Las	Group 1106 Appendicitis  540-543	Women	358
Palmas, Las	Group 1107 Inguinal hernia  550	Both sexes	1.322
Palmas, Las	Group 1107 Inguinal hernia  550	Men	1.217
Palmas, Las	Group 1107 Inguinal hernia  550	Women	105
Palmas, Las	Group 1108 Other abdominal hernia  551-553	Both sexes	1.184
Palmas, Las	Group 1108 Other abdominal hernia  551-553	Men	647
Palmas, Las	Group 1108 Other abdominal hernia  551-553	Women	537
Palmas, Las	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	235
Palmas, Las	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	122
Palmas, Las	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	113
Palmas, Las	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	617
Palmas, Las	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	291
Palmas, Las	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	326
Palmas, Las	Group 1111 Intestinal obstruction without hernia 560	Both sexes	398
Palmas, Las	Group 1111 Intestinal obstruction without hernia 560	Men	201
Palmas, Las	Group 1111 Intestinal obstruction without hernia 560	Women	197
Palmas, Las	Group 1112 Intestinal diverticulosis 562	Both sexes	463
Palmas, Las	Group 1112 Intestinal diverticulosis 562	Men	242
Palmas, Las	Group 1112 Intestinal diverticulosis 562	Women	221
Palmas, Las	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	422
Palmas, Las	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	290
Palmas, Las	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	132
Palmas, Las	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	337
Palmas, Las	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	159
Palmas, Las	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	178
Palmas, Las	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	201
Palmas, Las	Group 1115 Alcoholic hepatitis 5710-5713	Men	164
Palmas, Las	Group 1115 Alcoholic hepatitis 5710-5713	Women	37
Palmas, Las	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	315
Palmas, Las	Group 1116 Other diseases of the liver 570,5714-573	Men	186
Palmas, Las	Group 1116 Other diseases of the liver 570,5714-573	Women	129
Palmas, Las	Group 1117 Cholelithiasis  574	Both sexes	1.840
Palmas, Las	Group 1117 Cholelithiasis  574	Men	641
Palmas, Las	Group 1117 Cholelithiasis  574	Women	1.199
Palmas, Las	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	378
Palmas, Las	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	213
Palmas, Las	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	165
Palmas, Las	Group 1119 Pancreatic diseases 577	Both sexes	568
Palmas, Las	Group 1119 Pancreatic diseases 577	Men	346
Palmas, Las	Group 1119 Pancreatic diseases 577	Women	222
Palmas, Las	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	256
Palmas, Las	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	132
Palmas, Las	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	124
Palmas, Las	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.083
Palmas, Las	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	590
Palmas, Las	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	493
Palmas, Las	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	649
Palmas, Las	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	410
Palmas, Las	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	239
Palmas, Las	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	30
Palmas, Las	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
Palmas, Las	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	18
Palmas, Las	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	404
Palmas, Las	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	168
Palmas, Las	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	236
Palmas, Las	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.147
Palmas, Las	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.047
Palmas, Las	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.100
Palmas, Las	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Palmas, Las	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Palmas, Las	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Palmas, Las	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Palmas, Las	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Palmas, Las	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Palmas, Las	Group 1303 Internal derangement of knee 717	Both sexes	865
Palmas, Las	Group 1303 Internal derangement of knee 717	Men	653
Palmas, Las	Group 1303 Internal derangement of knee 717	Women	212
Palmas, Las	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.948
Palmas, Las	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	782
Palmas, Las	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.166
Palmas, Las	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	202
Palmas, Las	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	43
Palmas, Las	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	159
Palmas, Las	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	349
Palmas, Las	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	171
Palmas, Las	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	178
Palmas, Las	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.022
Palmas, Las	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	558
Palmas, Las	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	464
Palmas, Las	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	210
Palmas, Las	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	93
Palmas, Las	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	117
Palmas, Las	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	735
Palmas, Las	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	416
Palmas, Las	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	319
Palmas, Las	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	816
Palmas, Las	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	331
Palmas, Las	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	485
Palmas, Las	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.158
Palmas, Las	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.025
Palmas, Las	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.133
Palmas, Las	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	512
Palmas, Las	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	202
Palmas, Las	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	310
Palmas, Las	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	346
Palmas, Las	Group 1402 Renal failure  5836-5837, 584-586	Men	186
Palmas, Las	Group 1402 Renal failure  5836-5837, 584-586	Women	160
Palmas, Las	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	448
Palmas, Las	Group 1403 Urolithiasis  592, 594, 7880	Men	247
Palmas, Las	Group 1403 Urolithiasis  592, 594, 7880	Women	201
Palmas, Las	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.097
Palmas, Las	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	486
Palmas, Las	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	611
Palmas, Las	Group 1405 Prostatic hyperplasia  600	Both sexes	465
Palmas, Las	Group 1405 Prostatic hyperplasia  600	Men	465
Palmas, Las	Group 1405 Prostatic hyperplasia  600	Women	..
Palmas, Las	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	355
Palmas, Las	Group 1406 Other diseases of the male genital organs    601-608	Men	355
Palmas, Las	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Palmas, Las	Group 1407 Disorders of breast  610-612	Both sexes	747
Palmas, Las	Group 1407 Disorders of breast  610-612	Men	77
Palmas, Las	Group 1407 Disorders of breast  610-612	Women	670
Palmas, Las	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	155
Palmas, Las	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Palmas, Las	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	155
Palmas, Las	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	76
Palmas, Las	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Palmas, Las	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	76
Palmas, Las	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	957
Palmas, Las	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	7
Palmas, Las	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	950
Palmas, Las	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	10.024
Palmas, Las	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Palmas, Las	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	10.024
Palmas, Las	Group 1501 Legally induced abortion  635	Both sexes	94
Palmas, Las	Group 1501 Legally induced abortion  635	Men	..
Palmas, Las	Group 1501 Legally induced abortion  635	Women	94
Palmas, Las	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	445
Palmas, Las	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Palmas, Las	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	445
Palmas, Las	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.920
Palmas, Las	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Palmas, Las	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.920
Palmas, Las	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.771
Palmas, Las	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Palmas, Las	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.771
Palmas, Las	Group 1505 Single spontaneous delivery  650	Both sexes	211
Palmas, Las	Group 1505 Single spontaneous delivery  650	Men	..
Palmas, Las	Group 1505 Single spontaneous delivery  650	Women	211
Palmas, Las	Group 1506 Other deliveries  6695-6697	Both sexes	104
Palmas, Las	Group 1506 Other deliveries  6695-6697	Men	..
Palmas, Las	Group 1506 Other deliveries  6695-6697	Women	104
Palmas, Las	Group 1507 Complications related to the puerperium  670-676	Both sexes	36
Palmas, Las	Group 1507 Complications related to the puerperium  670-676	Men	..
Palmas, Las	Group 1507 Complications related to the puerperium  670-676	Women	36
Palmas, Las	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	443
Palmas, Las	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Palmas, Las	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	443
Palmas, Las	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.393
Palmas, Las	Group 1600 Some disorders originating in the perinatal period  760-779	Men	823
Palmas, Las	Group 1600 Some disorders originating in the perinatal period  760-779	Women	570
Palmas, Las	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	339
Palmas, Las	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	188
Palmas, Las	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	151
Palmas, Las	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.054
Palmas, Las	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	635
Palmas, Las	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	419
Palmas, Las	Grupo 1700 Congenital abnormalities  740-759	Both sexes	845
Palmas, Las	Grupo 1700 Congenital abnormalities  740-759	Men	518
Palmas, Las	Grupo 1700 Congenital abnormalities  740-759	Women	327
Palmas, Las	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	4.291
Palmas, Las	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.239
Palmas, Las	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.052
Palmas, Las	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	323
Palmas, Las	Group 1801 Pain in throat and chest 7841, 7865	Men	189
Palmas, Las	Group 1801 Pain in throat and chest 7841, 7865	Women	134
Palmas, Las	Group 1802 Abdominal pain   7890	Both sexes	270
Palmas, Las	Group 1802 Abdominal pain   7890	Men	95
Palmas, Las	Group 1802 Abdominal pain   7890	Women	175
Palmas, Las	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.153
Palmas, Las	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	578
Palmas, Las	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	575
Palmas, Las	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.545
Palmas, Las	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.377
Palmas, Las	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.168
Palmas, Las	Group 1900 Injuries and poisoning  800-999	Both sexes	7.535
Palmas, Las	Group 1900 Injuries and poisoning  800-999	Men	4.075
Palmas, Las	Group 1900 Injuries and poisoning  800-999	Women	3.460
Palmas, Las	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	584
Palmas, Las	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	341
Palmas, Las	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	243
Palmas, Las	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	191
Palmas, Las	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	139
Palmas, Las	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	52
Palmas, Las	Group 1903 Radius and ulna fracture 813	Both sexes	454
Palmas, Las	Group 1903 Radius and ulna fracture 813	Men	202
Palmas, Las	Group 1903 Radius and ulna fracture 813	Women	252
Palmas, Las	Group 1904 Femur fracture  820-821	Both sexes	916
Palmas, Las	Group 1904 Femur fracture  820-821	Men	311
Palmas, Las	Group 1904 Femur fracture  820-821	Women	605
Palmas, Las	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	760
Palmas, Las	Group 1905 Leg fracture, including the ankle 823-824	Men	389
Palmas, Las	Group 1905 Leg fracture, including the ankle 823-824	Women	371
Palmas, Las	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.143
Palmas, Las	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.330
Palmas, Las	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	813
Palmas, Las	Group 1907 Burns  940-949	Both sexes	64
Palmas, Las	Group 1907 Burns  940-949	Men	40
Palmas, Las	Group 1907 Burns  940-949	Women	24
Palmas, Las	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	157
Palmas, Las	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	73
Palmas, Las	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	84
Palmas, Las	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.080
Palmas, Las	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.145
Palmas, Las	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	935
Palmas, Las	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	10
Palmas, Las	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
Palmas, Las	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
Palmas, Las	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	176
Palmas, Las	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	97
Palmas, Las	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	79
Palmas, Las	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.714
Palmas, Las	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	791
Palmas, Las	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	923
Palmas, Las	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	166
Palmas, Las	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	86
Palmas, Las	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	80
Palmas, Las	Group 2102 Contraceptive management  V25	Both sexes	101
Palmas, Las	Group 2102 Contraceptive management  V25	Men	2
Palmas, Las	Group 2102 Contraceptive management  V25	Women	99
Palmas, Las	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Palmas, Las	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Palmas, Las	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Palmas, Las	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	489
Palmas, Las	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	263
Palmas, Las	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	226
Palmas, Las	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	958
Palmas, Las	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	440
Palmas, Las	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	518
Santa Cruz de Tenerife	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	95.364
Santa Cruz de Tenerife	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	44.211
Santa Cruz de Tenerife	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	51.153
Santa Cruz de Tenerife	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.980
Santa Cruz de Tenerife	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.038
Santa Cruz de Tenerife	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	941
Santa Cruz de Tenerife	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	157
Santa Cruz de Tenerife	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	72
Santa Cruz de Tenerife	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	85
Santa Cruz de Tenerife	Group 0102 Imprecise intestinal infections 009	Both sexes	121
Santa Cruz de Tenerife	Group 0102 Imprecise intestinal infections 009	Men	49
Santa Cruz de Tenerife	Group 0102 Imprecise intestinal infections 009	Women	72
Santa Cruz de Tenerife	Group 0103 Tuberculosis 010-018, 137	Both sexes	24
Santa Cruz de Tenerife	Group 0103 Tuberculosis 010-018, 137	Men	13
Santa Cruz de Tenerife	Group 0103 Tuberculosis 010-018, 137	Women	11
Santa Cruz de Tenerife	Group 0104 Septicaemia  038	Both sexes	975
Santa Cruz de Tenerife	Group 0104 Septicaemia  038	Men	519
Santa Cruz de Tenerife	Group 0104 Septicaemia  038	Women	455
Santa Cruz de Tenerife	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	61
Santa Cruz de Tenerife	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	51
Santa Cruz de Tenerife	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	10
Santa Cruz de Tenerife	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	642
Santa Cruz de Tenerife	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	334
Santa Cruz de Tenerife	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	308
Santa Cruz de Tenerife	Group 0200 Neoplasms  140-239	Both sexes	8.786
Santa Cruz de Tenerife	Group 0200 Neoplasms  140-239	Men	4.334
Santa Cruz de Tenerife	Group 0200 Neoplasms  140-239	Women	4.452
Santa Cruz de Tenerife	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	813
Santa Cruz de Tenerife	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	480
Santa Cruz de Tenerife	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	333
Santa Cruz de Tenerife	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	569
Santa Cruz de Tenerife	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	413
Santa Cruz de Tenerife	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	156
Santa Cruz de Tenerife	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	246
Santa Cruz de Tenerife	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	124
Santa Cruz de Tenerife	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	122
Santa Cruz de Tenerife	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	774
Santa Cruz de Tenerife	Group 0204 Malignant neoplasm of breast  174-175	Men	6
Santa Cruz de Tenerife	Group 0204 Malignant neoplasm of breast  174-175	Women	768
Santa Cruz de Tenerife	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	189
Santa Cruz de Tenerife	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Santa Cruz de Tenerife	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	189
Santa Cruz de Tenerife	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	89
Santa Cruz de Tenerife	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Santa Cruz de Tenerife	Group 0206 Malignant neoplasm of ovary  1830	Women	89
Santa Cruz de Tenerife	Group 0207 Malignant neoplasm of prostate  185	Both sexes	457
Santa Cruz de Tenerife	Group 0207 Malignant neoplasm of prostate  185	Men	457
Santa Cruz de Tenerife	Group 0207 Malignant neoplasm of prostate  185	Women	..
Santa Cruz de Tenerife	Group 0208 Malignant neoplasm of bladder  188	Both sexes	648
Santa Cruz de Tenerife	Group 0208 Malignant neoplasm of bladder  188	Men	541
Santa Cruz de Tenerife	Group 0208 Malignant neoplasm of bladder  188	Women	107
Santa Cruz de Tenerife	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.008
Santa Cruz de Tenerife	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.698
Santa Cruz de Tenerife	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.310
Santa Cruz de Tenerife	Group 0210 Carcinoma in situ  230-234	Both sexes	165
Santa Cruz de Tenerife	Group 0210 Carcinoma in situ  230-234	Men	33
Santa Cruz de Tenerife	Group 0210 Carcinoma in situ  230-234	Women	132
Santa Cruz de Tenerife	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	111
Santa Cruz de Tenerife	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	62
Santa Cruz de Tenerife	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	49
Santa Cruz de Tenerife	Grupo 0212 Leiomyoma of uterus  218	Both sexes	478
Santa Cruz de Tenerife	Grupo 0212 Leiomyoma of uterus  218	Men	..
Santa Cruz de Tenerife	Grupo 0212 Leiomyoma of uterus  218	Women	478
Santa Cruz de Tenerife	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.239
Santa Cruz de Tenerife	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	520
Santa Cruz de Tenerife	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	719
Santa Cruz de Tenerife	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	765
Santa Cruz de Tenerife	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	357
Santa Cruz de Tenerife	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	408
Santa Cruz de Tenerife	Group 0301 Anaemias 280-285	Both sexes	416
Santa Cruz de Tenerife	Group 0301 Anaemias 280-285	Men	189
Santa Cruz de Tenerife	Group 0301 Anaemias 280-285	Women	227
Santa Cruz de Tenerife	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	349
Santa Cruz de Tenerife	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	168
Santa Cruz de Tenerife	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	181
Santa Cruz de Tenerife	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.281
Santa Cruz de Tenerife	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	840
Santa Cruz de Tenerife	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.441
Santa Cruz de Tenerife	Group 0401 Diabetes mellitus  249-250	Both sexes	559
Santa Cruz de Tenerife	Group 0401 Diabetes mellitus  249-250	Men	297
Santa Cruz de Tenerife	Group 0401 Diabetes mellitus  249-250	Women	262
Santa Cruz de Tenerife	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.722
Santa Cruz de Tenerife	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	543
Santa Cruz de Tenerife	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.179
Santa Cruz de Tenerife	Group 0500 Mental disorders  290-319	Both sexes	1.757
Santa Cruz de Tenerife	Group 0500 Mental disorders  290-319	Men	1.000
Santa Cruz de Tenerife	Group 0500 Mental disorders  290-319	Women	757
Santa Cruz de Tenerife	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	26
Santa Cruz de Tenerife	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	9
Santa Cruz de Tenerife	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	17
Santa Cruz de Tenerife	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	273
Santa Cruz de Tenerife	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	221
Santa Cruz de Tenerife	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	52
Santa Cruz de Tenerife	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	283
Santa Cruz de Tenerife	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	229
Santa Cruz de Tenerife	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	54
Santa Cruz de Tenerife	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	489
Santa Cruz de Tenerife	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	281
Santa Cruz de Tenerife	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	208
Santa Cruz de Tenerife	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	370
Santa Cruz de Tenerife	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	136
Santa Cruz de Tenerife	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	234
Santa Cruz de Tenerife	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	316
Santa Cruz de Tenerife	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	124
Santa Cruz de Tenerife	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	192
Santa Cruz de Tenerife	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.513
Santa Cruz de Tenerife	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.312
Santa Cruz de Tenerife	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.200
Santa Cruz de Tenerife	Group 0601 Alzheimer's disease  3310	Both sexes	40
Santa Cruz de Tenerife	Group 0601 Alzheimer's disease  3310	Men	9
Santa Cruz de Tenerife	Group 0601 Alzheimer's disease  3310	Women	31
Santa Cruz de Tenerife	Group 0602 Multiple sclerosis 340	Both sexes	175
Santa Cruz de Tenerife	Group 0602 Multiple sclerosis 340	Men	55
Santa Cruz de Tenerife	Group 0602 Multiple sclerosis 340	Women	120
Santa Cruz de Tenerife	Group 0603 Epilepsy  345	Both sexes	257
Santa Cruz de Tenerife	Group 0603 Epilepsy  345	Men	127
Santa Cruz de Tenerife	Group 0603 Epilepsy  345	Women	130
Santa Cruz de Tenerife	Group 0604 Transient cerebral ischemia 435	Both sexes	264
Santa Cruz de Tenerife	Group 0604 Transient cerebral ischemia 435	Men	138
Santa Cruz de Tenerife	Group 0604 Transient cerebral ischemia 435	Women	126
Santa Cruz de Tenerife	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.776
Santa Cruz de Tenerife	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	983
Santa Cruz de Tenerife	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	793
Santa Cruz de Tenerife	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	822
Santa Cruz de Tenerife	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	408
Santa Cruz de Tenerife	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	414
Santa Cruz de Tenerife	Grupo 0701 Cataract  366	Both sexes	107
Santa Cruz de Tenerife	Grupo 0701 Cataract  366	Men	51
Santa Cruz de Tenerife	Grupo 0701 Cataract  366	Women	56
Santa Cruz de Tenerife	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	715
Santa Cruz de Tenerife	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	357
Santa Cruz de Tenerife	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	358
Santa Cruz de Tenerife	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	475
Santa Cruz de Tenerife	Group 0800 Diseases of the ear and the mastoid  380-389	Men	230
Santa Cruz de Tenerife	Group 0800 Diseases of the ear and the mastoid  380-389	Women	245
Santa Cruz de Tenerife	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	11.914
Santa Cruz de Tenerife	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.784
Santa Cruz de Tenerife	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	5.130
Santa Cruz de Tenerife	Group 0901 Hypertensive disease  401-405	Both sexes	768
Santa Cruz de Tenerife	Group 0901 Hypertensive disease  401-405	Men	331
Santa Cruz de Tenerife	Group 0901 Hypertensive disease  401-405	Women	437
Santa Cruz de Tenerife	Group 0902 Angina pectoris  4111, 413	Both sexes	393
Santa Cruz de Tenerife	Group 0902 Angina pectoris  4111, 413	Men	246
Santa Cruz de Tenerife	Group 0902 Angina pectoris  4111, 413	Women	147
Santa Cruz de Tenerife	Group 0903 Acute myocardial infarction  410	Both sexes	1.104
Santa Cruz de Tenerife	Group 0903 Acute myocardial infarction  410	Men	785
Santa Cruz de Tenerife	Group 0903 Acute myocardial infarction  410	Women	319
Santa Cruz de Tenerife	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	928
Santa Cruz de Tenerife	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	690
Santa Cruz de Tenerife	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	238
Santa Cruz de Tenerife	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	253
Santa Cruz de Tenerife	Group 0905 Diseases of the lungs circulation 415-417	Men	102
Santa Cruz de Tenerife	Group 0905 Diseases of the lungs circulation 415-417	Women	151
Santa Cruz de Tenerife	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.532
Santa Cruz de Tenerife	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	909
Santa Cruz de Tenerife	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	622
Santa Cruz de Tenerife	Grupo 0907 Heart failure  428	Both sexes	1.715
Santa Cruz de Tenerife	Grupo 0907 Heart failure  428	Men	864
Santa Cruz de Tenerife	Grupo 0907 Heart failure  428	Women	851
Santa Cruz de Tenerife	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.978
Santa Cruz de Tenerife	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.065
Santa Cruz de Tenerife	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	913
Santa Cruz de Tenerife	Grupo 0909 Atherosclerosis  440	Both sexes	404
Santa Cruz de Tenerife	Grupo 0909 Atherosclerosis  440	Men	289
Santa Cruz de Tenerife	Grupo 0909 Atherosclerosis  440	Women	115
Santa Cruz de Tenerife	Group 0910 Varicose veins of lower extremities 454	Both sexes	609
Santa Cruz de Tenerife	Group 0910 Varicose veins of lower extremities 454	Men	201
Santa Cruz de Tenerife	Group 0910 Varicose veins of lower extremities 454	Women	408
Santa Cruz de Tenerife	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.230
Santa Cruz de Tenerife	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.301
Santa Cruz de Tenerife	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	929
Santa Cruz de Tenerife	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	10.882
Santa Cruz de Tenerife	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.802
Santa Cruz de Tenerife	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.081
Santa Cruz de Tenerife	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	520
Santa Cruz de Tenerife	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	277
Santa Cruz de Tenerife	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	243
Santa Cruz de Tenerife	Group 1002 Pneumonia 480-486	Both sexes	2.511
Santa Cruz de Tenerife	Group 1002 Pneumonia 480-486	Men	1.378
Santa Cruz de Tenerife	Group 1002 Pneumonia 480-486	Women	1.133
Santa Cruz de Tenerife	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.294
Santa Cruz de Tenerife	Group 1003 Acute bronchitis and bronchiolitis  466	Men	610
Santa Cruz de Tenerife	Group 1003 Acute bronchitis and bronchiolitis  466	Women	684
Santa Cruz de Tenerife	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	849
Santa Cruz de Tenerife	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	411
Santa Cruz de Tenerife	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	438
Santa Cruz de Tenerife	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	927
Santa Cruz de Tenerife	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	580
Santa Cruz de Tenerife	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	347
Santa Cruz de Tenerife	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.236
Santa Cruz de Tenerife	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	809
Santa Cruz de Tenerife	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	427
Santa Cruz de Tenerife	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	350
Santa Cruz de Tenerife	Group 1007 Asthma 4930-4931,4938-4939	Men	128
Santa Cruz de Tenerife	Group 1007 Asthma 4930-4931,4938-4939	Women	222
Santa Cruz de Tenerife	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.195
Santa Cruz de Tenerife	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.608
Santa Cruz de Tenerife	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.586
Santa Cruz de Tenerife	Group 1100 Diseases of the digestive system  520-579	Both sexes	12.600
Santa Cruz de Tenerife	Group 1100 Diseases of the digestive system  520-579	Men	6.937
Santa Cruz de Tenerife	Group 1100 Diseases of the digestive system  520-579	Women	5.662
Santa Cruz de Tenerife	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	318
Santa Cruz de Tenerife	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	127
Santa Cruz de Tenerife	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	191
Santa Cruz de Tenerife	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	199
Santa Cruz de Tenerife	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	109
Santa Cruz de Tenerife	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	90
Santa Cruz de Tenerife	Group 1103 Diseases of the esophagus 530	Both sexes	207
Santa Cruz de Tenerife	Group 1103 Diseases of the esophagus 530	Men	118
Santa Cruz de Tenerife	Group 1103 Diseases of the esophagus 530	Women	89
Santa Cruz de Tenerife	Group 1104 Peptic ulcer 531-534	Both sexes	212
Santa Cruz de Tenerife	Group 1104 Peptic ulcer 531-534	Men	151
Santa Cruz de Tenerife	Group 1104 Peptic ulcer 531-534	Women	61
Santa Cruz de Tenerife	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	396
Santa Cruz de Tenerife	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	184
Santa Cruz de Tenerife	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	212
Santa Cruz de Tenerife	Group 1106 Appendicitis  540-543	Both sexes	858
Santa Cruz de Tenerife	Group 1106 Appendicitis  540-543	Men	517
Santa Cruz de Tenerife	Group 1106 Appendicitis  540-543	Women	341
Santa Cruz de Tenerife	Group 1107 Inguinal hernia  550	Both sexes	1.446
Santa Cruz de Tenerife	Group 1107 Inguinal hernia  550	Men	1.299
Santa Cruz de Tenerife	Group 1107 Inguinal hernia  550	Women	147
Santa Cruz de Tenerife	Group 1108 Other abdominal hernia  551-553	Both sexes	1.182
Santa Cruz de Tenerife	Group 1108 Other abdominal hernia  551-553	Men	634
Santa Cruz de Tenerife	Group 1108 Other abdominal hernia  551-553	Women	548
Santa Cruz de Tenerife	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	219
Santa Cruz de Tenerife	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	100
Santa Cruz de Tenerife	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	119
Santa Cruz de Tenerife	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.180
Santa Cruz de Tenerife	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	527
Santa Cruz de Tenerife	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	653
Santa Cruz de Tenerife	Group 1111 Intestinal obstruction without hernia 560	Both sexes	429
Santa Cruz de Tenerife	Group 1111 Intestinal obstruction without hernia 560	Men	218
Santa Cruz de Tenerife	Group 1111 Intestinal obstruction without hernia 560	Women	211
Santa Cruz de Tenerife	Group 1112 Intestinal diverticulosis 562	Both sexes	565
Santa Cruz de Tenerife	Group 1112 Intestinal diverticulosis 562	Men	281
Santa Cruz de Tenerife	Group 1112 Intestinal diverticulosis 562	Women	284
Santa Cruz de Tenerife	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	700
Santa Cruz de Tenerife	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	453
Santa Cruz de Tenerife	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	247
Santa Cruz de Tenerife	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	437
Santa Cruz de Tenerife	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	190
Santa Cruz de Tenerife	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	247
Santa Cruz de Tenerife	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	415
Santa Cruz de Tenerife	Group 1115 Alcoholic hepatitis 5710-5713	Men	364
Santa Cruz de Tenerife	Group 1115 Alcoholic hepatitis 5710-5713	Women	51
Santa Cruz de Tenerife	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	396
Santa Cruz de Tenerife	Group 1116 Other diseases of the liver 570,5714-573	Men	213
Santa Cruz de Tenerife	Group 1116 Other diseases of the liver 570,5714-573	Women	183
Santa Cruz de Tenerife	Group 1117 Cholelithiasis  574	Both sexes	2.019
Santa Cruz de Tenerife	Group 1117 Cholelithiasis  574	Men	774
Santa Cruz de Tenerife	Group 1117 Cholelithiasis  574	Women	1.245
Santa Cruz de Tenerife	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	570
Santa Cruz de Tenerife	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	234
Santa Cruz de Tenerife	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	336
Santa Cruz de Tenerife	Group 1119 Pancreatic diseases 577	Both sexes	489
Santa Cruz de Tenerife	Group 1119 Pancreatic diseases 577	Men	254
Santa Cruz de Tenerife	Group 1119 Pancreatic diseases 577	Women	235
Santa Cruz de Tenerife	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	362
Santa Cruz de Tenerife	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	190
Santa Cruz de Tenerife	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	172
Santa Cruz de Tenerife	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.483
Santa Cruz de Tenerife	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	815
Santa Cruz de Tenerife	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	668
Santa Cruz de Tenerife	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.088
Santa Cruz de Tenerife	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	635
Santa Cruz de Tenerife	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	453
Santa Cruz de Tenerife	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	64
Santa Cruz de Tenerife	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	33
Santa Cruz de Tenerife	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	31
Santa Cruz de Tenerife	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	331
Santa Cruz de Tenerife	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	147
Santa Cruz de Tenerife	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	184
Santa Cruz de Tenerife	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.699
Santa Cruz de Tenerife	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.188
Santa Cruz de Tenerife	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.511
Santa Cruz de Tenerife	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Santa Cruz de Tenerife	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Santa Cruz de Tenerife	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Santa Cruz de Tenerife	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Santa Cruz de Tenerife	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Santa Cruz de Tenerife	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Santa Cruz de Tenerife	Group 1303 Internal derangement of knee 717	Both sexes	1.083
Santa Cruz de Tenerife	Group 1303 Internal derangement of knee 717	Men	685
Santa Cruz de Tenerife	Group 1303 Internal derangement of knee 717	Women	398
Santa Cruz de Tenerife	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.565
Santa Cruz de Tenerife	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.011
Santa Cruz de Tenerife	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.554
Santa Cruz de Tenerife	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	95
Santa Cruz de Tenerife	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	27
Santa Cruz de Tenerife	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	68
Santa Cruz de Tenerife	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	302
Santa Cruz de Tenerife	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	165
Santa Cruz de Tenerife	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	137
Santa Cruz de Tenerife	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	703
Santa Cruz de Tenerife	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	364
Santa Cruz de Tenerife	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	339
Santa Cruz de Tenerife	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	166
Santa Cruz de Tenerife	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	75
Santa Cruz de Tenerife	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	91
Santa Cruz de Tenerife	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.011
Santa Cruz de Tenerife	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	539
Santa Cruz de Tenerife	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	472
Santa Cruz de Tenerife	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	774
Santa Cruz de Tenerife	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	322
Santa Cruz de Tenerife	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	452
Santa Cruz de Tenerife	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.614
Santa Cruz de Tenerife	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.113
Santa Cruz de Tenerife	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.500
Santa Cruz de Tenerife	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	465
Santa Cruz de Tenerife	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	171
Santa Cruz de Tenerife	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	294
Santa Cruz de Tenerife	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	288
Santa Cruz de Tenerife	Group 1402 Renal failure  5836-5837, 584-586	Men	166
Santa Cruz de Tenerife	Group 1402 Renal failure  5836-5837, 584-586	Women	122
Santa Cruz de Tenerife	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	675
Santa Cruz de Tenerife	Group 1403 Urolithiasis  592, 594, 7880	Men	383
Santa Cruz de Tenerife	Group 1403 Urolithiasis  592, 594, 7880	Women	292
Santa Cruz de Tenerife	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.787
Santa Cruz de Tenerife	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	738
Santa Cruz de Tenerife	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.049
Santa Cruz de Tenerife	Group 1405 Prostatic hyperplasia  600	Both sexes	303
Santa Cruz de Tenerife	Group 1405 Prostatic hyperplasia  600	Men	303
Santa Cruz de Tenerife	Group 1405 Prostatic hyperplasia  600	Women	..
Santa Cruz de Tenerife	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	292
Santa Cruz de Tenerife	Group 1406 Other diseases of the male genital organs    601-608	Men	292
Santa Cruz de Tenerife	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Santa Cruz de Tenerife	Group 1407 Disorders of breast  610-612	Both sexes	384
Santa Cruz de Tenerife	Group 1407 Disorders of breast  610-612	Men	50
Santa Cruz de Tenerife	Group 1407 Disorders of breast  610-612	Women	334
Santa Cruz de Tenerife	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	267
Santa Cruz de Tenerife	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Santa Cruz de Tenerife	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	267
Santa Cruz de Tenerife	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	80
Santa Cruz de Tenerife	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Santa Cruz de Tenerife	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	80
Santa Cruz de Tenerife	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.072
Santa Cruz de Tenerife	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	10
Santa Cruz de Tenerife	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.062
Santa Cruz de Tenerife	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.109
Santa Cruz de Tenerife	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Santa Cruz de Tenerife	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.109
Santa Cruz de Tenerife	Group 1501 Legally induced abortion  635	Both sexes	88
Santa Cruz de Tenerife	Group 1501 Legally induced abortion  635	Men	..
Santa Cruz de Tenerife	Group 1501 Legally induced abortion  635	Women	88
Santa Cruz de Tenerife	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	513
Santa Cruz de Tenerife	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Santa Cruz de Tenerife	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	513
Santa Cruz de Tenerife	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.230
Santa Cruz de Tenerife	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Santa Cruz de Tenerife	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.230
Santa Cruz de Tenerife	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.314
Santa Cruz de Tenerife	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Santa Cruz de Tenerife	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.314
Santa Cruz de Tenerife	Group 1505 Single spontaneous delivery  650	Both sexes	201
Santa Cruz de Tenerife	Group 1505 Single spontaneous delivery  650	Men	..
Santa Cruz de Tenerife	Group 1505 Single spontaneous delivery  650	Women	201
Santa Cruz de Tenerife	Group 1506 Other deliveries  6695-6697	Both sexes	25
Santa Cruz de Tenerife	Group 1506 Other deliveries  6695-6697	Men	..
Santa Cruz de Tenerife	Group 1506 Other deliveries  6695-6697	Women	25
Santa Cruz de Tenerife	Group 1507 Complications related to the puerperium  670-676	Both sexes	47
Santa Cruz de Tenerife	Group 1507 Complications related to the puerperium  670-676	Men	..
Santa Cruz de Tenerife	Group 1507 Complications related to the puerperium  670-676	Women	47
Santa Cruz de Tenerife	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	691
Santa Cruz de Tenerife	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Santa Cruz de Tenerife	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	691
Santa Cruz de Tenerife	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.207
Santa Cruz de Tenerife	Group 1600 Some disorders originating in the perinatal period  760-779	Men	669
Santa Cruz de Tenerife	Group 1600 Some disorders originating in the perinatal period  760-779	Women	538
Santa Cruz de Tenerife	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	357
Santa Cruz de Tenerife	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	176
Santa Cruz de Tenerife	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	181
Santa Cruz de Tenerife	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	850
Santa Cruz de Tenerife	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	493
Santa Cruz de Tenerife	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	357
Santa Cruz de Tenerife	Grupo 1700 Congenital abnormalities  740-759	Both sexes	641
Santa Cruz de Tenerife	Grupo 1700 Congenital abnormalities  740-759	Men	362
Santa Cruz de Tenerife	Grupo 1700 Congenital abnormalities  740-759	Women	279
Santa Cruz de Tenerife	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.761
Santa Cruz de Tenerife	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.984
Santa Cruz de Tenerife	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.777
Santa Cruz de Tenerife	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	524
Santa Cruz de Tenerife	Group 1801 Pain in throat and chest 7841, 7865	Men	296
Santa Cruz de Tenerife	Group 1801 Pain in throat and chest 7841, 7865	Women	228
Santa Cruz de Tenerife	Group 1802 Abdominal pain   7890	Both sexes	424
Santa Cruz de Tenerife	Group 1802 Abdominal pain   7890	Men	173
Santa Cruz de Tenerife	Group 1802 Abdominal pain   7890	Women	251
Santa Cruz de Tenerife	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	247
Santa Cruz de Tenerife	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	111
Santa Cruz de Tenerife	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	136
Santa Cruz de Tenerife	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.566
Santa Cruz de Tenerife	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.404
Santa Cruz de Tenerife	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.162
Santa Cruz de Tenerife	Group 1900 Injuries and poisoning  800-999	Both sexes	9.494
Santa Cruz de Tenerife	Group 1900 Injuries and poisoning  800-999	Men	4.991
Santa Cruz de Tenerife	Group 1900 Injuries and poisoning  800-999	Women	4.503
Santa Cruz de Tenerife	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	567
Santa Cruz de Tenerife	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	331
Santa Cruz de Tenerife	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	236
Santa Cruz de Tenerife	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	493
Santa Cruz de Tenerife	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	327
Santa Cruz de Tenerife	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	166
Santa Cruz de Tenerife	Group 1903 Radius and ulna fracture 813	Both sexes	827
Santa Cruz de Tenerife	Group 1903 Radius and ulna fracture 813	Men	339
Santa Cruz de Tenerife	Group 1903 Radius and ulna fracture 813	Women	488
Santa Cruz de Tenerife	Group 1904 Femur fracture  820-821	Both sexes	1.090
Santa Cruz de Tenerife	Group 1904 Femur fracture  820-821	Men	312
Santa Cruz de Tenerife	Group 1904 Femur fracture  820-821	Women	778
Santa Cruz de Tenerife	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	852
Santa Cruz de Tenerife	Group 1905 Leg fracture, including the ankle 823-824	Men	378
Santa Cruz de Tenerife	Group 1905 Leg fracture, including the ankle 823-824	Women	474
Santa Cruz de Tenerife	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.664
Santa Cruz de Tenerife	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.603
Santa Cruz de Tenerife	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.061
Santa Cruz de Tenerife	Group 1907 Burns  940-949	Both sexes	72
Santa Cruz de Tenerife	Group 1907 Burns  940-949	Men	46
Santa Cruz de Tenerife	Group 1907 Burns  940-949	Women	26
Santa Cruz de Tenerife	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	154
Santa Cruz de Tenerife	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	78
Santa Cruz de Tenerife	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	76
Santa Cruz de Tenerife	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.508
Santa Cruz de Tenerife	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.439
Santa Cruz de Tenerife	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.069
Santa Cruz de Tenerife	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	19
Santa Cruz de Tenerife	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	14
Santa Cruz de Tenerife	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
Santa Cruz de Tenerife	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	248
Santa Cruz de Tenerife	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	124
Santa Cruz de Tenerife	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	124
Santa Cruz de Tenerife	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.580
Santa Cruz de Tenerife	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.045
Santa Cruz de Tenerife	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.535
Santa Cruz de Tenerife	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	160
Santa Cruz de Tenerife	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	83
Santa Cruz de Tenerife	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	77
Santa Cruz de Tenerife	Group 2102 Contraceptive management  V25	Both sexes	147
Santa Cruz de Tenerife	Group 2102 Contraceptive management  V25	Men	3
Santa Cruz de Tenerife	Group 2102 Contraceptive management  V25	Women	144
Santa Cruz de Tenerife	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Santa Cruz de Tenerife	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Santa Cruz de Tenerife	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Santa Cruz de Tenerife	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	913
Santa Cruz de Tenerife	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	539
Santa Cruz de Tenerife	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	374
Santa Cruz de Tenerife	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.360
Santa Cruz de Tenerife	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	420
Santa Cruz de Tenerife	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	940
CANTABRIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	59.985
CANTABRIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	29.323
CANTABRIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	30.662
CANTABRIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.349
CANTABRIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	738
CANTABRIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	611
CANTABRIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	150
CANTABRIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	80
CANTABRIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	70
CANTABRIA	Group 0102 Imprecise intestinal infections 009	Both sexes	39
CANTABRIA	Group 0102 Imprecise intestinal infections 009	Men	23
CANTABRIA	Group 0102 Imprecise intestinal infections 009	Women	16
CANTABRIA	Group 0103 Tuberculosis 010-018, 137	Both sexes	54
CANTABRIA	Group 0103 Tuberculosis 010-018, 137	Men	31
CANTABRIA	Group 0103 Tuberculosis 010-018, 137	Women	23
CANTABRIA	Group 0104 Septicaemia  038	Both sexes	750
CANTABRIA	Group 0104 Septicaemia  038	Men	392
CANTABRIA	Group 0104 Septicaemia  038	Women	358
CANTABRIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	23
CANTABRIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	18
CANTABRIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	5
CANTABRIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	333
CANTABRIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	194
CANTABRIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	139
CANTABRIA	Group 0200 Neoplasms  140-239	Both sexes	5.617
CANTABRIA	Group 0200 Neoplasms  140-239	Men	3.003
CANTABRIA	Group 0200 Neoplasms  140-239	Women	2.614
CANTABRIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	591
CANTABRIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	380
CANTABRIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	211
CANTABRIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	421
CANTABRIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	346
CANTABRIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	75
CANTABRIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	97
CANTABRIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	45
CANTABRIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	52
CANTABRIA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	394
CANTABRIA	Group 0204 Malignant neoplasm of breast  174-175	Men	4
CANTABRIA	Group 0204 Malignant neoplasm of breast  174-175	Women	390
CANTABRIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	96
CANTABRIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CANTABRIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	96
CANTABRIA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	60
CANTABRIA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CANTABRIA	Group 0206 Malignant neoplasm of ovary  1830	Women	60
CANTABRIA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	140
CANTABRIA	Group 0207 Malignant neoplasm of prostate  185	Men	140
CANTABRIA	Group 0207 Malignant neoplasm of prostate  185	Women	..
CANTABRIA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	452
CANTABRIA	Group 0208 Malignant neoplasm of bladder  188	Men	381
CANTABRIA	Group 0208 Malignant neoplasm of bladder  188	Women	71
CANTABRIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.005
CANTABRIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.211
CANTABRIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	794
CANTABRIA	Group 0210 Carcinoma in situ  230-234	Both sexes	97
CANTABRIA	Group 0210 Carcinoma in situ  230-234	Men	39
CANTABRIA	Group 0210 Carcinoma in situ  230-234	Women	58
CANTABRIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	88
CANTABRIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	53
CANTABRIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	35
CANTABRIA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	230
CANTABRIA	Grupo 0212 Leiomyoma of uterus  218	Men	..
CANTABRIA	Grupo 0212 Leiomyoma of uterus  218	Women	230
CANTABRIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	946
CANTABRIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	404
CANTABRIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	542
CANTABRIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	689
CANTABRIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	357
CANTABRIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	332
CANTABRIA	Group 0301 Anaemias 280-285	Both sexes	459
CANTABRIA	Group 0301 Anaemias 280-285	Men	218
CANTABRIA	Group 0301 Anaemias 280-285	Women	241
CANTABRIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	230
CANTABRIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	139
CANTABRIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	91
CANTABRIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.089
CANTABRIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	443
CANTABRIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	646
CANTABRIA	Group 0401 Diabetes mellitus  249-250	Both sexes	329
CANTABRIA	Group 0401 Diabetes mellitus  249-250	Men	194
CANTABRIA	Group 0401 Diabetes mellitus  249-250	Women	135
CANTABRIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	760
CANTABRIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	249
CANTABRIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	511
CANTABRIA	Group 0500 Mental disorders  290-319	Both sexes	1.153
CANTABRIA	Group 0500 Mental disorders  290-319	Men	566
CANTABRIA	Group 0500 Mental disorders  290-319	Women	587
CANTABRIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	75
CANTABRIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	31
CANTABRIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	44
CANTABRIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	94
CANTABRIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	71
CANTABRIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	23
CANTABRIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	69
CANTABRIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	34
CANTABRIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	35
CANTABRIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	306
CANTABRIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	160
CANTABRIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	146
CANTABRIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	244
CANTABRIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	89
CANTABRIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	155
CANTABRIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	365
CANTABRIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	181
CANTABRIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	184
CANTABRIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.205
CANTABRIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	604
CANTABRIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	601
CANTABRIA	Group 0601 Alzheimer's disease  3310	Both sexes	44
CANTABRIA	Group 0601 Alzheimer's disease  3310	Men	14
CANTABRIA	Group 0601 Alzheimer's disease  3310	Women	30
CANTABRIA	Group 0602 Multiple sclerosis 340	Both sexes	12
CANTABRIA	Group 0602 Multiple sclerosis 340	Men	4
CANTABRIA	Group 0602 Multiple sclerosis 340	Women	8
CANTABRIA	Group 0603 Epilepsy  345	Both sexes	178
CANTABRIA	Group 0603 Epilepsy  345	Men	110
CANTABRIA	Group 0603 Epilepsy  345	Women	68
CANTABRIA	Group 0604 Transient cerebral ischemia 435	Both sexes	197
CANTABRIA	Group 0604 Transient cerebral ischemia 435	Men	99
CANTABRIA	Group 0604 Transient cerebral ischemia 435	Women	98
CANTABRIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	774
CANTABRIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	377
CANTABRIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	397
CANTABRIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	209
CANTABRIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	101
CANTABRIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	108
CANTABRIA	Grupo 0701 Cataract  366	Both sexes	42
CANTABRIA	Grupo 0701 Cataract  366	Men	20
CANTABRIA	Grupo 0701 Cataract  366	Women	22
CANTABRIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	167
CANTABRIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	81
CANTABRIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	86
CANTABRIA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	283
CANTABRIA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	132
CANTABRIA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	151
CANTABRIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.634
CANTABRIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.979
CANTABRIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.655
CANTABRIA	Group 0901 Hypertensive disease  401-405	Both sexes	453
CANTABRIA	Group 0901 Hypertensive disease  401-405	Men	207
CANTABRIA	Group 0901 Hypertensive disease  401-405	Women	246
CANTABRIA	Group 0902 Angina pectoris  4111, 413	Both sexes	392
CANTABRIA	Group 0902 Angina pectoris  4111, 413	Men	235
CANTABRIA	Group 0902 Angina pectoris  4111, 413	Women	157
CANTABRIA	Group 0903 Acute myocardial infarction  410	Both sexes	647
CANTABRIA	Group 0903 Acute myocardial infarction  410	Men	445
CANTABRIA	Group 0903 Acute myocardial infarction  410	Women	202
CANTABRIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	613
CANTABRIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	459
CANTABRIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	154
CANTABRIA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	273
CANTABRIA	Group 0905 Diseases of the lungs circulation 415-417	Men	116
CANTABRIA	Group 0905 Diseases of the lungs circulation 415-417	Women	157
CANTABRIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.287
CANTABRIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	727
CANTABRIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	560
CANTABRIA	Grupo 0907 Heart failure  428	Both sexes	1.367
CANTABRIA	Grupo 0907 Heart failure  428	Men	721
CANTABRIA	Grupo 0907 Heart failure  428	Women	646
CANTABRIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.510
CANTABRIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	784
CANTABRIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	726
CANTABRIA	Grupo 0909 Atherosclerosis  440	Both sexes	453
CANTABRIA	Grupo 0909 Atherosclerosis  440	Men	355
CANTABRIA	Grupo 0909 Atherosclerosis  440	Women	98
CANTABRIA	Group 0910 Varicose veins of lower extremities 454	Both sexes	57
CANTABRIA	Group 0910 Varicose veins of lower extremities 454	Men	24
CANTABRIA	Group 0910 Varicose veins of lower extremities 454	Women	33
CANTABRIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.582
CANTABRIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	906
CANTABRIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	676
CANTABRIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.036
CANTABRIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.004
CANTABRIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.032
CANTABRIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	369
CANTABRIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	195
CANTABRIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	174
CANTABRIA	Group 1002 Pneumonia 480-486	Both sexes	1.335
CANTABRIA	Group 1002 Pneumonia 480-486	Men	804
CANTABRIA	Group 1002 Pneumonia 480-486	Women	531
CANTABRIA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	248
CANTABRIA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	122
CANTABRIA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	126
CANTABRIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	568
CANTABRIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	287
CANTABRIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	281
CANTABRIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	362
CANTABRIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	247
CANTABRIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	115
CANTABRIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.405
CANTABRIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.035
CANTABRIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	370
CANTABRIA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	482
CANTABRIA	Group 1007 Asthma 4930-4931,4938-4939	Men	189
CANTABRIA	Group 1007 Asthma 4930-4931,4938-4939	Women	293
CANTABRIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.267
CANTABRIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.125
CANTABRIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.142
CANTABRIA	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.726
CANTABRIA	Group 1100 Diseases of the digestive system  520-579	Men	3.688
CANTABRIA	Group 1100 Diseases of the digestive system  520-579	Women	3.038
CANTABRIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	52
CANTABRIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	24
CANTABRIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	28
CANTABRIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	91
CANTABRIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	45
CANTABRIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	46
CANTABRIA	Group 1103 Diseases of the esophagus 530	Both sexes	128
CANTABRIA	Group 1103 Diseases of the esophagus 530	Men	80
CANTABRIA	Group 1103 Diseases of the esophagus 530	Women	48
CANTABRIA	Group 1104 Peptic ulcer 531-534	Both sexes	180
CANTABRIA	Group 1104 Peptic ulcer 531-534	Men	117
CANTABRIA	Group 1104 Peptic ulcer 531-534	Women	63
CANTABRIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	145
CANTABRIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	82
CANTABRIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	63
CANTABRIA	Group 1106 Appendicitis  540-543	Both sexes	650
CANTABRIA	Group 1106 Appendicitis  540-543	Men	385
CANTABRIA	Group 1106 Appendicitis  540-543	Women	265
CANTABRIA	Group 1107 Inguinal hernia  550	Both sexes	484
CANTABRIA	Group 1107 Inguinal hernia  550	Men	414
CANTABRIA	Group 1107 Inguinal hernia  550	Women	70
CANTABRIA	Group 1108 Other abdominal hernia  551-553	Both sexes	493
CANTABRIA	Group 1108 Other abdominal hernia  551-553	Men	236
CANTABRIA	Group 1108 Other abdominal hernia  551-553	Women	257
CANTABRIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	186
CANTABRIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	99
CANTABRIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	87
CANTABRIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	307
CANTABRIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	155
CANTABRIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	152
CANTABRIA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	330
CANTABRIA	Group 1111 Intestinal obstruction without hernia 560	Men	159
CANTABRIA	Group 1111 Intestinal obstruction without hernia 560	Women	171
CANTABRIA	Group 1112 Intestinal diverticulosis 562	Both sexes	346
CANTABRIA	Group 1112 Intestinal diverticulosis 562	Men	160
CANTABRIA	Group 1112 Intestinal diverticulosis 562	Women	186
CANTABRIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	276
CANTABRIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	180
CANTABRIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	96
CANTABRIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	248
CANTABRIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	108
CANTABRIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	140
CANTABRIA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	121
CANTABRIA	Group 1115 Alcoholic hepatitis 5710-5713	Men	98
CANTABRIA	Group 1115 Alcoholic hepatitis 5710-5713	Women	23
CANTABRIA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	247
CANTABRIA	Group 1116 Other diseases of the liver 570,5714-573	Men	149
CANTABRIA	Group 1116 Other diseases of the liver 570,5714-573	Women	98
CANTABRIA	Group 1117 Cholelithiasis  574	Both sexes	1.366
CANTABRIA	Group 1117 Cholelithiasis  574	Men	606
CANTABRIA	Group 1117 Cholelithiasis  574	Women	760
CANTABRIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	362
CANTABRIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	207
CANTABRIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	155
CANTABRIA	Group 1119 Pancreatic diseases 577	Both sexes	402
CANTABRIA	Group 1119 Pancreatic diseases 577	Men	228
CANTABRIA	Group 1119 Pancreatic diseases 577	Women	174
CANTABRIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	312
CANTABRIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	156
CANTABRIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	156
CANTABRIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	581
CANTABRIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	312
CANTABRIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	269
CANTABRIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	317
CANTABRIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	191
CANTABRIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	126
CANTABRIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	24
CANTABRIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
CANTABRIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	12
CANTABRIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	240
CANTABRIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	109
CANTABRIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	131
CANTABRIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.653
CANTABRIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.216
CANTABRIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.437
CANTABRIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CANTABRIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CANTABRIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CANTABRIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CANTABRIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CANTABRIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CANTABRIA	Group 1303 Internal derangement of knee 717	Both sexes	424
CANTABRIA	Group 1303 Internal derangement of knee 717	Men	287
CANTABRIA	Group 1303 Internal derangement of knee 717	Women	137
CANTABRIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.250
CANTABRIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.060
CANTABRIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.190
CANTABRIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	88
CANTABRIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	35
CANTABRIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	53
CANTABRIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	80
CANTABRIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	46
CANTABRIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	34
CANTABRIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	197
CANTABRIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	114
CANTABRIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	83
CANTABRIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	40
CANTABRIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	21
CANTABRIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	19
CANTABRIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	584
CANTABRIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	330
CANTABRIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	254
CANTABRIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	990
CANTABRIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	323
CANTABRIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	667
CANTABRIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.204
CANTABRIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.546
CANTABRIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.658
CANTABRIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	297
CANTABRIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	125
CANTABRIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	172
CANTABRIA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	267
CANTABRIA	Group 1402 Renal failure  5836-5837, 584-586	Men	139
CANTABRIA	Group 1402 Renal failure  5836-5837, 584-586	Women	128
CANTABRIA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	400
CANTABRIA	Group 1403 Urolithiasis  592, 594, 7880	Men	259
CANTABRIA	Group 1403 Urolithiasis  592, 594, 7880	Women	141
CANTABRIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	904
CANTABRIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	427
CANTABRIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	477
CANTABRIA	Group 1405 Prostatic hyperplasia  600	Both sexes	237
CANTABRIA	Group 1405 Prostatic hyperplasia  600	Men	237
CANTABRIA	Group 1405 Prostatic hyperplasia  600	Women	..
CANTABRIA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	347
CANTABRIA	Group 1406 Other diseases of the male genital organs    601-608	Men	347
CANTABRIA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CANTABRIA	Group 1407 Disorders of breast  610-612	Both sexes	92
CANTABRIA	Group 1407 Disorders of breast  610-612	Men	11
CANTABRIA	Group 1407 Disorders of breast  610-612	Women	81
CANTABRIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	108
CANTABRIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CANTABRIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	108
CANTABRIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	79
CANTABRIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CANTABRIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	79
CANTABRIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	473
CANTABRIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
CANTABRIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	472
CANTABRIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.340
CANTABRIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CANTABRIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.340
CANTABRIA	Group 1501 Legally induced abortion  635	Both sexes	2
CANTABRIA	Group 1501 Legally induced abortion  635	Men	..
CANTABRIA	Group 1501 Legally induced abortion  635	Women	2
CANTABRIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	528
CANTABRIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CANTABRIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	528
CANTABRIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.488
CANTABRIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CANTABRIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.488
CANTABRIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	655
CANTABRIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CANTABRIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	655
CANTABRIA	Group 1505 Single spontaneous delivery  650	Both sexes	119
CANTABRIA	Group 1505 Single spontaneous delivery  650	Men	..
CANTABRIA	Group 1505 Single spontaneous delivery  650	Women	119
CANTABRIA	Group 1506 Other deliveries  6695-6697	Both sexes	67
CANTABRIA	Group 1506 Other deliveries  6695-6697	Men	..
CANTABRIA	Group 1506 Other deliveries  6695-6697	Women	67
CANTABRIA	Group 1507 Complications related to the puerperium  670-676	Both sexes	57
CANTABRIA	Group 1507 Complications related to the puerperium  670-676	Men	..
CANTABRIA	Group 1507 Complications related to the puerperium  670-676	Women	57
CANTABRIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	424
CANTABRIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CANTABRIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	424
CANTABRIA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	673
CANTABRIA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	372
CANTABRIA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	301
CANTABRIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	144
CANTABRIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	74
CANTABRIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	70
CANTABRIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	529
CANTABRIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	298
CANTABRIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	231
CANTABRIA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	486
CANTABRIA	Grupo 1700 Congenital abnormalities  740-759	Men	310
CANTABRIA	Grupo 1700 Congenital abnormalities  740-759	Women	176
CANTABRIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.167
CANTABRIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.602
CANTABRIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.565
CANTABRIA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	369
CANTABRIA	Group 1801 Pain in throat and chest 7841, 7865	Men	210
CANTABRIA	Group 1801 Pain in throat and chest 7841, 7865	Women	159
CANTABRIA	Group 1802 Abdominal pain   7890	Both sexes	188
CANTABRIA	Group 1802 Abdominal pain   7890	Men	72
CANTABRIA	Group 1802 Abdominal pain   7890	Women	116
CANTABRIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	924
CANTABRIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	452
CANTABRIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	472
CANTABRIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.686
CANTABRIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	868
CANTABRIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	818
CANTABRIA	Group 1900 Injuries and poisoning  800-999	Both sexes	6.876
CANTABRIA	Group 1900 Injuries and poisoning  800-999	Men	3.734
CANTABRIA	Group 1900 Injuries and poisoning  800-999	Women	3.142
CANTABRIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	309
CANTABRIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	178
CANTABRIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	131
CANTABRIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	135
CANTABRIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	100
CANTABRIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	35
CANTABRIA	Group 1903 Radius and ulna fracture 813	Both sexes	408
CANTABRIA	Group 1903 Radius and ulna fracture 813	Men	159
CANTABRIA	Group 1903 Radius and ulna fracture 813	Women	249
CANTABRIA	Group 1904 Femur fracture  820-821	Both sexes	850
CANTABRIA	Group 1904 Femur fracture  820-821	Men	240
CANTABRIA	Group 1904 Femur fracture  820-821	Women	610
CANTABRIA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	519
CANTABRIA	Group 1905 Leg fracture, including the ankle 823-824	Men	270
CANTABRIA	Group 1905 Leg fracture, including the ankle 823-824	Women	249
CANTABRIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.949
CANTABRIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.255
CANTABRIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	694
CANTABRIA	Group 1907 Burns  940-949	Both sexes	30
CANTABRIA	Group 1907 Burns  940-949	Men	16
CANTABRIA	Group 1907 Burns  940-949	Women	14
CANTABRIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	110
CANTABRIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	54
CANTABRIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	56
CANTABRIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.150
CANTABRIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.267
CANTABRIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	883
CANTABRIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	33
CANTABRIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	21
CANTABRIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	12
CANTABRIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	383
CANTABRIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	174
CANTABRIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	209
CANTABRIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.015
CANTABRIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	616
CANTABRIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	399
CANTABRIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	64
CANTABRIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	41
CANTABRIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	23
CANTABRIA	Group 2102 Contraceptive management  V25	Both sexes	4
CANTABRIA	Group 2102 Contraceptive management  V25	Men	..
CANTABRIA	Group 2102 Contraceptive management  V25	Women	4
CANTABRIA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CANTABRIA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CANTABRIA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CANTABRIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	464
CANTABRIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	296
CANTABRIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	168
CANTABRIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	483
CANTABRIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	279
CANTABRIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	204
CASTILLA Y LEËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	269.748
CASTILLA Y LEËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	134.989
CASTILLA Y LEËN	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	134.759
CASTILLA Y LEËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	5.783
CASTILLA Y LEËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	3.210
CASTILLA Y LEËN	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.573
CASTILLA Y LEËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.040
CASTILLA Y LEËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	544
CASTILLA Y LEËN	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	496
CASTILLA Y LEËN	Group 0102 Imprecise intestinal infections 009	Both sexes	368
CASTILLA Y LEËN	Group 0102 Imprecise intestinal infections 009	Men	163
CASTILLA Y LEËN	Group 0102 Imprecise intestinal infections 009	Women	205
CASTILLA Y LEËN	Group 0103 Tuberculosis 010-018, 137	Both sexes	202
CASTILLA Y LEËN	Group 0103 Tuberculosis 010-018, 137	Men	123
CASTILLA Y LEËN	Group 0103 Tuberculosis 010-018, 137	Women	79
CASTILLA Y LEËN	Group 0104 Septicaemia  038	Both sexes	2.555
CASTILLA Y LEËN	Group 0104 Septicaemia  038	Men	1.426
CASTILLA Y LEËN	Group 0104 Septicaemia  038	Women	1.129
CASTILLA Y LEËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	113
CASTILLA Y LEËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	88
CASTILLA Y LEËN	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	25
CASTILLA Y LEËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.505
CASTILLA Y LEËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	866
CASTILLA Y LEËN	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	639
CASTILLA Y LEËN	Group 0200 Neoplasms  140-239	Both sexes	28.102
CASTILLA Y LEËN	Group 0200 Neoplasms  140-239	Men	15.293
CASTILLA Y LEËN	Group 0200 Neoplasms  140-239	Women	12.809
CASTILLA Y LEËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	3.360
CASTILLA Y LEËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	2.053
CASTILLA Y LEËN	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.307
CASTILLA Y LEËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	2.122
CASTILLA Y LEËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.674
CASTILLA Y LEËN	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	448
CASTILLA Y LEËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	622
CASTILLA Y LEËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	345
CASTILLA Y LEËN	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	277
CASTILLA Y LEËN	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.838
CASTILLA Y LEËN	Group 0204 Malignant neoplasm of breast  174-175	Men	20
CASTILLA Y LEËN	Group 0204 Malignant neoplasm of breast  174-175	Women	1.818
CASTILLA Y LEËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	441
CASTILLA Y LEËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CASTILLA Y LEËN	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	441
CASTILLA Y LEËN	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	318
CASTILLA Y LEËN	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CASTILLA Y LEËN	Group 0206 Malignant neoplasm of ovary  1830	Women	318
CASTILLA Y LEËN	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.149
CASTILLA Y LEËN	Group 0207 Malignant neoplasm of prostate  185	Men	1.149
CASTILLA Y LEËN	Group 0207 Malignant neoplasm of prostate  185	Women	..
CASTILLA Y LEËN	Group 0208 Malignant neoplasm of bladder  188	Both sexes	2.468
CASTILLA Y LEËN	Group 0208 Malignant neoplasm of bladder  188	Men	2.077
CASTILLA Y LEËN	Group 0208 Malignant neoplasm of bladder  188	Women	391
CASTILLA Y LEËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	10.138
CASTILLA Y LEËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	6.012
CASTILLA Y LEËN	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	4.126
CASTILLA Y LEËN	Group 0210 Carcinoma in situ  230-234	Both sexes	527
CASTILLA Y LEËN	Group 0210 Carcinoma in situ  230-234	Men	203
CASTILLA Y LEËN	Group 0210 Carcinoma in situ  230-234	Women	324
CASTILLA Y LEËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	257
CASTILLA Y LEËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	157
CASTILLA Y LEËN	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	100
CASTILLA Y LEËN	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.063
CASTILLA Y LEËN	Grupo 0212 Leiomyoma of uterus  218	Men	..
CASTILLA Y LEËN	Grupo 0212 Leiomyoma of uterus  218	Women	1.063
CASTILLA Y LEËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.799
CASTILLA Y LEËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.603
CASTILLA Y LEËN	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	2.196
CASTILLA Y LEËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.685
CASTILLA Y LEËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.299
CASTILLA Y LEËN	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.386
CASTILLA Y LEËN	Group 0301 Anaemias 280-285	Both sexes	1.755
CASTILLA Y LEËN	Group 0301 Anaemias 280-285	Men	825
CASTILLA Y LEËN	Group 0301 Anaemias 280-285	Women	930
CASTILLA Y LEËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	930
CASTILLA Y LEËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	474
CASTILLA Y LEËN	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	456
CASTILLA Y LEËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	4.932
CASTILLA Y LEËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	2.021
CASTILLA Y LEËN	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.911
CASTILLA Y LEËN	Group 0401 Diabetes mellitus  249-250	Both sexes	1.805
CASTILLA Y LEËN	Group 0401 Diabetes mellitus  249-250	Men	962
CASTILLA Y LEËN	Group 0401 Diabetes mellitus  249-250	Women	843
CASTILLA Y LEËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.127
CASTILLA Y LEËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	1.059
CASTILLA Y LEËN	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.068
CASTILLA Y LEËN	Group 0500 Mental disorders  290-319	Both sexes	6.392
CASTILLA Y LEËN	Group 0500 Mental disorders  290-319	Men	3.186
CASTILLA Y LEËN	Group 0500 Mental disorders  290-319	Women	3.206
CASTILLA Y LEËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	158
CASTILLA Y LEËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	76
CASTILLA Y LEËN	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	82
CASTILLA Y LEËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	485
CASTILLA Y LEËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	365
CASTILLA Y LEËN	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	120
CASTILLA Y LEËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	445
CASTILLA Y LEËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	351
CASTILLA Y LEËN	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	94
CASTILLA Y LEËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.652
CASTILLA Y LEËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	984
CASTILLA Y LEËN	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	668
CASTILLA Y LEËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.580
CASTILLA Y LEËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	499
CASTILLA Y LEËN	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.081
CASTILLA Y LEËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	2.072
CASTILLA Y LEËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	911
CASTILLA Y LEËN	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.161
CASTILLA Y LEËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.464
CASTILLA Y LEËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.648
CASTILLA Y LEËN	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.816
CASTILLA Y LEËN	Group 0601 Alzheimer's disease  3310	Both sexes	164
CASTILLA Y LEËN	Group 0601 Alzheimer's disease  3310	Men	59
CASTILLA Y LEËN	Group 0601 Alzheimer's disease  3310	Women	105
CASTILLA Y LEËN	Group 0602 Multiple sclerosis 340	Both sexes	191
CASTILLA Y LEËN	Group 0602 Multiple sclerosis 340	Men	77
CASTILLA Y LEËN	Group 0602 Multiple sclerosis 340	Women	114
CASTILLA Y LEËN	Group 0603 Epilepsy  345	Both sexes	831
CASTILLA Y LEËN	Group 0603 Epilepsy  345	Men	449
CASTILLA Y LEËN	Group 0603 Epilepsy  345	Women	382
CASTILLA Y LEËN	Group 0604 Transient cerebral ischemia 435	Both sexes	1.008
CASTILLA Y LEËN	Group 0604 Transient cerebral ischemia 435	Men	468
CASTILLA Y LEËN	Group 0604 Transient cerebral ischemia 435	Women	540
CASTILLA Y LEËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.270
CASTILLA Y LEËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.595
CASTILLA Y LEËN	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.675
CASTILLA Y LEËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.940
CASTILLA Y LEËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	964
CASTILLA Y LEËN	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	976
CASTILLA Y LEËN	Grupo 0701 Cataract  366	Both sexes	422
CASTILLA Y LEËN	Grupo 0701 Cataract  366	Men	204
CASTILLA Y LEËN	Grupo 0701 Cataract  366	Women	218
CASTILLA Y LEËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.518
CASTILLA Y LEËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	760
CASTILLA Y LEËN	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	758
CASTILLA Y LEËN	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.706
CASTILLA Y LEËN	Group 0800 Diseases of the ear and the mastoid  380-389	Men	843
CASTILLA Y LEËN	Group 0800 Diseases of the ear and the mastoid  380-389	Women	863
CASTILLA Y LEËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	37.863
CASTILLA Y LEËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	21.028
CASTILLA Y LEËN	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	16.835
CASTILLA Y LEËN	Group 0901 Hypertensive disease  401-405	Both sexes	2.288
CASTILLA Y LEËN	Group 0901 Hypertensive disease  401-405	Men	898
CASTILLA Y LEËN	Group 0901 Hypertensive disease  401-405	Women	1.390
CASTILLA Y LEËN	Group 0902 Angina pectoris  4111, 413	Both sexes	1.309
CASTILLA Y LEËN	Group 0902 Angina pectoris  4111, 413	Men	872
CASTILLA Y LEËN	Group 0902 Angina pectoris  4111, 413	Women	437
CASTILLA Y LEËN	Group 0903 Acute myocardial infarction  410	Both sexes	3.283
CASTILLA Y LEËN	Group 0903 Acute myocardial infarction  410	Men	2.361
CASTILLA Y LEËN	Group 0903 Acute myocardial infarction  410	Women	922
CASTILLA Y LEËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.785
CASTILLA Y LEËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.436
CASTILLA Y LEËN	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	349
CASTILLA Y LEËN	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.601
CASTILLA Y LEËN	Group 0905 Diseases of the lungs circulation 415-417	Men	741
CASTILLA Y LEËN	Group 0905 Diseases of the lungs circulation 415-417	Women	860
CASTILLA Y LEËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.768
CASTILLA Y LEËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.567
CASTILLA Y LEËN	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.201
CASTILLA Y LEËN	Grupo 0907 Heart failure  428	Both sexes	8.161
CASTILLA Y LEËN	Grupo 0907 Heart failure  428	Men	3.903
CASTILLA Y LEËN	Grupo 0907 Heart failure  428	Women	4.258
CASTILLA Y LEËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	6.149
CASTILLA Y LEËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	3.249
CASTILLA Y LEËN	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.900
CASTILLA Y LEËN	Grupo 0909 Atherosclerosis  440	Both sexes	1.228
CASTILLA Y LEËN	Grupo 0909 Atherosclerosis  440	Men	957
CASTILLA Y LEËN	Grupo 0909 Atherosclerosis  440	Women	271
CASTILLA Y LEËN	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.134
CASTILLA Y LEËN	Group 0910 Varicose veins of lower extremities 454	Men	460
CASTILLA Y LEËN	Group 0910 Varicose veins of lower extremities 454	Women	674
CASTILLA Y LEËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	6.157
CASTILLA Y LEËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.584
CASTILLA Y LEËN	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.573
CASTILLA Y LEËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	33.340
CASTILLA Y LEËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	19.626
CASTILLA Y LEËN	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	13.714
CASTILLA Y LEËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.459
CASTILLA Y LEËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	787
CASTILLA Y LEËN	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	672
CASTILLA Y LEËN	Group 1002 Pneumonia 480-486	Both sexes	6.953
CASTILLA Y LEËN	Group 1002 Pneumonia 480-486	Men	4.260
CASTILLA Y LEËN	Group 1002 Pneumonia 480-486	Women	2.693
CASTILLA Y LEËN	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.369
CASTILLA Y LEËN	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.145
CASTILLA Y LEËN	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.224
CASTILLA Y LEËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.874
CASTILLA Y LEËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.005
CASTILLA Y LEËN	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	869
CASTILLA Y LEËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	3.526
CASTILLA Y LEËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	2.319
CASTILLA Y LEËN	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	1.207
CASTILLA Y LEËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	5.583
CASTILLA Y LEËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	4.426
CASTILLA Y LEËN	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.157
CASTILLA Y LEËN	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.240
CASTILLA Y LEËN	Group 1007 Asthma 4930-4931,4938-4939	Men	387
CASTILLA Y LEËN	Group 1007 Asthma 4930-4931,4938-4939	Women	853
CASTILLA Y LEËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	10.336
CASTILLA Y LEËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	5.297
CASTILLA Y LEËN	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	5.039
CASTILLA Y LEËN	Group 1100 Diseases of the digestive system  520-579	Both sexes	36.280
CASTILLA Y LEËN	Group 1100 Diseases of the digestive system  520-579	Men	21.436
CASTILLA Y LEËN	Group 1100 Diseases of the digestive system  520-579	Women	14.844
CASTILLA Y LEËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	436
CASTILLA Y LEËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	214
CASTILLA Y LEËN	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	222
CASTILLA Y LEËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	478
CASTILLA Y LEËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	267
CASTILLA Y LEËN	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	211
CASTILLA Y LEËN	Group 1103 Diseases of the esophagus 530	Both sexes	606
CASTILLA Y LEËN	Group 1103 Diseases of the esophagus 530	Men	383
CASTILLA Y LEËN	Group 1103 Diseases of the esophagus 530	Women	223
CASTILLA Y LEËN	Group 1104 Peptic ulcer 531-534	Both sexes	776
CASTILLA Y LEËN	Group 1104 Peptic ulcer 531-534	Men	541
CASTILLA Y LEËN	Group 1104 Peptic ulcer 531-534	Women	235
CASTILLA Y LEËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	916
CASTILLA Y LEËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	464
CASTILLA Y LEËN	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	452
CASTILLA Y LEËN	Group 1106 Appendicitis  540-543	Both sexes	2.803
CASTILLA Y LEËN	Group 1106 Appendicitis  540-543	Men	1.603
CASTILLA Y LEËN	Group 1106 Appendicitis  540-543	Women	1.200
CASTILLA Y LEËN	Group 1107 Inguinal hernia  550	Both sexes	5.184
CASTILLA Y LEËN	Group 1107 Inguinal hernia  550	Men	4.704
CASTILLA Y LEËN	Group 1107 Inguinal hernia  550	Women	480
CASTILLA Y LEËN	Group 1108 Other abdominal hernia  551-553	Both sexes	2.898
CASTILLA Y LEËN	Group 1108 Other abdominal hernia  551-553	Men	1.450
CASTILLA Y LEËN	Group 1108 Other abdominal hernia  551-553	Women	1.448
CASTILLA Y LEËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	553
CASTILLA Y LEËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	305
CASTILLA Y LEËN	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	248
CASTILLA Y LEËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	2.198
CASTILLA Y LEËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.023
CASTILLA Y LEËN	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	1.175
CASTILLA Y LEËN	Group 1111 Intestinal obstruction without hernia 560	Both sexes	2.177
CASTILLA Y LEËN	Group 1111 Intestinal obstruction without hernia 560	Men	1.144
CASTILLA Y LEËN	Group 1111 Intestinal obstruction without hernia 560	Women	1.033
CASTILLA Y LEËN	Group 1112 Intestinal diverticulosis 562	Both sexes	1.528
CASTILLA Y LEËN	Group 1112 Intestinal diverticulosis 562	Men	746
CASTILLA Y LEËN	Group 1112 Intestinal diverticulosis 562	Women	782
CASTILLA Y LEËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.881
CASTILLA Y LEËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.212
CASTILLA Y LEËN	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	669
CASTILLA Y LEËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	1.418
CASTILLA Y LEËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	690
CASTILLA Y LEËN	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	728
CASTILLA Y LEËN	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	518
CASTILLA Y LEËN	Group 1115 Alcoholic hepatitis 5710-5713	Men	457
CASTILLA Y LEËN	Group 1115 Alcoholic hepatitis 5710-5713	Women	61
CASTILLA Y LEËN	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.108
CASTILLA Y LEËN	Group 1116 Other diseases of the liver 570,5714-573	Men	667
CASTILLA Y LEËN	Group 1116 Other diseases of the liver 570,5714-573	Women	441
CASTILLA Y LEËN	Group 1117 Cholelithiasis  574	Both sexes	6.135
CASTILLA Y LEËN	Group 1117 Cholelithiasis  574	Men	2.925
CASTILLA Y LEËN	Group 1117 Cholelithiasis  574	Women	3.210
CASTILLA Y LEËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.552
CASTILLA Y LEËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	911
CASTILLA Y LEËN	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	641
CASTILLA Y LEËN	Group 1119 Pancreatic diseases 577	Both sexes	1.573
CASTILLA Y LEËN	Group 1119 Pancreatic diseases 577	Men	904
CASTILLA Y LEËN	Group 1119 Pancreatic diseases 577	Women	669
CASTILLA Y LEËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.542
CASTILLA Y LEËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	826
CASTILLA Y LEËN	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	716
CASTILLA Y LEËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.825
CASTILLA Y LEËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.563
CASTILLA Y LEËN	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.262
CASTILLA Y LEËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.623
CASTILLA Y LEËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	982
CASTILLA Y LEËN	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	641
CASTILLA Y LEËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	132
CASTILLA Y LEËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	65
CASTILLA Y LEËN	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	67
CASTILLA Y LEËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	1.070
CASTILLA Y LEËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	516
CASTILLA Y LEËN	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	554
CASTILLA Y LEËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	16.992
CASTILLA Y LEËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	8.174
CASTILLA Y LEËN	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	8.818
CASTILLA Y LEËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA Y LEËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CASTILLA Y LEËN	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CASTILLA Y LEËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA Y LEËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CASTILLA Y LEËN	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CASTILLA Y LEËN	Group 1303 Internal derangement of knee 717	Both sexes	2.082
CASTILLA Y LEËN	Group 1303 Internal derangement of knee 717	Men	1.438
CASTILLA Y LEËN	Group 1303 Internal derangement of knee 717	Women	644
CASTILLA Y LEËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	6.560
CASTILLA Y LEËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	2.970
CASTILLA Y LEËN	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	3.590
CASTILLA Y LEËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	433
CASTILLA Y LEËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	148
CASTILLA Y LEËN	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	285
CASTILLA Y LEËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	856
CASTILLA Y LEËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	420
CASTILLA Y LEËN	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	436
CASTILLA Y LEËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.355
CASTILLA Y LEËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	732
CASTILLA Y LEËN	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	623
CASTILLA Y LEËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	569
CASTILLA Y LEËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	261
CASTILLA Y LEËN	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	308
CASTILLA Y LEËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	2.354
CASTILLA Y LEËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.274
CASTILLA Y LEËN	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.080
CASTILLA Y LEËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.783
CASTILLA Y LEËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	931
CASTILLA Y LEËN	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.852
CASTILLA Y LEËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	17.438
CASTILLA Y LEËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	8.599
CASTILLA Y LEËN	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	8.839
CASTILLA Y LEËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.242
CASTILLA Y LEËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	519
CASTILLA Y LEËN	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	723
CASTILLA Y LEËN	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.515
CASTILLA Y LEËN	Group 1402 Renal failure  5836-5837, 584-586	Men	888
CASTILLA Y LEËN	Group 1402 Renal failure  5836-5837, 584-586	Women	627
CASTILLA Y LEËN	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.335
CASTILLA Y LEËN	Group 1403 Urolithiasis  592, 594, 7880	Men	1.417
CASTILLA Y LEËN	Group 1403 Urolithiasis  592, 594, 7880	Women	918
CASTILLA Y LEËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	5.301
CASTILLA Y LEËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.585
CASTILLA Y LEËN	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.716
CASTILLA Y LEËN	Group 1405 Prostatic hyperplasia  600	Both sexes	1.595
CASTILLA Y LEËN	Group 1405 Prostatic hyperplasia  600	Men	1.595
CASTILLA Y LEËN	Group 1405 Prostatic hyperplasia  600	Women	..
CASTILLA Y LEËN	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	1.463
CASTILLA Y LEËN	Group 1406 Other diseases of the male genital organs    601-608	Men	1.463
CASTILLA Y LEËN	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CASTILLA Y LEËN	Group 1407 Disorders of breast  610-612	Both sexes	706
CASTILLA Y LEËN	Group 1407 Disorders of breast  610-612	Men	99
CASTILLA Y LEËN	Group 1407 Disorders of breast  610-612	Women	607
CASTILLA Y LEËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	451
CASTILLA Y LEËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CASTILLA Y LEËN	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	451
CASTILLA Y LEËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	315
CASTILLA Y LEËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CASTILLA Y LEËN	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	315
CASTILLA Y LEËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.515
CASTILLA Y LEËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	33
CASTILLA Y LEËN	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.482
CASTILLA Y LEËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	20.426
CASTILLA Y LEËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CASTILLA Y LEËN	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	20.426
CASTILLA Y LEËN	Group 1501 Legally induced abortion  635	Both sexes	10
CASTILLA Y LEËN	Group 1501 Legally induced abortion  635	Men	..
CASTILLA Y LEËN	Group 1501 Legally induced abortion  635	Women	10
CASTILLA Y LEËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.457
CASTILLA Y LEËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CASTILLA Y LEËN	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.457
CASTILLA Y LEËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	11.805
CASTILLA Y LEËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CASTILLA Y LEËN	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	11.805
CASTILLA Y LEËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.365
CASTILLA Y LEËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CASTILLA Y LEËN	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.365
CASTILLA Y LEËN	Group 1505 Single spontaneous delivery  650	Both sexes	1.610
CASTILLA Y LEËN	Group 1505 Single spontaneous delivery  650	Men	..
CASTILLA Y LEËN	Group 1505 Single spontaneous delivery  650	Women	1.610
CASTILLA Y LEËN	Group 1506 Other deliveries  6695-6697	Both sexes	781
CASTILLA Y LEËN	Group 1506 Other deliveries  6695-6697	Men	..
CASTILLA Y LEËN	Group 1506 Other deliveries  6695-6697	Women	781
CASTILLA Y LEËN	Group 1507 Complications related to the puerperium  670-676	Both sexes	166
CASTILLA Y LEËN	Group 1507 Complications related to the puerperium  670-676	Men	..
CASTILLA Y LEËN	Group 1507 Complications related to the puerperium  670-676	Women	166
CASTILLA Y LEËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.232
CASTILLA Y LEËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CASTILLA Y LEËN	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.232
CASTILLA Y LEËN	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.891
CASTILLA Y LEËN	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.614
CASTILLA Y LEËN	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.277
CASTILLA Y LEËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	703
CASTILLA Y LEËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	400
CASTILLA Y LEËN	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	303
CASTILLA Y LEËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.188
CASTILLA Y LEËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.214
CASTILLA Y LEËN	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	974
CASTILLA Y LEËN	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.499
CASTILLA Y LEËN	Grupo 1700 Congenital abnormalities  740-759	Men	905
CASTILLA Y LEËN	Grupo 1700 Congenital abnormalities  740-759	Women	594
CASTILLA Y LEËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	13.111
CASTILLA Y LEËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	7.301
CASTILLA Y LEËN	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.810
CASTILLA Y LEËN	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.346
CASTILLA Y LEËN	Group 1801 Pain in throat and chest 7841, 7865	Men	822
CASTILLA Y LEËN	Group 1801 Pain in throat and chest 7841, 7865	Women	524
CASTILLA Y LEËN	Group 1802 Abdominal pain   7890	Both sexes	1.540
CASTILLA Y LEËN	Group 1802 Abdominal pain   7890	Men	649
CASTILLA Y LEËN	Group 1802 Abdominal pain   7890	Women	891
CASTILLA Y LEËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.798
CASTILLA Y LEËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1.021
CASTILLA Y LEËN	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	777
CASTILLA Y LEËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	8.427
CASTILLA Y LEËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.809
CASTILLA Y LEËN	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.618
CASTILLA Y LEËN	Group 1900 Injuries and poisoning  800-999	Both sexes	24.545
CASTILLA Y LEËN	Group 1900 Injuries and poisoning  800-999	Men	12.345
CASTILLA Y LEËN	Group 1900 Injuries and poisoning  800-999	Women	12.200
CASTILLA Y LEËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.401
CASTILLA Y LEËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	806
CASTILLA Y LEËN	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	595
CASTILLA Y LEËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	735
CASTILLA Y LEËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	517
CASTILLA Y LEËN	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	218
CASTILLA Y LEËN	Group 1903 Radius and ulna fracture 813	Both sexes	1.131
CASTILLA Y LEËN	Group 1903 Radius and ulna fracture 813	Men	538
CASTILLA Y LEËN	Group 1903 Radius and ulna fracture 813	Women	593
CASTILLA Y LEËN	Group 1904 Femur fracture  820-821	Both sexes	4.469
CASTILLA Y LEËN	Group 1904 Femur fracture  820-821	Men	1.144
CASTILLA Y LEËN	Group 1904 Femur fracture  820-821	Women	3.325
CASTILLA Y LEËN	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.544
CASTILLA Y LEËN	Group 1905 Leg fracture, including the ankle 823-824	Men	777
CASTILLA Y LEËN	Group 1905 Leg fracture, including the ankle 823-824	Women	767
CASTILLA Y LEËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	6.708
CASTILLA Y LEËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.977
CASTILLA Y LEËN	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.731
CASTILLA Y LEËN	Group 1907 Burns  940-949	Both sexes	184
CASTILLA Y LEËN	Group 1907 Burns  940-949	Men	117
CASTILLA Y LEËN	Group 1907 Burns  940-949	Women	67
CASTILLA Y LEËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	726
CASTILLA Y LEËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	322
CASTILLA Y LEËN	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	404
CASTILLA Y LEËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	6.775
CASTILLA Y LEËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	3.693
CASTILLA Y LEËN	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	3.082
CASTILLA Y LEËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	30
CASTILLA Y LEËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	23
CASTILLA Y LEËN	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	7
CASTILLA Y LEËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	842
CASTILLA Y LEËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	431
CASTILLA Y LEËN	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	411
CASTILLA Y LEËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	5.534
CASTILLA Y LEËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	2.934
CASTILLA Y LEËN	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.600
CASTILLA Y LEËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	297
CASTILLA Y LEËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	194
CASTILLA Y LEËN	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	103
CASTILLA Y LEËN	Group 2102 Contraceptive management  V25	Both sexes	111
CASTILLA Y LEËN	Group 2102 Contraceptive management  V25	Men	5
CASTILLA Y LEËN	Group 2102 Contraceptive management  V25	Women	106
CASTILLA Y LEËN	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CASTILLA Y LEËN	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CASTILLA Y LEËN	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CASTILLA Y LEËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	2.420
CASTILLA Y LEËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.376
CASTILLA Y LEËN	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.044
CASTILLA Y LEËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.706
CASTILLA Y LEËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.359
CASTILLA Y LEËN	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.347
┴vila	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	14.353
┴vila	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	7.237
┴vila	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	7.116
┴vila	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	328
┴vila	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	181
┴vila	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	147
┴vila	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	54
┴vila	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	25
┴vila	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	29
┴vila	Group 0102 Imprecise intestinal infections 009	Both sexes	6
┴vila	Group 0102 Imprecise intestinal infections 009	Men	1
┴vila	Group 0102 Imprecise intestinal infections 009	Women	5
┴vila	Group 0103 Tuberculosis 010-018, 137	Both sexes	16
┴vila	Group 0103 Tuberculosis 010-018, 137	Men	12
┴vila	Group 0103 Tuberculosis 010-018, 137	Women	4
┴vila	Group 0104 Septicaemia  038	Both sexes	124
┴vila	Group 0104 Septicaemia  038	Men	76
┴vila	Group 0104 Septicaemia  038	Women	48
┴vila	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	10
┴vila	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	8
┴vila	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
┴vila	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	118
┴vila	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	59
┴vila	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	59
┴vila	Group 0200 Neoplasms  140-239	Both sexes	1.401
┴vila	Group 0200 Neoplasms  140-239	Men	800
┴vila	Group 0200 Neoplasms  140-239	Women	601
┴vila	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	182
┴vila	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	106
┴vila	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	76
┴vila	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	122
┴vila	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	101
┴vila	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	21
┴vila	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	38
┴vila	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	23
┴vila	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	15
┴vila	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	88
┴vila	Group 0204 Malignant neoplasm of breast  174-175	Men	1
┴vila	Group 0204 Malignant neoplasm of breast  174-175	Women	87
┴vila	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	18
┴vila	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
┴vila	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	18
┴vila	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	29
┴vila	Group 0206 Malignant neoplasm of ovary  1830	Men	..
┴vila	Group 0206 Malignant neoplasm of ovary  1830	Women	29
┴vila	Group 0207 Malignant neoplasm of prostate  185	Both sexes	72
┴vila	Group 0207 Malignant neoplasm of prostate  185	Men	72
┴vila	Group 0207 Malignant neoplasm of prostate  185	Women	..
┴vila	Group 0208 Malignant neoplasm of bladder  188	Both sexes	119
┴vila	Group 0208 Malignant neoplasm of bladder  188	Men	101
┴vila	Group 0208 Malignant neoplasm of bladder  188	Women	18
┴vila	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	481
┴vila	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	313
┴vila	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	168
┴vila	Group 0210 Carcinoma in situ  230-234	Both sexes	27
┴vila	Group 0210 Carcinoma in situ  230-234	Men	13
┴vila	Group 0210 Carcinoma in situ  230-234	Women	14
┴vila	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	12
┴vila	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	8
┴vila	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	4
┴vila	Grupo 0212 Leiomyoma of uterus  218	Both sexes	68
┴vila	Grupo 0212 Leiomyoma of uterus  218	Men	..
┴vila	Grupo 0212 Leiomyoma of uterus  218	Women	68
┴vila	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	145
┴vila	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	62
┴vila	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	83
┴vila	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	155
┴vila	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	79
┴vila	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	76
┴vila	Group 0301 Anaemias 280-285	Both sexes	98
┴vila	Group 0301 Anaemias 280-285	Men	43
┴vila	Group 0301 Anaemias 280-285	Women	55
┴vila	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	57
┴vila	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	36
┴vila	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	21
┴vila	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	307
┴vila	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	127
┴vila	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	180
┴vila	Group 0401 Diabetes mellitus  249-250	Both sexes	104
┴vila	Group 0401 Diabetes mellitus  249-250	Men	55
┴vila	Group 0401 Diabetes mellitus  249-250	Women	49
┴vila	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	203
┴vila	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	72
┴vila	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	131
┴vila	Group 0500 Mental disorders  290-319	Both sexes	357
┴vila	Group 0500 Mental disorders  290-319	Men	186
┴vila	Group 0500 Mental disorders  290-319	Women	171
┴vila	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	6
┴vila	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	5
┴vila	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1
┴vila	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	20
┴vila	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	15
┴vila	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	5
┴vila	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	8
┴vila	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	5
┴vila	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
┴vila	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	98
┴vila	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	60
┴vila	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	38
┴vila	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	81
┴vila	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	32
┴vila	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	49
┴vila	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	144
┴vila	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	69
┴vila	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	75
┴vila	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	275
┴vila	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	135
┴vila	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	140
┴vila	Group 0601 Alzheimer's disease  3310	Both sexes	2
┴vila	Group 0601 Alzheimer's disease  3310	Men	..
┴vila	Group 0601 Alzheimer's disease  3310	Women	2
┴vila	Group 0602 Multiple sclerosis 340	Both sexes	6
┴vila	Group 0602 Multiple sclerosis 340	Men	1
┴vila	Group 0602 Multiple sclerosis 340	Women	5
┴vila	Group 0603 Epilepsy  345	Both sexes	58
┴vila	Group 0603 Epilepsy  345	Men	41
┴vila	Group 0603 Epilepsy  345	Women	17
┴vila	Group 0604 Transient cerebral ischemia 435	Both sexes	45
┴vila	Group 0604 Transient cerebral ischemia 435	Men	18
┴vila	Group 0604 Transient cerebral ischemia 435	Women	27
┴vila	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	164
┴vila	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	75
┴vila	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	89
┴vila	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	105
┴vila	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	58
┴vila	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	47
┴vila	Grupo 0701 Cataract  366	Both sexes	12
┴vila	Grupo 0701 Cataract  366	Men	5
┴vila	Grupo 0701 Cataract  366	Women	7
┴vila	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	93
┴vila	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	53
┴vila	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	40
┴vila	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	76
┴vila	Group 0800 Diseases of the ear and the mastoid  380-389	Men	45
┴vila	Group 0800 Diseases of the ear and the mastoid  380-389	Women	31
┴vila	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.971
┴vila	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	985
┴vila	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	986
┴vila	Group 0901 Hypertensive disease  401-405	Both sexes	113
┴vila	Group 0901 Hypertensive disease  401-405	Men	40
┴vila	Group 0901 Hypertensive disease  401-405	Women	73
┴vila	Group 0902 Angina pectoris  4111, 413	Both sexes	104
┴vila	Group 0902 Angina pectoris  4111, 413	Men	69
┴vila	Group 0902 Angina pectoris  4111, 413	Women	35
┴vila	Group 0903 Acute myocardial infarction  410	Both sexes	140
┴vila	Group 0903 Acute myocardial infarction  410	Men	88
┴vila	Group 0903 Acute myocardial infarction  410	Women	52
┴vila	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2
┴vila	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	2
┴vila	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	..
┴vila	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	105
┴vila	Group 0905 Diseases of the lungs circulation 415-417	Men	51
┴vila	Group 0905 Diseases of the lungs circulation 415-417	Women	54
┴vila	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	296
┴vila	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	151
┴vila	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	145
┴vila	Grupo 0907 Heart failure  428	Both sexes	600
┴vila	Grupo 0907 Heart failure  428	Men	263
┴vila	Grupo 0907 Heart failure  428	Women	337
┴vila	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	339
┴vila	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	171
┴vila	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	168
┴vila	Grupo 0909 Atherosclerosis  440	Both sexes	2
┴vila	Grupo 0909 Atherosclerosis  440	Men	1
┴vila	Grupo 0909 Atherosclerosis  440	Women	1
┴vila	Group 0910 Varicose veins of lower extremities 454	Both sexes	44
┴vila	Group 0910 Varicose veins of lower extremities 454	Men	23
┴vila	Group 0910 Varicose veins of lower extremities 454	Women	21
┴vila	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	226
┴vila	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	126
┴vila	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	100
┴vila	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.929
┴vila	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.188
┴vila	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	741
┴vila	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	55
┴vila	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	35
┴vila	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	20
┴vila	Group 1002 Pneumonia 480-486	Both sexes	307
┴vila	Group 1002 Pneumonia 480-486	Men	201
┴vila	Group 1002 Pneumonia 480-486	Women	106
┴vila	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	62
┴vila	Group 1003 Acute bronchitis and bronchiolitis  466	Men	34
┴vila	Group 1003 Acute bronchitis and bronchiolitis  466	Women	28
┴vila	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	118
┴vila	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	65
┴vila	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	53
┴vila	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	258
┴vila	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	171
┴vila	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	87
┴vila	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	306
┴vila	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	265
┴vila	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	41
┴vila	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	63
┴vila	Group 1007 Asthma 4930-4931,4938-4939	Men	15
┴vila	Group 1007 Asthma 4930-4931,4938-4939	Women	48
┴vila	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	760
┴vila	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	402
┴vila	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	358
┴vila	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.091
┴vila	Group 1100 Diseases of the digestive system  520-579	Men	1.272
┴vila	Group 1100 Diseases of the digestive system  520-579	Women	819
┴vila	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	24
┴vila	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	13
┴vila	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	11
┴vila	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	29
┴vila	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	19
┴vila	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	10
┴vila	Group 1103 Diseases of the esophagus 530	Both sexes	35
┴vila	Group 1103 Diseases of the esophagus 530	Men	22
┴vila	Group 1103 Diseases of the esophagus 530	Women	13
┴vila	Group 1104 Peptic ulcer 531-534	Both sexes	42
┴vila	Group 1104 Peptic ulcer 531-534	Men	26
┴vila	Group 1104 Peptic ulcer 531-534	Women	16
┴vila	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	54
┴vila	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	25
┴vila	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	29
┴vila	Group 1106 Appendicitis  540-543	Both sexes	134
┴vila	Group 1106 Appendicitis  540-543	Men	81
┴vila	Group 1106 Appendicitis  540-543	Women	53
┴vila	Group 1107 Inguinal hernia  550	Both sexes	369
┴vila	Group 1107 Inguinal hernia  550	Men	344
┴vila	Group 1107 Inguinal hernia  550	Women	25
┴vila	Group 1108 Other abdominal hernia  551-553	Both sexes	204
┴vila	Group 1108 Other abdominal hernia  551-553	Men	104
┴vila	Group 1108 Other abdominal hernia  551-553	Women	100
┴vila	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	17
┴vila	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	8
┴vila	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	9
┴vila	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	141
┴vila	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	72
┴vila	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	69
┴vila	Group 1111 Intestinal obstruction without hernia 560	Both sexes	124
┴vila	Group 1111 Intestinal obstruction without hernia 560	Men	58
┴vila	Group 1111 Intestinal obstruction without hernia 560	Women	66
┴vila	Group 1112 Intestinal diverticulosis 562	Both sexes	67
┴vila	Group 1112 Intestinal diverticulosis 562	Men	27
┴vila	Group 1112 Intestinal diverticulosis 562	Women	40
┴vila	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	124
┴vila	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	84
┴vila	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	40
┴vila	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	61
┴vila	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	32
┴vila	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	29
┴vila	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	23
┴vila	Group 1115 Alcoholic hepatitis 5710-5713	Men	18
┴vila	Group 1115 Alcoholic hepatitis 5710-5713	Women	5
┴vila	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	33
┴vila	Group 1116 Other diseases of the liver 570,5714-573	Men	22
┴vila	Group 1116 Other diseases of the liver 570,5714-573	Women	11
┴vila	Group 1117 Cholelithiasis  574	Both sexes	314
┴vila	Group 1117 Cholelithiasis  574	Men	139
┴vila	Group 1117 Cholelithiasis  574	Women	175
┴vila	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	87
┴vila	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	60
┴vila	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	27
┴vila	Group 1119 Pancreatic diseases 577	Both sexes	94
┴vila	Group 1119 Pancreatic diseases 577	Men	52
┴vila	Group 1119 Pancreatic diseases 577	Women	42
┴vila	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	115
┴vila	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	66
┴vila	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	49
┴vila	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	146
┴vila	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	79
┴vila	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	67
┴vila	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	84
┴vila	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	49
┴vila	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	35
┴vila	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	7
┴vila	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	5
┴vila	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
┴vila	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	55
┴vila	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	25
┴vila	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	30
┴vila	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	528
┴vila	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	268
┴vila	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	260
┴vila	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
┴vila	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
┴vila	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
┴vila	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
┴vila	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
┴vila	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
┴vila	Group 1303 Internal derangement of knee 717	Both sexes	76
┴vila	Group 1303 Internal derangement of knee 717	Men	54
┴vila	Group 1303 Internal derangement of knee 717	Women	22
┴vila	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	234
┴vila	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	108
┴vila	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	126
┴vila	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	10
┴vila	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	4
┴vila	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	6
┴vila	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	5
┴vila	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	3
┴vila	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	2
┴vila	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	28
┴vila	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	21
┴vila	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	7
┴vila	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	7
┴vila	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	6
┴vila	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	1
┴vila	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	75
┴vila	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	44
┴vila	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	31
┴vila	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	93
┴vila	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	28
┴vila	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	65
┴vila	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	964
┴vila	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	521
┴vila	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	443
┴vila	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	47
┴vila	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	27
┴vila	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	20
┴vila	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	91
┴vila	Group 1402 Renal failure  5836-5837, 584-586	Men	52
┴vila	Group 1402 Renal failure  5836-5837, 584-586	Women	39
┴vila	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	107
┴vila	Group 1403 Urolithiasis  592, 594, 7880	Men	58
┴vila	Group 1403 Urolithiasis  592, 594, 7880	Women	49
┴vila	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	320
┴vila	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	165
┴vila	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	155
┴vila	Group 1405 Prostatic hyperplasia  600	Both sexes	100
┴vila	Group 1405 Prostatic hyperplasia  600	Men	100
┴vila	Group 1405 Prostatic hyperplasia  600	Women	..
┴vila	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	114
┴vila	Group 1406 Other diseases of the male genital organs    601-608	Men	114
┴vila	Group 1406 Other diseases of the male genital organs    601-608	Women	..
┴vila	Group 1407 Disorders of breast  610-612	Both sexes	12
┴vila	Group 1407 Disorders of breast  610-612	Men	5
┴vila	Group 1407 Disorders of breast  610-612	Women	7
┴vila	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	28
┴vila	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
┴vila	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	28
┴vila	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	13
┴vila	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
┴vila	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	13
┴vila	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	132
┴vila	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
┴vila	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	132
┴vila	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.191
┴vila	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
┴vila	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.191
┴vila	Group 1501 Legally induced abortion  635	Both sexes	..
┴vila	Group 1501 Legally induced abortion  635	Men	..
┴vila	Group 1501 Legally induced abortion  635	Women	..
┴vila	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	68
┴vila	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
┴vila	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	68
┴vila	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	594
┴vila	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
┴vila	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	594
┴vila	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	347
┴vila	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
┴vila	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	347
┴vila	Group 1505 Single spontaneous delivery  650	Both sexes	61
┴vila	Group 1505 Single spontaneous delivery  650	Men	..
┴vila	Group 1505 Single spontaneous delivery  650	Women	61
┴vila	Group 1506 Other deliveries  6695-6697	Both sexes	38
┴vila	Group 1506 Other deliveries  6695-6697	Men	..
┴vila	Group 1506 Other deliveries  6695-6697	Women	38
┴vila	Group 1507 Complications related to the puerperium  670-676	Both sexes	13
┴vila	Group 1507 Complications related to the puerperium  670-676	Men	..
┴vila	Group 1507 Complications related to the puerperium  670-676	Women	13
┴vila	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	70
┴vila	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
┴vila	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	70
┴vila	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	231
┴vila	Group 1600 Some disorders originating in the perinatal period  760-779	Men	143
┴vila	Group 1600 Some disorders originating in the perinatal period  760-779	Women	88
┴vila	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	31
┴vila	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	18
┴vila	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	13
┴vila	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	200
┴vila	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	125
┴vila	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	75
┴vila	Grupo 1700 Congenital abnormalities  740-759	Both sexes	70
┴vila	Grupo 1700 Congenital abnormalities  740-759	Men	43
┴vila	Grupo 1700 Congenital abnormalities  740-759	Women	27
┴vila	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	906
┴vila	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	485
┴vila	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	421
┴vila	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	145
┴vila	Group 1801 Pain in throat and chest 7841, 7865	Men	82
┴vila	Group 1801 Pain in throat and chest 7841, 7865	Women	63
┴vila	Group 1802 Abdominal pain   7890	Both sexes	137
┴vila	Group 1802 Abdominal pain   7890	Men	57
┴vila	Group 1802 Abdominal pain   7890	Women	80
┴vila	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	..
┴vila	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
┴vila	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
┴vila	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	624
┴vila	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	346
┴vila	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	278
┴vila	Group 1900 Injuries and poisoning  800-999	Both sexes	1.191
┴vila	Group 1900 Injuries and poisoning  800-999	Men	565
┴vila	Group 1900 Injuries and poisoning  800-999	Women	626
┴vila	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	67
┴vila	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	31
┴vila	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	36
┴vila	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	13
┴vila	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	6
┴vila	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	7
┴vila	Group 1903 Radius and ulna fracture 813	Both sexes	45
┴vila	Group 1903 Radius and ulna fracture 813	Men	26
┴vila	Group 1903 Radius and ulna fracture 813	Women	19
┴vila	Group 1904 Femur fracture  820-821	Both sexes	265
┴vila	Group 1904 Femur fracture  820-821	Men	64
┴vila	Group 1904 Femur fracture  820-821	Women	201
┴vila	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	87
┴vila	Group 1905 Leg fracture, including the ankle 823-824	Men	48
┴vila	Group 1905 Leg fracture, including the ankle 823-824	Women	39
┴vila	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	255
┴vila	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	151
┴vila	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	104
┴vila	Group 1907 Burns  940-949	Both sexes	3
┴vila	Group 1907 Burns  940-949	Men	3
┴vila	Group 1907 Burns  940-949	Women	..
┴vila	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	25
┴vila	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	14
┴vila	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	11
┴vila	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	381
┴vila	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	195
┴vila	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	186
┴vila	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
┴vila	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
┴vila	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
┴vila	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	50
┴vila	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	27
┴vila	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	23
┴vila	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	131
┴vila	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	77
┴vila	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	54
┴vila	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	6
┴vila	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	4
┴vila	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2
┴vila	Group 2102 Contraceptive management  V25	Both sexes	4
┴vila	Group 2102 Contraceptive management  V25	Men	..
┴vila	Group 2102 Contraceptive management  V25	Women	4
┴vila	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
┴vila	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
┴vila	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
┴vila	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	66
┴vila	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	46
┴vila	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	20
┴vila	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	55
┴vila	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	27
┴vila	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	28
Burgos	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	42.901
Burgos	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	21.565
Burgos	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	21.336
Burgos	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	970
Burgos	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	552
Burgos	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	418
Burgos	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	161
Burgos	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	83
Burgos	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	78
Burgos	Group 0102 Imprecise intestinal infections 009	Both sexes	67
Burgos	Group 0102 Imprecise intestinal infections 009	Men	23
Burgos	Group 0102 Imprecise intestinal infections 009	Women	44
Burgos	Group 0103 Tuberculosis 010-018, 137	Both sexes	34
Burgos	Group 0103 Tuberculosis 010-018, 137	Men	21
Burgos	Group 0103 Tuberculosis 010-018, 137	Women	13
Burgos	Group 0104 Septicaemia  038	Both sexes	452
Burgos	Group 0104 Septicaemia  038	Men	266
Burgos	Group 0104 Septicaemia  038	Women	186
Burgos	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	41
Burgos	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	33
Burgos	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	8
Burgos	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	215
Burgos	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	126
Burgos	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	89
Burgos	Group 0200 Neoplasms  140-239	Both sexes	4.488
Burgos	Group 0200 Neoplasms  140-239	Men	2.487
Burgos	Group 0200 Neoplasms  140-239	Women	2.001
Burgos	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	505
Burgos	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	314
Burgos	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	191
Burgos	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	260
Burgos	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	192
Burgos	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	68
Burgos	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	76
Burgos	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	38
Burgos	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	38
Burgos	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	366
Burgos	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Burgos	Group 0204 Malignant neoplasm of breast  174-175	Women	362
Burgos	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	56
Burgos	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Burgos	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	56
Burgos	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	22
Burgos	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Burgos	Group 0206 Malignant neoplasm of ovary  1830	Women	22
Burgos	Group 0207 Malignant neoplasm of prostate  185	Both sexes	185
Burgos	Group 0207 Malignant neoplasm of prostate  185	Men	185
Burgos	Group 0207 Malignant neoplasm of prostate  185	Women	..
Burgos	Group 0208 Malignant neoplasm of bladder  188	Both sexes	351
Burgos	Group 0208 Malignant neoplasm of bladder  188	Men	288
Burgos	Group 0208 Malignant neoplasm of bladder  188	Women	63
Burgos	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.752
Burgos	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.111
Burgos	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	641
Burgos	Group 0210 Carcinoma in situ  230-234	Both sexes	94
Burgos	Group 0210 Carcinoma in situ  230-234	Men	35
Burgos	Group 0210 Carcinoma in situ  230-234	Women	59
Burgos	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	87
Burgos	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	56
Burgos	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	31
Burgos	Grupo 0212 Leiomyoma of uterus  218	Both sexes	115
Burgos	Grupo 0212 Leiomyoma of uterus  218	Men	..
Burgos	Grupo 0212 Leiomyoma of uterus  218	Women	115
Burgos	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	619
Burgos	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	264
Burgos	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	355
Burgos	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	432
Burgos	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	196
Burgos	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	236
Burgos	Group 0301 Anaemias 280-285	Both sexes	296
Burgos	Group 0301 Anaemias 280-285	Men	136
Burgos	Group 0301 Anaemias 280-285	Women	160
Burgos	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	136
Burgos	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	60
Burgos	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	76
Burgos	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	735
Burgos	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	322
Burgos	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	413
Burgos	Group 0401 Diabetes mellitus  249-250	Both sexes	258
Burgos	Group 0401 Diabetes mellitus  249-250	Men	137
Burgos	Group 0401 Diabetes mellitus  249-250	Women	121
Burgos	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	477
Burgos	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	185
Burgos	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	292
Burgos	Group 0500 Mental disorders  290-319	Both sexes	1.009
Burgos	Group 0500 Mental disorders  290-319	Men	403
Burgos	Group 0500 Mental disorders  290-319	Women	606
Burgos	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	11
Burgos	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	6
Burgos	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	5
Burgos	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	58
Burgos	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	43
Burgos	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	15
Burgos	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	22
Burgos	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	13
Burgos	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	9
Burgos	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	239
Burgos	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	133
Burgos	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	106
Burgos	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	433
Burgos	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	102
Burgos	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	331
Burgos	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	246
Burgos	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	106
Burgos	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	140
Burgos	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	775
Burgos	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	385
Burgos	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	390
Burgos	Group 0601 Alzheimer's disease  3310	Both sexes	15
Burgos	Group 0601 Alzheimer's disease  3310	Men	3
Burgos	Group 0601 Alzheimer's disease  3310	Women	12
Burgos	Group 0602 Multiple sclerosis 340	Both sexes	13
Burgos	Group 0602 Multiple sclerosis 340	Men	3
Burgos	Group 0602 Multiple sclerosis 340	Women	10
Burgos	Group 0603 Epilepsy  345	Both sexes	141
Burgos	Group 0603 Epilepsy  345	Men	67
Burgos	Group 0603 Epilepsy  345	Women	74
Burgos	Group 0604 Transient cerebral ischemia 435	Both sexes	111
Burgos	Group 0604 Transient cerebral ischemia 435	Men	48
Burgos	Group 0604 Transient cerebral ischemia 435	Women	63
Burgos	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	495
Burgos	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	264
Burgos	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	231
Burgos	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	424
Burgos	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	210
Burgos	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	214
Burgos	Grupo 0701 Cataract  366	Both sexes	148
Burgos	Grupo 0701 Cataract  366	Men	77
Burgos	Grupo 0701 Cataract  366	Women	71
Burgos	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	276
Burgos	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	133
Burgos	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	143
Burgos	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	268
Burgos	Group 0800 Diseases of the ear and the mastoid  380-389	Men	140
Burgos	Group 0800 Diseases of the ear and the mastoid  380-389	Women	128
Burgos	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.210
Burgos	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.905
Burgos	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.305
Burgos	Group 0901 Hypertensive disease  401-405	Both sexes	220
Burgos	Group 0901 Hypertensive disease  401-405	Men	93
Burgos	Group 0901 Hypertensive disease  401-405	Women	127
Burgos	Group 0902 Angina pectoris  4111, 413	Both sexes	146
Burgos	Group 0902 Angina pectoris  4111, 413	Men	102
Burgos	Group 0902 Angina pectoris  4111, 413	Women	44
Burgos	Group 0903 Acute myocardial infarction  410	Both sexes	343
Burgos	Group 0903 Acute myocardial infarction  410	Men	239
Burgos	Group 0903 Acute myocardial infarction  410	Women	104
Burgos	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	173
Burgos	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	141
Burgos	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	32
Burgos	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	192
Burgos	Group 0905 Diseases of the lungs circulation 415-417	Men	95
Burgos	Group 0905 Diseases of the lungs circulation 415-417	Women	97
Burgos	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	746
Burgos	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	405
Burgos	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	341
Burgos	Grupo 0907 Heart failure  428	Both sexes	1.579
Burgos	Grupo 0907 Heart failure  428	Men	754
Burgos	Grupo 0907 Heart failure  428	Women	825
Burgos	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	902
Burgos	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	491
Burgos	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	411
Burgos	Grupo 0909 Atherosclerosis  440	Both sexes	211
Burgos	Grupo 0909 Atherosclerosis  440	Men	167
Burgos	Grupo 0909 Atherosclerosis  440	Women	44
Burgos	Group 0910 Varicose veins of lower extremities 454	Both sexes	27
Burgos	Group 0910 Varicose veins of lower extremities 454	Men	12
Burgos	Group 0910 Varicose veins of lower extremities 454	Women	15
Burgos	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	671
Burgos	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	406
Burgos	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	265
Burgos	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.684
Burgos	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.301
Burgos	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.383
Burgos	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	360
Burgos	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	192
Burgos	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	168
Burgos	Group 1002 Pneumonia 480-486	Both sexes	1.261
Burgos	Group 1002 Pneumonia 480-486	Men	765
Burgos	Group 1002 Pneumonia 480-486	Women	496
Burgos	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	357
Burgos	Group 1003 Acute bronchitis and bronchiolitis  466	Men	177
Burgos	Group 1003 Acute bronchitis and bronchiolitis  466	Women	180
Burgos	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	317
Burgos	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	170
Burgos	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	147
Burgos	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	471
Burgos	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	314
Burgos	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	157
Burgos	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.064
Burgos	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	791
Burgos	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	273
Burgos	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	296
Burgos	Group 1007 Asthma 4930-4931,4938-4939	Men	116
Burgos	Group 1007 Asthma 4930-4931,4938-4939	Women	180
Burgos	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.558
Burgos	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	776
Burgos	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	782
Burgos	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.724
Burgos	Group 1100 Diseases of the digestive system  520-579	Men	3.357
Burgos	Group 1100 Diseases of the digestive system  520-579	Women	2.367
Burgos	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	75
Burgos	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	43
Burgos	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	32
Burgos	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	68
Burgos	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	38
Burgos	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	30
Burgos	Group 1103 Diseases of the esophagus 530	Both sexes	64
Burgos	Group 1103 Diseases of the esophagus 530	Men	40
Burgos	Group 1103 Diseases of the esophagus 530	Women	24
Burgos	Group 1104 Peptic ulcer 531-534	Both sexes	127
Burgos	Group 1104 Peptic ulcer 531-534	Men	93
Burgos	Group 1104 Peptic ulcer 531-534	Women	34
Burgos	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	132
Burgos	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	66
Burgos	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	66
Burgos	Group 1106 Appendicitis  540-543	Both sexes	498
Burgos	Group 1106 Appendicitis  540-543	Men	282
Burgos	Group 1106 Appendicitis  540-543	Women	216
Burgos	Group 1107 Inguinal hernia  550	Both sexes	816
Burgos	Group 1107 Inguinal hernia  550	Men	725
Burgos	Group 1107 Inguinal hernia  550	Women	91
Burgos	Group 1108 Other abdominal hernia  551-553	Both sexes	413
Burgos	Group 1108 Other abdominal hernia  551-553	Men	224
Burgos	Group 1108 Other abdominal hernia  551-553	Women	189
Burgos	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	85
Burgos	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	41
Burgos	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	44
Burgos	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	393
Burgos	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	183
Burgos	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	210
Burgos	Group 1111 Intestinal obstruction without hernia 560	Both sexes	419
Burgos	Group 1111 Intestinal obstruction without hernia 560	Men	220
Burgos	Group 1111 Intestinal obstruction without hernia 560	Women	199
Burgos	Group 1112 Intestinal diverticulosis 562	Both sexes	195
Burgos	Group 1112 Intestinal diverticulosis 562	Men	110
Burgos	Group 1112 Intestinal diverticulosis 562	Women	85
Burgos	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	286
Burgos	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	179
Burgos	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	107
Burgos	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	187
Burgos	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	99
Burgos	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	88
Burgos	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	89
Burgos	Group 1115 Alcoholic hepatitis 5710-5713	Men	77
Burgos	Group 1115 Alcoholic hepatitis 5710-5713	Women	12
Burgos	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	209
Burgos	Group 1116 Other diseases of the liver 570,5714-573	Men	115
Burgos	Group 1116 Other diseases of the liver 570,5714-573	Women	94
Burgos	Group 1117 Cholelithiasis  574	Both sexes	895
Burgos	Group 1117 Cholelithiasis  574	Men	394
Burgos	Group 1117 Cholelithiasis  574	Women	501
Burgos	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	270
Burgos	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	156
Burgos	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	114
Burgos	Group 1119 Pancreatic diseases 577	Both sexes	271
Burgos	Group 1119 Pancreatic diseases 577	Men	139
Burgos	Group 1119 Pancreatic diseases 577	Women	132
Burgos	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	232
Burgos	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	133
Burgos	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	99
Burgos	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	527
Burgos	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	284
Burgos	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	243
Burgos	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	296
Burgos	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	182
Burgos	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	114
Burgos	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	22
Burgos	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	9
Burgos	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
Burgos	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	209
Burgos	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	93
Burgos	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	116
Burgos	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.826
Burgos	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.476
Burgos	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.350
Burgos	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Burgos	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Burgos	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Burgos	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Burgos	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Burgos	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Burgos	Group 1303 Internal derangement of knee 717	Both sexes	472
Burgos	Group 1303 Internal derangement of knee 717	Men	347
Burgos	Group 1303 Internal derangement of knee 717	Women	125
Burgos	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.030
Burgos	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	500
Burgos	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	530
Burgos	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	50
Burgos	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	21
Burgos	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	29
Burgos	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	100
Burgos	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	60
Burgos	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	40
Burgos	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	156
Burgos	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	88
Burgos	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	68
Burgos	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	130
Burgos	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	54
Burgos	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	76
Burgos	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	418
Burgos	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	243
Burgos	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	175
Burgos	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	470
Burgos	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	163
Burgos	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	307
Burgos	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.799
Burgos	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.345
Burgos	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.454
Burgos	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	236
Burgos	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	96
Burgos	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	140
Burgos	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	209
Burgos	Group 1402 Renal failure  5836-5837, 584-586	Men	131
Burgos	Group 1402 Renal failure  5836-5837, 584-586	Women	78
Burgos	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	412
Burgos	Group 1403 Urolithiasis  592, 594, 7880	Men	254
Burgos	Group 1403 Urolithiasis  592, 594, 7880	Women	158
Burgos	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.034
Burgos	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	467
Burgos	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	567
Burgos	Group 1405 Prostatic hyperplasia  600	Both sexes	217
Burgos	Group 1405 Prostatic hyperplasia  600	Men	217
Burgos	Group 1405 Prostatic hyperplasia  600	Women	..
Burgos	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	159
Burgos	Group 1406 Other diseases of the male genital organs    601-608	Men	159
Burgos	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Burgos	Group 1407 Disorders of breast  610-612	Both sexes	149
Burgos	Group 1407 Disorders of breast  610-612	Men	14
Burgos	Group 1407 Disorders of breast  610-612	Women	135
Burgos	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	68
Burgos	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Burgos	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	68
Burgos	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	22
Burgos	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Burgos	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	22
Burgos	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	293
Burgos	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	7
Burgos	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	286
Burgos	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.269
Burgos	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Burgos	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.269
Burgos	Group 1501 Legally induced abortion  635	Both sexes	8
Burgos	Group 1501 Legally induced abortion  635	Men	..
Burgos	Group 1501 Legally induced abortion  635	Women	8
Burgos	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	231
Burgos	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Burgos	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	231
Burgos	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.002
Burgos	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Burgos	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.002
Burgos	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	569
Burgos	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Burgos	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	569
Burgos	Group 1505 Single spontaneous delivery  650	Both sexes	158
Burgos	Group 1505 Single spontaneous delivery  650	Men	..
Burgos	Group 1505 Single spontaneous delivery  650	Women	158
Burgos	Group 1506 Other deliveries  6695-6697	Both sexes	29
Burgos	Group 1506 Other deliveries  6695-6697	Men	..
Burgos	Group 1506 Other deliveries  6695-6697	Women	29
Burgos	Group 1507 Complications related to the puerperium  670-676	Both sexes	29
Burgos	Group 1507 Complications related to the puerperium  670-676	Men	..
Burgos	Group 1507 Complications related to the puerperium  670-676	Women	29
Burgos	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	243
Burgos	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Burgos	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	243
Burgos	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	559
Burgos	Group 1600 Some disorders originating in the perinatal period  760-779	Men	309
Burgos	Group 1600 Some disorders originating in the perinatal period  760-779	Women	250
Burgos	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	120
Burgos	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	74
Burgos	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	46
Burgos	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	439
Burgos	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	235
Burgos	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	204
Burgos	Grupo 1700 Congenital abnormalities  740-759	Both sexes	341
Burgos	Grupo 1700 Congenital abnormalities  740-759	Men	208
Burgos	Grupo 1700 Congenital abnormalities  740-759	Women	133
Burgos	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.939
Burgos	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.088
Burgos	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	851
Burgos	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	164
Burgos	Group 1801 Pain in throat and chest 7841, 7865	Men	104
Burgos	Group 1801 Pain in throat and chest 7841, 7865	Women	60
Burgos	Group 1802 Abdominal pain   7890	Both sexes	294
Burgos	Group 1802 Abdominal pain   7890	Men	121
Burgos	Group 1802 Abdominal pain   7890	Women	173
Burgos	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Burgos	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Burgos	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Burgos	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.480
Burgos	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	862
Burgos	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	618
Burgos	Group 1900 Injuries and poisoning  800-999	Both sexes	4.181
Burgos	Group 1900 Injuries and poisoning  800-999	Men	2.216
Burgos	Group 1900 Injuries and poisoning  800-999	Women	1.965
Burgos	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	278
Burgos	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	177
Burgos	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	101
Burgos	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	191
Burgos	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	145
Burgos	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	46
Burgos	Group 1903 Radius and ulna fracture 813	Both sexes	246
Burgos	Group 1903 Radius and ulna fracture 813	Men	109
Burgos	Group 1903 Radius and ulna fracture 813	Women	137
Burgos	Group 1904 Femur fracture  820-821	Both sexes	569
Burgos	Group 1904 Femur fracture  820-821	Men	149
Burgos	Group 1904 Femur fracture  820-821	Women	420
Burgos	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	240
Burgos	Group 1905 Leg fracture, including the ankle 823-824	Men	126
Burgos	Group 1905 Leg fracture, including the ankle 823-824	Women	114
Burgos	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.347
Burgos	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	825
Burgos	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	522
Burgos	Group 1907 Burns  940-949	Both sexes	69
Burgos	Group 1907 Burns  940-949	Men	40
Burgos	Group 1907 Burns  940-949	Women	29
Burgos	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	87
Burgos	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	37
Burgos	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	50
Burgos	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.015
Burgos	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	541
Burgos	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	474
Burgos	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	7
Burgos	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	4
Burgos	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	3
Burgos	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	132
Burgos	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	63
Burgos	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	69
Burgos	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	741
Burgos	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	381
Burgos	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	360
Burgos	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	26
Burgos	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	19
Burgos	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	7
Burgos	Group 2102 Contraceptive management  V25	Both sexes	10
Burgos	Group 2102 Contraceptive management  V25	Men	..
Burgos	Group 2102 Contraceptive management  V25	Women	10
Burgos	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Burgos	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Burgos	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Burgos	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	145
Burgos	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	88
Burgos	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	57
Burgos	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	560
Burgos	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	274
Burgos	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	286
Le¾n	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	59.348
Le¾n	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	29.561
Le¾n	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	29.787
Le¾n	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.005
Le¾n	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	529
Le¾n	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	476
Le¾n	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	201
Le¾n	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	110
Le¾n	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	91
Le¾n	Group 0102 Imprecise intestinal infections 009	Both sexes	155
Le¾n	Group 0102 Imprecise intestinal infections 009	Men	66
Le¾n	Group 0102 Imprecise intestinal infections 009	Women	89
Le¾n	Group 0103 Tuberculosis 010-018, 137	Both sexes	54
Le¾n	Group 0103 Tuberculosis 010-018, 137	Men	39
Le¾n	Group 0103 Tuberculosis 010-018, 137	Women	15
Le¾n	Group 0104 Septicaemia  038	Both sexes	298
Le¾n	Group 0104 Septicaemia  038	Men	158
Le¾n	Group 0104 Septicaemia  038	Women	140
Le¾n	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	12
Le¾n	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
Le¾n	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	5
Le¾n	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	285
Le¾n	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	149
Le¾n	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	136
Le¾n	Group 0200 Neoplasms  140-239	Both sexes	5.924
Le¾n	Group 0200 Neoplasms  140-239	Men	3.132
Le¾n	Group 0200 Neoplasms  140-239	Women	2.792
Le¾n	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	785
Le¾n	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	437
Le¾n	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	348
Le¾n	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	397
Le¾n	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	312
Le¾n	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	85
Le¾n	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	253
Le¾n	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	137
Le¾n	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	116
Le¾n	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	378
Le¾n	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Le¾n	Group 0204 Malignant neoplasm of breast  174-175	Women	375
Le¾n	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	88
Le¾n	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Le¾n	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	88
Le¾n	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	86
Le¾n	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Le¾n	Group 0206 Malignant neoplasm of ovary  1830	Women	86
Le¾n	Group 0207 Malignant neoplasm of prostate  185	Both sexes	213
Le¾n	Group 0207 Malignant neoplasm of prostate  185	Men	213
Le¾n	Group 0207 Malignant neoplasm of prostate  185	Women	..
Le¾n	Group 0208 Malignant neoplasm of bladder  188	Both sexes	521
Le¾n	Group 0208 Malignant neoplasm of bladder  188	Men	446
Le¾n	Group 0208 Malignant neoplasm of bladder  188	Women	75
Le¾n	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.062
Le¾n	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.219
Le¾n	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	843
Le¾n	Group 0210 Carcinoma in situ  230-234	Both sexes	152
Le¾n	Group 0210 Carcinoma in situ  230-234	Men	50
Le¾n	Group 0210 Carcinoma in situ  230-234	Women	102
Le¾n	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	41
Le¾n	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	23
Le¾n	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	18
Le¾n	Grupo 0212 Leiomyoma of uterus  218	Both sexes	208
Le¾n	Grupo 0212 Leiomyoma of uterus  218	Men	..
Le¾n	Grupo 0212 Leiomyoma of uterus  218	Women	208
Le¾n	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	740
Le¾n	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	292
Le¾n	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	448
Le¾n	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	529
Le¾n	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	237
Le¾n	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	292
Le¾n	Group 0301 Anaemias 280-285	Both sexes	377
Le¾n	Group 0301 Anaemias 280-285	Men	160
Le¾n	Group 0301 Anaemias 280-285	Women	217
Le¾n	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	152
Le¾n	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	77
Le¾n	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	75
Le¾n	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	925
Le¾n	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	354
Le¾n	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	571
Le¾n	Group 0401 Diabetes mellitus  249-250	Both sexes	321
Le¾n	Group 0401 Diabetes mellitus  249-250	Men	167
Le¾n	Group 0401 Diabetes mellitus  249-250	Women	154
Le¾n	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	604
Le¾n	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	187
Le¾n	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	417
Le¾n	Group 0500 Mental disorders  290-319	Both sexes	1.203
Le¾n	Group 0500 Mental disorders  290-319	Men	596
Le¾n	Group 0500 Mental disorders  290-319	Women	607
Le¾n	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	56
Le¾n	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	34
Le¾n	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	22
Le¾n	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	67
Le¾n	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	52
Le¾n	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	15
Le¾n	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	26
Le¾n	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	23
Le¾n	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Le¾n	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	343
Le¾n	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	206
Le¾n	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	137
Le¾n	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	246
Le¾n	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	75
Le¾n	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	171
Le¾n	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	465
Le¾n	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	206
Le¾n	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	259
Le¾n	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.157
Le¾n	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	599
Le¾n	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	558
Le¾n	Group 0601 Alzheimer's disease  3310	Both sexes	29
Le¾n	Group 0601 Alzheimer's disease  3310	Men	11
Le¾n	Group 0601 Alzheimer's disease  3310	Women	18
Le¾n	Group 0602 Multiple sclerosis 340	Both sexes	63
Le¾n	Group 0602 Multiple sclerosis 340	Men	31
Le¾n	Group 0602 Multiple sclerosis 340	Women	32
Le¾n	Group 0603 Epilepsy  345	Both sexes	147
Le¾n	Group 0603 Epilepsy  345	Men	74
Le¾n	Group 0603 Epilepsy  345	Women	73
Le¾n	Group 0604 Transient cerebral ischemia 435	Both sexes	303
Le¾n	Group 0604 Transient cerebral ischemia 435	Men	144
Le¾n	Group 0604 Transient cerebral ischemia 435	Women	159
Le¾n	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	615
Le¾n	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	339
Le¾n	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	276
Le¾n	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	701
Le¾n	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	349
Le¾n	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	352
Le¾n	Grupo 0701 Cataract  366	Both sexes	170
Le¾n	Grupo 0701 Cataract  366	Men	79
Le¾n	Grupo 0701 Cataract  366	Women	91
Le¾n	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	531
Le¾n	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	270
Le¾n	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	261
Le¾n	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	250
Le¾n	Group 0800 Diseases of the ear and the mastoid  380-389	Men	105
Le¾n	Group 0800 Diseases of the ear and the mastoid  380-389	Women	145
Le¾n	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	9.038
Le¾n	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.907
Le¾n	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.131
Le¾n	Group 0901 Hypertensive disease  401-405	Both sexes	749
Le¾n	Group 0901 Hypertensive disease  401-405	Men	308
Le¾n	Group 0901 Hypertensive disease  401-405	Women	441
Le¾n	Group 0902 Angina pectoris  4111, 413	Both sexes	206
Le¾n	Group 0902 Angina pectoris  4111, 413	Men	139
Le¾n	Group 0902 Angina pectoris  4111, 413	Women	67
Le¾n	Group 0903 Acute myocardial infarction  410	Both sexes	688
Le¾n	Group 0903 Acute myocardial infarction  410	Men	504
Le¾n	Group 0903 Acute myocardial infarction  410	Women	184
Le¾n	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	485
Le¾n	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	401
Le¾n	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	84
Le¾n	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	382
Le¾n	Group 0905 Diseases of the lungs circulation 415-417	Men	176
Le¾n	Group 0905 Diseases of the lungs circulation 415-417	Women	206
Le¾n	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.043
Le¾n	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	552
Le¾n	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	491
Le¾n	Grupo 0907 Heart failure  428	Both sexes	1.716
Le¾n	Grupo 0907 Heart failure  428	Men	812
Le¾n	Grupo 0907 Heart failure  428	Women	904
Le¾n	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.441
Le¾n	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	756
Le¾n	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	685
Le¾n	Grupo 0909 Atherosclerosis  440	Both sexes	241
Le¾n	Grupo 0909 Atherosclerosis  440	Men	166
Le¾n	Grupo 0909 Atherosclerosis  440	Women	75
Le¾n	Group 0910 Varicose veins of lower extremities 454	Both sexes	478
Le¾n	Group 0910 Varicose veins of lower extremities 454	Men	181
Le¾n	Group 0910 Varicose veins of lower extremities 454	Women	297
Le¾n	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.609
Le¾n	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	912
Le¾n	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	697
Le¾n	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.179
Le¾n	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.291
Le¾n	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.888
Le¾n	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	189
Le¾n	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	113
Le¾n	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	76
Le¾n	Group 1002 Pneumonia 480-486	Both sexes	1.609
Le¾n	Group 1002 Pneumonia 480-486	Men	1.007
Le¾n	Group 1002 Pneumonia 480-486	Women	602
Le¾n	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	431
Le¾n	Group 1003 Acute bronchitis and bronchiolitis  466	Men	221
Le¾n	Group 1003 Acute bronchitis and bronchiolitis  466	Women	210
Le¾n	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	272
Le¾n	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	130
Le¾n	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	142
Le¾n	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	656
Le¾n	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	422
Le¾n	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	234
Le¾n	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.293
Le¾n	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.023
Le¾n	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	270
Le¾n	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	241
Le¾n	Group 1007 Asthma 4930-4931,4938-4939	Men	74
Le¾n	Group 1007 Asthma 4930-4931,4938-4939	Women	167
Le¾n	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.488
Le¾n	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.301
Le¾n	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.187
Le¾n	Group 1100 Diseases of the digestive system  520-579	Both sexes	7.665
Le¾n	Group 1100 Diseases of the digestive system  520-579	Men	4.609
Le¾n	Group 1100 Diseases of the digestive system  520-579	Women	3.056
Le¾n	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	99
Le¾n	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	44
Le¾n	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	55
Le¾n	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	86
Le¾n	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	45
Le¾n	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	41
Le¾n	Group 1103 Diseases of the esophagus 530	Both sexes	98
Le¾n	Group 1103 Diseases of the esophagus 530	Men	58
Le¾n	Group 1103 Diseases of the esophagus 530	Women	40
Le¾n	Group 1104 Peptic ulcer 531-534	Both sexes	121
Le¾n	Group 1104 Peptic ulcer 531-534	Men	83
Le¾n	Group 1104 Peptic ulcer 531-534	Women	38
Le¾n	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	222
Le¾n	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	117
Le¾n	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	105
Le¾n	Group 1106 Appendicitis  540-543	Both sexes	545
Le¾n	Group 1106 Appendicitis  540-543	Men	324
Le¾n	Group 1106 Appendicitis  540-543	Women	221
Le¾n	Group 1107 Inguinal hernia  550	Both sexes	1.271
Le¾n	Group 1107 Inguinal hernia  550	Men	1.162
Le¾n	Group 1107 Inguinal hernia  550	Women	109
Le¾n	Group 1108 Other abdominal hernia  551-553	Both sexes	666
Le¾n	Group 1108 Other abdominal hernia  551-553	Men	342
Le¾n	Group 1108 Other abdominal hernia  551-553	Women	324
Le¾n	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	124
Le¾n	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	72
Le¾n	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	52
Le¾n	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	465
Le¾n	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	233
Le¾n	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	232
Le¾n	Group 1111 Intestinal obstruction without hernia 560	Both sexes	382
Le¾n	Group 1111 Intestinal obstruction without hernia 560	Men	198
Le¾n	Group 1111 Intestinal obstruction without hernia 560	Women	184
Le¾n	Group 1112 Intestinal diverticulosis 562	Both sexes	355
Le¾n	Group 1112 Intestinal diverticulosis 562	Men	176
Le¾n	Group 1112 Intestinal diverticulosis 562	Women	179
Le¾n	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	411
Le¾n	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	257
Le¾n	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	154
Le¾n	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	388
Le¾n	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	184
Le¾n	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	204
Le¾n	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	110
Le¾n	Group 1115 Alcoholic hepatitis 5710-5713	Men	92
Le¾n	Group 1115 Alcoholic hepatitis 5710-5713	Women	18
Le¾n	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	194
Le¾n	Group 1116 Other diseases of the liver 570,5714-573	Men	126
Le¾n	Group 1116 Other diseases of the liver 570,5714-573	Women	68
Le¾n	Group 1117 Cholelithiasis  574	Both sexes	1.288
Le¾n	Group 1117 Cholelithiasis  574	Men	607
Le¾n	Group 1117 Cholelithiasis  574	Women	681
Le¾n	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	313
Le¾n	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	189
Le¾n	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	124
Le¾n	Group 1119 Pancreatic diseases 577	Both sexes	312
Le¾n	Group 1119 Pancreatic diseases 577	Men	182
Le¾n	Group 1119 Pancreatic diseases 577	Women	130
Le¾n	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	215
Le¾n	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	118
Le¾n	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	97
Le¾n	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	799
Le¾n	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	444
Le¾n	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	355
Le¾n	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	405
Le¾n	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	259
Le¾n	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	146
Le¾n	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	40
Le¾n	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	17
Le¾n	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	23
Le¾n	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	354
Le¾n	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	168
Le¾n	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	186
Le¾n	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.885
Le¾n	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.299
Le¾n	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.586
Le¾n	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Le¾n	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Le¾n	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Le¾n	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Le¾n	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Le¾n	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Le¾n	Group 1303 Internal derangement of knee 717	Both sexes	651
Le¾n	Group 1303 Internal derangement of knee 717	Men	416
Le¾n	Group 1303 Internal derangement of knee 717	Women	235
Le¾n	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.710
Le¾n	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	776
Le¾n	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	934
Le¾n	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	95
Le¾n	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	34
Le¾n	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	61
Le¾n	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	338
Le¾n	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	162
Le¾n	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	176
Le¾n	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	439
Le¾n	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	236
Le¾n	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	203
Le¾n	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	259
Le¾n	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	123
Le¾n	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	136
Le¾n	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	680
Le¾n	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	310
Le¾n	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	370
Le¾n	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	713
Le¾n	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	242
Le¾n	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	471
Le¾n	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.759
Le¾n	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.603
Le¾n	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.156
Le¾n	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	196
Le¾n	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	87
Le¾n	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	109
Le¾n	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	329
Le¾n	Group 1402 Renal failure  5836-5837, 584-586	Men	194
Le¾n	Group 1402 Renal failure  5836-5837, 584-586	Women	135
Le¾n	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	329
Le¾n	Group 1403 Urolithiasis  592, 594, 7880	Men	184
Le¾n	Group 1403 Urolithiasis  592, 594, 7880	Women	145
Le¾n	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.186
Le¾n	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	478
Le¾n	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	708
Le¾n	Group 1405 Prostatic hyperplasia  600	Both sexes	329
Le¾n	Group 1405 Prostatic hyperplasia  600	Men	329
Le¾n	Group 1405 Prostatic hyperplasia  600	Women	..
Le¾n	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	307
Le¾n	Group 1406 Other diseases of the male genital organs    601-608	Men	307
Le¾n	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Le¾n	Group 1407 Disorders of breast  610-612	Both sexes	147
Le¾n	Group 1407 Disorders of breast  610-612	Men	20
Le¾n	Group 1407 Disorders of breast  610-612	Women	127
Le¾n	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	97
Le¾n	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Le¾n	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	97
Le¾n	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	184
Le¾n	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Le¾n	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	184
Le¾n	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	655
Le¾n	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	4
Le¾n	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	651
Le¾n	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.669
Le¾n	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Le¾n	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.669
Le¾n	Group 1501 Legally induced abortion  635	Both sexes	..
Le¾n	Group 1501 Legally induced abortion  635	Men	..
Le¾n	Group 1501 Legally induced abortion  635	Women	..
Le¾n	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	250
Le¾n	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Le¾n	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	250
Le¾n	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.996
Le¾n	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Le¾n	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.996
Le¾n	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	526
Le¾n	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Le¾n	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	526
Le¾n	Group 1505 Single spontaneous delivery  650	Both sexes	556
Le¾n	Group 1505 Single spontaneous delivery  650	Men	..
Le¾n	Group 1505 Single spontaneous delivery  650	Women	556
Le¾n	Group 1506 Other deliveries  6695-6697	Both sexes	141
Le¾n	Group 1506 Other deliveries  6695-6697	Men	..
Le¾n	Group 1506 Other deliveries  6695-6697	Women	141
Le¾n	Group 1507 Complications related to the puerperium  670-676	Both sexes	18
Le¾n	Group 1507 Complications related to the puerperium  670-676	Men	..
Le¾n	Group 1507 Complications related to the puerperium  670-676	Women	18
Le¾n	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	182
Le¾n	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Le¾n	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	182
Le¾n	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	545
Le¾n	Group 1600 Some disorders originating in the perinatal period  760-779	Men	303
Le¾n	Group 1600 Some disorders originating in the perinatal period  760-779	Women	242
Le¾n	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	172
Le¾n	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	93
Le¾n	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	79
Le¾n	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	373
Le¾n	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	210
Le¾n	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	163
Le¾n	Grupo 1700 Congenital abnormalities  740-759	Both sexes	244
Le¾n	Grupo 1700 Congenital abnormalities  740-759	Men	143
Le¾n	Grupo 1700 Congenital abnormalities  740-759	Women	101
Le¾n	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.716
Le¾n	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.463
Le¾n	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.253
Le¾n	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	220
Le¾n	Group 1801 Pain in throat and chest 7841, 7865	Men	123
Le¾n	Group 1801 Pain in throat and chest 7841, 7865	Women	97
Le¾n	Group 1802 Abdominal pain   7890	Both sexes	265
Le¾n	Group 1802 Abdominal pain   7890	Men	125
Le¾n	Group 1802 Abdominal pain   7890	Women	140
Le¾n	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	364
Le¾n	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	192
Le¾n	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	172
Le¾n	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.867
Le¾n	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.023
Le¾n	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	844
Le¾n	Group 1900 Injuries and poisoning  800-999	Both sexes	5.528
Le¾n	Group 1900 Injuries and poisoning  800-999	Men	2.746
Le¾n	Group 1900 Injuries and poisoning  800-999	Women	2.782
Le¾n	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	352
Le¾n	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	181
Le¾n	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	171
Le¾n	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	157
Le¾n	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	109
Le¾n	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	48
Le¾n	Group 1903 Radius and ulna fracture 813	Both sexes	193
Le¾n	Group 1903 Radius and ulna fracture 813	Men	86
Le¾n	Group 1903 Radius and ulna fracture 813	Women	107
Le¾n	Group 1904 Femur fracture  820-821	Both sexes	1.118
Le¾n	Group 1904 Femur fracture  820-821	Men	314
Le¾n	Group 1904 Femur fracture  820-821	Women	804
Le¾n	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	296
Le¾n	Group 1905 Leg fracture, including the ankle 823-824	Men	151
Le¾n	Group 1905 Leg fracture, including the ankle 823-824	Women	145
Le¾n	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.669
Le¾n	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	954
Le¾n	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	715
Le¾n	Group 1907 Burns  940-949	Both sexes	44
Le¾n	Group 1907 Burns  940-949	Men	31
Le¾n	Group 1907 Burns  940-949	Women	13
Le¾n	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	161
Le¾n	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	65
Le¾n	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	96
Le¾n	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.276
Le¾n	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	709
Le¾n	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	567
Le¾n	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	7
Le¾n	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	7
Le¾n	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Le¾n	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	255
Le¾n	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	139
Le¾n	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	116
Le¾n	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.627
Le¾n	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	852
Le¾n	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	775
Le¾n	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	56
Le¾n	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	38
Le¾n	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	18
Le¾n	Group 2102 Contraceptive management  V25	Both sexes	36
Le¾n	Group 2102 Contraceptive management  V25	Men	..
Le¾n	Group 2102 Contraceptive management  V25	Women	36
Le¾n	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Le¾n	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Le¾n	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Le¾n	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	328
Le¾n	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	205
Le¾n	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	123
Le¾n	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.207
Le¾n	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	609
Le¾n	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	598
Palencia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	18.680
Palencia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	9.567
Palencia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	9.113
Palencia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	332
Palencia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	204
Palencia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	128
Palencia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	91
Palencia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	49
Palencia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	42
Palencia	Group 0102 Imprecise intestinal infections 009	Both sexes	12
Palencia	Group 0102 Imprecise intestinal infections 009	Men	7
Palencia	Group 0102 Imprecise intestinal infections 009	Women	5
Palencia	Group 0103 Tuberculosis 010-018, 137	Both sexes	13
Palencia	Group 0103 Tuberculosis 010-018, 137	Men	6
Palencia	Group 0103 Tuberculosis 010-018, 137	Women	7
Palencia	Group 0104 Septicaemia  038	Both sexes	66
Palencia	Group 0104 Septicaemia  038	Men	39
Palencia	Group 0104 Septicaemia  038	Women	27
Palencia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	10
Palencia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
Palencia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
Palencia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	140
Palencia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	96
Palencia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	44
Palencia	Group 0200 Neoplasms  140-239	Both sexes	1.640
Palencia	Group 0200 Neoplasms  140-239	Men	894
Palencia	Group 0200 Neoplasms  140-239	Women	746
Palencia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	221
Palencia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	133
Palencia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	88
Palencia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	124
Palencia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	102
Palencia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	22
Palencia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	3
Palencia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	1
Palencia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	2
Palencia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	112
Palencia	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Palencia	Group 0204 Malignant neoplasm of breast  174-175	Women	111
Palencia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	39
Palencia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Palencia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	39
Palencia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	16
Palencia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Palencia	Group 0206 Malignant neoplasm of ovary  1830	Women	16
Palencia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	63
Palencia	Group 0207 Malignant neoplasm of prostate  185	Men	63
Palencia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Palencia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	185
Palencia	Group 0208 Malignant neoplasm of bladder  188	Men	157
Palencia	Group 0208 Malignant neoplasm of bladder  188	Women	28
Palencia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	574
Palencia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	340
Palencia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	234
Palencia	Group 0210 Carcinoma in situ  230-234	Both sexes	29
Palencia	Group 0210 Carcinoma in situ  230-234	Men	8
Palencia	Group 0210 Carcinoma in situ  230-234	Women	21
Palencia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	13
Palencia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	10
Palencia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	3
Palencia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	78
Palencia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Palencia	Grupo 0212 Leiomyoma of uterus  218	Women	78
Palencia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	183
Palencia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	79
Palencia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	104
Palencia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	161
Palencia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	80
Palencia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	81
Palencia	Group 0301 Anaemias 280-285	Both sexes	115
Palencia	Group 0301 Anaemias 280-285	Men	57
Palencia	Group 0301 Anaemias 280-285	Women	58
Palencia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	46
Palencia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	23
Palencia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	23
Palencia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	277
Palencia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	120
Palencia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	157
Palencia	Group 0401 Diabetes mellitus  249-250	Both sexes	101
Palencia	Group 0401 Diabetes mellitus  249-250	Men	51
Palencia	Group 0401 Diabetes mellitus  249-250	Women	50
Palencia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	176
Palencia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	69
Palencia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	107
Palencia	Group 0500 Mental disorders  290-319	Both sexes	820
Palencia	Group 0500 Mental disorders  290-319	Men	463
Palencia	Group 0500 Mental disorders  290-319	Women	357
Palencia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	29
Palencia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	13
Palencia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	16
Palencia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	75
Palencia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	63
Palencia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	12
Palencia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	117
Palencia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	100
Palencia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	17
Palencia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	217
Palencia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	120
Palencia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	97
Palencia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	167
Palencia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	61
Palencia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	106
Palencia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	215
Palencia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	106
Palencia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	109
Palencia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	409
Palencia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	206
Palencia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	203
Palencia	Group 0601 Alzheimer's disease  3310	Both sexes	22
Palencia	Group 0601 Alzheimer's disease  3310	Men	8
Palencia	Group 0601 Alzheimer's disease  3310	Women	14
Palencia	Group 0602 Multiple sclerosis 340	Both sexes	26
Palencia	Group 0602 Multiple sclerosis 340	Men	11
Palencia	Group 0602 Multiple sclerosis 340	Women	15
Palencia	Group 0603 Epilepsy  345	Both sexes	73
Palencia	Group 0603 Epilepsy  345	Men	43
Palencia	Group 0603 Epilepsy  345	Women	30
Palencia	Group 0604 Transient cerebral ischemia 435	Both sexes	91
Palencia	Group 0604 Transient cerebral ischemia 435	Men	40
Palencia	Group 0604 Transient cerebral ischemia 435	Women	51
Palencia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	197
Palencia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	104
Palencia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	93
Palencia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	78
Palencia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	25
Palencia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	53
Palencia	Grupo 0701 Cataract  366	Both sexes	11
Palencia	Grupo 0701 Cataract  366	Men	..
Palencia	Grupo 0701 Cataract  366	Women	11
Palencia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	67
Palencia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	25
Palencia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	42
Palencia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	92
Palencia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	45
Palencia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	47
Palencia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.493
Palencia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.248
Palencia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.245
Palencia	Group 0901 Hypertensive disease  401-405	Both sexes	241
Palencia	Group 0901 Hypertensive disease  401-405	Men	69
Palencia	Group 0901 Hypertensive disease  401-405	Women	172
Palencia	Group 0902 Angina pectoris  4111, 413	Both sexes	87
Palencia	Group 0902 Angina pectoris  4111, 413	Men	50
Palencia	Group 0902 Angina pectoris  4111, 413	Women	37
Palencia	Group 0903 Acute myocardial infarction  410	Both sexes	243
Palencia	Group 0903 Acute myocardial infarction  410	Men	162
Palencia	Group 0903 Acute myocardial infarction  410	Women	81
Palencia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	115
Palencia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	91
Palencia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	24
Palencia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	85
Palencia	Group 0905 Diseases of the lungs circulation 415-417	Men	33
Palencia	Group 0905 Diseases of the lungs circulation 415-417	Women	52
Palencia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	470
Palencia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	221
Palencia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	249
Palencia	Grupo 0907 Heart failure  428	Both sexes	553
Palencia	Grupo 0907 Heart failure  428	Men	269
Palencia	Grupo 0907 Heart failure  428	Women	284
Palencia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	380
Palencia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	177
Palencia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	203
Palencia	Grupo 0909 Atherosclerosis  440	Both sexes	29
Palencia	Grupo 0909 Atherosclerosis  440	Men	17
Palencia	Grupo 0909 Atherosclerosis  440	Women	12
Palencia	Group 0910 Varicose veins of lower extremities 454	Both sexes	2
Palencia	Group 0910 Varicose veins of lower extremities 454	Men	1
Palencia	Group 0910 Varicose veins of lower extremities 454	Women	1
Palencia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	288
Palencia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	158
Palencia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	130
Palencia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.765
Palencia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.596
Palencia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.169
Palencia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	144
Palencia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	85
Palencia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	59
Palencia	Group 1002 Pneumonia 480-486	Both sexes	484
Palencia	Group 1002 Pneumonia 480-486	Men	300
Palencia	Group 1002 Pneumonia 480-486	Women	184
Palencia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	162
Palencia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	74
Palencia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	88
Palencia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	183
Palencia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	106
Palencia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	77
Palencia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	306
Palencia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	203
Palencia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	103
Palencia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	531
Palencia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	397
Palencia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	134
Palencia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	123
Palencia	Group 1007 Asthma 4930-4931,4938-4939	Men	27
Palencia	Group 1007 Asthma 4930-4931,4938-4939	Women	96
Palencia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	832
Palencia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	404
Palencia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	428
Palencia	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.694
Palencia	Group 1100 Diseases of the digestive system  520-579	Men	1.650
Palencia	Group 1100 Diseases of the digestive system  520-579	Women	1.044
Palencia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	13
Palencia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	7
Palencia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	6
Palencia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	10
Palencia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	7
Palencia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	3
Palencia	Group 1103 Diseases of the esophagus 530	Both sexes	42
Palencia	Group 1103 Diseases of the esophagus 530	Men	33
Palencia	Group 1103 Diseases of the esophagus 530	Women	9
Palencia	Group 1104 Peptic ulcer 531-534	Both sexes	66
Palencia	Group 1104 Peptic ulcer 531-534	Men	47
Palencia	Group 1104 Peptic ulcer 531-534	Women	19
Palencia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	95
Palencia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	56
Palencia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	39
Palencia	Group 1106 Appendicitis  540-543	Both sexes	191
Palencia	Group 1106 Appendicitis  540-543	Men	106
Palencia	Group 1106 Appendicitis  540-543	Women	85
Palencia	Group 1107 Inguinal hernia  550	Both sexes	415
Palencia	Group 1107 Inguinal hernia  550	Men	386
Palencia	Group 1107 Inguinal hernia  550	Women	29
Palencia	Group 1108 Other abdominal hernia  551-553	Both sexes	190
Palencia	Group 1108 Other abdominal hernia  551-553	Men	86
Palencia	Group 1108 Other abdominal hernia  551-553	Women	104
Palencia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	26
Palencia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	11
Palencia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	15
Palencia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	193
Palencia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	99
Palencia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	94
Palencia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	118
Palencia	Group 1111 Intestinal obstruction without hernia 560	Men	75
Palencia	Group 1111 Intestinal obstruction without hernia 560	Women	43
Palencia	Group 1112 Intestinal diverticulosis 562	Both sexes	95
Palencia	Group 1112 Intestinal diverticulosis 562	Men	46
Palencia	Group 1112 Intestinal diverticulosis 562	Women	49
Palencia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	150
Palencia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	100
Palencia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	50
Palencia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	112
Palencia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	53
Palencia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	59
Palencia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	56
Palencia	Group 1115 Alcoholic hepatitis 5710-5713	Men	46
Palencia	Group 1115 Alcoholic hepatitis 5710-5713	Women	10
Palencia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	89
Palencia	Group 1116 Other diseases of the liver 570,5714-573	Men	57
Palencia	Group 1116 Other diseases of the liver 570,5714-573	Women	32
Palencia	Group 1117 Cholelithiasis  574	Both sexes	443
Palencia	Group 1117 Cholelithiasis  574	Men	215
Palencia	Group 1117 Cholelithiasis  574	Women	228
Palencia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	146
Palencia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	80
Palencia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	66
Palencia	Group 1119 Pancreatic diseases 577	Both sexes	139
Palencia	Group 1119 Pancreatic diseases 577	Men	82
Palencia	Group 1119 Pancreatic diseases 577	Women	57
Palencia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	105
Palencia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	58
Palencia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	47
Palencia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	198
Palencia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	114
Palencia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	84
Palencia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	140
Palencia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	93
Palencia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	47
Palencia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	6
Palencia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	3
Palencia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	3
Palencia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	52
Palencia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	18
Palencia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	34
Palencia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.036
Palencia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	533
Palencia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	503
Palencia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Palencia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Palencia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Palencia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Palencia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Palencia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Palencia	Group 1303 Internal derangement of knee 717	Both sexes	172
Palencia	Group 1303 Internal derangement of knee 717	Men	119
Palencia	Group 1303 Internal derangement of knee 717	Women	53
Palencia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	382
Palencia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	189
Palencia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	193
Palencia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	13
Palencia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	4
Palencia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	9
Palencia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	16
Palencia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	10
Palencia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	6
Palencia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	44
Palencia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	29
Palencia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	15
Palencia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	38
Palencia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	13
Palencia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	25
Palencia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	200
Palencia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	112
Palencia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	88
Palencia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	171
Palencia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	57
Palencia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	114
Palencia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.331
Palencia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	704
Palencia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	627
Palencia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	90
Palencia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	31
Palencia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	59
Palencia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	130
Palencia	Group 1402 Renal failure  5836-5837, 584-586	Men	75
Palencia	Group 1402 Renal failure  5836-5837, 584-586	Women	55
Palencia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	228
Palencia	Group 1403 Urolithiasis  592, 594, 7880	Men	140
Palencia	Group 1403 Urolithiasis  592, 594, 7880	Women	88
Palencia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	423
Palencia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	233
Palencia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	190
Palencia	Group 1405 Prostatic hyperplasia  600	Both sexes	117
Palencia	Group 1405 Prostatic hyperplasia  600	Men	117
Palencia	Group 1405 Prostatic hyperplasia  600	Women	..
Palencia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	104
Palencia	Group 1406 Other diseases of the male genital organs    601-608	Men	104
Palencia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Palencia	Group 1407 Disorders of breast  610-612	Both sexes	26
Palencia	Group 1407 Disorders of breast  610-612	Men	4
Palencia	Group 1407 Disorders of breast  610-612	Women	22
Palencia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	28
Palencia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Palencia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	28
Palencia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	14
Palencia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Palencia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	14
Palencia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	171
Palencia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Palencia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	171
Palencia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.320
Palencia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Palencia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.320
Palencia	Group 1501 Legally induced abortion  635	Both sexes	..
Palencia	Group 1501 Legally induced abortion  635	Men	..
Palencia	Group 1501 Legally induced abortion  635	Women	..
Palencia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	188
Palencia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Palencia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	188
Palencia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	664
Palencia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Palencia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	664
Palencia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	273
Palencia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Palencia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	273
Palencia	Group 1505 Single spontaneous delivery  650	Both sexes	42
Palencia	Group 1505 Single spontaneous delivery  650	Men	..
Palencia	Group 1505 Single spontaneous delivery  650	Women	42
Palencia	Group 1506 Other deliveries  6695-6697	Both sexes	82
Palencia	Group 1506 Other deliveries  6695-6697	Men	..
Palencia	Group 1506 Other deliveries  6695-6697	Women	82
Palencia	Group 1507 Complications related to the puerperium  670-676	Both sexes	10
Palencia	Group 1507 Complications related to the puerperium  670-676	Men	..
Palencia	Group 1507 Complications related to the puerperium  670-676	Women	10
Palencia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	61
Palencia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Palencia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	61
Palencia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	205
Palencia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	102
Palencia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	103
Palencia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	43
Palencia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	17
Palencia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	26
Palencia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	162
Palencia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	85
Palencia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	77
Palencia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	53
Palencia	Grupo 1700 Congenital abnormalities  740-759	Men	26
Palencia	Grupo 1700 Congenital abnormalities  740-759	Women	27
Palencia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	903
Palencia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	543
Palencia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	360
Palencia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	192
Palencia	Group 1801 Pain in throat and chest 7841, 7865	Men	130
Palencia	Group 1801 Pain in throat and chest 7841, 7865	Women	62
Palencia	Group 1802 Abdominal pain   7890	Both sexes	85
Palencia	Group 1802 Abdominal pain   7890	Men	35
Palencia	Group 1802 Abdominal pain   7890	Women	50
Palencia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	10
Palencia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	8
Palencia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	2
Palencia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	616
Palencia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	370
Palencia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	246
Palencia	Group 1900 Injuries and poisoning  800-999	Both sexes	1.617
Palencia	Group 1900 Injuries and poisoning  800-999	Men	821
Palencia	Group 1900 Injuries and poisoning  800-999	Women	796
Palencia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	109
Palencia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	63
Palencia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	46
Palencia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	22
Palencia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	11
Palencia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	11
Palencia	Group 1903 Radius and ulna fracture 813	Both sexes	85
Palencia	Group 1903 Radius and ulna fracture 813	Men	43
Palencia	Group 1903 Radius and ulna fracture 813	Women	42
Palencia	Group 1904 Femur fracture  820-821	Both sexes	330
Palencia	Group 1904 Femur fracture  820-821	Men	83
Palencia	Group 1904 Femur fracture  820-821	Women	247
Palencia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	121
Palencia	Group 1905 Leg fracture, including the ankle 823-824	Men	63
Palencia	Group 1905 Leg fracture, including the ankle 823-824	Women	58
Palencia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	414
Palencia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	247
Palencia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	167
Palencia	Group 1907 Burns  940-949	Both sexes	2
Palencia	Group 1907 Burns  940-949	Men	1
Palencia	Group 1907 Burns  940-949	Women	1
Palencia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	76
Palencia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	39
Palencia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	37
Palencia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	393
Palencia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	240
Palencia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	153
Palencia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	4
Palencia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Palencia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Palencia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	61
Palencia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	28
Palencia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	33
Palencia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	256
Palencia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	193
Palencia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	63
Palencia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	1
Palencia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	1
Palencia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	..
Palencia	Group 2102 Contraceptive management  V25	Both sexes	1
Palencia	Group 2102 Contraceptive management  V25	Men	1
Palencia	Group 2102 Contraceptive management  V25	Women	..
Palencia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Palencia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Palencia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Palencia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	177
Palencia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	140
Palencia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	37
Palencia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	77
Palencia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	51
Palencia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	26
Salamanca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	34.379
Salamanca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	16.939
Salamanca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	17.440
Salamanca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	952
Salamanca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	546
Salamanca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	406
Salamanca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	83
Salamanca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	39
Salamanca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	44
Salamanca	Group 0102 Imprecise intestinal infections 009	Both sexes	39
Salamanca	Group 0102 Imprecise intestinal infections 009	Men	21
Salamanca	Group 0102 Imprecise intestinal infections 009	Women	18
Salamanca	Group 0103 Tuberculosis 010-018, 137	Both sexes	20
Salamanca	Group 0103 Tuberculosis 010-018, 137	Men	14
Salamanca	Group 0103 Tuberculosis 010-018, 137	Women	6
Salamanca	Group 0104 Septicaemia  038	Both sexes	630
Salamanca	Group 0104 Septicaemia  038	Men	358
Salamanca	Group 0104 Septicaemia  038	Women	272
Salamanca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	16
Salamanca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	12
Salamanca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	4
Salamanca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	164
Salamanca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	102
Salamanca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	62
Salamanca	Group 0200 Neoplasms  140-239	Both sexes	3.774
Salamanca	Group 0200 Neoplasms  140-239	Men	2.019
Salamanca	Group 0200 Neoplasms  140-239	Women	1.755
Salamanca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	410
Salamanca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	236
Salamanca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	174
Salamanca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	297
Salamanca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	235
Salamanca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	62
Salamanca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	131
Salamanca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	73
Salamanca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	58
Salamanca	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	159
Salamanca	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Salamanca	Group 0204 Malignant neoplasm of breast  174-175	Women	156
Salamanca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	53
Salamanca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Salamanca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	53
Salamanca	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	51
Salamanca	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Salamanca	Group 0206 Malignant neoplasm of ovary  1830	Women	51
Salamanca	Group 0207 Malignant neoplasm of prostate  185	Both sexes	123
Salamanca	Group 0207 Malignant neoplasm of prostate  185	Men	123
Salamanca	Group 0207 Malignant neoplasm of prostate  185	Women	..
Salamanca	Group 0208 Malignant neoplasm of bladder  188	Both sexes	338
Salamanca	Group 0208 Malignant neoplasm of bladder  188	Men	282
Salamanca	Group 0208 Malignant neoplasm of bladder  188	Women	56
Salamanca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.470
Salamanca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	788
Salamanca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	682
Salamanca	Group 0210 Carcinoma in situ  230-234	Both sexes	33
Salamanca	Group 0210 Carcinoma in situ  230-234	Men	10
Salamanca	Group 0210 Carcinoma in situ  230-234	Women	23
Salamanca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	25
Salamanca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	14
Salamanca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	11
Salamanca	Grupo 0212 Leiomyoma of uterus  218	Both sexes	146
Salamanca	Grupo 0212 Leiomyoma of uterus  218	Men	..
Salamanca	Grupo 0212 Leiomyoma of uterus  218	Women	146
Salamanca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	538
Salamanca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	255
Salamanca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	283
Salamanca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	368
Salamanca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	180
Salamanca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	188
Salamanca	Group 0301 Anaemias 280-285	Both sexes	247
Salamanca	Group 0301 Anaemias 280-285	Men	112
Salamanca	Group 0301 Anaemias 280-285	Women	135
Salamanca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	121
Salamanca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	68
Salamanca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	53
Salamanca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	749
Salamanca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	325
Salamanca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	424
Salamanca	Group 0401 Diabetes mellitus  249-250	Both sexes	365
Salamanca	Group 0401 Diabetes mellitus  249-250	Men	191
Salamanca	Group 0401 Diabetes mellitus  249-250	Women	174
Salamanca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	384
Salamanca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	134
Salamanca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	250
Salamanca	Group 0500 Mental disorders  290-319	Both sexes	748
Salamanca	Group 0500 Mental disorders  290-319	Men	438
Salamanca	Group 0500 Mental disorders  290-319	Women	310
Salamanca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	8
Salamanca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	2
Salamanca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	6
Salamanca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	70
Salamanca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	58
Salamanca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	12
Salamanca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	187
Salamanca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	144
Salamanca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	43
Salamanca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	162
Salamanca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	106
Salamanca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	56
Salamanca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	132
Salamanca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	46
Salamanca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	86
Salamanca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	189
Salamanca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	82
Salamanca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	107
Salamanca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	905
Salamanca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	372
Salamanca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	533
Salamanca	Group 0601 Alzheimer's disease  3310	Both sexes	6
Salamanca	Group 0601 Alzheimer's disease  3310	Men	2
Salamanca	Group 0601 Alzheimer's disease  3310	Women	4
Salamanca	Group 0602 Multiple sclerosis 340	Both sexes	4
Salamanca	Group 0602 Multiple sclerosis 340	Men	1
Salamanca	Group 0602 Multiple sclerosis 340	Women	3
Salamanca	Group 0603 Epilepsy  345	Both sexes	91
Salamanca	Group 0603 Epilepsy  345	Men	45
Salamanca	Group 0603 Epilepsy  345	Women	46
Salamanca	Group 0604 Transient cerebral ischemia 435	Both sexes	84
Salamanca	Group 0604 Transient cerebral ischemia 435	Men	34
Salamanca	Group 0604 Transient cerebral ischemia 435	Women	50
Salamanca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	720
Salamanca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	290
Salamanca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	430
Salamanca	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	118
Salamanca	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	68
Salamanca	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	50
Salamanca	Grupo 0701 Cataract  366	Both sexes	10
Salamanca	Grupo 0701 Cataract  366	Men	3
Salamanca	Grupo 0701 Cataract  366	Women	7
Salamanca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	108
Salamanca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	65
Salamanca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	43
Salamanca	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	241
Salamanca	Group 0800 Diseases of the ear and the mastoid  380-389	Men	130
Salamanca	Group 0800 Diseases of the ear and the mastoid  380-389	Women	111
Salamanca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.891
Salamanca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.779
Salamanca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.112
Salamanca	Group 0901 Hypertensive disease  401-405	Both sexes	338
Salamanca	Group 0901 Hypertensive disease  401-405	Men	130
Salamanca	Group 0901 Hypertensive disease  401-405	Women	208
Salamanca	Group 0902 Angina pectoris  4111, 413	Both sexes	120
Salamanca	Group 0902 Angina pectoris  4111, 413	Men	89
Salamanca	Group 0902 Angina pectoris  4111, 413	Women	31
Salamanca	Group 0903 Acute myocardial infarction  410	Both sexes	575
Salamanca	Group 0903 Acute myocardial infarction  410	Men	419
Salamanca	Group 0903 Acute myocardial infarction  410	Women	156
Salamanca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	210
Salamanca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	163
Salamanca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	47
Salamanca	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	215
Salamanca	Group 0905 Diseases of the lungs circulation 415-417	Men	105
Salamanca	Group 0905 Diseases of the lungs circulation 415-417	Women	110
Salamanca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	475
Salamanca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	268
Salamanca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	207
Salamanca	Grupo 0907 Heart failure  428	Both sexes	963
Salamanca	Grupo 0907 Heart failure  428	Men	439
Salamanca	Grupo 0907 Heart failure  428	Women	524
Salamanca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	778
Salamanca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	438
Salamanca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	340
Salamanca	Grupo 0909 Atherosclerosis  440	Both sexes	124
Salamanca	Grupo 0909 Atherosclerosis  440	Men	105
Salamanca	Grupo 0909 Atherosclerosis  440	Women	19
Salamanca	Group 0910 Varicose veins of lower extremities 454	Both sexes	190
Salamanca	Group 0910 Varicose veins of lower extremities 454	Men	74
Salamanca	Group 0910 Varicose veins of lower extremities 454	Women	116
Salamanca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	903
Salamanca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	549
Salamanca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	354
Salamanca	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	3.632
Salamanca	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.168
Salamanca	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.464
Salamanca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	104
Salamanca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	51
Salamanca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	53
Salamanca	Group 1002 Pneumonia 480-486	Both sexes	728
Salamanca	Group 1002 Pneumonia 480-486	Men	440
Salamanca	Group 1002 Pneumonia 480-486	Women	288
Salamanca	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	494
Salamanca	Group 1003 Acute bronchitis and bronchiolitis  466	Men	228
Salamanca	Group 1003 Acute bronchitis and bronchiolitis  466	Women	266
Salamanca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	101
Salamanca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	52
Salamanca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	49
Salamanca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	409
Salamanca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	262
Salamanca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	147
Salamanca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	569
Salamanca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	488
Salamanca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	81
Salamanca	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	109
Salamanca	Group 1007 Asthma 4930-4931,4938-4939	Men	34
Salamanca	Group 1007 Asthma 4930-4931,4938-4939	Women	75
Salamanca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.118
Salamanca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	613
Salamanca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	505
Salamanca	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.018
Salamanca	Group 1100 Diseases of the digestive system  520-579	Men	2.226
Salamanca	Group 1100 Diseases of the digestive system  520-579	Women	1.792
Salamanca	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	49
Salamanca	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	22
Salamanca	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	27
Salamanca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	63
Salamanca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	37
Salamanca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	26
Salamanca	Group 1103 Diseases of the esophagus 530	Both sexes	92
Salamanca	Group 1103 Diseases of the esophagus 530	Men	46
Salamanca	Group 1103 Diseases of the esophagus 530	Women	46
Salamanca	Group 1104 Peptic ulcer 531-534	Both sexes	102
Salamanca	Group 1104 Peptic ulcer 531-534	Men	63
Salamanca	Group 1104 Peptic ulcer 531-534	Women	39
Salamanca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	100
Salamanca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	59
Salamanca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	41
Salamanca	Group 1106 Appendicitis  540-543	Both sexes	303
Salamanca	Group 1106 Appendicitis  540-543	Men	173
Salamanca	Group 1106 Appendicitis  540-543	Women	130
Salamanca	Group 1107 Inguinal hernia  550	Both sexes	372
Salamanca	Group 1107 Inguinal hernia  550	Men	320
Salamanca	Group 1107 Inguinal hernia  550	Women	52
Salamanca	Group 1108 Other abdominal hernia  551-553	Both sexes	323
Salamanca	Group 1108 Other abdominal hernia  551-553	Men	156
Salamanca	Group 1108 Other abdominal hernia  551-553	Women	167
Salamanca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	39
Salamanca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	24
Salamanca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	15
Salamanca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	167
Salamanca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	65
Salamanca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	102
Salamanca	Group 1111 Intestinal obstruction without hernia 560	Both sexes	302
Salamanca	Group 1111 Intestinal obstruction without hernia 560	Men	146
Salamanca	Group 1111 Intestinal obstruction without hernia 560	Women	156
Salamanca	Group 1112 Intestinal diverticulosis 562	Both sexes	198
Salamanca	Group 1112 Intestinal diverticulosis 562	Men	96
Salamanca	Group 1112 Intestinal diverticulosis 562	Women	102
Salamanca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	184
Salamanca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	120
Salamanca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	64
Salamanca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	171
Salamanca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	87
Salamanca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	84
Salamanca	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	49
Salamanca	Group 1115 Alcoholic hepatitis 5710-5713	Men	41
Salamanca	Group 1115 Alcoholic hepatitis 5710-5713	Women	8
Salamanca	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	134
Salamanca	Group 1116 Other diseases of the liver 570,5714-573	Men	89
Salamanca	Group 1116 Other diseases of the liver 570,5714-573	Women	45
Salamanca	Group 1117 Cholelithiasis  574	Both sexes	782
Salamanca	Group 1117 Cholelithiasis  574	Men	355
Salamanca	Group 1117 Cholelithiasis  574	Women	427
Salamanca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	178
Salamanca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	99
Salamanca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	79
Salamanca	Group 1119 Pancreatic diseases 577	Both sexes	178
Salamanca	Group 1119 Pancreatic diseases 577	Men	104
Salamanca	Group 1119 Pancreatic diseases 577	Women	74
Salamanca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	232
Salamanca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	124
Salamanca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	108
Salamanca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	250
Salamanca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	144
Salamanca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	106
Salamanca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	131
Salamanca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	75
Salamanca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	56
Salamanca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	12
Salamanca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	8
Salamanca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	4
Salamanca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	107
Salamanca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	61
Salamanca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	46
Salamanca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.697
Salamanca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	738
Salamanca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	959
Salamanca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Salamanca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Salamanca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Salamanca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Salamanca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Salamanca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Salamanca	Group 1303 Internal derangement of knee 717	Both sexes	47
Salamanca	Group 1303 Internal derangement of knee 717	Men	35
Salamanca	Group 1303 Internal derangement of knee 717	Women	12
Salamanca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	719
Salamanca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	283
Salamanca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	436
Salamanca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	48
Salamanca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	24
Salamanca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	24
Salamanca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	160
Salamanca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	71
Salamanca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	89
Salamanca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	244
Salamanca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	120
Salamanca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	124
Salamanca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	27
Salamanca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	12
Salamanca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	15
Salamanca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	183
Salamanca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	90
Salamanca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	93
Salamanca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	269
Salamanca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	103
Salamanca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	166
Salamanca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.992
Salamanca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	978
Salamanca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.014
Salamanca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	167
Salamanca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	72
Salamanca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	95
Salamanca	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	223
Salamanca	Group 1402 Renal failure  5836-5837, 584-586	Men	132
Salamanca	Group 1402 Renal failure  5836-5837, 584-586	Women	91
Salamanca	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	255
Salamanca	Group 1403 Urolithiasis  592, 594, 7880	Men	160
Salamanca	Group 1403 Urolithiasis  592, 594, 7880	Women	95
Salamanca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	442
Salamanca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	226
Salamanca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	216
Salamanca	Group 1405 Prostatic hyperplasia  600	Both sexes	216
Salamanca	Group 1405 Prostatic hyperplasia  600	Men	216
Salamanca	Group 1405 Prostatic hyperplasia  600	Women	..
Salamanca	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	154
Salamanca	Group 1406 Other diseases of the male genital organs    601-608	Men	154
Salamanca	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Salamanca	Group 1407 Disorders of breast  610-612	Both sexes	97
Salamanca	Group 1407 Disorders of breast  610-612	Men	6
Salamanca	Group 1407 Disorders of breast  610-612	Women	91
Salamanca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	69
Salamanca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Salamanca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	69
Salamanca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	23
Salamanca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Salamanca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	23
Salamanca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	346
Salamanca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	12
Salamanca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	334
Salamanca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.895
Salamanca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Salamanca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.895
Salamanca	Group 1501 Legally induced abortion  635	Both sexes	1
Salamanca	Group 1501 Legally induced abortion  635	Men	..
Salamanca	Group 1501 Legally induced abortion  635	Women	1
Salamanca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	236
Salamanca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Salamanca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	236
Salamanca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.646
Salamanca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Salamanca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.646
Salamanca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	574
Salamanca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Salamanca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	574
Salamanca	Group 1505 Single spontaneous delivery  650	Both sexes	179
Salamanca	Group 1505 Single spontaneous delivery  650	Men	..
Salamanca	Group 1505 Single spontaneous delivery  650	Women	179
Salamanca	Group 1506 Other deliveries  6695-6697	Both sexes	63
Salamanca	Group 1506 Other deliveries  6695-6697	Men	..
Salamanca	Group 1506 Other deliveries  6695-6697	Women	63
Salamanca	Group 1507 Complications related to the puerperium  670-676	Both sexes	20
Salamanca	Group 1507 Complications related to the puerperium  670-676	Men	..
Salamanca	Group 1507 Complications related to the puerperium  670-676	Women	20
Salamanca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	176
Salamanca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Salamanca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	176
Salamanca	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	371
Salamanca	Group 1600 Some disorders originating in the perinatal period  760-779	Men	204
Salamanca	Group 1600 Some disorders originating in the perinatal period  760-779	Women	167
Salamanca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	131
Salamanca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	86
Salamanca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	45
Salamanca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	240
Salamanca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	118
Salamanca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	122
Salamanca	Grupo 1700 Congenital abnormalities  740-759	Both sexes	224
Salamanca	Grupo 1700 Congenital abnormalities  740-759	Men	156
Salamanca	Grupo 1700 Congenital abnormalities  740-759	Women	68
Salamanca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.368
Salamanca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.322
Salamanca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.046
Salamanca	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	104
Salamanca	Group 1801 Pain in throat and chest 7841, 7865	Men	64
Salamanca	Group 1801 Pain in throat and chest 7841, 7865	Women	40
Salamanca	Group 1802 Abdominal pain   7890	Both sexes	170
Salamanca	Group 1802 Abdominal pain   7890	Men	75
Salamanca	Group 1802 Abdominal pain   7890	Women	95
Salamanca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.220
Salamanca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	701
Salamanca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	519
Salamanca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	874
Salamanca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	482
Salamanca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	392
Salamanca	Group 1900 Injuries and poisoning  800-999	Both sexes	3.365
Salamanca	Group 1900 Injuries and poisoning  800-999	Men	1.679
Salamanca	Group 1900 Injuries and poisoning  800-999	Women	1.686
Salamanca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	214
Salamanca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	132
Salamanca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	82
Salamanca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	76
Salamanca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	55
Salamanca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	21
Salamanca	Group 1903 Radius and ulna fracture 813	Both sexes	183
Salamanca	Group 1903 Radius and ulna fracture 813	Men	80
Salamanca	Group 1903 Radius and ulna fracture 813	Women	103
Salamanca	Group 1904 Femur fracture  820-821	Both sexes	603
Salamanca	Group 1904 Femur fracture  820-821	Men	145
Salamanca	Group 1904 Femur fracture  820-821	Women	458
Salamanca	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	224
Salamanca	Group 1905 Leg fracture, including the ankle 823-824	Men	103
Salamanca	Group 1905 Leg fracture, including the ankle 823-824	Women	121
Salamanca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	874
Salamanca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	540
Salamanca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	334
Salamanca	Group 1907 Burns  940-949	Both sexes	28
Salamanca	Group 1907 Burns  940-949	Men	16
Salamanca	Group 1907 Burns  940-949	Women	12
Salamanca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	93
Salamanca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	41
Salamanca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	52
Salamanca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	970
Salamanca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	511
Salamanca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	459
Salamanca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Salamanca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Salamanca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Salamanca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	100
Salamanca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	56
Salamanca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	44
Salamanca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	821
Salamanca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	467
Salamanca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	354
Salamanca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	20
Salamanca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	14
Salamanca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	6
Salamanca	Group 2102 Contraceptive management  V25	Both sexes	11
Salamanca	Group 2102 Contraceptive management  V25	Men	1
Salamanca	Group 2102 Contraceptive management  V25	Women	10
Salamanca	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Salamanca	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Salamanca	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Salamanca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	624
Salamanca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	373
Salamanca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	251
Salamanca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	166
Salamanca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	79
Salamanca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	87
Segovia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	12.781
Segovia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	6.382
Segovia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	6.399
Segovia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	238
Segovia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	133
Segovia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	105
Segovia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	67
Segovia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	33
Segovia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	34
Segovia	Group 0102 Imprecise intestinal infections 009	Both sexes	6
Segovia	Group 0102 Imprecise intestinal infections 009	Men	1
Segovia	Group 0102 Imprecise intestinal infections 009	Women	5
Segovia	Group 0103 Tuberculosis 010-018, 137	Both sexes	1
Segovia	Group 0103 Tuberculosis 010-018, 137	Men	..
Segovia	Group 0103 Tuberculosis 010-018, 137	Women	1
Segovia	Group 0104 Septicaemia  038	Both sexes	95
Segovia	Group 0104 Septicaemia  038	Men	57
Segovia	Group 0104 Septicaemia  038	Women	38
Segovia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	2
Segovia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	2
Segovia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Segovia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	67
Segovia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	40
Segovia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	27
Segovia	Group 0200 Neoplasms  140-239	Both sexes	1.208
Segovia	Group 0200 Neoplasms  140-239	Men	684
Segovia	Group 0200 Neoplasms  140-239	Women	524
Segovia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	196
Segovia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	131
Segovia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	65
Segovia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	82
Segovia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	64
Segovia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	18
Segovia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	21
Segovia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	12
Segovia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	9
Segovia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	92
Segovia	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Segovia	Group 0204 Malignant neoplasm of breast  174-175	Women	92
Segovia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	24
Segovia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Segovia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	24
Segovia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	13
Segovia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Segovia	Group 0206 Malignant neoplasm of ovary  1830	Women	13
Segovia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	51
Segovia	Group 0207 Malignant neoplasm of prostate  185	Men	51
Segovia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Segovia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	121
Segovia	Group 0208 Malignant neoplasm of bladder  188	Men	99
Segovia	Group 0208 Malignant neoplasm of bladder  188	Women	22
Segovia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	403
Segovia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	243
Segovia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	160
Segovia	Group 0210 Carcinoma in situ  230-234	Both sexes	52
Segovia	Group 0210 Carcinoma in situ  230-234	Men	31
Segovia	Group 0210 Carcinoma in situ  230-234	Women	21
Segovia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	5
Segovia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	4
Segovia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	1
Segovia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	40
Segovia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Segovia	Grupo 0212 Leiomyoma of uterus  218	Women	40
Segovia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	108
Segovia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	49
Segovia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	59
Segovia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	113
Segovia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	67
Segovia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	46
Segovia	Group 0301 Anaemias 280-285	Both sexes	68
Segovia	Group 0301 Anaemias 280-285	Men	45
Segovia	Group 0301 Anaemias 280-285	Women	23
Segovia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	45
Segovia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	22
Segovia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	23
Segovia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	191
Segovia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	68
Segovia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	123
Segovia	Group 0401 Diabetes mellitus  249-250	Both sexes	52
Segovia	Group 0401 Diabetes mellitus  249-250	Men	32
Segovia	Group 0401 Diabetes mellitus  249-250	Women	20
Segovia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	139
Segovia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	36
Segovia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	103
Segovia	Group 0500 Mental disorders  290-319	Both sexes	347
Segovia	Group 0500 Mental disorders  290-319	Men	170
Segovia	Group 0500 Mental disorders  290-319	Women	177
Segovia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	8
Segovia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	3
Segovia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	5
Segovia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	37
Segovia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	25
Segovia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	12
Segovia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	9
Segovia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	6
Segovia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Segovia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	83
Segovia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	48
Segovia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	35
Segovia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	122
Segovia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	44
Segovia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	78
Segovia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	88
Segovia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	44
Segovia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	44
Segovia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	251
Segovia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	135
Segovia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	116
Segovia	Group 0601 Alzheimer's disease  3310	Both sexes	11
Segovia	Group 0601 Alzheimer's disease  3310	Men	5
Segovia	Group 0601 Alzheimer's disease  3310	Women	6
Segovia	Group 0602 Multiple sclerosis 340	Both sexes	16
Segovia	Group 0602 Multiple sclerosis 340	Men	8
Segovia	Group 0602 Multiple sclerosis 340	Women	8
Segovia	Group 0603 Epilepsy  345	Both sexes	36
Segovia	Group 0603 Epilepsy  345	Men	16
Segovia	Group 0603 Epilepsy  345	Women	20
Segovia	Group 0604 Transient cerebral ischemia 435	Both sexes	48
Segovia	Group 0604 Transient cerebral ischemia 435	Men	27
Segovia	Group 0604 Transient cerebral ischemia 435	Women	21
Segovia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	140
Segovia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	79
Segovia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	61
Segovia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	187
Segovia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	94
Segovia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	93
Segovia	Grupo 0701 Cataract  366	Both sexes	35
Segovia	Grupo 0701 Cataract  366	Men	19
Segovia	Grupo 0701 Cataract  366	Women	16
Segovia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	152
Segovia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	75
Segovia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	77
Segovia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	64
Segovia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	28
Segovia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	36
Segovia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.643
Segovia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	890
Segovia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	753
Segovia	Group 0901 Hypertensive disease  401-405	Both sexes	59
Segovia	Group 0901 Hypertensive disease  401-405	Men	28
Segovia	Group 0901 Hypertensive disease  401-405	Women	31
Segovia	Group 0902 Angina pectoris  4111, 413	Both sexes	38
Segovia	Group 0902 Angina pectoris  4111, 413	Men	29
Segovia	Group 0902 Angina pectoris  4111, 413	Women	9
Segovia	Group 0903 Acute myocardial infarction  410	Both sexes	195
Segovia	Group 0903 Acute myocardial infarction  410	Men	149
Segovia	Group 0903 Acute myocardial infarction  410	Women	46
Segovia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	55
Segovia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	40
Segovia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	15
Segovia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	61
Segovia	Group 0905 Diseases of the lungs circulation 415-417	Men	31
Segovia	Group 0905 Diseases of the lungs circulation 415-417	Women	30
Segovia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	203
Segovia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	104
Segovia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	99
Segovia	Grupo 0907 Heart failure  428	Both sexes	438
Segovia	Grupo 0907 Heart failure  428	Men	203
Segovia	Grupo 0907 Heart failure  428	Women	235
Segovia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	310
Segovia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	149
Segovia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	161
Segovia	Grupo 0909 Atherosclerosis  440	Both sexes	35
Segovia	Grupo 0909 Atherosclerosis  440	Men	25
Segovia	Grupo 0909 Atherosclerosis  440	Women	10
Segovia	Group 0910 Varicose veins of lower extremities 454	Both sexes	12
Segovia	Group 0910 Varicose veins of lower extremities 454	Men	5
Segovia	Group 0910 Varicose veins of lower extremities 454	Women	7
Segovia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	237
Segovia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	127
Segovia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	110
Segovia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.559
Segovia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	940
Segovia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	619
Segovia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	126
Segovia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	62
Segovia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	64
Segovia	Group 1002 Pneumonia 480-486	Both sexes	338
Segovia	Group 1002 Pneumonia 480-486	Men	198
Segovia	Group 1002 Pneumonia 480-486	Women	140
Segovia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	90
Segovia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	55
Segovia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	35
Segovia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	82
Segovia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	47
Segovia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	35
Segovia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	165
Segovia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	111
Segovia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	54
Segovia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	252
Segovia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	209
Segovia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	43
Segovia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	62
Segovia	Group 1007 Asthma 4930-4931,4938-4939	Men	29
Segovia	Group 1007 Asthma 4930-4931,4938-4939	Women	33
Segovia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	444
Segovia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	229
Segovia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	215
Segovia	Group 1100 Diseases of the digestive system  520-579	Both sexes	1.834
Segovia	Group 1100 Diseases of the digestive system  520-579	Men	1.097
Segovia	Group 1100 Diseases of the digestive system  520-579	Women	737
Segovia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	19
Segovia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	10
Segovia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	9
Segovia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	27
Segovia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	17
Segovia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	10
Segovia	Group 1103 Diseases of the esophagus 530	Both sexes	30
Segovia	Group 1103 Diseases of the esophagus 530	Men	18
Segovia	Group 1103 Diseases of the esophagus 530	Women	12
Segovia	Group 1104 Peptic ulcer 531-534	Both sexes	35
Segovia	Group 1104 Peptic ulcer 531-534	Men	26
Segovia	Group 1104 Peptic ulcer 531-534	Women	9
Segovia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	32
Segovia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	21
Segovia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	11
Segovia	Group 1106 Appendicitis  540-543	Both sexes	178
Segovia	Group 1106 Appendicitis  540-543	Men	102
Segovia	Group 1106 Appendicitis  540-543	Women	76
Segovia	Group 1107 Inguinal hernia  550	Both sexes	257
Segovia	Group 1107 Inguinal hernia  550	Men	235
Segovia	Group 1107 Inguinal hernia  550	Women	22
Segovia	Group 1108 Other abdominal hernia  551-553	Both sexes	131
Segovia	Group 1108 Other abdominal hernia  551-553	Men	64
Segovia	Group 1108 Other abdominal hernia  551-553	Women	67
Segovia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	16
Segovia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	8
Segovia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	8
Segovia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	139
Segovia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	75
Segovia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	64
Segovia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	118
Segovia	Group 1111 Intestinal obstruction without hernia 560	Men	62
Segovia	Group 1111 Intestinal obstruction without hernia 560	Women	56
Segovia	Group 1112 Intestinal diverticulosis 562	Both sexes	73
Segovia	Group 1112 Intestinal diverticulosis 562	Men	38
Segovia	Group 1112 Intestinal diverticulosis 562	Women	35
Segovia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	117
Segovia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	77
Segovia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	40
Segovia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	42
Segovia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	22
Segovia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	20
Segovia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	11
Segovia	Group 1115 Alcoholic hepatitis 5710-5713	Men	9
Segovia	Group 1115 Alcoholic hepatitis 5710-5713	Women	2
Segovia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	54
Segovia	Group 1116 Other diseases of the liver 570,5714-573	Men	30
Segovia	Group 1116 Other diseases of the liver 570,5714-573	Women	24
Segovia	Group 1117 Cholelithiasis  574	Both sexes	321
Segovia	Group 1117 Cholelithiasis  574	Men	149
Segovia	Group 1117 Cholelithiasis  574	Women	172
Segovia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	75
Segovia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	45
Segovia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	30
Segovia	Group 1119 Pancreatic diseases 577	Both sexes	99
Segovia	Group 1119 Pancreatic diseases 577	Men	55
Segovia	Group 1119 Pancreatic diseases 577	Women	44
Segovia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	60
Segovia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	34
Segovia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	26
Segovia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	149
Segovia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	70
Segovia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	79
Segovia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	94
Segovia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	42
Segovia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	52
Segovia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	6
Segovia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	4
Segovia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Segovia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	49
Segovia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	24
Segovia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	25
Segovia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	736
Segovia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	380
Segovia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	356
Segovia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Segovia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Segovia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Segovia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Segovia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Segovia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Segovia	Group 1303 Internal derangement of knee 717	Both sexes	124
Segovia	Group 1303 Internal derangement of knee 717	Men	87
Segovia	Group 1303 Internal derangement of knee 717	Women	37
Segovia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	391
Segovia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	176
Segovia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	215
Segovia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	12
Segovia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	4
Segovia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	8
Segovia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	1
Segovia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	..
Segovia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1
Segovia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	12
Segovia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	3
Segovia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	9
Segovia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	4
Segovia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	2
Segovia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	2
Segovia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	115
Segovia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	69
Segovia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	46
Segovia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	77
Segovia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	39
Segovia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	38
Segovia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	893
Segovia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	485
Segovia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	408
Segovia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	66
Segovia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	13
Segovia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	53
Segovia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	61
Segovia	Group 1402 Renal failure  5836-5837, 584-586	Men	34
Segovia	Group 1402 Renal failure  5836-5837, 584-586	Women	27
Segovia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	179
Segovia	Group 1403 Urolithiasis  592, 594, 7880	Men	116
Segovia	Group 1403 Urolithiasis  592, 594, 7880	Women	63
Segovia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	214
Segovia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	131
Segovia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	83
Segovia	Group 1405 Prostatic hyperplasia  600	Both sexes	111
Segovia	Group 1405 Prostatic hyperplasia  600	Men	111
Segovia	Group 1405 Prostatic hyperplasia  600	Women	..
Segovia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	79
Segovia	Group 1406 Other diseases of the male genital organs    601-608	Men	79
Segovia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Segovia	Group 1407 Disorders of breast  610-612	Both sexes	10
Segovia	Group 1407 Disorders of breast  610-612	Men	..
Segovia	Group 1407 Disorders of breast  610-612	Women	10
Segovia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	15
Segovia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Segovia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	15
Segovia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	11
Segovia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Segovia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	11
Segovia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	147
Segovia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Segovia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	146
Segovia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.132
Segovia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Segovia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.132
Segovia	Group 1501 Legally induced abortion  635	Both sexes	1
Segovia	Group 1501 Legally induced abortion  635	Men	..
Segovia	Group 1501 Legally induced abortion  635	Women	1
Segovia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	45
Segovia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Segovia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	45
Segovia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	578
Segovia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Segovia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	578
Segovia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	260
Segovia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Segovia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	260
Segovia	Group 1505 Single spontaneous delivery  650	Both sexes	100
Segovia	Group 1505 Single spontaneous delivery  650	Men	..
Segovia	Group 1505 Single spontaneous delivery  650	Women	100
Segovia	Group 1506 Other deliveries  6695-6697	Both sexes	2
Segovia	Group 1506 Other deliveries  6695-6697	Men	..
Segovia	Group 1506 Other deliveries  6695-6697	Women	2
Segovia	Group 1507 Complications related to the puerperium  670-676	Both sexes	4
Segovia	Group 1507 Complications related to the puerperium  670-676	Men	..
Segovia	Group 1507 Complications related to the puerperium  670-676	Women	4
Segovia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	142
Segovia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Segovia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	142
Segovia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	149
Segovia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	87
Segovia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	62
Segovia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	45
Segovia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	25
Segovia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	20
Segovia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	104
Segovia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	62
Segovia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	42
Segovia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	42
Segovia	Grupo 1700 Congenital abnormalities  740-759	Men	21
Segovia	Grupo 1700 Congenital abnormalities  740-759	Women	21
Segovia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	581
Segovia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	326
Segovia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	255
Segovia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	39
Segovia	Group 1801 Pain in throat and chest 7841, 7865	Men	27
Segovia	Group 1801 Pain in throat and chest 7841, 7865	Women	12
Segovia	Group 1802 Abdominal pain   7890	Both sexes	98
Segovia	Group 1802 Abdominal pain   7890	Men	38
Segovia	Group 1802 Abdominal pain   7890	Women	60
Segovia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Segovia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Segovia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Segovia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	443
Segovia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	261
Segovia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	182
Segovia	Group 1900 Injuries and poisoning  800-999	Both sexes	1.212
Segovia	Group 1900 Injuries and poisoning  800-999	Men	563
Segovia	Group 1900 Injuries and poisoning  800-999	Women	649
Segovia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	67
Segovia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	39
Segovia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	28
Segovia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	24
Segovia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	15
Segovia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	9
Segovia	Group 1903 Radius and ulna fracture 813	Both sexes	64
Segovia	Group 1903 Radius and ulna fracture 813	Men	31
Segovia	Group 1903 Radius and ulna fracture 813	Women	33
Segovia	Group 1904 Femur fracture  820-821	Both sexes	242
Segovia	Group 1904 Femur fracture  820-821	Men	64
Segovia	Group 1904 Femur fracture  820-821	Women	178
Segovia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	84
Segovia	Group 1905 Leg fracture, including the ankle 823-824	Men	36
Segovia	Group 1905 Leg fracture, including the ankle 823-824	Women	48
Segovia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	309
Segovia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	162
Segovia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	147
Segovia	Group 1907 Burns  940-949	Both sexes	3
Segovia	Group 1907 Burns  940-949	Men	2
Segovia	Group 1907 Burns  940-949	Women	1
Segovia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	22
Segovia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	13
Segovia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	9
Segovia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	344
Segovia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	171
Segovia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	173
Segovia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Segovia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Segovia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Segovia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	53
Segovia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	30
Segovia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	23
Segovia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	252
Segovia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	144
Segovia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	108
Segovia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	7
Segovia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	5
Segovia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2
Segovia	Group 2102 Contraceptive management  V25	Both sexes	6
Segovia	Group 2102 Contraceptive management  V25	Men	..
Segovia	Group 2102 Contraceptive management  V25	Women	6
Segovia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Segovia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Segovia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Segovia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	189
Segovia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	109
Segovia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	80
Segovia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	50
Segovia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	30
Segovia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	20
Soria	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	8.609
Soria	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	4.458
Soria	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	4.151
Soria	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	221
Soria	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	116
Soria	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	105
Soria	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	33
Soria	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	17
Soria	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	16
Soria	Group 0102 Imprecise intestinal infections 009	Both sexes	1
Soria	Group 0102 Imprecise intestinal infections 009	Men	1
Soria	Group 0102 Imprecise intestinal infections 009	Women	..
Soria	Group 0103 Tuberculosis 010-018, 137	Both sexes	4
Soria	Group 0103 Tuberculosis 010-018, 137	Men	3
Soria	Group 0103 Tuberculosis 010-018, 137	Women	1
Soria	Group 0104 Septicaemia  038	Both sexes	151
Soria	Group 0104 Septicaemia  038	Men	79
Soria	Group 0104 Septicaemia  038	Women	72
Soria	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	2
Soria	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	2
Soria	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Soria	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	30
Soria	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	14
Soria	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	16
Soria	Group 0200 Neoplasms  140-239	Both sexes	861
Soria	Group 0200 Neoplasms  140-239	Men	496
Soria	Group 0200 Neoplasms  140-239	Women	365
Soria	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	123
Soria	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	81
Soria	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	42
Soria	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	48
Soria	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	40
Soria	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	8
Soria	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	9
Soria	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	4
Soria	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	5
Soria	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	59
Soria	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Soria	Group 0204 Malignant neoplasm of breast  174-175	Women	59
Soria	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	20
Soria	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Soria	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	20
Soria	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	9
Soria	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Soria	Group 0206 Malignant neoplasm of ovary  1830	Women	9
Soria	Group 0207 Malignant neoplasm of prostate  185	Both sexes	63
Soria	Group 0207 Malignant neoplasm of prostate  185	Men	63
Soria	Group 0207 Malignant neoplasm of prostate  185	Women	..
Soria	Group 0208 Malignant neoplasm of bladder  188	Both sexes	92
Soria	Group 0208 Malignant neoplasm of bladder  188	Men	78
Soria	Group 0208 Malignant neoplasm of bladder  188	Women	14
Soria	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	324
Soria	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	186
Soria	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	138
Soria	Group 0210 Carcinoma in situ  230-234	Both sexes	14
Soria	Group 0210 Carcinoma in situ  230-234	Men	7
Soria	Group 0210 Carcinoma in situ  230-234	Women	7
Soria	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	5
Soria	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	2
Soria	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	3
Soria	Grupo 0212 Leiomyoma of uterus  218	Both sexes	16
Soria	Grupo 0212 Leiomyoma of uterus  218	Men	..
Soria	Grupo 0212 Leiomyoma of uterus  218	Women	16
Soria	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	79
Soria	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	35
Soria	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	44
Soria	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	81
Soria	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	45
Soria	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	36
Soria	Group 0301 Anaemias 280-285	Both sexes	53
Soria	Group 0301 Anaemias 280-285	Men	27
Soria	Group 0301 Anaemias 280-285	Women	26
Soria	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	28
Soria	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	18
Soria	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	10
Soria	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	142
Soria	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	65
Soria	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	77
Soria	Group 0401 Diabetes mellitus  249-250	Both sexes	59
Soria	Group 0401 Diabetes mellitus  249-250	Men	34
Soria	Group 0401 Diabetes mellitus  249-250	Women	25
Soria	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	83
Soria	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	31
Soria	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	52
Soria	Group 0500 Mental disorders  290-319	Both sexes	312
Soria	Group 0500 Mental disorders  290-319	Men	166
Soria	Group 0500 Mental disorders  290-319	Women	146
Soria	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	6
Soria	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	1
Soria	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	5
Soria	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	19
Soria	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	16
Soria	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	3
Soria	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	3
Soria	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	2
Soria	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1
Soria	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	131
Soria	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	86
Soria	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	45
Soria	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	27
Soria	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	10
Soria	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	17
Soria	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	126
Soria	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	51
Soria	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	75
Soria	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	182
Soria	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	100
Soria	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	82
Soria	Group 0601 Alzheimer's disease  3310	Both sexes	6
Soria	Group 0601 Alzheimer's disease  3310	Men	4
Soria	Group 0601 Alzheimer's disease  3310	Women	2
Soria	Group 0602 Multiple sclerosis 340	Both sexes	3
Soria	Group 0602 Multiple sclerosis 340	Men	2
Soria	Group 0602 Multiple sclerosis 340	Women	1
Soria	Group 0603 Epilepsy  345	Both sexes	35
Soria	Group 0603 Epilepsy  345	Men	12
Soria	Group 0603 Epilepsy  345	Women	23
Soria	Group 0604 Transient cerebral ischemia 435	Both sexes	54
Soria	Group 0604 Transient cerebral ischemia 435	Men	32
Soria	Group 0604 Transient cerebral ischemia 435	Women	22
Soria	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	84
Soria	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	50
Soria	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	34
Soria	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	21
Soria	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	7
Soria	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	14
Soria	Grupo 0701 Cataract  366	Both sexes	..
Soria	Grupo 0701 Cataract  366	Men	..
Soria	Grupo 0701 Cataract  366	Women	..
Soria	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	21
Soria	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	7
Soria	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	14
Soria	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	28
Soria	Group 0800 Diseases of the ear and the mastoid  380-389	Men	12
Soria	Group 0800 Diseases of the ear and the mastoid  380-389	Women	16
Soria	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.403
Soria	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	759
Soria	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	644
Soria	Group 0901 Hypertensive disease  401-405	Both sexes	59
Soria	Group 0901 Hypertensive disease  401-405	Men	27
Soria	Group 0901 Hypertensive disease  401-405	Women	32
Soria	Group 0902 Angina pectoris  4111, 413	Both sexes	91
Soria	Group 0902 Angina pectoris  4111, 413	Men	55
Soria	Group 0902 Angina pectoris  4111, 413	Women	36
Soria	Group 0903 Acute myocardial infarction  410	Both sexes	154
Soria	Group 0903 Acute myocardial infarction  410	Men	96
Soria	Group 0903 Acute myocardial infarction  410	Women	58
Soria	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	32
Soria	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	26
Soria	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	6
Soria	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	58
Soria	Group 0905 Diseases of the lungs circulation 415-417	Men	25
Soria	Group 0905 Diseases of the lungs circulation 415-417	Women	33
Soria	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	170
Soria	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	91
Soria	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	79
Soria	Grupo 0907 Heart failure  428	Both sexes	390
Soria	Grupo 0907 Heart failure  428	Men	209
Soria	Grupo 0907 Heart failure  428	Women	181
Soria	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	203
Soria	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	103
Soria	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	100
Soria	Grupo 0909 Atherosclerosis  440	Both sexes	15
Soria	Grupo 0909 Atherosclerosis  440	Men	9
Soria	Grupo 0909 Atherosclerosis  440	Women	6
Soria	Group 0910 Varicose veins of lower extremities 454	Both sexes	97
Soria	Group 0910 Varicose veins of lower extremities 454	Men	44
Soria	Group 0910 Varicose veins of lower extremities 454	Women	53
Soria	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	134
Soria	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	74
Soria	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	60
Soria	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.138
Soria	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	645
Soria	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	493
Soria	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	18
Soria	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	13
Soria	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	5
Soria	Group 1002 Pneumonia 480-486	Both sexes	245
Soria	Group 1002 Pneumonia 480-486	Men	145
Soria	Group 1002 Pneumonia 480-486	Women	100
Soria	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	23
Soria	Group 1003 Acute bronchitis and bronchiolitis  466	Men	14
Soria	Group 1003 Acute bronchitis and bronchiolitis  466	Women	9
Soria	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	83
Soria	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	38
Soria	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	45
Soria	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	102
Soria	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	72
Soria	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	30
Soria	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	136
Soria	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	108
Soria	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	28
Soria	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	24
Soria	Group 1007 Asthma 4930-4931,4938-4939	Men	5
Soria	Group 1007 Asthma 4930-4931,4938-4939	Women	19
Soria	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	507
Soria	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	250
Soria	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	257
Soria	Group 1100 Diseases of the digestive system  520-579	Both sexes	1.242
Soria	Group 1100 Diseases of the digestive system  520-579	Men	787
Soria	Group 1100 Diseases of the digestive system  520-579	Women	455
Soria	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	2
Soria	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	1
Soria	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	1
Soria	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	18
Soria	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	12
Soria	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	6
Soria	Group 1103 Diseases of the esophagus 530	Both sexes	32
Soria	Group 1103 Diseases of the esophagus 530	Men	17
Soria	Group 1103 Diseases of the esophagus 530	Women	15
Soria	Group 1104 Peptic ulcer 531-534	Both sexes	34
Soria	Group 1104 Peptic ulcer 531-534	Men	27
Soria	Group 1104 Peptic ulcer 531-534	Women	7
Soria	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	20
Soria	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	11
Soria	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	9
Soria	Group 1106 Appendicitis  540-543	Both sexes	108
Soria	Group 1106 Appendicitis  540-543	Men	67
Soria	Group 1106 Appendicitis  540-543	Women	41
Soria	Group 1107 Inguinal hernia  550	Both sexes	163
Soria	Group 1107 Inguinal hernia  550	Men	157
Soria	Group 1107 Inguinal hernia  550	Women	6
Soria	Group 1108 Other abdominal hernia  551-553	Both sexes	108
Soria	Group 1108 Other abdominal hernia  551-553	Men	48
Soria	Group 1108 Other abdominal hernia  551-553	Women	60
Soria	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	18
Soria	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	15
Soria	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	3
Soria	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	47
Soria	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	25
Soria	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	22
Soria	Group 1111 Intestinal obstruction without hernia 560	Both sexes	102
Soria	Group 1111 Intestinal obstruction without hernia 560	Men	60
Soria	Group 1111 Intestinal obstruction without hernia 560	Women	42
Soria	Group 1112 Intestinal diverticulosis 562	Both sexes	54
Soria	Group 1112 Intestinal diverticulosis 562	Men	32
Soria	Group 1112 Intestinal diverticulosis 562	Women	22
Soria	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	34
Soria	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	26
Soria	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	8
Soria	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	26
Soria	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	16
Soria	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	10
Soria	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	9
Soria	Group 1115 Alcoholic hepatitis 5710-5713	Men	9
Soria	Group 1115 Alcoholic hepatitis 5710-5713	Women	..
Soria	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	31
Soria	Group 1116 Other diseases of the liver 570,5714-573	Men	26
Soria	Group 1116 Other diseases of the liver 570,5714-573	Women	5
Soria	Group 1117 Cholelithiasis  574	Both sexes	200
Soria	Group 1117 Cholelithiasis  574	Men	105
Soria	Group 1117 Cholelithiasis  574	Women	95
Soria	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	53
Soria	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	31
Soria	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	22
Soria	Group 1119 Pancreatic diseases 577	Both sexes	65
Soria	Group 1119 Pancreatic diseases 577	Men	42
Soria	Group 1119 Pancreatic diseases 577	Women	23
Soria	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	118
Soria	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	60
Soria	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	58
Soria	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	71
Soria	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	45
Soria	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	26
Soria	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	53
Soria	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	34
Soria	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	19
Soria	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	2
Soria	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	1
Soria	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	1
Soria	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	16
Soria	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	10
Soria	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	6
Soria	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	505
Soria	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	269
Soria	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	236
Soria	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Soria	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Soria	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Soria	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Soria	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Soria	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Soria	Group 1303 Internal derangement of knee 717	Both sexes	122
Soria	Group 1303 Internal derangement of knee 717	Men	85
Soria	Group 1303 Internal derangement of knee 717	Women	37
Soria	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	198
Soria	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	89
Soria	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	109
Soria	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	13
Soria	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	5
Soria	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	8
Soria	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	6
Soria	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1
Soria	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	5
Soria	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	13
Soria	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	10
Soria	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	3
Soria	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	17
Soria	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	9
Soria	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	8
Soria	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	68
Soria	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	45
Soria	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	23
Soria	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	68
Soria	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	25
Soria	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	43
Soria	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	457
Soria	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	264
Soria	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	193
Soria	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	36
Soria	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	20
Soria	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	16
Soria	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	42
Soria	Group 1402 Renal failure  5836-5837, 584-586	Men	22
Soria	Group 1402 Renal failure  5836-5837, 584-586	Women	20
Soria	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	43
Soria	Group 1403 Urolithiasis  592, 594, 7880	Men	33
Soria	Group 1403 Urolithiasis  592, 594, 7880	Women	10
Soria	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	178
Soria	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	80
Soria	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	98
Soria	Group 1405 Prostatic hyperplasia  600	Both sexes	41
Soria	Group 1405 Prostatic hyperplasia  600	Men	41
Soria	Group 1405 Prostatic hyperplasia  600	Women	..
Soria	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	68
Soria	Group 1406 Other diseases of the male genital organs    601-608	Men	68
Soria	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Soria	Group 1407 Disorders of breast  610-612	Both sexes	17
Soria	Group 1407 Disorders of breast  610-612	Men	..
Soria	Group 1407 Disorders of breast  610-612	Women	17
Soria	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	6
Soria	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Soria	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	6
Soria	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	2
Soria	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Soria	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	2
Soria	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	24
Soria	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Soria	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	24
Soria	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	652
Soria	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Soria	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	652
Soria	Group 1501 Legally induced abortion  635	Both sexes	..
Soria	Group 1501 Legally induced abortion  635	Men	..
Soria	Group 1501 Legally induced abortion  635	Women	..
Soria	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	24
Soria	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Soria	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	24
Soria	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	460
Soria	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Soria	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	460
Soria	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	127
Soria	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Soria	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	127
Soria	Group 1505 Single spontaneous delivery  650	Both sexes	12
Soria	Group 1505 Single spontaneous delivery  650	Men	..
Soria	Group 1505 Single spontaneous delivery  650	Women	12
Soria	Group 1506 Other deliveries  6695-6697	Both sexes	8
Soria	Group 1506 Other deliveries  6695-6697	Men	..
Soria	Group 1506 Other deliveries  6695-6697	Women	8
Soria	Group 1507 Complications related to the puerperium  670-676	Both sexes	..
Soria	Group 1507 Complications related to the puerperium  670-676	Men	..
Soria	Group 1507 Complications related to the puerperium  670-676	Women	..
Soria	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	21
Soria	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Soria	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	21
Soria	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	83
Soria	Group 1600 Some disorders originating in the perinatal period  760-779	Men	46
Soria	Group 1600 Some disorders originating in the perinatal period  760-779	Women	37
Soria	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	13
Soria	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	6
Soria	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	7
Soria	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	70
Soria	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	40
Soria	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	30
Soria	Grupo 1700 Congenital abnormalities  740-759	Both sexes	28
Soria	Grupo 1700 Congenital abnormalities  740-759	Men	21
Soria	Grupo 1700 Congenital abnormalities  740-759	Women	7
Soria	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	348
Soria	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	203
Soria	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	145
Soria	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	48
Soria	Group 1801 Pain in throat and chest 7841, 7865	Men	28
Soria	Group 1801 Pain in throat and chest 7841, 7865	Women	20
Soria	Group 1802 Abdominal pain   7890	Both sexes	62
Soria	Group 1802 Abdominal pain   7890	Men	22
Soria	Group 1802 Abdominal pain   7890	Women	40
Soria	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2
Soria	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Soria	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Soria	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	236
Soria	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	152
Soria	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	84
Soria	Group 1900 Injuries and poisoning  800-999	Both sexes	735
Soria	Group 1900 Injuries and poisoning  800-999	Men	369
Soria	Group 1900 Injuries and poisoning  800-999	Women	366
Soria	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	55
Soria	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	29
Soria	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	26
Soria	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	13
Soria	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	10
Soria	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3
Soria	Group 1903 Radius and ulna fracture 813	Both sexes	28
Soria	Group 1903 Radius and ulna fracture 813	Men	16
Soria	Group 1903 Radius and ulna fracture 813	Women	12
Soria	Group 1904 Femur fracture  820-821	Both sexes	173
Soria	Group 1904 Femur fracture  820-821	Men	51
Soria	Group 1904 Femur fracture  820-821	Women	122
Soria	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	55
Soria	Group 1905 Leg fracture, including the ankle 823-824	Men	23
Soria	Group 1905 Leg fracture, including the ankle 823-824	Women	32
Soria	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	192
Soria	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	110
Soria	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	82
Soria	Group 1907 Burns  940-949	Both sexes	2
Soria	Group 1907 Burns  940-949	Men	2
Soria	Group 1907 Burns  940-949	Women	..
Soria	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	25
Soria	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	14
Soria	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	11
Soria	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	173
Soria	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	106
Soria	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	67
Soria	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	3
Soria	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Soria	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Soria	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	16
Soria	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	5
Soria	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	11
Soria	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	99
Soria	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	43
Soria	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	56
Soria	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	2
Soria	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	2
Soria	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	..
Soria	Group 2102 Contraceptive management  V25	Both sexes	3
Soria	Group 2102 Contraceptive management  V25	Men	3
Soria	Group 2102 Contraceptive management  V25	Women	..
Soria	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Soria	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Soria	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Soria	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	68
Soria	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	23
Soria	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	45
Soria	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	26
Soria	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	15
Soria	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	11
Valladolid	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	60.404
Valladolid	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	30.252
Valladolid	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	30.152
Valladolid	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.108
Valladolid	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	604
Valladolid	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	504
Valladolid	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	219
Valladolid	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	115
Valladolid	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	104
Valladolid	Group 0102 Imprecise intestinal infections 009	Both sexes	40
Valladolid	Group 0102 Imprecise intestinal infections 009	Men	19
Valladolid	Group 0102 Imprecise intestinal infections 009	Women	21
Valladolid	Group 0103 Tuberculosis 010-018, 137	Both sexes	29
Valladolid	Group 0103 Tuberculosis 010-018, 137	Men	17
Valladolid	Group 0103 Tuberculosis 010-018, 137	Women	12
Valladolid	Group 0104 Septicaemia  038	Both sexes	504
Valladolid	Group 0104 Septicaemia  038	Men	271
Valladolid	Group 0104 Septicaemia  038	Women	233
Valladolid	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	6
Valladolid	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	4
Valladolid	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
Valladolid	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	310
Valladolid	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	178
Valladolid	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	132
Valladolid	Group 0200 Neoplasms  140-239	Both sexes	6.758
Valladolid	Group 0200 Neoplasms  140-239	Men	3.651
Valladolid	Group 0200 Neoplasms  140-239	Women	3.107
Valladolid	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	630
Valladolid	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	419
Valladolid	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	211
Valladolid	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	642
Valladolid	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	504
Valladolid	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	138
Valladolid	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	78
Valladolid	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	48
Valladolid	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	30
Valladolid	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	426
Valladolid	Group 0204 Malignant neoplasm of breast  174-175	Men	5
Valladolid	Group 0204 Malignant neoplasm of breast  174-175	Women	421
Valladolid	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	93
Valladolid	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Valladolid	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	93
Valladolid	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	58
Valladolid	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Valladolid	Group 0206 Malignant neoplasm of ovary  1830	Women	58
Valladolid	Group 0207 Malignant neoplasm of prostate  185	Both sexes	297
Valladolid	Group 0207 Malignant neoplasm of prostate  185	Men	297
Valladolid	Group 0207 Malignant neoplasm of prostate  185	Women	..
Valladolid	Group 0208 Malignant neoplasm of bladder  188	Both sexes	522
Valladolid	Group 0208 Malignant neoplasm of bladder  188	Men	440
Valladolid	Group 0208 Malignant neoplasm of bladder  188	Women	82
Valladolid	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.351
Valladolid	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.382
Valladolid	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	969
Valladolid	Group 0210 Carcinoma in situ  230-234	Both sexes	99
Valladolid	Group 0210 Carcinoma in situ  230-234	Men	39
Valladolid	Group 0210 Carcinoma in situ  230-234	Women	60
Valladolid	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	49
Valladolid	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	27
Valladolid	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	22
Valladolid	Grupo 0212 Leiomyoma of uterus  218	Both sexes	335
Valladolid	Grupo 0212 Leiomyoma of uterus  218	Men	..
Valladolid	Grupo 0212 Leiomyoma of uterus  218	Women	335
Valladolid	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.178
Valladolid	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	490
Valladolid	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	688
Valladolid	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	712
Valladolid	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	345
Valladolid	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	367
Valladolid	Group 0301 Anaemias 280-285	Both sexes	435
Valladolid	Group 0301 Anaemias 280-285	Men	213
Valladolid	Group 0301 Anaemias 280-285	Women	222
Valladolid	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	277
Valladolid	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	132
Valladolid	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	145
Valladolid	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.261
Valladolid	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	501
Valladolid	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	760
Valladolid	Group 0401 Diabetes mellitus  249-250	Both sexes	398
Valladolid	Group 0401 Diabetes mellitus  249-250	Men	222
Valladolid	Group 0401 Diabetes mellitus  249-250	Women	176
Valladolid	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	863
Valladolid	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	279
Valladolid	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	584
Valladolid	Group 0500 Mental disorders  290-319	Both sexes	1.256
Valladolid	Group 0500 Mental disorders  290-319	Men	582
Valladolid	Group 0500 Mental disorders  290-319	Women	674
Valladolid	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	25
Valladolid	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	8
Valladolid	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	17
Valladolid	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	117
Valladolid	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	75
Valladolid	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	42
Valladolid	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	59
Valladolid	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	47
Valladolid	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	12
Valladolid	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	274
Valladolid	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	161
Valladolid	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	113
Valladolid	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	304
Valladolid	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	97
Valladolid	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	207
Valladolid	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	477
Valladolid	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	194
Valladolid	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	283
Valladolid	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.204
Valladolid	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	557
Valladolid	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	647
Valladolid	Group 0601 Alzheimer's disease  3310	Both sexes	67
Valladolid	Group 0601 Alzheimer's disease  3310	Men	25
Valladolid	Group 0601 Alzheimer's disease  3310	Women	42
Valladolid	Group 0602 Multiple sclerosis 340	Both sexes	53
Valladolid	Group 0602 Multiple sclerosis 340	Men	17
Valladolid	Group 0602 Multiple sclerosis 340	Women	36
Valladolid	Group 0603 Epilepsy  345	Both sexes	200
Valladolid	Group 0603 Epilepsy  345	Men	119
Valladolid	Group 0603 Epilepsy  345	Women	81
Valladolid	Group 0604 Transient cerebral ischemia 435	Both sexes	182
Valladolid	Group 0604 Transient cerebral ischemia 435	Men	77
Valladolid	Group 0604 Transient cerebral ischemia 435	Women	105
Valladolid	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	702
Valladolid	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	319
Valladolid	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	383
Valladolid	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	286
Valladolid	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	140
Valladolid	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	146
Valladolid	Grupo 0701 Cataract  366	Both sexes	35
Valladolid	Grupo 0701 Cataract  366	Men	21
Valladolid	Grupo 0701 Cataract  366	Women	14
Valladolid	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	251
Valladolid	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	119
Valladolid	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	132
Valladolid	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	494
Valladolid	Group 0800 Diseases of the ear and the mastoid  380-389	Men	248
Valladolid	Group 0800 Diseases of the ear and the mastoid  380-389	Women	246
Valladolid	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.905
Valladolid	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.308
Valladolid	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.597
Valladolid	Group 0901 Hypertensive disease  401-405	Both sexes	423
Valladolid	Group 0901 Hypertensive disease  401-405	Men	170
Valladolid	Group 0901 Hypertensive disease  401-405	Women	253
Valladolid	Group 0902 Angina pectoris  4111, 413	Both sexes	465
Valladolid	Group 0902 Angina pectoris  4111, 413	Men	300
Valladolid	Group 0902 Angina pectoris  4111, 413	Women	165
Valladolid	Group 0903 Acute myocardial infarction  410	Both sexes	788
Valladolid	Group 0903 Acute myocardial infarction  410	Men	588
Valladolid	Group 0903 Acute myocardial infarction  410	Women	200
Valladolid	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	616
Valladolid	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	491
Valladolid	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	125
Valladolid	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	385
Valladolid	Group 0905 Diseases of the lungs circulation 415-417	Men	165
Valladolid	Group 0905 Diseases of the lungs circulation 415-417	Women	220
Valladolid	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.067
Valladolid	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	611
Valladolid	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	456
Valladolid	Grupo 0907 Heart failure  428	Both sexes	1.312
Valladolid	Grupo 0907 Heart failure  428	Men	661
Valladolid	Grupo 0907 Heart failure  428	Women	651
Valladolid	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.369
Valladolid	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	743
Valladolid	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	626
Valladolid	Grupo 0909 Atherosclerosis  440	Both sexes	553
Valladolid	Grupo 0909 Atherosclerosis  440	Men	457
Valladolid	Grupo 0909 Atherosclerosis  440	Women	96
Valladolid	Group 0910 Varicose veins of lower extremities 454	Both sexes	204
Valladolid	Group 0910 Varicose veins of lower extremities 454	Men	88
Valladolid	Group 0910 Varicose veins of lower extremities 454	Women	116
Valladolid	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.723
Valladolid	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.034
Valladolid	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	689
Valladolid	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	6.806
Valladolid	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.989
Valladolid	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.817
Valladolid	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	317
Valladolid	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	167
Valladolid	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	150
Valladolid	Group 1002 Pneumonia 480-486	Both sexes	1.436
Valladolid	Group 1002 Pneumonia 480-486	Men	879
Valladolid	Group 1002 Pneumonia 480-486	Women	557
Valladolid	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	523
Valladolid	Group 1003 Acute bronchitis and bronchiolitis  466	Men	235
Valladolid	Group 1003 Acute bronchitis and bronchiolitis  466	Women	288
Valladolid	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	512
Valladolid	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	294
Valladolid	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	218
Valladolid	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	858
Valladolid	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	587
Valladolid	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	271
Valladolid	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	979
Valladolid	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	764
Valladolid	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	215
Valladolid	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	195
Valladolid	Group 1007 Asthma 4930-4931,4938-4939	Men	49
Valladolid	Group 1007 Asthma 4930-4931,4938-4939	Women	146
Valladolid	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.986
Valladolid	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.014
Valladolid	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	972
Valladolid	Group 1100 Diseases of the digestive system  520-579	Both sexes	8.246
Valladolid	Group 1100 Diseases of the digestive system  520-579	Men	4.812
Valladolid	Group 1100 Diseases of the digestive system  520-579	Women	3.434
Valladolid	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	138
Valladolid	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	67
Valladolid	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	71
Valladolid	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	136
Valladolid	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	74
Valladolid	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	62
Valladolid	Group 1103 Diseases of the esophagus 530	Both sexes	159
Valladolid	Group 1103 Diseases of the esophagus 530	Men	105
Valladolid	Group 1103 Diseases of the esophagus 530	Women	54
Valladolid	Group 1104 Peptic ulcer 531-534	Both sexes	191
Valladolid	Group 1104 Peptic ulcer 531-534	Men	133
Valladolid	Group 1104 Peptic ulcer 531-534	Women	58
Valladolid	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	182
Valladolid	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	75
Valladolid	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	107
Valladolid	Group 1106 Appendicitis  540-543	Both sexes	642
Valladolid	Group 1106 Appendicitis  540-543	Men	351
Valladolid	Group 1106 Appendicitis  540-543	Women	291
Valladolid	Group 1107 Inguinal hernia  550	Both sexes	1.187
Valladolid	Group 1107 Inguinal hernia  550	Men	1.068
Valladolid	Group 1107 Inguinal hernia  550	Women	119
Valladolid	Group 1108 Other abdominal hernia  551-553	Both sexes	716
Valladolid	Group 1108 Other abdominal hernia  551-553	Men	360
Valladolid	Group 1108 Other abdominal hernia  551-553	Women	356
Valladolid	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	181
Valladolid	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	101
Valladolid	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	80
Valladolid	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	439
Valladolid	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	183
Valladolid	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	256
Valladolid	Group 1111 Intestinal obstruction without hernia 560	Both sexes	430
Valladolid	Group 1111 Intestinal obstruction without hernia 560	Men	224
Valladolid	Group 1111 Intestinal obstruction without hernia 560	Women	206
Valladolid	Group 1112 Intestinal diverticulosis 562	Both sexes	339
Valladolid	Group 1112 Intestinal diverticulosis 562	Men	145
Valladolid	Group 1112 Intestinal diverticulosis 562	Women	194
Valladolid	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	460
Valladolid	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	282
Valladolid	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	178
Valladolid	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	313
Valladolid	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	139
Valladolid	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	174
Valladolid	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	128
Valladolid	Group 1115 Alcoholic hepatitis 5710-5713	Men	125
Valladolid	Group 1115 Alcoholic hepatitis 5710-5713	Women	3
Valladolid	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	290
Valladolid	Group 1116 Other diseases of the liver 570,5714-573	Men	162
Valladolid	Group 1116 Other diseases of the liver 570,5714-573	Women	128
Valladolid	Group 1117 Cholelithiasis  574	Both sexes	1.351
Valladolid	Group 1117 Cholelithiasis  574	Men	667
Valladolid	Group 1117 Cholelithiasis  574	Women	684
Valladolid	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	351
Valladolid	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	204
Valladolid	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	147
Valladolid	Group 1119 Pancreatic diseases 577	Both sexes	303
Valladolid	Group 1119 Pancreatic diseases 577	Men	187
Valladolid	Group 1119 Pancreatic diseases 577	Women	116
Valladolid	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	310
Valladolid	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	160
Valladolid	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	150
Valladolid	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	533
Valladolid	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	303
Valladolid	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	230
Valladolid	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	323
Valladolid	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	199
Valladolid	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	124
Valladolid	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	28
Valladolid	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	13
Valladolid	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	15
Valladolid	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	182
Valladolid	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	91
Valladolid	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	91
Valladolid	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.781
Valladolid	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.765
Valladolid	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.016
Valladolid	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Valladolid	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Valladolid	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Valladolid	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Valladolid	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Valladolid	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Valladolid	Group 1303 Internal derangement of knee 717	Both sexes	342
Valladolid	Group 1303 Internal derangement of knee 717	Men	244
Valladolid	Group 1303 Internal derangement of knee 717	Women	98
Valladolid	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.360
Valladolid	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	606
Valladolid	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	754
Valladolid	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	171
Valladolid	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	43
Valladolid	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	128
Valladolid	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	222
Valladolid	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	108
Valladolid	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	114
Valladolid	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	394
Valladolid	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	215
Valladolid	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	179
Valladolid	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	79
Valladolid	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	36
Valladolid	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	43
Valladolid	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	505
Valladolid	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	290
Valladolid	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	215
Valladolid	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	708
Valladolid	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	223
Valladolid	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	485
Valladolid	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.083
Valladolid	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.103
Valladolid	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.980
Valladolid	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	316
Valladolid	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	137
Valladolid	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	179
Valladolid	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	324
Valladolid	Group 1402 Renal failure  5836-5837, 584-586	Men	202
Valladolid	Group 1402 Renal failure  5836-5837, 584-586	Women	122
Valladolid	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	666
Valladolid	Group 1403 Urolithiasis  592, 594, 7880	Men	405
Valladolid	Group 1403 Urolithiasis  592, 594, 7880	Women	261
Valladolid	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.082
Valladolid	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	575
Valladolid	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	507
Valladolid	Group 1405 Prostatic hyperplasia  600	Both sexes	321
Valladolid	Group 1405 Prostatic hyperplasia  600	Men	321
Valladolid	Group 1405 Prostatic hyperplasia  600	Women	..
Valladolid	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	410
Valladolid	Group 1406 Other diseases of the male genital organs    601-608	Men	410
Valladolid	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Valladolid	Group 1407 Disorders of breast  610-612	Both sexes	218
Valladolid	Group 1407 Disorders of breast  610-612	Men	44
Valladolid	Group 1407 Disorders of breast  610-612	Women	174
Valladolid	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	112
Valladolid	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Valladolid	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	112
Valladolid	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	35
Valladolid	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Valladolid	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	35
Valladolid	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	599
Valladolid	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	9
Valladolid	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	590
Valladolid	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.026
Valladolid	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Valladolid	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.026
Valladolid	Group 1501 Legally induced abortion  635	Both sexes	..
Valladolid	Group 1501 Legally induced abortion  635	Men	..
Valladolid	Group 1501 Legally induced abortion  635	Women	..
Valladolid	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	309
Valladolid	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Valladolid	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	309
Valladolid	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.005
Valladolid	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Valladolid	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.005
Valladolid	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	523
Valladolid	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Valladolid	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	523
Valladolid	Group 1505 Single spontaneous delivery  650	Both sexes	460
Valladolid	Group 1505 Single spontaneous delivery  650	Men	..
Valladolid	Group 1505 Single spontaneous delivery  650	Women	460
Valladolid	Group 1506 Other deliveries  6695-6697	Both sexes	405
Valladolid	Group 1506 Other deliveries  6695-6697	Men	..
Valladolid	Group 1506 Other deliveries  6695-6697	Women	405
Valladolid	Group 1507 Complications related to the puerperium  670-676	Both sexes	44
Valladolid	Group 1507 Complications related to the puerperium  670-676	Men	..
Valladolid	Group 1507 Complications related to the puerperium  670-676	Women	44
Valladolid	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	280
Valladolid	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Valladolid	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	280
Valladolid	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	620
Valladolid	Group 1600 Some disorders originating in the perinatal period  760-779	Men	349
Valladolid	Group 1600 Some disorders originating in the perinatal period  760-779	Women	271
Valladolid	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	112
Valladolid	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	65
Valladolid	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	47
Valladolid	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	508
Valladolid	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	284
Valladolid	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	224
Valladolid	Grupo 1700 Congenital abnormalities  740-759	Both sexes	447
Valladolid	Grupo 1700 Congenital abnormalities  740-759	Men	266
Valladolid	Grupo 1700 Congenital abnormalities  740-759	Women	181
Valladolid	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.631
Valladolid	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.470
Valladolid	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.161
Valladolid	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	341
Valladolid	Group 1801 Pain in throat and chest 7841, 7865	Men	200
Valladolid	Group 1801 Pain in throat and chest 7841, 7865	Women	141
Valladolid	Group 1802 Abdominal pain   7890	Both sexes	319
Valladolid	Group 1802 Abdominal pain   7890	Men	131
Valladolid	Group 1802 Abdominal pain   7890	Women	188
Valladolid	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	143
Valladolid	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	84
Valladolid	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	59
Valladolid	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.828
Valladolid	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.055
Valladolid	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	773
Valladolid	Group 1900 Injuries and poisoning  800-999	Both sexes	5.147
Valladolid	Group 1900 Injuries and poisoning  800-999	Men	2.675
Valladolid	Group 1900 Injuries and poisoning  800-999	Women	2.472
Valladolid	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	170
Valladolid	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	106
Valladolid	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	64
Valladolid	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	177
Valladolid	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	127
Valladolid	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	50
Valladolid	Group 1903 Radius and ulna fracture 813	Both sexes	207
Valladolid	Group 1903 Radius and ulna fracture 813	Men	117
Valladolid	Group 1903 Radius and ulna fracture 813	Women	90
Valladolid	Group 1904 Femur fracture  820-821	Both sexes	831
Valladolid	Group 1904 Femur fracture  820-821	Men	202
Valladolid	Group 1904 Femur fracture  820-821	Women	629
Valladolid	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	341
Valladolid	Group 1905 Leg fracture, including the ankle 823-824	Men	186
Valladolid	Group 1905 Leg fracture, including the ankle 823-824	Women	155
Valladolid	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.369
Valladolid	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	814
Valladolid	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	555
Valladolid	Group 1907 Burns  940-949	Both sexes	32
Valladolid	Group 1907 Burns  940-949	Men	21
Valladolid	Group 1907 Burns  940-949	Women	11
Valladolid	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	178
Valladolid	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	77
Valladolid	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	101
Valladolid	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.730
Valladolid	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	966
Valladolid	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	764
Valladolid	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	9
Valladolid	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	6
Valladolid	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	3
Valladolid	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	103
Valladolid	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	53
Valladolid	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	50
Valladolid	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.100
Valladolid	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	584
Valladolid	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	516
Valladolid	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	171
Valladolid	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	107
Valladolid	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	64
Valladolid	Group 2102 Contraceptive management  V25	Both sexes	33
Valladolid	Group 2102 Contraceptive management  V25	Men	..
Valladolid	Group 2102 Contraceptive management  V25	Women	33
Valladolid	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Valladolid	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Valladolid	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Valladolid	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	506
Valladolid	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	296
Valladolid	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	210
Valladolid	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	390
Valladolid	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	181
Valladolid	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	209
Zamora	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	18.293
Zamora	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	9.028
Zamora	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	9.265
Zamora	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	629
Zamora	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	345
Zamora	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	284
Zamora	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	131
Zamora	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	73
Zamora	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	58
Zamora	Group 0102 Imprecise intestinal infections 009	Both sexes	42
Zamora	Group 0102 Imprecise intestinal infections 009	Men	24
Zamora	Group 0102 Imprecise intestinal infections 009	Women	18
Zamora	Group 0103 Tuberculosis 010-018, 137	Both sexes	31
Zamora	Group 0103 Tuberculosis 010-018, 137	Men	11
Zamora	Group 0103 Tuberculosis 010-018, 137	Women	20
Zamora	Group 0104 Septicaemia  038	Both sexes	235
Zamora	Group 0104 Septicaemia  038	Men	122
Zamora	Group 0104 Septicaemia  038	Women	113
Zamora	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	14
Zamora	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	13
Zamora	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Zamora	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	176
Zamora	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	102
Zamora	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	74
Zamora	Group 0200 Neoplasms  140-239	Both sexes	2.048
Zamora	Group 0200 Neoplasms  140-239	Men	1.130
Zamora	Group 0200 Neoplasms  140-239	Women	918
Zamora	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	308
Zamora	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	196
Zamora	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	112
Zamora	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	150
Zamora	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	124
Zamora	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	26
Zamora	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	13
Zamora	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	9
Zamora	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	4
Zamora	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	158
Zamora	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Zamora	Group 0204 Malignant neoplasm of breast  174-175	Women	155
Zamora	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	50
Zamora	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Zamora	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	50
Zamora	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	34
Zamora	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Zamora	Group 0206 Malignant neoplasm of ovary  1830	Women	34
Zamora	Group 0207 Malignant neoplasm of prostate  185	Both sexes	82
Zamora	Group 0207 Malignant neoplasm of prostate  185	Men	82
Zamora	Group 0207 Malignant neoplasm of prostate  185	Women	..
Zamora	Group 0208 Malignant neoplasm of bladder  188	Both sexes	219
Zamora	Group 0208 Malignant neoplasm of bladder  188	Men	186
Zamora	Group 0208 Malignant neoplasm of bladder  188	Women	33
Zamora	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	721
Zamora	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	430
Zamora	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	291
Zamora	Group 0210 Carcinoma in situ  230-234	Both sexes	27
Zamora	Group 0210 Carcinoma in situ  230-234	Men	10
Zamora	Group 0210 Carcinoma in situ  230-234	Women	17
Zamora	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	20
Zamora	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	13
Zamora	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	7
Zamora	Grupo 0212 Leiomyoma of uterus  218	Both sexes	57
Zamora	Grupo 0212 Leiomyoma of uterus  218	Men	..
Zamora	Grupo 0212 Leiomyoma of uterus  218	Women	57
Zamora	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	209
Zamora	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	77
Zamora	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	132
Zamora	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	134
Zamora	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	70
Zamora	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	64
Zamora	Group 0301 Anaemias 280-285	Both sexes	66
Zamora	Group 0301 Anaemias 280-285	Men	32
Zamora	Group 0301 Anaemias 280-285	Women	34
Zamora	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	68
Zamora	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	38
Zamora	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	30
Zamora	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	345
Zamora	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	139
Zamora	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	206
Zamora	Group 0401 Diabetes mellitus  249-250	Both sexes	147
Zamora	Group 0401 Diabetes mellitus  249-250	Men	73
Zamora	Group 0401 Diabetes mellitus  249-250	Women	74
Zamora	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	198
Zamora	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	66
Zamora	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	132
Zamora	Group 0500 Mental disorders  290-319	Both sexes	340
Zamora	Group 0500 Mental disorders  290-319	Men	182
Zamora	Group 0500 Mental disorders  290-319	Women	158
Zamora	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	9
Zamora	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	4
Zamora	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	5
Zamora	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	22
Zamora	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	18
Zamora	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	4
Zamora	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	14
Zamora	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	11
Zamora	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Zamora	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	105
Zamora	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	64
Zamora	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	41
Zamora	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	68
Zamora	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	32
Zamora	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	36
Zamora	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	122
Zamora	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	53
Zamora	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	69
Zamora	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	306
Zamora	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	159
Zamora	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	147
Zamora	Group 0601 Alzheimer's disease  3310	Both sexes	6
Zamora	Group 0601 Alzheimer's disease  3310	Men	1
Zamora	Group 0601 Alzheimer's disease  3310	Women	5
Zamora	Group 0602 Multiple sclerosis 340	Both sexes	7
Zamora	Group 0602 Multiple sclerosis 340	Men	3
Zamora	Group 0602 Multiple sclerosis 340	Women	4
Zamora	Group 0603 Epilepsy  345	Both sexes	50
Zamora	Group 0603 Epilepsy  345	Men	32
Zamora	Group 0603 Epilepsy  345	Women	18
Zamora	Group 0604 Transient cerebral ischemia 435	Both sexes	90
Zamora	Group 0604 Transient cerebral ischemia 435	Men	48
Zamora	Group 0604 Transient cerebral ischemia 435	Women	42
Zamora	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	153
Zamora	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	75
Zamora	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	78
Zamora	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	20
Zamora	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	13
Zamora	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	7
Zamora	Grupo 0701 Cataract  366	Both sexes	1
Zamora	Grupo 0701 Cataract  366	Men	..
Zamora	Grupo 0701 Cataract  366	Women	1
Zamora	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	19
Zamora	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	13
Zamora	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	6
Zamora	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	193
Zamora	Group 0800 Diseases of the ear and the mastoid  380-389	Men	90
Zamora	Group 0800 Diseases of the ear and the mastoid  380-389	Women	103
Zamora	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.309
Zamora	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.247
Zamora	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.062
Zamora	Group 0901 Hypertensive disease  401-405	Both sexes	86
Zamora	Group 0901 Hypertensive disease  401-405	Men	33
Zamora	Group 0901 Hypertensive disease  401-405	Women	53
Zamora	Group 0902 Angina pectoris  4111, 413	Both sexes	52
Zamora	Group 0902 Angina pectoris  4111, 413	Men	39
Zamora	Group 0902 Angina pectoris  4111, 413	Women	13
Zamora	Group 0903 Acute myocardial infarction  410	Both sexes	157
Zamora	Group 0903 Acute myocardial infarction  410	Men	116
Zamora	Group 0903 Acute myocardial infarction  410	Women	41
Zamora	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	97
Zamora	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	81
Zamora	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	16
Zamora	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	118
Zamora	Group 0905 Diseases of the lungs circulation 415-417	Men	60
Zamora	Group 0905 Diseases of the lungs circulation 415-417	Women	58
Zamora	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	298
Zamora	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	164
Zamora	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	134
Zamora	Grupo 0907 Heart failure  428	Both sexes	610
Zamora	Grupo 0907 Heart failure  428	Men	293
Zamora	Grupo 0907 Heart failure  428	Women	317
Zamora	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	427
Zamora	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	221
Zamora	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	206
Zamora	Grupo 0909 Atherosclerosis  440	Both sexes	18
Zamora	Grupo 0909 Atherosclerosis  440	Men	10
Zamora	Grupo 0909 Atherosclerosis  440	Women	8
Zamora	Group 0910 Varicose veins of lower extremities 454	Both sexes	80
Zamora	Group 0910 Varicose veins of lower extremities 454	Men	32
Zamora	Group 0910 Varicose veins of lower extremities 454	Women	48
Zamora	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	366
Zamora	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	198
Zamora	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	168
Zamora	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.648
Zamora	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.508
Zamora	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.140
Zamora	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	146
Zamora	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	69
Zamora	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	77
Zamora	Group 1002 Pneumonia 480-486	Both sexes	545
Zamora	Group 1002 Pneumonia 480-486	Men	325
Zamora	Group 1002 Pneumonia 480-486	Women	220
Zamora	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	227
Zamora	Group 1003 Acute bronchitis and bronchiolitis  466	Men	107
Zamora	Group 1003 Acute bronchitis and bronchiolitis  466	Women	120
Zamora	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	206
Zamora	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	103
Zamora	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	103
Zamora	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	301
Zamora	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	177
Zamora	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	124
Zamora	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	453
Zamora	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	381
Zamora	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	72
Zamora	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	127
Zamora	Group 1007 Asthma 4930-4931,4938-4939	Men	38
Zamora	Group 1007 Asthma 4930-4931,4938-4939	Women	89
Zamora	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	643
Zamora	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	308
Zamora	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	335
Zamora	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.766
Zamora	Group 1100 Diseases of the digestive system  520-579	Men	1.626
Zamora	Group 1100 Diseases of the digestive system  520-579	Women	1.140
Zamora	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	17
Zamora	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	7
Zamora	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	10
Zamora	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	41
Zamora	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	18
Zamora	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	23
Zamora	Group 1103 Diseases of the esophagus 530	Both sexes	54
Zamora	Group 1103 Diseases of the esophagus 530	Men	44
Zamora	Group 1103 Diseases of the esophagus 530	Women	10
Zamora	Group 1104 Peptic ulcer 531-534	Both sexes	58
Zamora	Group 1104 Peptic ulcer 531-534	Men	43
Zamora	Group 1104 Peptic ulcer 531-534	Women	15
Zamora	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	79
Zamora	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	34
Zamora	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	45
Zamora	Group 1106 Appendicitis  540-543	Both sexes	204
Zamora	Group 1106 Appendicitis  540-543	Men	117
Zamora	Group 1106 Appendicitis  540-543	Women	87
Zamora	Group 1107 Inguinal hernia  550	Both sexes	334
Zamora	Group 1107 Inguinal hernia  550	Men	307
Zamora	Group 1107 Inguinal hernia  550	Women	27
Zamora	Group 1108 Other abdominal hernia  551-553	Both sexes	147
Zamora	Group 1108 Other abdominal hernia  551-553	Men	66
Zamora	Group 1108 Other abdominal hernia  551-553	Women	81
Zamora	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	47
Zamora	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	25
Zamora	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	22
Zamora	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	214
Zamora	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	88
Zamora	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	126
Zamora	Group 1111 Intestinal obstruction without hernia 560	Both sexes	182
Zamora	Group 1111 Intestinal obstruction without hernia 560	Men	101
Zamora	Group 1111 Intestinal obstruction without hernia 560	Women	81
Zamora	Group 1112 Intestinal diverticulosis 562	Both sexes	152
Zamora	Group 1112 Intestinal diverticulosis 562	Men	76
Zamora	Group 1112 Intestinal diverticulosis 562	Women	76
Zamora	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	115
Zamora	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	87
Zamora	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	28
Zamora	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	118
Zamora	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	58
Zamora	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	60
Zamora	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	43
Zamora	Group 1115 Alcoholic hepatitis 5710-5713	Men	40
Zamora	Group 1115 Alcoholic hepatitis 5710-5713	Women	3
Zamora	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	74
Zamora	Group 1116 Other diseases of the liver 570,5714-573	Men	40
Zamora	Group 1116 Other diseases of the liver 570,5714-573	Women	34
Zamora	Group 1117 Cholelithiasis  574	Both sexes	541
Zamora	Group 1117 Cholelithiasis  574	Men	294
Zamora	Group 1117 Cholelithiasis  574	Women	247
Zamora	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	79
Zamora	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	47
Zamora	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	32
Zamora	Group 1119 Pancreatic diseases 577	Both sexes	112
Zamora	Group 1119 Pancreatic diseases 577	Men	61
Zamora	Group 1119 Pancreatic diseases 577	Women	51
Zamora	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	155
Zamora	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	73
Zamora	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	82
Zamora	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	152
Zamora	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	80
Zamora	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	72
Zamora	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	97
Zamora	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	49
Zamora	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	48
Zamora	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	9
Zamora	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	5
Zamora	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	4
Zamora	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	46
Zamora	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	26
Zamora	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	20
Zamora	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	998
Zamora	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	446
Zamora	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	552
Zamora	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Zamora	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Zamora	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Zamora	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Zamora	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Zamora	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Zamora	Group 1303 Internal derangement of knee 717	Both sexes	76
Zamora	Group 1303 Internal derangement of knee 717	Men	51
Zamora	Group 1303 Internal derangement of knee 717	Women	25
Zamora	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	536
Zamora	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	243
Zamora	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	293
Zamora	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	21
Zamora	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	9
Zamora	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	12
Zamora	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	8
Zamora	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	5
Zamora	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	3
Zamora	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	25
Zamora	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	10
Zamora	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	15
Zamora	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	8
Zamora	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	6
Zamora	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	2
Zamora	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	110
Zamora	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	71
Zamora	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	39
Zamora	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	214
Zamora	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	51
Zamora	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	163
Zamora	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.160
Zamora	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	596
Zamora	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	564
Zamora	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	88
Zamora	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	36
Zamora	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	52
Zamora	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	106
Zamora	Group 1402 Renal failure  5836-5837, 584-586	Men	46
Zamora	Group 1402 Renal failure  5836-5837, 584-586	Women	60
Zamora	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	116
Zamora	Group 1403 Urolithiasis  592, 594, 7880	Men	67
Zamora	Group 1403 Urolithiasis  592, 594, 7880	Women	49
Zamora	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	422
Zamora	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	230
Zamora	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	192
Zamora	Group 1405 Prostatic hyperplasia  600	Both sexes	143
Zamora	Group 1405 Prostatic hyperplasia  600	Men	143
Zamora	Group 1405 Prostatic hyperplasia  600	Women	..
Zamora	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	68
Zamora	Group 1406 Other diseases of the male genital organs    601-608	Men	68
Zamora	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Zamora	Group 1407 Disorders of breast  610-612	Both sexes	30
Zamora	Group 1407 Disorders of breast  610-612	Men	6
Zamora	Group 1407 Disorders of breast  610-612	Women	24
Zamora	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	28
Zamora	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Zamora	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	28
Zamora	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	11
Zamora	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Zamora	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	11
Zamora	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	148
Zamora	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Zamora	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	148
Zamora	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.272
Zamora	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Zamora	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.272
Zamora	Group 1501 Legally induced abortion  635	Both sexes	..
Zamora	Group 1501 Legally induced abortion  635	Men	..
Zamora	Group 1501 Legally induced abortion  635	Women	..
Zamora	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	106
Zamora	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Zamora	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	106
Zamora	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	860
Zamora	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Zamora	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	860
Zamora	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	166
Zamora	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Zamora	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	166
Zamora	Group 1505 Single spontaneous delivery  650	Both sexes	42
Zamora	Group 1505 Single spontaneous delivery  650	Men	..
Zamora	Group 1505 Single spontaneous delivery  650	Women	42
Zamora	Group 1506 Other deliveries  6695-6697	Both sexes	13
Zamora	Group 1506 Other deliveries  6695-6697	Men	..
Zamora	Group 1506 Other deliveries  6695-6697	Women	13
Zamora	Group 1507 Complications related to the puerperium  670-676	Both sexes	28
Zamora	Group 1507 Complications related to the puerperium  670-676	Men	..
Zamora	Group 1507 Complications related to the puerperium  670-676	Women	28
Zamora	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	57
Zamora	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Zamora	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	57
Zamora	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	128
Zamora	Group 1600 Some disorders originating in the perinatal period  760-779	Men	71
Zamora	Group 1600 Some disorders originating in the perinatal period  760-779	Women	57
Zamora	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	36
Zamora	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	16
Zamora	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	20
Zamora	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	92
Zamora	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	55
Zamora	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	37
Zamora	Grupo 1700 Congenital abnormalities  740-759	Both sexes	50
Zamora	Grupo 1700 Congenital abnormalities  740-759	Men	21
Zamora	Grupo 1700 Congenital abnormalities  740-759	Women	29
Zamora	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	719
Zamora	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	401
Zamora	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	318
Zamora	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	93
Zamora	Group 1801 Pain in throat and chest 7841, 7865	Men	64
Zamora	Group 1801 Pain in throat and chest 7841, 7865	Women	29
Zamora	Group 1802 Abdominal pain   7890	Both sexes	110
Zamora	Group 1802 Abdominal pain   7890	Men	45
Zamora	Group 1802 Abdominal pain   7890	Women	65
Zamora	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	57
Zamora	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	34
Zamora	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	23
Zamora	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	459
Zamora	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	258
Zamora	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	201
Zamora	Group 1900 Injuries and poisoning  800-999	Both sexes	1.569
Zamora	Group 1900 Injuries and poisoning  800-999	Men	711
Zamora	Group 1900 Injuries and poisoning  800-999	Women	858
Zamora	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	89
Zamora	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	48
Zamora	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	41
Zamora	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	62
Zamora	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	39
Zamora	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	23
Zamora	Group 1903 Radius and ulna fracture 813	Both sexes	80
Zamora	Group 1903 Radius and ulna fracture 813	Men	30
Zamora	Group 1903 Radius and ulna fracture 813	Women	50
Zamora	Group 1904 Femur fracture  820-821	Both sexes	338
Zamora	Group 1904 Femur fracture  820-821	Men	72
Zamora	Group 1904 Femur fracture  820-821	Women	266
Zamora	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	96
Zamora	Group 1905 Leg fracture, including the ankle 823-824	Men	41
Zamora	Group 1905 Leg fracture, including the ankle 823-824	Women	55
Zamora	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	279
Zamora	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	174
Zamora	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	105
Zamora	Group 1907 Burns  940-949	Both sexes	1
Zamora	Group 1907 Burns  940-949	Men	1
Zamora	Group 1907 Burns  940-949	Women	..
Zamora	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	59
Zamora	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	22
Zamora	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	37
Zamora	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	493
Zamora	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	254
Zamora	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	239
Zamora	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Zamora	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Zamora	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Zamora	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	72
Zamora	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	30
Zamora	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	42
Zamora	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	507
Zamora	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	193
Zamora	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	314
Zamora	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	8
Zamora	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	4
Zamora	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	4
Zamora	Group 2102 Contraceptive management  V25	Both sexes	7
Zamora	Group 2102 Contraceptive management  V25	Men	..
Zamora	Group 2102 Contraceptive management  V25	Women	7
Zamora	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Zamora	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Zamora	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Zamora	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	317
Zamora	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	96
Zamora	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	221
Zamora	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	175
Zamora	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	93
Zamora	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	82
CASTILLA - LA MANCHA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	173.204
CASTILLA - LA MANCHA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	82.897
CASTILLA - LA MANCHA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	90.307
CASTILLA - LA MANCHA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.289
CASTILLA - LA MANCHA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.445
CASTILLA - LA MANCHA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.844
CASTILLA - LA MANCHA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	643
CASTILLA - LA MANCHA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	344
CASTILLA - LA MANCHA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	299
CASTILLA - LA MANCHA	Group 0102 Imprecise intestinal infections 009	Both sexes	185
CASTILLA - LA MANCHA	Group 0102 Imprecise intestinal infections 009	Men	92
CASTILLA - LA MANCHA	Group 0102 Imprecise intestinal infections 009	Women	93
CASTILLA - LA MANCHA	Group 0103 Tuberculosis 010-018, 137	Both sexes	111
CASTILLA - LA MANCHA	Group 0103 Tuberculosis 010-018, 137	Men	73
CASTILLA - LA MANCHA	Group 0103 Tuberculosis 010-018, 137	Women	38
CASTILLA - LA MANCHA	Group 0104 Septicaemia  038	Both sexes	2.055
CASTILLA - LA MANCHA	Group 0104 Septicaemia  038	Men	1.135
CASTILLA - LA MANCHA	Group 0104 Septicaemia  038	Women	920
CASTILLA - LA MANCHA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	63
CASTILLA - LA MANCHA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	49
CASTILLA - LA MANCHA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	14
CASTILLA - LA MANCHA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.232
CASTILLA - LA MANCHA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	752
CASTILLA - LA MANCHA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	480
CASTILLA - LA MANCHA	Group 0200 Neoplasms  140-239	Both sexes	16.097
CASTILLA - LA MANCHA	Group 0200 Neoplasms  140-239	Men	8.911
CASTILLA - LA MANCHA	Group 0200 Neoplasms  140-239	Women	7.186
CASTILLA - LA MANCHA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.781
CASTILLA - LA MANCHA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.108
CASTILLA - LA MANCHA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	673
CASTILLA - LA MANCHA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.309
CASTILLA - LA MANCHA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.119
CASTILLA - LA MANCHA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	190
CASTILLA - LA MANCHA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	341
CASTILLA - LA MANCHA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	217
CASTILLA - LA MANCHA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	124
CASTILLA - LA MANCHA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.115
CASTILLA - LA MANCHA	Group 0204 Malignant neoplasm of breast  174-175	Men	11
CASTILLA - LA MANCHA	Group 0204 Malignant neoplasm of breast  174-175	Women	1.104
CASTILLA - LA MANCHA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	366
CASTILLA - LA MANCHA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CASTILLA - LA MANCHA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	366
CASTILLA - LA MANCHA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	145
CASTILLA - LA MANCHA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CASTILLA - LA MANCHA	Group 0206 Malignant neoplasm of ovary  1830	Women	145
CASTILLA - LA MANCHA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	428
CASTILLA - LA MANCHA	Group 0207 Malignant neoplasm of prostate  185	Men	428
CASTILLA - LA MANCHA	Group 0207 Malignant neoplasm of prostate  185	Women	..
CASTILLA - LA MANCHA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.351
CASTILLA - LA MANCHA	Group 0208 Malignant neoplasm of bladder  188	Men	1.158
CASTILLA - LA MANCHA	Group 0208 Malignant neoplasm of bladder  188	Women	193
CASTILLA - LA MANCHA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.526
CASTILLA - LA MANCHA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.331
CASTILLA - LA MANCHA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.195
CASTILLA - LA MANCHA	Group 0210 Carcinoma in situ  230-234	Both sexes	227
CASTILLA - LA MANCHA	Group 0210 Carcinoma in situ  230-234	Men	99
CASTILLA - LA MANCHA	Group 0210 Carcinoma in situ  230-234	Women	128
CASTILLA - LA MANCHA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	184
CASTILLA - LA MANCHA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	118
CASTILLA - LA MANCHA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	66
CASTILLA - LA MANCHA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	707
CASTILLA - LA MANCHA	Grupo 0212 Leiomyoma of uterus  218	Men	..
CASTILLA - LA MANCHA	Grupo 0212 Leiomyoma of uterus  218	Women	707
CASTILLA - LA MANCHA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.617
CASTILLA - LA MANCHA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.322
CASTILLA - LA MANCHA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.295
CASTILLA - LA MANCHA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.545
CASTILLA - LA MANCHA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	800
CASTILLA - LA MANCHA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	745
CASTILLA - LA MANCHA	Group 0301 Anaemias 280-285	Both sexes	853
CASTILLA - LA MANCHA	Group 0301 Anaemias 280-285	Men	424
CASTILLA - LA MANCHA	Group 0301 Anaemias 280-285	Women	429
CASTILLA - LA MANCHA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	692
CASTILLA - LA MANCHA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	376
CASTILLA - LA MANCHA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	316
CASTILLA - LA MANCHA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.916
CASTILLA - LA MANCHA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.161
CASTILLA - LA MANCHA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.755
CASTILLA - LA MANCHA	Group 0401 Diabetes mellitus  249-250	Both sexes	994
CASTILLA - LA MANCHA	Group 0401 Diabetes mellitus  249-250	Men	532
CASTILLA - LA MANCHA	Group 0401 Diabetes mellitus  249-250	Women	462
CASTILLA - LA MANCHA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.922
CASTILLA - LA MANCHA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	629
CASTILLA - LA MANCHA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.293
CASTILLA - LA MANCHA	Group 0500 Mental disorders  290-319	Both sexes	4.112
CASTILLA - LA MANCHA	Group 0500 Mental disorders  290-319	Men	2.107
CASTILLA - LA MANCHA	Group 0500 Mental disorders  290-319	Women	2.005
CASTILLA - LA MANCHA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	79
CASTILLA - LA MANCHA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	47
CASTILLA - LA MANCHA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	32
CASTILLA - LA MANCHA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	222
CASTILLA - LA MANCHA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	166
CASTILLA - LA MANCHA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	56
CASTILLA - LA MANCHA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	155
CASTILLA - LA MANCHA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	121
CASTILLA - LA MANCHA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	34
CASTILLA - LA MANCHA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.278
CASTILLA - LA MANCHA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	843
CASTILLA - LA MANCHA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	435
CASTILLA - LA MANCHA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	956
CASTILLA - LA MANCHA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	373
CASTILLA - LA MANCHA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	583
CASTILLA - LA MANCHA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.422
CASTILLA - LA MANCHA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	557
CASTILLA - LA MANCHA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	865
CASTILLA - LA MANCHA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	4.610
CASTILLA - LA MANCHA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.438
CASTILLA - LA MANCHA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.172
CASTILLA - LA MANCHA	Group 0601 Alzheimer's disease  3310	Both sexes	51
CASTILLA - LA MANCHA	Group 0601 Alzheimer's disease  3310	Men	18
CASTILLA - LA MANCHA	Group 0601 Alzheimer's disease  3310	Women	33
CASTILLA - LA MANCHA	Group 0602 Multiple sclerosis 340	Both sexes	155
CASTILLA - LA MANCHA	Group 0602 Multiple sclerosis 340	Men	50
CASTILLA - LA MANCHA	Group 0602 Multiple sclerosis 340	Women	105
CASTILLA - LA MANCHA	Group 0603 Epilepsy  345	Both sexes	553
CASTILLA - LA MANCHA	Group 0603 Epilepsy  345	Men	309
CASTILLA - LA MANCHA	Group 0603 Epilepsy  345	Women	244
CASTILLA - LA MANCHA	Group 0604 Transient cerebral ischemia 435	Both sexes	734
CASTILLA - LA MANCHA	Group 0604 Transient cerebral ischemia 435	Men	365
CASTILLA - LA MANCHA	Group 0604 Transient cerebral ischemia 435	Women	369
CASTILLA - LA MANCHA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.117
CASTILLA - LA MANCHA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.696
CASTILLA - LA MANCHA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.421
CASTILLA - LA MANCHA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.029
CASTILLA - LA MANCHA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	558
CASTILLA - LA MANCHA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	471
CASTILLA - LA MANCHA	Grupo 0701 Cataract  366	Both sexes	153
CASTILLA - LA MANCHA	Grupo 0701 Cataract  366	Men	74
CASTILLA - LA MANCHA	Grupo 0701 Cataract  366	Women	79
CASTILLA - LA MANCHA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	876
CASTILLA - LA MANCHA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	484
CASTILLA - LA MANCHA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	392
CASTILLA - LA MANCHA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	771
CASTILLA - LA MANCHA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	383
CASTILLA - LA MANCHA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	388
CASTILLA - LA MANCHA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	22.768
CASTILLA - LA MANCHA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	12.693
CASTILLA - LA MANCHA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	10.075
CASTILLA - LA MANCHA	Group 0901 Hypertensive disease  401-405	Both sexes	1.134
CASTILLA - LA MANCHA	Group 0901 Hypertensive disease  401-405	Men	469
CASTILLA - LA MANCHA	Group 0901 Hypertensive disease  401-405	Women	665
CASTILLA - LA MANCHA	Group 0902 Angina pectoris  4111, 413	Both sexes	1.215
CASTILLA - LA MANCHA	Group 0902 Angina pectoris  4111, 413	Men	781
CASTILLA - LA MANCHA	Group 0902 Angina pectoris  4111, 413	Women	434
CASTILLA - LA MANCHA	Group 0903 Acute myocardial infarction  410	Both sexes	2.190
CASTILLA - LA MANCHA	Group 0903 Acute myocardial infarction  410	Men	1.545
CASTILLA - LA MANCHA	Group 0903 Acute myocardial infarction  410	Women	645
CASTILLA - LA MANCHA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.367
CASTILLA - LA MANCHA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.039
CASTILLA - LA MANCHA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	328
CASTILLA - LA MANCHA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	776
CASTILLA - LA MANCHA	Group 0905 Diseases of the lungs circulation 415-417	Men	361
CASTILLA - LA MANCHA	Group 0905 Diseases of the lungs circulation 415-417	Women	415
CASTILLA - LA MANCHA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	3.041
CASTILLA - LA MANCHA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.656
CASTILLA - LA MANCHA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.385
CASTILLA - LA MANCHA	Grupo 0907 Heart failure  428	Both sexes	4.703
CASTILLA - LA MANCHA	Grupo 0907 Heart failure  428	Men	2.037
CASTILLA - LA MANCHA	Grupo 0907 Heart failure  428	Women	2.666
CASTILLA - LA MANCHA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.983
CASTILLA - LA MANCHA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.165
CASTILLA - LA MANCHA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.818
CASTILLA - LA MANCHA	Grupo 0909 Atherosclerosis  440	Both sexes	841
CASTILLA - LA MANCHA	Grupo 0909 Atherosclerosis  440	Men	620
CASTILLA - LA MANCHA	Grupo 0909 Atherosclerosis  440	Women	221
CASTILLA - LA MANCHA	Group 0910 Varicose veins of lower extremities 454	Both sexes	212
CASTILLA - LA MANCHA	Group 0910 Varicose veins of lower extremities 454	Men	79
CASTILLA - LA MANCHA	Group 0910 Varicose veins of lower extremities 454	Women	133
CASTILLA - LA MANCHA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.306
CASTILLA - LA MANCHA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.941
CASTILLA - LA MANCHA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.365
CASTILLA - LA MANCHA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	21.455
CASTILLA - LA MANCHA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	12.639
CASTILLA - LA MANCHA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	8.816
CASTILLA - LA MANCHA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.031
CASTILLA - LA MANCHA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	526
CASTILLA - LA MANCHA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	505
CASTILLA - LA MANCHA	Group 1002 Pneumonia 480-486	Both sexes	5.159
CASTILLA - LA MANCHA	Group 1002 Pneumonia 480-486	Men	3.217
CASTILLA - LA MANCHA	Group 1002 Pneumonia 480-486	Women	1.942
CASTILLA - LA MANCHA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.696
CASTILLA - LA MANCHA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	814
CASTILLA - LA MANCHA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	882
CASTILLA - LA MANCHA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	883
CASTILLA - LA MANCHA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	486
CASTILLA - LA MANCHA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	397
CASTILLA - LA MANCHA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.327
CASTILLA - LA MANCHA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	898
CASTILLA - LA MANCHA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	429
CASTILLA - LA MANCHA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.088
CASTILLA - LA MANCHA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.570
CASTILLA - LA MANCHA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	518
CASTILLA - LA MANCHA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	725
CASTILLA - LA MANCHA	Group 1007 Asthma 4930-4931,4938-4939	Men	252
CASTILLA - LA MANCHA	Group 1007 Asthma 4930-4931,4938-4939	Women	473
CASTILLA - LA MANCHA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	7.546
CASTILLA - LA MANCHA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.876
CASTILLA - LA MANCHA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	3.670
CASTILLA - LA MANCHA	Group 1100 Diseases of the digestive system  520-579	Both sexes	22.666
CASTILLA - LA MANCHA	Group 1100 Diseases of the digestive system  520-579	Men	12.711
CASTILLA - LA MANCHA	Group 1100 Diseases of the digestive system  520-579	Women	9.955
CASTILLA - LA MANCHA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	265
CASTILLA - LA MANCHA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	135
CASTILLA - LA MANCHA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	130
CASTILLA - LA MANCHA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	278
CASTILLA - LA MANCHA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	158
CASTILLA - LA MANCHA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	120
CASTILLA - LA MANCHA	Group 1103 Diseases of the esophagus 530	Both sexes	435
CASTILLA - LA MANCHA	Group 1103 Diseases of the esophagus 530	Men	273
CASTILLA - LA MANCHA	Group 1103 Diseases of the esophagus 530	Women	162
CASTILLA - LA MANCHA	Group 1104 Peptic ulcer 531-534	Both sexes	546
CASTILLA - LA MANCHA	Group 1104 Peptic ulcer 531-534	Men	369
CASTILLA - LA MANCHA	Group 1104 Peptic ulcer 531-534	Women	177
CASTILLA - LA MANCHA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	598
CASTILLA - LA MANCHA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	304
CASTILLA - LA MANCHA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	294
CASTILLA - LA MANCHA	Group 1106 Appendicitis  540-543	Both sexes	1.868
CASTILLA - LA MANCHA	Group 1106 Appendicitis  540-543	Men	1.098
CASTILLA - LA MANCHA	Group 1106 Appendicitis  540-543	Women	770
CASTILLA - LA MANCHA	Group 1107 Inguinal hernia  550	Both sexes	1.644
CASTILLA - LA MANCHA	Group 1107 Inguinal hernia  550	Men	1.468
CASTILLA - LA MANCHA	Group 1107 Inguinal hernia  550	Women	176
CASTILLA - LA MANCHA	Group 1108 Other abdominal hernia  551-553	Both sexes	1.747
CASTILLA - LA MANCHA	Group 1108 Other abdominal hernia  551-553	Men	761
CASTILLA - LA MANCHA	Group 1108 Other abdominal hernia  551-553	Women	986
CASTILLA - LA MANCHA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	405
CASTILLA - LA MANCHA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	217
CASTILLA - LA MANCHA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	188
CASTILLA - LA MANCHA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.326
CASTILLA - LA MANCHA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	668
CASTILLA - LA MANCHA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	658
CASTILLA - LA MANCHA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.367
CASTILLA - LA MANCHA	Group 1111 Intestinal obstruction without hernia 560	Men	710
CASTILLA - LA MANCHA	Group 1111 Intestinal obstruction without hernia 560	Women	657
CASTILLA - LA MANCHA	Group 1112 Intestinal diverticulosis 562	Both sexes	810
CASTILLA - LA MANCHA	Group 1112 Intestinal diverticulosis 562	Men	418
CASTILLA - LA MANCHA	Group 1112 Intestinal diverticulosis 562	Women	392
CASTILLA - LA MANCHA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.296
CASTILLA - LA MANCHA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	870
CASTILLA - LA MANCHA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	426
CASTILLA - LA MANCHA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	870
CASTILLA - LA MANCHA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	399
CASTILLA - LA MANCHA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	471
CASTILLA - LA MANCHA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	292
CASTILLA - LA MANCHA	Group 1115 Alcoholic hepatitis 5710-5713	Men	256
CASTILLA - LA MANCHA	Group 1115 Alcoholic hepatitis 5710-5713	Women	36
CASTILLA - LA MANCHA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	747
CASTILLA - LA MANCHA	Group 1116 Other diseases of the liver 570,5714-573	Men	499
CASTILLA - LA MANCHA	Group 1116 Other diseases of the liver 570,5714-573	Women	248
CASTILLA - LA MANCHA	Group 1117 Cholelithiasis  574	Both sexes	4.293
CASTILLA - LA MANCHA	Group 1117 Cholelithiasis  574	Men	1.984
CASTILLA - LA MANCHA	Group 1117 Cholelithiasis  574	Women	2.309
CASTILLA - LA MANCHA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.288
CASTILLA - LA MANCHA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	695
CASTILLA - LA MANCHA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	593
CASTILLA - LA MANCHA	Group 1119 Pancreatic diseases 577	Both sexes	1.593
CASTILLA - LA MANCHA	Group 1119 Pancreatic diseases 577	Men	865
CASTILLA - LA MANCHA	Group 1119 Pancreatic diseases 577	Women	728
CASTILLA - LA MANCHA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	998
CASTILLA - LA MANCHA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	564
CASTILLA - LA MANCHA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	434
CASTILLA - LA MANCHA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.330
CASTILLA - LA MANCHA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	686
CASTILLA - LA MANCHA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	644
CASTILLA - LA MANCHA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	807
CASTILLA - LA MANCHA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	440
CASTILLA - LA MANCHA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	367
CASTILLA - LA MANCHA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	63
CASTILLA - LA MANCHA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	27
CASTILLA - LA MANCHA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	36
CASTILLA - LA MANCHA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	460
CASTILLA - LA MANCHA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	219
CASTILLA - LA MANCHA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	241
CASTILLA - LA MANCHA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.720
CASTILLA - LA MANCHA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.665
CASTILLA - LA MANCHA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.055
CASTILLA - LA MANCHA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA - LA MANCHA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CASTILLA - LA MANCHA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CASTILLA - LA MANCHA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CASTILLA - LA MANCHA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CASTILLA - LA MANCHA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CASTILLA - LA MANCHA	Group 1303 Internal derangement of knee 717	Both sexes	949
CASTILLA - LA MANCHA	Group 1303 Internal derangement of knee 717	Men	671
CASTILLA - LA MANCHA	Group 1303 Internal derangement of knee 717	Women	278
CASTILLA - LA MANCHA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.852
CASTILLA - LA MANCHA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.583
CASTILLA - LA MANCHA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.269
CASTILLA - LA MANCHA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	165
CASTILLA - LA MANCHA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	70
CASTILLA - LA MANCHA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	95
CASTILLA - LA MANCHA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	647
CASTILLA - LA MANCHA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	335
CASTILLA - LA MANCHA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	312
CASTILLA - LA MANCHA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	889
CASTILLA - LA MANCHA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	466
CASTILLA - LA MANCHA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	423
CASTILLA - LA MANCHA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	169
CASTILLA - LA MANCHA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	84
CASTILLA - LA MANCHA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	85
CASTILLA - LA MANCHA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.399
CASTILLA - LA MANCHA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	769
CASTILLA - LA MANCHA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	630
CASTILLA - LA MANCHA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.650
CASTILLA - LA MANCHA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	687
CASTILLA - LA MANCHA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	963
CASTILLA - LA MANCHA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	11.284
CASTILLA - LA MANCHA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	5.218
CASTILLA - LA MANCHA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	6.066
CASTILLA - LA MANCHA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.143
CASTILLA - LA MANCHA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	414
CASTILLA - LA MANCHA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	729
CASTILLA - LA MANCHA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.184
CASTILLA - LA MANCHA	Group 1402 Renal failure  5836-5837, 584-586	Men	678
CASTILLA - LA MANCHA	Group 1402 Renal failure  5836-5837, 584-586	Women	506
CASTILLA - LA MANCHA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.415
CASTILLA - LA MANCHA	Group 1403 Urolithiasis  592, 594, 7880	Men	866
CASTILLA - LA MANCHA	Group 1403 Urolithiasis  592, 594, 7880	Women	549
CASTILLA - LA MANCHA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.304
CASTILLA - LA MANCHA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.634
CASTILLA - LA MANCHA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.670
CASTILLA - LA MANCHA	Group 1405 Prostatic hyperplasia  600	Both sexes	672
CASTILLA - LA MANCHA	Group 1405 Prostatic hyperplasia  600	Men	672
CASTILLA - LA MANCHA	Group 1405 Prostatic hyperplasia  600	Women	..
CASTILLA - LA MANCHA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	884
CASTILLA - LA MANCHA	Group 1406 Other diseases of the male genital organs    601-608	Men	884
CASTILLA - LA MANCHA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CASTILLA - LA MANCHA	Group 1407 Disorders of breast  610-612	Both sexes	471
CASTILLA - LA MANCHA	Group 1407 Disorders of breast  610-612	Men	63
CASTILLA - LA MANCHA	Group 1407 Disorders of breast  610-612	Women	408
CASTILLA - LA MANCHA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	319
CASTILLA - LA MANCHA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CASTILLA - LA MANCHA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	319
CASTILLA - LA MANCHA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	169
CASTILLA - LA MANCHA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CASTILLA - LA MANCHA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	169
CASTILLA - LA MANCHA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.723
CASTILLA - LA MANCHA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	7
CASTILLA - LA MANCHA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.716
CASTILLA - LA MANCHA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.117
CASTILLA - LA MANCHA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CASTILLA - LA MANCHA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.117
CASTILLA - LA MANCHA	Group 1501 Legally induced abortion  635	Both sexes	20
CASTILLA - LA MANCHA	Group 1501 Legally induced abortion  635	Men	..
CASTILLA - LA MANCHA	Group 1501 Legally induced abortion  635	Women	20
CASTILLA - LA MANCHA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.605
CASTILLA - LA MANCHA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CASTILLA - LA MANCHA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.605
CASTILLA - LA MANCHA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	11.860
CASTILLA - LA MANCHA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CASTILLA - LA MANCHA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	11.860
CASTILLA - LA MANCHA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.430
CASTILLA - LA MANCHA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CASTILLA - LA MANCHA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.430
CASTILLA - LA MANCHA	Group 1505 Single spontaneous delivery  650	Both sexes	1.114
CASTILLA - LA MANCHA	Group 1505 Single spontaneous delivery  650	Men	..
CASTILLA - LA MANCHA	Group 1505 Single spontaneous delivery  650	Women	1.114
CASTILLA - LA MANCHA	Group 1506 Other deliveries  6695-6697	Both sexes	675
CASTILLA - LA MANCHA	Group 1506 Other deliveries  6695-6697	Men	..
CASTILLA - LA MANCHA	Group 1506 Other deliveries  6695-6697	Women	675
CASTILLA - LA MANCHA	Group 1507 Complications related to the puerperium  670-676	Both sexes	115
CASTILLA - LA MANCHA	Group 1507 Complications related to the puerperium  670-676	Men	..
CASTILLA - LA MANCHA	Group 1507 Complications related to the puerperium  670-676	Women	115
CASTILLA - LA MANCHA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.298
CASTILLA - LA MANCHA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CASTILLA - LA MANCHA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.298
CASTILLA - LA MANCHA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.958
CASTILLA - LA MANCHA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.642
CASTILLA - LA MANCHA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.316
CASTILLA - LA MANCHA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	847
CASTILLA - LA MANCHA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	455
CASTILLA - LA MANCHA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	392
CASTILLA - LA MANCHA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.111
CASTILLA - LA MANCHA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.187
CASTILLA - LA MANCHA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	924
CASTILLA - LA MANCHA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.015
CASTILLA - LA MANCHA	Grupo 1700 Congenital abnormalities  740-759	Men	649
CASTILLA - LA MANCHA	Grupo 1700 Congenital abnormalities  740-759	Women	366
CASTILLA - LA MANCHA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.976
CASTILLA - LA MANCHA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.242
CASTILLA - LA MANCHA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.734
CASTILLA - LA MANCHA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	874
CASTILLA - LA MANCHA	Group 1801 Pain in throat and chest 7841, 7865	Men	479
CASTILLA - LA MANCHA	Group 1801 Pain in throat and chest 7841, 7865	Women	395
CASTILLA - LA MANCHA	Group 1802 Abdominal pain   7890	Both sexes	1.025
CASTILLA - LA MANCHA	Group 1802 Abdominal pain   7890	Men	439
CASTILLA - LA MANCHA	Group 1802 Abdominal pain   7890	Women	586
CASTILLA - LA MANCHA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	897
CASTILLA - LA MANCHA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	419
CASTILLA - LA MANCHA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	478
CASTILLA - LA MANCHA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.180
CASTILLA - LA MANCHA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.905
CASTILLA - LA MANCHA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.275
CASTILLA - LA MANCHA	Group 1900 Injuries and poisoning  800-999	Both sexes	14.831
CASTILLA - LA MANCHA	Group 1900 Injuries and poisoning  800-999	Men	7.382
CASTILLA - LA MANCHA	Group 1900 Injuries and poisoning  800-999	Women	7.449
CASTILLA - LA MANCHA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	790
CASTILLA - LA MANCHA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	483
CASTILLA - LA MANCHA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	307
CASTILLA - LA MANCHA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	361
CASTILLA - LA MANCHA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	256
CASTILLA - LA MANCHA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	105
CASTILLA - LA MANCHA	Group 1903 Radius and ulna fracture 813	Both sexes	811
CASTILLA - LA MANCHA	Group 1903 Radius and ulna fracture 813	Men	402
CASTILLA - LA MANCHA	Group 1903 Radius and ulna fracture 813	Women	409
CASTILLA - LA MANCHA	Group 1904 Femur fracture  820-821	Both sexes	3.099
CASTILLA - LA MANCHA	Group 1904 Femur fracture  820-821	Men	848
CASTILLA - LA MANCHA	Group 1904 Femur fracture  820-821	Women	2.251
CASTILLA - LA MANCHA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.086
CASTILLA - LA MANCHA	Group 1905 Leg fracture, including the ankle 823-824	Men	549
CASTILLA - LA MANCHA	Group 1905 Leg fracture, including the ankle 823-824	Women	537
CASTILLA - LA MANCHA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.986
CASTILLA - LA MANCHA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.463
CASTILLA - LA MANCHA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.523
CASTILLA - LA MANCHA	Group 1907 Burns  940-949	Both sexes	39
CASTILLA - LA MANCHA	Group 1907 Burns  940-949	Men	28
CASTILLA - LA MANCHA	Group 1907 Burns  940-949	Women	11
CASTILLA - LA MANCHA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	478
CASTILLA - LA MANCHA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	200
CASTILLA - LA MANCHA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	278
CASTILLA - LA MANCHA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.664
CASTILLA - LA MANCHA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.866
CASTILLA - LA MANCHA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.798
CASTILLA - LA MANCHA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	36
CASTILLA - LA MANCHA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	25
CASTILLA - LA MANCHA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	11
CASTILLA - LA MANCHA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	481
CASTILLA - LA MANCHA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	262
CASTILLA - LA MANCHA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	219
CASTILLA - LA MANCHA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.715
CASTILLA - LA MANCHA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.567
CASTILLA - LA MANCHA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.148
CASTILLA - LA MANCHA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	165
CASTILLA - LA MANCHA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	113
CASTILLA - LA MANCHA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	52
CASTILLA - LA MANCHA	Group 2102 Contraceptive management  V25	Both sexes	58
CASTILLA - LA MANCHA	Group 2102 Contraceptive management  V25	Men	6
CASTILLA - LA MANCHA	Group 2102 Contraceptive management  V25	Women	52
CASTILLA - LA MANCHA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CASTILLA - LA MANCHA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CASTILLA - LA MANCHA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CASTILLA - LA MANCHA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.242
CASTILLA - LA MANCHA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	765
CASTILLA - LA MANCHA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	477
CASTILLA - LA MANCHA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.250
CASTILLA - LA MANCHA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	683
CASTILLA - LA MANCHA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	567
Albacete	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	40.021
Albacete	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.782
Albacete	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	21.239
Albacete	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	989
Albacete	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	582
Albacete	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	407
Albacete	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	158
Albacete	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	91
Albacete	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	67
Albacete	Group 0102 Imprecise intestinal infections 009	Both sexes	59
Albacete	Group 0102 Imprecise intestinal infections 009	Men	31
Albacete	Group 0102 Imprecise intestinal infections 009	Women	28
Albacete	Group 0103 Tuberculosis 010-018, 137	Both sexes	41
Albacete	Group 0103 Tuberculosis 010-018, 137	Men	30
Albacete	Group 0103 Tuberculosis 010-018, 137	Women	11
Albacete	Group 0104 Septicaemia  038	Both sexes	434
Albacete	Group 0104 Septicaemia  038	Men	244
Albacete	Group 0104 Septicaemia  038	Women	190
Albacete	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	15
Albacete	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	10
Albacete	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	5
Albacete	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	282
Albacete	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	176
Albacete	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	106
Albacete	Group 0200 Neoplasms  140-239	Both sexes	3.609
Albacete	Group 0200 Neoplasms  140-239	Men	2.003
Albacete	Group 0200 Neoplasms  140-239	Women	1.606
Albacete	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	384
Albacete	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	234
Albacete	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	150
Albacete	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	284
Albacete	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	244
Albacete	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	40
Albacete	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	77
Albacete	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	44
Albacete	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	33
Albacete	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	208
Albacete	Group 0204 Malignant neoplasm of breast  174-175	Men	2
Albacete	Group 0204 Malignant neoplasm of breast  174-175	Women	206
Albacete	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	62
Albacete	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Albacete	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	62
Albacete	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	16
Albacete	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Albacete	Group 0206 Malignant neoplasm of ovary  1830	Women	16
Albacete	Group 0207 Malignant neoplasm of prostate  185	Both sexes	74
Albacete	Group 0207 Malignant neoplasm of prostate  185	Men	74
Albacete	Group 0207 Malignant neoplasm of prostate  185	Women	..
Albacete	Group 0208 Malignant neoplasm of bladder  188	Both sexes	300
Albacete	Group 0208 Malignant neoplasm of bladder  188	Men	261
Albacete	Group 0208 Malignant neoplasm of bladder  188	Women	39
Albacete	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.337
Albacete	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	814
Albacete	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	523
Albacete	Group 0210 Carcinoma in situ  230-234	Both sexes	45
Albacete	Group 0210 Carcinoma in situ  230-234	Men	18
Albacete	Group 0210 Carcinoma in situ  230-234	Women	27
Albacete	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	25
Albacete	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	15
Albacete	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	10
Albacete	Grupo 0212 Leiomyoma of uterus  218	Both sexes	207
Albacete	Grupo 0212 Leiomyoma of uterus  218	Men	..
Albacete	Grupo 0212 Leiomyoma of uterus  218	Women	207
Albacete	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	590
Albacete	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	297
Albacete	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	293
Albacete	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	275
Albacete	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	133
Albacete	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	142
Albacete	Group 0301 Anaemias 280-285	Both sexes	144
Albacete	Group 0301 Anaemias 280-285	Men	74
Albacete	Group 0301 Anaemias 280-285	Women	70
Albacete	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	131
Albacete	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	59
Albacete	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	72
Albacete	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	634
Albacete	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	261
Albacete	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	373
Albacete	Group 0401 Diabetes mellitus  249-250	Both sexes	233
Albacete	Group 0401 Diabetes mellitus  249-250	Men	147
Albacete	Group 0401 Diabetes mellitus  249-250	Women	86
Albacete	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	401
Albacete	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	114
Albacete	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	287
Albacete	Group 0500 Mental disorders  290-319	Both sexes	895
Albacete	Group 0500 Mental disorders  290-319	Men	393
Albacete	Group 0500 Mental disorders  290-319	Women	502
Albacete	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	17
Albacete	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	11
Albacete	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	6
Albacete	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	28
Albacete	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	23
Albacete	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	5
Albacete	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	39
Albacete	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	30
Albacete	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	9
Albacete	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	225
Albacete	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	144
Albacete	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	81
Albacete	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	246
Albacete	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	92
Albacete	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	154
Albacete	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	340
Albacete	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	93
Albacete	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	247
Albacete	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	537
Albacete	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	303
Albacete	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	234
Albacete	Group 0601 Alzheimer's disease  3310	Both sexes	5
Albacete	Group 0601 Alzheimer's disease  3310	Men	1
Albacete	Group 0601 Alzheimer's disease  3310	Women	4
Albacete	Group 0602 Multiple sclerosis 340	Both sexes	11
Albacete	Group 0602 Multiple sclerosis 340	Men	4
Albacete	Group 0602 Multiple sclerosis 340	Women	7
Albacete	Group 0603 Epilepsy  345	Both sexes	85
Albacete	Group 0603 Epilepsy  345	Men	58
Albacete	Group 0603 Epilepsy  345	Women	27
Albacete	Group 0604 Transient cerebral ischemia 435	Both sexes	125
Albacete	Group 0604 Transient cerebral ischemia 435	Men	65
Albacete	Group 0604 Transient cerebral ischemia 435	Women	60
Albacete	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	311
Albacete	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	175
Albacete	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	136
Albacete	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	183
Albacete	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	88
Albacete	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	95
Albacete	Grupo 0701 Cataract  366	Both sexes	59
Albacete	Grupo 0701 Cataract  366	Men	27
Albacete	Grupo 0701 Cataract  366	Women	32
Albacete	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	124
Albacete	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	61
Albacete	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	63
Albacete	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	142
Albacete	Group 0800 Diseases of the ear and the mastoid  380-389	Men	70
Albacete	Group 0800 Diseases of the ear and the mastoid  380-389	Women	72
Albacete	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.085
Albacete	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.843
Albacete	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.242
Albacete	Group 0901 Hypertensive disease  401-405	Both sexes	226
Albacete	Group 0901 Hypertensive disease  401-405	Men	95
Albacete	Group 0901 Hypertensive disease  401-405	Women	131
Albacete	Group 0902 Angina pectoris  4111, 413	Both sexes	242
Albacete	Group 0902 Angina pectoris  4111, 413	Men	139
Albacete	Group 0902 Angina pectoris  4111, 413	Women	103
Albacete	Group 0903 Acute myocardial infarction  410	Both sexes	450
Albacete	Group 0903 Acute myocardial infarction  410	Men	326
Albacete	Group 0903 Acute myocardial infarction  410	Women	124
Albacete	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	329
Albacete	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	254
Albacete	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	75
Albacete	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	201
Albacete	Group 0905 Diseases of the lungs circulation 415-417	Men	92
Albacete	Group 0905 Diseases of the lungs circulation 415-417	Women	109
Albacete	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	579
Albacete	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	317
Albacete	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	262
Albacete	Grupo 0907 Heart failure  428	Both sexes	1.038
Albacete	Grupo 0907 Heart failure  428	Men	477
Albacete	Grupo 0907 Heart failure  428	Women	561
Albacete	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	979
Albacete	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	525
Albacete	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	454
Albacete	Grupo 0909 Atherosclerosis  440	Both sexes	151
Albacete	Grupo 0909 Atherosclerosis  440	Men	110
Albacete	Grupo 0909 Atherosclerosis  440	Women	41
Albacete	Group 0910 Varicose veins of lower extremities 454	Both sexes	37
Albacete	Group 0910 Varicose veins of lower extremities 454	Men	14
Albacete	Group 0910 Varicose veins of lower extremities 454	Women	23
Albacete	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	853
Albacete	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	494
Albacete	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	359
Albacete	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.582
Albacete	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.680
Albacete	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.902
Albacete	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	214
Albacete	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	124
Albacete	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	90
Albacete	Group 1002 Pneumonia 480-486	Both sexes	1.010
Albacete	Group 1002 Pneumonia 480-486	Men	626
Albacete	Group 1002 Pneumonia 480-486	Women	384
Albacete	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	378
Albacete	Group 1003 Acute bronchitis and bronchiolitis  466	Men	195
Albacete	Group 1003 Acute bronchitis and bronchiolitis  466	Women	183
Albacete	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	239
Albacete	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	129
Albacete	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	110
Albacete	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	211
Albacete	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	132
Albacete	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	79
Albacete	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	518
Albacete	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	424
Albacete	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	94
Albacete	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	142
Albacete	Group 1007 Asthma 4930-4931,4938-4939	Men	64
Albacete	Group 1007 Asthma 4930-4931,4938-4939	Women	78
Albacete	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.870
Albacete	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	986
Albacete	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	884
Albacete	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.658
Albacete	Group 1100 Diseases of the digestive system  520-579	Men	2.627
Albacete	Group 1100 Diseases of the digestive system  520-579	Women	2.031
Albacete	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	56
Albacete	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	35
Albacete	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	21
Albacete	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	49
Albacete	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	25
Albacete	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	24
Albacete	Group 1103 Diseases of the esophagus 530	Both sexes	88
Albacete	Group 1103 Diseases of the esophagus 530	Men	51
Albacete	Group 1103 Diseases of the esophagus 530	Women	37
Albacete	Group 1104 Peptic ulcer 531-534	Both sexes	165
Albacete	Group 1104 Peptic ulcer 531-534	Men	97
Albacete	Group 1104 Peptic ulcer 531-534	Women	68
Albacete	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	151
Albacete	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	86
Albacete	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	65
Albacete	Group 1106 Appendicitis  540-543	Both sexes	438
Albacete	Group 1106 Appendicitis  540-543	Men	260
Albacete	Group 1106 Appendicitis  540-543	Women	178
Albacete	Group 1107 Inguinal hernia  550	Both sexes	264
Albacete	Group 1107 Inguinal hernia  550	Men	232
Albacete	Group 1107 Inguinal hernia  550	Women	32
Albacete	Group 1108 Other abdominal hernia  551-553	Both sexes	276
Albacete	Group 1108 Other abdominal hernia  551-553	Men	126
Albacete	Group 1108 Other abdominal hernia  551-553	Women	150
Albacete	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	63
Albacete	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	35
Albacete	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	28
Albacete	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	254
Albacete	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	129
Albacete	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	125
Albacete	Group 1111 Intestinal obstruction without hernia 560	Both sexes	303
Albacete	Group 1111 Intestinal obstruction without hernia 560	Men	176
Albacete	Group 1111 Intestinal obstruction without hernia 560	Women	127
Albacete	Group 1112 Intestinal diverticulosis 562	Both sexes	173
Albacete	Group 1112 Intestinal diverticulosis 562	Men	89
Albacete	Group 1112 Intestinal diverticulosis 562	Women	84
Albacete	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	373
Albacete	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	257
Albacete	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	116
Albacete	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	140
Albacete	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	72
Albacete	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	68
Albacete	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	62
Albacete	Group 1115 Alcoholic hepatitis 5710-5713	Men	51
Albacete	Group 1115 Alcoholic hepatitis 5710-5713	Women	11
Albacete	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	161
Albacete	Group 1116 Other diseases of the liver 570,5714-573	Men	101
Albacete	Group 1116 Other diseases of the liver 570,5714-573	Women	60
Albacete	Group 1117 Cholelithiasis  574	Both sexes	747
Albacete	Group 1117 Cholelithiasis  574	Men	322
Albacete	Group 1117 Cholelithiasis  574	Women	425
Albacete	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	334
Albacete	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	181
Albacete	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	153
Albacete	Group 1119 Pancreatic diseases 577	Both sexes	333
Albacete	Group 1119 Pancreatic diseases 577	Men	180
Albacete	Group 1119 Pancreatic diseases 577	Women	153
Albacete	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	228
Albacete	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	122
Albacete	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	106
Albacete	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	295
Albacete	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	144
Albacete	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	151
Albacete	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	178
Albacete	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	84
Albacete	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	94
Albacete	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	12
Albacete	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	5
Albacete	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	7
Albacete	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	105
Albacete	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	55
Albacete	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	50
Albacete	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.132
Albacete	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.024
Albacete	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.108
Albacete	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Albacete	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Albacete	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Albacete	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Albacete	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Albacete	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Albacete	Group 1303 Internal derangement of knee 717	Both sexes	95
Albacete	Group 1303 Internal derangement of knee 717	Men	72
Albacete	Group 1303 Internal derangement of knee 717	Women	23
Albacete	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	958
Albacete	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	410
Albacete	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	548
Albacete	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	28
Albacete	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	12
Albacete	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	16
Albacete	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	137
Albacete	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	71
Albacete	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	66
Albacete	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	273
Albacete	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	132
Albacete	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	141
Albacete	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	36
Albacete	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	15
Albacete	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	21
Albacete	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	333
Albacete	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	187
Albacete	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	146
Albacete	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	272
Albacete	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	125
Albacete	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	147
Albacete	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.986
Albacete	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.318
Albacete	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.668
Albacete	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	229
Albacete	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	87
Albacete	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	142
Albacete	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	318
Albacete	Group 1402 Renal failure  5836-5837, 584-586	Men	185
Albacete	Group 1402 Renal failure  5836-5837, 584-586	Women	133
Albacete	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	513
Albacete	Group 1403 Urolithiasis  592, 594, 7880	Men	312
Albacete	Group 1403 Urolithiasis  592, 594, 7880	Women	201
Albacete	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	722
Albacete	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	354
Albacete	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	368
Albacete	Group 1405 Prostatic hyperplasia  600	Both sexes	171
Albacete	Group 1405 Prostatic hyperplasia  600	Men	171
Albacete	Group 1405 Prostatic hyperplasia  600	Women	..
Albacete	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	185
Albacete	Group 1406 Other diseases of the male genital organs    601-608	Men	185
Albacete	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Albacete	Group 1407 Disorders of breast  610-612	Both sexes	194
Albacete	Group 1407 Disorders of breast  610-612	Men	21
Albacete	Group 1407 Disorders of breast  610-612	Women	173
Albacete	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	74
Albacete	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Albacete	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	74
Albacete	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	25
Albacete	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Albacete	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	25
Albacete	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	555
Albacete	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
Albacete	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	552
Albacete	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.003
Albacete	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Albacete	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.003
Albacete	Group 1501 Legally induced abortion  635	Both sexes	16
Albacete	Group 1501 Legally induced abortion  635	Men	..
Albacete	Group 1501 Legally induced abortion  635	Women	16
Albacete	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	401
Albacete	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Albacete	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	401
Albacete	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.639
Albacete	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Albacete	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.639
Albacete	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	920
Albacete	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Albacete	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	920
Albacete	Group 1505 Single spontaneous delivery  650	Both sexes	507
Albacete	Group 1505 Single spontaneous delivery  650	Men	..
Albacete	Group 1505 Single spontaneous delivery  650	Women	507
Albacete	Group 1506 Other deliveries  6695-6697	Both sexes	259
Albacete	Group 1506 Other deliveries  6695-6697	Men	..
Albacete	Group 1506 Other deliveries  6695-6697	Women	259
Albacete	Group 1507 Complications related to the puerperium  670-676	Both sexes	31
Albacete	Group 1507 Complications related to the puerperium  670-676	Men	..
Albacete	Group 1507 Complications related to the puerperium  670-676	Women	31
Albacete	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	230
Albacete	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Albacete	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	230
Albacete	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	694
Albacete	Group 1600 Some disorders originating in the perinatal period  760-779	Men	397
Albacete	Group 1600 Some disorders originating in the perinatal period  760-779	Women	297
Albacete	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	219
Albacete	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	117
Albacete	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	102
Albacete	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	475
Albacete	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	280
Albacete	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	195
Albacete	Grupo 1700 Congenital abnormalities  740-759	Both sexes	323
Albacete	Grupo 1700 Congenital abnormalities  740-759	Men	216
Albacete	Grupo 1700 Congenital abnormalities  740-759	Women	107
Albacete	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.541
Albacete	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.310
Albacete	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.231
Albacete	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	171
Albacete	Group 1801 Pain in throat and chest 7841, 7865	Men	97
Albacete	Group 1801 Pain in throat and chest 7841, 7865	Women	74
Albacete	Group 1802 Abdominal pain   7890	Both sexes	287
Albacete	Group 1802 Abdominal pain   7890	Men	121
Albacete	Group 1802 Abdominal pain   7890	Women	166
Albacete	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	880
Albacete	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	413
Albacete	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	467
Albacete	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.203
Albacete	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	679
Albacete	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	524
Albacete	Group 1900 Injuries and poisoning  800-999	Both sexes	3.657
Albacete	Group 1900 Injuries and poisoning  800-999	Men	1.921
Albacete	Group 1900 Injuries and poisoning  800-999	Women	1.736
Albacete	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	203
Albacete	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	136
Albacete	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	67
Albacete	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	86
Albacete	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	64
Albacete	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	22
Albacete	Group 1903 Radius and ulna fracture 813	Both sexes	185
Albacete	Group 1903 Radius and ulna fracture 813	Men	96
Albacete	Group 1903 Radius and ulna fracture 813	Women	89
Albacete	Group 1904 Femur fracture  820-821	Both sexes	687
Albacete	Group 1904 Femur fracture  820-821	Men	200
Albacete	Group 1904 Femur fracture  820-821	Women	487
Albacete	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	256
Albacete	Group 1905 Leg fracture, including the ankle 823-824	Men	126
Albacete	Group 1905 Leg fracture, including the ankle 823-824	Women	130
Albacete	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.031
Albacete	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	681
Albacete	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	350
Albacete	Group 1907 Burns  940-949	Both sexes	16
Albacete	Group 1907 Burns  940-949	Men	12
Albacete	Group 1907 Burns  940-949	Women	4
Albacete	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	103
Albacete	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	37
Albacete	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	66
Albacete	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	943
Albacete	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	486
Albacete	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	457
Albacete	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	15
Albacete	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	11
Albacete	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	4
Albacete	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	132
Albacete	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	72
Albacete	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	60
Albacete	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	801
Albacete	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	469
Albacete	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	332
Albacete	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	71
Albacete	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	49
Albacete	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	22
Albacete	Group 2102 Contraceptive management  V25	Both sexes	8
Albacete	Group 2102 Contraceptive management  V25	Men	1
Albacete	Group 2102 Contraceptive management  V25	Women	7
Albacete	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Albacete	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Albacete	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Albacete	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	435
Albacete	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	280
Albacete	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	155
Albacete	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	287
Albacete	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	139
Albacete	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	148
Ciudad Real	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	52.778
Ciudad Real	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	24.934
Ciudad Real	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	27.844
Ciudad Real	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.145
Ciudad Real	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	650
Ciudad Real	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	495
Ciudad Real	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	189
Ciudad Real	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	99
Ciudad Real	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	90
Ciudad Real	Group 0102 Imprecise intestinal infections 009	Both sexes	31
Ciudad Real	Group 0102 Imprecise intestinal infections 009	Men	19
Ciudad Real	Group 0102 Imprecise intestinal infections 009	Women	12
Ciudad Real	Group 0103 Tuberculosis 010-018, 137	Both sexes	27
Ciudad Real	Group 0103 Tuberculosis 010-018, 137	Men	18
Ciudad Real	Group 0103 Tuberculosis 010-018, 137	Women	9
Ciudad Real	Group 0104 Septicaemia  038	Both sexes	525
Ciudad Real	Group 0104 Septicaemia  038	Men	275
Ciudad Real	Group 0104 Septicaemia  038	Women	250
Ciudad Real	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	15
Ciudad Real	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	12
Ciudad Real	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
Ciudad Real	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	358
Ciudad Real	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	227
Ciudad Real	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	131
Ciudad Real	Group 0200 Neoplasms  140-239	Both sexes	5.334
Ciudad Real	Group 0200 Neoplasms  140-239	Men	2.950
Ciudad Real	Group 0200 Neoplasms  140-239	Women	2.384
Ciudad Real	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	595
Ciudad Real	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	364
Ciudad Real	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	231
Ciudad Real	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	484
Ciudad Real	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	422
Ciudad Real	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	62
Ciudad Real	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	62
Ciudad Real	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	41
Ciudad Real	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	21
Ciudad Real	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	425
Ciudad Real	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Ciudad Real	Group 0204 Malignant neoplasm of breast  174-175	Women	421
Ciudad Real	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	136
Ciudad Real	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Ciudad Real	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	136
Ciudad Real	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	48
Ciudad Real	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Ciudad Real	Group 0206 Malignant neoplasm of ovary  1830	Women	48
Ciudad Real	Group 0207 Malignant neoplasm of prostate  185	Both sexes	141
Ciudad Real	Group 0207 Malignant neoplasm of prostate  185	Men	141
Ciudad Real	Group 0207 Malignant neoplasm of prostate  185	Women	..
Ciudad Real	Group 0208 Malignant neoplasm of bladder  188	Both sexes	557
Ciudad Real	Group 0208 Malignant neoplasm of bladder  188	Men	483
Ciudad Real	Group 0208 Malignant neoplasm of bladder  188	Women	74
Ciudad Real	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.891
Ciudad Real	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.126
Ciudad Real	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	765
Ciudad Real	Group 0210 Carcinoma in situ  230-234	Both sexes	56
Ciudad Real	Group 0210 Carcinoma in situ  230-234	Men	26
Ciudad Real	Group 0210 Carcinoma in situ  230-234	Women	30
Ciudad Real	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	79
Ciudad Real	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	51
Ciudad Real	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	28
Ciudad Real	Grupo 0212 Leiomyoma of uterus  218	Both sexes	215
Ciudad Real	Grupo 0212 Leiomyoma of uterus  218	Men	..
Ciudad Real	Grupo 0212 Leiomyoma of uterus  218	Women	215
Ciudad Real	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	645
Ciudad Real	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	292
Ciudad Real	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	353
Ciudad Real	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	504
Ciudad Real	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	255
Ciudad Real	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	249
Ciudad Real	Group 0301 Anaemias 280-285	Both sexes	290
Ciudad Real	Group 0301 Anaemias 280-285	Men	132
Ciudad Real	Group 0301 Anaemias 280-285	Women	158
Ciudad Real	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	214
Ciudad Real	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	123
Ciudad Real	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	91
Ciudad Real	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	860
Ciudad Real	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	323
Ciudad Real	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	537
Ciudad Real	Group 0401 Diabetes mellitus  249-250	Both sexes	270
Ciudad Real	Group 0401 Diabetes mellitus  249-250	Men	115
Ciudad Real	Group 0401 Diabetes mellitus  249-250	Women	155
Ciudad Real	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	590
Ciudad Real	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	208
Ciudad Real	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	382
Ciudad Real	Group 0500 Mental disorders  290-319	Both sexes	977
Ciudad Real	Group 0500 Mental disorders  290-319	Men	472
Ciudad Real	Group 0500 Mental disorders  290-319	Women	505
Ciudad Real	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	26
Ciudad Real	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	12
Ciudad Real	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	14
Ciudad Real	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	46
Ciudad Real	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	37
Ciudad Real	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	9
Ciudad Real	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	27
Ciudad Real	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	20
Ciudad Real	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	7
Ciudad Real	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	204
Ciudad Real	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	130
Ciudad Real	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	74
Ciudad Real	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	216
Ciudad Real	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	93
Ciudad Real	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	123
Ciudad Real	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	458
Ciudad Real	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	180
Ciudad Real	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	278
Ciudad Real	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.452
Ciudad Real	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	695
Ciudad Real	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	757
Ciudad Real	Group 0601 Alzheimer's disease  3310	Both sexes	21
Ciudad Real	Group 0601 Alzheimer's disease  3310	Men	6
Ciudad Real	Group 0601 Alzheimer's disease  3310	Women	15
Ciudad Real	Group 0602 Multiple sclerosis 340	Both sexes	47
Ciudad Real	Group 0602 Multiple sclerosis 340	Men	18
Ciudad Real	Group 0602 Multiple sclerosis 340	Women	29
Ciudad Real	Group 0603 Epilepsy  345	Both sexes	135
Ciudad Real	Group 0603 Epilepsy  345	Men	71
Ciudad Real	Group 0603 Epilepsy  345	Women	64
Ciudad Real	Group 0604 Transient cerebral ischemia 435	Both sexes	244
Ciudad Real	Group 0604 Transient cerebral ischemia 435	Men	131
Ciudad Real	Group 0604 Transient cerebral ischemia 435	Women	113
Ciudad Real	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.005
Ciudad Real	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	469
Ciudad Real	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	536
Ciudad Real	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	336
Ciudad Real	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	198
Ciudad Real	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	138
Ciudad Real	Grupo 0701 Cataract  366	Both sexes	27
Ciudad Real	Grupo 0701 Cataract  366	Men	15
Ciudad Real	Grupo 0701 Cataract  366	Women	12
Ciudad Real	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	309
Ciudad Real	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	183
Ciudad Real	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	126
Ciudad Real	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	289
Ciudad Real	Group 0800 Diseases of the ear and the mastoid  380-389	Men	145
Ciudad Real	Group 0800 Diseases of the ear and the mastoid  380-389	Women	144
Ciudad Real	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.886
Ciudad Real	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.746
Ciudad Real	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.140
Ciudad Real	Group 0901 Hypertensive disease  401-405	Both sexes	303
Ciudad Real	Group 0901 Hypertensive disease  401-405	Men	135
Ciudad Real	Group 0901 Hypertensive disease  401-405	Women	168
Ciudad Real	Group 0902 Angina pectoris  4111, 413	Both sexes	460
Ciudad Real	Group 0902 Angina pectoris  4111, 413	Men	288
Ciudad Real	Group 0902 Angina pectoris  4111, 413	Women	172
Ciudad Real	Group 0903 Acute myocardial infarction  410	Both sexes	698
Ciudad Real	Group 0903 Acute myocardial infarction  410	Men	482
Ciudad Real	Group 0903 Acute myocardial infarction  410	Women	216
Ciudad Real	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	422
Ciudad Real	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	315
Ciudad Real	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	107
Ciudad Real	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	245
Ciudad Real	Group 0905 Diseases of the lungs circulation 415-417	Men	111
Ciudad Real	Group 0905 Diseases of the lungs circulation 415-417	Women	134
Ciudad Real	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	931
Ciudad Real	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	497
Ciudad Real	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	434
Ciudad Real	Grupo 0907 Heart failure  428	Both sexes	1.457
Ciudad Real	Grupo 0907 Heart failure  428	Men	571
Ciudad Real	Grupo 0907 Heart failure  428	Women	886
Ciudad Real	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.127
Ciudad Real	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	603
Ciudad Real	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	524
Ciudad Real	Grupo 0909 Atherosclerosis  440	Both sexes	311
Ciudad Real	Grupo 0909 Atherosclerosis  440	Men	221
Ciudad Real	Grupo 0909 Atherosclerosis  440	Women	90
Ciudad Real	Group 0910 Varicose veins of lower extremities 454	Both sexes	45
Ciudad Real	Group 0910 Varicose veins of lower extremities 454	Men	24
Ciudad Real	Group 0910 Varicose veins of lower extremities 454	Women	21
Ciudad Real	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	887
Ciudad Real	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	499
Ciudad Real	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	388
Ciudad Real	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.247
Ciudad Real	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.260
Ciudad Real	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.987
Ciudad Real	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	346
Ciudad Real	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	175
Ciudad Real	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	171
Ciudad Real	Group 1002 Pneumonia 480-486	Both sexes	1.555
Ciudad Real	Group 1002 Pneumonia 480-486	Men	978
Ciudad Real	Group 1002 Pneumonia 480-486	Women	577
Ciudad Real	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	676
Ciudad Real	Group 1003 Acute bronchitis and bronchiolitis  466	Men	298
Ciudad Real	Group 1003 Acute bronchitis and bronchiolitis  466	Women	378
Ciudad Real	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	332
Ciudad Real	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	179
Ciudad Real	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	153
Ciudad Real	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	475
Ciudad Real	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	312
Ciudad Real	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	163
Ciudad Real	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.150
Ciudad Real	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	971
Ciudad Real	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	179
Ciudad Real	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	229
Ciudad Real	Group 1007 Asthma 4930-4931,4938-4939	Men	62
Ciudad Real	Group 1007 Asthma 4930-4931,4938-4939	Women	167
Ciudad Real	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.484
Ciudad Real	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.285
Ciudad Real	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.199
Ciudad Real	Group 1100 Diseases of the digestive system  520-579	Both sexes	7.422
Ciudad Real	Group 1100 Diseases of the digestive system  520-579	Men	4.146
Ciudad Real	Group 1100 Diseases of the digestive system  520-579	Women	3.276
Ciudad Real	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	75
Ciudad Real	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	38
Ciudad Real	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	37
Ciudad Real	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	97
Ciudad Real	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	56
Ciudad Real	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	41
Ciudad Real	Group 1103 Diseases of the esophagus 530	Both sexes	164
Ciudad Real	Group 1103 Diseases of the esophagus 530	Men	111
Ciudad Real	Group 1103 Diseases of the esophagus 530	Women	53
Ciudad Real	Group 1104 Peptic ulcer 531-534	Both sexes	176
Ciudad Real	Group 1104 Peptic ulcer 531-534	Men	127
Ciudad Real	Group 1104 Peptic ulcer 531-534	Women	49
Ciudad Real	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	206
Ciudad Real	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	106
Ciudad Real	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	100
Ciudad Real	Group 1106 Appendicitis  540-543	Both sexes	541
Ciudad Real	Group 1106 Appendicitis  540-543	Men	322
Ciudad Real	Group 1106 Appendicitis  540-543	Women	219
Ciudad Real	Group 1107 Inguinal hernia  550	Both sexes	533
Ciudad Real	Group 1107 Inguinal hernia  550	Men	476
Ciudad Real	Group 1107 Inguinal hernia  550	Women	57
Ciudad Real	Group 1108 Other abdominal hernia  551-553	Both sexes	645
Ciudad Real	Group 1108 Other abdominal hernia  551-553	Men	288
Ciudad Real	Group 1108 Other abdominal hernia  551-553	Women	357
Ciudad Real	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	142
Ciudad Real	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	66
Ciudad Real	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	76
Ciudad Real	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	346
Ciudad Real	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	173
Ciudad Real	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	173
Ciudad Real	Group 1111 Intestinal obstruction without hernia 560	Both sexes	425
Ciudad Real	Group 1111 Intestinal obstruction without hernia 560	Men	217
Ciudad Real	Group 1111 Intestinal obstruction without hernia 560	Women	208
Ciudad Real	Group 1112 Intestinal diverticulosis 562	Both sexes	229
Ciudad Real	Group 1112 Intestinal diverticulosis 562	Men	119
Ciudad Real	Group 1112 Intestinal diverticulosis 562	Women	110
Ciudad Real	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	286
Ciudad Real	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	191
Ciudad Real	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	95
Ciudad Real	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	284
Ciudad Real	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	138
Ciudad Real	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	146
Ciudad Real	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	122
Ciudad Real	Group 1115 Alcoholic hepatitis 5710-5713	Men	114
Ciudad Real	Group 1115 Alcoholic hepatitis 5710-5713	Women	8
Ciudad Real	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	201
Ciudad Real	Group 1116 Other diseases of the liver 570,5714-573	Men	123
Ciudad Real	Group 1116 Other diseases of the liver 570,5714-573	Women	78
Ciudad Real	Group 1117 Cholelithiasis  574	Both sexes	1.709
Ciudad Real	Group 1117 Cholelithiasis  574	Men	803
Ciudad Real	Group 1117 Cholelithiasis  574	Women	906
Ciudad Real	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	368
Ciudad Real	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	206
Ciudad Real	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	162
Ciudad Real	Group 1119 Pancreatic diseases 577	Both sexes	559
Ciudad Real	Group 1119 Pancreatic diseases 577	Men	296
Ciudad Real	Group 1119 Pancreatic diseases 577	Women	263
Ciudad Real	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	314
Ciudad Real	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	176
Ciudad Real	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	138
Ciudad Real	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	359
Ciudad Real	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	178
Ciudad Real	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	181
Ciudad Real	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	217
Ciudad Real	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	109
Ciudad Real	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	108
Ciudad Real	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	15
Ciudad Real	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	7
Ciudad Real	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	8
Ciudad Real	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	127
Ciudad Real	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	62
Ciudad Real	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	65
Ciudad Real	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.257
Ciudad Real	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.498
Ciudad Real	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.759
Ciudad Real	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Ciudad Real	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Ciudad Real	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Ciudad Real	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Ciudad Real	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Ciudad Real	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Ciudad Real	Group 1303 Internal derangement of knee 717	Both sexes	315
Ciudad Real	Group 1303 Internal derangement of knee 717	Men	228
Ciudad Real	Group 1303 Internal derangement of knee 717	Women	87
Ciudad Real	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.235
Ciudad Real	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	458
Ciudad Real	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	777
Ciudad Real	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	59
Ciudad Real	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	23
Ciudad Real	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	36
Ciudad Real	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	313
Ciudad Real	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	167
Ciudad Real	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	146
Ciudad Real	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	292
Ciudad Real	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	156
Ciudad Real	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	136
Ciudad Real	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	34
Ciudad Real	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	17
Ciudad Real	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	17
Ciudad Real	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	444
Ciudad Real	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	226
Ciudad Real	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	218
Ciudad Real	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	565
Ciudad Real	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	223
Ciudad Real	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	342
Ciudad Real	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.269
Ciudad Real	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.494
Ciudad Real	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.775
Ciudad Real	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	284
Ciudad Real	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	111
Ciudad Real	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	173
Ciudad Real	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	351
Ciudad Real	Group 1402 Renal failure  5836-5837, 584-586	Men	203
Ciudad Real	Group 1402 Renal failure  5836-5837, 584-586	Women	148
Ciudad Real	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	294
Ciudad Real	Group 1403 Urolithiasis  592, 594, 7880	Men	198
Ciudad Real	Group 1403 Urolithiasis  592, 594, 7880	Women	96
Ciudad Real	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.119
Ciudad Real	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	534
Ciudad Real	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	585
Ciudad Real	Group 1405 Prostatic hyperplasia  600	Both sexes	210
Ciudad Real	Group 1405 Prostatic hyperplasia  600	Men	210
Ciudad Real	Group 1405 Prostatic hyperplasia  600	Women	..
Ciudad Real	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	223
Ciudad Real	Group 1406 Other diseases of the male genital organs    601-608	Men	223
Ciudad Real	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Ciudad Real	Group 1407 Disorders of breast  610-612	Both sexes	104
Ciudad Real	Group 1407 Disorders of breast  610-612	Men	15
Ciudad Real	Group 1407 Disorders of breast  610-612	Women	89
Ciudad Real	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	100
Ciudad Real	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Ciudad Real	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	100
Ciudad Real	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	82
Ciudad Real	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Ciudad Real	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	82
Ciudad Real	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	502
Ciudad Real	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Ciudad Real	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	502
Ciudad Real	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.736
Ciudad Real	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Ciudad Real	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.736
Ciudad Real	Group 1501 Legally induced abortion  635	Both sexes	1
Ciudad Real	Group 1501 Legally induced abortion  635	Men	..
Ciudad Real	Group 1501 Legally induced abortion  635	Women	1
Ciudad Real	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	550
Ciudad Real	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Ciudad Real	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	550
Ciudad Real	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.806
Ciudad Real	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Ciudad Real	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.806
Ciudad Real	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	814
Ciudad Real	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Ciudad Real	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	814
Ciudad Real	Group 1505 Single spontaneous delivery  650	Both sexes	192
Ciudad Real	Group 1505 Single spontaneous delivery  650	Men	..
Ciudad Real	Group 1505 Single spontaneous delivery  650	Women	192
Ciudad Real	Group 1506 Other deliveries  6695-6697	Both sexes	23
Ciudad Real	Group 1506 Other deliveries  6695-6697	Men	..
Ciudad Real	Group 1506 Other deliveries  6695-6697	Women	23
Ciudad Real	Group 1507 Complications related to the puerperium  670-676	Both sexes	24
Ciudad Real	Group 1507 Complications related to the puerperium  670-676	Men	..
Ciudad Real	Group 1507 Complications related to the puerperium  670-676	Women	24
Ciudad Real	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	326
Ciudad Real	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Ciudad Real	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	326
Ciudad Real	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.108
Ciudad Real	Group 1600 Some disorders originating in the perinatal period  760-779	Men	616
Ciudad Real	Group 1600 Some disorders originating in the perinatal period  760-779	Women	492
Ciudad Real	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	243
Ciudad Real	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	133
Ciudad Real	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	110
Ciudad Real	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	865
Ciudad Real	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	483
Ciudad Real	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	382
Ciudad Real	Grupo 1700 Congenital abnormalities  740-759	Both sexes	241
Ciudad Real	Grupo 1700 Congenital abnormalities  740-759	Men	160
Ciudad Real	Grupo 1700 Congenital abnormalities  740-759	Women	81
Ciudad Real	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.936
Ciudad Real	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.021
Ciudad Real	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	915
Ciudad Real	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	280
Ciudad Real	Group 1801 Pain in throat and chest 7841, 7865	Men	145
Ciudad Real	Group 1801 Pain in throat and chest 7841, 7865	Women	135
Ciudad Real	Group 1802 Abdominal pain   7890	Both sexes	168
Ciudad Real	Group 1802 Abdominal pain   7890	Men	77
Ciudad Real	Group 1802 Abdominal pain   7890	Women	91
Ciudad Real	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2
Ciudad Real	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Ciudad Real	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	2
Ciudad Real	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.486
Ciudad Real	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	799
Ciudad Real	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	687
Ciudad Real	Group 1900 Injuries and poisoning  800-999	Both sexes	3.795
Ciudad Real	Group 1900 Injuries and poisoning  800-999	Men	1.804
Ciudad Real	Group 1900 Injuries and poisoning  800-999	Women	1.991
Ciudad Real	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	168
Ciudad Real	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	92
Ciudad Real	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	76
Ciudad Real	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	94
Ciudad Real	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	56
Ciudad Real	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	38
Ciudad Real	Group 1903 Radius and ulna fracture 813	Both sexes	244
Ciudad Real	Group 1903 Radius and ulna fracture 813	Men	114
Ciudad Real	Group 1903 Radius and ulna fracture 813	Women	130
Ciudad Real	Group 1904 Femur fracture  820-821	Both sexes	935
Ciudad Real	Group 1904 Femur fracture  820-821	Men	274
Ciudad Real	Group 1904 Femur fracture  820-821	Women	661
Ciudad Real	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	273
Ciudad Real	Group 1905 Leg fracture, including the ankle 823-824	Men	134
Ciudad Real	Group 1905 Leg fracture, including the ankle 823-824	Women	139
Ciudad Real	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	790
Ciudad Real	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	472
Ciudad Real	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	318
Ciudad Real	Group 1907 Burns  940-949	Both sexes	7
Ciudad Real	Group 1907 Burns  940-949	Men	4
Ciudad Real	Group 1907 Burns  940-949	Women	3
Ciudad Real	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	130
Ciudad Real	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	60
Ciudad Real	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	70
Ciudad Real	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.027
Ciudad Real	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	522
Ciudad Real	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	505
Ciudad Real	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	13
Ciudad Real	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	11
Ciudad Real	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
Ciudad Real	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	114
Ciudad Real	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	65
Ciudad Real	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	49
Ciudad Real	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	625
Ciudad Real	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	323
Ciudad Real	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	302
Ciudad Real	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	21
Ciudad Real	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	14
Ciudad Real	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	7
Ciudad Real	Group 2102 Contraceptive management  V25	Both sexes	32
Ciudad Real	Group 2102 Contraceptive management  V25	Men	..
Ciudad Real	Group 2102 Contraceptive management  V25	Women	32
Ciudad Real	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Ciudad Real	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Ciudad Real	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Ciudad Real	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	253
Ciudad Real	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	144
Ciudad Real	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	109
Ciudad Real	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	319
Ciudad Real	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	165
Ciudad Real	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	154
Cuenca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	14.000
Cuenca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	6.880
Cuenca	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	7.120
Cuenca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	399
Cuenca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	221
Cuenca	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	178
Cuenca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	56
Cuenca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	28
Cuenca	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	28
Cuenca	Group 0102 Imprecise intestinal infections 009	Both sexes	11
Cuenca	Group 0102 Imprecise intestinal infections 009	Men	5
Cuenca	Group 0102 Imprecise intestinal infections 009	Women	6
Cuenca	Group 0103 Tuberculosis 010-018, 137	Both sexes	7
Cuenca	Group 0103 Tuberculosis 010-018, 137	Men	3
Cuenca	Group 0103 Tuberculosis 010-018, 137	Women	4
Cuenca	Group 0104 Septicaemia  038	Both sexes	208
Cuenca	Group 0104 Septicaemia  038	Men	123
Cuenca	Group 0104 Septicaemia  038	Women	85
Cuenca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	7
Cuenca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
Cuenca	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Cuenca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	110
Cuenca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	55
Cuenca	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	55
Cuenca	Group 0200 Neoplasms  140-239	Both sexes	976
Cuenca	Group 0200 Neoplasms  140-239	Men	540
Cuenca	Group 0200 Neoplasms  140-239	Women	436
Cuenca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	131
Cuenca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	81
Cuenca	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	50
Cuenca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	55
Cuenca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	48
Cuenca	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7
Cuenca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	21
Cuenca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	12
Cuenca	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	9
Cuenca	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	68
Cuenca	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Cuenca	Group 0204 Malignant neoplasm of breast  174-175	Women	67
Cuenca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	17
Cuenca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Cuenca	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	17
Cuenca	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	13
Cuenca	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Cuenca	Group 0206 Malignant neoplasm of ovary  1830	Women	13
Cuenca	Group 0207 Malignant neoplasm of prostate  185	Both sexes	25
Cuenca	Group 0207 Malignant neoplasm of prostate  185	Men	25
Cuenca	Group 0207 Malignant neoplasm of prostate  185	Women	..
Cuenca	Group 0208 Malignant neoplasm of bladder  188	Both sexes	52
Cuenca	Group 0208 Malignant neoplasm of bladder  188	Men	36
Cuenca	Group 0208 Malignant neoplasm of bladder  188	Women	16
Cuenca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	302
Cuenca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	194
Cuenca	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	108
Cuenca	Group 0210 Carcinoma in situ  230-234	Both sexes	23
Cuenca	Group 0210 Carcinoma in situ  230-234	Men	7
Cuenca	Group 0210 Carcinoma in situ  230-234	Women	16
Cuenca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	21
Cuenca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	17
Cuenca	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	4
Cuenca	Grupo 0212 Leiomyoma of uterus  218	Both sexes	34
Cuenca	Grupo 0212 Leiomyoma of uterus  218	Men	..
Cuenca	Grupo 0212 Leiomyoma of uterus  218	Women	34
Cuenca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	214
Cuenca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	119
Cuenca	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	95
Cuenca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	132
Cuenca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	62
Cuenca	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	70
Cuenca	Group 0301 Anaemias 280-285	Both sexes	98
Cuenca	Group 0301 Anaemias 280-285	Men	41
Cuenca	Group 0301 Anaemias 280-285	Women	57
Cuenca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	34
Cuenca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	21
Cuenca	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	13
Cuenca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	255
Cuenca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	96
Cuenca	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	159
Cuenca	Group 0401 Diabetes mellitus  249-250	Both sexes	99
Cuenca	Group 0401 Diabetes mellitus  249-250	Men	46
Cuenca	Group 0401 Diabetes mellitus  249-250	Women	53
Cuenca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	156
Cuenca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	50
Cuenca	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	106
Cuenca	Group 0500 Mental disorders  290-319	Both sexes	460
Cuenca	Group 0500 Mental disorders  290-319	Men	256
Cuenca	Group 0500 Mental disorders  290-319	Women	204
Cuenca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	12
Cuenca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	10
Cuenca	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	2
Cuenca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	52
Cuenca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	43
Cuenca	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	9
Cuenca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	25
Cuenca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	22
Cuenca	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	3
Cuenca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	150
Cuenca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	100
Cuenca	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	50
Cuenca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	99
Cuenca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	27
Cuenca	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	72
Cuenca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	122
Cuenca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	54
Cuenca	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	68
Cuenca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	443
Cuenca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	214
Cuenca	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	229
Cuenca	Group 0601 Alzheimer's disease  3310	Both sexes	7
Cuenca	Group 0601 Alzheimer's disease  3310	Men	1
Cuenca	Group 0601 Alzheimer's disease  3310	Women	6
Cuenca	Group 0602 Multiple sclerosis 340	Both sexes	41
Cuenca	Group 0602 Multiple sclerosis 340	Men	10
Cuenca	Group 0602 Multiple sclerosis 340	Women	31
Cuenca	Group 0603 Epilepsy  345	Both sexes	91
Cuenca	Group 0603 Epilepsy  345	Men	57
Cuenca	Group 0603 Epilepsy  345	Women	34
Cuenca	Group 0604 Transient cerebral ischemia 435	Both sexes	91
Cuenca	Group 0604 Transient cerebral ischemia 435	Men	35
Cuenca	Group 0604 Transient cerebral ischemia 435	Women	56
Cuenca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	213
Cuenca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	111
Cuenca	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	102
Cuenca	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	111
Cuenca	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	66
Cuenca	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	45
Cuenca	Grupo 0701 Cataract  366	Both sexes	9
Cuenca	Grupo 0701 Cataract  366	Men	5
Cuenca	Grupo 0701 Cataract  366	Women	4
Cuenca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	102
Cuenca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	61
Cuenca	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	41
Cuenca	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	59
Cuenca	Group 0800 Diseases of the ear and the mastoid  380-389	Men	27
Cuenca	Group 0800 Diseases of the ear and the mastoid  380-389	Women	32
Cuenca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	1.995
Cuenca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.086
Cuenca	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	909
Cuenca	Group 0901 Hypertensive disease  401-405	Both sexes	136
Cuenca	Group 0901 Hypertensive disease  401-405	Men	54
Cuenca	Group 0901 Hypertensive disease  401-405	Women	82
Cuenca	Group 0902 Angina pectoris  4111, 413	Both sexes	126
Cuenca	Group 0902 Angina pectoris  4111, 413	Men	94
Cuenca	Group 0902 Angina pectoris  4111, 413	Women	32
Cuenca	Group 0903 Acute myocardial infarction  410	Both sexes	104
Cuenca	Group 0903 Acute myocardial infarction  410	Men	59
Cuenca	Group 0903 Acute myocardial infarction  410	Women	45
Cuenca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	48
Cuenca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	41
Cuenca	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	7
Cuenca	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	42
Cuenca	Group 0905 Diseases of the lungs circulation 415-417	Men	18
Cuenca	Group 0905 Diseases of the lungs circulation 415-417	Women	24
Cuenca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	284
Cuenca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	136
Cuenca	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	148
Cuenca	Grupo 0907 Heart failure  428	Both sexes	451
Cuenca	Grupo 0907 Heart failure  428	Men	213
Cuenca	Grupo 0907 Heart failure  428	Women	238
Cuenca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	415
Cuenca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	228
Cuenca	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	187
Cuenca	Grupo 0909 Atherosclerosis  440	Both sexes	90
Cuenca	Grupo 0909 Atherosclerosis  440	Men	75
Cuenca	Grupo 0909 Atherosclerosis  440	Women	15
Cuenca	Group 0910 Varicose veins of lower extremities 454	Both sexes	45
Cuenca	Group 0910 Varicose veins of lower extremities 454	Men	20
Cuenca	Group 0910 Varicose veins of lower extremities 454	Women	25
Cuenca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	254
Cuenca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	148
Cuenca	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	106
Cuenca	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	1.839
Cuenca	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.089
Cuenca	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	750
Cuenca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	64
Cuenca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	32
Cuenca	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	32
Cuenca	Group 1002 Pneumonia 480-486	Both sexes	424
Cuenca	Group 1002 Pneumonia 480-486	Men	250
Cuenca	Group 1002 Pneumonia 480-486	Women	174
Cuenca	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	75
Cuenca	Group 1003 Acute bronchitis and bronchiolitis  466	Men	36
Cuenca	Group 1003 Acute bronchitis and bronchiolitis  466	Women	39
Cuenca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	57
Cuenca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	32
Cuenca	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	25
Cuenca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	95
Cuenca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	70
Cuenca	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	25
Cuenca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	278
Cuenca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	226
Cuenca	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	52
Cuenca	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	51
Cuenca	Group 1007 Asthma 4930-4931,4938-4939	Men	21
Cuenca	Group 1007 Asthma 4930-4931,4938-4939	Women	30
Cuenca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	795
Cuenca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	422
Cuenca	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	373
Cuenca	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.164
Cuenca	Group 1100 Diseases of the digestive system  520-579	Men	1.211
Cuenca	Group 1100 Diseases of the digestive system  520-579	Women	953
Cuenca	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	49
Cuenca	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	22
Cuenca	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	27
Cuenca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	21
Cuenca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	11
Cuenca	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	10
Cuenca	Group 1103 Diseases of the esophagus 530	Both sexes	37
Cuenca	Group 1103 Diseases of the esophagus 530	Men	26
Cuenca	Group 1103 Diseases of the esophagus 530	Women	11
Cuenca	Group 1104 Peptic ulcer 531-534	Both sexes	47
Cuenca	Group 1104 Peptic ulcer 531-534	Men	29
Cuenca	Group 1104 Peptic ulcer 531-534	Women	18
Cuenca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	67
Cuenca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	38
Cuenca	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	29
Cuenca	Group 1106 Appendicitis  540-543	Both sexes	142
Cuenca	Group 1106 Appendicitis  540-543	Men	74
Cuenca	Group 1106 Appendicitis  540-543	Women	68
Cuenca	Group 1107 Inguinal hernia  550	Both sexes	185
Cuenca	Group 1107 Inguinal hernia  550	Men	171
Cuenca	Group 1107 Inguinal hernia  550	Women	14
Cuenca	Group 1108 Other abdominal hernia  551-553	Both sexes	121
Cuenca	Group 1108 Other abdominal hernia  551-553	Men	43
Cuenca	Group 1108 Other abdominal hernia  551-553	Women	78
Cuenca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	51
Cuenca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	36
Cuenca	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	15
Cuenca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	184
Cuenca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	90
Cuenca	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	94
Cuenca	Group 1111 Intestinal obstruction without hernia 560	Both sexes	113
Cuenca	Group 1111 Intestinal obstruction without hernia 560	Men	47
Cuenca	Group 1111 Intestinal obstruction without hernia 560	Women	66
Cuenca	Group 1112 Intestinal diverticulosis 562	Both sexes	75
Cuenca	Group 1112 Intestinal diverticulosis 562	Men	44
Cuenca	Group 1112 Intestinal diverticulosis 562	Women	31
Cuenca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	145
Cuenca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	94
Cuenca	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	51
Cuenca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	110
Cuenca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	44
Cuenca	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	66
Cuenca	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	10
Cuenca	Group 1115 Alcoholic hepatitis 5710-5713	Men	10
Cuenca	Group 1115 Alcoholic hepatitis 5710-5713	Women	..
Cuenca	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	71
Cuenca	Group 1116 Other diseases of the liver 570,5714-573	Men	64
Cuenca	Group 1116 Other diseases of the liver 570,5714-573	Women	7
Cuenca	Group 1117 Cholelithiasis  574	Both sexes	364
Cuenca	Group 1117 Cholelithiasis  574	Men	163
Cuenca	Group 1117 Cholelithiasis  574	Women	201
Cuenca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	110
Cuenca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	56
Cuenca	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	54
Cuenca	Group 1119 Pancreatic diseases 577	Both sexes	132
Cuenca	Group 1119 Pancreatic diseases 577	Men	76
Cuenca	Group 1119 Pancreatic diseases 577	Women	56
Cuenca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	130
Cuenca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	73
Cuenca	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	57
Cuenca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	134
Cuenca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	64
Cuenca	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	70
Cuenca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	76
Cuenca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	40
Cuenca	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	36
Cuenca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	4
Cuenca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	2
Cuenca	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Cuenca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	54
Cuenca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	22
Cuenca	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	32
Cuenca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	611
Cuenca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	282
Cuenca	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	329
Cuenca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Cuenca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Cuenca	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Cuenca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Cuenca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Cuenca	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Cuenca	Group 1303 Internal derangement of knee 717	Both sexes	98
Cuenca	Group 1303 Internal derangement of knee 717	Men	64
Cuenca	Group 1303 Internal derangement of knee 717	Women	34
Cuenca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	259
Cuenca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	103
Cuenca	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	156
Cuenca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	15
Cuenca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	5
Cuenca	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	10
Cuenca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	19
Cuenca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	11
Cuenca	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	8
Cuenca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	31
Cuenca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	16
Cuenca	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	15
Cuenca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	25
Cuenca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	13
Cuenca	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	12
Cuenca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	64
Cuenca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	36
Cuenca	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	28
Cuenca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	100
Cuenca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	34
Cuenca	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	66
Cuenca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	829
Cuenca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	383
Cuenca	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	446
Cuenca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	73
Cuenca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	17
Cuenca	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	56
Cuenca	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	82
Cuenca	Group 1402 Renal failure  5836-5837, 584-586	Men	46
Cuenca	Group 1402 Renal failure  5836-5837, 584-586	Women	36
Cuenca	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	107
Cuenca	Group 1403 Urolithiasis  592, 594, 7880	Men	65
Cuenca	Group 1403 Urolithiasis  592, 594, 7880	Women	42
Cuenca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	257
Cuenca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	119
Cuenca	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	138
Cuenca	Group 1405 Prostatic hyperplasia  600	Both sexes	66
Cuenca	Group 1405 Prostatic hyperplasia  600	Men	66
Cuenca	Group 1405 Prostatic hyperplasia  600	Women	..
Cuenca	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	68
Cuenca	Group 1406 Other diseases of the male genital organs    601-608	Men	68
Cuenca	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Cuenca	Group 1407 Disorders of breast  610-612	Both sexes	12
Cuenca	Group 1407 Disorders of breast  610-612	Men	..
Cuenca	Group 1407 Disorders of breast  610-612	Women	12
Cuenca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	22
Cuenca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Cuenca	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	22
Cuenca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	6
Cuenca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Cuenca	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	6
Cuenca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	136
Cuenca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	2
Cuenca	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	134
Cuenca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.141
Cuenca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Cuenca	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.141
Cuenca	Group 1501 Legally induced abortion  635	Both sexes	..
Cuenca	Group 1501 Legally induced abortion  635	Men	..
Cuenca	Group 1501 Legally induced abortion  635	Women	..
Cuenca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	146
Cuenca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Cuenca	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	146
Cuenca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	589
Cuenca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Cuenca	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	589
Cuenca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	184
Cuenca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Cuenca	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	184
Cuenca	Group 1505 Single spontaneous delivery  650	Both sexes	58
Cuenca	Group 1505 Single spontaneous delivery  650	Men	..
Cuenca	Group 1505 Single spontaneous delivery  650	Women	58
Cuenca	Group 1506 Other deliveries  6695-6697	Both sexes	108
Cuenca	Group 1506 Other deliveries  6695-6697	Men	..
Cuenca	Group 1506 Other deliveries  6695-6697	Women	108
Cuenca	Group 1507 Complications related to the puerperium  670-676	Both sexes	3
Cuenca	Group 1507 Complications related to the puerperium  670-676	Men	..
Cuenca	Group 1507 Complications related to the puerperium  670-676	Women	3
Cuenca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	53
Cuenca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Cuenca	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	53
Cuenca	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	106
Cuenca	Group 1600 Some disorders originating in the perinatal period  760-779	Men	62
Cuenca	Group 1600 Some disorders originating in the perinatal period  760-779	Women	44
Cuenca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	34
Cuenca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	16
Cuenca	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	18
Cuenca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	72
Cuenca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	46
Cuenca	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	26
Cuenca	Grupo 1700 Congenital abnormalities  740-759	Both sexes	39
Cuenca	Grupo 1700 Congenital abnormalities  740-759	Men	18
Cuenca	Grupo 1700 Congenital abnormalities  740-759	Women	21
Cuenca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	916
Cuenca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	489
Cuenca	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	427
Cuenca	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	133
Cuenca	Group 1801 Pain in throat and chest 7841, 7865	Men	76
Cuenca	Group 1801 Pain in throat and chest 7841, 7865	Women	57
Cuenca	Group 1802 Abdominal pain   7890	Both sexes	128
Cuenca	Group 1802 Abdominal pain   7890	Men	61
Cuenca	Group 1802 Abdominal pain   7890	Women	67
Cuenca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	11
Cuenca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	6
Cuenca	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	5
Cuenca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	644
Cuenca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	346
Cuenca	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	298
Cuenca	Group 1900 Injuries and poisoning  800-999	Both sexes	1.185
Cuenca	Group 1900 Injuries and poisoning  800-999	Men	595
Cuenca	Group 1900 Injuries and poisoning  800-999	Women	590
Cuenca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	83
Cuenca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	43
Cuenca	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	40
Cuenca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	30
Cuenca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	26
Cuenca	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	4
Cuenca	Group 1903 Radius and ulna fracture 813	Both sexes	48
Cuenca	Group 1903 Radius and ulna fracture 813	Men	32
Cuenca	Group 1903 Radius and ulna fracture 813	Women	16
Cuenca	Group 1904 Femur fracture  820-821	Both sexes	288
Cuenca	Group 1904 Femur fracture  820-821	Men	73
Cuenca	Group 1904 Femur fracture  820-821	Women	215
Cuenca	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	87
Cuenca	Group 1905 Leg fracture, including the ankle 823-824	Men	43
Cuenca	Group 1905 Leg fracture, including the ankle 823-824	Women	44
Cuenca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	398
Cuenca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	237
Cuenca	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	161
Cuenca	Group 1907 Burns  940-949	Both sexes	4
Cuenca	Group 1907 Burns  940-949	Men	3
Cuenca	Group 1907 Burns  940-949	Women	1
Cuenca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	50
Cuenca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	25
Cuenca	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	25
Cuenca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	169
Cuenca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	93
Cuenca	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	76
Cuenca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Cuenca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
Cuenca	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Cuenca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	26
Cuenca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	19
Cuenca	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	7
Cuenca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	206
Cuenca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	119
Cuenca	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	87
Cuenca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	9
Cuenca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	7
Cuenca	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	2
Cuenca	Group 2102 Contraceptive management  V25	Both sexes	1
Cuenca	Group 2102 Contraceptive management  V25	Men	1
Cuenca	Group 2102 Contraceptive management  V25	Women	..
Cuenca	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Cuenca	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Cuenca	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Cuenca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	85
Cuenca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	44
Cuenca	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	41
Cuenca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	111
Cuenca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	67
Cuenca	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	44
Guadalajara	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	18.288
Guadalajara	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	8.911
Guadalajara	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	9.377
Guadalajara	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	578
Guadalajara	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	326
Guadalajara	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	252
Guadalajara	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	114
Guadalajara	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	61
Guadalajara	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	53
Guadalajara	Group 0102 Imprecise intestinal infections 009	Both sexes	14
Guadalajara	Group 0102 Imprecise intestinal infections 009	Men	7
Guadalajara	Group 0102 Imprecise intestinal infections 009	Women	7
Guadalajara	Group 0103 Tuberculosis 010-018, 137	Both sexes	5
Guadalajara	Group 0103 Tuberculosis 010-018, 137	Men	2
Guadalajara	Group 0103 Tuberculosis 010-018, 137	Women	3
Guadalajara	Group 0104 Septicaemia  038	Both sexes	226
Guadalajara	Group 0104 Septicaemia  038	Men	119
Guadalajara	Group 0104 Septicaemia  038	Women	107
Guadalajara	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	15
Guadalajara	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	13
Guadalajara	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
Guadalajara	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	204
Guadalajara	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	124
Guadalajara	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	80
Guadalajara	Group 0200 Neoplasms  140-239	Both sexes	1.491
Guadalajara	Group 0200 Neoplasms  140-239	Men	832
Guadalajara	Group 0200 Neoplasms  140-239	Women	659
Guadalajara	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	180
Guadalajara	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	119
Guadalajara	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	61
Guadalajara	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	92
Guadalajara	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	70
Guadalajara	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	22
Guadalajara	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	57
Guadalajara	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	41
Guadalajara	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	16
Guadalajara	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	74
Guadalajara	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Guadalajara	Group 0204 Malignant neoplasm of breast  174-175	Women	74
Guadalajara	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	33
Guadalajara	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Guadalajara	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	33
Guadalajara	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	17
Guadalajara	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Guadalajara	Group 0206 Malignant neoplasm of ovary  1830	Women	17
Guadalajara	Group 0207 Malignant neoplasm of prostate  185	Both sexes	56
Guadalajara	Group 0207 Malignant neoplasm of prostate  185	Men	56
Guadalajara	Group 0207 Malignant neoplasm of prostate  185	Women	..
Guadalajara	Group 0208 Malignant neoplasm of bladder  188	Both sexes	179
Guadalajara	Group 0208 Malignant neoplasm of bladder  188	Men	154
Guadalajara	Group 0208 Malignant neoplasm of bladder  188	Women	25
Guadalajara	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	525
Guadalajara	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	309
Guadalajara	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	216
Guadalajara	Group 0210 Carcinoma in situ  230-234	Both sexes	24
Guadalajara	Group 0210 Carcinoma in situ  230-234	Men	14
Guadalajara	Group 0210 Carcinoma in situ  230-234	Women	10
Guadalajara	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	8
Guadalajara	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	7
Guadalajara	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	1
Guadalajara	Grupo 0212 Leiomyoma of uterus  218	Both sexes	64
Guadalajara	Grupo 0212 Leiomyoma of uterus  218	Men	..
Guadalajara	Grupo 0212 Leiomyoma of uterus  218	Women	64
Guadalajara	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	182
Guadalajara	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	62
Guadalajara	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	120
Guadalajara	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	223
Guadalajara	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	126
Guadalajara	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	97
Guadalajara	Group 0301 Anaemias 280-285	Both sexes	120
Guadalajara	Group 0301 Anaemias 280-285	Men	61
Guadalajara	Group 0301 Anaemias 280-285	Women	59
Guadalajara	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	103
Guadalajara	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	65
Guadalajara	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	38
Guadalajara	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	358
Guadalajara	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	169
Guadalajara	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	189
Guadalajara	Group 0401 Diabetes mellitus  249-250	Both sexes	151
Guadalajara	Group 0401 Diabetes mellitus  249-250	Men	86
Guadalajara	Group 0401 Diabetes mellitus  249-250	Women	65
Guadalajara	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	207
Guadalajara	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	83
Guadalajara	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	124
Guadalajara	Group 0500 Mental disorders  290-319	Both sexes	380
Guadalajara	Group 0500 Mental disorders  290-319	Men	210
Guadalajara	Group 0500 Mental disorders  290-319	Women	170
Guadalajara	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	6
Guadalajara	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	3
Guadalajara	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	3
Guadalajara	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	24
Guadalajara	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	13
Guadalajara	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	11
Guadalajara	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	16
Guadalajara	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	11
Guadalajara	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
Guadalajara	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	166
Guadalajara	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	110
Guadalajara	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	56
Guadalajara	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	78
Guadalajara	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	37
Guadalajara	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	41
Guadalajara	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	90
Guadalajara	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	36
Guadalajara	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	54
Guadalajara	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	408
Guadalajara	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	191
Guadalajara	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	217
Guadalajara	Group 0601 Alzheimer's disease  3310	Both sexes	2
Guadalajara	Group 0601 Alzheimer's disease  3310	Men	..
Guadalajara	Group 0601 Alzheimer's disease  3310	Women	2
Guadalajara	Group 0602 Multiple sclerosis 340	Both sexes	16
Guadalajara	Group 0602 Multiple sclerosis 340	Men	4
Guadalajara	Group 0602 Multiple sclerosis 340	Women	12
Guadalajara	Group 0603 Epilepsy  345	Both sexes	88
Guadalajara	Group 0603 Epilepsy  345	Men	42
Guadalajara	Group 0603 Epilepsy  345	Women	46
Guadalajara	Group 0604 Transient cerebral ischemia 435	Both sexes	92
Guadalajara	Group 0604 Transient cerebral ischemia 435	Men	46
Guadalajara	Group 0604 Transient cerebral ischemia 435	Women	46
Guadalajara	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	210
Guadalajara	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	99
Guadalajara	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	111
Guadalajara	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	95
Guadalajara	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	45
Guadalajara	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	50
Guadalajara	Grupo 0701 Cataract  366	Both sexes	43
Guadalajara	Grupo 0701 Cataract  366	Men	21
Guadalajara	Grupo 0701 Cataract  366	Women	22
Guadalajara	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	52
Guadalajara	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	24
Guadalajara	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	28
Guadalajara	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	86
Guadalajara	Group 0800 Diseases of the ear and the mastoid  380-389	Men	43
Guadalajara	Group 0800 Diseases of the ear and the mastoid  380-389	Women	43
Guadalajara	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	2.573
Guadalajara	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	1.470
Guadalajara	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.103
Guadalajara	Group 0901 Hypertensive disease  401-405	Both sexes	241
Guadalajara	Group 0901 Hypertensive disease  401-405	Men	95
Guadalajara	Group 0901 Hypertensive disease  401-405	Women	146
Guadalajara	Group 0902 Angina pectoris  4111, 413	Both sexes	64
Guadalajara	Group 0902 Angina pectoris  4111, 413	Men	35
Guadalajara	Group 0902 Angina pectoris  4111, 413	Women	29
Guadalajara	Group 0903 Acute myocardial infarction  410	Both sexes	189
Guadalajara	Group 0903 Acute myocardial infarction  410	Men	137
Guadalajara	Group 0903 Acute myocardial infarction  410	Women	52
Guadalajara	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	239
Guadalajara	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	175
Guadalajara	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	64
Guadalajara	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	85
Guadalajara	Group 0905 Diseases of the lungs circulation 415-417	Men	43
Guadalajara	Group 0905 Diseases of the lungs circulation 415-417	Women	42
Guadalajara	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	448
Guadalajara	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	274
Guadalajara	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	174
Guadalajara	Grupo 0907 Heart failure  428	Both sexes	547
Guadalajara	Grupo 0907 Heart failure  428	Men	260
Guadalajara	Grupo 0907 Heart failure  428	Women	287
Guadalajara	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	314
Guadalajara	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	166
Guadalajara	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	148
Guadalajara	Grupo 0909 Atherosclerosis  440	Both sexes	103
Guadalajara	Grupo 0909 Atherosclerosis  440	Men	83
Guadalajara	Grupo 0909 Atherosclerosis  440	Women	20
Guadalajara	Group 0910 Varicose veins of lower extremities 454	Both sexes	36
Guadalajara	Group 0910 Varicose veins of lower extremities 454	Men	9
Guadalajara	Group 0910 Varicose veins of lower extremities 454	Women	27
Guadalajara	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	307
Guadalajara	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	193
Guadalajara	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	114
Guadalajara	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	2.352
Guadalajara	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	1.417
Guadalajara	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	935
Guadalajara	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	155
Guadalajara	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	74
Guadalajara	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	81
Guadalajara	Group 1002 Pneumonia 480-486	Both sexes	761
Guadalajara	Group 1002 Pneumonia 480-486	Men	494
Guadalajara	Group 1002 Pneumonia 480-486	Women	267
Guadalajara	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	209
Guadalajara	Group 1003 Acute bronchitis and bronchiolitis  466	Men	88
Guadalajara	Group 1003 Acute bronchitis and bronchiolitis  466	Women	121
Guadalajara	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	98
Guadalajara	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	54
Guadalajara	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	44
Guadalajara	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	114
Guadalajara	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	79
Guadalajara	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	35
Guadalajara	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	305
Guadalajara	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	262
Guadalajara	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	43
Guadalajara	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	77
Guadalajara	Group 1007 Asthma 4930-4931,4938-4939	Men	21
Guadalajara	Group 1007 Asthma 4930-4931,4938-4939	Women	56
Guadalajara	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	633
Guadalajara	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	345
Guadalajara	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	288
Guadalajara	Group 1100 Diseases of the digestive system  520-579	Both sexes	2.672
Guadalajara	Group 1100 Diseases of the digestive system  520-579	Men	1.467
Guadalajara	Group 1100 Diseases of the digestive system  520-579	Women	1.205
Guadalajara	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	32
Guadalajara	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	10
Guadalajara	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	22
Guadalajara	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	29
Guadalajara	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	14
Guadalajara	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	15
Guadalajara	Group 1103 Diseases of the esophagus 530	Both sexes	61
Guadalajara	Group 1103 Diseases of the esophagus 530	Men	36
Guadalajara	Group 1103 Diseases of the esophagus 530	Women	25
Guadalajara	Group 1104 Peptic ulcer 531-534	Both sexes	57
Guadalajara	Group 1104 Peptic ulcer 531-534	Men	37
Guadalajara	Group 1104 Peptic ulcer 531-534	Women	20
Guadalajara	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	56
Guadalajara	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	21
Guadalajara	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	35
Guadalajara	Group 1106 Appendicitis  540-543	Both sexes	220
Guadalajara	Group 1106 Appendicitis  540-543	Men	145
Guadalajara	Group 1106 Appendicitis  540-543	Women	75
Guadalajara	Group 1107 Inguinal hernia  550	Both sexes	237
Guadalajara	Group 1107 Inguinal hernia  550	Men	211
Guadalajara	Group 1107 Inguinal hernia  550	Women	26
Guadalajara	Group 1108 Other abdominal hernia  551-553	Both sexes	216
Guadalajara	Group 1108 Other abdominal hernia  551-553	Men	96
Guadalajara	Group 1108 Other abdominal hernia  551-553	Women	120
Guadalajara	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	40
Guadalajara	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	22
Guadalajara	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	18
Guadalajara	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	229
Guadalajara	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	115
Guadalajara	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	114
Guadalajara	Group 1111 Intestinal obstruction without hernia 560	Both sexes	144
Guadalajara	Group 1111 Intestinal obstruction without hernia 560	Men	70
Guadalajara	Group 1111 Intestinal obstruction without hernia 560	Women	74
Guadalajara	Group 1112 Intestinal diverticulosis 562	Both sexes	103
Guadalajara	Group 1112 Intestinal diverticulosis 562	Men	45
Guadalajara	Group 1112 Intestinal diverticulosis 562	Women	58
Guadalajara	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	100
Guadalajara	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	74
Guadalajara	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	26
Guadalajara	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	110
Guadalajara	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	42
Guadalajara	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	68
Guadalajara	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	25
Guadalajara	Group 1115 Alcoholic hepatitis 5710-5713	Men	20
Guadalajara	Group 1115 Alcoholic hepatitis 5710-5713	Women	5
Guadalajara	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	82
Guadalajara	Group 1116 Other diseases of the liver 570,5714-573	Men	57
Guadalajara	Group 1116 Other diseases of the liver 570,5714-573	Women	25
Guadalajara	Group 1117 Cholelithiasis  574	Both sexes	519
Guadalajara	Group 1117 Cholelithiasis  574	Men	229
Guadalajara	Group 1117 Cholelithiasis  574	Women	290
Guadalajara	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	156
Guadalajara	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	85
Guadalajara	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	71
Guadalajara	Group 1119 Pancreatic diseases 577	Both sexes	152
Guadalajara	Group 1119 Pancreatic diseases 577	Men	75
Guadalajara	Group 1119 Pancreatic diseases 577	Women	77
Guadalajara	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	104
Guadalajara	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	63
Guadalajara	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	41
Guadalajara	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	143
Guadalajara	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	81
Guadalajara	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	62
Guadalajara	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	87
Guadalajara	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	56
Guadalajara	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	31
Guadalajara	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	11
Guadalajara	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	5
Guadalajara	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	6
Guadalajara	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	45
Guadalajara	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	20
Guadalajara	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	25
Guadalajara	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	1.082
Guadalajara	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	496
Guadalajara	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	586
Guadalajara	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Guadalajara	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Guadalajara	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Guadalajara	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Guadalajara	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Guadalajara	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Guadalajara	Group 1303 Internal derangement of knee 717	Both sexes	91
Guadalajara	Group 1303 Internal derangement of knee 717	Men	65
Guadalajara	Group 1303 Internal derangement of knee 717	Women	26
Guadalajara	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	367
Guadalajara	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	156
Guadalajara	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	211
Guadalajara	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	15
Guadalajara	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	6
Guadalajara	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	9
Guadalajara	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	69
Guadalajara	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	31
Guadalajara	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	38
Guadalajara	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	71
Guadalajara	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	33
Guadalajara	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	38
Guadalajara	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	22
Guadalajara	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	14
Guadalajara	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	8
Guadalajara	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	158
Guadalajara	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	79
Guadalajara	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	79
Guadalajara	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	289
Guadalajara	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	112
Guadalajara	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	177
Guadalajara	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	1.127
Guadalajara	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	519
Guadalajara	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	608
Guadalajara	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	177
Guadalajara	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	54
Guadalajara	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	123
Guadalajara	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	107
Guadalajara	Group 1402 Renal failure  5836-5837, 584-586	Men	58
Guadalajara	Group 1402 Renal failure  5836-5837, 584-586	Women	49
Guadalajara	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	98
Guadalajara	Group 1403 Urolithiasis  592, 594, 7880	Men	56
Guadalajara	Group 1403 Urolithiasis  592, 594, 7880	Women	42
Guadalajara	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	395
Guadalajara	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	202
Guadalajara	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	193
Guadalajara	Group 1405 Prostatic hyperplasia  600	Both sexes	63
Guadalajara	Group 1405 Prostatic hyperplasia  600	Men	63
Guadalajara	Group 1405 Prostatic hyperplasia  600	Women	..
Guadalajara	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	77
Guadalajara	Group 1406 Other diseases of the male genital organs    601-608	Men	77
Guadalajara	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Guadalajara	Group 1407 Disorders of breast  610-612	Both sexes	36
Guadalajara	Group 1407 Disorders of breast  610-612	Men	8
Guadalajara	Group 1407 Disorders of breast  610-612	Women	28
Guadalajara	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	28
Guadalajara	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Guadalajara	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	28
Guadalajara	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	4
Guadalajara	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Guadalajara	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	4
Guadalajara	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	142
Guadalajara	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Guadalajara	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	141
Guadalajara	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.830
Guadalajara	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Guadalajara	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.830
Guadalajara	Group 1501 Legally induced abortion  635	Both sexes	1
Guadalajara	Group 1501 Legally induced abortion  635	Men	..
Guadalajara	Group 1501 Legally induced abortion  635	Women	1
Guadalajara	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	111
Guadalajara	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Guadalajara	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	111
Guadalajara	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.270
Guadalajara	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Guadalajara	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.270
Guadalajara	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	166
Guadalajara	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Guadalajara	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	166
Guadalajara	Group 1505 Single spontaneous delivery  650	Both sexes	12
Guadalajara	Group 1505 Single spontaneous delivery  650	Men	..
Guadalajara	Group 1505 Single spontaneous delivery  650	Women	12
Guadalajara	Group 1506 Other deliveries  6695-6697	Both sexes	71
Guadalajara	Group 1506 Other deliveries  6695-6697	Men	..
Guadalajara	Group 1506 Other deliveries  6695-6697	Women	71
Guadalajara	Group 1507 Complications related to the puerperium  670-676	Both sexes	22
Guadalajara	Group 1507 Complications related to the puerperium  670-676	Men	..
Guadalajara	Group 1507 Complications related to the puerperium  670-676	Women	22
Guadalajara	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	177
Guadalajara	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Guadalajara	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	177
Guadalajara	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	177
Guadalajara	Group 1600 Some disorders originating in the perinatal period  760-779	Men	93
Guadalajara	Group 1600 Some disorders originating in the perinatal period  760-779	Women	84
Guadalajara	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	74
Guadalajara	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	37
Guadalajara	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	37
Guadalajara	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	103
Guadalajara	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	56
Guadalajara	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	47
Guadalajara	Grupo 1700 Congenital abnormalities  740-759	Both sexes	69
Guadalajara	Grupo 1700 Congenital abnormalities  740-759	Men	41
Guadalajara	Grupo 1700 Congenital abnormalities  740-759	Women	28
Guadalajara	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	863
Guadalajara	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	471
Guadalajara	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	392
Guadalajara	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	135
Guadalajara	Group 1801 Pain in throat and chest 7841, 7865	Men	64
Guadalajara	Group 1801 Pain in throat and chest 7841, 7865	Women	71
Guadalajara	Group 1802 Abdominal pain   7890	Both sexes	138
Guadalajara	Group 1802 Abdominal pain   7890	Men	60
Guadalajara	Group 1802 Abdominal pain   7890	Women	78
Guadalajara	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1
Guadalajara	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Guadalajara	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Guadalajara	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	589
Guadalajara	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	347
Guadalajara	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	242
Guadalajara	Group 1900 Injuries and poisoning  800-999	Both sexes	1.448
Guadalajara	Group 1900 Injuries and poisoning  800-999	Men	698
Guadalajara	Group 1900 Injuries and poisoning  800-999	Women	750
Guadalajara	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	79
Guadalajara	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	46
Guadalajara	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	33
Guadalajara	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	36
Guadalajara	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	24
Guadalajara	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	12
Guadalajara	Group 1903 Radius and ulna fracture 813	Both sexes	53
Guadalajara	Group 1903 Radius and ulna fracture 813	Men	27
Guadalajara	Group 1903 Radius and ulna fracture 813	Women	26
Guadalajara	Group 1904 Femur fracture  820-821	Both sexes	318
Guadalajara	Group 1904 Femur fracture  820-821	Men	61
Guadalajara	Group 1904 Femur fracture  820-821	Women	257
Guadalajara	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	84
Guadalajara	Group 1905 Leg fracture, including the ankle 823-824	Men	52
Guadalajara	Group 1905 Leg fracture, including the ankle 823-824	Women	32
Guadalajara	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	292
Guadalajara	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	185
Guadalajara	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	107
Guadalajara	Group 1907 Burns  940-949	Both sexes	5
Guadalajara	Group 1907 Burns  940-949	Men	3
Guadalajara	Group 1907 Burns  940-949	Women	2
Guadalajara	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	60
Guadalajara	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	30
Guadalajara	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	30
Guadalajara	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	419
Guadalajara	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	227
Guadalajara	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	192
Guadalajara	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Guadalajara	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Guadalajara	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Guadalajara	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	102
Guadalajara	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	43
Guadalajara	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	59
Guadalajara	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	333
Guadalajara	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	216
Guadalajara	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	117
Guadalajara	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	44
Guadalajara	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	30
Guadalajara	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	14
Guadalajara	Group 2102 Contraceptive management  V25	Both sexes	6
Guadalajara	Group 2102 Contraceptive management  V25	Men	..
Guadalajara	Group 2102 Contraceptive management  V25	Women	6
Guadalajara	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Guadalajara	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Guadalajara	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Guadalajara	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	122
Guadalajara	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	85
Guadalajara	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	37
Guadalajara	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	161
Guadalajara	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	101
Guadalajara	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	60
Toledo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	48.117
Toledo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	23.390
Toledo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	24.727
Toledo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.178
Toledo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	666
Toledo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	512
Toledo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	126
Toledo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	65
Toledo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	61
Toledo	Group 0102 Imprecise intestinal infections 009	Both sexes	70
Toledo	Group 0102 Imprecise intestinal infections 009	Men	30
Toledo	Group 0102 Imprecise intestinal infections 009	Women	40
Toledo	Group 0103 Tuberculosis 010-018, 137	Both sexes	31
Toledo	Group 0103 Tuberculosis 010-018, 137	Men	20
Toledo	Group 0103 Tuberculosis 010-018, 137	Women	11
Toledo	Group 0104 Septicaemia  038	Both sexes	662
Toledo	Group 0104 Septicaemia  038	Men	374
Toledo	Group 0104 Septicaemia  038	Women	288
Toledo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	11
Toledo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	7
Toledo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	4
Toledo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	278
Toledo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	170
Toledo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	108
Toledo	Group 0200 Neoplasms  140-239	Both sexes	4.687
Toledo	Group 0200 Neoplasms  140-239	Men	2.586
Toledo	Group 0200 Neoplasms  140-239	Women	2.101
Toledo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	491
Toledo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	310
Toledo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	181
Toledo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	394
Toledo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	335
Toledo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	59
Toledo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	124
Toledo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	79
Toledo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	45
Toledo	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	340
Toledo	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Toledo	Group 0204 Malignant neoplasm of breast  174-175	Women	336
Toledo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	118
Toledo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Toledo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	118
Toledo	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	51
Toledo	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Toledo	Group 0206 Malignant neoplasm of ovary  1830	Women	51
Toledo	Group 0207 Malignant neoplasm of prostate  185	Both sexes	132
Toledo	Group 0207 Malignant neoplasm of prostate  185	Men	132
Toledo	Group 0207 Malignant neoplasm of prostate  185	Women	..
Toledo	Group 0208 Malignant neoplasm of bladder  188	Both sexes	263
Toledo	Group 0208 Malignant neoplasm of bladder  188	Men	224
Toledo	Group 0208 Malignant neoplasm of bladder  188	Women	39
Toledo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.471
Toledo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	888
Toledo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	583
Toledo	Group 0210 Carcinoma in situ  230-234	Both sexes	79
Toledo	Group 0210 Carcinoma in situ  230-234	Men	34
Toledo	Group 0210 Carcinoma in situ  230-234	Women	45
Toledo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	51
Toledo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	28
Toledo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	23
Toledo	Grupo 0212 Leiomyoma of uterus  218	Both sexes	187
Toledo	Grupo 0212 Leiomyoma of uterus  218	Men	..
Toledo	Grupo 0212 Leiomyoma of uterus  218	Women	187
Toledo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	986
Toledo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	552
Toledo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	434
Toledo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	411
Toledo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	224
Toledo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	187
Toledo	Group 0301 Anaemias 280-285	Both sexes	201
Toledo	Group 0301 Anaemias 280-285	Men	116
Toledo	Group 0301 Anaemias 280-285	Women	85
Toledo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	210
Toledo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	108
Toledo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	102
Toledo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	809
Toledo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	312
Toledo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	497
Toledo	Group 0401 Diabetes mellitus  249-250	Both sexes	241
Toledo	Group 0401 Diabetes mellitus  249-250	Men	138
Toledo	Group 0401 Diabetes mellitus  249-250	Women	103
Toledo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	568
Toledo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	174
Toledo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	394
Toledo	Group 0500 Mental disorders  290-319	Both sexes	1.400
Toledo	Group 0500 Mental disorders  290-319	Men	776
Toledo	Group 0500 Mental disorders  290-319	Women	624
Toledo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	18
Toledo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	11
Toledo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	7
Toledo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	72
Toledo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	50
Toledo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	22
Toledo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	48
Toledo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	38
Toledo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	10
Toledo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	533
Toledo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	359
Toledo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	174
Toledo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	317
Toledo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	124
Toledo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	193
Toledo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	412
Toledo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	194
Toledo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	218
Toledo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.770
Toledo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.035
Toledo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	735
Toledo	Group 0601 Alzheimer's disease  3310	Both sexes	16
Toledo	Group 0601 Alzheimer's disease  3310	Men	10
Toledo	Group 0601 Alzheimer's disease  3310	Women	6
Toledo	Group 0602 Multiple sclerosis 340	Both sexes	40
Toledo	Group 0602 Multiple sclerosis 340	Men	14
Toledo	Group 0602 Multiple sclerosis 340	Women	26
Toledo	Group 0603 Epilepsy  345	Both sexes	154
Toledo	Group 0603 Epilepsy  345	Men	81
Toledo	Group 0603 Epilepsy  345	Women	73
Toledo	Group 0604 Transient cerebral ischemia 435	Both sexes	182
Toledo	Group 0604 Transient cerebral ischemia 435	Men	88
Toledo	Group 0604 Transient cerebral ischemia 435	Women	94
Toledo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.378
Toledo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	842
Toledo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	536
Toledo	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	304
Toledo	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	161
Toledo	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	143
Toledo	Grupo 0701 Cataract  366	Both sexes	15
Toledo	Grupo 0701 Cataract  366	Men	6
Toledo	Grupo 0701 Cataract  366	Women	9
Toledo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	289
Toledo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	155
Toledo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	134
Toledo	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	195
Toledo	Group 0800 Diseases of the ear and the mastoid  380-389	Men	98
Toledo	Group 0800 Diseases of the ear and the mastoid  380-389	Women	97
Toledo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.229
Toledo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.548
Toledo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.681
Toledo	Group 0901 Hypertensive disease  401-405	Both sexes	228
Toledo	Group 0901 Hypertensive disease  401-405	Men	90
Toledo	Group 0901 Hypertensive disease  401-405	Women	138
Toledo	Group 0902 Angina pectoris  4111, 413	Both sexes	323
Toledo	Group 0902 Angina pectoris  4111, 413	Men	225
Toledo	Group 0902 Angina pectoris  4111, 413	Women	98
Toledo	Group 0903 Acute myocardial infarction  410	Both sexes	749
Toledo	Group 0903 Acute myocardial infarction  410	Men	541
Toledo	Group 0903 Acute myocardial infarction  410	Women	208
Toledo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	329
Toledo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	254
Toledo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	75
Toledo	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	203
Toledo	Group 0905 Diseases of the lungs circulation 415-417	Men	97
Toledo	Group 0905 Diseases of the lungs circulation 415-417	Women	106
Toledo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	799
Toledo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	432
Toledo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	367
Toledo	Grupo 0907 Heart failure  428	Both sexes	1.210
Toledo	Grupo 0907 Heart failure  428	Men	516
Toledo	Grupo 0907 Heart failure  428	Women	694
Toledo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.148
Toledo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	643
Toledo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	505
Toledo	Grupo 0909 Atherosclerosis  440	Both sexes	186
Toledo	Grupo 0909 Atherosclerosis  440	Men	131
Toledo	Grupo 0909 Atherosclerosis  440	Women	55
Toledo	Group 0910 Varicose veins of lower extremities 454	Both sexes	49
Toledo	Group 0910 Varicose veins of lower extremities 454	Men	12
Toledo	Group 0910 Varicose veins of lower extremities 454	Women	37
Toledo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.005
Toledo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	607
Toledo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	398
Toledo	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.435
Toledo	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.193
Toledo	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.242
Toledo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	252
Toledo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	121
Toledo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	131
Toledo	Group 1002 Pneumonia 480-486	Both sexes	1.409
Toledo	Group 1002 Pneumonia 480-486	Men	869
Toledo	Group 1002 Pneumonia 480-486	Women	540
Toledo	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	358
Toledo	Group 1003 Acute bronchitis and bronchiolitis  466	Men	197
Toledo	Group 1003 Acute bronchitis and bronchiolitis  466	Women	161
Toledo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	157
Toledo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	92
Toledo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	65
Toledo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	432
Toledo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	305
Toledo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	127
Toledo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	837
Toledo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	687
Toledo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	150
Toledo	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	226
Toledo	Group 1007 Asthma 4930-4931,4938-4939	Men	84
Toledo	Group 1007 Asthma 4930-4931,4938-4939	Women	142
Toledo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.764
Toledo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	838
Toledo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	926
Toledo	Group 1100 Diseases of the digestive system  520-579	Both sexes	5.750
Toledo	Group 1100 Diseases of the digestive system  520-579	Men	3.260
Toledo	Group 1100 Diseases of the digestive system  520-579	Women	2.490
Toledo	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	53
Toledo	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	30
Toledo	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	23
Toledo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	82
Toledo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	52
Toledo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	30
Toledo	Group 1103 Diseases of the esophagus 530	Both sexes	85
Toledo	Group 1103 Diseases of the esophagus 530	Men	49
Toledo	Group 1103 Diseases of the esophagus 530	Women	36
Toledo	Group 1104 Peptic ulcer 531-534	Both sexes	101
Toledo	Group 1104 Peptic ulcer 531-534	Men	79
Toledo	Group 1104 Peptic ulcer 531-534	Women	22
Toledo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	118
Toledo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	53
Toledo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	65
Toledo	Group 1106 Appendicitis  540-543	Both sexes	527
Toledo	Group 1106 Appendicitis  540-543	Men	297
Toledo	Group 1106 Appendicitis  540-543	Women	230
Toledo	Group 1107 Inguinal hernia  550	Both sexes	425
Toledo	Group 1107 Inguinal hernia  550	Men	378
Toledo	Group 1107 Inguinal hernia  550	Women	47
Toledo	Group 1108 Other abdominal hernia  551-553	Both sexes	489
Toledo	Group 1108 Other abdominal hernia  551-553	Men	208
Toledo	Group 1108 Other abdominal hernia  551-553	Women	281
Toledo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	109
Toledo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	58
Toledo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	51
Toledo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	313
Toledo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	161
Toledo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	152
Toledo	Group 1111 Intestinal obstruction without hernia 560	Both sexes	382
Toledo	Group 1111 Intestinal obstruction without hernia 560	Men	200
Toledo	Group 1111 Intestinal obstruction without hernia 560	Women	182
Toledo	Group 1112 Intestinal diverticulosis 562	Both sexes	230
Toledo	Group 1112 Intestinal diverticulosis 562	Men	121
Toledo	Group 1112 Intestinal diverticulosis 562	Women	109
Toledo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	392
Toledo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	254
Toledo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	138
Toledo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	226
Toledo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	103
Toledo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	123
Toledo	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	73
Toledo	Group 1115 Alcoholic hepatitis 5710-5713	Men	61
Toledo	Group 1115 Alcoholic hepatitis 5710-5713	Women	12
Toledo	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	232
Toledo	Group 1116 Other diseases of the liver 570,5714-573	Men	154
Toledo	Group 1116 Other diseases of the liver 570,5714-573	Women	78
Toledo	Group 1117 Cholelithiasis  574	Both sexes	954
Toledo	Group 1117 Cholelithiasis  574	Men	467
Toledo	Group 1117 Cholelithiasis  574	Women	487
Toledo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	320
Toledo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	167
Toledo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	153
Toledo	Group 1119 Pancreatic diseases 577	Both sexes	417
Toledo	Group 1119 Pancreatic diseases 577	Men	238
Toledo	Group 1119 Pancreatic diseases 577	Women	179
Toledo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	222
Toledo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	130
Toledo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	92
Toledo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	399
Toledo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	219
Toledo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	180
Toledo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	249
Toledo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	151
Toledo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	98
Toledo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	21
Toledo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	8
Toledo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
Toledo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	129
Toledo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	60
Toledo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	69
Toledo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.638
Toledo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.365
Toledo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.273
Toledo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Toledo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Toledo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Toledo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Toledo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Toledo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Toledo	Group 1303 Internal derangement of knee 717	Both sexes	350
Toledo	Group 1303 Internal derangement of knee 717	Men	242
Toledo	Group 1303 Internal derangement of knee 717	Women	108
Toledo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.033
Toledo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	456
Toledo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	577
Toledo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	48
Toledo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	24
Toledo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	24
Toledo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	109
Toledo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	55
Toledo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	54
Toledo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	222
Toledo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	129
Toledo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	93
Toledo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	52
Toledo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	25
Toledo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	27
Toledo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	400
Toledo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	241
Toledo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	159
Toledo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	424
Toledo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	193
Toledo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	231
Toledo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.073
Toledo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.504
Toledo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.569
Toledo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	380
Toledo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	145
Toledo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	235
Toledo	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	326
Toledo	Group 1402 Renal failure  5836-5837, 584-586	Men	186
Toledo	Group 1402 Renal failure  5836-5837, 584-586	Women	140
Toledo	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	403
Toledo	Group 1403 Urolithiasis  592, 594, 7880	Men	235
Toledo	Group 1403 Urolithiasis  592, 594, 7880	Women	168
Toledo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	811
Toledo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	425
Toledo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	386
Toledo	Group 1405 Prostatic hyperplasia  600	Both sexes	162
Toledo	Group 1405 Prostatic hyperplasia  600	Men	162
Toledo	Group 1405 Prostatic hyperplasia  600	Women	..
Toledo	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	331
Toledo	Group 1406 Other diseases of the male genital organs    601-608	Men	331
Toledo	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Toledo	Group 1407 Disorders of breast  610-612	Both sexes	125
Toledo	Group 1407 Disorders of breast  610-612	Men	19
Toledo	Group 1407 Disorders of breast  610-612	Women	106
Toledo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	95
Toledo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Toledo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	95
Toledo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	52
Toledo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Toledo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	52
Toledo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	388
Toledo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Toledo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	387
Toledo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.407
Toledo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Toledo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.407
Toledo	Group 1501 Legally induced abortion  635	Both sexes	2
Toledo	Group 1501 Legally induced abortion  635	Men	..
Toledo	Group 1501 Legally induced abortion  635	Women	2
Toledo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	397
Toledo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Toledo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	397
Toledo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.556
Toledo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Toledo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.556
Toledo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	346
Toledo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Toledo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	346
Toledo	Group 1505 Single spontaneous delivery  650	Both sexes	345
Toledo	Group 1505 Single spontaneous delivery  650	Men	..
Toledo	Group 1505 Single spontaneous delivery  650	Women	345
Toledo	Group 1506 Other deliveries  6695-6697	Both sexes	214
Toledo	Group 1506 Other deliveries  6695-6697	Men	..
Toledo	Group 1506 Other deliveries  6695-6697	Women	214
Toledo	Group 1507 Complications related to the puerperium  670-676	Both sexes	35
Toledo	Group 1507 Complications related to the puerperium  670-676	Men	..
Toledo	Group 1507 Complications related to the puerperium  670-676	Women	35
Toledo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	512
Toledo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Toledo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	512
Toledo	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	873
Toledo	Group 1600 Some disorders originating in the perinatal period  760-779	Men	474
Toledo	Group 1600 Some disorders originating in the perinatal period  760-779	Women	399
Toledo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	277
Toledo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	152
Toledo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	125
Toledo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	596
Toledo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	322
Toledo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	274
Toledo	Grupo 1700 Congenital abnormalities  740-759	Both sexes	343
Toledo	Grupo 1700 Congenital abnormalities  740-759	Men	214
Toledo	Grupo 1700 Congenital abnormalities  740-759	Women	129
Toledo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.720
Toledo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	951
Toledo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	769
Toledo	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	155
Toledo	Group 1801 Pain in throat and chest 7841, 7865	Men	97
Toledo	Group 1801 Pain in throat and chest 7841, 7865	Women	58
Toledo	Group 1802 Abdominal pain   7890	Both sexes	304
Toledo	Group 1802 Abdominal pain   7890	Men	120
Toledo	Group 1802 Abdominal pain   7890	Women	184
Toledo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	3
Toledo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Toledo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	3
Toledo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.258
Toledo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	734
Toledo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	524
Toledo	Group 1900 Injuries and poisoning  800-999	Both sexes	4.746
Toledo	Group 1900 Injuries and poisoning  800-999	Men	2.364
Toledo	Group 1900 Injuries and poisoning  800-999	Women	2.382
Toledo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	257
Toledo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	166
Toledo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	91
Toledo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	115
Toledo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	86
Toledo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	29
Toledo	Group 1903 Radius and ulna fracture 813	Both sexes	281
Toledo	Group 1903 Radius and ulna fracture 813	Men	133
Toledo	Group 1903 Radius and ulna fracture 813	Women	148
Toledo	Group 1904 Femur fracture  820-821	Both sexes	871
Toledo	Group 1904 Femur fracture  820-821	Men	240
Toledo	Group 1904 Femur fracture  820-821	Women	631
Toledo	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	386
Toledo	Group 1905 Leg fracture, including the ankle 823-824	Men	194
Toledo	Group 1905 Leg fracture, including the ankle 823-824	Women	192
Toledo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.475
Toledo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	888
Toledo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	587
Toledo	Group 1907 Burns  940-949	Both sexes	7
Toledo	Group 1907 Burns  940-949	Men	6
Toledo	Group 1907 Burns  940-949	Women	1
Toledo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	135
Toledo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	48
Toledo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	87
Toledo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.106
Toledo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	538
Toledo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	568
Toledo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	6
Toledo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Toledo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	4
Toledo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	107
Toledo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	63
Toledo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	44
Toledo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	750
Toledo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	440
Toledo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	310
Toledo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	20
Toledo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	13
Toledo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	7
Toledo	Group 2102 Contraceptive management  V25	Both sexes	11
Toledo	Group 2102 Contraceptive management  V25	Men	4
Toledo	Group 2102 Contraceptive management  V25	Women	7
Toledo	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Toledo	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Toledo	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Toledo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	347
Toledo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	212
Toledo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	135
Toledo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	372
Toledo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	211
Toledo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	161
CATALUÐA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	829.556
CATALUÐA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	390.473
CATALUÐA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	439.083
CATALUÐA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	14.922
CATALUÐA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	8.279
CATALUÐA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	6.643
CATALUÐA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	2.591
CATALUÐA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	1.348
CATALUÐA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	1.242
CATALUÐA	Group 0102 Imprecise intestinal infections 009	Both sexes	1.941
CATALUÐA	Group 0102 Imprecise intestinal infections 009	Men	968
CATALUÐA	Group 0102 Imprecise intestinal infections 009	Women	973
CATALUÐA	Group 0103 Tuberculosis 010-018, 137	Both sexes	720
CATALUÐA	Group 0103 Tuberculosis 010-018, 137	Men	459
CATALUÐA	Group 0103 Tuberculosis 010-018, 137	Women	260
CATALUÐA	Group 0104 Septicaemia  038	Both sexes	4.125
CATALUÐA	Group 0104 Septicaemia  038	Men	2.259
CATALUÐA	Group 0104 Septicaemia  038	Women	1.865
CATALUÐA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	639
CATALUÐA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	452
CATALUÐA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	187
CATALUÐA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	4.908
CATALUÐA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.793
CATALUÐA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	2.115
CATALUÐA	Group 0200 Neoplasms  140-239	Both sexes	79.048
CATALUÐA	Group 0200 Neoplasms  140-239	Men	42.962
CATALUÐA	Group 0200 Neoplasms  140-239	Women	36.086
CATALUÐA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	8.699
CATALUÐA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	5.275
CATALUÐA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	3.424
CATALUÐA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	6.621
CATALUÐA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	5.206
CATALUÐA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1.415
CATALUÐA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1.059
CATALUÐA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	619
CATALUÐA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	440
CATALUÐA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	5.604
CATALUÐA	Group 0204 Malignant neoplasm of breast  174-175	Men	43
CATALUÐA	Group 0204 Malignant neoplasm of breast  174-175	Women	5.562
CATALUÐA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.602
CATALUÐA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
CATALUÐA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.602
CATALUÐA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	916
CATALUÐA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
CATALUÐA	Group 0206 Malignant neoplasm of ovary  1830	Women	916
CATALUÐA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	3.013
CATALUÐA	Group 0207 Malignant neoplasm of prostate  185	Men	3.013
CATALUÐA	Group 0207 Malignant neoplasm of prostate  185	Women	..
CATALUÐA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	8.552
CATALUÐA	Group 0208 Malignant neoplasm of bladder  188	Men	7.199
CATALUÐA	Group 0208 Malignant neoplasm of bladder  188	Women	1.354
CATALUÐA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	28.839
CATALUÐA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	17.028
CATALUÐA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	11.811
CATALUÐA	Group 0210 Carcinoma in situ  230-234	Both sexes	820
CATALUÐA	Group 0210 Carcinoma in situ  230-234	Men	324
CATALUÐA	Group 0210 Carcinoma in situ  230-234	Women	496
CATALUÐA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	832
CATALUÐA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	521
CATALUÐA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	312
CATALUÐA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	3.745
CATALUÐA	Grupo 0212 Leiomyoma of uterus  218	Men	..
CATALUÐA	Grupo 0212 Leiomyoma of uterus  218	Women	3.745
CATALUÐA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	8.745
CATALUÐA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.735
CATALUÐA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	5.010
CATALUÐA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	6.818
CATALUÐA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	3.401
CATALUÐA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	3.417
CATALUÐA	Group 0301 Anaemias 280-285	Both sexes	3.744
CATALUÐA	Group 0301 Anaemias 280-285	Men	1.777
CATALUÐA	Group 0301 Anaemias 280-285	Women	1.967
CATALUÐA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	3.074
CATALUÐA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.624
CATALUÐA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.450
CATALUÐA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	13.877
CATALUÐA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	5.379
CATALUÐA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	8.499
CATALUÐA	Group 0401 Diabetes mellitus  249-250	Both sexes	4.348
CATALUÐA	Group 0401 Diabetes mellitus  249-250	Men	2.481
CATALUÐA	Group 0401 Diabetes mellitus  249-250	Women	1.868
CATALUÐA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	9.529
CATALUÐA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.898
CATALUÐA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	6.631
CATALUÐA	Group 0500 Mental disorders  290-319	Both sexes	29.031
CATALUÐA	Group 0500 Mental disorders  290-319	Men	14.904
CATALUÐA	Group 0500 Mental disorders  290-319	Women	14.127
CATALUÐA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	2.143
CATALUÐA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	897
CATALUÐA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1.246
CATALUÐA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	1.774
CATALUÐA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	1.301
CATALUÐA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	472
CATALUÐA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	1.661
CATALUÐA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	1.204
CATALUÐA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	457
CATALUÐA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	8.741
CATALUÐA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	5.473
CATALUÐA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	3.267
CATALUÐA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	6.678
CATALUÐA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	2.619
CATALUÐA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	4.060
CATALUÐA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	8.033
CATALUÐA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	3.409
CATALUÐA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	4.624
CATALUÐA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	16.774
CATALUÐA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	8.001
CATALUÐA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	8.772
CATALUÐA	Group 0601 Alzheimer's disease  3310	Both sexes	1.685
CATALUÐA	Group 0601 Alzheimer's disease  3310	Men	544
CATALUÐA	Group 0601 Alzheimer's disease  3310	Women	1.141
CATALUÐA	Group 0602 Multiple sclerosis 340	Both sexes	207
CATALUÐA	Group 0602 Multiple sclerosis 340	Men	78
CATALUÐA	Group 0602 Multiple sclerosis 340	Women	129
CATALUÐA	Group 0603 Epilepsy  345	Both sexes	2.763
CATALUÐA	Group 0603 Epilepsy  345	Men	1.497
CATALUÐA	Group 0603 Epilepsy  345	Women	1.265
CATALUÐA	Group 0604 Transient cerebral ischemia 435	Both sexes	2.192
CATALUÐA	Group 0604 Transient cerebral ischemia 435	Men	1.123
CATALUÐA	Group 0604 Transient cerebral ischemia 435	Women	1.069
CATALUÐA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	9.926
CATALUÐA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	4.758
CATALUÐA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	5.168
CATALUÐA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	5.426
CATALUÐA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.709
CATALUÐA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.717
CATALUÐA	Grupo 0701 Cataract  366	Both sexes	1.757
CATALUÐA	Grupo 0701 Cataract  366	Men	768
CATALUÐA	Grupo 0701 Cataract  366	Women	989
CATALUÐA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	3.669
CATALUÐA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.941
CATALUÐA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.728
CATALUÐA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	4.027
CATALUÐA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.952
CATALUÐA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	2.075
CATALUÐA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	106.085
CATALUÐA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	58.596
CATALUÐA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	47.490
CATALUÐA	Group 0901 Hypertensive disease  401-405	Both sexes	4.157
CATALUÐA	Group 0901 Hypertensive disease  401-405	Men	1.689
CATALUÐA	Group 0901 Hypertensive disease  401-405	Women	2.468
CATALUÐA	Group 0902 Angina pectoris  4111, 413	Both sexes	3.404
CATALUÐA	Group 0902 Angina pectoris  4111, 413	Men	2.134
CATALUÐA	Group 0902 Angina pectoris  4111, 413	Women	1.270
CATALUÐA	Group 0903 Acute myocardial infarction  410	Both sexes	9.427
CATALUÐA	Group 0903 Acute myocardial infarction  410	Men	6.688
CATALUÐA	Group 0903 Acute myocardial infarction  410	Women	2.738
CATALUÐA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	7.380
CATALUÐA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	5.664
CATALUÐA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.716
CATALUÐA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.954
CATALUÐA	Group 0905 Diseases of the lungs circulation 415-417	Men	1.385
CATALUÐA	Group 0905 Diseases of the lungs circulation 415-417	Women	1.569
CATALUÐA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	13.276
CATALUÐA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	6.994
CATALUÐA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	6.282
CATALUÐA	Grupo 0907 Heart failure  428	Both sexes	25.042
CATALUÐA	Grupo 0907 Heart failure  428	Men	11.285
CATALUÐA	Grupo 0907 Heart failure  428	Women	13.757
CATALUÐA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	19.040
CATALUÐA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	10.082
CATALUÐA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	8.958
CATALUÐA	Grupo 0909 Atherosclerosis  440	Both sexes	4.675
CATALUÐA	Grupo 0909 Atherosclerosis  440	Men	3.308
CATALUÐA	Grupo 0909 Atherosclerosis  440	Women	1.368
CATALUÐA	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.902
CATALUÐA	Group 0910 Varicose veins of lower extremities 454	Men	641
CATALUÐA	Group 0910 Varicose veins of lower extremities 454	Women	1.261
CATALUÐA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	14.828
CATALUÐA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	8.725
CATALUÐA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	6.103
CATALUÐA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	97.779
CATALUÐA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	55.452
CATALUÐA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	42.327
CATALUÐA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.455
CATALUÐA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.832
CATALUÐA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.623
CATALUÐA	Group 1002 Pneumonia 480-486	Both sexes	20.138
CATALUÐA	Group 1002 Pneumonia 480-486	Men	11.821
CATALUÐA	Group 1002 Pneumonia 480-486	Women	8.317
CATALUÐA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	13.509
CATALUÐA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	6.316
CATALUÐA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	7.193
CATALUÐA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	3.880
CATALUÐA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	2.038
CATALUÐA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.842
CATALUÐA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	6.561
CATALUÐA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	3.904
CATALUÐA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.657
CATALUÐA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	18.800
CATALUÐA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	14.062
CATALUÐA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	4.738
CATALUÐA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	3.815
CATALUÐA	Group 1007 Asthma 4930-4931,4938-4939	Men	1.039
CATALUÐA	Group 1007 Asthma 4930-4931,4938-4939	Women	2.776
CATALUÐA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	27.621
CATALUÐA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	14.439
CATALUÐA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	13.183
CATALUÐA	Group 1100 Diseases of the digestive system  520-579	Both sexes	95.164
CATALUÐA	Group 1100 Diseases of the digestive system  520-579	Men	52.260
CATALUÐA	Group 1100 Diseases of the digestive system  520-579	Women	42.904
CATALUÐA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	1.392
CATALUÐA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	668
CATALUÐA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	724
CATALUÐA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1.225
CATALUÐA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	726
CATALUÐA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	498
CATALUÐA	Group 1103 Diseases of the esophagus 530	Both sexes	1.514
CATALUÐA	Group 1103 Diseases of the esophagus 530	Men	881
CATALUÐA	Group 1103 Diseases of the esophagus 530	Women	633
CATALUÐA	Group 1104 Peptic ulcer 531-534	Both sexes	1.764
CATALUÐA	Group 1104 Peptic ulcer 531-534	Men	1.246
CATALUÐA	Group 1104 Peptic ulcer 531-534	Women	518
CATALUÐA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	2.130
CATALUÐA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	1.021
CATALUÐA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	1.110
CATALUÐA	Group 1106 Appendicitis  540-543	Both sexes	8.101
CATALUÐA	Group 1106 Appendicitis  540-543	Men	4.605
CATALUÐA	Group 1106 Appendicitis  540-543	Women	3.496
CATALUÐA	Group 1107 Inguinal hernia  550	Both sexes	10.123
CATALUÐA	Group 1107 Inguinal hernia  550	Men	8.918
CATALUÐA	Group 1107 Inguinal hernia  550	Women	1.205
CATALUÐA	Group 1108 Other abdominal hernia  551-553	Both sexes	7.969
CATALUÐA	Group 1108 Other abdominal hernia  551-553	Men	3.442
CATALUÐA	Group 1108 Other abdominal hernia  551-553	Women	4.528
CATALUÐA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.573
CATALUÐA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	795
CATALUÐA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	778
CATALUÐA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	4.369
CATALUÐA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	2.047
CATALUÐA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.322
CATALUÐA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	4.631
CATALUÐA	Group 1111 Intestinal obstruction without hernia 560	Men	2.354
CATALUÐA	Group 1111 Intestinal obstruction without hernia 560	Women	2.277
CATALUÐA	Group 1112 Intestinal diverticulosis 562	Both sexes	4.319
CATALUÐA	Group 1112 Intestinal diverticulosis 562	Men	2.156
CATALUÐA	Group 1112 Intestinal diverticulosis 562	Women	2.163
CATALUÐA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	5.283
CATALUÐA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	3.277
CATALUÐA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	2.006
CATALUÐA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	3.192
CATALUÐA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.447
CATALUÐA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.745
CATALUÐA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.739
CATALUÐA	Group 1115 Alcoholic hepatitis 5710-5713	Men	1.458
CATALUÐA	Group 1115 Alcoholic hepatitis 5710-5713	Women	281
CATALUÐA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	3.680
CATALUÐA	Group 1116 Other diseases of the liver 570,5714-573	Men	2.111
CATALUÐA	Group 1116 Other diseases of the liver 570,5714-573	Women	1.569
CATALUÐA	Group 1117 Cholelithiasis  574	Both sexes	18.709
CATALUÐA	Group 1117 Cholelithiasis  574	Men	7.685
CATALUÐA	Group 1117 Cholelithiasis  574	Women	11.025
CATALUÐA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	4.750
CATALUÐA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.580
CATALUÐA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	2.170
CATALUÐA	Group 1119 Pancreatic diseases 577	Both sexes	5.125
CATALUÐA	Group 1119 Pancreatic diseases 577	Men	2.863
CATALUÐA	Group 1119 Pancreatic diseases 577	Women	2.262
CATALUÐA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.576
CATALUÐA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.980
CATALUÐA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.595
CATALUÐA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	8.850
CATALUÐA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	4.723
CATALUÐA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	4.126
CATALUÐA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	5.705
CATALUÐA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	3.247
CATALUÐA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	2.458
CATALUÐA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	326
CATALUÐA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	182
CATALUÐA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	144
CATALUÐA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.819
CATALUÐA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.294
CATALUÐA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.525
CATALUÐA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	68.180
CATALUÐA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	31.291
CATALUÐA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	36.889
CATALUÐA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
CATALUÐA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
CATALUÐA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
CATALUÐA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
CATALUÐA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
CATALUÐA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
CATALUÐA	Group 1303 Internal derangement of knee 717	Both sexes	9.322
CATALUÐA	Group 1303 Internal derangement of knee 717	Men	5.961
CATALUÐA	Group 1303 Internal derangement of knee 717	Women	3.361
CATALUÐA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	26.055
CATALUÐA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	10.520
CATALUÐA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	15.535
CATALUÐA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	975
CATALUÐA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	374
CATALUÐA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	602
CATALUÐA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	3.373
CATALUÐA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.488
CATALUÐA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.886
CATALUÐA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	5.512
CATALUÐA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	2.975
CATALUÐA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	2.537
CATALUÐA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1.840
CATALUÐA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	818
CATALUÐA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	1.022
CATALUÐA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	10.657
CATALUÐA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	5.106
CATALUÐA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	5.551
CATALUÐA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	10.445
CATALUÐA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	4.050
CATALUÐA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	6.395
CATALUÐA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	61.901
CATALUÐA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	28.420
CATALUÐA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	33.480
CATALUÐA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	7.411
CATALUÐA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	2.226
CATALUÐA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	5.186
CATALUÐA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	5.827
CATALUÐA	Group 1402 Renal failure  5836-5837, 584-586	Men	3.333
CATALUÐA	Group 1402 Renal failure  5836-5837, 584-586	Women	2.494
CATALUÐA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	7.620
CATALUÐA	Group 1403 Urolithiasis  592, 594, 7880	Men	4.572
CATALUÐA	Group 1403 Urolithiasis  592, 594, 7880	Women	3.048
CATALUÐA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	15.121
CATALUÐA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	7.302
CATALUÐA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	7.819
CATALUÐA	Group 1405 Prostatic hyperplasia  600	Both sexes	5.471
CATALUÐA	Group 1405 Prostatic hyperplasia  600	Men	5.471
CATALUÐA	Group 1405 Prostatic hyperplasia  600	Women	..
CATALUÐA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	5.071
CATALUÐA	Group 1406 Other diseases of the male genital organs    601-608	Men	5.071
CATALUÐA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
CATALUÐA	Group 1407 Disorders of breast  610-612	Both sexes	5.012
CATALUÐA	Group 1407 Disorders of breast  610-612	Men	255
CATALUÐA	Group 1407 Disorders of breast  610-612	Women	4.757
CATALUÐA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1.244
CATALUÐA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
CATALUÐA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1.244
CATALUÐA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	473
CATALUÐA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
CATALUÐA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	473
CATALUÐA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	8.652
CATALUÐA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	191
CATALUÐA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	8.460
CATALUÐA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	78.938
CATALUÐA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
CATALUÐA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	78.938
CATALUÐA	Group 1501 Legally induced abortion  635	Both sexes	605
CATALUÐA	Group 1501 Legally induced abortion  635	Men	..
CATALUÐA	Group 1501 Legally induced abortion  635	Women	605
CATALUÐA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.779
CATALUÐA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
CATALUÐA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.779
CATALUÐA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	39.858
CATALUÐA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
CATALUÐA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	39.858
CATALUÐA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	19.242
CATALUÐA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
CATALUÐA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	19.242
CATALUÐA	Group 1505 Single spontaneous delivery  650	Both sexes	6.512
CATALUÐA	Group 1505 Single spontaneous delivery  650	Men	..
CATALUÐA	Group 1505 Single spontaneous delivery  650	Women	6.512
CATALUÐA	Group 1506 Other deliveries  6695-6697	Both sexes	2.196
CATALUÐA	Group 1506 Other deliveries  6695-6697	Men	..
CATALUÐA	Group 1506 Other deliveries  6695-6697	Women	2.196
CATALUÐA	Group 1507 Complications related to the puerperium  670-676	Both sexes	890
CATALUÐA	Group 1507 Complications related to the puerperium  670-676	Men	..
CATALUÐA	Group 1507 Complications related to the puerperium  670-676	Women	890
CATALUÐA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	6.855
CATALUÐA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
CATALUÐA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	6.855
CATALUÐA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	11.368
CATALUÐA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	6.138
CATALUÐA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	5.229
CATALUÐA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	3.633
CATALUÐA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.909
CATALUÐA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.724
CATALUÐA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	7.735
CATALUÐA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	4.229
CATALUÐA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	3.506
CATALUÐA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	6.911
CATALUÐA	Grupo 1700 Congenital abnormalities  740-759	Men	3.761
CATALUÐA	Grupo 1700 Congenital abnormalities  740-759	Women	3.149
CATALUÐA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	29.722
CATALUÐA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	16.341
CATALUÐA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	13.380
CATALUÐA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	3.024
CATALUÐA	Group 1801 Pain in throat and chest 7841, 7865	Men	1.737
CATALUÐA	Group 1801 Pain in throat and chest 7841, 7865	Women	1.287
CATALUÐA	Group 1802 Abdominal pain   7890	Both sexes	3.622
CATALUÐA	Group 1802 Abdominal pain   7890	Men	1.428
CATALUÐA	Group 1802 Abdominal pain   7890	Women	2.194
CATALUÐA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	830
CATALUÐA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	415
CATALUÐA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	415
CATALUÐA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	22.246
CATALUÐA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	12.761
CATALUÐA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	9.485
CATALUÐA	Group 1900 Injuries and poisoning  800-999	Both sexes	78.458
CATALUÐA	Group 1900 Injuries and poisoning  800-999	Men	37.545
CATALUÐA	Group 1900 Injuries and poisoning  800-999	Women	40.913
CATALUÐA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	4.892
CATALUÐA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	2.662
CATALUÐA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	2.230
CATALUÐA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.645
CATALUÐA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	1.082
CATALUÐA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	563
CATALUÐA	Group 1903 Radius and ulna fracture 813	Both sexes	4.254
CATALUÐA	Group 1903 Radius and ulna fracture 813	Men	2.004
CATALUÐA	Group 1903 Radius and ulna fracture 813	Women	2.251
CATALUÐA	Group 1904 Femur fracture  820-821	Both sexes	15.795
CATALUÐA	Group 1904 Femur fracture  820-821	Men	4.420
CATALUÐA	Group 1904 Femur fracture  820-821	Women	11.376
CATALUÐA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	5.213
CATALUÐA	Group 1905 Leg fracture, including the ankle 823-824	Men	2.543
CATALUÐA	Group 1905 Leg fracture, including the ankle 823-824	Women	2.669
CATALUÐA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	22.391
CATALUÐA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	12.379
CATALUÐA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	10.012
CATALUÐA	Group 1907 Burns  940-949	Both sexes	611
CATALUÐA	Group 1907 Burns  940-949	Men	378
CATALUÐA	Group 1907 Burns  940-949	Women	232
CATALUÐA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	2.229
CATALUÐA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	968
CATALUÐA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	1.261
CATALUÐA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	19.384
CATALUÐA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	9.976
CATALUÐA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	9.408
CATALUÐA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	220
CATALUÐA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	136
CATALUÐA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	84
CATALUÐA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.824
CATALUÐA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	998
CATALUÐA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	825
CATALUÐA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	16.277
CATALUÐA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	8.356
CATALUÐA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	7.921
CATALUÐA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	346
CATALUÐA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	217
CATALUÐA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	129
CATALUÐA	Group 2102 Contraceptive management  V25	Both sexes	298
CATALUÐA	Group 2102 Contraceptive management  V25	Men	21
CATALUÐA	Group 2102 Contraceptive management  V25	Women	277
CATALUÐA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
CATALUÐA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
CATALUÐA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
CATALUÐA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	4.168
CATALUÐA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2.575
CATALUÐA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.593
CATALUÐA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	11.465
CATALUÐA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	5.543
CATALUÐA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	5.922
Barcelona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	643.805
Barcelona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	302.523
Barcelona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	341.281
Barcelona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	11.931
Barcelona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	6.565
Barcelona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	5.366
Barcelona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	2.127
Barcelona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	1.099
Barcelona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	1.027
Barcelona	Group 0102 Imprecise intestinal infections 009	Both sexes	1.425
Barcelona	Group 0102 Imprecise intestinal infections 009	Men	695
Barcelona	Group 0102 Imprecise intestinal infections 009	Women	730
Barcelona	Group 0103 Tuberculosis 010-018, 137	Both sexes	536
Barcelona	Group 0103 Tuberculosis 010-018, 137	Men	338
Barcelona	Group 0103 Tuberculosis 010-018, 137	Women	198
Barcelona	Group 0104 Septicaemia  038	Both sexes	3.415
Barcelona	Group 0104 Septicaemia  038	Men	1.850
Barcelona	Group 0104 Septicaemia  038	Women	1.565
Barcelona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	502
Barcelona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	350
Barcelona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	153
Barcelona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	3.926
Barcelona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.233
Barcelona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	1.693
Barcelona	Group 0200 Neoplasms  140-239	Both sexes	62.358
Barcelona	Group 0200 Neoplasms  140-239	Men	33.678
Barcelona	Group 0200 Neoplasms  140-239	Women	28.680
Barcelona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	6.579
Barcelona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.964
Barcelona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.615
Barcelona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	5.099
Barcelona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	4.024
Barcelona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1.074
Barcelona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	831
Barcelona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	473
Barcelona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	358
Barcelona	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	4.376
Barcelona	Group 0204 Malignant neoplasm of breast  174-175	Men	32
Barcelona	Group 0204 Malignant neoplasm of breast  174-175	Women	4.344
Barcelona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.265
Barcelona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Barcelona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.265
Barcelona	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	752
Barcelona	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Barcelona	Group 0206 Malignant neoplasm of ovary  1830	Women	752
Barcelona	Group 0207 Malignant neoplasm of prostate  185	Both sexes	2.455
Barcelona	Group 0207 Malignant neoplasm of prostate  185	Men	2.455
Barcelona	Group 0207 Malignant neoplasm of prostate  185	Women	..
Barcelona	Group 0208 Malignant neoplasm of bladder  188	Both sexes	6.467
Barcelona	Group 0208 Malignant neoplasm of bladder  188	Men	5.439
Barcelona	Group 0208 Malignant neoplasm of bladder  188	Women	1.028
Barcelona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	23.297
Barcelona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	13.689
Barcelona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	9.607
Barcelona	Group 0210 Carcinoma in situ  230-234	Both sexes	675
Barcelona	Group 0210 Carcinoma in situ  230-234	Men	272
Barcelona	Group 0210 Carcinoma in situ  230-234	Women	404
Barcelona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	625
Barcelona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	385
Barcelona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	240
Barcelona	Grupo 0212 Leiomyoma of uterus  218	Both sexes	2.973
Barcelona	Grupo 0212 Leiomyoma of uterus  218	Men	..
Barcelona	Grupo 0212 Leiomyoma of uterus  218	Women	2.973
Barcelona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	6.964
Barcelona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	2.945
Barcelona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	4.019
Barcelona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	5.334
Barcelona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	2.650
Barcelona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	2.684
Barcelona	Group 0301 Anaemias 280-285	Both sexes	2.777
Barcelona	Group 0301 Anaemias 280-285	Men	1.299
Barcelona	Group 0301 Anaemias 280-285	Women	1.478
Barcelona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.557
Barcelona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.351
Barcelona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.206
Barcelona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	11.349
Barcelona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.325
Barcelona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	7.024
Barcelona	Group 0401 Diabetes mellitus  249-250	Both sexes	3.459
Barcelona	Group 0401 Diabetes mellitus  249-250	Men	1.976
Barcelona	Group 0401 Diabetes mellitus  249-250	Women	1.483
Barcelona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	7.890
Barcelona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.349
Barcelona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	5.541
Barcelona	Group 0500 Mental disorders  290-319	Both sexes	22.676
Barcelona	Group 0500 Mental disorders  290-319	Men	11.475
Barcelona	Group 0500 Mental disorders  290-319	Women	11.200
Barcelona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	1.751
Barcelona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	734
Barcelona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1.017
Barcelona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	1.462
Barcelona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	1.068
Barcelona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	394
Barcelona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	1.344
Barcelona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	970
Barcelona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	373
Barcelona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	6.678
Barcelona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	4.118
Barcelona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	2.560
Barcelona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	5.351
Barcelona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	2.068
Barcelona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	3.283
Barcelona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	6.090
Barcelona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	2.517
Barcelona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	3.573
Barcelona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	13.677
Barcelona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	6.515
Barcelona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	7.162
Barcelona	Group 0601 Alzheimer's disease  3310	Both sexes	1.405
Barcelona	Group 0601 Alzheimer's disease  3310	Men	447
Barcelona	Group 0601 Alzheimer's disease  3310	Women	958
Barcelona	Group 0602 Multiple sclerosis 340	Both sexes	156
Barcelona	Group 0602 Multiple sclerosis 340	Men	60
Barcelona	Group 0602 Multiple sclerosis 340	Women	96
Barcelona	Group 0603 Epilepsy  345	Both sexes	2.310
Barcelona	Group 0603 Epilepsy  345	Men	1.233
Barcelona	Group 0603 Epilepsy  345	Women	1.077
Barcelona	Group 0604 Transient cerebral ischemia 435	Both sexes	1.740
Barcelona	Group 0604 Transient cerebral ischemia 435	Men	883
Barcelona	Group 0604 Transient cerebral ischemia 435	Women	857
Barcelona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	8.065
Barcelona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	3.892
Barcelona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	4.173
Barcelona	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	4.259
Barcelona	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.162
Barcelona	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.097
Barcelona	Grupo 0701 Cataract  366	Both sexes	1.087
Barcelona	Grupo 0701 Cataract  366	Men	470
Barcelona	Grupo 0701 Cataract  366	Women	617
Barcelona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	3.172
Barcelona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.692
Barcelona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.480
Barcelona	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	3.204
Barcelona	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.562
Barcelona	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.642
Barcelona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	83.082
Barcelona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	45.721
Barcelona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	37.360
Barcelona	Group 0901 Hypertensive disease  401-405	Both sexes	3.720
Barcelona	Group 0901 Hypertensive disease  401-405	Men	1.481
Barcelona	Group 0901 Hypertensive disease  401-405	Women	2.239
Barcelona	Group 0902 Angina pectoris  4111, 413	Both sexes	2.400
Barcelona	Group 0902 Angina pectoris  4111, 413	Men	1.475
Barcelona	Group 0902 Angina pectoris  4111, 413	Women	925
Barcelona	Group 0903 Acute myocardial infarction  410	Both sexes	7.109
Barcelona	Group 0903 Acute myocardial infarction  410	Men	5.004
Barcelona	Group 0903 Acute myocardial infarction  410	Women	2.105
Barcelona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	6.266
Barcelona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	4.845
Barcelona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.421
Barcelona	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.231
Barcelona	Group 0905 Diseases of the lungs circulation 415-417	Men	1.046
Barcelona	Group 0905 Diseases of the lungs circulation 415-417	Women	1.185
Barcelona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	10.401
Barcelona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	5.481
Barcelona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	4.921
Barcelona	Grupo 0907 Heart failure  428	Both sexes	19.443
Barcelona	Grupo 0907 Heart failure  428	Men	8.568
Barcelona	Grupo 0907 Heart failure  428	Women	10.875
Barcelona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	14.568
Barcelona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	7.668
Barcelona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	6.900
Barcelona	Grupo 0909 Atherosclerosis  440	Both sexes	3.748
Barcelona	Grupo 0909 Atherosclerosis  440	Men	2.663
Barcelona	Grupo 0909 Atherosclerosis  440	Women	1.085
Barcelona	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.282
Barcelona	Group 0910 Varicose veins of lower extremities 454	Men	407
Barcelona	Group 0910 Varicose veins of lower extremities 454	Women	875
Barcelona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	11.914
Barcelona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	7.084
Barcelona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	4.831
Barcelona	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	74.739
Barcelona	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	42.179
Barcelona	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	32.560
Barcelona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	2.656
Barcelona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.386
Barcelona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.271
Barcelona	Group 1002 Pneumonia 480-486	Both sexes	15.188
Barcelona	Group 1002 Pneumonia 480-486	Men	8.871
Barcelona	Group 1002 Pneumonia 480-486	Women	6.316
Barcelona	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	9.234
Barcelona	Group 1003 Acute bronchitis and bronchiolitis  466	Men	4.293
Barcelona	Group 1003 Acute bronchitis and bronchiolitis  466	Women	4.941
Barcelona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	2.638
Barcelona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.382
Barcelona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.257
Barcelona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	5.034
Barcelona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	2.961
Barcelona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.073
Barcelona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	14.406
Barcelona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	10.867
Barcelona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	3.539
Barcelona	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	2.892
Barcelona	Group 1007 Asthma 4930-4931,4938-4939	Men	753
Barcelona	Group 1007 Asthma 4930-4931,4938-4939	Women	2.139
Barcelona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	22.691
Barcelona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	11.666
Barcelona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	11.024
Barcelona	Group 1100 Diseases of the digestive system  520-579	Both sexes	72.081
Barcelona	Group 1100 Diseases of the digestive system  520-579	Men	39.348
Barcelona	Group 1100 Diseases of the digestive system  520-579	Women	32.733
Barcelona	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	964
Barcelona	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	450
Barcelona	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	514
Barcelona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	996
Barcelona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	585
Barcelona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	411
Barcelona	Group 1103 Diseases of the esophagus 530	Both sexes	1.221
Barcelona	Group 1103 Diseases of the esophagus 530	Men	693
Barcelona	Group 1103 Diseases of the esophagus 530	Women	527
Barcelona	Group 1104 Peptic ulcer 531-534	Both sexes	1.366
Barcelona	Group 1104 Peptic ulcer 531-534	Men	938
Barcelona	Group 1104 Peptic ulcer 531-534	Women	427
Barcelona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	1.673
Barcelona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	794
Barcelona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	879
Barcelona	Group 1106 Appendicitis  540-543	Both sexes	6.255
Barcelona	Group 1106 Appendicitis  540-543	Men	3.535
Barcelona	Group 1106 Appendicitis  540-543	Women	2.720
Barcelona	Group 1107 Inguinal hernia  550	Both sexes	7.497
Barcelona	Group 1107 Inguinal hernia  550	Men	6.606
Barcelona	Group 1107 Inguinal hernia  550	Women	891
Barcelona	Group 1108 Other abdominal hernia  551-553	Both sexes	5.975
Barcelona	Group 1108 Other abdominal hernia  551-553	Men	2.567
Barcelona	Group 1108 Other abdominal hernia  551-553	Women	3.407
Barcelona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.267
Barcelona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	644
Barcelona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	622
Barcelona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	3.263
Barcelona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.517
Barcelona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	1.746
Barcelona	Group 1111 Intestinal obstruction without hernia 560	Both sexes	3.477
Barcelona	Group 1111 Intestinal obstruction without hernia 560	Men	1.777
Barcelona	Group 1111 Intestinal obstruction without hernia 560	Women	1.700
Barcelona	Group 1112 Intestinal diverticulosis 562	Both sexes	3.451
Barcelona	Group 1112 Intestinal diverticulosis 562	Men	1.724
Barcelona	Group 1112 Intestinal diverticulosis 562	Women	1.726
Barcelona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	3.792
Barcelona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	2.364
Barcelona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.428
Barcelona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.529
Barcelona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.123
Barcelona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.406
Barcelona	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.293
Barcelona	Group 1115 Alcoholic hepatitis 5710-5713	Men	1.078
Barcelona	Group 1115 Alcoholic hepatitis 5710-5713	Women	215
Barcelona	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	2.956
Barcelona	Group 1116 Other diseases of the liver 570,5714-573	Men	1.685
Barcelona	Group 1116 Other diseases of the liver 570,5714-573	Women	1.271
Barcelona	Group 1117 Cholelithiasis  574	Both sexes	14.066
Barcelona	Group 1117 Cholelithiasis  574	Men	5.730
Barcelona	Group 1117 Cholelithiasis  574	Women	8.336
Barcelona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	3.508
Barcelona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	1.909
Barcelona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.599
Barcelona	Group 1119 Pancreatic diseases 577	Both sexes	3.878
Barcelona	Group 1119 Pancreatic diseases 577	Men	2.151
Barcelona	Group 1119 Pancreatic diseases 577	Women	1.727
Barcelona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	2.656
Barcelona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.476
Barcelona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.180
Barcelona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	6.859
Barcelona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	3.627
Barcelona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	3.232
Barcelona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	4.310
Barcelona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	2.440
Barcelona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.870
Barcelona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	269
Barcelona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	146
Barcelona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	123
Barcelona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.279
Barcelona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.041
Barcelona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.238
Barcelona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	53.912
Barcelona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	24.807
Barcelona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	29.105
Barcelona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Barcelona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Barcelona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Barcelona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Barcelona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Barcelona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Barcelona	Group 1303 Internal derangement of knee 717	Both sexes	7.794
Barcelona	Group 1303 Internal derangement of knee 717	Men	5.028
Barcelona	Group 1303 Internal derangement of knee 717	Women	2.765
Barcelona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	19.632
Barcelona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	7.775
Barcelona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	11.857
Barcelona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	792
Barcelona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	296
Barcelona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	496
Barcelona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.905
Barcelona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.249
Barcelona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.657
Barcelona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	4.676
Barcelona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	2.554
Barcelona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	2.121
Barcelona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1.311
Barcelona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	595
Barcelona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	716
Barcelona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	8.373
Barcelona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	4.009
Barcelona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	4.364
Barcelona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	8.429
Barcelona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	3.301
Barcelona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	5.129
Barcelona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	48.715
Barcelona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	22.237
Barcelona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	26.478
Barcelona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	5.727
Barcelona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.701
Barcelona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	4.026
Barcelona	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	4.668
Barcelona	Group 1402 Renal failure  5836-5837, 584-586	Men	2.644
Barcelona	Group 1402 Renal failure  5836-5837, 584-586	Women	2.024
Barcelona	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	5.891
Barcelona	Group 1403 Urolithiasis  592, 594, 7880	Men	3.510
Barcelona	Group 1403 Urolithiasis  592, 594, 7880	Women	2.381
Barcelona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	11.840
Barcelona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	5.619
Barcelona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	6.221
Barcelona	Group 1405 Prostatic hyperplasia  600	Both sexes	4.309
Barcelona	Group 1405 Prostatic hyperplasia  600	Men	4.309
Barcelona	Group 1405 Prostatic hyperplasia  600	Women	..
Barcelona	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	4.090
Barcelona	Group 1406 Other diseases of the male genital organs    601-608	Men	4.090
Barcelona	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Barcelona	Group 1407 Disorders of breast  610-612	Both sexes	4.449
Barcelona	Group 1407 Disorders of breast  610-612	Men	213
Barcelona	Group 1407 Disorders of breast  610-612	Women	4.236
Barcelona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	931
Barcelona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Barcelona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	931
Barcelona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	299
Barcelona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Barcelona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	299
Barcelona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	6.512
Barcelona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	151
Barcelona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	6.361
Barcelona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	59.225
Barcelona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Barcelona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	59.225
Barcelona	Group 1501 Legally induced abortion  635	Both sexes	488
Barcelona	Group 1501 Legally induced abortion  635	Men	..
Barcelona	Group 1501 Legally induced abortion  635	Women	488
Barcelona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.883
Barcelona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Barcelona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.883
Barcelona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	30.488
Barcelona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Barcelona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	30.488
Barcelona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	14.834
Barcelona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Barcelona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	14.834
Barcelona	Group 1505 Single spontaneous delivery  650	Both sexes	3.937
Barcelona	Group 1505 Single spontaneous delivery  650	Men	..
Barcelona	Group 1505 Single spontaneous delivery  650	Women	3.937
Barcelona	Group 1506 Other deliveries  6695-6697	Both sexes	1.828
Barcelona	Group 1506 Other deliveries  6695-6697	Men	..
Barcelona	Group 1506 Other deliveries  6695-6697	Women	1.828
Barcelona	Group 1507 Complications related to the puerperium  670-676	Both sexes	614
Barcelona	Group 1507 Complications related to the puerperium  670-676	Men	..
Barcelona	Group 1507 Complications related to the puerperium  670-676	Women	614
Barcelona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	5.152
Barcelona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Barcelona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	5.152
Barcelona	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	8.949
Barcelona	Group 1600 Some disorders originating in the perinatal period  760-779	Men	4.793
Barcelona	Group 1600 Some disorders originating in the perinatal period  760-779	Women	4.156
Barcelona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	2.876
Barcelona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.486
Barcelona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.390
Barcelona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	6.073
Barcelona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	3.306
Barcelona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	2.766
Barcelona	Grupo 1700 Congenital abnormalities  740-759	Both sexes	6.032
Barcelona	Grupo 1700 Congenital abnormalities  740-759	Men	3.242
Barcelona	Grupo 1700 Congenital abnormalities  740-759	Women	2.791
Barcelona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	21.931
Barcelona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	11.948
Barcelona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	9.983
Barcelona	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.227
Barcelona	Group 1801 Pain in throat and chest 7841, 7865	Men	1.283
Barcelona	Group 1801 Pain in throat and chest 7841, 7865	Women	943
Barcelona	Group 1802 Abdominal pain   7890	Both sexes	2.520
Barcelona	Group 1802 Abdominal pain   7890	Men	978
Barcelona	Group 1802 Abdominal pain   7890	Women	1.543
Barcelona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	759
Barcelona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	383
Barcelona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	376
Barcelona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	16.425
Barcelona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	9.304
Barcelona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	7.121
Barcelona	Group 1900 Injuries and poisoning  800-999	Both sexes	60.036
Barcelona	Group 1900 Injuries and poisoning  800-999	Men	28.805
Barcelona	Group 1900 Injuries and poisoning  800-999	Women	31.230
Barcelona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	3.588
Barcelona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.915
Barcelona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.673
Barcelona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.239
Barcelona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	809
Barcelona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	429
Barcelona	Group 1903 Radius and ulna fracture 813	Both sexes	3.111
Barcelona	Group 1903 Radius and ulna fracture 813	Men	1.433
Barcelona	Group 1903 Radius and ulna fracture 813	Women	1.677
Barcelona	Group 1904 Femur fracture  820-821	Both sexes	11.515
Barcelona	Group 1904 Femur fracture  820-821	Men	3.222
Barcelona	Group 1904 Femur fracture  820-821	Women	8.294
Barcelona	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	3.939
Barcelona	Group 1905 Leg fracture, including the ankle 823-824	Men	1.879
Barcelona	Group 1905 Leg fracture, including the ankle 823-824	Women	2.060
Barcelona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	16.847
Barcelona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	9.333
Barcelona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	7.514
Barcelona	Group 1907 Burns  940-949	Both sexes	560
Barcelona	Group 1907 Burns  940-949	Men	353
Barcelona	Group 1907 Burns  940-949	Women	207
Barcelona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.719
Barcelona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	744
Barcelona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	974
Barcelona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	15.981
Barcelona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	8.259
Barcelona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	7.722
Barcelona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	169
Barcelona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	107
Barcelona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	62
Barcelona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.368
Barcelona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	751
Barcelona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	618
Barcelona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	13.457
Barcelona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	6.884
Barcelona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	6.573
Barcelona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	315
Barcelona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	195
Barcelona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	120
Barcelona	Group 2102 Contraceptive management  V25	Both sexes	166
Barcelona	Group 2102 Contraceptive management  V25	Men	14
Barcelona	Group 2102 Contraceptive management  V25	Women	152
Barcelona	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Barcelona	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Barcelona	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Barcelona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	3.444
Barcelona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2.106
Barcelona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.338
Barcelona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	9.532
Barcelona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	4.568
Barcelona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	4.964
Girona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	68.245
Girona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	32.219
Girona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	36.026
Girona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.176
Girona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	667
Girona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	509
Girona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	139
Girona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	82
Girona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	57
Girona	Group 0102 Imprecise intestinal infections 009	Both sexes	247
Girona	Group 0102 Imprecise intestinal infections 009	Men	126
Girona	Group 0102 Imprecise intestinal infections 009	Women	121
Girona	Group 0103 Tuberculosis 010-018, 137	Both sexes	73
Girona	Group 0103 Tuberculosis 010-018, 137	Men	49
Girona	Group 0103 Tuberculosis 010-018, 137	Women	24
Girona	Group 0104 Septicaemia  038	Both sexes	342
Girona	Group 0104 Septicaemia  038	Men	196
Girona	Group 0104 Septicaemia  038	Women	146
Girona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	21
Girona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	17
Girona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	4
Girona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	355
Girona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	198
Girona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	156
Girona	Group 0200 Neoplasms  140-239	Both sexes	5.914
Girona	Group 0200 Neoplasms  140-239	Men	3.177
Girona	Group 0200 Neoplasms  140-239	Women	2.737
Girona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	724
Girona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	438
Girona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	286
Girona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	489
Girona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	372
Girona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	118
Girona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	113
Girona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	69
Girona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	43
Girona	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	500
Girona	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Girona	Group 0204 Malignant neoplasm of breast  174-175	Women	497
Girona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	106
Girona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Girona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	106
Girona	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	51
Girona	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Girona	Group 0206 Malignant neoplasm of ovary  1830	Women	51
Girona	Group 0207 Malignant neoplasm of prostate  185	Both sexes	184
Girona	Group 0207 Malignant neoplasm of prostate  185	Men	184
Girona	Group 0207 Malignant neoplasm of prostate  185	Women	..
Girona	Group 0208 Malignant neoplasm of bladder  188	Both sexes	626
Girona	Group 0208 Malignant neoplasm of bladder  188	Men	519
Girona	Group 0208 Malignant neoplasm of bladder  188	Women	108
Girona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.089
Girona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.271
Girona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	818
Girona	Group 0210 Carcinoma in situ  230-234	Both sexes	49
Girona	Group 0210 Carcinoma in situ  230-234	Men	9
Girona	Group 0210 Carcinoma in situ  230-234	Women	39
Girona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	40
Girona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	25
Girona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	16
Girona	Grupo 0212 Leiomyoma of uterus  218	Both sexes	266
Girona	Grupo 0212 Leiomyoma of uterus  218	Men	..
Girona	Grupo 0212 Leiomyoma of uterus  218	Women	266
Girona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	675
Girona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	286
Girona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	389
Girona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	517
Girona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	251
Girona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	265
Girona	Group 0301 Anaemias 280-285	Both sexes	307
Girona	Group 0301 Anaemias 280-285	Men	143
Girona	Group 0301 Anaemias 280-285	Women	164
Girona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	210
Girona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	109
Girona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	101
Girona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	895
Girona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	365
Girona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	530
Girona	Group 0401 Diabetes mellitus  249-250	Both sexes	311
Girona	Group 0401 Diabetes mellitus  249-250	Men	175
Girona	Group 0401 Diabetes mellitus  249-250	Women	136
Girona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	584
Girona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	189
Girona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	395
Girona	Group 0500 Mental disorders  290-319	Both sexes	1.839
Girona	Group 0500 Mental disorders  290-319	Men	1.031
Girona	Group 0500 Mental disorders  290-319	Women	808
Girona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	107
Girona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	49
Girona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	57
Girona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	96
Girona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	77
Girona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	19
Girona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	80
Girona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	62
Girona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	18
Girona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	764
Girona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	505
Girona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	259
Girona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	378
Girona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	161
Girona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	216
Girona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	415
Girona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	177
Girona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	238
Girona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.260
Girona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	629
Girona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	631
Girona	Group 0601 Alzheimer's disease  3310	Both sexes	115
Girona	Group 0601 Alzheimer's disease  3310	Men	47
Girona	Group 0601 Alzheimer's disease  3310	Women	67
Girona	Group 0602 Multiple sclerosis 340	Both sexes	11
Girona	Group 0602 Multiple sclerosis 340	Men	6
Girona	Group 0602 Multiple sclerosis 340	Women	5
Girona	Group 0603 Epilepsy  345	Both sexes	214
Girona	Group 0603 Epilepsy  345	Men	131
Girona	Group 0603 Epilepsy  345	Women	84
Girona	Group 0604 Transient cerebral ischemia 435	Both sexes	133
Girona	Group 0604 Transient cerebral ischemia 435	Men	76
Girona	Group 0604 Transient cerebral ischemia 435	Women	57
Girona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	787
Girona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	369
Girona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	418
Girona	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	717
Girona	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	339
Girona	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	379
Girona	Grupo 0701 Cataract  366	Both sexes	450
Girona	Grupo 0701 Cataract  366	Men	201
Girona	Grupo 0701 Cataract  366	Women	248
Girona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	268
Girona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	137
Girona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	131
Girona	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	271
Girona	Group 0800 Diseases of the ear and the mastoid  380-389	Men	133
Girona	Group 0800 Diseases of the ear and the mastoid  380-389	Women	138
Girona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	8.565
Girona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.761
Girona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.804
Girona	Group 0901 Hypertensive disease  401-405	Both sexes	130
Girona	Group 0901 Hypertensive disease  401-405	Men	55
Girona	Group 0901 Hypertensive disease  401-405	Women	75
Girona	Group 0902 Angina pectoris  4111, 413	Both sexes	353
Girona	Group 0902 Angina pectoris  4111, 413	Men	223
Girona	Group 0902 Angina pectoris  4111, 413	Women	130
Girona	Group 0903 Acute myocardial infarction  410	Both sexes	909
Girona	Group 0903 Acute myocardial infarction  410	Men	660
Girona	Group 0903 Acute myocardial infarction  410	Women	249
Girona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	422
Girona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	300
Girona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	122
Girona	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	277
Girona	Group 0905 Diseases of the lungs circulation 415-417	Men	133
Girona	Group 0905 Diseases of the lungs circulation 415-417	Women	143
Girona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.043
Girona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	548
Girona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	495
Girona	Grupo 0907 Heart failure  428	Both sexes	1.858
Girona	Grupo 0907 Heart failure  428	Men	923
Girona	Grupo 0907 Heart failure  428	Women	935
Girona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.609
Girona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	866
Girona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	743
Girona	Grupo 0909 Atherosclerosis  440	Both sexes	367
Girona	Grupo 0909 Atherosclerosis  440	Men	231
Girona	Grupo 0909 Atherosclerosis  440	Women	136
Girona	Group 0910 Varicose veins of lower extremities 454	Both sexes	345
Girona	Group 0910 Varicose veins of lower extremities 454	Men	126
Girona	Group 0910 Varicose veins of lower extremities 454	Women	219
Girona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.251
Girona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	695
Girona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	556
Girona	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.858
Girona	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.576
Girona	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.282
Girona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	201
Girona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	119
Girona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	82
Girona	Group 1002 Pneumonia 480-486	Both sexes	1.622
Girona	Group 1002 Pneumonia 480-486	Men	964
Girona	Group 1002 Pneumonia 480-486	Women	658
Girona	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.253
Girona	Group 1003 Acute bronchitis and bronchiolitis  466	Men	609
Girona	Group 1003 Acute bronchitis and bronchiolitis  466	Women	644
Girona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	572
Girona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	312
Girona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	261
Girona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	606
Girona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	382
Girona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	224
Girona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.319
Girona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	982
Girona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	337
Girona	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	331
Girona	Group 1007 Asthma 4930-4931,4938-4939	Men	126
Girona	Group 1007 Asthma 4930-4931,4938-4939	Women	205
Girona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.954
Girona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.083
Girona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	871
Girona	Group 1100 Diseases of the digestive system  520-579	Both sexes	7.924
Girona	Group 1100 Diseases of the digestive system  520-579	Men	4.559
Girona	Group 1100 Diseases of the digestive system  520-579	Women	3.365
Girona	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	34
Girona	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	23
Girona	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	11
Girona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	74
Girona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	43
Girona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	31
Girona	Group 1103 Diseases of the esophagus 530	Both sexes	97
Girona	Group 1103 Diseases of the esophagus 530	Men	65
Girona	Group 1103 Diseases of the esophagus 530	Women	32
Girona	Group 1104 Peptic ulcer 531-534	Both sexes	131
Girona	Group 1104 Peptic ulcer 531-534	Men	105
Girona	Group 1104 Peptic ulcer 531-534	Women	26
Girona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	144
Girona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	78
Girona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	66
Girona	Group 1106 Appendicitis  540-543	Both sexes	706
Girona	Group 1106 Appendicitis  540-543	Men	431
Girona	Group 1106 Appendicitis  540-543	Women	275
Girona	Group 1107 Inguinal hernia  550	Both sexes	1.008
Girona	Group 1107 Inguinal hernia  550	Men	874
Girona	Group 1107 Inguinal hernia  550	Women	134
Girona	Group 1108 Other abdominal hernia  551-553	Both sexes	751
Girona	Group 1108 Other abdominal hernia  551-553	Men	357
Girona	Group 1108 Other abdominal hernia  551-553	Women	393
Girona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	97
Girona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	45
Girona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	53
Girona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	361
Girona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	171
Girona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	190
Girona	Group 1111 Intestinal obstruction without hernia 560	Both sexes	372
Girona	Group 1111 Intestinal obstruction without hernia 560	Men	189
Girona	Group 1111 Intestinal obstruction without hernia 560	Women	183
Girona	Group 1112 Intestinal diverticulosis 562	Both sexes	290
Girona	Group 1112 Intestinal diverticulosis 562	Men	152
Girona	Group 1112 Intestinal diverticulosis 562	Women	138
Girona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	500
Girona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	306
Girona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	194
Girona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	215
Girona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	98
Girona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	117
Girona	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	116
Girona	Group 1115 Alcoholic hepatitis 5710-5713	Men	93
Girona	Group 1115 Alcoholic hepatitis 5710-5713	Women	23
Girona	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	233
Girona	Group 1116 Other diseases of the liver 570,5714-573	Men	153
Girona	Group 1116 Other diseases of the liver 570,5714-573	Women	80
Girona	Group 1117 Cholelithiasis  574	Both sexes	1.583
Girona	Group 1117 Cholelithiasis  574	Men	702
Girona	Group 1117 Cholelithiasis  574	Women	881
Girona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	462
Girona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	246
Girona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	217
Girona	Group 1119 Pancreatic diseases 577	Both sexes	429
Girona	Group 1119 Pancreatic diseases 577	Men	256
Girona	Group 1119 Pancreatic diseases 577	Women	172
Girona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	320
Girona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	172
Girona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	148
Girona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	821
Girona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	455
Girona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	367
Girona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	585
Girona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	347
Girona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	237
Girona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	9
Girona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	6
Girona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	3
Girona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	227
Girona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	101
Girona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	126
Girona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.977
Girona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.728
Girona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.250
Girona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Girona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Girona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Girona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Girona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Girona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Girona	Group 1303 Internal derangement of knee 717	Both sexes	532
Girona	Group 1303 Internal derangement of knee 717	Men	313
Girona	Group 1303 Internal derangement of knee 717	Women	219
Girona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.512
Girona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.101
Girona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.411
Girona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	61
Girona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	25
Girona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	36
Girona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	180
Girona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	83
Girona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	97
Girona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	346
Girona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	175
Girona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	170
Girona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	250
Girona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	105
Girona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	145
Girona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.171
Girona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	570
Girona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	601
Girona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	926
Girona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	356
Girona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	570
Girona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.736
Girona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.233
Girona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.503
Girona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	673
Girona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	234
Girona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	439
Girona	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	472
Girona	Group 1402 Renal failure  5836-5837, 584-586	Men	276
Girona	Group 1402 Renal failure  5836-5837, 584-586	Women	196
Girona	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	528
Girona	Group 1403 Urolithiasis  592, 594, 7880	Men	335
Girona	Group 1403 Urolithiasis  592, 594, 7880	Women	193
Girona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.045
Girona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	577
Girona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	468
Girona	Group 1405 Prostatic hyperplasia  600	Both sexes	378
Girona	Group 1405 Prostatic hyperplasia  600	Men	378
Girona	Group 1405 Prostatic hyperplasia  600	Women	..
Girona	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	394
Girona	Group 1406 Other diseases of the male genital organs    601-608	Men	394
Girona	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Girona	Group 1407 Disorders of breast  610-612	Both sexes	279
Girona	Group 1407 Disorders of breast  610-612	Men	25
Girona	Group 1407 Disorders of breast  610-612	Women	254
Girona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	108
Girona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Girona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	108
Girona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	49
Girona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Girona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	49
Girona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	809
Girona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	13
Girona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	795
Girona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.389
Girona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Girona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.389
Girona	Group 1501 Legally induced abortion  635	Both sexes	57
Girona	Group 1501 Legally induced abortion  635	Men	..
Girona	Group 1501 Legally induced abortion  635	Women	57
Girona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	288
Girona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Girona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	288
Girona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.617
Girona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Girona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.617
Girona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.596
Girona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Girona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.596
Girona	Group 1505 Single spontaneous delivery  650	Both sexes	939
Girona	Group 1505 Single spontaneous delivery  650	Men	..
Girona	Group 1505 Single spontaneous delivery  650	Women	939
Girona	Group 1506 Other deliveries  6695-6697	Both sexes	186
Girona	Group 1506 Other deliveries  6695-6697	Men	..
Girona	Group 1506 Other deliveries  6695-6697	Women	186
Girona	Group 1507 Complications related to the puerperium  670-676	Both sexes	75
Girona	Group 1507 Complications related to the puerperium  670-676	Men	..
Girona	Group 1507 Complications related to the puerperium  670-676	Women	75
Girona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	632
Girona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Girona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	632
Girona	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	893
Girona	Group 1600 Some disorders originating in the perinatal period  760-779	Men	520
Girona	Group 1600 Some disorders originating in the perinatal period  760-779	Women	373
Girona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	291
Girona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	163
Girona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	128
Girona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	602
Girona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	357
Girona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	245
Girona	Grupo 1700 Congenital abnormalities  740-759	Both sexes	317
Girona	Grupo 1700 Congenital abnormalities  740-759	Men	193
Girona	Grupo 1700 Congenital abnormalities  740-759	Women	123
Girona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.542
Girona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.437
Girona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.105
Girona	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	239
Girona	Group 1801 Pain in throat and chest 7841, 7865	Men	138
Girona	Group 1801 Pain in throat and chest 7841, 7865	Women	101
Girona	Group 1802 Abdominal pain   7890	Both sexes	373
Girona	Group 1802 Abdominal pain   7890	Men	167
Girona	Group 1802 Abdominal pain   7890	Women	206
Girona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	58
Girona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	27
Girona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	31
Girona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.873
Girona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.105
Girona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	768
Girona	Group 1900 Injuries and poisoning  800-999	Both sexes	7.492
Girona	Group 1900 Injuries and poisoning  800-999	Men	3.548
Girona	Group 1900 Injuries and poisoning  800-999	Women	3.944
Girona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	438
Girona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	257
Girona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	181
Girona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	127
Girona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	83
Girona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	44
Girona	Group 1903 Radius and ulna fracture 813	Both sexes	518
Girona	Group 1903 Radius and ulna fracture 813	Men	244
Girona	Group 1903 Radius and ulna fracture 813	Women	274
Girona	Group 1904 Femur fracture  820-821	Both sexes	1.755
Girona	Group 1904 Femur fracture  820-821	Men	498
Girona	Group 1904 Femur fracture  820-821	Women	1.257
Girona	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	581
Girona	Group 1905 Leg fracture, including the ankle 823-824	Men	307
Girona	Group 1905 Leg fracture, including the ankle 823-824	Women	274
Girona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.350
Girona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.312
Girona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.038
Girona	Group 1907 Burns  940-949	Both sexes	18
Girona	Group 1907 Burns  940-949	Men	10
Girona	Group 1907 Burns  940-949	Women	7
Girona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	197
Girona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	73
Girona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	123
Girona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.359
Girona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	678
Girona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	681
Girona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	22
Girona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	9
Girona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	12
Girona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	128
Girona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	76
Girona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	53
Girona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.142
Girona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	618
Girona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	524
Girona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	8
Girona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	3
Girona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
Girona	Group 2102 Contraceptive management  V25	Both sexes	21
Girona	Group 2102 Contraceptive management  V25	Men	2
Girona	Group 2102 Contraceptive management  V25	Women	19
Girona	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Girona	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Girona	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Girona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	236
Girona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	155
Girona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	81
Girona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	877
Girona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	458
Girona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	419
Lleida	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	38.298
Lleida	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.210
Lleida	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	20.088
Lleida	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	626
Lleida	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	372
Lleida	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	254
Lleida	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	122
Lleida	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	62
Lleida	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	60
Lleida	Group 0102 Imprecise intestinal infections 009	Both sexes	98
Lleida	Group 0102 Imprecise intestinal infections 009	Men	57
Lleida	Group 0102 Imprecise intestinal infections 009	Women	41
Lleida	Group 0103 Tuberculosis 010-018, 137	Both sexes	51
Lleida	Group 0103 Tuberculosis 010-018, 137	Men	35
Lleida	Group 0103 Tuberculosis 010-018, 137	Women	16
Lleida	Group 0104 Septicaemia  038	Both sexes	128
Lleida	Group 0104 Septicaemia  038	Men	79
Lleida	Group 0104 Septicaemia  038	Women	49
Lleida	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	33
Lleida	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	24
Lleida	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	9
Lleida	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	194
Lleida	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	115
Lleida	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	79
Lleida	Group 0200 Neoplasms  140-239	Both sexes	3.551
Lleida	Group 0200 Neoplasms  140-239	Men	1.972
Lleida	Group 0200 Neoplasms  140-239	Women	1.579
Lleida	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	473
Lleida	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	268
Lleida	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	205
Lleida	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	278
Lleida	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	209
Lleida	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	69
Lleida	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	23
Lleida	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	11
Lleida	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	12
Lleida	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	215
Lleida	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Lleida	Group 0204 Malignant neoplasm of breast  174-175	Women	211
Lleida	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	73
Lleida	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Lleida	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	73
Lleida	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	28
Lleida	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Lleida	Group 0206 Malignant neoplasm of ovary  1830	Women	28
Lleida	Group 0207 Malignant neoplasm of prostate  185	Both sexes	143
Lleida	Group 0207 Malignant neoplasm of prostate  185	Men	143
Lleida	Group 0207 Malignant neoplasm of prostate  185	Women	..
Lleida	Group 0208 Malignant neoplasm of bladder  188	Both sexes	467
Lleida	Group 0208 Malignant neoplasm of bladder  188	Men	398
Lleida	Group 0208 Malignant neoplasm of bladder  188	Women	69
Lleida	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.222
Lleida	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	710
Lleida	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	512
Lleida	Group 0210 Carcinoma in situ  230-234	Both sexes	30
Lleida	Group 0210 Carcinoma in situ  230-234	Men	16
Lleida	Group 0210 Carcinoma in situ  230-234	Women	14
Lleida	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	76
Lleida	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	47
Lleida	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	29
Lleida	Grupo 0212 Leiomyoma of uterus  218	Both sexes	146
Lleida	Grupo 0212 Leiomyoma of uterus  218	Men	..
Lleida	Grupo 0212 Leiomyoma of uterus  218	Women	146
Lleida	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	377
Lleida	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	166
Lleida	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	211
Lleida	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	268
Lleida	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	152
Lleida	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	116
Lleida	Group 0301 Anaemias 280-285	Both sexes	156
Lleida	Group 0301 Anaemias 280-285	Men	83
Lleida	Group 0301 Anaemias 280-285	Women	73
Lleida	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	112
Lleida	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	69
Lleida	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	43
Lleida	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	458
Lleida	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	209
Lleida	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	249
Lleida	Group 0401 Diabetes mellitus  249-250	Both sexes	177
Lleida	Group 0401 Diabetes mellitus  249-250	Men	103
Lleida	Group 0401 Diabetes mellitus  249-250	Women	74
Lleida	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	281
Lleida	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	106
Lleida	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	175
Lleida	Group 0500 Mental disorders  290-319	Both sexes	1.997
Lleida	Group 0500 Mental disorders  290-319	Men	1.035
Lleida	Group 0500 Mental disorders  290-319	Women	962
Lleida	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	95
Lleida	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	44
Lleida	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	51
Lleida	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	84
Lleida	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	59
Lleida	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	25
Lleida	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	140
Lleida	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	98
Lleida	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	42
Lleida	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	635
Lleida	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	405
Lleida	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	230
Lleida	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	470
Lleida	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	174
Lleida	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	296
Lleida	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	573
Lleida	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	255
Lleida	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	318
Lleida	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	646
Lleida	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	289
Lleida	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	357
Lleida	Group 0601 Alzheimer's disease  3310	Both sexes	78
Lleida	Group 0601 Alzheimer's disease  3310	Men	24
Lleida	Group 0601 Alzheimer's disease  3310	Women	54
Lleida	Group 0602 Multiple sclerosis 340	Both sexes	9
Lleida	Group 0602 Multiple sclerosis 340	Men	4
Lleida	Group 0602 Multiple sclerosis 340	Women	5
Lleida	Group 0603 Epilepsy  345	Both sexes	61
Lleida	Group 0603 Epilepsy  345	Men	35
Lleida	Group 0603 Epilepsy  345	Women	26
Lleida	Group 0604 Transient cerebral ischemia 435	Both sexes	115
Lleida	Group 0604 Transient cerebral ischemia 435	Men	56
Lleida	Group 0604 Transient cerebral ischemia 435	Women	59
Lleida	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	383
Lleida	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	170
Lleida	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	213
Lleida	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	127
Lleida	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	63
Lleida	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	64
Lleida	Grupo 0701 Cataract  366	Both sexes	32
Lleida	Grupo 0701 Cataract  366	Men	19
Lleida	Grupo 0701 Cataract  366	Women	13
Lleida	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	95
Lleida	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	44
Lleida	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	51
Lleida	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	109
Lleida	Group 0800 Diseases of the ear and the mastoid  380-389	Men	47
Lleida	Group 0800 Diseases of the ear and the mastoid  380-389	Women	62
Lleida	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.763
Lleida	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.639
Lleida	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.124
Lleida	Group 0901 Hypertensive disease  401-405	Both sexes	103
Lleida	Group 0901 Hypertensive disease  401-405	Men	51
Lleida	Group 0901 Hypertensive disease  401-405	Women	52
Lleida	Group 0902 Angina pectoris  4111, 413	Both sexes	209
Lleida	Group 0902 Angina pectoris  4111, 413	Men	144
Lleida	Group 0902 Angina pectoris  4111, 413	Women	65
Lleida	Group 0903 Acute myocardial infarction  410	Both sexes	336
Lleida	Group 0903 Acute myocardial infarction  410	Men	256
Lleida	Group 0903 Acute myocardial infarction  410	Women	80
Lleida	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	226
Lleida	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	171
Lleida	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	55
Lleida	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	154
Lleida	Group 0905 Diseases of the lungs circulation 415-417	Men	60
Lleida	Group 0905 Diseases of the lungs circulation 415-417	Women	94
Lleida	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	600
Lleida	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	293
Lleida	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	307
Lleida	Grupo 0907 Heart failure  428	Both sexes	1.346
Lleida	Grupo 0907 Heart failure  428	Men	646
Lleida	Grupo 0907 Heart failure  428	Women	700
Lleida	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.023
Lleida	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	573
Lleida	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	450
Lleida	Grupo 0909 Atherosclerosis  440	Both sexes	217
Lleida	Grupo 0909 Atherosclerosis  440	Men	148
Lleida	Grupo 0909 Atherosclerosis  440	Women	69
Lleida	Group 0910 Varicose veins of lower extremities 454	Both sexes	35
Lleida	Group 0910 Varicose veins of lower extremities 454	Men	10
Lleida	Group 0910 Varicose veins of lower extremities 454	Women	25
Lleida	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	514
Lleida	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	287
Lleida	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	227
Lleida	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.922
Lleida	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.861
Lleida	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.061
Lleida	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	109
Lleida	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	63
Lleida	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	46
Lleida	Group 1002 Pneumonia 480-486	Both sexes	953
Lleida	Group 1002 Pneumonia 480-486	Men	567
Lleida	Group 1002 Pneumonia 480-486	Women	386
Lleida	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	905
Lleida	Group 1003 Acute bronchitis and bronchiolitis  466	Men	418
Lleida	Group 1003 Acute bronchitis and bronchiolitis  466	Women	487
Lleida	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	210
Lleida	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	111
Lleida	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	99
Lleida	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	249
Lleida	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	152
Lleida	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	97
Lleida	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.124
Lleida	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	796
Lleida	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	328
Lleida	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	127
Lleida	Group 1007 Asthma 4930-4931,4938-4939	Men	41
Lleida	Group 1007 Asthma 4930-4931,4938-4939	Women	86
Lleida	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.245
Lleida	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	713
Lleida	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	532
Lleida	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.724
Lleida	Group 1100 Diseases of the digestive system  520-579	Men	2.621
Lleida	Group 1100 Diseases of the digestive system  520-579	Women	2.103
Lleida	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	66
Lleida	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	34
Lleida	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	32
Lleida	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	54
Lleida	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	40
Lleida	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	14
Lleida	Group 1103 Diseases of the esophagus 530	Both sexes	61
Lleida	Group 1103 Diseases of the esophagus 530	Men	38
Lleida	Group 1103 Diseases of the esophagus 530	Women	23
Lleida	Group 1104 Peptic ulcer 531-534	Both sexes	91
Lleida	Group 1104 Peptic ulcer 531-534	Men	74
Lleida	Group 1104 Peptic ulcer 531-534	Women	17
Lleida	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	96
Lleida	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	47
Lleida	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	49
Lleida	Group 1106 Appendicitis  540-543	Both sexes	385
Lleida	Group 1106 Appendicitis  540-543	Men	208
Lleida	Group 1106 Appendicitis  540-543	Women	177
Lleida	Group 1107 Inguinal hernia  550	Both sexes	364
Lleida	Group 1107 Inguinal hernia  550	Men	330
Lleida	Group 1107 Inguinal hernia  550	Women	34
Lleida	Group 1108 Other abdominal hernia  551-553	Both sexes	328
Lleida	Group 1108 Other abdominal hernia  551-553	Men	135
Lleida	Group 1108 Other abdominal hernia  551-553	Women	193
Lleida	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	61
Lleida	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	32
Lleida	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	29
Lleida	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	246
Lleida	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	117
Lleida	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	129
Lleida	Group 1111 Intestinal obstruction without hernia 560	Both sexes	247
Lleida	Group 1111 Intestinal obstruction without hernia 560	Men	128
Lleida	Group 1111 Intestinal obstruction without hernia 560	Women	119
Lleida	Group 1112 Intestinal diverticulosis 562	Both sexes	186
Lleida	Group 1112 Intestinal diverticulosis 562	Men	85
Lleida	Group 1112 Intestinal diverticulosis 562	Women	101
Lleida	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	215
Lleida	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	140
Lleida	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	75
Lleida	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	161
Lleida	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	84
Lleida	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	77
Lleida	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	141
Lleida	Group 1115 Alcoholic hepatitis 5710-5713	Men	121
Lleida	Group 1115 Alcoholic hepatitis 5710-5713	Women	20
Lleida	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	171
Lleida	Group 1116 Other diseases of the liver 570,5714-573	Men	101
Lleida	Group 1116 Other diseases of the liver 570,5714-573	Women	70
Lleida	Group 1117 Cholelithiasis  574	Both sexes	1.103
Lleida	Group 1117 Cholelithiasis  574	Men	479
Lleida	Group 1117 Cholelithiasis  574	Women	624
Lleida	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	318
Lleida	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	170
Lleida	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	148
Lleida	Group 1119 Pancreatic diseases 577	Both sexes	235
Lleida	Group 1119 Pancreatic diseases 577	Men	134
Lleida	Group 1119 Pancreatic diseases 577	Women	101
Lleida	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	195
Lleida	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	124
Lleida	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	71
Lleida	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	302
Lleida	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	174
Lleida	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	128
Lleida	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	187
Lleida	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	126
Lleida	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	61
Lleida	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	9
Lleida	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	5
Lleida	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	4
Lleida	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	106
Lleida	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	43
Lleida	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	63
Lleida	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.351
Lleida	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.061
Lleida	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.290
Lleida	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Lleida	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Lleida	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Lleida	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Lleida	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Lleida	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Lleida	Group 1303 Internal derangement of knee 717	Both sexes	165
Lleida	Group 1303 Internal derangement of knee 717	Men	97
Lleida	Group 1303 Internal derangement of knee 717	Women	68
Lleida	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.108
Lleida	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	464
Lleida	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	644
Lleida	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	51
Lleida	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	24
Lleida	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	27
Lleida	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	101
Lleida	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	55
Lleida	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	46
Lleida	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	209
Lleida	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	102
Lleida	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	107
Lleida	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	86
Lleida	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	36
Lleida	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	50
Lleida	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	341
Lleida	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	166
Lleida	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	175
Lleida	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	290
Lleida	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	117
Lleida	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	173
Lleida	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.800
Lleida	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.425
Lleida	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.375
Lleida	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	360
Lleida	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	99
Lleida	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	261
Lleida	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	205
Lleida	Group 1402 Renal failure  5836-5837, 584-586	Men	124
Lleida	Group 1402 Renal failure  5836-5837, 584-586	Women	81
Lleida	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	471
Lleida	Group 1403 Urolithiasis  592, 594, 7880	Men	270
Lleida	Group 1403 Urolithiasis  592, 594, 7880	Women	201
Lleida	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	743
Lleida	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	416
Lleida	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	327
Lleida	Group 1405 Prostatic hyperplasia  600	Both sexes	341
Lleida	Group 1405 Prostatic hyperplasia  600	Men	341
Lleida	Group 1405 Prostatic hyperplasia  600	Women	..
Lleida	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	146
Lleida	Group 1406 Other diseases of the male genital organs    601-608	Men	146
Lleida	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Lleida	Group 1407 Disorders of breast  610-612	Both sexes	101
Lleida	Group 1407 Disorders of breast  610-612	Men	8
Lleida	Group 1407 Disorders of breast  610-612	Women	93
Lleida	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	60
Lleida	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Lleida	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	60
Lleida	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	35
Lleida	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Lleida	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	35
Lleida	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	338
Lleida	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	21
Lleida	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	317
Lleida	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	4.185
Lleida	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Lleida	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	4.185
Lleida	Group 1501 Legally induced abortion  635	Both sexes	33
Lleida	Group 1501 Legally induced abortion  635	Men	..
Lleida	Group 1501 Legally induced abortion  635	Women	33
Lleida	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	182
Lleida	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Lleida	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	182
Lleida	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.247
Lleida	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Lleida	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.247
Lleida	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	862
Lleida	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Lleida	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	862
Lleida	Group 1505 Single spontaneous delivery  650	Both sexes	373
Lleida	Group 1505 Single spontaneous delivery  650	Men	..
Lleida	Group 1505 Single spontaneous delivery  650	Women	373
Lleida	Group 1506 Other deliveries  6695-6697	Both sexes	68
Lleida	Group 1506 Other deliveries  6695-6697	Men	..
Lleida	Group 1506 Other deliveries  6695-6697	Women	68
Lleida	Group 1507 Complications related to the puerperium  670-676	Both sexes	60
Lleida	Group 1507 Complications related to the puerperium  670-676	Men	..
Lleida	Group 1507 Complications related to the puerperium  670-676	Women	60
Lleida	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	360
Lleida	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Lleida	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	360
Lleida	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	355
Lleida	Group 1600 Some disorders originating in the perinatal period  760-779	Men	208
Lleida	Group 1600 Some disorders originating in the perinatal period  760-779	Women	147
Lleida	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	86
Lleida	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	44
Lleida	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	42
Lleida	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	269
Lleida	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	164
Lleida	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	105
Lleida	Grupo 1700 Congenital abnormalities  740-759	Both sexes	71
Lleida	Grupo 1700 Congenital abnormalities  740-759	Men	33
Lleida	Grupo 1700 Congenital abnormalities  740-759	Women	38
Lleida	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.768
Lleida	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	977
Lleida	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	791
Lleida	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	149
Lleida	Group 1801 Pain in throat and chest 7841, 7865	Men	84
Lleida	Group 1801 Pain in throat and chest 7841, 7865	Women	65
Lleida	Group 1802 Abdominal pain   7890	Both sexes	254
Lleida	Group 1802 Abdominal pain   7890	Men	97
Lleida	Group 1802 Abdominal pain   7890	Women	157
Lleida	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	10
Lleida	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	3
Lleida	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	7
Lleida	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.355
Lleida	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	793
Lleida	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	562
Lleida	Group 1900 Injuries and poisoning  800-999	Both sexes	3.842
Lleida	Group 1900 Injuries and poisoning  800-999	Men	1.839
Lleida	Group 1900 Injuries and poisoning  800-999	Women	2.003
Lleida	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	358
Lleida	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	204
Lleida	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	154
Lleida	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	92
Lleida	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	66
Lleida	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	26
Lleida	Group 1903 Radius and ulna fracture 813	Both sexes	173
Lleida	Group 1903 Radius and ulna fracture 813	Men	95
Lleida	Group 1903 Radius and ulna fracture 813	Women	78
Lleida	Group 1904 Femur fracture  820-821	Both sexes	987
Lleida	Group 1904 Femur fracture  820-821	Men	281
Lleida	Group 1904 Femur fracture  820-821	Women	706
Lleida	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	224
Lleida	Group 1905 Leg fracture, including the ankle 823-824	Men	108
Lleida	Group 1905 Leg fracture, including the ankle 823-824	Women	116
Lleida	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.140
Lleida	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	656
Lleida	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	484
Lleida	Group 1907 Burns  940-949	Both sexes	13
Lleida	Group 1907 Burns  940-949	Men	6
Lleida	Group 1907 Burns  940-949	Women	7
Lleida	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	110
Lleida	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	50
Lleida	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	60
Lleida	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	656
Lleida	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	328
Lleida	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	328
Lleida	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Lleida	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Lleida	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Lleida	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	87
Lleida	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	43
Lleida	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	44
Lleida	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	433
Lleida	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	233
Lleida	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	200
Lleida	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	11
Lleida	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	8
Lleida	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	3
Lleida	Group 2102 Contraceptive management  V25	Both sexes	13
Lleida	Group 2102 Contraceptive management  V25	Men	1
Lleida	Group 2102 Contraceptive management  V25	Women	12
Lleida	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Lleida	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Lleida	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Lleida	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	174
Lleida	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	115
Lleida	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	59
Lleida	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	235
Lleida	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	109
Lleida	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	126
Tarragona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	79.208
Tarragona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	37.521
Tarragona	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	41.687
Tarragona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.190
Tarragona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	675
Tarragona	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	515
Tarragona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	203
Tarragona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	105
Tarragona	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	98
Tarragona	Group 0102 Imprecise intestinal infections 009	Both sexes	170
Tarragona	Group 0102 Imprecise intestinal infections 009	Men	90
Tarragona	Group 0102 Imprecise intestinal infections 009	Women	81
Tarragona	Group 0103 Tuberculosis 010-018, 137	Both sexes	60
Tarragona	Group 0103 Tuberculosis 010-018, 137	Men	38
Tarragona	Group 0103 Tuberculosis 010-018, 137	Women	22
Tarragona	Group 0104 Septicaemia  038	Both sexes	240
Tarragona	Group 0104 Septicaemia  038	Men	134
Tarragona	Group 0104 Septicaemia  038	Women	106
Tarragona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	83
Tarragona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	61
Tarragona	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	21
Tarragona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	434
Tarragona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	248
Tarragona	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	186
Tarragona	Group 0200 Neoplasms  140-239	Both sexes	7.225
Tarragona	Group 0200 Neoplasms  140-239	Men	4.135
Tarragona	Group 0200 Neoplasms  140-239	Women	3.091
Tarragona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	922
Tarragona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	604
Tarragona	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	318
Tarragona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	755
Tarragona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	601
Tarragona	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	153
Tarragona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	92
Tarragona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	66
Tarragona	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	27
Tarragona	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	514
Tarragona	Group 0204 Malignant neoplasm of breast  174-175	Men	4
Tarragona	Group 0204 Malignant neoplasm of breast  174-175	Women	509
Tarragona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	159
Tarragona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Tarragona	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	159
Tarragona	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	85
Tarragona	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Tarragona	Group 0206 Malignant neoplasm of ovary  1830	Women	85
Tarragona	Group 0207 Malignant neoplasm of prostate  185	Both sexes	230
Tarragona	Group 0207 Malignant neoplasm of prostate  185	Men	230
Tarragona	Group 0207 Malignant neoplasm of prostate  185	Women	..
Tarragona	Group 0208 Malignant neoplasm of bladder  188	Both sexes	992
Tarragona	Group 0208 Malignant neoplasm of bladder  188	Men	843
Tarragona	Group 0208 Malignant neoplasm of bladder  188	Women	149
Tarragona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.232
Tarragona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.358
Tarragona	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	874
Tarragona	Group 0210 Carcinoma in situ  230-234	Both sexes	65
Tarragona	Group 0210 Carcinoma in situ  230-234	Men	27
Tarragona	Group 0210 Carcinoma in situ  230-234	Women	39
Tarragona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	91
Tarragona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	64
Tarragona	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	27
Tarragona	Grupo 0212 Leiomyoma of uterus  218	Both sexes	360
Tarragona	Grupo 0212 Leiomyoma of uterus  218	Men	..
Tarragona	Grupo 0212 Leiomyoma of uterus  218	Women	360
Tarragona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	729
Tarragona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	338
Tarragona	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	391
Tarragona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	700
Tarragona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	348
Tarragona	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	352
Tarragona	Group 0301 Anaemias 280-285	Both sexes	504
Tarragona	Group 0301 Anaemias 280-285	Men	252
Tarragona	Group 0301 Anaemias 280-285	Women	252
Tarragona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	196
Tarragona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	96
Tarragona	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	100
Tarragona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.175
Tarragona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	480
Tarragona	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	695
Tarragona	Group 0401 Diabetes mellitus  249-250	Both sexes	402
Tarragona	Group 0401 Diabetes mellitus  249-250	Men	227
Tarragona	Group 0401 Diabetes mellitus  249-250	Women	175
Tarragona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	774
Tarragona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	254
Tarragona	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	520
Tarragona	Group 0500 Mental disorders  290-319	Both sexes	2.518
Tarragona	Group 0500 Mental disorders  290-319	Men	1.362
Tarragona	Group 0500 Mental disorders  290-319	Women	1.156
Tarragona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	190
Tarragona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	70
Tarragona	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	120
Tarragona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	132
Tarragona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	97
Tarragona	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	34
Tarragona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	97
Tarragona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	73
Tarragona	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	24
Tarragona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	664
Tarragona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	445
Tarragona	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	218
Tarragona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	480
Tarragona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	215
Tarragona	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	265
Tarragona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	955
Tarragona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	461
Tarragona	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	494
Tarragona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.191
Tarragona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	568
Tarragona	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	622
Tarragona	Group 0601 Alzheimer's disease  3310	Both sexes	87
Tarragona	Group 0601 Alzheimer's disease  3310	Men	26
Tarragona	Group 0601 Alzheimer's disease  3310	Women	61
Tarragona	Group 0602 Multiple sclerosis 340	Both sexes	31
Tarragona	Group 0602 Multiple sclerosis 340	Men	8
Tarragona	Group 0602 Multiple sclerosis 340	Women	23
Tarragona	Group 0603 Epilepsy  345	Both sexes	177
Tarragona	Group 0603 Epilepsy  345	Men	99
Tarragona	Group 0603 Epilepsy  345	Women	79
Tarragona	Group 0604 Transient cerebral ischemia 435	Both sexes	204
Tarragona	Group 0604 Transient cerebral ischemia 435	Men	108
Tarragona	Group 0604 Transient cerebral ischemia 435	Women	96
Tarragona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	691
Tarragona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	327
Tarragona	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	364
Tarragona	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	323
Tarragona	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	146
Tarragona	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	177
Tarragona	Grupo 0701 Cataract  366	Both sexes	188
Tarragona	Grupo 0701 Cataract  366	Men	78
Tarragona	Grupo 0701 Cataract  366	Women	110
Tarragona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	135
Tarragona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	68
Tarragona	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	67
Tarragona	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	443
Tarragona	Group 0800 Diseases of the ear and the mastoid  380-389	Men	210
Tarragona	Group 0800 Diseases of the ear and the mastoid  380-389	Women	233
Tarragona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	9.676
Tarragona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.474
Tarragona	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.201
Tarragona	Group 0901 Hypertensive disease  401-405	Both sexes	203
Tarragona	Group 0901 Hypertensive disease  401-405	Men	102
Tarragona	Group 0901 Hypertensive disease  401-405	Women	101
Tarragona	Group 0902 Angina pectoris  4111, 413	Both sexes	442
Tarragona	Group 0902 Angina pectoris  4111, 413	Men	291
Tarragona	Group 0902 Angina pectoris  4111, 413	Women	151
Tarragona	Group 0903 Acute myocardial infarction  410	Both sexes	1.073
Tarragona	Group 0903 Acute myocardial infarction  410	Men	769
Tarragona	Group 0903 Acute myocardial infarction  410	Women	305
Tarragona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	466
Tarragona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	349
Tarragona	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	117
Tarragona	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	293
Tarragona	Group 0905 Diseases of the lungs circulation 415-417	Men	146
Tarragona	Group 0905 Diseases of the lungs circulation 415-417	Women	147
Tarragona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.231
Tarragona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	672
Tarragona	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	559
Tarragona	Grupo 0907 Heart failure  428	Both sexes	2.396
Tarragona	Grupo 0907 Heart failure  428	Men	1.148
Tarragona	Grupo 0907 Heart failure  428	Women	1.248
Tarragona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.840
Tarragona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	975
Tarragona	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	864
Tarragona	Grupo 0909 Atherosclerosis  440	Both sexes	343
Tarragona	Grupo 0909 Atherosclerosis  440	Men	265
Tarragona	Grupo 0909 Atherosclerosis  440	Women	78
Tarragona	Group 0910 Varicose veins of lower extremities 454	Both sexes	240
Tarragona	Group 0910 Varicose veins of lower extremities 454	Men	98
Tarragona	Group 0910 Varicose veins of lower extremities 454	Women	142
Tarragona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.148
Tarragona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	660
Tarragona	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	489
Tarragona	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	10.259
Tarragona	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.835
Tarragona	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.424
Tarragona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	489
Tarragona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	264
Tarragona	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	224
Tarragona	Group 1002 Pneumonia 480-486	Both sexes	2.376
Tarragona	Group 1002 Pneumonia 480-486	Men	1.419
Tarragona	Group 1002 Pneumonia 480-486	Women	957
Tarragona	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.117
Tarragona	Group 1003 Acute bronchitis and bronchiolitis  466	Men	997
Tarragona	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.120
Tarragona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	459
Tarragona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	234
Tarragona	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	225
Tarragona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	671
Tarragona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	408
Tarragona	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	263
Tarragona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.950
Tarragona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.417
Tarragona	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	533
Tarragona	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	466
Tarragona	Group 1007 Asthma 4930-4931,4938-4939	Men	120
Tarragona	Group 1007 Asthma 4930-4931,4938-4939	Women	346
Tarragona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.732
Tarragona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	976
Tarragona	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	756
Tarragona	Group 1100 Diseases of the digestive system  520-579	Both sexes	10.435
Tarragona	Group 1100 Diseases of the digestive system  520-579	Men	5.732
Tarragona	Group 1100 Diseases of the digestive system  520-579	Women	4.703
Tarragona	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	328
Tarragona	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	162
Tarragona	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	167
Tarragona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	101
Tarragona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	58
Tarragona	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	42
Tarragona	Group 1103 Diseases of the esophagus 530	Both sexes	135
Tarragona	Group 1103 Diseases of the esophagus 530	Men	85
Tarragona	Group 1103 Diseases of the esophagus 530	Women	50
Tarragona	Group 1104 Peptic ulcer 531-534	Both sexes	176
Tarragona	Group 1104 Peptic ulcer 531-534	Men	128
Tarragona	Group 1104 Peptic ulcer 531-534	Women	48
Tarragona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	217
Tarragona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	102
Tarragona	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	115
Tarragona	Group 1106 Appendicitis  540-543	Both sexes	755
Tarragona	Group 1106 Appendicitis  540-543	Men	430
Tarragona	Group 1106 Appendicitis  540-543	Women	324
Tarragona	Group 1107 Inguinal hernia  550	Both sexes	1.254
Tarragona	Group 1107 Inguinal hernia  550	Men	1.108
Tarragona	Group 1107 Inguinal hernia  550	Women	146
Tarragona	Group 1108 Other abdominal hernia  551-553	Both sexes	916
Tarragona	Group 1108 Other abdominal hernia  551-553	Men	382
Tarragona	Group 1108 Other abdominal hernia  551-553	Women	534
Tarragona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	148
Tarragona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	74
Tarragona	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	74
Tarragona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	499
Tarragona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	242
Tarragona	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	257
Tarragona	Group 1111 Intestinal obstruction without hernia 560	Both sexes	535
Tarragona	Group 1111 Intestinal obstruction without hernia 560	Men	260
Tarragona	Group 1111 Intestinal obstruction without hernia 560	Women	276
Tarragona	Group 1112 Intestinal diverticulosis 562	Both sexes	392
Tarragona	Group 1112 Intestinal diverticulosis 562	Men	195
Tarragona	Group 1112 Intestinal diverticulosis 562	Women	198
Tarragona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	776
Tarragona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	467
Tarragona	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	308
Tarragona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	287
Tarragona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	142
Tarragona	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	145
Tarragona	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	189
Tarragona	Group 1115 Alcoholic hepatitis 5710-5713	Men	165
Tarragona	Group 1115 Alcoholic hepatitis 5710-5713	Women	24
Tarragona	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	320
Tarragona	Group 1116 Other diseases of the liver 570,5714-573	Men	172
Tarragona	Group 1116 Other diseases of the liver 570,5714-573	Women	148
Tarragona	Group 1117 Cholelithiasis  574	Both sexes	1.957
Tarragona	Group 1117 Cholelithiasis  574	Men	774
Tarragona	Group 1117 Cholelithiasis  574	Women	1.183
Tarragona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	461
Tarragona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	255
Tarragona	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	206
Tarragona	Group 1119 Pancreatic diseases 577	Both sexes	584
Tarragona	Group 1119 Pancreatic diseases 577	Men	322
Tarragona	Group 1119 Pancreatic diseases 577	Women	262
Tarragona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	405
Tarragona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	209
Tarragona	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	196
Tarragona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	868
Tarragona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	468
Tarragona	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	399
Tarragona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	624
Tarragona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	334
Tarragona	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	289
Tarragona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	38
Tarragona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	24
Tarragona	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
Tarragona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	206
Tarragona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	109
Tarragona	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	97
Tarragona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	5.940
Tarragona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.695
Tarragona	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.245
Tarragona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Tarragona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Tarragona	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Tarragona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Tarragona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Tarragona	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Tarragona	Group 1303 Internal derangement of knee 717	Both sexes	832
Tarragona	Group 1303 Internal derangement of knee 717	Men	523
Tarragona	Group 1303 Internal derangement of knee 717	Women	309
Tarragona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.803
Tarragona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.180
Tarragona	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.623
Tarragona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	72
Tarragona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	29
Tarragona	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	43
Tarragona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	187
Tarragona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	101
Tarragona	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	86
Tarragona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	281
Tarragona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	143
Tarragona	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	138
Tarragona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	193
Tarragona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	82
Tarragona	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	112
Tarragona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	773
Tarragona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	361
Tarragona	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	412
Tarragona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	800
Tarragona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	277
Tarragona	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	523
Tarragona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.650
Tarragona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.526
Tarragona	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.124
Tarragona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	651
Tarragona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	191
Tarragona	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	460
Tarragona	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	482
Tarragona	Group 1402 Renal failure  5836-5837, 584-586	Men	289
Tarragona	Group 1402 Renal failure  5836-5837, 584-586	Women	193
Tarragona	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	730
Tarragona	Group 1403 Urolithiasis  592, 594, 7880	Men	457
Tarragona	Group 1403 Urolithiasis  592, 594, 7880	Women	273
Tarragona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.493
Tarragona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	690
Tarragona	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	803
Tarragona	Group 1405 Prostatic hyperplasia  600	Both sexes	443
Tarragona	Group 1405 Prostatic hyperplasia  600	Men	443
Tarragona	Group 1405 Prostatic hyperplasia  600	Women	..
Tarragona	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	441
Tarragona	Group 1406 Other diseases of the male genital organs    601-608	Men	441
Tarragona	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Tarragona	Group 1407 Disorders of breast  610-612	Both sexes	183
Tarragona	Group 1407 Disorders of breast  610-612	Men	9
Tarragona	Group 1407 Disorders of breast  610-612	Women	173
Tarragona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	145
Tarragona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Tarragona	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	145
Tarragona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	90
Tarragona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Tarragona	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	90
Tarragona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	993
Tarragona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	6
Tarragona	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	986
Tarragona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	8.139
Tarragona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Tarragona	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	8.139
Tarragona	Group 1501 Legally induced abortion  635	Both sexes	26
Tarragona	Group 1501 Legally induced abortion  635	Men	..
Tarragona	Group 1501 Legally induced abortion  635	Women	26
Tarragona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	427
Tarragona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Tarragona	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	427
Tarragona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.506
Tarragona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Tarragona	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.506
Tarragona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.951
Tarragona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Tarragona	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.951
Tarragona	Group 1505 Single spontaneous delivery  650	Both sexes	1.264
Tarragona	Group 1505 Single spontaneous delivery  650	Men	..
Tarragona	Group 1505 Single spontaneous delivery  650	Women	1.264
Tarragona	Group 1506 Other deliveries  6695-6697	Both sexes	114
Tarragona	Group 1506 Other deliveries  6695-6697	Men	..
Tarragona	Group 1506 Other deliveries  6695-6697	Women	114
Tarragona	Group 1507 Complications related to the puerperium  670-676	Both sexes	142
Tarragona	Group 1507 Complications related to the puerperium  670-676	Men	..
Tarragona	Group 1507 Complications related to the puerperium  670-676	Women	142
Tarragona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	710
Tarragona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Tarragona	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	710
Tarragona	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.171
Tarragona	Group 1600 Some disorders originating in the perinatal period  760-779	Men	618
Tarragona	Group 1600 Some disorders originating in the perinatal period  760-779	Women	553
Tarragona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	380
Tarragona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	216
Tarragona	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	164
Tarragona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	791
Tarragona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	402
Tarragona	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	389
Tarragona	Grupo 1700 Congenital abnormalities  740-759	Both sexes	491
Tarragona	Grupo 1700 Congenital abnormalities  740-759	Men	294
Tarragona	Grupo 1700 Congenital abnormalities  740-759	Women	197
Tarragona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.481
Tarragona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.980
Tarragona	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.502
Tarragona	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	410
Tarragona	Group 1801 Pain in throat and chest 7841, 7865	Men	232
Tarragona	Group 1801 Pain in throat and chest 7841, 7865	Women	178
Tarragona	Group 1802 Abdominal pain   7890	Both sexes	475
Tarragona	Group 1802 Abdominal pain   7890	Men	186
Tarragona	Group 1802 Abdominal pain   7890	Women	289
Tarragona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	3
Tarragona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	2
Tarragona	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Tarragona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.594
Tarragona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.560
Tarragona	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.034
Tarragona	Group 1900 Injuries and poisoning  800-999	Both sexes	7.088
Tarragona	Group 1900 Injuries and poisoning  800-999	Men	3.353
Tarragona	Group 1900 Injuries and poisoning  800-999	Women	3.735
Tarragona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	509
Tarragona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	286
Tarragona	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	222
Tarragona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	188
Tarragona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	123
Tarragona	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	64
Tarragona	Group 1903 Radius and ulna fracture 813	Both sexes	452
Tarragona	Group 1903 Radius and ulna fracture 813	Men	231
Tarragona	Group 1903 Radius and ulna fracture 813	Women	221
Tarragona	Group 1904 Femur fracture  820-821	Both sexes	1.538
Tarragona	Group 1904 Femur fracture  820-821	Men	419
Tarragona	Group 1904 Femur fracture  820-821	Women	1.119
Tarragona	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	469
Tarragona	Group 1905 Leg fracture, including the ankle 823-824	Men	249
Tarragona	Group 1905 Leg fracture, including the ankle 823-824	Women	220
Tarragona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.055
Tarragona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.078
Tarragona	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	977
Tarragona	Group 1907 Burns  940-949	Both sexes	20
Tarragona	Group 1907 Burns  940-949	Men	9
Tarragona	Group 1907 Burns  940-949	Women	11
Tarragona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	204
Tarragona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	100
Tarragona	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	104
Tarragona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.388
Tarragona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	711
Tarragona	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	677
Tarragona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	27
Tarragona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	17
Tarragona	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	9
Tarragona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	240
Tarragona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	129
Tarragona	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	111
Tarragona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.245
Tarragona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	622
Tarragona	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	623
Tarragona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	11
Tarragona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	10
Tarragona	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	1
Tarragona	Group 2102 Contraceptive management  V25	Both sexes	99
Tarragona	Group 2102 Contraceptive management  V25	Men	4
Tarragona	Group 2102 Contraceptive management  V25	Women	95
Tarragona	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Tarragona	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Tarragona	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Tarragona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	314
Tarragona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	200
Tarragona	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	114
Tarragona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	821
Tarragona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	408
Tarragona	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	414
COMUNITAT VALENCIANA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	508.486
COMUNITAT VALENCIANA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	241.981
COMUNITAT VALENCIANA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	266.505
COMUNITAT VALENCIANA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	11.551
COMUNITAT VALENCIANA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	6.317
COMUNITAT VALENCIANA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	5.234
COMUNITAT VALENCIANA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.813
COMUNITAT VALENCIANA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	963
COMUNITAT VALENCIANA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	850
COMUNITAT VALENCIANA	Group 0102 Imprecise intestinal infections 009	Both sexes	1.158
COMUNITAT VALENCIANA	Group 0102 Imprecise intestinal infections 009	Men	588
COMUNITAT VALENCIANA	Group 0102 Imprecise intestinal infections 009	Women	570
COMUNITAT VALENCIANA	Group 0103 Tuberculosis 010-018, 137	Both sexes	360
COMUNITAT VALENCIANA	Group 0103 Tuberculosis 010-018, 137	Men	238
COMUNITAT VALENCIANA	Group 0103 Tuberculosis 010-018, 137	Women	122
COMUNITAT VALENCIANA	Group 0104 Septicaemia  038	Both sexes	4.261
COMUNITAT VALENCIANA	Group 0104 Septicaemia  038	Men	2.256
COMUNITAT VALENCIANA	Group 0104 Septicaemia  038	Women	2.005
COMUNITAT VALENCIANA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	404
COMUNITAT VALENCIANA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	267
COMUNITAT VALENCIANA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	137
COMUNITAT VALENCIANA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	3.555
COMUNITAT VALENCIANA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.005
COMUNITAT VALENCIANA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	1.550
COMUNITAT VALENCIANA	Group 0200 Neoplasms  140-239	Both sexes	51.274
COMUNITAT VALENCIANA	Group 0200 Neoplasms  140-239	Men	27.059
COMUNITAT VALENCIANA	Group 0200 Neoplasms  140-239	Women	24.215
COMUNITAT VALENCIANA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	5.396
COMUNITAT VALENCIANA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.170
COMUNITAT VALENCIANA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.226
COMUNITAT VALENCIANA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	4.268
COMUNITAT VALENCIANA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.347
COMUNITAT VALENCIANA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	921
COMUNITAT VALENCIANA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	738
COMUNITAT VALENCIANA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	437
COMUNITAT VALENCIANA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	301
COMUNITAT VALENCIANA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	4.294
COMUNITAT VALENCIANA	Group 0204 Malignant neoplasm of breast  174-175	Men	35
COMUNITAT VALENCIANA	Group 0204 Malignant neoplasm of breast  174-175	Women	4.259
COMUNITAT VALENCIANA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.115
COMUNITAT VALENCIANA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
COMUNITAT VALENCIANA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.115
COMUNITAT VALENCIANA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	668
COMUNITAT VALENCIANA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
COMUNITAT VALENCIANA	Group 0206 Malignant neoplasm of ovary  1830	Women	668
COMUNITAT VALENCIANA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.884
COMUNITAT VALENCIANA	Group 0207 Malignant neoplasm of prostate  185	Men	1.884
COMUNITAT VALENCIANA	Group 0207 Malignant neoplasm of prostate  185	Women	..
COMUNITAT VALENCIANA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	5.531
COMUNITAT VALENCIANA	Group 0208 Malignant neoplasm of bladder  188	Men	4.686
COMUNITAT VALENCIANA	Group 0208 Malignant neoplasm of bladder  188	Women	845
COMUNITAT VALENCIANA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	16.364
COMUNITAT VALENCIANA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	9.801
COMUNITAT VALENCIANA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	6.563
COMUNITAT VALENCIANA	Group 0210 Carcinoma in situ  230-234	Both sexes	745
COMUNITAT VALENCIANA	Group 0210 Carcinoma in situ  230-234	Men	203
COMUNITAT VALENCIANA	Group 0210 Carcinoma in situ  230-234	Women	542
COMUNITAT VALENCIANA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	685
COMUNITAT VALENCIANA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	413
COMUNITAT VALENCIANA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	272
COMUNITAT VALENCIANA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	2.791
COMUNITAT VALENCIANA	Grupo 0212 Leiomyoma of uterus  218	Men	..
COMUNITAT VALENCIANA	Grupo 0212 Leiomyoma of uterus  218	Women	2.791
COMUNITAT VALENCIANA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	6.795
COMUNITAT VALENCIANA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	3.083
COMUNITAT VALENCIANA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	3.712
COMUNITAT VALENCIANA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	4.406
COMUNITAT VALENCIANA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	2.158
COMUNITAT VALENCIANA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	2.248
COMUNITAT VALENCIANA	Group 0301 Anaemias 280-285	Both sexes	2.306
COMUNITAT VALENCIANA	Group 0301 Anaemias 280-285	Men	1.070
COMUNITAT VALENCIANA	Group 0301 Anaemias 280-285	Women	1.236
COMUNITAT VALENCIANA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.100
COMUNITAT VALENCIANA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.088
COMUNITAT VALENCIANA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.012
COMUNITAT VALENCIANA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	10.054
COMUNITAT VALENCIANA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.031
COMUNITAT VALENCIANA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	6.023
COMUNITAT VALENCIANA	Group 0401 Diabetes mellitus  249-250	Both sexes	3.363
COMUNITAT VALENCIANA	Group 0401 Diabetes mellitus  249-250	Men	1.977
COMUNITAT VALENCIANA	Group 0401 Diabetes mellitus  249-250	Women	1.386
COMUNITAT VALENCIANA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	6.691
COMUNITAT VALENCIANA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	2.054
COMUNITAT VALENCIANA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	4.637
COMUNITAT VALENCIANA	Group 0500 Mental disorders  290-319	Both sexes	10.780
COMUNITAT VALENCIANA	Group 0500 Mental disorders  290-319	Men	5.648
COMUNITAT VALENCIANA	Group 0500 Mental disorders  290-319	Women	5.132
COMUNITAT VALENCIANA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	305
COMUNITAT VALENCIANA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	147
COMUNITAT VALENCIANA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	158
COMUNITAT VALENCIANA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	768
COMUNITAT VALENCIANA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	593
COMUNITAT VALENCIANA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	175
COMUNITAT VALENCIANA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	636
COMUNITAT VALENCIANA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	456
COMUNITAT VALENCIANA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	180
COMUNITAT VALENCIANA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	3.172
COMUNITAT VALENCIANA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	1.937
COMUNITAT VALENCIANA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	1.235
COMUNITAT VALENCIANA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	2.343
COMUNITAT VALENCIANA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	988
COMUNITAT VALENCIANA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.355
COMUNITAT VALENCIANA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	3.556
COMUNITAT VALENCIANA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	1.527
COMUNITAT VALENCIANA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	2.029
COMUNITAT VALENCIANA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	12.219
COMUNITAT VALENCIANA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	6.231
COMUNITAT VALENCIANA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	5.988
COMUNITAT VALENCIANA	Group 0601 Alzheimer's disease  3310	Both sexes	190
COMUNITAT VALENCIANA	Group 0601 Alzheimer's disease  3310	Men	69
COMUNITAT VALENCIANA	Group 0601 Alzheimer's disease  3310	Women	121
COMUNITAT VALENCIANA	Group 0602 Multiple sclerosis 340	Both sexes	267
COMUNITAT VALENCIANA	Group 0602 Multiple sclerosis 340	Men	74
COMUNITAT VALENCIANA	Group 0602 Multiple sclerosis 340	Women	193
COMUNITAT VALENCIANA	Group 0603 Epilepsy  345	Both sexes	2.692
COMUNITAT VALENCIANA	Group 0603 Epilepsy  345	Men	1.488
COMUNITAT VALENCIANA	Group 0603 Epilepsy  345	Women	1.204
COMUNITAT VALENCIANA	Group 0604 Transient cerebral ischemia 435	Both sexes	1.922
COMUNITAT VALENCIANA	Group 0604 Transient cerebral ischemia 435	Men	991
COMUNITAT VALENCIANA	Group 0604 Transient cerebral ischemia 435	Women	931
COMUNITAT VALENCIANA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	7.148
COMUNITAT VALENCIANA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	3.609
COMUNITAT VALENCIANA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	3.539
COMUNITAT VALENCIANA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	2.628
COMUNITAT VALENCIANA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	1.434
COMUNITAT VALENCIANA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	1.194
COMUNITAT VALENCIANA	Grupo 0701 Cataract  366	Both sexes	307
COMUNITAT VALENCIANA	Grupo 0701 Cataract  366	Men	153
COMUNITAT VALENCIANA	Grupo 0701 Cataract  366	Women	154
COMUNITAT VALENCIANA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	2.321
COMUNITAT VALENCIANA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.281
COMUNITAT VALENCIANA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.040
COMUNITAT VALENCIANA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	2.435
COMUNITAT VALENCIANA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.164
COMUNITAT VALENCIANA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.271
COMUNITAT VALENCIANA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	65.521
COMUNITAT VALENCIANA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	37.092
COMUNITAT VALENCIANA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	28.429
COMUNITAT VALENCIANA	Group 0901 Hypertensive disease  401-405	Both sexes	2.141
COMUNITAT VALENCIANA	Group 0901 Hypertensive disease  401-405	Men	1.048
COMUNITAT VALENCIANA	Group 0901 Hypertensive disease  401-405	Women	1.093
COMUNITAT VALENCIANA	Group 0902 Angina pectoris  4111, 413	Both sexes	3.439
COMUNITAT VALENCIANA	Group 0902 Angina pectoris  4111, 413	Men	2.174
COMUNITAT VALENCIANA	Group 0902 Angina pectoris  4111, 413	Women	1.265
COMUNITAT VALENCIANA	Group 0903 Acute myocardial infarction  410	Both sexes	5.857
COMUNITAT VALENCIANA	Group 0903 Acute myocardial infarction  410	Men	4.211
COMUNITAT VALENCIANA	Group 0903 Acute myocardial infarction  410	Women	1.646
COMUNITAT VALENCIANA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	4.372
COMUNITAT VALENCIANA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	3.258
COMUNITAT VALENCIANA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.114
COMUNITAT VALENCIANA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	2.057
COMUNITAT VALENCIANA	Group 0905 Diseases of the lungs circulation 415-417	Men	944
COMUNITAT VALENCIANA	Group 0905 Diseases of the lungs circulation 415-417	Women	1.113
COMUNITAT VALENCIANA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	8.815
COMUNITAT VALENCIANA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	4.704
COMUNITAT VALENCIANA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	4.111
COMUNITAT VALENCIANA	Grupo 0907 Heart failure  428	Both sexes	13.062
COMUNITAT VALENCIANA	Grupo 0907 Heart failure  428	Men	6.078
COMUNITAT VALENCIANA	Grupo 0907 Heart failure  428	Women	6.984
COMUNITAT VALENCIANA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	11.930
COMUNITAT VALENCIANA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	6.602
COMUNITAT VALENCIANA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	5.328
COMUNITAT VALENCIANA	Grupo 0909 Atherosclerosis  440	Both sexes	1.595
COMUNITAT VALENCIANA	Grupo 0909 Atherosclerosis  440	Men	1.213
COMUNITAT VALENCIANA	Grupo 0909 Atherosclerosis  440	Women	382
COMUNITAT VALENCIANA	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.399
COMUNITAT VALENCIANA	Group 0910 Varicose veins of lower extremities 454	Men	504
COMUNITAT VALENCIANA	Group 0910 Varicose veins of lower extremities 454	Women	895
COMUNITAT VALENCIANA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	10.854
COMUNITAT VALENCIANA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	6.356
COMUNITAT VALENCIANA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	4.498
COMUNITAT VALENCIANA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	55.370
COMUNITAT VALENCIANA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	31.711
COMUNITAT VALENCIANA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	23.659
COMUNITAT VALENCIANA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.433
COMUNITAT VALENCIANA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.822
COMUNITAT VALENCIANA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.611
COMUNITAT VALENCIANA	Group 1002 Pneumonia 480-486	Both sexes	13.107
COMUNITAT VALENCIANA	Group 1002 Pneumonia 480-486	Men	7.634
COMUNITAT VALENCIANA	Group 1002 Pneumonia 480-486	Women	5.473
COMUNITAT VALENCIANA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	5.348
COMUNITAT VALENCIANA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	2.683
COMUNITAT VALENCIANA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	2.665
COMUNITAT VALENCIANA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	3.877
COMUNITAT VALENCIANA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	2.116
COMUNITAT VALENCIANA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.761
COMUNITAT VALENCIANA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	3.722
COMUNITAT VALENCIANA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	2.300
COMUNITAT VALENCIANA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	1.422
COMUNITAT VALENCIANA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	8.060
COMUNITAT VALENCIANA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	6.154
COMUNITAT VALENCIANA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.906
COMUNITAT VALENCIANA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.779
COMUNITAT VALENCIANA	Group 1007 Asthma 4930-4931,4938-4939	Men	481
COMUNITAT VALENCIANA	Group 1007 Asthma 4930-4931,4938-4939	Women	1.298
COMUNITAT VALENCIANA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	16.044
COMUNITAT VALENCIANA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	8.521
COMUNITAT VALENCIANA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	7.523
COMUNITAT VALENCIANA	Group 1100 Diseases of the digestive system  520-579	Both sexes	64.148
COMUNITAT VALENCIANA	Group 1100 Diseases of the digestive system  520-579	Men	35.546
COMUNITAT VALENCIANA	Group 1100 Diseases of the digestive system  520-579	Women	28.602
COMUNITAT VALENCIANA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	1.202
COMUNITAT VALENCIANA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	551
COMUNITAT VALENCIANA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	651
COMUNITAT VALENCIANA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	908
COMUNITAT VALENCIANA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	499
COMUNITAT VALENCIANA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	409
COMUNITAT VALENCIANA	Group 1103 Diseases of the esophagus 530	Both sexes	1.240
COMUNITAT VALENCIANA	Group 1103 Diseases of the esophagus 530	Men	759
COMUNITAT VALENCIANA	Group 1103 Diseases of the esophagus 530	Women	481
COMUNITAT VALENCIANA	Group 1104 Peptic ulcer 531-534	Both sexes	1.485
COMUNITAT VALENCIANA	Group 1104 Peptic ulcer 531-534	Men	1.041
COMUNITAT VALENCIANA	Group 1104 Peptic ulcer 531-534	Women	444
COMUNITAT VALENCIANA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	1.884
COMUNITAT VALENCIANA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	907
COMUNITAT VALENCIANA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	977
COMUNITAT VALENCIANA	Group 1106 Appendicitis  540-543	Both sexes	5.480
COMUNITAT VALENCIANA	Group 1106 Appendicitis  540-543	Men	3.093
COMUNITAT VALENCIANA	Group 1106 Appendicitis  540-543	Women	2.387
COMUNITAT VALENCIANA	Group 1107 Inguinal hernia  550	Both sexes	5.962
COMUNITAT VALENCIANA	Group 1107 Inguinal hernia  550	Men	5.252
COMUNITAT VALENCIANA	Group 1107 Inguinal hernia  550	Women	710
COMUNITAT VALENCIANA	Group 1108 Other abdominal hernia  551-553	Both sexes	5.144
COMUNITAT VALENCIANA	Group 1108 Other abdominal hernia  551-553	Men	2.469
COMUNITAT VALENCIANA	Group 1108 Other abdominal hernia  551-553	Women	2.675
COMUNITAT VALENCIANA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.473
COMUNITAT VALENCIANA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	729
COMUNITAT VALENCIANA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	744
COMUNITAT VALENCIANA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	3.786
COMUNITAT VALENCIANA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.741
COMUNITAT VALENCIANA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.045
COMUNITAT VALENCIANA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	2.810
COMUNITAT VALENCIANA	Group 1111 Intestinal obstruction without hernia 560	Men	1.446
COMUNITAT VALENCIANA	Group 1111 Intestinal obstruction without hernia 560	Women	1.364
COMUNITAT VALENCIANA	Group 1112 Intestinal diverticulosis 562	Both sexes	2.515
COMUNITAT VALENCIANA	Group 1112 Intestinal diverticulosis 562	Men	1.236
COMUNITAT VALENCIANA	Group 1112 Intestinal diverticulosis 562	Women	1.279
COMUNITAT VALENCIANA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	3.892
COMUNITAT VALENCIANA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	2.467
COMUNITAT VALENCIANA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.425
COMUNITAT VALENCIANA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.030
COMUNITAT VALENCIANA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	897
COMUNITAT VALENCIANA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.133
COMUNITAT VALENCIANA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.042
COMUNITAT VALENCIANA	Group 1115 Alcoholic hepatitis 5710-5713	Men	890
COMUNITAT VALENCIANA	Group 1115 Alcoholic hepatitis 5710-5713	Women	152
COMUNITAT VALENCIANA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	2.523
COMUNITAT VALENCIANA	Group 1116 Other diseases of the liver 570,5714-573	Men	1.513
COMUNITAT VALENCIANA	Group 1116 Other diseases of the liver 570,5714-573	Women	1.010
COMUNITAT VALENCIANA	Group 1117 Cholelithiasis  574	Both sexes	10.550
COMUNITAT VALENCIANA	Group 1117 Cholelithiasis  574	Men	4.332
COMUNITAT VALENCIANA	Group 1117 Cholelithiasis  574	Women	6.218
COMUNITAT VALENCIANA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	3.408
COMUNITAT VALENCIANA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	1.844
COMUNITAT VALENCIANA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	1.564
COMUNITAT VALENCIANA	Group 1119 Pancreatic diseases 577	Both sexes	3.516
COMUNITAT VALENCIANA	Group 1119 Pancreatic diseases 577	Men	2.029
COMUNITAT VALENCIANA	Group 1119 Pancreatic diseases 577	Women	1.487
COMUNITAT VALENCIANA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.298
COMUNITAT VALENCIANA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.851
COMUNITAT VALENCIANA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.447
COMUNITAT VALENCIANA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	4.936
COMUNITAT VALENCIANA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	2.799
COMUNITAT VALENCIANA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	2.137
COMUNITAT VALENCIANA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	3.249
COMUNITAT VALENCIANA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.986
COMUNITAT VALENCIANA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.263
COMUNITAT VALENCIANA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	190
COMUNITAT VALENCIANA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	97
COMUNITAT VALENCIANA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	93
COMUNITAT VALENCIANA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	1.497
COMUNITAT VALENCIANA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	716
COMUNITAT VALENCIANA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	781
COMUNITAT VALENCIANA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	35.732
COMUNITAT VALENCIANA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	17.960
COMUNITAT VALENCIANA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	17.772
COMUNITAT VALENCIANA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
COMUNITAT VALENCIANA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
COMUNITAT VALENCIANA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
COMUNITAT VALENCIANA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
COMUNITAT VALENCIANA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
COMUNITAT VALENCIANA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
COMUNITAT VALENCIANA	Group 1303 Internal derangement of knee 717	Both sexes	5.773
COMUNITAT VALENCIANA	Group 1303 Internal derangement of knee 717	Men	4.098
COMUNITAT VALENCIANA	Group 1303 Internal derangement of knee 717	Women	1.675
COMUNITAT VALENCIANA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	11.977
COMUNITAT VALENCIANA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	5.252
COMUNITAT VALENCIANA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	6.725
COMUNITAT VALENCIANA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	623
COMUNITAT VALENCIANA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	241
COMUNITAT VALENCIANA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	382
COMUNITAT VALENCIANA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	2.064
COMUNITAT VALENCIANA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.053
COMUNITAT VALENCIANA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.011
COMUNITAT VALENCIANA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	3.174
COMUNITAT VALENCIANA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	1.721
COMUNITAT VALENCIANA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	1.453
COMUNITAT VALENCIANA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	817
COMUNITAT VALENCIANA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	389
COMUNITAT VALENCIANA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	428
COMUNITAT VALENCIANA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	5.531
COMUNITAT VALENCIANA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	2.943
COMUNITAT VALENCIANA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	2.588
COMUNITAT VALENCIANA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	5.773
COMUNITAT VALENCIANA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	2.263
COMUNITAT VALENCIANA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	3.510
COMUNITAT VALENCIANA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	35.032
COMUNITAT VALENCIANA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	15.784
COMUNITAT VALENCIANA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	19.248
COMUNITAT VALENCIANA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	3.625
COMUNITAT VALENCIANA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.258
COMUNITAT VALENCIANA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	2.367
COMUNITAT VALENCIANA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	2.960
COMUNITAT VALENCIANA	Group 1402 Renal failure  5836-5837, 584-586	Men	1.776
COMUNITAT VALENCIANA	Group 1402 Renal failure  5836-5837, 584-586	Women	1.184
COMUNITAT VALENCIANA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	4.480
COMUNITAT VALENCIANA	Group 1403 Urolithiasis  592, 594, 7880	Men	2.656
COMUNITAT VALENCIANA	Group 1403 Urolithiasis  592, 594, 7880	Women	1.824
COMUNITAT VALENCIANA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	9.563
COMUNITAT VALENCIANA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	4.849
COMUNITAT VALENCIANA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	4.714
COMUNITAT VALENCIANA	Group 1405 Prostatic hyperplasia  600	Both sexes	2.862
COMUNITAT VALENCIANA	Group 1405 Prostatic hyperplasia  600	Men	2.862
COMUNITAT VALENCIANA	Group 1405 Prostatic hyperplasia  600	Women	..
COMUNITAT VALENCIANA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	2.133
COMUNITAT VALENCIANA	Group 1406 Other diseases of the male genital organs    601-608	Men	2.133
COMUNITAT VALENCIANA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
COMUNITAT VALENCIANA	Group 1407 Disorders of breast  610-612	Both sexes	2.657
COMUNITAT VALENCIANA	Group 1407 Disorders of breast  610-612	Men	211
COMUNITAT VALENCIANA	Group 1407 Disorders of breast  610-612	Women	2.446
COMUNITAT VALENCIANA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	923
COMUNITAT VALENCIANA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
COMUNITAT VALENCIANA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	923
COMUNITAT VALENCIANA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	501
COMUNITAT VALENCIANA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
COMUNITAT VALENCIANA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	501
COMUNITAT VALENCIANA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	5.328
COMUNITAT VALENCIANA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	39
COMUNITAT VALENCIANA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	5.289
COMUNITAT VALENCIANA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	52.499
COMUNITAT VALENCIANA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
COMUNITAT VALENCIANA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	52.499
COMUNITAT VALENCIANA	Group 1501 Legally induced abortion  635	Both sexes	229
COMUNITAT VALENCIANA	Group 1501 Legally induced abortion  635	Men	..
COMUNITAT VALENCIANA	Group 1501 Legally induced abortion  635	Women	229
COMUNITAT VALENCIANA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	3.392
COMUNITAT VALENCIANA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
COMUNITAT VALENCIANA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	3.392
COMUNITAT VALENCIANA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	31.190
COMUNITAT VALENCIANA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
COMUNITAT VALENCIANA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	31.190
COMUNITAT VALENCIANA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	7.893
COMUNITAT VALENCIANA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
COMUNITAT VALENCIANA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	7.893
COMUNITAT VALENCIANA	Group 1505 Single spontaneous delivery  650	Both sexes	3.649
COMUNITAT VALENCIANA	Group 1505 Single spontaneous delivery  650	Men	..
COMUNITAT VALENCIANA	Group 1505 Single spontaneous delivery  650	Women	3.649
COMUNITAT VALENCIANA	Group 1506 Other deliveries  6695-6697	Both sexes	1.714
COMUNITAT VALENCIANA	Group 1506 Other deliveries  6695-6697	Men	..
COMUNITAT VALENCIANA	Group 1506 Other deliveries  6695-6697	Women	1.714
COMUNITAT VALENCIANA	Group 1507 Complications related to the puerperium  670-676	Both sexes	432
COMUNITAT VALENCIANA	Group 1507 Complications related to the puerperium  670-676	Men	..
COMUNITAT VALENCIANA	Group 1507 Complications related to the puerperium  670-676	Women	432
COMUNITAT VALENCIANA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	4.000
COMUNITAT VALENCIANA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
COMUNITAT VALENCIANA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	4.000
COMUNITAT VALENCIANA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	7.160
COMUNITAT VALENCIANA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	3.974
COMUNITAT VALENCIANA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	3.186
COMUNITAT VALENCIANA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	2.091
COMUNITAT VALENCIANA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.133
COMUNITAT VALENCIANA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	958
COMUNITAT VALENCIANA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	5.069
COMUNITAT VALENCIANA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	2.841
COMUNITAT VALENCIANA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	2.228
COMUNITAT VALENCIANA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	3.787
COMUNITAT VALENCIANA	Grupo 1700 Congenital abnormalities  740-759	Men	2.219
COMUNITAT VALENCIANA	Grupo 1700 Congenital abnormalities  740-759	Women	1.568
COMUNITAT VALENCIANA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	23.620
COMUNITAT VALENCIANA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	12.799
COMUNITAT VALENCIANA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	10.821
COMUNITAT VALENCIANA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	3.550
COMUNITAT VALENCIANA	Group 1801 Pain in throat and chest 7841, 7865	Men	2.055
COMUNITAT VALENCIANA	Group 1801 Pain in throat and chest 7841, 7865	Women	1.495
COMUNITAT VALENCIANA	Group 1802 Abdominal pain   7890	Both sexes	2.560
COMUNITAT VALENCIANA	Group 1802 Abdominal pain   7890	Men	930
COMUNITAT VALENCIANA	Group 1802 Abdominal pain   7890	Women	1.630
COMUNITAT VALENCIANA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	293
COMUNITAT VALENCIANA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	155
COMUNITAT VALENCIANA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	138
COMUNITAT VALENCIANA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	17.217
COMUNITAT VALENCIANA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	9.659
COMUNITAT VALENCIANA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	7.558
COMUNITAT VALENCIANA	Group 1900 Injuries and poisoning  800-999	Both sexes	44.878
COMUNITAT VALENCIANA	Group 1900 Injuries and poisoning  800-999	Men	23.139
COMUNITAT VALENCIANA	Group 1900 Injuries and poisoning  800-999	Women	21.739
COMUNITAT VALENCIANA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	2.405
COMUNITAT VALENCIANA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.383
COMUNITAT VALENCIANA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.022
COMUNITAT VALENCIANA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.088
COMUNITAT VALENCIANA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	761
COMUNITAT VALENCIANA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	327
COMUNITAT VALENCIANA	Group 1903 Radius and ulna fracture 813	Both sexes	3.346
COMUNITAT VALENCIANA	Group 1903 Radius and ulna fracture 813	Men	1.567
COMUNITAT VALENCIANA	Group 1903 Radius and ulna fracture 813	Women	1.779
COMUNITAT VALENCIANA	Group 1904 Femur fracture  820-821	Both sexes	6.875
COMUNITAT VALENCIANA	Group 1904 Femur fracture  820-821	Men	2.038
COMUNITAT VALENCIANA	Group 1904 Femur fracture  820-821	Women	4.837
COMUNITAT VALENCIANA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	3.377
COMUNITAT VALENCIANA	Group 1905 Leg fracture, including the ankle 823-824	Men	1.772
COMUNITAT VALENCIANA	Group 1905 Leg fracture, including the ankle 823-824	Women	1.605
COMUNITAT VALENCIANA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	13.874
COMUNITAT VALENCIANA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	8.325
COMUNITAT VALENCIANA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	5.549
COMUNITAT VALENCIANA	Group 1907 Burns  940-949	Both sexes	301
COMUNITAT VALENCIANA	Group 1907 Burns  940-949	Men	185
COMUNITAT VALENCIANA	Group 1907 Burns  940-949	Women	116
COMUNITAT VALENCIANA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.331
COMUNITAT VALENCIANA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	593
COMUNITAT VALENCIANA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	738
COMUNITAT VALENCIANA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	10.429
COMUNITAT VALENCIANA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	5.527
COMUNITAT VALENCIANA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	4.902
COMUNITAT VALENCIANA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	245
COMUNITAT VALENCIANA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	158
COMUNITAT VALENCIANA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	87
COMUNITAT VALENCIANA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.607
COMUNITAT VALENCIANA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	830
COMUNITAT VALENCIANA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	777
COMUNITAT VALENCIANA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	10.456
COMUNITAT VALENCIANA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	4.916
COMUNITAT VALENCIANA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	5.540
COMUNITAT VALENCIANA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	444
COMUNITAT VALENCIANA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	231
COMUNITAT VALENCIANA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	213
COMUNITAT VALENCIANA	Group 2102 Contraceptive management  V25	Both sexes	149
COMUNITAT VALENCIANA	Group 2102 Contraceptive management  V25	Men	11
COMUNITAT VALENCIANA	Group 2102 Contraceptive management  V25	Women	138
COMUNITAT VALENCIANA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
COMUNITAT VALENCIANA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
COMUNITAT VALENCIANA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
COMUNITAT VALENCIANA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	2.990
COMUNITAT VALENCIANA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.830
COMUNITAT VALENCIANA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	1.160
COMUNITAT VALENCIANA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	6.873
COMUNITAT VALENCIANA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	2.844
COMUNITAT VALENCIANA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	4.029
Alicante/Alacant	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	197.815
Alicante/Alacant	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	94.052
Alicante/Alacant	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	103.763
Alicante/Alacant	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	5.064
Alicante/Alacant	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.705
Alicante/Alacant	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.359
Alicante/Alacant	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	682
Alicante/Alacant	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	359
Alicante/Alacant	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	323
Alicante/Alacant	Group 0102 Imprecise intestinal infections 009	Both sexes	625
Alicante/Alacant	Group 0102 Imprecise intestinal infections 009	Men	317
Alicante/Alacant	Group 0102 Imprecise intestinal infections 009	Women	308
Alicante/Alacant	Group 0103 Tuberculosis 010-018, 137	Both sexes	112
Alicante/Alacant	Group 0103 Tuberculosis 010-018, 137	Men	74
Alicante/Alacant	Group 0103 Tuberculosis 010-018, 137	Women	38
Alicante/Alacant	Group 0104 Septicaemia  038	Both sexes	2.274
Alicante/Alacant	Group 0104 Septicaemia  038	Men	1.186
Alicante/Alacant	Group 0104 Septicaemia  038	Women	1.088
Alicante/Alacant	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	133
Alicante/Alacant	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	84
Alicante/Alacant	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	49
Alicante/Alacant	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.238
Alicante/Alacant	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	685
Alicante/Alacant	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	553
Alicante/Alacant	Group 0200 Neoplasms  140-239	Both sexes	17.129
Alicante/Alacant	Group 0200 Neoplasms  140-239	Men	8.924
Alicante/Alacant	Group 0200 Neoplasms  140-239	Women	8.205
Alicante/Alacant	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	2.008
Alicante/Alacant	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.154
Alicante/Alacant	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	854
Alicante/Alacant	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.430
Alicante/Alacant	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.065
Alicante/Alacant	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	365
Alicante/Alacant	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	196
Alicante/Alacant	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	122
Alicante/Alacant	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	74
Alicante/Alacant	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.239
Alicante/Alacant	Group 0204 Malignant neoplasm of breast  174-175	Men	13
Alicante/Alacant	Group 0204 Malignant neoplasm of breast  174-175	Women	1.226
Alicante/Alacant	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	352
Alicante/Alacant	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Alicante/Alacant	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	352
Alicante/Alacant	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	174
Alicante/Alacant	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Alicante/Alacant	Group 0206 Malignant neoplasm of ovary  1830	Women	174
Alicante/Alacant	Group 0207 Malignant neoplasm of prostate  185	Both sexes	454
Alicante/Alacant	Group 0207 Malignant neoplasm of prostate  185	Men	454
Alicante/Alacant	Group 0207 Malignant neoplasm of prostate  185	Women	..
Alicante/Alacant	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.635
Alicante/Alacant	Group 0208 Malignant neoplasm of bladder  188	Men	1.366
Alicante/Alacant	Group 0208 Malignant neoplasm of bladder  188	Women	269
Alicante/Alacant	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.455
Alicante/Alacant	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.263
Alicante/Alacant	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.192
Alicante/Alacant	Group 0210 Carcinoma in situ  230-234	Both sexes	226
Alicante/Alacant	Group 0210 Carcinoma in situ  230-234	Men	43
Alicante/Alacant	Group 0210 Carcinoma in situ  230-234	Women	183
Alicante/Alacant	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	320
Alicante/Alacant	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	197
Alicante/Alacant	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	123
Alicante/Alacant	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.042
Alicante/Alacant	Grupo 0212 Leiomyoma of uterus  218	Men	..
Alicante/Alacant	Grupo 0212 Leiomyoma of uterus  218	Women	1.042
Alicante/Alacant	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.598
Alicante/Alacant	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.247
Alicante/Alacant	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.351
Alicante/Alacant	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.790
Alicante/Alacant	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	859
Alicante/Alacant	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	931
Alicante/Alacant	Group 0301 Anaemias 280-285	Both sexes	1.020
Alicante/Alacant	Group 0301 Anaemias 280-285	Men	460
Alicante/Alacant	Group 0301 Anaemias 280-285	Women	560
Alicante/Alacant	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	770
Alicante/Alacant	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	399
Alicante/Alacant	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	371
Alicante/Alacant	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.889
Alicante/Alacant	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.669
Alicante/Alacant	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.220
Alicante/Alacant	Group 0401 Diabetes mellitus  249-250	Both sexes	1.403
Alicante/Alacant	Group 0401 Diabetes mellitus  249-250	Men	837
Alicante/Alacant	Group 0401 Diabetes mellitus  249-250	Women	566
Alicante/Alacant	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.486
Alicante/Alacant	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	832
Alicante/Alacant	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.654
Alicante/Alacant	Group 0500 Mental disorders  290-319	Both sexes	4.179
Alicante/Alacant	Group 0500 Mental disorders  290-319	Men	2.238
Alicante/Alacant	Group 0500 Mental disorders  290-319	Women	1.941
Alicante/Alacant	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	136
Alicante/Alacant	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	70
Alicante/Alacant	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	66
Alicante/Alacant	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	310
Alicante/Alacant	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	229
Alicante/Alacant	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	81
Alicante/Alacant	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	242
Alicante/Alacant	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	181
Alicante/Alacant	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	61
Alicante/Alacant	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.188
Alicante/Alacant	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	756
Alicante/Alacant	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	432
Alicante/Alacant	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	843
Alicante/Alacant	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	322
Alicante/Alacant	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	521
Alicante/Alacant	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.460
Alicante/Alacant	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	680
Alicante/Alacant	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	780
Alicante/Alacant	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.843
Alicante/Alacant	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	3.030
Alicante/Alacant	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.813
Alicante/Alacant	Group 0601 Alzheimer's disease  3310	Both sexes	81
Alicante/Alacant	Group 0601 Alzheimer's disease  3310	Men	33
Alicante/Alacant	Group 0601 Alzheimer's disease  3310	Women	48
Alicante/Alacant	Group 0602 Multiple sclerosis 340	Both sexes	104
Alicante/Alacant	Group 0602 Multiple sclerosis 340	Men	26
Alicante/Alacant	Group 0602 Multiple sclerosis 340	Women	78
Alicante/Alacant	Group 0603 Epilepsy  345	Both sexes	1.207
Alicante/Alacant	Group 0603 Epilepsy  345	Men	650
Alicante/Alacant	Group 0603 Epilepsy  345	Women	557
Alicante/Alacant	Group 0604 Transient cerebral ischemia 435	Both sexes	995
Alicante/Alacant	Group 0604 Transient cerebral ischemia 435	Men	491
Alicante/Alacant	Group 0604 Transient cerebral ischemia 435	Women	504
Alicante/Alacant	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.456
Alicante/Alacant	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.830
Alicante/Alacant	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.626
Alicante/Alacant	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.027
Alicante/Alacant	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	558
Alicante/Alacant	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	469
Alicante/Alacant	Grupo 0701 Cataract  366	Both sexes	125
Alicante/Alacant	Grupo 0701 Cataract  366	Men	59
Alicante/Alacant	Grupo 0701 Cataract  366	Women	66
Alicante/Alacant	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	902
Alicante/Alacant	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	499
Alicante/Alacant	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	403
Alicante/Alacant	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	865
Alicante/Alacant	Group 0800 Diseases of the ear and the mastoid  380-389	Men	418
Alicante/Alacant	Group 0800 Diseases of the ear and the mastoid  380-389	Women	447
Alicante/Alacant	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	28.722
Alicante/Alacant	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	16.293
Alicante/Alacant	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	12.429
Alicante/Alacant	Group 0901 Hypertensive disease  401-405	Both sexes	1.089
Alicante/Alacant	Group 0901 Hypertensive disease  401-405	Men	526
Alicante/Alacant	Group 0901 Hypertensive disease  401-405	Women	563
Alicante/Alacant	Group 0902 Angina pectoris  4111, 413	Both sexes	1.576
Alicante/Alacant	Group 0902 Angina pectoris  4111, 413	Men	952
Alicante/Alacant	Group 0902 Angina pectoris  4111, 413	Women	624
Alicante/Alacant	Group 0903 Acute myocardial infarction  410	Both sexes	2.672
Alicante/Alacant	Group 0903 Acute myocardial infarction  410	Men	1.951
Alicante/Alacant	Group 0903 Acute myocardial infarction  410	Women	721
Alicante/Alacant	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.922
Alicante/Alacant	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.427
Alicante/Alacant	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	495
Alicante/Alacant	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	928
Alicante/Alacant	Group 0905 Diseases of the lungs circulation 415-417	Men	452
Alicante/Alacant	Group 0905 Diseases of the lungs circulation 415-417	Women	476
Alicante/Alacant	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.326
Alicante/Alacant	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.300
Alicante/Alacant	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.026
Alicante/Alacant	Grupo 0907 Heart failure  428	Both sexes	5.906
Alicante/Alacant	Grupo 0907 Heart failure  428	Men	2.733
Alicante/Alacant	Grupo 0907 Heart failure  428	Women	3.173
Alicante/Alacant	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	4.920
Alicante/Alacant	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.772
Alicante/Alacant	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.148
Alicante/Alacant	Grupo 0909 Atherosclerosis  440	Both sexes	561
Alicante/Alacant	Grupo 0909 Atherosclerosis  440	Men	407
Alicante/Alacant	Grupo 0909 Atherosclerosis  440	Women	154
Alicante/Alacant	Group 0910 Varicose veins of lower extremities 454	Both sexes	531
Alicante/Alacant	Group 0910 Varicose veins of lower extremities 454	Men	217
Alicante/Alacant	Group 0910 Varicose veins of lower extremities 454	Women	314
Alicante/Alacant	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	4.291
Alicante/Alacant	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	2.556
Alicante/Alacant	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.735
Alicante/Alacant	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	20.786
Alicante/Alacant	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	11.791
Alicante/Alacant	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	8.995
Alicante/Alacant	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.306
Alicante/Alacant	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	672
Alicante/Alacant	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	634
Alicante/Alacant	Group 1002 Pneumonia 480-486	Both sexes	4.610
Alicante/Alacant	Group 1002 Pneumonia 480-486	Men	2.706
Alicante/Alacant	Group 1002 Pneumonia 480-486	Women	1.904
Alicante/Alacant	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.133
Alicante/Alacant	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.057
Alicante/Alacant	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.076
Alicante/Alacant	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.140
Alicante/Alacant	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	605
Alicante/Alacant	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	535
Alicante/Alacant	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.231
Alicante/Alacant	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	785
Alicante/Alacant	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	446
Alicante/Alacant	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.309
Alicante/Alacant	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.468
Alicante/Alacant	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	841
Alicante/Alacant	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	747
Alicante/Alacant	Group 1007 Asthma 4930-4931,4938-4939	Men	174
Alicante/Alacant	Group 1007 Asthma 4930-4931,4938-4939	Women	573
Alicante/Alacant	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	6.310
Alicante/Alacant	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.324
Alicante/Alacant	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.986
Alicante/Alacant	Group 1100 Diseases of the digestive system  520-579	Both sexes	25.821
Alicante/Alacant	Group 1100 Diseases of the digestive system  520-579	Men	14.222
Alicante/Alacant	Group 1100 Diseases of the digestive system  520-579	Women	11.599
Alicante/Alacant	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	325
Alicante/Alacant	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	142
Alicante/Alacant	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	183
Alicante/Alacant	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	270
Alicante/Alacant	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	159
Alicante/Alacant	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	111
Alicante/Alacant	Group 1103 Diseases of the esophagus 530	Both sexes	593
Alicante/Alacant	Group 1103 Diseases of the esophagus 530	Men	367
Alicante/Alacant	Group 1103 Diseases of the esophagus 530	Women	226
Alicante/Alacant	Group 1104 Peptic ulcer 531-534	Both sexes	661
Alicante/Alacant	Group 1104 Peptic ulcer 531-534	Men	443
Alicante/Alacant	Group 1104 Peptic ulcer 531-534	Women	218
Alicante/Alacant	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	814
Alicante/Alacant	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	374
Alicante/Alacant	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	440
Alicante/Alacant	Group 1106 Appendicitis  540-543	Both sexes	2.175
Alicante/Alacant	Group 1106 Appendicitis  540-543	Men	1.203
Alicante/Alacant	Group 1106 Appendicitis  540-543	Women	972
Alicante/Alacant	Group 1107 Inguinal hernia  550	Both sexes	2.498
Alicante/Alacant	Group 1107 Inguinal hernia  550	Men	2.215
Alicante/Alacant	Group 1107 Inguinal hernia  550	Women	283
Alicante/Alacant	Group 1108 Other abdominal hernia  551-553	Both sexes	1.934
Alicante/Alacant	Group 1108 Other abdominal hernia  551-553	Men	938
Alicante/Alacant	Group 1108 Other abdominal hernia  551-553	Women	996
Alicante/Alacant	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	613
Alicante/Alacant	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	304
Alicante/Alacant	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	309
Alicante/Alacant	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.945
Alicante/Alacant	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	889
Alicante/Alacant	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	1.056
Alicante/Alacant	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.102
Alicante/Alacant	Group 1111 Intestinal obstruction without hernia 560	Men	555
Alicante/Alacant	Group 1111 Intestinal obstruction without hernia 560	Women	547
Alicante/Alacant	Group 1112 Intestinal diverticulosis 562	Both sexes	1.180
Alicante/Alacant	Group 1112 Intestinal diverticulosis 562	Men	569
Alicante/Alacant	Group 1112 Intestinal diverticulosis 562	Women	611
Alicante/Alacant	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.423
Alicante/Alacant	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	886
Alicante/Alacant	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	537
Alicante/Alacant	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	904
Alicante/Alacant	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	409
Alicante/Alacant	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	495
Alicante/Alacant	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	493
Alicante/Alacant	Group 1115 Alcoholic hepatitis 5710-5713	Men	409
Alicante/Alacant	Group 1115 Alcoholic hepatitis 5710-5713	Women	84
Alicante/Alacant	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.041
Alicante/Alacant	Group 1116 Other diseases of the liver 570,5714-573	Men	609
Alicante/Alacant	Group 1116 Other diseases of the liver 570,5714-573	Women	432
Alicante/Alacant	Group 1117 Cholelithiasis  574	Both sexes	4.064
Alicante/Alacant	Group 1117 Cholelithiasis  574	Men	1.621
Alicante/Alacant	Group 1117 Cholelithiasis  574	Women	2.443
Alicante/Alacant	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.144
Alicante/Alacant	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	638
Alicante/Alacant	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	506
Alicante/Alacant	Group 1119 Pancreatic diseases 577	Both sexes	1.525
Alicante/Alacant	Group 1119 Pancreatic diseases 577	Men	851
Alicante/Alacant	Group 1119 Pancreatic diseases 577	Women	674
Alicante/Alacant	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.117
Alicante/Alacant	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	641
Alicante/Alacant	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	476
Alicante/Alacant	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.129
Alicante/Alacant	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.239
Alicante/Alacant	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	890
Alicante/Alacant	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.449
Alicante/Alacant	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	912
Alicante/Alacant	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	537
Alicante/Alacant	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	89
Alicante/Alacant	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	46
Alicante/Alacant	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	43
Alicante/Alacant	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	591
Alicante/Alacant	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	281
Alicante/Alacant	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	310
Alicante/Alacant	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	12.368
Alicante/Alacant	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	5.922
Alicante/Alacant	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	6.446
Alicante/Alacant	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Alicante/Alacant	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Alicante/Alacant	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Alicante/Alacant	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Alicante/Alacant	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Alicante/Alacant	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Alicante/Alacant	Group 1303 Internal derangement of knee 717	Both sexes	1.540
Alicante/Alacant	Group 1303 Internal derangement of knee 717	Men	1.070
Alicante/Alacant	Group 1303 Internal derangement of knee 717	Women	470
Alicante/Alacant	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	4.362
Alicante/Alacant	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.858
Alicante/Alacant	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.504
Alicante/Alacant	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	232
Alicante/Alacant	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	108
Alicante/Alacant	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	124
Alicante/Alacant	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	926
Alicante/Alacant	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	489
Alicante/Alacant	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	437
Alicante/Alacant	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	970
Alicante/Alacant	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	499
Alicante/Alacant	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	471
Alicante/Alacant	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	321
Alicante/Alacant	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	130
Alicante/Alacant	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	191
Alicante/Alacant	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.920
Alicante/Alacant	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.003
Alicante/Alacant	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	917
Alicante/Alacant	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.097
Alicante/Alacant	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	765
Alicante/Alacant	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.332
Alicante/Alacant	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	13.130
Alicante/Alacant	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	5.784
Alicante/Alacant	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	7.346
Alicante/Alacant	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.468
Alicante/Alacant	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	478
Alicante/Alacant	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	990
Alicante/Alacant	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.156
Alicante/Alacant	Group 1402 Renal failure  5836-5837, 584-586	Men	692
Alicante/Alacant	Group 1402 Renal failure  5836-5837, 584-586	Women	464
Alicante/Alacant	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.809
Alicante/Alacant	Group 1403 Urolithiasis  592, 594, 7880	Men	1.110
Alicante/Alacant	Group 1403 Urolithiasis  592, 594, 7880	Women	699
Alicante/Alacant	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.250
Alicante/Alacant	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.636
Alicante/Alacant	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.614
Alicante/Alacant	Group 1405 Prostatic hyperplasia  600	Both sexes	919
Alicante/Alacant	Group 1405 Prostatic hyperplasia  600	Men	919
Alicante/Alacant	Group 1405 Prostatic hyperplasia  600	Women	..
Alicante/Alacant	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	830
Alicante/Alacant	Group 1406 Other diseases of the male genital organs    601-608	Men	830
Alicante/Alacant	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Alicante/Alacant	Group 1407 Disorders of breast  610-612	Both sexes	1.290
Alicante/Alacant	Group 1407 Disorders of breast  610-612	Men	108
Alicante/Alacant	Group 1407 Disorders of breast  610-612	Women	1.182
Alicante/Alacant	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	375
Alicante/Alacant	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Alicante/Alacant	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	375
Alicante/Alacant	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	186
Alicante/Alacant	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Alicante/Alacant	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	186
Alicante/Alacant	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.847
Alicante/Alacant	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	11
Alicante/Alacant	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.836
Alicante/Alacant	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.420
Alicante/Alacant	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Alicante/Alacant	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.420
Alicante/Alacant	Group 1501 Legally induced abortion  635	Both sexes	52
Alicante/Alacant	Group 1501 Legally induced abortion  635	Men	..
Alicante/Alacant	Group 1501 Legally induced abortion  635	Women	52
Alicante/Alacant	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.933
Alicante/Alacant	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Alicante/Alacant	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.933
Alicante/Alacant	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	11.226
Alicante/Alacant	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Alicante/Alacant	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	11.226
Alicante/Alacant	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.794
Alicante/Alacant	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Alicante/Alacant	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.794
Alicante/Alacant	Group 1505 Single spontaneous delivery  650	Both sexes	1.247
Alicante/Alacant	Group 1505 Single spontaneous delivery  650	Men	..
Alicante/Alacant	Group 1505 Single spontaneous delivery  650	Women	1.247
Alicante/Alacant	Group 1506 Other deliveries  6695-6697	Both sexes	836
Alicante/Alacant	Group 1506 Other deliveries  6695-6697	Men	..
Alicante/Alacant	Group 1506 Other deliveries  6695-6697	Women	836
Alicante/Alacant	Group 1507 Complications related to the puerperium  670-676	Both sexes	184
Alicante/Alacant	Group 1507 Complications related to the puerperium  670-676	Men	..
Alicante/Alacant	Group 1507 Complications related to the puerperium  670-676	Women	184
Alicante/Alacant	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.148
Alicante/Alacant	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Alicante/Alacant	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.148
Alicante/Alacant	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.552
Alicante/Alacant	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.387
Alicante/Alacant	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.165
Alicante/Alacant	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	670
Alicante/Alacant	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	368
Alicante/Alacant	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	302
Alicante/Alacant	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.882
Alicante/Alacant	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.019
Alicante/Alacant	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	863
Alicante/Alacant	Grupo 1700 Congenital abnormalities  740-759	Both sexes	988
Alicante/Alacant	Grupo 1700 Congenital abnormalities  740-759	Men	600
Alicante/Alacant	Grupo 1700 Congenital abnormalities  740-759	Women	388
Alicante/Alacant	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	10.820
Alicante/Alacant	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	5.791
Alicante/Alacant	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.029
Alicante/Alacant	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.817
Alicante/Alacant	Group 1801 Pain in throat and chest 7841, 7865	Men	1.055
Alicante/Alacant	Group 1801 Pain in throat and chest 7841, 7865	Women	762
Alicante/Alacant	Group 1802 Abdominal pain   7890	Both sexes	1.217
Alicante/Alacant	Group 1802 Abdominal pain   7890	Men	440
Alicante/Alacant	Group 1802 Abdominal pain   7890	Women	777
Alicante/Alacant	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	144
Alicante/Alacant	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	75
Alicante/Alacant	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	69
Alicante/Alacant	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	7.642
Alicante/Alacant	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.221
Alicante/Alacant	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.421
Alicante/Alacant	Group 1900 Injuries and poisoning  800-999	Both sexes	16.974
Alicante/Alacant	Group 1900 Injuries and poisoning  800-999	Men	8.634
Alicante/Alacant	Group 1900 Injuries and poisoning  800-999	Women	8.340
Alicante/Alacant	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	974
Alicante/Alacant	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	549
Alicante/Alacant	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	425
Alicante/Alacant	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	410
Alicante/Alacant	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	285
Alicante/Alacant	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	125
Alicante/Alacant	Group 1903 Radius and ulna fracture 813	Both sexes	1.322
Alicante/Alacant	Group 1903 Radius and ulna fracture 813	Men	573
Alicante/Alacant	Group 1903 Radius and ulna fracture 813	Women	749
Alicante/Alacant	Group 1904 Femur fracture  820-821	Both sexes	2.544
Alicante/Alacant	Group 1904 Femur fracture  820-821	Men	772
Alicante/Alacant	Group 1904 Femur fracture  820-821	Women	1.772
Alicante/Alacant	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.256
Alicante/Alacant	Group 1905 Leg fracture, including the ankle 823-824	Men	611
Alicante/Alacant	Group 1905 Leg fracture, including the ankle 823-824	Women	645
Alicante/Alacant	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	5.245
Alicante/Alacant	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.078
Alicante/Alacant	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.167
Alicante/Alacant	Group 1907 Burns  940-949	Both sexes	131
Alicante/Alacant	Group 1907 Burns  940-949	Men	78
Alicante/Alacant	Group 1907 Burns  940-949	Women	53
Alicante/Alacant	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	583
Alicante/Alacant	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	274
Alicante/Alacant	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	309
Alicante/Alacant	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.831
Alicante/Alacant	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.045
Alicante/Alacant	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.786
Alicante/Alacant	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	69
Alicante/Alacant	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	42
Alicante/Alacant	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	27
Alicante/Alacant	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	609
Alicante/Alacant	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	327
Alicante/Alacant	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	282
Alicante/Alacant	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	4.319
Alicante/Alacant	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.988
Alicante/Alacant	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.331
Alicante/Alacant	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	242
Alicante/Alacant	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	113
Alicante/Alacant	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	129
Alicante/Alacant	Group 2102 Contraceptive management  V25	Both sexes	25
Alicante/Alacant	Group 2102 Contraceptive management  V25	Men	3
Alicante/Alacant	Group 2102 Contraceptive management  V25	Women	22
Alicante/Alacant	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Alicante/Alacant	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Alicante/Alacant	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Alicante/Alacant	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	952
Alicante/Alacant	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	615
Alicante/Alacant	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	337
Alicante/Alacant	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	3.100
Alicante/Alacant	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.257
Alicante/Alacant	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.843
Castell¾n/Castell¾	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	49.559
Castell¾n/Castell¾	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	23.800
Castell¾n/Castell¾	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	25.759
Castell¾n/Castell¾	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.267
Castell¾n/Castell¾	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	710
Castell¾n/Castell¾	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	557
Castell¾n/Castell¾	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	229
Castell¾n/Castell¾	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	130
Castell¾n/Castell¾	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	99
Castell¾n/Castell¾	Group 0102 Imprecise intestinal infections 009	Both sexes	181
Castell¾n/Castell¾	Group 0102 Imprecise intestinal infections 009	Men	90
Castell¾n/Castell¾	Group 0102 Imprecise intestinal infections 009	Women	91
Castell¾n/Castell¾	Group 0103 Tuberculosis 010-018, 137	Both sexes	41
Castell¾n/Castell¾	Group 0103 Tuberculosis 010-018, 137	Men	23
Castell¾n/Castell¾	Group 0103 Tuberculosis 010-018, 137	Women	18
Castell¾n/Castell¾	Group 0104 Septicaemia  038	Both sexes	374
Castell¾n/Castell¾	Group 0104 Septicaemia  038	Men	196
Castell¾n/Castell¾	Group 0104 Septicaemia  038	Women	178
Castell¾n/Castell¾	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	27
Castell¾n/Castell¾	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	19
Castell¾n/Castell¾	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	8
Castell¾n/Castell¾	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	415
Castell¾n/Castell¾	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	252
Castell¾n/Castell¾	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	163
Castell¾n/Castell¾	Group 0200 Neoplasms  140-239	Both sexes	4.941
Castell¾n/Castell¾	Group 0200 Neoplasms  140-239	Men	2.650
Castell¾n/Castell¾	Group 0200 Neoplasms  140-239	Women	2.291
Castell¾n/Castell¾	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	604
Castell¾n/Castell¾	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	363
Castell¾n/Castell¾	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	241
Castell¾n/Castell¾	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	399
Castell¾n/Castell¾	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	335
Castell¾n/Castell¾	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	64
Castell¾n/Castell¾	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	59
Castell¾n/Castell¾	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	31
Castell¾n/Castell¾	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	28
Castell¾n/Castell¾	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	439
Castell¾n/Castell¾	Group 0204 Malignant neoplasm of breast  174-175	Men	9
Castell¾n/Castell¾	Group 0204 Malignant neoplasm of breast  174-175	Women	430
Castell¾n/Castell¾	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	141
Castell¾n/Castell¾	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Castell¾n/Castell¾	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	141
Castell¾n/Castell¾	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	78
Castell¾n/Castell¾	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Castell¾n/Castell¾	Group 0206 Malignant neoplasm of ovary  1830	Women	78
Castell¾n/Castell¾	Group 0207 Malignant neoplasm of prostate  185	Both sexes	220
Castell¾n/Castell¾	Group 0207 Malignant neoplasm of prostate  185	Men	220
Castell¾n/Castell¾	Group 0207 Malignant neoplasm of prostate  185	Women	..
Castell¾n/Castell¾	Group 0208 Malignant neoplasm of bladder  188	Both sexes	544
Castell¾n/Castell¾	Group 0208 Malignant neoplasm of bladder  188	Men	466
Castell¾n/Castell¾	Group 0208 Malignant neoplasm of bladder  188	Women	78
Castell¾n/Castell¾	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.533
Castell¾n/Castell¾	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	936
Castell¾n/Castell¾	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	597
Castell¾n/Castell¾	Group 0210 Carcinoma in situ  230-234	Both sexes	69
Castell¾n/Castell¾	Group 0210 Carcinoma in situ  230-234	Men	23
Castell¾n/Castell¾	Group 0210 Carcinoma in situ  230-234	Women	46
Castell¾n/Castell¾	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	87
Castell¾n/Castell¾	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	50
Castell¾n/Castell¾	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	37
Castell¾n/Castell¾	Grupo 0212 Leiomyoma of uterus  218	Both sexes	228
Castell¾n/Castell¾	Grupo 0212 Leiomyoma of uterus  218	Men	..
Castell¾n/Castell¾	Grupo 0212 Leiomyoma of uterus  218	Women	228
Castell¾n/Castell¾	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	540
Castell¾n/Castell¾	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	217
Castell¾n/Castell¾	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	323
Castell¾n/Castell¾	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	426
Castell¾n/Castell¾	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	218
Castell¾n/Castell¾	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	208
Castell¾n/Castell¾	Group 0301 Anaemias 280-285	Both sexes	245
Castell¾n/Castell¾	Group 0301 Anaemias 280-285	Men	132
Castell¾n/Castell¾	Group 0301 Anaemias 280-285	Women	113
Castell¾n/Castell¾	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	181
Castell¾n/Castell¾	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	86
Castell¾n/Castell¾	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	95
Castell¾n/Castell¾	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	916
Castell¾n/Castell¾	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	355
Castell¾n/Castell¾	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	561
Castell¾n/Castell¾	Group 0401 Diabetes mellitus  249-250	Both sexes	337
Castell¾n/Castell¾	Group 0401 Diabetes mellitus  249-250	Men	193
Castell¾n/Castell¾	Group 0401 Diabetes mellitus  249-250	Women	144
Castell¾n/Castell¾	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	579
Castell¾n/Castell¾	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	162
Castell¾n/Castell¾	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	417
Castell¾n/Castell¾	Group 0500 Mental disorders  290-319	Both sexes	774
Castell¾n/Castell¾	Group 0500 Mental disorders  290-319	Men	447
Castell¾n/Castell¾	Group 0500 Mental disorders  290-319	Women	327
Castell¾n/Castell¾	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	14
Castell¾n/Castell¾	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	10
Castell¾n/Castell¾	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	4
Castell¾n/Castell¾	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	68
Castell¾n/Castell¾	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	62
Castell¾n/Castell¾	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	6
Castell¾n/Castell¾	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	52
Castell¾n/Castell¾	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	40
Castell¾n/Castell¾	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	12
Castell¾n/Castell¾	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	268
Castell¾n/Castell¾	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	175
Castell¾n/Castell¾	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	93
Castell¾n/Castell¾	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	200
Castell¾n/Castell¾	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	78
Castell¾n/Castell¾	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	122
Castell¾n/Castell¾	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	172
Castell¾n/Castell¾	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	82
Castell¾n/Castell¾	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	90
Castell¾n/Castell¾	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	916
Castell¾n/Castell¾	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	479
Castell¾n/Castell¾	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	437
Castell¾n/Castell¾	Group 0601 Alzheimer's disease  3310	Both sexes	14
Castell¾n/Castell¾	Group 0601 Alzheimer's disease  3310	Men	5
Castell¾n/Castell¾	Group 0601 Alzheimer's disease  3310	Women	9
Castell¾n/Castell¾	Group 0602 Multiple sclerosis 340	Both sexes	24
Castell¾n/Castell¾	Group 0602 Multiple sclerosis 340	Men	9
Castell¾n/Castell¾	Group 0602 Multiple sclerosis 340	Women	15
Castell¾n/Castell¾	Group 0603 Epilepsy  345	Both sexes	221
Castell¾n/Castell¾	Group 0603 Epilepsy  345	Men	134
Castell¾n/Castell¾	Group 0603 Epilepsy  345	Women	87
Castell¾n/Castell¾	Group 0604 Transient cerebral ischemia 435	Both sexes	178
Castell¾n/Castell¾	Group 0604 Transient cerebral ischemia 435	Men	91
Castell¾n/Castell¾	Group 0604 Transient cerebral ischemia 435	Women	87
Castell¾n/Castell¾	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	479
Castell¾n/Castell¾	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	240
Castell¾n/Castell¾	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	239
Castell¾n/Castell¾	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	241
Castell¾n/Castell¾	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	125
Castell¾n/Castell¾	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	116
Castell¾n/Castell¾	Grupo 0701 Cataract  366	Both sexes	34
Castell¾n/Castell¾	Grupo 0701 Cataract  366	Men	19
Castell¾n/Castell¾	Grupo 0701 Cataract  366	Women	15
Castell¾n/Castell¾	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	207
Castell¾n/Castell¾	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	106
Castell¾n/Castell¾	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	101
Castell¾n/Castell¾	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	167
Castell¾n/Castell¾	Group 0800 Diseases of the ear and the mastoid  380-389	Men	83
Castell¾n/Castell¾	Group 0800 Diseases of the ear and the mastoid  380-389	Women	84
Castell¾n/Castell¾	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	6.271
Castell¾n/Castell¾	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	3.546
Castell¾n/Castell¾	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.725
Castell¾n/Castell¾	Group 0901 Hypertensive disease  401-405	Both sexes	271
Castell¾n/Castell¾	Group 0901 Hypertensive disease  401-405	Men	148
Castell¾n/Castell¾	Group 0901 Hypertensive disease  401-405	Women	123
Castell¾n/Castell¾	Group 0902 Angina pectoris  4111, 413	Both sexes	316
Castell¾n/Castell¾	Group 0902 Angina pectoris  4111, 413	Men	203
Castell¾n/Castell¾	Group 0902 Angina pectoris  4111, 413	Women	113
Castell¾n/Castell¾	Group 0903 Acute myocardial infarction  410	Both sexes	504
Castell¾n/Castell¾	Group 0903 Acute myocardial infarction  410	Men	380
Castell¾n/Castell¾	Group 0903 Acute myocardial infarction  410	Women	124
Castell¾n/Castell¾	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	339
Castell¾n/Castell¾	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	248
Castell¾n/Castell¾	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	91
Castell¾n/Castell¾	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	122
Castell¾n/Castell¾	Group 0905 Diseases of the lungs circulation 415-417	Men	47
Castell¾n/Castell¾	Group 0905 Diseases of the lungs circulation 415-417	Women	75
Castell¾n/Castell¾	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	834
Castell¾n/Castell¾	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	444
Castell¾n/Castell¾	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	390
Castell¾n/Castell¾	Grupo 0907 Heart failure  428	Both sexes	1.407
Castell¾n/Castell¾	Grupo 0907 Heart failure  428	Men	659
Castell¾n/Castell¾	Grupo 0907 Heart failure  428	Women	748
Castell¾n/Castell¾	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.229
Castell¾n/Castell¾	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	698
Castell¾n/Castell¾	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	531
Castell¾n/Castell¾	Grupo 0909 Atherosclerosis  440	Both sexes	113
Castell¾n/Castell¾	Grupo 0909 Atherosclerosis  440	Men	85
Castell¾n/Castell¾	Grupo 0909 Atherosclerosis  440	Women	28
Castell¾n/Castell¾	Group 0910 Varicose veins of lower extremities 454	Both sexes	170
Castell¾n/Castell¾	Group 0910 Varicose veins of lower extremities 454	Men	64
Castell¾n/Castell¾	Group 0910 Varicose veins of lower extremities 454	Women	106
Castell¾n/Castell¾	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	966
Castell¾n/Castell¾	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	570
Castell¾n/Castell¾	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	396
Castell¾n/Castell¾	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.935
Castell¾n/Castell¾	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.421
Castell¾n/Castell¾	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.514
Castell¾n/Castell¾	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	409
Castell¾n/Castell¾	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	233
Castell¾n/Castell¾	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	176
Castell¾n/Castell¾	Group 1002 Pneumonia 480-486	Both sexes	1.441
Castell¾n/Castell¾	Group 1002 Pneumonia 480-486	Men	850
Castell¾n/Castell¾	Group 1002 Pneumonia 480-486	Women	591
Castell¾n/Castell¾	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	708
Castell¾n/Castell¾	Group 1003 Acute bronchitis and bronchiolitis  466	Men	325
Castell¾n/Castell¾	Group 1003 Acute bronchitis and bronchiolitis  466	Women	383
Castell¾n/Castell¾	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	548
Castell¾n/Castell¾	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	280
Castell¾n/Castell¾	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	268
Castell¾n/Castell¾	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	290
Castell¾n/Castell¾	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	183
Castell¾n/Castell¾	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	107
Castell¾n/Castell¾	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.177
Castell¾n/Castell¾	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	920
Castell¾n/Castell¾	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	257
Castell¾n/Castell¾	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	221
Castell¾n/Castell¾	Group 1007 Asthma 4930-4931,4938-4939	Men	62
Castell¾n/Castell¾	Group 1007 Asthma 4930-4931,4938-4939	Women	159
Castell¾n/Castell¾	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.141
Castell¾n/Castell¾	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	568
Castell¾n/Castell¾	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	573
Castell¾n/Castell¾	Group 1100 Diseases of the digestive system  520-579	Both sexes	6.372
Castell¾n/Castell¾	Group 1100 Diseases of the digestive system  520-579	Men	3.646
Castell¾n/Castell¾	Group 1100 Diseases of the digestive system  520-579	Women	2.726
Castell¾n/Castell¾	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	52
Castell¾n/Castell¾	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	18
Castell¾n/Castell¾	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	34
Castell¾n/Castell¾	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	68
Castell¾n/Castell¾	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	39
Castell¾n/Castell¾	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	29
Castell¾n/Castell¾	Group 1103 Diseases of the esophagus 530	Both sexes	88
Castell¾n/Castell¾	Group 1103 Diseases of the esophagus 530	Men	54
Castell¾n/Castell¾	Group 1103 Diseases of the esophagus 530	Women	34
Castell¾n/Castell¾	Group 1104 Peptic ulcer 531-534	Both sexes	173
Castell¾n/Castell¾	Group 1104 Peptic ulcer 531-534	Men	122
Castell¾n/Castell¾	Group 1104 Peptic ulcer 531-534	Women	51
Castell¾n/Castell¾	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	192
Castell¾n/Castell¾	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	96
Castell¾n/Castell¾	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	96
Castell¾n/Castell¾	Group 1106 Appendicitis  540-543	Both sexes	521
Castell¾n/Castell¾	Group 1106 Appendicitis  540-543	Men	284
Castell¾n/Castell¾	Group 1106 Appendicitis  540-543	Women	237
Castell¾n/Castell¾	Group 1107 Inguinal hernia  550	Both sexes	725
Castell¾n/Castell¾	Group 1107 Inguinal hernia  550	Men	639
Castell¾n/Castell¾	Group 1107 Inguinal hernia  550	Women	86
Castell¾n/Castell¾	Group 1108 Other abdominal hernia  551-553	Both sexes	577
Castell¾n/Castell¾	Group 1108 Other abdominal hernia  551-553	Men	280
Castell¾n/Castell¾	Group 1108 Other abdominal hernia  551-553	Women	297
Castell¾n/Castell¾	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	105
Castell¾n/Castell¾	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	51
Castell¾n/Castell¾	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	54
Castell¾n/Castell¾	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	281
Castell¾n/Castell¾	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	133
Castell¾n/Castell¾	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	148
Castell¾n/Castell¾	Group 1111 Intestinal obstruction without hernia 560	Both sexes	281
Castell¾n/Castell¾	Group 1111 Intestinal obstruction without hernia 560	Men	154
Castell¾n/Castell¾	Group 1111 Intestinal obstruction without hernia 560	Women	127
Castell¾n/Castell¾	Group 1112 Intestinal diverticulosis 562	Both sexes	199
Castell¾n/Castell¾	Group 1112 Intestinal diverticulosis 562	Men	96
Castell¾n/Castell¾	Group 1112 Intestinal diverticulosis 562	Women	103
Castell¾n/Castell¾	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	392
Castell¾n/Castell¾	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	251
Castell¾n/Castell¾	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	141
Castell¾n/Castell¾	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	130
Castell¾n/Castell¾	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	76
Castell¾n/Castell¾	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	54
Castell¾n/Castell¾	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	131
Castell¾n/Castell¾	Group 1115 Alcoholic hepatitis 5710-5713	Men	115
Castell¾n/Castell¾	Group 1115 Alcoholic hepatitis 5710-5713	Women	16
Castell¾n/Castell¾	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	195
Castell¾n/Castell¾	Group 1116 Other diseases of the liver 570,5714-573	Men	118
Castell¾n/Castell¾	Group 1116 Other diseases of the liver 570,5714-573	Women	77
Castell¾n/Castell¾	Group 1117 Cholelithiasis  574	Both sexes	1.242
Castell¾n/Castell¾	Group 1117 Cholelithiasis  574	Men	549
Castell¾n/Castell¾	Group 1117 Cholelithiasis  574	Women	693
Castell¾n/Castell¾	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	398
Castell¾n/Castell¾	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	206
Castell¾n/Castell¾	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	192
Castell¾n/Castell¾	Group 1119 Pancreatic diseases 577	Both sexes	335
Castell¾n/Castell¾	Group 1119 Pancreatic diseases 577	Men	206
Castell¾n/Castell¾	Group 1119 Pancreatic diseases 577	Women	129
Castell¾n/Castell¾	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	287
Castell¾n/Castell¾	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	159
Castell¾n/Castell¾	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	128
Castell¾n/Castell¾	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	389
Castell¾n/Castell¾	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	227
Castell¾n/Castell¾	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	162
Castell¾n/Castell¾	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	245
Castell¾n/Castell¾	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	154
Castell¾n/Castell¾	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	91
Castell¾n/Castell¾	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	21
Castell¾n/Castell¾	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	10
Castell¾n/Castell¾	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	11
Castell¾n/Castell¾	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	123
Castell¾n/Castell¾	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	63
Castell¾n/Castell¾	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	60
Castell¾n/Castell¾	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.008
Castell¾n/Castell¾	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.572
Castell¾n/Castell¾	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.436
Castell¾n/Castell¾	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Castell¾n/Castell¾	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Castell¾n/Castell¾	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Castell¾n/Castell¾	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Castell¾n/Castell¾	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Castell¾n/Castell¾	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Castell¾n/Castell¾	Group 1303 Internal derangement of knee 717	Both sexes	484
Castell¾n/Castell¾	Group 1303 Internal derangement of knee 717	Men	377
Castell¾n/Castell¾	Group 1303 Internal derangement of knee 717	Women	107
Castell¾n/Castell¾	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.061
Castell¾n/Castell¾	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	492
Castell¾n/Castell¾	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	569
Castell¾n/Castell¾	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	48
Castell¾n/Castell¾	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	19
Castell¾n/Castell¾	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	29
Castell¾n/Castell¾	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	131
Castell¾n/Castell¾	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	81
Castell¾n/Castell¾	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	50
Castell¾n/Castell¾	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	234
Castell¾n/Castell¾	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	135
Castell¾n/Castell¾	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	99
Castell¾n/Castell¾	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	76
Castell¾n/Castell¾	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	50
Castell¾n/Castell¾	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	26
Castell¾n/Castell¾	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	378
Castell¾n/Castell¾	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	196
Castell¾n/Castell¾	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	182
Castell¾n/Castell¾	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	596
Castell¾n/Castell¾	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	222
Castell¾n/Castell¾	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	374
Castell¾n/Castell¾	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.633
Castell¾n/Castell¾	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.688
Castell¾n/Castell¾	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.945
Castell¾n/Castell¾	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	453
Castell¾n/Castell¾	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	173
Castell¾n/Castell¾	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	280
Castell¾n/Castell¾	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	258
Castell¾n/Castell¾	Group 1402 Renal failure  5836-5837, 584-586	Men	158
Castell¾n/Castell¾	Group 1402 Renal failure  5836-5837, 584-586	Women	100
Castell¾n/Castell¾	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	473
Castell¾n/Castell¾	Group 1403 Urolithiasis  592, 594, 7880	Men	288
Castell¾n/Castell¾	Group 1403 Urolithiasis  592, 594, 7880	Women	185
Castell¾n/Castell¾	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	860
Castell¾n/Castell¾	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	434
Castell¾n/Castell¾	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	426
Castell¾n/Castell¾	Group 1405 Prostatic hyperplasia  600	Both sexes	330
Castell¾n/Castell¾	Group 1405 Prostatic hyperplasia  600	Men	330
Castell¾n/Castell¾	Group 1405 Prostatic hyperplasia  600	Women	..
Castell¾n/Castell¾	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	279
Castell¾n/Castell¾	Group 1406 Other diseases of the male genital organs    601-608	Men	279
Castell¾n/Castell¾	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Castell¾n/Castell¾	Group 1407 Disorders of breast  610-612	Both sexes	193
Castell¾n/Castell¾	Group 1407 Disorders of breast  610-612	Men	17
Castell¾n/Castell¾	Group 1407 Disorders of breast  610-612	Women	176
Castell¾n/Castell¾	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	95
Castell¾n/Castell¾	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Castell¾n/Castell¾	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	95
Castell¾n/Castell¾	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	60
Castell¾n/Castell¾	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Castell¾n/Castell¾	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	60
Castell¾n/Castell¾	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	632
Castell¾n/Castell¾	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	9
Castell¾n/Castell¾	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	623
Castell¾n/Castell¾	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	5.793
Castell¾n/Castell¾	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Castell¾n/Castell¾	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	5.793
Castell¾n/Castell¾	Group 1501 Legally induced abortion  635	Both sexes	27
Castell¾n/Castell¾	Group 1501 Legally induced abortion  635	Men	..
Castell¾n/Castell¾	Group 1501 Legally induced abortion  635	Women	27
Castell¾n/Castell¾	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	251
Castell¾n/Castell¾	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Castell¾n/Castell¾	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	251
Castell¾n/Castell¾	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	3.896
Castell¾n/Castell¾	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Castell¾n/Castell¾	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	3.896
Castell¾n/Castell¾	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	785
Castell¾n/Castell¾	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Castell¾n/Castell¾	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	785
Castell¾n/Castell¾	Group 1505 Single spontaneous delivery  650	Both sexes	188
Castell¾n/Castell¾	Group 1505 Single spontaneous delivery  650	Men	..
Castell¾n/Castell¾	Group 1505 Single spontaneous delivery  650	Women	188
Castell¾n/Castell¾	Group 1506 Other deliveries  6695-6697	Both sexes	42
Castell¾n/Castell¾	Group 1506 Other deliveries  6695-6697	Men	..
Castell¾n/Castell¾	Group 1506 Other deliveries  6695-6697	Women	42
Castell¾n/Castell¾	Group 1507 Complications related to the puerperium  670-676	Both sexes	39
Castell¾n/Castell¾	Group 1507 Complications related to the puerperium  670-676	Men	..
Castell¾n/Castell¾	Group 1507 Complications related to the puerperium  670-676	Women	39
Castell¾n/Castell¾	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	565
Castell¾n/Castell¾	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Castell¾n/Castell¾	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	565
Castell¾n/Castell¾	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	972
Castell¾n/Castell¾	Group 1600 Some disorders originating in the perinatal period  760-779	Men	525
Castell¾n/Castell¾	Group 1600 Some disorders originating in the perinatal period  760-779	Women	447
Castell¾n/Castell¾	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	305
Castell¾n/Castell¾	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	153
Castell¾n/Castell¾	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	152
Castell¾n/Castell¾	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	667
Castell¾n/Castell¾	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	372
Castell¾n/Castell¾	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	295
Castell¾n/Castell¾	Grupo 1700 Congenital abnormalities  740-759	Both sexes	281
Castell¾n/Castell¾	Grupo 1700 Congenital abnormalities  740-759	Men	178
Castell¾n/Castell¾	Grupo 1700 Congenital abnormalities  740-759	Women	103
Castell¾n/Castell¾	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.783
Castell¾n/Castell¾	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.000
Castell¾n/Castell¾	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	783
Castell¾n/Castell¾	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	267
Castell¾n/Castell¾	Group 1801 Pain in throat and chest 7841, 7865	Men	160
Castell¾n/Castell¾	Group 1801 Pain in throat and chest 7841, 7865	Women	107
Castell¾n/Castell¾	Group 1802 Abdominal pain   7890	Both sexes	223
Castell¾n/Castell¾	Group 1802 Abdominal pain   7890	Men	82
Castell¾n/Castell¾	Group 1802 Abdominal pain   7890	Women	141
Castell¾n/Castell¾	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	26
Castell¾n/Castell¾	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	13
Castell¾n/Castell¾	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	13
Castell¾n/Castell¾	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.267
Castell¾n/Castell¾	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	745
Castell¾n/Castell¾	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	522
Castell¾n/Castell¾	Group 1900 Injuries and poisoning  800-999	Both sexes	4.351
Castell¾n/Castell¾	Group 1900 Injuries and poisoning  800-999	Men	2.253
Castell¾n/Castell¾	Group 1900 Injuries and poisoning  800-999	Women	2.098
Castell¾n/Castell¾	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	311
Castell¾n/Castell¾	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	184
Castell¾n/Castell¾	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	127
Castell¾n/Castell¾	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	122
Castell¾n/Castell¾	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	72
Castell¾n/Castell¾	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	50
Castell¾n/Castell¾	Group 1903 Radius and ulna fracture 813	Both sexes	301
Castell¾n/Castell¾	Group 1903 Radius and ulna fracture 813	Men	147
Castell¾n/Castell¾	Group 1903 Radius and ulna fracture 813	Women	154
Castell¾n/Castell¾	Group 1904 Femur fracture  820-821	Both sexes	749
Castell¾n/Castell¾	Group 1904 Femur fracture  820-821	Men	220
Castell¾n/Castell¾	Group 1904 Femur fracture  820-821	Women	529
Castell¾n/Castell¾	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	317
Castell¾n/Castell¾	Group 1905 Leg fracture, including the ankle 823-824	Men	166
Castell¾n/Castell¾	Group 1905 Leg fracture, including the ankle 823-824	Women	151
Castell¾n/Castell¾	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.245
Castell¾n/Castell¾	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	773
Castell¾n/Castell¾	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	472
Castell¾n/Castell¾	Group 1907 Burns  940-949	Both sexes	6
Castell¾n/Castell¾	Group 1907 Burns  940-949	Men	3
Castell¾n/Castell¾	Group 1907 Burns  940-949	Women	3
Castell¾n/Castell¾	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	118
Castell¾n/Castell¾	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	55
Castell¾n/Castell¾	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	63
Castell¾n/Castell¾	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.009
Castell¾n/Castell¾	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	537
Castell¾n/Castell¾	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	472
Castell¾n/Castell¾	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	7
Castell¾n/Castell¾	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Castell¾n/Castell¾	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	4
Castell¾n/Castell¾	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	166
Castell¾n/Castell¾	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	93
Castell¾n/Castell¾	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	73
Castell¾n/Castell¾	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.123
Castell¾n/Castell¾	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	677
Castell¾n/Castell¾	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	446
Castell¾n/Castell¾	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	50
Castell¾n/Castell¾	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	31
Castell¾n/Castell¾	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	19
Castell¾n/Castell¾	Group 2102 Contraceptive management  V25	Both sexes	44
Castell¾n/Castell¾	Group 2102 Contraceptive management  V25	Men	1
Castell¾n/Castell¾	Group 2102 Contraceptive management  V25	Women	43
Castell¾n/Castell¾	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Castell¾n/Castell¾	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Castell¾n/Castell¾	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Castell¾n/Castell¾	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	467
Castell¾n/Castell¾	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	338
Castell¾n/Castell¾	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	129
Castell¾n/Castell¾	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	562
Castell¾n/Castell¾	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	307
Castell¾n/Castell¾	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	255
Valencia/ValÞncia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	261.112
Valencia/ValÞncia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	124.129
Valencia/ValÞncia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	136.983
Valencia/ValÞncia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	5.220
Valencia/ValÞncia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.902
Valencia/ValÞncia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.318
Valencia/ValÞncia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	902
Valencia/ValÞncia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	474
Valencia/ValÞncia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	428
Valencia/ValÞncia	Group 0102 Imprecise intestinal infections 009	Both sexes	352
Valencia/ValÞncia	Group 0102 Imprecise intestinal infections 009	Men	181
Valencia/ValÞncia	Group 0102 Imprecise intestinal infections 009	Women	171
Valencia/ValÞncia	Group 0103 Tuberculosis 010-018, 137	Both sexes	207
Valencia/ValÞncia	Group 0103 Tuberculosis 010-018, 137	Men	141
Valencia/ValÞncia	Group 0103 Tuberculosis 010-018, 137	Women	66
Valencia/ValÞncia	Group 0104 Septicaemia  038	Both sexes	1.613
Valencia/ValÞncia	Group 0104 Septicaemia  038	Men	874
Valencia/ValÞncia	Group 0104 Septicaemia  038	Women	739
Valencia/ValÞncia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	244
Valencia/ValÞncia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	164
Valencia/ValÞncia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	80
Valencia/ValÞncia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.902
Valencia/ValÞncia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	1.068
Valencia/ValÞncia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	834
Valencia/ValÞncia	Group 0200 Neoplasms  140-239	Both sexes	29.204
Valencia/ValÞncia	Group 0200 Neoplasms  140-239	Men	15.485
Valencia/ValÞncia	Group 0200 Neoplasms  140-239	Women	13.719
Valencia/ValÞncia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	2.784
Valencia/ValÞncia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.653
Valencia/ValÞncia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.131
Valencia/ValÞncia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	2.439
Valencia/ValÞncia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.947
Valencia/ValÞncia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	492
Valencia/ValÞncia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	483
Valencia/ValÞncia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	284
Valencia/ValÞncia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	199
Valencia/ValÞncia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	2.616
Valencia/ValÞncia	Group 0204 Malignant neoplasm of breast  174-175	Men	13
Valencia/ValÞncia	Group 0204 Malignant neoplasm of breast  174-175	Women	2.603
Valencia/ValÞncia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	622
Valencia/ValÞncia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Valencia/ValÞncia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	622
Valencia/ValÞncia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	416
Valencia/ValÞncia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Valencia/ValÞncia	Group 0206 Malignant neoplasm of ovary  1830	Women	416
Valencia/ValÞncia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.210
Valencia/ValÞncia	Group 0207 Malignant neoplasm of prostate  185	Men	1.210
Valencia/ValÞncia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Valencia/ValÞncia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	3.352
Valencia/ValÞncia	Group 0208 Malignant neoplasm of bladder  188	Men	2.854
Valencia/ValÞncia	Group 0208 Malignant neoplasm of bladder  188	Women	498
Valencia/ValÞncia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	9.376
Valencia/ValÞncia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	5.602
Valencia/ValÞncia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	3.774
Valencia/ValÞncia	Group 0210 Carcinoma in situ  230-234	Both sexes	450
Valencia/ValÞncia	Group 0210 Carcinoma in situ  230-234	Men	137
Valencia/ValÞncia	Group 0210 Carcinoma in situ  230-234	Women	313
Valencia/ValÞncia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	278
Valencia/ValÞncia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	166
Valencia/ValÞncia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	112
Valencia/ValÞncia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.521
Valencia/ValÞncia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Valencia/ValÞncia	Grupo 0212 Leiomyoma of uterus  218	Women	1.521
Valencia/ValÞncia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.657
Valencia/ValÞncia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.619
Valencia/ValÞncia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	2.038
Valencia/ValÞncia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.190
Valencia/ValÞncia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.081
Valencia/ValÞncia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.109
Valencia/ValÞncia	Group 0301 Anaemias 280-285	Both sexes	1.041
Valencia/ValÞncia	Group 0301 Anaemias 280-285	Men	478
Valencia/ValÞncia	Group 0301 Anaemias 280-285	Women	563
Valencia/ValÞncia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	1.149
Valencia/ValÞncia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	603
Valencia/ValÞncia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	546
Valencia/ValÞncia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	5.249
Valencia/ValÞncia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	2.007
Valencia/ValÞncia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	3.242
Valencia/ValÞncia	Group 0401 Diabetes mellitus  249-250	Both sexes	1.623
Valencia/ValÞncia	Group 0401 Diabetes mellitus  249-250	Men	947
Valencia/ValÞncia	Group 0401 Diabetes mellitus  249-250	Women	676
Valencia/ValÞncia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.626
Valencia/ValÞncia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	1.060
Valencia/ValÞncia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.566
Valencia/ValÞncia	Group 0500 Mental disorders  290-319	Both sexes	5.827
Valencia/ValÞncia	Group 0500 Mental disorders  290-319	Men	2.963
Valencia/ValÞncia	Group 0500 Mental disorders  290-319	Women	2.864
Valencia/ValÞncia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	155
Valencia/ValÞncia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	67
Valencia/ValÞncia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	88
Valencia/ValÞncia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	390
Valencia/ValÞncia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	302
Valencia/ValÞncia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	88
Valencia/ValÞncia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	342
Valencia/ValÞncia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	235
Valencia/ValÞncia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	107
Valencia/ValÞncia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.716
Valencia/ValÞncia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	1.006
Valencia/ValÞncia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	710
Valencia/ValÞncia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.300
Valencia/ValÞncia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	588
Valencia/ValÞncia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	712
Valencia/ValÞncia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.924
Valencia/ValÞncia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	765
Valencia/ValÞncia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.159
Valencia/ValÞncia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.460
Valencia/ValÞncia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.722
Valencia/ValÞncia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.738
Valencia/ValÞncia	Group 0601 Alzheimer's disease  3310	Both sexes	95
Valencia/ValÞncia	Group 0601 Alzheimer's disease  3310	Men	31
Valencia/ValÞncia	Group 0601 Alzheimer's disease  3310	Women	64
Valencia/ValÞncia	Group 0602 Multiple sclerosis 340	Both sexes	139
Valencia/ValÞncia	Group 0602 Multiple sclerosis 340	Men	39
Valencia/ValÞncia	Group 0602 Multiple sclerosis 340	Women	100
Valencia/ValÞncia	Group 0603 Epilepsy  345	Both sexes	1.264
Valencia/ValÞncia	Group 0603 Epilepsy  345	Men	704
Valencia/ValÞncia	Group 0603 Epilepsy  345	Women	560
Valencia/ValÞncia	Group 0604 Transient cerebral ischemia 435	Both sexes	749
Valencia/ValÞncia	Group 0604 Transient cerebral ischemia 435	Men	409
Valencia/ValÞncia	Group 0604 Transient cerebral ischemia 435	Women	340
Valencia/ValÞncia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.213
Valencia/ValÞncia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.539
Valencia/ValÞncia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.674
Valencia/ValÞncia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.360
Valencia/ValÞncia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	751
Valencia/ValÞncia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	609
Valencia/ValÞncia	Grupo 0701 Cataract  366	Both sexes	148
Valencia/ValÞncia	Grupo 0701 Cataract  366	Men	75
Valencia/ValÞncia	Grupo 0701 Cataract  366	Women	73
Valencia/ValÞncia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.212
Valencia/ValÞncia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	676
Valencia/ValÞncia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	536
Valencia/ValÞncia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.403
Valencia/ValÞncia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	663
Valencia/ValÞncia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	740
Valencia/ValÞncia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	30.528
Valencia/ValÞncia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	17.253
Valencia/ValÞncia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	13.275
Valencia/ValÞncia	Group 0901 Hypertensive disease  401-405	Both sexes	781
Valencia/ValÞncia	Group 0901 Hypertensive disease  401-405	Men	374
Valencia/ValÞncia	Group 0901 Hypertensive disease  401-405	Women	407
Valencia/ValÞncia	Group 0902 Angina pectoris  4111, 413	Both sexes	1.547
Valencia/ValÞncia	Group 0902 Angina pectoris  4111, 413	Men	1.019
Valencia/ValÞncia	Group 0902 Angina pectoris  4111, 413	Women	528
Valencia/ValÞncia	Group 0903 Acute myocardial infarction  410	Both sexes	2.681
Valencia/ValÞncia	Group 0903 Acute myocardial infarction  410	Men	1.880
Valencia/ValÞncia	Group 0903 Acute myocardial infarction  410	Women	801
Valencia/ValÞncia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2.111
Valencia/ValÞncia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.583
Valencia/ValÞncia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	528
Valencia/ValÞncia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.007
Valencia/ValÞncia	Group 0905 Diseases of the lungs circulation 415-417	Men	445
Valencia/ValÞncia	Group 0905 Diseases of the lungs circulation 415-417	Women	562
Valencia/ValÞncia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	3.655
Valencia/ValÞncia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.960
Valencia/ValÞncia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.695
Valencia/ValÞncia	Grupo 0907 Heart failure  428	Both sexes	5.749
Valencia/ValÞncia	Grupo 0907 Heart failure  428	Men	2.686
Valencia/ValÞncia	Grupo 0907 Heart failure  428	Women	3.063
Valencia/ValÞncia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	5.781
Valencia/ValÞncia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	3.132
Valencia/ValÞncia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.649
Valencia/ValÞncia	Grupo 0909 Atherosclerosis  440	Both sexes	921
Valencia/ValÞncia	Grupo 0909 Atherosclerosis  440	Men	721
Valencia/ValÞncia	Grupo 0909 Atherosclerosis  440	Women	200
Valencia/ValÞncia	Group 0910 Varicose veins of lower extremities 454	Both sexes	698
Valencia/ValÞncia	Group 0910 Varicose veins of lower extremities 454	Men	223
Valencia/ValÞncia	Group 0910 Varicose veins of lower extremities 454	Women	475
Valencia/ValÞncia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	5.597
Valencia/ValÞncia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.230
Valencia/ValÞncia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.367
Valencia/ValÞncia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	28.649
Valencia/ValÞncia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	16.499
Valencia/ValÞncia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	12.150
Valencia/ValÞncia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.718
Valencia/ValÞncia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	917
Valencia/ValÞncia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	801
Valencia/ValÞncia	Group 1002 Pneumonia 480-486	Both sexes	7.056
Valencia/ValÞncia	Group 1002 Pneumonia 480-486	Men	4.078
Valencia/ValÞncia	Group 1002 Pneumonia 480-486	Women	2.978
Valencia/ValÞncia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.507
Valencia/ValÞncia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.301
Valencia/ValÞncia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.206
Valencia/ValÞncia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	2.189
Valencia/ValÞncia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.231
Valencia/ValÞncia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	958
Valencia/ValÞncia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	2.201
Valencia/ValÞncia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.332
Valencia/ValÞncia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	869
Valencia/ValÞncia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	3.574
Valencia/ValÞncia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.766
Valencia/ValÞncia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	808
Valencia/ValÞncia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	811
Valencia/ValÞncia	Group 1007 Asthma 4930-4931,4938-4939	Men	245
Valencia/ValÞncia	Group 1007 Asthma 4930-4931,4938-4939	Women	566
Valencia/ValÞncia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	8.593
Valencia/ValÞncia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	4.629
Valencia/ValÞncia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	3.964
Valencia/ValÞncia	Group 1100 Diseases of the digestive system  520-579	Both sexes	31.955
Valencia/ValÞncia	Group 1100 Diseases of the digestive system  520-579	Men	17.678
Valencia/ValÞncia	Group 1100 Diseases of the digestive system  520-579	Women	14.277
Valencia/ValÞncia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	825
Valencia/ValÞncia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	391
Valencia/ValÞncia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	434
Valencia/ValÞncia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	570
Valencia/ValÞncia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	301
Valencia/ValÞncia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	269
Valencia/ValÞncia	Group 1103 Diseases of the esophagus 530	Both sexes	559
Valencia/ValÞncia	Group 1103 Diseases of the esophagus 530	Men	338
Valencia/ValÞncia	Group 1103 Diseases of the esophagus 530	Women	221
Valencia/ValÞncia	Group 1104 Peptic ulcer 531-534	Both sexes	651
Valencia/ValÞncia	Group 1104 Peptic ulcer 531-534	Men	476
Valencia/ValÞncia	Group 1104 Peptic ulcer 531-534	Women	175
Valencia/ValÞncia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	878
Valencia/ValÞncia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	437
Valencia/ValÞncia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	441
Valencia/ValÞncia	Group 1106 Appendicitis  540-543	Both sexes	2.784
Valencia/ValÞncia	Group 1106 Appendicitis  540-543	Men	1.606
Valencia/ValÞncia	Group 1106 Appendicitis  540-543	Women	1.178
Valencia/ValÞncia	Group 1107 Inguinal hernia  550	Both sexes	2.739
Valencia/ValÞncia	Group 1107 Inguinal hernia  550	Men	2.398
Valencia/ValÞncia	Group 1107 Inguinal hernia  550	Women	341
Valencia/ValÞncia	Group 1108 Other abdominal hernia  551-553	Both sexes	2.633
Valencia/ValÞncia	Group 1108 Other abdominal hernia  551-553	Men	1.251
Valencia/ValÞncia	Group 1108 Other abdominal hernia  551-553	Women	1.382
Valencia/ValÞncia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	755
Valencia/ValÞncia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	374
Valencia/ValÞncia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	381
Valencia/ValÞncia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.560
Valencia/ValÞncia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	719
Valencia/ValÞncia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	841
Valencia/ValÞncia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.427
Valencia/ValÞncia	Group 1111 Intestinal obstruction without hernia 560	Men	737
Valencia/ValÞncia	Group 1111 Intestinal obstruction without hernia 560	Women	690
Valencia/ValÞncia	Group 1112 Intestinal diverticulosis 562	Both sexes	1.136
Valencia/ValÞncia	Group 1112 Intestinal diverticulosis 562	Men	571
Valencia/ValÞncia	Group 1112 Intestinal diverticulosis 562	Women	565
Valencia/ValÞncia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	2.077
Valencia/ValÞncia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.330
Valencia/ValÞncia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	747
Valencia/ValÞncia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	996
Valencia/ValÞncia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	412
Valencia/ValÞncia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	584
Valencia/ValÞncia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	418
Valencia/ValÞncia	Group 1115 Alcoholic hepatitis 5710-5713	Men	366
Valencia/ValÞncia	Group 1115 Alcoholic hepatitis 5710-5713	Women	52
Valencia/ValÞncia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.287
Valencia/ValÞncia	Group 1116 Other diseases of the liver 570,5714-573	Men	786
Valencia/ValÞncia	Group 1116 Other diseases of the liver 570,5714-573	Women	501
Valencia/ValÞncia	Group 1117 Cholelithiasis  574	Both sexes	5.244
Valencia/ValÞncia	Group 1117 Cholelithiasis  574	Men	2.162
Valencia/ValÞncia	Group 1117 Cholelithiasis  574	Women	3.082
Valencia/ValÞncia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.866
Valencia/ValÞncia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	1.000
Valencia/ValÞncia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	866
Valencia/ValÞncia	Group 1119 Pancreatic diseases 577	Both sexes	1.656
Valencia/ValÞncia	Group 1119 Pancreatic diseases 577	Men	972
Valencia/ValÞncia	Group 1119 Pancreatic diseases 577	Women	684
Valencia/ValÞncia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.894
Valencia/ValÞncia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.051
Valencia/ValÞncia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	843
Valencia/ValÞncia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.418
Valencia/ValÞncia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.333
Valencia/ValÞncia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.085
Valencia/ValÞncia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.555
Valencia/ValÞncia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	920
Valencia/ValÞncia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	635
Valencia/ValÞncia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	80
Valencia/ValÞncia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	41
Valencia/ValÞncia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	39
Valencia/ValÞncia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	783
Valencia/ValÞncia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	372
Valencia/ValÞncia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	411
Valencia/ValÞncia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	20.356
Valencia/ValÞncia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	10.466
Valencia/ValÞncia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	9.890
Valencia/ValÞncia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Valencia/ValÞncia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Valencia/ValÞncia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Valencia/ValÞncia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Valencia/ValÞncia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Valencia/ValÞncia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Valencia/ValÞncia	Group 1303 Internal derangement of knee 717	Both sexes	3.749
Valencia/ValÞncia	Group 1303 Internal derangement of knee 717	Men	2.651
Valencia/ValÞncia	Group 1303 Internal derangement of knee 717	Women	1.098
Valencia/ValÞncia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	6.554
Valencia/ValÞncia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	2.902
Valencia/ValÞncia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	3.652
Valencia/ValÞncia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	343
Valencia/ValÞncia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	114
Valencia/ValÞncia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	229
Valencia/ValÞncia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	1.007
Valencia/ValÞncia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	483
Valencia/ValÞncia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	524
Valencia/ValÞncia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.970
Valencia/ValÞncia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	1.087
Valencia/ValÞncia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	883
Valencia/ValÞncia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	420
Valencia/ValÞncia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	209
Valencia/ValÞncia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	211
Valencia/ValÞncia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	3.233
Valencia/ValÞncia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.744
Valencia/ValÞncia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.489
Valencia/ValÞncia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	3.080
Valencia/ValÞncia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	1.276
Valencia/ValÞncia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.804
Valencia/ValÞncia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	18.269
Valencia/ValÞncia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	8.312
Valencia/ValÞncia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	9.957
Valencia/ValÞncia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.704
Valencia/ValÞncia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	607
Valencia/ValÞncia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	1.097
Valencia/ValÞncia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.546
Valencia/ValÞncia	Group 1402 Renal failure  5836-5837, 584-586	Men	926
Valencia/ValÞncia	Group 1402 Renal failure  5836-5837, 584-586	Women	620
Valencia/ValÞncia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.198
Valencia/ValÞncia	Group 1403 Urolithiasis  592, 594, 7880	Men	1.258
Valencia/ValÞncia	Group 1403 Urolithiasis  592, 594, 7880	Women	940
Valencia/ValÞncia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	5.453
Valencia/ValÞncia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.779
Valencia/ValÞncia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.674
Valencia/ValÞncia	Group 1405 Prostatic hyperplasia  600	Both sexes	1.613
Valencia/ValÞncia	Group 1405 Prostatic hyperplasia  600	Men	1.613
Valencia/ValÞncia	Group 1405 Prostatic hyperplasia  600	Women	..
Valencia/ValÞncia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	1.024
Valencia/ValÞncia	Group 1406 Other diseases of the male genital organs    601-608	Men	1.024
Valencia/ValÞncia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Valencia/ValÞncia	Group 1407 Disorders of breast  610-612	Both sexes	1.174
Valencia/ValÞncia	Group 1407 Disorders of breast  610-612	Men	86
Valencia/ValÞncia	Group 1407 Disorders of breast  610-612	Women	1.088
Valencia/ValÞncia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	453
Valencia/ValÞncia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Valencia/ValÞncia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	453
Valencia/ValÞncia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	255
Valencia/ValÞncia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Valencia/ValÞncia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	255
Valencia/ValÞncia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.849
Valencia/ValÞncia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	19
Valencia/ValÞncia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.830
Valencia/ValÞncia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	27.286
Valencia/ValÞncia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Valencia/ValÞncia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	27.286
Valencia/ValÞncia	Group 1501 Legally induced abortion  635	Both sexes	150
Valencia/ValÞncia	Group 1501 Legally induced abortion  635	Men	..
Valencia/ValÞncia	Group 1501 Legally induced abortion  635	Women	150
Valencia/ValÞncia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.208
Valencia/ValÞncia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Valencia/ValÞncia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.208
Valencia/ValÞncia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	16.068
Valencia/ValÞncia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Valencia/ValÞncia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	16.068
Valencia/ValÞncia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	4.314
Valencia/ValÞncia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Valencia/ValÞncia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	4.314
Valencia/ValÞncia	Group 1505 Single spontaneous delivery  650	Both sexes	2.214
Valencia/ValÞncia	Group 1505 Single spontaneous delivery  650	Men	..
Valencia/ValÞncia	Group 1505 Single spontaneous delivery  650	Women	2.214
Valencia/ValÞncia	Group 1506 Other deliveries  6695-6697	Both sexes	836
Valencia/ValÞncia	Group 1506 Other deliveries  6695-6697	Men	..
Valencia/ValÞncia	Group 1506 Other deliveries  6695-6697	Women	836
Valencia/ValÞncia	Group 1507 Complications related to the puerperium  670-676	Both sexes	209
Valencia/ValÞncia	Group 1507 Complications related to the puerperium  670-676	Men	..
Valencia/ValÞncia	Group 1507 Complications related to the puerperium  670-676	Women	209
Valencia/ValÞncia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	2.287
Valencia/ValÞncia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Valencia/ValÞncia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	2.287
Valencia/ValÞncia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	3.636
Valencia/ValÞncia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	2.062
Valencia/ValÞncia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.574
Valencia/ValÞncia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	1.116
Valencia/ValÞncia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	612
Valencia/ValÞncia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	504
Valencia/ValÞncia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.520
Valencia/ValÞncia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.450
Valencia/ValÞncia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	1.070
Valencia/ValÞncia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	2.518
Valencia/ValÞncia	Grupo 1700 Congenital abnormalities  740-759	Men	1.441
Valencia/ValÞncia	Grupo 1700 Congenital abnormalities  740-759	Women	1.077
Valencia/ValÞncia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	11.017
Valencia/ValÞncia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	6.008
Valencia/ValÞncia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	5.009
Valencia/ValÞncia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.466
Valencia/ValÞncia	Group 1801 Pain in throat and chest 7841, 7865	Men	840
Valencia/ValÞncia	Group 1801 Pain in throat and chest 7841, 7865	Women	626
Valencia/ValÞncia	Group 1802 Abdominal pain   7890	Both sexes	1.120
Valencia/ValÞncia	Group 1802 Abdominal pain   7890	Men	408
Valencia/ValÞncia	Group 1802 Abdominal pain   7890	Women	712
Valencia/ValÞncia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	123
Valencia/ValÞncia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	67
Valencia/ValÞncia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	56
Valencia/ValÞncia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	8.308
Valencia/ValÞncia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.693
Valencia/ValÞncia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.615
Valencia/ValÞncia	Group 1900 Injuries and poisoning  800-999	Both sexes	23.553
Valencia/ValÞncia	Group 1900 Injuries and poisoning  800-999	Men	12.252
Valencia/ValÞncia	Group 1900 Injuries and poisoning  800-999	Women	11.301
Valencia/ValÞncia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.120
Valencia/ValÞncia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	650
Valencia/ValÞncia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	470
Valencia/ValÞncia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	556
Valencia/ValÞncia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	404
Valencia/ValÞncia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	152
Valencia/ValÞncia	Group 1903 Radius and ulna fracture 813	Both sexes	1.723
Valencia/ValÞncia	Group 1903 Radius and ulna fracture 813	Men	847
Valencia/ValÞncia	Group 1903 Radius and ulna fracture 813	Women	876
Valencia/ValÞncia	Group 1904 Femur fracture  820-821	Both sexes	3.582
Valencia/ValÞncia	Group 1904 Femur fracture  820-821	Men	1.046
Valencia/ValÞncia	Group 1904 Femur fracture  820-821	Women	2.536
Valencia/ValÞncia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.804
Valencia/ValÞncia	Group 1905 Leg fracture, including the ankle 823-824	Men	995
Valencia/ValÞncia	Group 1905 Leg fracture, including the ankle 823-824	Women	809
Valencia/ValÞncia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	7.384
Valencia/ValÞncia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	4.474
Valencia/ValÞncia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.910
Valencia/ValÞncia	Group 1907 Burns  940-949	Both sexes	164
Valencia/ValÞncia	Group 1907 Burns  940-949	Men	104
Valencia/ValÞncia	Group 1907 Burns  940-949	Women	60
Valencia/ValÞncia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	630
Valencia/ValÞncia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	264
Valencia/ValÞncia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	366
Valencia/ValÞncia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	5.589
Valencia/ValÞncia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.945
Valencia/ValÞncia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.644
Valencia/ValÞncia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	169
Valencia/ValÞncia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	113
Valencia/ValÞncia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	56
Valencia/ValÞncia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	832
Valencia/ValÞncia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	410
Valencia/ValÞncia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	422
Valencia/ValÞncia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	5.014
Valencia/ValÞncia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	2.251
Valencia/ValÞncia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.763
Valencia/ValÞncia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	152
Valencia/ValÞncia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	87
Valencia/ValÞncia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	65
Valencia/ValÞncia	Group 2102 Contraceptive management  V25	Both sexes	80
Valencia/ValÞncia	Group 2102 Contraceptive management  V25	Men	7
Valencia/ValÞncia	Group 2102 Contraceptive management  V25	Women	73
Valencia/ValÞncia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Valencia/ValÞncia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Valencia/ValÞncia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Valencia/ValÞncia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.571
Valencia/ValÞncia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	877
Valencia/ValÞncia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	694
Valencia/ValÞncia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	3.211
Valencia/ValÞncia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.280
Valencia/ValÞncia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.931
EXTREMADURA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	111.830
EXTREMADURA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	53.042
EXTREMADURA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	58.788
EXTREMADURA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.834
EXTREMADURA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	982
EXTREMADURA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	852
EXTREMADURA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	328
EXTREMADURA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	177
EXTREMADURA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	151
EXTREMADURA	Group 0102 Imprecise intestinal infections 009	Both sexes	268
EXTREMADURA	Group 0102 Imprecise intestinal infections 009	Men	126
EXTREMADURA	Group 0102 Imprecise intestinal infections 009	Women	143
EXTREMADURA	Group 0103 Tuberculosis 010-018, 137	Both sexes	65
EXTREMADURA	Group 0103 Tuberculosis 010-018, 137	Men	33
EXTREMADURA	Group 0103 Tuberculosis 010-018, 137	Women	32
EXTREMADURA	Group 0104 Septicaemia  038	Both sexes	417
EXTREMADURA	Group 0104 Septicaemia  038	Men	204
EXTREMADURA	Group 0104 Septicaemia  038	Women	213
EXTREMADURA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	43
EXTREMADURA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	29
EXTREMADURA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	14
EXTREMADURA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	712
EXTREMADURA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	413
EXTREMADURA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	299
EXTREMADURA	Group 0200 Neoplasms  140-239	Both sexes	10.248
EXTREMADURA	Group 0200 Neoplasms  140-239	Men	5.363
EXTREMADURA	Group 0200 Neoplasms  140-239	Women	4.885
EXTREMADURA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.013
EXTREMADURA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	627
EXTREMADURA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	386
EXTREMADURA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	733
EXTREMADURA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	634
EXTREMADURA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	98
EXTREMADURA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	459
EXTREMADURA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	260
EXTREMADURA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	198
EXTREMADURA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	817
EXTREMADURA	Group 0204 Malignant neoplasm of breast  174-175	Men	4
EXTREMADURA	Group 0204 Malignant neoplasm of breast  174-175	Women	813
EXTREMADURA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	219
EXTREMADURA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
EXTREMADURA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	219
EXTREMADURA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	101
EXTREMADURA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
EXTREMADURA	Group 0206 Malignant neoplasm of ovary  1830	Women	101
EXTREMADURA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	301
EXTREMADURA	Group 0207 Malignant neoplasm of prostate  185	Men	301
EXTREMADURA	Group 0207 Malignant neoplasm of prostate  185	Women	..
EXTREMADURA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	774
EXTREMADURA	Group 0208 Malignant neoplasm of bladder  188	Men	665
EXTREMADURA	Group 0208 Malignant neoplasm of bladder  188	Women	109
EXTREMADURA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.847
EXTREMADURA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.712
EXTREMADURA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.136
EXTREMADURA	Group 0210 Carcinoma in situ  230-234	Both sexes	242
EXTREMADURA	Group 0210 Carcinoma in situ  230-234	Men	63
EXTREMADURA	Group 0210 Carcinoma in situ  230-234	Women	179
EXTREMADURA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	122
EXTREMADURA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	82
EXTREMADURA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	39
EXTREMADURA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	552
EXTREMADURA	Grupo 0212 Leiomyoma of uterus  218	Men	..
EXTREMADURA	Grupo 0212 Leiomyoma of uterus  218	Women	552
EXTREMADURA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	2.069
EXTREMADURA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.014
EXTREMADURA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.055
EXTREMADURA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.112
EXTREMADURA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	532
EXTREMADURA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	580
EXTREMADURA	Group 0301 Anaemias 280-285	Both sexes	719
EXTREMADURA	Group 0301 Anaemias 280-285	Men	327
EXTREMADURA	Group 0301 Anaemias 280-285	Women	392
EXTREMADURA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	393
EXTREMADURA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	205
EXTREMADURA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	188
EXTREMADURA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.642
EXTREMADURA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	680
EXTREMADURA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	961
EXTREMADURA	Group 0401 Diabetes mellitus  249-250	Both sexes	575
EXTREMADURA	Group 0401 Diabetes mellitus  249-250	Men	316
EXTREMADURA	Group 0401 Diabetes mellitus  249-250	Women	259
EXTREMADURA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.067
EXTREMADURA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	365
EXTREMADURA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	702
EXTREMADURA	Group 0500 Mental disorders  290-319	Both sexes	3.231
EXTREMADURA	Group 0500 Mental disorders  290-319	Men	1.824
EXTREMADURA	Group 0500 Mental disorders  290-319	Women	1.407
EXTREMADURA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	51
EXTREMADURA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	28
EXTREMADURA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	23
EXTREMADURA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	247
EXTREMADURA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	210
EXTREMADURA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	37
EXTREMADURA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	91
EXTREMADURA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	67
EXTREMADURA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	24
EXTREMADURA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	749
EXTREMADURA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	501
EXTREMADURA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	249
EXTREMADURA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	743
EXTREMADURA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	346
EXTREMADURA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	397
EXTREMADURA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.350
EXTREMADURA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	673
EXTREMADURA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	677
EXTREMADURA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.623
EXTREMADURA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.249
EXTREMADURA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.374
EXTREMADURA	Group 0601 Alzheimer's disease  3310	Both sexes	51
EXTREMADURA	Group 0601 Alzheimer's disease  3310	Men	23
EXTREMADURA	Group 0601 Alzheimer's disease  3310	Women	28
EXTREMADURA	Group 0602 Multiple sclerosis 340	Both sexes	104
EXTREMADURA	Group 0602 Multiple sclerosis 340	Men	36
EXTREMADURA	Group 0602 Multiple sclerosis 340	Women	67
EXTREMADURA	Group 0603 Epilepsy  345	Both sexes	508
EXTREMADURA	Group 0603 Epilepsy  345	Men	283
EXTREMADURA	Group 0603 Epilepsy  345	Women	225
EXTREMADURA	Group 0604 Transient cerebral ischemia 435	Both sexes	629
EXTREMADURA	Group 0604 Transient cerebral ischemia 435	Men	301
EXTREMADURA	Group 0604 Transient cerebral ischemia 435	Women	328
EXTREMADURA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.332
EXTREMADURA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	606
EXTREMADURA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	725
EXTREMADURA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.698
EXTREMADURA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	914
EXTREMADURA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	785
EXTREMADURA	Grupo 0701 Cataract  366	Both sexes	598
EXTREMADURA	Grupo 0701 Cataract  366	Men	274
EXTREMADURA	Grupo 0701 Cataract  366	Women	324
EXTREMADURA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.100
EXTREMADURA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	639
EXTREMADURA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	461
EXTREMADURA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	530
EXTREMADURA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	241
EXTREMADURA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	288
EXTREMADURA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	14.848
EXTREMADURA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	8.293
EXTREMADURA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	6.555
EXTREMADURA	Group 0901 Hypertensive disease  401-405	Both sexes	519
EXTREMADURA	Group 0901 Hypertensive disease  401-405	Men	225
EXTREMADURA	Group 0901 Hypertensive disease  401-405	Women	294
EXTREMADURA	Group 0902 Angina pectoris  4111, 413	Both sexes	906
EXTREMADURA	Group 0902 Angina pectoris  4111, 413	Men	536
EXTREMADURA	Group 0902 Angina pectoris  4111, 413	Women	370
EXTREMADURA	Group 0903 Acute myocardial infarction  410	Both sexes	1.288
EXTREMADURA	Group 0903 Acute myocardial infarction  410	Men	899
EXTREMADURA	Group 0903 Acute myocardial infarction  410	Women	390
EXTREMADURA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.091
EXTREMADURA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	811
EXTREMADURA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	280
EXTREMADURA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	589
EXTREMADURA	Group 0905 Diseases of the lungs circulation 415-417	Men	312
EXTREMADURA	Group 0905 Diseases of the lungs circulation 415-417	Women	277
EXTREMADURA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.095
EXTREMADURA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.118
EXTREMADURA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	977
EXTREMADURA	Grupo 0907 Heart failure  428	Both sexes	2.905
EXTREMADURA	Grupo 0907 Heart failure  428	Men	1.311
EXTREMADURA	Grupo 0907 Heart failure  428	Women	1.595
EXTREMADURA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.594
EXTREMADURA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.373
EXTREMADURA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.222
EXTREMADURA	Grupo 0909 Atherosclerosis  440	Both sexes	299
EXTREMADURA	Grupo 0909 Atherosclerosis  440	Men	234
EXTREMADURA	Grupo 0909 Atherosclerosis  440	Women	65
EXTREMADURA	Group 0910 Varicose veins of lower extremities 454	Both sexes	340
EXTREMADURA	Group 0910 Varicose veins of lower extremities 454	Men	111
EXTREMADURA	Group 0910 Varicose veins of lower extremities 454	Women	229
EXTREMADURA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.221
EXTREMADURA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.365
EXTREMADURA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	856
EXTREMADURA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	13.626
EXTREMADURA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.127
EXTREMADURA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	5.499
EXTREMADURA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	610
EXTREMADURA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	332
EXTREMADURA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	278
EXTREMADURA	Group 1002 Pneumonia 480-486	Both sexes	2.690
EXTREMADURA	Group 1002 Pneumonia 480-486	Men	1.656
EXTREMADURA	Group 1002 Pneumonia 480-486	Women	1.034
EXTREMADURA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	826
EXTREMADURA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	475
EXTREMADURA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	351
EXTREMADURA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	884
EXTREMADURA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	459
EXTREMADURA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	424
EXTREMADURA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	967
EXTREMADURA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	638
EXTREMADURA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	329
EXTREMADURA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.538
EXTREMADURA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.358
EXTREMADURA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	180
EXTREMADURA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	301
EXTREMADURA	Group 1007 Asthma 4930-4931,4938-4939	Men	99
EXTREMADURA	Group 1007 Asthma 4930-4931,4938-4939	Women	202
EXTREMADURA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.810
EXTREMADURA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.110
EXTREMADURA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.700
EXTREMADURA	Group 1100 Diseases of the digestive system  520-579	Both sexes	13.885
EXTREMADURA	Group 1100 Diseases of the digestive system  520-579	Men	7.894
EXTREMADURA	Group 1100 Diseases of the digestive system  520-579	Women	5.991
EXTREMADURA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	162
EXTREMADURA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	64
EXTREMADURA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	98
EXTREMADURA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	168
EXTREMADURA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	86
EXTREMADURA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	81
EXTREMADURA	Group 1103 Diseases of the esophagus 530	Both sexes	282
EXTREMADURA	Group 1103 Diseases of the esophagus 530	Men	175
EXTREMADURA	Group 1103 Diseases of the esophagus 530	Women	107
EXTREMADURA	Group 1104 Peptic ulcer 531-534	Both sexes	231
EXTREMADURA	Group 1104 Peptic ulcer 531-534	Men	153
EXTREMADURA	Group 1104 Peptic ulcer 531-534	Women	78
EXTREMADURA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	411
EXTREMADURA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	203
EXTREMADURA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	208
EXTREMADURA	Group 1106 Appendicitis  540-543	Both sexes	1.049
EXTREMADURA	Group 1106 Appendicitis  540-543	Men	608
EXTREMADURA	Group 1106 Appendicitis  540-543	Women	441
EXTREMADURA	Group 1107 Inguinal hernia  550	Both sexes	1.283
EXTREMADURA	Group 1107 Inguinal hernia  550	Men	1.136
EXTREMADURA	Group 1107 Inguinal hernia  550	Women	148
EXTREMADURA	Group 1108 Other abdominal hernia  551-553	Both sexes	985
EXTREMADURA	Group 1108 Other abdominal hernia  551-553	Men	481
EXTREMADURA	Group 1108 Other abdominal hernia  551-553	Women	504
EXTREMADURA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	247
EXTREMADURA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	126
EXTREMADURA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	122
EXTREMADURA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	907
EXTREMADURA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	491
EXTREMADURA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	415
EXTREMADURA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	836
EXTREMADURA	Group 1111 Intestinal obstruction without hernia 560	Men	457
EXTREMADURA	Group 1111 Intestinal obstruction without hernia 560	Women	379
EXTREMADURA	Group 1112 Intestinal diverticulosis 562	Both sexes	443
EXTREMADURA	Group 1112 Intestinal diverticulosis 562	Men	242
EXTREMADURA	Group 1112 Intestinal diverticulosis 562	Women	201
EXTREMADURA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.025
EXTREMADURA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	691
EXTREMADURA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	333
EXTREMADURA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	450
EXTREMADURA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	219
EXTREMADURA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	230
EXTREMADURA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	215
EXTREMADURA	Group 1115 Alcoholic hepatitis 5710-5713	Men	196
EXTREMADURA	Group 1115 Alcoholic hepatitis 5710-5713	Women	19
EXTREMADURA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	405
EXTREMADURA	Group 1116 Other diseases of the liver 570,5714-573	Men	248
EXTREMADURA	Group 1116 Other diseases of the liver 570,5714-573	Women	157
EXTREMADURA	Group 1117 Cholelithiasis  574	Both sexes	2.261
EXTREMADURA	Group 1117 Cholelithiasis  574	Men	933
EXTREMADURA	Group 1117 Cholelithiasis  574	Women	1.328
EXTREMADURA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	864
EXTREMADURA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	461
EXTREMADURA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	403
EXTREMADURA	Group 1119 Pancreatic diseases 577	Both sexes	884
EXTREMADURA	Group 1119 Pancreatic diseases 577	Men	484
EXTREMADURA	Group 1119 Pancreatic diseases 577	Women	400
EXTREMADURA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	775
EXTREMADURA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	438
EXTREMADURA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	337
EXTREMADURA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.048
EXTREMADURA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	549
EXTREMADURA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	499
EXTREMADURA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	605
EXTREMADURA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	350
EXTREMADURA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	255
EXTREMADURA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	54
EXTREMADURA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	24
EXTREMADURA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	30
EXTREMADURA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	389
EXTREMADURA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	175
EXTREMADURA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	214
EXTREMADURA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.610
EXTREMADURA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.944
EXTREMADURA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.665
EXTREMADURA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
EXTREMADURA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
EXTREMADURA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
EXTREMADURA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
EXTREMADURA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
EXTREMADURA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
EXTREMADURA	Group 1303 Internal derangement of knee 717	Both sexes	721
EXTREMADURA	Group 1303 Internal derangement of knee 717	Men	504
EXTREMADURA	Group 1303 Internal derangement of knee 717	Women	217
EXTREMADURA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.531
EXTREMADURA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	960
EXTREMADURA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.572
EXTREMADURA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	108
EXTREMADURA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	46
EXTREMADURA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	61
EXTREMADURA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	397
EXTREMADURA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	205
EXTREMADURA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	192
EXTREMADURA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	625
EXTREMADURA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	345
EXTREMADURA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	280
EXTREMADURA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	176
EXTREMADURA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	80
EXTREMADURA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	95
EXTREMADURA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	799
EXTREMADURA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	440
EXTREMADURA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	359
EXTREMADURA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.253
EXTREMADURA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	364
EXTREMADURA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	889
EXTREMADURA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	7.511
EXTREMADURA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.006
EXTREMADURA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.505
EXTREMADURA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	642
EXTREMADURA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	270
EXTREMADURA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	372
EXTREMADURA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	812
EXTREMADURA	Group 1402 Renal failure  5836-5837, 584-586	Men	431
EXTREMADURA	Group 1402 Renal failure  5836-5837, 584-586	Women	381
EXTREMADURA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	725
EXTREMADURA	Group 1403 Urolithiasis  592, 594, 7880	Men	403
EXTREMADURA	Group 1403 Urolithiasis  592, 594, 7880	Women	322
EXTREMADURA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.602
EXTREMADURA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	719
EXTREMADURA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	883
EXTREMADURA	Group 1405 Prostatic hyperplasia  600	Both sexes	443
EXTREMADURA	Group 1405 Prostatic hyperplasia  600	Men	443
EXTREMADURA	Group 1405 Prostatic hyperplasia  600	Women	..
EXTREMADURA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	669
EXTREMADURA	Group 1406 Other diseases of the male genital organs    601-608	Men	669
EXTREMADURA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
EXTREMADURA	Group 1407 Disorders of breast  610-612	Both sexes	362
EXTREMADURA	Group 1407 Disorders of breast  610-612	Men	43
EXTREMADURA	Group 1407 Disorders of breast  610-612	Women	318
EXTREMADURA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	254
EXTREMADURA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
EXTREMADURA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	254
EXTREMADURA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	279
EXTREMADURA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
EXTREMADURA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	279
EXTREMADURA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.722
EXTREMADURA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	27
EXTREMADURA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.695
EXTREMADURA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	11.736
EXTREMADURA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
EXTREMADURA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	11.736
EXTREMADURA	Group 1501 Legally induced abortion  635	Both sexes	1
EXTREMADURA	Group 1501 Legally induced abortion  635	Men	..
EXTREMADURA	Group 1501 Legally induced abortion  635	Women	1
EXTREMADURA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.187
EXTREMADURA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
EXTREMADURA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.187
EXTREMADURA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.035
EXTREMADURA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
EXTREMADURA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.035
EXTREMADURA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.765
EXTREMADURA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
EXTREMADURA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.765
EXTREMADURA	Group 1505 Single spontaneous delivery  650	Both sexes	533
EXTREMADURA	Group 1505 Single spontaneous delivery  650	Men	..
EXTREMADURA	Group 1505 Single spontaneous delivery  650	Women	533
EXTREMADURA	Group 1506 Other deliveries  6695-6697	Both sexes	580
EXTREMADURA	Group 1506 Other deliveries  6695-6697	Men	..
EXTREMADURA	Group 1506 Other deliveries  6695-6697	Women	580
EXTREMADURA	Group 1507 Complications related to the puerperium  670-676	Both sexes	55
EXTREMADURA	Group 1507 Complications related to the puerperium  670-676	Men	..
EXTREMADURA	Group 1507 Complications related to the puerperium  670-676	Women	55
EXTREMADURA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	579
EXTREMADURA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
EXTREMADURA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	579
EXTREMADURA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.667
EXTREMADURA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	884
EXTREMADURA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	783
EXTREMADURA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	325
EXTREMADURA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	173
EXTREMADURA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	153
EXTREMADURA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.342
EXTREMADURA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	712
EXTREMADURA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	630
EXTREMADURA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	790
EXTREMADURA	Grupo 1700 Congenital abnormalities  740-759	Men	505
EXTREMADURA	Grupo 1700 Congenital abnormalities  740-759	Women	285
EXTREMADURA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.248
EXTREMADURA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.012
EXTREMADURA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.236
EXTREMADURA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	676
EXTREMADURA	Group 1801 Pain in throat and chest 7841, 7865	Men	385
EXTREMADURA	Group 1801 Pain in throat and chest 7841, 7865	Women	291
EXTREMADURA	Group 1802 Abdominal pain   7890	Both sexes	649
EXTREMADURA	Group 1802 Abdominal pain   7890	Men	275
EXTREMADURA	Group 1802 Abdominal pain   7890	Women	374
EXTREMADURA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	889
EXTREMADURA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	462
EXTREMADURA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	427
EXTREMADURA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.033
EXTREMADURA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.890
EXTREMADURA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.143
EXTREMADURA	Group 1900 Injuries and poisoning  800-999	Both sexes	8.015
EXTREMADURA	Group 1900 Injuries and poisoning  800-999	Men	3.940
EXTREMADURA	Group 1900 Injuries and poisoning  800-999	Women	4.075
EXTREMADURA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	360
EXTREMADURA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	206
EXTREMADURA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	154
EXTREMADURA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	221
EXTREMADURA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	155
EXTREMADURA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	66
EXTREMADURA	Group 1903 Radius and ulna fracture 813	Both sexes	462
EXTREMADURA	Group 1903 Radius and ulna fracture 813	Men	209
EXTREMADURA	Group 1903 Radius and ulna fracture 813	Women	253
EXTREMADURA	Group 1904 Femur fracture  820-821	Both sexes	1.532
EXTREMADURA	Group 1904 Femur fracture  820-821	Men	423
EXTREMADURA	Group 1904 Femur fracture  820-821	Women	1.109
EXTREMADURA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	606
EXTREMADURA	Group 1905 Leg fracture, including the ankle 823-824	Men	305
EXTREMADURA	Group 1905 Leg fracture, including the ankle 823-824	Women	301
EXTREMADURA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	2.104
EXTREMADURA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.272
EXTREMADURA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	833
EXTREMADURA	Group 1907 Burns  940-949	Both sexes	78
EXTREMADURA	Group 1907 Burns  940-949	Men	46
EXTREMADURA	Group 1907 Burns  940-949	Women	32
EXTREMADURA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	287
EXTREMADURA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	132
EXTREMADURA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	156
EXTREMADURA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.042
EXTREMADURA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.047
EXTREMADURA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	995
EXTREMADURA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	50
EXTREMADURA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	27
EXTREMADURA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	23
EXTREMADURA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	271
EXTREMADURA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	119
EXTREMADURA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	153
EXTREMADURA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.931
EXTREMADURA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.104
EXTREMADURA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	827
EXTREMADURA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	390
EXTREMADURA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	285
EXTREMADURA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	105
EXTREMADURA	Group 2102 Contraceptive management  V25	Both sexes	72
EXTREMADURA	Group 2102 Contraceptive management  V25	Men	1
EXTREMADURA	Group 2102 Contraceptive management  V25	Women	71
EXTREMADURA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
EXTREMADURA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
EXTREMADURA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
EXTREMADURA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	634
EXTREMADURA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	375
EXTREMADURA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	259
EXTREMADURA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	836
EXTREMADURA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	443
EXTREMADURA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	392
Badajoz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	72.886
Badajoz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	34.361
Badajoz	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	38.525
Badajoz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.194
Badajoz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	644
Badajoz	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	550
Badajoz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	154
Badajoz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	92
Badajoz	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	62
Badajoz	Group 0102 Imprecise intestinal infections 009	Both sexes	169
Badajoz	Group 0102 Imprecise intestinal infections 009	Men	82
Badajoz	Group 0102 Imprecise intestinal infections 009	Women	88
Badajoz	Group 0103 Tuberculosis 010-018, 137	Both sexes	45
Badajoz	Group 0103 Tuberculosis 010-018, 137	Men	24
Badajoz	Group 0103 Tuberculosis 010-018, 137	Women	21
Badajoz	Group 0104 Septicaemia  038	Both sexes	281
Badajoz	Group 0104 Septicaemia  038	Men	127
Badajoz	Group 0104 Septicaemia  038	Women	154
Badajoz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	38
Badajoz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	27
Badajoz	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	11
Badajoz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	506
Badajoz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	292
Badajoz	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	214
Badajoz	Group 0200 Neoplasms  140-239	Both sexes	6.267
Badajoz	Group 0200 Neoplasms  140-239	Men	3.299
Badajoz	Group 0200 Neoplasms  140-239	Women	2.968
Badajoz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	631
Badajoz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	394
Badajoz	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	237
Badajoz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	468
Badajoz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	406
Badajoz	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	61
Badajoz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	68
Badajoz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	33
Badajoz	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	34
Badajoz	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	489
Badajoz	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Badajoz	Group 0204 Malignant neoplasm of breast  174-175	Women	486
Badajoz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	131
Badajoz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Badajoz	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	131
Badajoz	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	61
Badajoz	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Badajoz	Group 0206 Malignant neoplasm of ovary  1830	Women	61
Badajoz	Group 0207 Malignant neoplasm of prostate  185	Both sexes	156
Badajoz	Group 0207 Malignant neoplasm of prostate  185	Men	156
Badajoz	Group 0207 Malignant neoplasm of prostate  185	Women	..
Badajoz	Group 0208 Malignant neoplasm of bladder  188	Both sexes	438
Badajoz	Group 0208 Malignant neoplasm of bladder  188	Men	381
Badajoz	Group 0208 Malignant neoplasm of bladder  188	Women	57
Badajoz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.888
Badajoz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.133
Badajoz	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	756
Badajoz	Group 0210 Carcinoma in situ  230-234	Both sexes	162
Badajoz	Group 0210 Carcinoma in situ  230-234	Men	47
Badajoz	Group 0210 Carcinoma in situ  230-234	Women	115
Badajoz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	67
Badajoz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	43
Badajoz	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	23
Badajoz	Grupo 0212 Leiomyoma of uterus  218	Both sexes	336
Badajoz	Grupo 0212 Leiomyoma of uterus  218	Men	..
Badajoz	Grupo 0212 Leiomyoma of uterus  218	Women	336
Badajoz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.373
Badajoz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	702
Badajoz	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	671
Badajoz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	748
Badajoz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	359
Badajoz	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	389
Badajoz	Group 0301 Anaemias 280-285	Both sexes	523
Badajoz	Group 0301 Anaemias 280-285	Men	240
Badajoz	Group 0301 Anaemias 280-285	Women	283
Badajoz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	225
Badajoz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	119
Badajoz	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	106
Badajoz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.004
Badajoz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	425
Badajoz	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	578
Badajoz	Group 0401 Diabetes mellitus  249-250	Both sexes	376
Badajoz	Group 0401 Diabetes mellitus  249-250	Men	204
Badajoz	Group 0401 Diabetes mellitus  249-250	Women	172
Badajoz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	628
Badajoz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	222
Badajoz	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	406
Badajoz	Group 0500 Mental disorders  290-319	Both sexes	1.625
Badajoz	Group 0500 Mental disorders  290-319	Men	871
Badajoz	Group 0500 Mental disorders  290-319	Women	754
Badajoz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	43
Badajoz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	23
Badajoz	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	20
Badajoz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	97
Badajoz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	81
Badajoz	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	16
Badajoz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	60
Badajoz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	44
Badajoz	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	16
Badajoz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	304
Badajoz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	201
Badajoz	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	104
Badajoz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	380
Badajoz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	161
Badajoz	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	219
Badajoz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	741
Badajoz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	362
Badajoz	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	379
Badajoz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.016
Badajoz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	956
Badajoz	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.060
Badajoz	Group 0601 Alzheimer's disease  3310	Both sexes	42
Badajoz	Group 0601 Alzheimer's disease  3310	Men	19
Badajoz	Group 0601 Alzheimer's disease  3310	Women	23
Badajoz	Group 0602 Multiple sclerosis 340	Both sexes	87
Badajoz	Group 0602 Multiple sclerosis 340	Men	27
Badajoz	Group 0602 Multiple sclerosis 340	Women	59
Badajoz	Group 0603 Epilepsy  345	Both sexes	369
Badajoz	Group 0603 Epilepsy  345	Men	204
Badajoz	Group 0603 Epilepsy  345	Women	165
Badajoz	Group 0604 Transient cerebral ischemia 435	Both sexes	510
Badajoz	Group 0604 Transient cerebral ischemia 435	Men	242
Badajoz	Group 0604 Transient cerebral ischemia 435	Women	268
Badajoz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.009
Badajoz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	464
Badajoz	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	544
Badajoz	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	851
Badajoz	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	472
Badajoz	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	380
Badajoz	Grupo 0701 Cataract  366	Both sexes	134
Badajoz	Grupo 0701 Cataract  366	Men	60
Badajoz	Grupo 0701 Cataract  366	Women	74
Badajoz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	717
Badajoz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	411
Badajoz	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	306
Badajoz	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	345
Badajoz	Group 0800 Diseases of the ear and the mastoid  380-389	Men	154
Badajoz	Group 0800 Diseases of the ear and the mastoid  380-389	Women	190
Badajoz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	9.809
Badajoz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	5.433
Badajoz	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.376
Badajoz	Group 0901 Hypertensive disease  401-405	Both sexes	372
Badajoz	Group 0901 Hypertensive disease  401-405	Men	154
Badajoz	Group 0901 Hypertensive disease  401-405	Women	218
Badajoz	Group 0902 Angina pectoris  4111, 413	Both sexes	640
Badajoz	Group 0902 Angina pectoris  4111, 413	Men	376
Badajoz	Group 0902 Angina pectoris  4111, 413	Women	264
Badajoz	Group 0903 Acute myocardial infarction  410	Both sexes	730
Badajoz	Group 0903 Acute myocardial infarction  410	Men	493
Badajoz	Group 0903 Acute myocardial infarction  410	Women	238
Badajoz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	683
Badajoz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	507
Badajoz	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	176
Badajoz	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	383
Badajoz	Group 0905 Diseases of the lungs circulation 415-417	Men	207
Badajoz	Group 0905 Diseases of the lungs circulation 415-417	Women	176
Badajoz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.519
Badajoz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	808
Badajoz	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	711
Badajoz	Grupo 0907 Heart failure  428	Both sexes	2.056
Badajoz	Grupo 0907 Heart failure  428	Men	920
Badajoz	Grupo 0907 Heart failure  428	Women	1.137
Badajoz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.619
Badajoz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	877
Badajoz	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	743
Badajoz	Grupo 0909 Atherosclerosis  440	Both sexes	120
Badajoz	Grupo 0909 Atherosclerosis  440	Men	95
Badajoz	Grupo 0909 Atherosclerosis  440	Women	25
Badajoz	Group 0910 Varicose veins of lower extremities 454	Both sexes	209
Badajoz	Group 0910 Varicose veins of lower extremities 454	Men	72
Badajoz	Group 0910 Varicose veins of lower extremities 454	Women	137
Badajoz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.477
Badajoz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	926
Badajoz	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	551
Badajoz	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	9.114
Badajoz	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.383
Badajoz	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.731
Badajoz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	394
Badajoz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	208
Badajoz	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	186
Badajoz	Group 1002 Pneumonia 480-486	Both sexes	1.705
Badajoz	Group 1002 Pneumonia 480-486	Men	1.045
Badajoz	Group 1002 Pneumonia 480-486	Women	660
Badajoz	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	500
Badajoz	Group 1003 Acute bronchitis and bronchiolitis  466	Men	293
Badajoz	Group 1003 Acute bronchitis and bronchiolitis  466	Women	207
Badajoz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	634
Badajoz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	322
Badajoz	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	311
Badajoz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	532
Badajoz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	344
Badajoz	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	188
Badajoz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.001
Badajoz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	871
Badajoz	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	130
Badajoz	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	191
Badajoz	Group 1007 Asthma 4930-4931,4938-4939	Men	60
Badajoz	Group 1007 Asthma 4930-4931,4938-4939	Women	131
Badajoz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	4.157
Badajoz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.240
Badajoz	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.917
Badajoz	Group 1100 Diseases of the digestive system  520-579	Both sexes	8.960
Badajoz	Group 1100 Diseases of the digestive system  520-579	Men	5.019
Badajoz	Group 1100 Diseases of the digestive system  520-579	Women	3.941
Badajoz	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	146
Badajoz	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	58
Badajoz	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	88
Badajoz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	122
Badajoz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	63
Badajoz	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	58
Badajoz	Group 1103 Diseases of the esophagus 530	Both sexes	172
Badajoz	Group 1103 Diseases of the esophagus 530	Men	109
Badajoz	Group 1103 Diseases of the esophagus 530	Women	63
Badajoz	Group 1104 Peptic ulcer 531-534	Both sexes	151
Badajoz	Group 1104 Peptic ulcer 531-534	Men	101
Badajoz	Group 1104 Peptic ulcer 531-534	Women	50
Badajoz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	308
Badajoz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	145
Badajoz	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	163
Badajoz	Group 1106 Appendicitis  540-543	Both sexes	725
Badajoz	Group 1106 Appendicitis  540-543	Men	406
Badajoz	Group 1106 Appendicitis  540-543	Women	319
Badajoz	Group 1107 Inguinal hernia  550	Both sexes	700
Badajoz	Group 1107 Inguinal hernia  550	Men	616
Badajoz	Group 1107 Inguinal hernia  550	Women	85
Badajoz	Group 1108 Other abdominal hernia  551-553	Both sexes	661
Badajoz	Group 1108 Other abdominal hernia  551-553	Men	333
Badajoz	Group 1108 Other abdominal hernia  551-553	Women	328
Badajoz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	177
Badajoz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	92
Badajoz	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	86
Badajoz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	614
Badajoz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	323
Badajoz	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	290
Badajoz	Group 1111 Intestinal obstruction without hernia 560	Both sexes	556
Badajoz	Group 1111 Intestinal obstruction without hernia 560	Men	294
Badajoz	Group 1111 Intestinal obstruction without hernia 560	Women	262
Badajoz	Group 1112 Intestinal diverticulosis 562	Both sexes	292
Badajoz	Group 1112 Intestinal diverticulosis 562	Men	153
Badajoz	Group 1112 Intestinal diverticulosis 562	Women	139
Badajoz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	612
Badajoz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	434
Badajoz	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	177
Badajoz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	343
Badajoz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	165
Badajoz	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	177
Badajoz	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	169
Badajoz	Group 1115 Alcoholic hepatitis 5710-5713	Men	152
Badajoz	Group 1115 Alcoholic hepatitis 5710-5713	Women	17
Badajoz	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	279
Badajoz	Group 1116 Other diseases of the liver 570,5714-573	Men	162
Badajoz	Group 1116 Other diseases of the liver 570,5714-573	Women	117
Badajoz	Group 1117 Cholelithiasis  574	Both sexes	1.369
Badajoz	Group 1117 Cholelithiasis  574	Men	560
Badajoz	Group 1117 Cholelithiasis  574	Women	809
Badajoz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	509
Badajoz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	270
Badajoz	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	239
Badajoz	Group 1119 Pancreatic diseases 577	Both sexes	536
Badajoz	Group 1119 Pancreatic diseases 577	Men	302
Badajoz	Group 1119 Pancreatic diseases 577	Women	234
Badajoz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	517
Badajoz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	279
Badajoz	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	238
Badajoz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	652
Badajoz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	349
Badajoz	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	303
Badajoz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	373
Badajoz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	206
Badajoz	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	167
Badajoz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	40
Badajoz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	19
Badajoz	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	21
Badajoz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	239
Badajoz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	124
Badajoz	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	115
Badajoz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	4.456
Badajoz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	2.017
Badajoz	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	2.438
Badajoz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Badajoz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Badajoz	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Badajoz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Badajoz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Badajoz	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Badajoz	Group 1303 Internal derangement of knee 717	Both sexes	525
Badajoz	Group 1303 Internal derangement of knee 717	Men	375
Badajoz	Group 1303 Internal derangement of knee 717	Women	150
Badajoz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.613
Badajoz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	616
Badajoz	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	998
Badajoz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	77
Badajoz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	30
Badajoz	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	46
Badajoz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	295
Badajoz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	159
Badajoz	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	136
Badajoz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	484
Badajoz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	265
Badajoz	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	219
Badajoz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	99
Badajoz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	41
Badajoz	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	57
Badajoz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	552
Badajoz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	296
Badajoz	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	256
Badajoz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	811
Badajoz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	235
Badajoz	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	576
Badajoz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	4.842
Badajoz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.957
Badajoz	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.885
Badajoz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	473
Badajoz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	203
Badajoz	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	270
Badajoz	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	569
Badajoz	Group 1402 Renal failure  5836-5837, 584-586	Men	291
Badajoz	Group 1402 Renal failure  5836-5837, 584-586	Women	278
Badajoz	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	506
Badajoz	Group 1403 Urolithiasis  592, 594, 7880	Men	278
Badajoz	Group 1403 Urolithiasis  592, 594, 7880	Women	228
Badajoz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	978
Badajoz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	440
Badajoz	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	538
Badajoz	Group 1405 Prostatic hyperplasia  600	Both sexes	249
Badajoz	Group 1405 Prostatic hyperplasia  600	Men	249
Badajoz	Group 1405 Prostatic hyperplasia  600	Women	..
Badajoz	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	447
Badajoz	Group 1406 Other diseases of the male genital organs    601-608	Men	447
Badajoz	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Badajoz	Group 1407 Disorders of breast  610-612	Both sexes	214
Badajoz	Group 1407 Disorders of breast  610-612	Men	25
Badajoz	Group 1407 Disorders of breast  610-612	Women	188
Badajoz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	161
Badajoz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Badajoz	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	161
Badajoz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	150
Badajoz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Badajoz	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	150
Badajoz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.094
Badajoz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	23
Badajoz	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.071
Badajoz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	8.098
Badajoz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Badajoz	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	8.098
Badajoz	Group 1501 Legally induced abortion  635	Both sexes	..
Badajoz	Group 1501 Legally induced abortion  635	Men	..
Badajoz	Group 1501 Legally induced abortion  635	Women	..
Badajoz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	805
Badajoz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Badajoz	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	805
Badajoz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.155
Badajoz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Badajoz	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.155
Badajoz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.887
Badajoz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Badajoz	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.887
Badajoz	Group 1505 Single spontaneous delivery  650	Both sexes	309
Badajoz	Group 1505 Single spontaneous delivery  650	Men	..
Badajoz	Group 1505 Single spontaneous delivery  650	Women	309
Badajoz	Group 1506 Other deliveries  6695-6697	Both sexes	518
Badajoz	Group 1506 Other deliveries  6695-6697	Men	..
Badajoz	Group 1506 Other deliveries  6695-6697	Women	518
Badajoz	Group 1507 Complications related to the puerperium  670-676	Both sexes	42
Badajoz	Group 1507 Complications related to the puerperium  670-676	Men	..
Badajoz	Group 1507 Complications related to the puerperium  670-676	Women	42
Badajoz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	381
Badajoz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Badajoz	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	381
Badajoz	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	829
Badajoz	Group 1600 Some disorders originating in the perinatal period  760-779	Men	443
Badajoz	Group 1600 Some disorders originating in the perinatal period  760-779	Women	386
Badajoz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	180
Badajoz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	95
Badajoz	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	86
Badajoz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	649
Badajoz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	349
Badajoz	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	300
Badajoz	Grupo 1700 Congenital abnormalities  740-759	Both sexes	605
Badajoz	Grupo 1700 Congenital abnormalities  740-759	Men	401
Badajoz	Grupo 1700 Congenital abnormalities  740-759	Women	204
Badajoz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	5.293
Badajoz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.938
Badajoz	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.355
Badajoz	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	428
Badajoz	Group 1801 Pain in throat and chest 7841, 7865	Men	243
Badajoz	Group 1801 Pain in throat and chest 7841, 7865	Women	185
Badajoz	Group 1802 Abdominal pain   7890	Both sexes	435
Badajoz	Group 1802 Abdominal pain   7890	Men	181
Badajoz	Group 1802 Abdominal pain   7890	Women	254
Badajoz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	809
Badajoz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	411
Badajoz	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	398
Badajoz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	3.620
Badajoz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.103
Badajoz	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.517
Badajoz	Group 1900 Injuries and poisoning  800-999	Both sexes	5.043
Badajoz	Group 1900 Injuries and poisoning  800-999	Men	2.537
Badajoz	Group 1900 Injuries and poisoning  800-999	Women	2.506
Badajoz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	260
Badajoz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	154
Badajoz	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	106
Badajoz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	154
Badajoz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	114
Badajoz	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	40
Badajoz	Group 1903 Radius and ulna fracture 813	Both sexes	269
Badajoz	Group 1903 Radius and ulna fracture 813	Men	125
Badajoz	Group 1903 Radius and ulna fracture 813	Women	144
Badajoz	Group 1904 Femur fracture  820-821	Both sexes	928
Badajoz	Group 1904 Femur fracture  820-821	Men	258
Badajoz	Group 1904 Femur fracture  820-821	Women	670
Badajoz	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	383
Badajoz	Group 1905 Leg fracture, including the ankle 823-824	Men	206
Badajoz	Group 1905 Leg fracture, including the ankle 823-824	Women	177
Badajoz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.257
Badajoz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	784
Badajoz	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	474
Badajoz	Group 1907 Burns  940-949	Both sexes	17
Badajoz	Group 1907 Burns  940-949	Men	10
Badajoz	Group 1907 Burns  940-949	Women	7
Badajoz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	184
Badajoz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	87
Badajoz	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	98
Badajoz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.358
Badajoz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	694
Badajoz	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	664
Badajoz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	49
Badajoz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	26
Badajoz	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	23
Badajoz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	182
Badajoz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	80
Badajoz	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	103
Badajoz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.138
Badajoz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	705
Badajoz	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	433
Badajoz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	377
Badajoz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	277
Badajoz	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	100
Badajoz	Group 2102 Contraceptive management  V25	Both sexes	34
Badajoz	Group 2102 Contraceptive management  V25	Men	1
Badajoz	Group 2102 Contraceptive management  V25	Women	33
Badajoz	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Badajoz	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Badajoz	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Badajoz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	262
Badajoz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	156
Badajoz	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	106
Badajoz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	466
Badajoz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	271
Badajoz	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	194
Cßceres	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	38.944
Cßceres	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.681
Cßceres	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	20.263
Cßceres	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	640
Cßceres	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	338
Cßceres	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	302
Cßceres	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	174
Cßceres	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	85
Cßceres	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	89
Cßceres	Group 0102 Imprecise intestinal infections 009	Both sexes	99
Cßceres	Group 0102 Imprecise intestinal infections 009	Men	44
Cßceres	Group 0102 Imprecise intestinal infections 009	Women	55
Cßceres	Group 0103 Tuberculosis 010-018, 137	Both sexes	20
Cßceres	Group 0103 Tuberculosis 010-018, 137	Men	9
Cßceres	Group 0103 Tuberculosis 010-018, 137	Women	11
Cßceres	Group 0104 Septicaemia  038	Both sexes	136
Cßceres	Group 0104 Septicaemia  038	Men	77
Cßceres	Group 0104 Septicaemia  038	Women	59
Cßceres	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	5
Cßceres	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	2
Cßceres	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	3
Cßceres	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	206
Cßceres	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	121
Cßceres	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	85
Cßceres	Group 0200 Neoplasms  140-239	Both sexes	3.981
Cßceres	Group 0200 Neoplasms  140-239	Men	2.064
Cßceres	Group 0200 Neoplasms  140-239	Women	1.917
Cßceres	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	382
Cßceres	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	233
Cßceres	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	149
Cßceres	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	265
Cßceres	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	228
Cßceres	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	37
Cßceres	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	391
Cßceres	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	227
Cßceres	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	164
Cßceres	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	328
Cßceres	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Cßceres	Group 0204 Malignant neoplasm of breast  174-175	Women	327
Cßceres	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	88
Cßceres	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Cßceres	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	88
Cßceres	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	40
Cßceres	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Cßceres	Group 0206 Malignant neoplasm of ovary  1830	Women	40
Cßceres	Group 0207 Malignant neoplasm of prostate  185	Both sexes	145
Cßceres	Group 0207 Malignant neoplasm of prostate  185	Men	145
Cßceres	Group 0207 Malignant neoplasm of prostate  185	Women	..
Cßceres	Group 0208 Malignant neoplasm of bladder  188	Both sexes	336
Cßceres	Group 0208 Malignant neoplasm of bladder  188	Men	284
Cßceres	Group 0208 Malignant neoplasm of bladder  188	Women	52
Cßceres	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	959
Cßceres	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	579
Cßceres	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	380
Cßceres	Group 0210 Carcinoma in situ  230-234	Both sexes	80
Cßceres	Group 0210 Carcinoma in situ  230-234	Men	16
Cßceres	Group 0210 Carcinoma in situ  230-234	Women	64
Cßceres	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	55
Cßceres	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	39
Cßceres	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	16
Cßceres	Grupo 0212 Leiomyoma of uterus  218	Both sexes	216
Cßceres	Grupo 0212 Leiomyoma of uterus  218	Men	..
Cßceres	Grupo 0212 Leiomyoma of uterus  218	Women	216
Cßceres	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	696
Cßceres	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	312
Cßceres	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	384
Cßceres	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	364
Cßceres	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	173
Cßceres	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	191
Cßceres	Group 0301 Anaemias 280-285	Both sexes	196
Cßceres	Group 0301 Anaemias 280-285	Men	87
Cßceres	Group 0301 Anaemias 280-285	Women	109
Cßceres	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	168
Cßceres	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	86
Cßceres	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	82
Cßceres	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	638
Cßceres	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	255
Cßceres	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	383
Cßceres	Group 0401 Diabetes mellitus  249-250	Both sexes	199
Cßceres	Group 0401 Diabetes mellitus  249-250	Men	112
Cßceres	Group 0401 Diabetes mellitus  249-250	Women	87
Cßceres	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	439
Cßceres	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	143
Cßceres	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	296
Cßceres	Group 0500 Mental disorders  290-319	Both sexes	1.606
Cßceres	Group 0500 Mental disorders  290-319	Men	953
Cßceres	Group 0500 Mental disorders  290-319	Women	653
Cßceres	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	8
Cßceres	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	5
Cßceres	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	3
Cßceres	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	150
Cßceres	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	129
Cßceres	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	21
Cßceres	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	31
Cßceres	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	23
Cßceres	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	8
Cßceres	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	445
Cßceres	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	300
Cßceres	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	145
Cßceres	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	363
Cßceres	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	185
Cßceres	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	178
Cßceres	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	609
Cßceres	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	311
Cßceres	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	298
Cßceres	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	607
Cßceres	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	293
Cßceres	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	314
Cßceres	Group 0601 Alzheimer's disease  3310	Both sexes	9
Cßceres	Group 0601 Alzheimer's disease  3310	Men	4
Cßceres	Group 0601 Alzheimer's disease  3310	Women	5
Cßceres	Group 0602 Multiple sclerosis 340	Both sexes	17
Cßceres	Group 0602 Multiple sclerosis 340	Men	9
Cßceres	Group 0602 Multiple sclerosis 340	Women	8
Cßceres	Group 0603 Epilepsy  345	Both sexes	139
Cßceres	Group 0603 Epilepsy  345	Men	79
Cßceres	Group 0603 Epilepsy  345	Women	60
Cßceres	Group 0604 Transient cerebral ischemia 435	Both sexes	119
Cßceres	Group 0604 Transient cerebral ischemia 435	Men	59
Cßceres	Group 0604 Transient cerebral ischemia 435	Women	60
Cßceres	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	323
Cßceres	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	142
Cßceres	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	181
Cßceres	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	847
Cßceres	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	442
Cßceres	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	405
Cßceres	Grupo 0701 Cataract  366	Both sexes	464
Cßceres	Grupo 0701 Cataract  366	Men	214
Cßceres	Grupo 0701 Cataract  366	Women	250
Cßceres	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	383
Cßceres	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	228
Cßceres	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	155
Cßceres	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	185
Cßceres	Group 0800 Diseases of the ear and the mastoid  380-389	Men	87
Cßceres	Group 0800 Diseases of the ear and the mastoid  380-389	Women	98
Cßceres	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.039
Cßceres	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.860
Cßceres	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.179
Cßceres	Group 0901 Hypertensive disease  401-405	Both sexes	147
Cßceres	Group 0901 Hypertensive disease  401-405	Men	71
Cßceres	Group 0901 Hypertensive disease  401-405	Women	76
Cßceres	Group 0902 Angina pectoris  4111, 413	Both sexes	266
Cßceres	Group 0902 Angina pectoris  4111, 413	Men	160
Cßceres	Group 0902 Angina pectoris  4111, 413	Women	106
Cßceres	Group 0903 Acute myocardial infarction  410	Both sexes	558
Cßceres	Group 0903 Acute myocardial infarction  410	Men	406
Cßceres	Group 0903 Acute myocardial infarction  410	Women	152
Cßceres	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	408
Cßceres	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	304
Cßceres	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	104
Cßceres	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	206
Cßceres	Group 0905 Diseases of the lungs circulation 415-417	Men	105
Cßceres	Group 0905 Diseases of the lungs circulation 415-417	Women	101
Cßceres	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	576
Cßceres	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	310
Cßceres	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	266
Cßceres	Grupo 0907 Heart failure  428	Both sexes	849
Cßceres	Grupo 0907 Heart failure  428	Men	391
Cßceres	Grupo 0907 Heart failure  428	Women	458
Cßceres	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	975
Cßceres	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	496
Cßceres	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	479
Cßceres	Grupo 0909 Atherosclerosis  440	Both sexes	179
Cßceres	Grupo 0909 Atherosclerosis  440	Men	139
Cßceres	Grupo 0909 Atherosclerosis  440	Women	40
Cßceres	Group 0910 Varicose veins of lower extremities 454	Both sexes	131
Cßceres	Group 0910 Varicose veins of lower extremities 454	Men	39
Cßceres	Group 0910 Varicose veins of lower extremities 454	Women	92
Cßceres	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	744
Cßceres	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	439
Cßceres	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	305
Cßceres	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.512
Cßceres	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.744
Cßceres	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.768
Cßceres	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	216
Cßceres	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	124
Cßceres	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	92
Cßceres	Group 1002 Pneumonia 480-486	Both sexes	985
Cßceres	Group 1002 Pneumonia 480-486	Men	611
Cßceres	Group 1002 Pneumonia 480-486	Women	374
Cßceres	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	326
Cßceres	Group 1003 Acute bronchitis and bronchiolitis  466	Men	182
Cßceres	Group 1003 Acute bronchitis and bronchiolitis  466	Women	144
Cßceres	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	250
Cßceres	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	137
Cßceres	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	113
Cßceres	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	435
Cßceres	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	294
Cßceres	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	141
Cßceres	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	537
Cßceres	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	487
Cßceres	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	50
Cßceres	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	110
Cßceres	Group 1007 Asthma 4930-4931,4938-4939	Men	39
Cßceres	Group 1007 Asthma 4930-4931,4938-4939	Women	71
Cßceres	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.653
Cßceres	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	870
Cßceres	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	783
Cßceres	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.925
Cßceres	Group 1100 Diseases of the digestive system  520-579	Men	2.875
Cßceres	Group 1100 Diseases of the digestive system  520-579	Women	2.050
Cßceres	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	16
Cßceres	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	6
Cßceres	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	10
Cßceres	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	46
Cßceres	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	23
Cßceres	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	23
Cßceres	Group 1103 Diseases of the esophagus 530	Both sexes	110
Cßceres	Group 1103 Diseases of the esophagus 530	Men	66
Cßceres	Group 1103 Diseases of the esophagus 530	Women	44
Cßceres	Group 1104 Peptic ulcer 531-534	Both sexes	80
Cßceres	Group 1104 Peptic ulcer 531-534	Men	52
Cßceres	Group 1104 Peptic ulcer 531-534	Women	28
Cßceres	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	103
Cßceres	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	58
Cßceres	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	45
Cßceres	Group 1106 Appendicitis  540-543	Both sexes	324
Cßceres	Group 1106 Appendicitis  540-543	Men	202
Cßceres	Group 1106 Appendicitis  540-543	Women	122
Cßceres	Group 1107 Inguinal hernia  550	Both sexes	583
Cßceres	Group 1107 Inguinal hernia  550	Men	520
Cßceres	Group 1107 Inguinal hernia  550	Women	63
Cßceres	Group 1108 Other abdominal hernia  551-553	Both sexes	324
Cßceres	Group 1108 Other abdominal hernia  551-553	Men	148
Cßceres	Group 1108 Other abdominal hernia  551-553	Women	176
Cßceres	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	70
Cßceres	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	34
Cßceres	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	36
Cßceres	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	293
Cßceres	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	168
Cßceres	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	125
Cßceres	Group 1111 Intestinal obstruction without hernia 560	Both sexes	280
Cßceres	Group 1111 Intestinal obstruction without hernia 560	Men	163
Cßceres	Group 1111 Intestinal obstruction without hernia 560	Women	117
Cßceres	Group 1112 Intestinal diverticulosis 562	Both sexes	151
Cßceres	Group 1112 Intestinal diverticulosis 562	Men	89
Cßceres	Group 1112 Intestinal diverticulosis 562	Women	62
Cßceres	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	413
Cßceres	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	257
Cßceres	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	156
Cßceres	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	107
Cßceres	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	54
Cßceres	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	53
Cßceres	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	46
Cßceres	Group 1115 Alcoholic hepatitis 5710-5713	Men	44
Cßceres	Group 1115 Alcoholic hepatitis 5710-5713	Women	2
Cßceres	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	126
Cßceres	Group 1116 Other diseases of the liver 570,5714-573	Men	86
Cßceres	Group 1116 Other diseases of the liver 570,5714-573	Women	40
Cßceres	Group 1117 Cholelithiasis  574	Both sexes	892
Cßceres	Group 1117 Cholelithiasis  574	Men	373
Cßceres	Group 1117 Cholelithiasis  574	Women	519
Cßceres	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	355
Cßceres	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	191
Cßceres	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	164
Cßceres	Group 1119 Pancreatic diseases 577	Both sexes	348
Cßceres	Group 1119 Pancreatic diseases 577	Men	182
Cßceres	Group 1119 Pancreatic diseases 577	Women	166
Cßceres	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	258
Cßceres	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	159
Cßceres	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	99
Cßceres	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	396
Cßceres	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	200
Cßceres	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	196
Cßceres	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	232
Cßceres	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	144
Cßceres	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	88
Cßceres	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	14
Cßceres	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	5
Cßceres	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	9
Cßceres	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	150
Cßceres	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	51
Cßceres	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	99
Cßceres	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.154
Cßceres	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	927
Cßceres	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.227
Cßceres	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Cßceres	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Cßceres	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Cßceres	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Cßceres	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Cßceres	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Cßceres	Group 1303 Internal derangement of knee 717	Both sexes	196
Cßceres	Group 1303 Internal derangement of knee 717	Men	129
Cßceres	Group 1303 Internal derangement of knee 717	Women	67
Cßceres	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	918
Cßceres	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	344
Cßceres	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	574
Cßceres	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	31
Cßceres	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	16
Cßceres	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	15
Cßceres	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	102
Cßceres	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	46
Cßceres	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	56
Cßceres	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	141
Cßceres	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	80
Cßceres	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	61
Cßceres	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	77
Cßceres	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	39
Cßceres	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	38
Cßceres	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	247
Cßceres	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	144
Cßceres	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	103
Cßceres	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	442
Cßceres	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	129
Cßceres	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	313
Cßceres	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.669
Cßceres	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.049
Cßceres	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.620
Cßceres	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	169
Cßceres	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	67
Cßceres	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	102
Cßceres	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	243
Cßceres	Group 1402 Renal failure  5836-5837, 584-586	Men	140
Cßceres	Group 1402 Renal failure  5836-5837, 584-586	Women	103
Cßceres	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	219
Cßceres	Group 1403 Urolithiasis  592, 594, 7880	Men	125
Cßceres	Group 1403 Urolithiasis  592, 594, 7880	Women	94
Cßceres	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	624
Cßceres	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	279
Cßceres	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	345
Cßceres	Group 1405 Prostatic hyperplasia  600	Both sexes	194
Cßceres	Group 1405 Prostatic hyperplasia  600	Men	194
Cßceres	Group 1405 Prostatic hyperplasia  600	Women	..
Cßceres	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	222
Cßceres	Group 1406 Other diseases of the male genital organs    601-608	Men	222
Cßceres	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Cßceres	Group 1407 Disorders of breast  610-612	Both sexes	148
Cßceres	Group 1407 Disorders of breast  610-612	Men	18
Cßceres	Group 1407 Disorders of breast  610-612	Women	130
Cßceres	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	93
Cßceres	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Cßceres	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	93
Cßceres	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	129
Cßceres	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Cßceres	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	129
Cßceres	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	628
Cßceres	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	4
Cßceres	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	624
Cßceres	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.638
Cßceres	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Cßceres	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.638
Cßceres	Group 1501 Legally induced abortion  635	Both sexes	1
Cßceres	Group 1501 Legally induced abortion  635	Men	..
Cßceres	Group 1501 Legally induced abortion  635	Women	1
Cßceres	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	382
Cßceres	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Cßceres	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	382
Cßceres	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.880
Cßceres	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Cßceres	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.880
Cßceres	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	878
Cßceres	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Cßceres	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	878
Cßceres	Group 1505 Single spontaneous delivery  650	Both sexes	224
Cßceres	Group 1505 Single spontaneous delivery  650	Men	..
Cßceres	Group 1505 Single spontaneous delivery  650	Women	224
Cßceres	Group 1506 Other deliveries  6695-6697	Both sexes	62
Cßceres	Group 1506 Other deliveries  6695-6697	Men	..
Cßceres	Group 1506 Other deliveries  6695-6697	Women	62
Cßceres	Group 1507 Complications related to the puerperium  670-676	Both sexes	13
Cßceres	Group 1507 Complications related to the puerperium  670-676	Men	..
Cßceres	Group 1507 Complications related to the puerperium  670-676	Women	13
Cßceres	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	198
Cßceres	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Cßceres	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	198
Cßceres	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	838
Cßceres	Group 1600 Some disorders originating in the perinatal period  760-779	Men	441
Cßceres	Group 1600 Some disorders originating in the perinatal period  760-779	Women	397
Cßceres	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	145
Cßceres	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	78
Cßceres	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	67
Cßceres	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	693
Cßceres	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	363
Cßceres	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	330
Cßceres	Grupo 1700 Congenital abnormalities  740-759	Both sexes	185
Cßceres	Grupo 1700 Congenital abnormalities  740-759	Men	104
Cßceres	Grupo 1700 Congenital abnormalities  740-759	Women	81
Cßceres	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.955
Cßceres	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.074
Cßceres	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	881
Cßceres	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	248
Cßceres	Group 1801 Pain in throat and chest 7841, 7865	Men	142
Cßceres	Group 1801 Pain in throat and chest 7841, 7865	Women	106
Cßceres	Group 1802 Abdominal pain   7890	Both sexes	214
Cßceres	Group 1802 Abdominal pain   7890	Men	94
Cßceres	Group 1802 Abdominal pain   7890	Women	120
Cßceres	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	80
Cßceres	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	51
Cßceres	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	29
Cßceres	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.413
Cßceres	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	787
Cßceres	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	626
Cßceres	Group 1900 Injuries and poisoning  800-999	Both sexes	2.972
Cßceres	Group 1900 Injuries and poisoning  800-999	Men	1.403
Cßceres	Group 1900 Injuries and poisoning  800-999	Women	1.569
Cßceres	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	100
Cßceres	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	52
Cßceres	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	48
Cßceres	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	67
Cßceres	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	41
Cßceres	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	26
Cßceres	Group 1903 Radius and ulna fracture 813	Both sexes	193
Cßceres	Group 1903 Radius and ulna fracture 813	Men	84
Cßceres	Group 1903 Radius and ulna fracture 813	Women	109
Cßceres	Group 1904 Femur fracture  820-821	Both sexes	604
Cßceres	Group 1904 Femur fracture  820-821	Men	165
Cßceres	Group 1904 Femur fracture  820-821	Women	439
Cßceres	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	223
Cßceres	Group 1905 Leg fracture, including the ankle 823-824	Men	99
Cßceres	Group 1905 Leg fracture, including the ankle 823-824	Women	124
Cßceres	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	847
Cßceres	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	488
Cßceres	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	359
Cßceres	Group 1907 Burns  940-949	Both sexes	61
Cßceres	Group 1907 Burns  940-949	Men	36
Cßceres	Group 1907 Burns  940-949	Women	25
Cßceres	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	103
Cßceres	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	45
Cßceres	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	58
Cßceres	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	684
Cßceres	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	353
Cßceres	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	331
Cßceres	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1
Cßceres	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
Cßceres	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Cßceres	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	89
Cßceres	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	39
Cßceres	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	50
Cßceres	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	793
Cßceres	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	399
Cßceres	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	394
Cßceres	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	13
Cßceres	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	8
Cßceres	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
Cßceres	Group 2102 Contraceptive management  V25	Both sexes	38
Cßceres	Group 2102 Contraceptive management  V25	Men	..
Cßceres	Group 2102 Contraceptive management  V25	Women	38
Cßceres	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Cßceres	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Cßceres	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Cßceres	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	372
Cßceres	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	219
Cßceres	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	153
Cßceres	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	370
Cßceres	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	172
Cßceres	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	198
GALICIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	293.533
GALICIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	142.872
GALICIA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	150.661
GALICIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	5.635
GALICIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	3.108
GALICIA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	2.527
GALICIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	1.045
GALICIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	550
GALICIA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	495
GALICIA	Group 0102 Imprecise intestinal infections 009	Both sexes	206
GALICIA	Group 0102 Imprecise intestinal infections 009	Men	88
GALICIA	Group 0102 Imprecise intestinal infections 009	Women	118
GALICIA	Group 0103 Tuberculosis 010-018, 137	Both sexes	246
GALICIA	Group 0103 Tuberculosis 010-018, 137	Men	176
GALICIA	Group 0103 Tuberculosis 010-018, 137	Women	70
GALICIA	Group 0104 Septicaemia  038	Both sexes	1.854
GALICIA	Group 0104 Septicaemia  038	Men	940
GALICIA	Group 0104 Septicaemia  038	Women	914
GALICIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	248
GALICIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	182
GALICIA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	66
GALICIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	2.036
GALICIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	1.172
GALICIA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	864
GALICIA	Group 0200 Neoplasms  140-239	Both sexes	30.411
GALICIA	Group 0200 Neoplasms  140-239	Men	16.190
GALICIA	Group 0200 Neoplasms  140-239	Women	14.221
GALICIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	3.114
GALICIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.860
GALICIA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.254
GALICIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	2.131
GALICIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.704
GALICIA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	427
GALICIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	497
GALICIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	236
GALICIA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	261
GALICIA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	2.152
GALICIA	Group 0204 Malignant neoplasm of breast  174-175	Men	16
GALICIA	Group 0204 Malignant neoplasm of breast  174-175	Women	2.136
GALICIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	693
GALICIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
GALICIA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	693
GALICIA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	330
GALICIA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
GALICIA	Group 0206 Malignant neoplasm of ovary  1830	Women	330
GALICIA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.710
GALICIA	Group 0207 Malignant neoplasm of prostate  185	Men	1.710
GALICIA	Group 0207 Malignant neoplasm of prostate  185	Women	..
GALICIA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	2.334
GALICIA	Group 0208 Malignant neoplasm of bladder  188	Men	1.960
GALICIA	Group 0208 Malignant neoplasm of bladder  188	Women	374
GALICIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	11.353
GALICIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	6.678
GALICIA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	4.675
GALICIA	Group 0210 Carcinoma in situ  230-234	Both sexes	640
GALICIA	Group 0210 Carcinoma in situ  230-234	Men	277
GALICIA	Group 0210 Carcinoma in situ  230-234	Women	363
GALICIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	330
GALICIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	210
GALICIA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	120
GALICIA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	1.244
GALICIA	Grupo 0212 Leiomyoma of uterus  218	Men	..
GALICIA	Grupo 0212 Leiomyoma of uterus  218	Women	1.244
GALICIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.883
GALICIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.539
GALICIA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	2.344
GALICIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.640
GALICIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.345
GALICIA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.295
GALICIA	Group 0301 Anaemias 280-285	Both sexes	1.637
GALICIA	Group 0301 Anaemias 280-285	Men	804
GALICIA	Group 0301 Anaemias 280-285	Women	833
GALICIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	1.003
GALICIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	541
GALICIA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	462
GALICIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	4.720
GALICIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.930
GALICIA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.790
GALICIA	Group 0401 Diabetes mellitus  249-250	Both sexes	1.646
GALICIA	Group 0401 Diabetes mellitus  249-250	Men	918
GALICIA	Group 0401 Diabetes mellitus  249-250	Women	728
GALICIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	3.074
GALICIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	1.012
GALICIA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.062
GALICIA	Group 0500 Mental disorders  290-319	Both sexes	5.533
GALICIA	Group 0500 Mental disorders  290-319	Men	2.699
GALICIA	Group 0500 Mental disorders  290-319	Women	2.834
GALICIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	183
GALICIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	74
GALICIA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	109
GALICIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	401
GALICIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	304
GALICIA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	97
GALICIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	256
GALICIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	179
GALICIA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	77
GALICIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.576
GALICIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	880
GALICIA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	696
GALICIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.318
GALICIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	469
GALICIA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	849
GALICIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.799
GALICIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	793
GALICIA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.006
GALICIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.755
GALICIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.771
GALICIA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.984
GALICIA	Group 0601 Alzheimer's disease  3310	Both sexes	86
GALICIA	Group 0601 Alzheimer's disease  3310	Men	24
GALICIA	Group 0601 Alzheimer's disease  3310	Women	62
GALICIA	Group 0602 Multiple sclerosis 340	Both sexes	334
GALICIA	Group 0602 Multiple sclerosis 340	Men	86
GALICIA	Group 0602 Multiple sclerosis 340	Women	248
GALICIA	Group 0603 Epilepsy  345	Both sexes	927
GALICIA	Group 0603 Epilepsy  345	Men	493
GALICIA	Group 0603 Epilepsy  345	Women	434
GALICIA	Group 0604 Transient cerebral ischemia 435	Both sexes	1.010
GALICIA	Group 0604 Transient cerebral ischemia 435	Men	463
GALICIA	Group 0604 Transient cerebral ischemia 435	Women	547
GALICIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.398
GALICIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.705
GALICIA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.693
GALICIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	1.352
GALICIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	709
GALICIA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	643
GALICIA	Grupo 0701 Cataract  366	Both sexes	137
GALICIA	Grupo 0701 Cataract  366	Men	70
GALICIA	Grupo 0701 Cataract  366	Women	67
GALICIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	1.215
GALICIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	639
GALICIA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	576
GALICIA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.304
GALICIA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	641
GALICIA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	663
GALICIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	39.988
GALICIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	22.521
GALICIA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	17.467
GALICIA	Group 0901 Hypertensive disease  401-405	Both sexes	2.468
GALICIA	Group 0901 Hypertensive disease  401-405	Men	1.117
GALICIA	Group 0901 Hypertensive disease  401-405	Women	1.351
GALICIA	Group 0902 Angina pectoris  4111, 413	Both sexes	1.456
GALICIA	Group 0902 Angina pectoris  4111, 413	Men	897
GALICIA	Group 0902 Angina pectoris  4111, 413	Women	559
GALICIA	Group 0903 Acute myocardial infarction  410	Both sexes	3.203
GALICIA	Group 0903 Acute myocardial infarction  410	Men	2.297
GALICIA	Group 0903 Acute myocardial infarction  410	Women	906
GALICIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2.896
GALICIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	2.260
GALICIA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	636
GALICIA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.512
GALICIA	Group 0905 Diseases of the lungs circulation 415-417	Men	636
GALICIA	Group 0905 Diseases of the lungs circulation 415-417	Women	876
GALICIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.725
GALICIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.708
GALICIA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.017
GALICIA	Grupo 0907 Heart failure  428	Both sexes	7.938
GALICIA	Grupo 0907 Heart failure  428	Men	3.970
GALICIA	Grupo 0907 Heart failure  428	Women	3.968
GALICIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	6.371
GALICIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	3.211
GALICIA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	3.160
GALICIA	Grupo 0909 Atherosclerosis  440	Both sexes	1.474
GALICIA	Grupo 0909 Atherosclerosis  440	Men	1.079
GALICIA	Grupo 0909 Atherosclerosis  440	Women	395
GALICIA	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.375
GALICIA	Group 0910 Varicose veins of lower extremities 454	Men	458
GALICIA	Group 0910 Varicose veins of lower extremities 454	Women	917
GALICIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	6.570
GALICIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.888
GALICIA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.682
GALICIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	38.335
GALICIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	21.614
GALICIA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	16.721
GALICIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.413
GALICIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	754
GALICIA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	659
GALICIA	Group 1002 Pneumonia 480-486	Both sexes	8.096
GALICIA	Group 1002 Pneumonia 480-486	Men	4.760
GALICIA	Group 1002 Pneumonia 480-486	Women	3.336
GALICIA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.533
GALICIA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	839
GALICIA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	694
GALICIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	2.028
GALICIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	1.034
GALICIA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	994
GALICIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	2.836
GALICIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.745
GALICIA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	1.091
GALICIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	6.385
GALICIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	4.700
GALICIA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.685
GALICIA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.414
GALICIA	Group 1007 Asthma 4930-4931,4938-4939	Men	428
GALICIA	Group 1007 Asthma 4930-4931,4938-4939	Women	986
GALICIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	14.630
GALICIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	7.354
GALICIA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	7.276
GALICIA	Group 1100 Diseases of the digestive system  520-579	Both sexes	35.589
GALICIA	Group 1100 Diseases of the digestive system  520-579	Men	20.117
GALICIA	Group 1100 Diseases of the digestive system  520-579	Women	15.472
GALICIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	486
GALICIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	231
GALICIA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	255
GALICIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	448
GALICIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	247
GALICIA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	201
GALICIA	Group 1103 Diseases of the esophagus 530	Both sexes	602
GALICIA	Group 1103 Diseases of the esophagus 530	Men	373
GALICIA	Group 1103 Diseases of the esophagus 530	Women	229
GALICIA	Group 1104 Peptic ulcer 531-534	Both sexes	542
GALICIA	Group 1104 Peptic ulcer 531-534	Men	357
GALICIA	Group 1104 Peptic ulcer 531-534	Women	185
GALICIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	787
GALICIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	412
GALICIA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	375
GALICIA	Group 1106 Appendicitis  540-543	Both sexes	3.034
GALICIA	Group 1106 Appendicitis  540-543	Men	1.705
GALICIA	Group 1106 Appendicitis  540-543	Women	1.329
GALICIA	Group 1107 Inguinal hernia  550	Both sexes	3.951
GALICIA	Group 1107 Inguinal hernia  550	Men	3.547
GALICIA	Group 1107 Inguinal hernia  550	Women	404
GALICIA	Group 1108 Other abdominal hernia  551-553	Both sexes	2.664
GALICIA	Group 1108 Other abdominal hernia  551-553	Men	1.365
GALICIA	Group 1108 Other abdominal hernia  551-553	Women	1.299
GALICIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	712
GALICIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	382
GALICIA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	330
GALICIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.735
GALICIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	819
GALICIA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	916
GALICIA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.810
GALICIA	Group 1111 Intestinal obstruction without hernia 560	Men	937
GALICIA	Group 1111 Intestinal obstruction without hernia 560	Women	873
GALICIA	Group 1112 Intestinal diverticulosis 562	Both sexes	1.471
GALICIA	Group 1112 Intestinal diverticulosis 562	Men	689
GALICIA	Group 1112 Intestinal diverticulosis 562	Women	782
GALICIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	2.098
GALICIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.333
GALICIA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	765
GALICIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	1.176
GALICIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	529
GALICIA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	647
GALICIA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	847
GALICIA	Group 1115 Alcoholic hepatitis 5710-5713	Men	703
GALICIA	Group 1115 Alcoholic hepatitis 5710-5713	Women	144
GALICIA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.405
GALICIA	Group 1116 Other diseases of the liver 570,5714-573	Men	883
GALICIA	Group 1116 Other diseases of the liver 570,5714-573	Women	522
GALICIA	Group 1117 Cholelithiasis  574	Both sexes	6.860
GALICIA	Group 1117 Cholelithiasis  574	Men	2.909
GALICIA	Group 1117 Cholelithiasis  574	Women	3.951
GALICIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.544
GALICIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	851
GALICIA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	693
GALICIA	Group 1119 Pancreatic diseases 577	Both sexes	2.074
GALICIA	Group 1119 Pancreatic diseases 577	Men	1.133
GALICIA	Group 1119 Pancreatic diseases 577	Women	941
GALICIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.343
GALICIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	712
GALICIA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	631
GALICIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	3.695
GALICIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	2.007
GALICIA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.688
GALICIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	2.435
GALICIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.422
GALICIA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.013
GALICIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	222
GALICIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	112
GALICIA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	110
GALICIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	1.038
GALICIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	473
GALICIA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	565
GALICIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	21.829
GALICIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	10.129
GALICIA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	11.700
GALICIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
GALICIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
GALICIA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
GALICIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
GALICIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
GALICIA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
GALICIA	Group 1303 Internal derangement of knee 717	Both sexes	3.092
GALICIA	Group 1303 Internal derangement of knee 717	Men	2.050
GALICIA	Group 1303 Internal derangement of knee 717	Women	1.042
GALICIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	8.356
GALICIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	3.411
GALICIA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	4.945
GALICIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	464
GALICIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	158
GALICIA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	306
GALICIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	788
GALICIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	386
GALICIA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	402
GALICIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.735
GALICIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	942
GALICIA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	793
GALICIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	313
GALICIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	144
GALICIA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	169
GALICIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	3.395
GALICIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.846
GALICIA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.549
GALICIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	3.686
GALICIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	1.192
GALICIA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	2.494
GALICIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	17.746
GALICIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	8.421
GALICIA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	9.325
GALICIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.595
GALICIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	621
GALICIA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	974
GALICIA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.484
GALICIA	Group 1402 Renal failure  5836-5837, 584-586	Men	834
GALICIA	Group 1402 Renal failure  5836-5837, 584-586	Women	650
GALICIA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.807
GALICIA	Group 1403 Urolithiasis  592, 594, 7880	Men	1.057
GALICIA	Group 1403 Urolithiasis  592, 594, 7880	Women	750
GALICIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	5.541
GALICIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.592
GALICIA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.949
GALICIA	Group 1405 Prostatic hyperplasia  600	Both sexes	1.782
GALICIA	Group 1405 Prostatic hyperplasia  600	Men	1.782
GALICIA	Group 1405 Prostatic hyperplasia  600	Women	..
GALICIA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	1.416
GALICIA	Group 1406 Other diseases of the male genital organs    601-608	Men	1.416
GALICIA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
GALICIA	Group 1407 Disorders of breast  610-612	Both sexes	744
GALICIA	Group 1407 Disorders of breast  610-612	Men	87
GALICIA	Group 1407 Disorders of breast  610-612	Women	657
GALICIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	469
GALICIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
GALICIA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	469
GALICIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	290
GALICIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
GALICIA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	290
GALICIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.618
GALICIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	32
GALICIA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.586
GALICIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	25.153
GALICIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
GALICIA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	25.153
GALICIA	Group 1501 Legally induced abortion  635	Both sexes	278
GALICIA	Group 1501 Legally induced abortion  635	Men	..
GALICIA	Group 1501 Legally induced abortion  635	Women	278
GALICIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.641
GALICIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
GALICIA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.641
GALICIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	14.868
GALICIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
GALICIA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	14.868
GALICIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.976
GALICIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
GALICIA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.976
GALICIA	Group 1505 Single spontaneous delivery  650	Both sexes	1.218
GALICIA	Group 1505 Single spontaneous delivery  650	Men	..
GALICIA	Group 1505 Single spontaneous delivery  650	Women	1.218
GALICIA	Group 1506 Other deliveries  6695-6697	Both sexes	624
GALICIA	Group 1506 Other deliveries  6695-6697	Men	..
GALICIA	Group 1506 Other deliveries  6695-6697	Women	624
GALICIA	Group 1507 Complications related to the puerperium  670-676	Both sexes	206
GALICIA	Group 1507 Complications related to the puerperium  670-676	Men	..
GALICIA	Group 1507 Complications related to the puerperium  670-676	Women	206
GALICIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.342
GALICIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
GALICIA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.342
GALICIA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	3.596
GALICIA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	2.031
GALICIA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.565
GALICIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	903
GALICIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	493
GALICIA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	410
GALICIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	2.693
GALICIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	1.538
GALICIA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	1.155
GALICIA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	2.313
GALICIA	Grupo 1700 Congenital abnormalities  740-759	Men	1.422
GALICIA	Grupo 1700 Congenital abnormalities  740-759	Women	891
GALICIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	12.966
GALICIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	6.870
GALICIA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	6.096
GALICIA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.235
GALICIA	Group 1801 Pain in throat and chest 7841, 7865	Men	731
GALICIA	Group 1801 Pain in throat and chest 7841, 7865	Women	504
GALICIA	Group 1802 Abdominal pain   7890	Both sexes	1.185
GALICIA	Group 1802 Abdominal pain   7890	Men	442
GALICIA	Group 1802 Abdominal pain   7890	Women	743
GALICIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2.654
GALICIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1.314
GALICIA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1.340
GALICIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	7.892
GALICIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	4.383
GALICIA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.509
GALICIA	Group 1900 Injuries and poisoning  800-999	Both sexes	29.171
GALICIA	Group 1900 Injuries and poisoning  800-999	Men	15.134
GALICIA	Group 1900 Injuries and poisoning  800-999	Women	14.037
GALICIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.895
GALICIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.078
GALICIA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	817
GALICIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	947
GALICIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	666
GALICIA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	281
GALICIA	Group 1903 Radius and ulna fracture 813	Both sexes	1.644
GALICIA	Group 1903 Radius and ulna fracture 813	Men	695
GALICIA	Group 1903 Radius and ulna fracture 813	Women	949
GALICIA	Group 1904 Femur fracture  820-821	Both sexes	4.061
GALICIA	Group 1904 Femur fracture  820-821	Men	1.005
GALICIA	Group 1904 Femur fracture  820-821	Women	3.056
GALICIA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	2.153
GALICIA	Group 1905 Leg fracture, including the ankle 823-824	Men	1.056
GALICIA	Group 1905 Leg fracture, including the ankle 823-824	Women	1.097
GALICIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	9.106
GALICIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	5.493
GALICIA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	3.613
GALICIA	Group 1907 Burns  940-949	Both sexes	324
GALICIA	Group 1907 Burns  940-949	Men	192
GALICIA	Group 1907 Burns  940-949	Women	132
GALICIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	677
GALICIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	344
GALICIA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	333
GALICIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	7.742
GALICIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	4.269
GALICIA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	3.473
GALICIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	57
GALICIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	34
GALICIA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	23
GALICIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	565
GALICIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	302
GALICIA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	263
GALICIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	5.802
GALICIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	3.213
GALICIA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.589
GALICIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	306
GALICIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	160
GALICIA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	146
GALICIA	Group 2102 Contraceptive management  V25	Both sexes	126
GALICIA	Group 2102 Contraceptive management  V25	Men	3
GALICIA	Group 2102 Contraceptive management  V25	Women	123
GALICIA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
GALICIA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
GALICIA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
GALICIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	2.576
GALICIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.721
GALICIA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	855
GALICIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	2.794
GALICIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.329
GALICIA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.465
Coru±a, A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	124.590
Coru±a, A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	60.744
Coru±a, A	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	63.846
Coru±a, A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.311
Coru±a, A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.290
Coru±a, A	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.021
Coru±a, A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	406
Coru±a, A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	213
Coru±a, A	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	193
Coru±a, A	Group 0102 Imprecise intestinal infections 009	Both sexes	116
Coru±a, A	Group 0102 Imprecise intestinal infections 009	Men	56
Coru±a, A	Group 0102 Imprecise intestinal infections 009	Women	60
Coru±a, A	Group 0103 Tuberculosis 010-018, 137	Both sexes	108
Coru±a, A	Group 0103 Tuberculosis 010-018, 137	Men	72
Coru±a, A	Group 0103 Tuberculosis 010-018, 137	Women	36
Coru±a, A	Group 0104 Septicaemia  038	Both sexes	710
Coru±a, A	Group 0104 Septicaemia  038	Men	383
Coru±a, A	Group 0104 Septicaemia  038	Women	327
Coru±a, A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	106
Coru±a, A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	81
Coru±a, A	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	25
Coru±a, A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	865
Coru±a, A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	485
Coru±a, A	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	380
Coru±a, A	Group 0200 Neoplasms  140-239	Both sexes	14.430
Coru±a, A	Group 0200 Neoplasms  140-239	Men	7.742
Coru±a, A	Group 0200 Neoplasms  140-239	Women	6.688
Coru±a, A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.368
Coru±a, A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	839
Coru±a, A	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	529
Coru±a, A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.132
Coru±a, A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	890
Coru±a, A	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	242
Coru±a, A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	268
Coru±a, A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	130
Coru±a, A	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	138
Coru±a, A	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.014
Coru±a, A	Group 0204 Malignant neoplasm of breast  174-175	Men	7
Coru±a, A	Group 0204 Malignant neoplasm of breast  174-175	Women	1.007
Coru±a, A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	346
Coru±a, A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Coru±a, A	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	346
Coru±a, A	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	197
Coru±a, A	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Coru±a, A	Group 0206 Malignant neoplasm of ovary  1830	Women	197
Coru±a, A	Group 0207 Malignant neoplasm of prostate  185	Both sexes	747
Coru±a, A	Group 0207 Malignant neoplasm of prostate  185	Men	747
Coru±a, A	Group 0207 Malignant neoplasm of prostate  185	Women	..
Coru±a, A	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.004
Coru±a, A	Group 0208 Malignant neoplasm of bladder  188	Men	855
Coru±a, A	Group 0208 Malignant neoplasm of bladder  188	Women	149
Coru±a, A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.375
Coru±a, A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.211
Coru±a, A	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.164
Coru±a, A	Group 0210 Carcinoma in situ  230-234	Both sexes	329
Coru±a, A	Group 0210 Carcinoma in situ  230-234	Men	172
Coru±a, A	Group 0210 Carcinoma in situ  230-234	Women	157
Coru±a, A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	177
Coru±a, A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	115
Coru±a, A	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	62
Coru±a, A	Grupo 0212 Leiomyoma of uterus  218	Both sexes	572
Coru±a, A	Grupo 0212 Leiomyoma of uterus  218	Men	..
Coru±a, A	Grupo 0212 Leiomyoma of uterus  218	Women	572
Coru±a, A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.901
Coru±a, A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	776
Coru±a, A	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.125
Coru±a, A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.026
Coru±a, A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	498
Coru±a, A	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	528
Coru±a, A	Group 0301 Anaemias 280-285	Both sexes	587
Coru±a, A	Group 0301 Anaemias 280-285	Men	288
Coru±a, A	Group 0301 Anaemias 280-285	Women	299
Coru±a, A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	439
Coru±a, A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	210
Coru±a, A	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	229
Coru±a, A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.808
Coru±a, A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	737
Coru±a, A	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.071
Coru±a, A	Group 0401 Diabetes mellitus  249-250	Both sexes	630
Coru±a, A	Group 0401 Diabetes mellitus  249-250	Men	377
Coru±a, A	Group 0401 Diabetes mellitus  249-250	Women	253
Coru±a, A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.178
Coru±a, A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	360
Coru±a, A	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	818
Coru±a, A	Group 0500 Mental disorders  290-319	Both sexes	2.263
Coru±a, A	Group 0500 Mental disorders  290-319	Men	1.116
Coru±a, A	Group 0500 Mental disorders  290-319	Women	1.147
Coru±a, A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	74
Coru±a, A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	32
Coru±a, A	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	42
Coru±a, A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	194
Coru±a, A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	148
Coru±a, A	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	46
Coru±a, A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	125
Coru±a, A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	89
Coru±a, A	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	36
Coru±a, A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	638
Coru±a, A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	340
Coru±a, A	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	298
Coru±a, A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	587
Coru±a, A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	220
Coru±a, A	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	367
Coru±a, A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	645
Coru±a, A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	287
Coru±a, A	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	358
Coru±a, A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.362
Coru±a, A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.169
Coru±a, A	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.193
Coru±a, A	Group 0601 Alzheimer's disease  3310	Both sexes	31
Coru±a, A	Group 0601 Alzheimer's disease  3310	Men	10
Coru±a, A	Group 0601 Alzheimer's disease  3310	Women	21
Coru±a, A	Group 0602 Multiple sclerosis 340	Both sexes	78
Coru±a, A	Group 0602 Multiple sclerosis 340	Men	22
Coru±a, A	Group 0602 Multiple sclerosis 340	Women	56
Coru±a, A	Group 0603 Epilepsy  345	Both sexes	394
Coru±a, A	Group 0603 Epilepsy  345	Men	220
Coru±a, A	Group 0603 Epilepsy  345	Women	174
Coru±a, A	Group 0604 Transient cerebral ischemia 435	Both sexes	368
Coru±a, A	Group 0604 Transient cerebral ischemia 435	Men	168
Coru±a, A	Group 0604 Transient cerebral ischemia 435	Women	200
Coru±a, A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.491
Coru±a, A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	749
Coru±a, A	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	742
Coru±a, A	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	495
Coru±a, A	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	249
Coru±a, A	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	246
Coru±a, A	Grupo 0701 Cataract  366	Both sexes	32
Coru±a, A	Grupo 0701 Cataract  366	Men	13
Coru±a, A	Grupo 0701 Cataract  366	Women	19
Coru±a, A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	463
Coru±a, A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	236
Coru±a, A	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	227
Coru±a, A	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	497
Coru±a, A	Group 0800 Diseases of the ear and the mastoid  380-389	Men	230
Coru±a, A	Group 0800 Diseases of the ear and the mastoid  380-389	Women	267
Coru±a, A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	17.602
Coru±a, A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.106
Coru±a, A	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.496
Coru±a, A	Group 0901 Hypertensive disease  401-405	Both sexes	1.032
Coru±a, A	Group 0901 Hypertensive disease  401-405	Men	504
Coru±a, A	Group 0901 Hypertensive disease  401-405	Women	528
Coru±a, A	Group 0902 Angina pectoris  4111, 413	Both sexes	599
Coru±a, A	Group 0902 Angina pectoris  4111, 413	Men	344
Coru±a, A	Group 0902 Angina pectoris  4111, 413	Women	255
Coru±a, A	Group 0903 Acute myocardial infarction  410	Both sexes	1.566
Coru±a, A	Group 0903 Acute myocardial infarction  410	Men	1.113
Coru±a, A	Group 0903 Acute myocardial infarction  410	Women	453
Coru±a, A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.578
Coru±a, A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.244
Coru±a, A	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	334
Coru±a, A	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	579
Coru±a, A	Group 0905 Diseases of the lungs circulation 415-417	Men	239
Coru±a, A	Group 0905 Diseases of the lungs circulation 415-417	Women	340
Coru±a, A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.077
Coru±a, A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.216
Coru±a, A	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	861
Coru±a, A	Grupo 0907 Heart failure  428	Both sexes	2.998
Coru±a, A	Grupo 0907 Heart failure  428	Men	1.521
Coru±a, A	Grupo 0907 Heart failure  428	Women	1.477
Coru±a, A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.572
Coru±a, A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.305
Coru±a, A	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.267
Coru±a, A	Grupo 0909 Atherosclerosis  440	Both sexes	615
Coru±a, A	Grupo 0909 Atherosclerosis  440	Men	471
Coru±a, A	Grupo 0909 Atherosclerosis  440	Women	144
Coru±a, A	Group 0910 Varicose veins of lower extremities 454	Both sexes	776
Coru±a, A	Group 0910 Varicose veins of lower extremities 454	Men	254
Coru±a, A	Group 0910 Varicose veins of lower extremities 454	Women	522
Coru±a, A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.210
Coru±a, A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.895
Coru±a, A	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.315
Coru±a, A	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	15.122
Coru±a, A	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	8.627
Coru±a, A	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.495
Coru±a, A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	606
Coru±a, A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	323
Coru±a, A	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	283
Coru±a, A	Group 1002 Pneumonia 480-486	Both sexes	3.033
Coru±a, A	Group 1002 Pneumonia 480-486	Men	1.765
Coru±a, A	Group 1002 Pneumonia 480-486	Women	1.268
Coru±a, A	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	526
Coru±a, A	Group 1003 Acute bronchitis and bronchiolitis  466	Men	277
Coru±a, A	Group 1003 Acute bronchitis and bronchiolitis  466	Women	249
Coru±a, A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	744
Coru±a, A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	363
Coru±a, A	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	381
Coru±a, A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.146
Coru±a, A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	696
Coru±a, A	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	450
Coru±a, A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.808
Coru±a, A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.182
Coru±a, A	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	626
Coru±a, A	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	649
Coru±a, A	Group 1007 Asthma 4930-4931,4938-4939	Men	150
Coru±a, A	Group 1007 Asthma 4930-4931,4938-4939	Women	499
Coru±a, A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.610
Coru±a, A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.871
Coru±a, A	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.739
Coru±a, A	Group 1100 Diseases of the digestive system  520-579	Both sexes	14.861
Coru±a, A	Group 1100 Diseases of the digestive system  520-579	Men	8.295
Coru±a, A	Group 1100 Diseases of the digestive system  520-579	Women	6.566
Coru±a, A	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	212
Coru±a, A	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	100
Coru±a, A	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	112
Coru±a, A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	173
Coru±a, A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	96
Coru±a, A	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	77
Coru±a, A	Group 1103 Diseases of the esophagus 530	Both sexes	295
Coru±a, A	Group 1103 Diseases of the esophagus 530	Men	181
Coru±a, A	Group 1103 Diseases of the esophagus 530	Women	114
Coru±a, A	Group 1104 Peptic ulcer 531-534	Both sexes	253
Coru±a, A	Group 1104 Peptic ulcer 531-534	Men	166
Coru±a, A	Group 1104 Peptic ulcer 531-534	Women	87
Coru±a, A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	316
Coru±a, A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	167
Coru±a, A	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	149
Coru±a, A	Group 1106 Appendicitis  540-543	Both sexes	1.192
Coru±a, A	Group 1106 Appendicitis  540-543	Men	642
Coru±a, A	Group 1106 Appendicitis  540-543	Women	550
Coru±a, A	Group 1107 Inguinal hernia  550	Both sexes	1.578
Coru±a, A	Group 1107 Inguinal hernia  550	Men	1.413
Coru±a, A	Group 1107 Inguinal hernia  550	Women	165
Coru±a, A	Group 1108 Other abdominal hernia  551-553	Both sexes	1.074
Coru±a, A	Group 1108 Other abdominal hernia  551-553	Men	554
Coru±a, A	Group 1108 Other abdominal hernia  551-553	Women	520
Coru±a, A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	330
Coru±a, A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	160
Coru±a, A	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	170
Coru±a, A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	651
Coru±a, A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	299
Coru±a, A	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	352
Coru±a, A	Group 1111 Intestinal obstruction without hernia 560	Both sexes	763
Coru±a, A	Group 1111 Intestinal obstruction without hernia 560	Men	413
Coru±a, A	Group 1111 Intestinal obstruction without hernia 560	Women	350
Coru±a, A	Group 1112 Intestinal diverticulosis 562	Both sexes	545
Coru±a, A	Group 1112 Intestinal diverticulosis 562	Men	256
Coru±a, A	Group 1112 Intestinal diverticulosis 562	Women	289
Coru±a, A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	858
Coru±a, A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	552
Coru±a, A	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	306
Coru±a, A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	451
Coru±a, A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	214
Coru±a, A	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	237
Coru±a, A	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	347
Coru±a, A	Group 1115 Alcoholic hepatitis 5710-5713	Men	298
Coru±a, A	Group 1115 Alcoholic hepatitis 5710-5713	Women	49
Coru±a, A	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	536
Coru±a, A	Group 1116 Other diseases of the liver 570,5714-573	Men	316
Coru±a, A	Group 1116 Other diseases of the liver 570,5714-573	Women	220
Coru±a, A	Group 1117 Cholelithiasis  574	Both sexes	3.218
Coru±a, A	Group 1117 Cholelithiasis  574	Men	1.330
Coru±a, A	Group 1117 Cholelithiasis  574	Women	1.888
Coru±a, A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	604
Coru±a, A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	347
Coru±a, A	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	257
Coru±a, A	Group 1119 Pancreatic diseases 577	Both sexes	874
Coru±a, A	Group 1119 Pancreatic diseases 577	Men	466
Coru±a, A	Group 1119 Pancreatic diseases 577	Women	408
Coru±a, A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	591
Coru±a, A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	325
Coru±a, A	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	266
Coru±a, A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.428
Coru±a, A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	814
Coru±a, A	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	614
Coru±a, A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	918
Coru±a, A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	548
Coru±a, A	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	370
Coru±a, A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	89
Coru±a, A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	50
Coru±a, A	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	39
Coru±a, A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	421
Coru±a, A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	216
Coru±a, A	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	205
Coru±a, A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.176
Coru±a, A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.106
Coru±a, A	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.070
Coru±a, A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Coru±a, A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Coru±a, A	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Coru±a, A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Coru±a, A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Coru±a, A	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Coru±a, A	Group 1303 Internal derangement of knee 717	Both sexes	929
Coru±a, A	Group 1303 Internal derangement of knee 717	Men	642
Coru±a, A	Group 1303 Internal derangement of knee 717	Women	287
Coru±a, A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.527
Coru±a, A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.428
Coru±a, A	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.099
Coru±a, A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	235
Coru±a, A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	75
Coru±a, A	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	160
Coru±a, A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	304
Coru±a, A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	142
Coru±a, A	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	162
Coru±a, A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	749
Coru±a, A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	411
Coru±a, A	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	338
Coru±a, A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	110
Coru±a, A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	57
Coru±a, A	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	53
Coru±a, A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.489
Coru±a, A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	785
Coru±a, A	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	704
Coru±a, A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.833
Coru±a, A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	566
Coru±a, A	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.267
Coru±a, A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	6.998
Coru±a, A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.306
Coru±a, A	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.692
Coru±a, A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	634
Coru±a, A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	253
Coru±a, A	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	381
Coru±a, A	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	587
Coru±a, A	Group 1402 Renal failure  5836-5837, 584-586	Men	324
Coru±a, A	Group 1402 Renal failure  5836-5837, 584-586	Women	263
Coru±a, A	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	699
Coru±a, A	Group 1403 Urolithiasis  592, 594, 7880	Men	409
Coru±a, A	Group 1403 Urolithiasis  592, 594, 7880	Women	290
Coru±a, A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.051
Coru±a, A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.016
Coru±a, A	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.035
Coru±a, A	Group 1405 Prostatic hyperplasia  600	Both sexes	719
Coru±a, A	Group 1405 Prostatic hyperplasia  600	Men	719
Coru±a, A	Group 1405 Prostatic hyperplasia  600	Women	..
Coru±a, A	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	536
Coru±a, A	Group 1406 Other diseases of the male genital organs    601-608	Men	536
Coru±a, A	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Coru±a, A	Group 1407 Disorders of breast  610-612	Both sexes	393
Coru±a, A	Group 1407 Disorders of breast  610-612	Men	42
Coru±a, A	Group 1407 Disorders of breast  610-612	Women	351
Coru±a, A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	162
Coru±a, A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Coru±a, A	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	162
Coru±a, A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	135
Coru±a, A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Coru±a, A	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	135
Coru±a, A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.082
Coru±a, A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	7
Coru±a, A	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.075
Coru±a, A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	11.265
Coru±a, A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Coru±a, A	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	11.265
Coru±a, A	Group 1501 Legally induced abortion  635	Both sexes	79
Coru±a, A	Group 1501 Legally induced abortion  635	Men	..
Coru±a, A	Group 1501 Legally induced abortion  635	Women	79
Coru±a, A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	1.250
Coru±a, A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Coru±a, A	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	1.250
Coru±a, A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.994
Coru±a, A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Coru±a, A	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.994
Coru±a, A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.290
Coru±a, A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Coru±a, A	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.290
Coru±a, A	Group 1505 Single spontaneous delivery  650	Both sexes	622
Coru±a, A	Group 1505 Single spontaneous delivery  650	Men	..
Coru±a, A	Group 1505 Single spontaneous delivery  650	Women	622
Coru±a, A	Group 1506 Other deliveries  6695-6697	Both sexes	305
Coru±a, A	Group 1506 Other deliveries  6695-6697	Men	..
Coru±a, A	Group 1506 Other deliveries  6695-6697	Women	305
Coru±a, A	Group 1507 Complications related to the puerperium  670-676	Both sexes	78
Coru±a, A	Group 1507 Complications related to the puerperium  670-676	Men	..
Coru±a, A	Group 1507 Complications related to the puerperium  670-676	Women	78
Coru±a, A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	647
Coru±a, A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Coru±a, A	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	647
Coru±a, A	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.945
Coru±a, A	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.088
Coru±a, A	Group 1600 Some disorders originating in the perinatal period  760-779	Women	857
Coru±a, A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	432
Coru±a, A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	230
Coru±a, A	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	202
Coru±a, A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.513
Coru±a, A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	858
Coru±a, A	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	655
Coru±a, A	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.327
Coru±a, A	Grupo 1700 Congenital abnormalities  740-759	Men	784
Coru±a, A	Grupo 1700 Congenital abnormalities  740-759	Women	543
Coru±a, A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	4.892
Coru±a, A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.633
Coru±a, A	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.259
Coru±a, A	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	589
Coru±a, A	Group 1801 Pain in throat and chest 7841, 7865	Men	351
Coru±a, A	Group 1801 Pain in throat and chest 7841, 7865	Women	238
Coru±a, A	Group 1802 Abdominal pain   7890	Both sexes	411
Coru±a, A	Group 1802 Abdominal pain   7890	Men	151
Coru±a, A	Group 1802 Abdominal pain   7890	Women	260
Coru±a, A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	878
Coru±a, A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	456
Coru±a, A	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	422
Coru±a, A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	3.014
Coru±a, A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.675
Coru±a, A	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.339
Coru±a, A	Group 1900 Injuries and poisoning  800-999	Both sexes	11.853
Coru±a, A	Group 1900 Injuries and poisoning  800-999	Men	6.321
Coru±a, A	Group 1900 Injuries and poisoning  800-999	Women	5.532
Coru±a, A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	590
Coru±a, A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	336
Coru±a, A	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	254
Coru±a, A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	421
Coru±a, A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	300
Coru±a, A	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	121
Coru±a, A	Group 1903 Radius and ulna fracture 813	Both sexes	734
Coru±a, A	Group 1903 Radius and ulna fracture 813	Men	309
Coru±a, A	Group 1903 Radius and ulna fracture 813	Women	425
Coru±a, A	Group 1904 Femur fracture  820-821	Both sexes	1.629
Coru±a, A	Group 1904 Femur fracture  820-821	Men	399
Coru±a, A	Group 1904 Femur fracture  820-821	Women	1.230
Coru±a, A	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	860
Coru±a, A	Group 1905 Leg fracture, including the ankle 823-824	Men	411
Coru±a, A	Group 1905 Leg fracture, including the ankle 823-824	Women	449
Coru±a, A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.256
Coru±a, A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.068
Coru±a, A	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.188
Coru±a, A	Group 1907 Burns  940-949	Both sexes	172
Coru±a, A	Group 1907 Burns  940-949	Men	109
Coru±a, A	Group 1907 Burns  940-949	Women	63
Coru±a, A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	270
Coru±a, A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	141
Coru±a, A	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	129
Coru±a, A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.631
Coru±a, A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	2.092
Coru±a, A	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.539
Coru±a, A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	49
Coru±a, A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	27
Coru±a, A	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	22
Coru±a, A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	241
Coru±a, A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	129
Coru±a, A	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	112
Coru±a, A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.929
Coru±a, A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.633
Coru±a, A	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.296
Coru±a, A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	157
Coru±a, A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	77
Coru±a, A	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	80
Coru±a, A	Group 2102 Contraceptive management  V25	Both sexes	12
Coru±a, A	Group 2102 Contraceptive management  V25	Men	..
Coru±a, A	Group 2102 Contraceptive management  V25	Women	12
Coru±a, A	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Coru±a, A	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Coru±a, A	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Coru±a, A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.218
Coru±a, A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	806
Coru±a, A	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	412
Coru±a, A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.542
Coru±a, A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	750
Coru±a, A	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	792
Lugo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	34.847
Lugo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	17.147
Lugo	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	17.700
Lugo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	654
Lugo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	373
Lugo	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	281
Lugo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	161
Lugo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	85
Lugo	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	76
Lugo	Group 0102 Imprecise intestinal infections 009	Both sexes	28
Lugo	Group 0102 Imprecise intestinal infections 009	Men	12
Lugo	Group 0102 Imprecise intestinal infections 009	Women	16
Lugo	Group 0103 Tuberculosis 010-018, 137	Both sexes	27
Lugo	Group 0103 Tuberculosis 010-018, 137	Men	23
Lugo	Group 0103 Tuberculosis 010-018, 137	Women	4
Lugo	Group 0104 Septicaemia  038	Both sexes	139
Lugo	Group 0104 Septicaemia  038	Men	70
Lugo	Group 0104 Septicaemia  038	Women	69
Lugo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	28
Lugo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	20
Lugo	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	8
Lugo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	271
Lugo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	163
Lugo	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	108
Lugo	Group 0200 Neoplasms  140-239	Both sexes	2.991
Lugo	Group 0200 Neoplasms  140-239	Men	1.480
Lugo	Group 0200 Neoplasms  140-239	Women	1.511
Lugo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	403
Lugo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	246
Lugo	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	157
Lugo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	142
Lugo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	110
Lugo	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	32
Lugo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	45
Lugo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	21
Lugo	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	24
Lugo	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	256
Lugo	Group 0204 Malignant neoplasm of breast  174-175	Men	1
Lugo	Group 0204 Malignant neoplasm of breast  174-175	Women	255
Lugo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	100
Lugo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Lugo	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	100
Lugo	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	37
Lugo	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Lugo	Group 0206 Malignant neoplasm of ovary  1830	Women	37
Lugo	Group 0207 Malignant neoplasm of prostate  185	Both sexes	133
Lugo	Group 0207 Malignant neoplasm of prostate  185	Men	133
Lugo	Group 0207 Malignant neoplasm of prostate  185	Women	..
Lugo	Group 0208 Malignant neoplasm of bladder  188	Both sexes	267
Lugo	Group 0208 Malignant neoplasm of bladder  188	Men	222
Lugo	Group 0208 Malignant neoplasm of bladder  188	Women	45
Lugo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	953
Lugo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	573
Lugo	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	380
Lugo	Group 0210 Carcinoma in situ  230-234	Both sexes	55
Lugo	Group 0210 Carcinoma in situ  230-234	Men	21
Lugo	Group 0210 Carcinoma in situ  230-234	Women	34
Lugo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	24
Lugo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	14
Lugo	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	10
Lugo	Grupo 0212 Leiomyoma of uterus  218	Both sexes	177
Lugo	Grupo 0212 Leiomyoma of uterus  218	Men	..
Lugo	Grupo 0212 Leiomyoma of uterus  218	Women	177
Lugo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	399
Lugo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	139
Lugo	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	260
Lugo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	412
Lugo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	228
Lugo	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	184
Lugo	Group 0301 Anaemias 280-285	Both sexes	241
Lugo	Group 0301 Anaemias 280-285	Men	121
Lugo	Group 0301 Anaemias 280-285	Women	120
Lugo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	171
Lugo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	107
Lugo	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	64
Lugo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	640
Lugo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	297
Lugo	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	343
Lugo	Group 0401 Diabetes mellitus  249-250	Both sexes	248
Lugo	Group 0401 Diabetes mellitus  249-250	Men	145
Lugo	Group 0401 Diabetes mellitus  249-250	Women	103
Lugo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	392
Lugo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	152
Lugo	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	240
Lugo	Group 0500 Mental disorders  290-319	Both sexes	652
Lugo	Group 0500 Mental disorders  290-319	Men	332
Lugo	Group 0500 Mental disorders  290-319	Women	320
Lugo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	44
Lugo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	19
Lugo	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	25
Lugo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	49
Lugo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	39
Lugo	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	10
Lugo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	29
Lugo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	18
Lugo	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	11
Lugo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	206
Lugo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	110
Lugo	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	96
Lugo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	124
Lugo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	50
Lugo	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	74
Lugo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	200
Lugo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	96
Lugo	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	104
Lugo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	731
Lugo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	335
Lugo	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	396
Lugo	Group 0601 Alzheimer's disease  3310	Both sexes	17
Lugo	Group 0601 Alzheimer's disease  3310	Men	5
Lugo	Group 0601 Alzheimer's disease  3310	Women	12
Lugo	Group 0602 Multiple sclerosis 340	Both sexes	75
Lugo	Group 0602 Multiple sclerosis 340	Men	15
Lugo	Group 0602 Multiple sclerosis 340	Women	60
Lugo	Group 0603 Epilepsy  345	Both sexes	155
Lugo	Group 0603 Epilepsy  345	Men	86
Lugo	Group 0603 Epilepsy  345	Women	69
Lugo	Group 0604 Transient cerebral ischemia 435	Both sexes	91
Lugo	Group 0604 Transient cerebral ischemia 435	Men	44
Lugo	Group 0604 Transient cerebral ischemia 435	Women	47
Lugo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	393
Lugo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	185
Lugo	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	208
Lugo	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	272
Lugo	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	161
Lugo	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	111
Lugo	Grupo 0701 Cataract  366	Both sexes	55
Lugo	Grupo 0701 Cataract  366	Men	33
Lugo	Grupo 0701 Cataract  366	Women	22
Lugo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	217
Lugo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	128
Lugo	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	89
Lugo	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	151
Lugo	Group 0800 Diseases of the ear and the mastoid  380-389	Men	89
Lugo	Group 0800 Diseases of the ear and the mastoid  380-389	Women	62
Lugo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.612
Lugo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.614
Lugo	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.998
Lugo	Group 0901 Hypertensive disease  401-405	Both sexes	327
Lugo	Group 0901 Hypertensive disease  401-405	Men	138
Lugo	Group 0901 Hypertensive disease  401-405	Women	189
Lugo	Group 0902 Angina pectoris  4111, 413	Both sexes	250
Lugo	Group 0902 Angina pectoris  4111, 413	Men	171
Lugo	Group 0902 Angina pectoris  4111, 413	Women	79
Lugo	Group 0903 Acute myocardial infarction  410	Both sexes	336
Lugo	Group 0903 Acute myocardial infarction  410	Men	239
Lugo	Group 0903 Acute myocardial infarction  410	Women	97
Lugo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	276
Lugo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	206
Lugo	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	70
Lugo	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	257
Lugo	Group 0905 Diseases of the lungs circulation 415-417	Men	105
Lugo	Group 0905 Diseases of the lungs circulation 415-417	Women	152
Lugo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	479
Lugo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	260
Lugo	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	219
Lugo	Grupo 0907 Heart failure  428	Both sexes	751
Lugo	Grupo 0907 Heart failure  428	Men	387
Lugo	Grupo 0907 Heart failure  428	Women	364
Lugo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	918
Lugo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	470
Lugo	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	448
Lugo	Grupo 0909 Atherosclerosis  440	Both sexes	205
Lugo	Grupo 0909 Atherosclerosis  440	Men	143
Lugo	Grupo 0909 Atherosclerosis  440	Women	62
Lugo	Group 0910 Varicose veins of lower extremities 454	Both sexes	28
Lugo	Group 0910 Varicose veins of lower extremities 454	Men	10
Lugo	Group 0910 Varicose veins of lower extremities 454	Women	18
Lugo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	785
Lugo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	485
Lugo	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	300
Lugo	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.004
Lugo	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.317
Lugo	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.687
Lugo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	219
Lugo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	118
Lugo	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	101
Lugo	Group 1002 Pneumonia 480-486	Both sexes	1.004
Lugo	Group 1002 Pneumonia 480-486	Men	638
Lugo	Group 1002 Pneumonia 480-486	Women	366
Lugo	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	145
Lugo	Group 1003 Acute bronchitis and bronchiolitis  466	Men	75
Lugo	Group 1003 Acute bronchitis and bronchiolitis  466	Women	70
Lugo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	107
Lugo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	55
Lugo	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	52
Lugo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	267
Lugo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	162
Lugo	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	105
Lugo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	498
Lugo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	379
Lugo	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	119
Lugo	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	143
Lugo	Group 1007 Asthma 4930-4931,4938-4939	Men	61
Lugo	Group 1007 Asthma 4930-4931,4938-4939	Women	82
Lugo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.621
Lugo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	829
Lugo	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	792
Lugo	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.850
Lugo	Group 1100 Diseases of the digestive system  520-579	Men	2.773
Lugo	Group 1100 Diseases of the digestive system  520-579	Women	2.077
Lugo	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	61
Lugo	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	28
Lugo	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	33
Lugo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	43
Lugo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	23
Lugo	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	20
Lugo	Group 1103 Diseases of the esophagus 530	Both sexes	73
Lugo	Group 1103 Diseases of the esophagus 530	Men	53
Lugo	Group 1103 Diseases of the esophagus 530	Women	20
Lugo	Group 1104 Peptic ulcer 531-534	Both sexes	66
Lugo	Group 1104 Peptic ulcer 531-534	Men	42
Lugo	Group 1104 Peptic ulcer 531-534	Women	24
Lugo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	104
Lugo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	60
Lugo	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	44
Lugo	Group 1106 Appendicitis  540-543	Both sexes	416
Lugo	Group 1106 Appendicitis  540-543	Men	240
Lugo	Group 1106 Appendicitis  540-543	Women	176
Lugo	Group 1107 Inguinal hernia  550	Both sexes	518
Lugo	Group 1107 Inguinal hernia  550	Men	468
Lugo	Group 1107 Inguinal hernia  550	Women	50
Lugo	Group 1108 Other abdominal hernia  551-553	Both sexes	339
Lugo	Group 1108 Other abdominal hernia  551-553	Men	171
Lugo	Group 1108 Other abdominal hernia  551-553	Women	168
Lugo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	67
Lugo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	36
Lugo	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	31
Lugo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	270
Lugo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	127
Lugo	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	143
Lugo	Group 1111 Intestinal obstruction without hernia 560	Both sexes	286
Lugo	Group 1111 Intestinal obstruction without hernia 560	Men	132
Lugo	Group 1111 Intestinal obstruction without hernia 560	Women	154
Lugo	Group 1112 Intestinal diverticulosis 562	Both sexes	224
Lugo	Group 1112 Intestinal diverticulosis 562	Men	106
Lugo	Group 1112 Intestinal diverticulosis 562	Women	118
Lugo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	236
Lugo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	168
Lugo	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	68
Lugo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	180
Lugo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	76
Lugo	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	104
Lugo	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	113
Lugo	Group 1115 Alcoholic hepatitis 5710-5713	Men	95
Lugo	Group 1115 Alcoholic hepatitis 5710-5713	Women	18
Lugo	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	124
Lugo	Group 1116 Other diseases of the liver 570,5714-573	Men	74
Lugo	Group 1116 Other diseases of the liver 570,5714-573	Women	50
Lugo	Group 1117 Cholelithiasis  574	Both sexes	958
Lugo	Group 1117 Cholelithiasis  574	Men	452
Lugo	Group 1117 Cholelithiasis  574	Women	506
Lugo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	285
Lugo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	153
Lugo	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	132
Lugo	Group 1119 Pancreatic diseases 577	Both sexes	300
Lugo	Group 1119 Pancreatic diseases 577	Men	176
Lugo	Group 1119 Pancreatic diseases 577	Women	124
Lugo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	187
Lugo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	93
Lugo	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	94
Lugo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	499
Lugo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	259
Lugo	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	240
Lugo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	355
Lugo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	199
Lugo	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	156
Lugo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	27
Lugo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	13
Lugo	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	14
Lugo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	117
Lugo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	47
Lugo	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	70
Lugo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.497
Lugo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.112
Lugo	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.385
Lugo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Lugo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Lugo	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Lugo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Lugo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Lugo	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Lugo	Group 1303 Internal derangement of knee 717	Both sexes	283
Lugo	Group 1303 Internal derangement of knee 717	Men	189
Lugo	Group 1303 Internal derangement of knee 717	Women	94
Lugo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.057
Lugo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	413
Lugo	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	644
Lugo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	60
Lugo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	25
Lugo	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	35
Lugo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	112
Lugo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	50
Lugo	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	62
Lugo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	129
Lugo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	74
Lugo	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	55
Lugo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	56
Lugo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	23
Lugo	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	33
Lugo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	432
Lugo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	220
Lugo	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	212
Lugo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	368
Lugo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	118
Lugo	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	250
Lugo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.126
Lugo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.074
Lugo	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.052
Lugo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	186
Lugo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	92
Lugo	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	94
Lugo	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	213
Lugo	Group 1402 Renal failure  5836-5837, 584-586	Men	129
Lugo	Group 1402 Renal failure  5836-5837, 584-586	Women	84
Lugo	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	187
Lugo	Group 1403 Urolithiasis  592, 594, 7880	Men	118
Lugo	Group 1403 Urolithiasis  592, 594, 7880	Women	69
Lugo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	626
Lugo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	282
Lugo	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	344
Lugo	Group 1405 Prostatic hyperplasia  600	Both sexes	239
Lugo	Group 1405 Prostatic hyperplasia  600	Men	239
Lugo	Group 1405 Prostatic hyperplasia  600	Women	..
Lugo	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	196
Lugo	Group 1406 Other diseases of the male genital organs    601-608	Men	196
Lugo	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Lugo	Group 1407 Disorders of breast  610-612	Both sexes	59
Lugo	Group 1407 Disorders of breast  610-612	Men	17
Lugo	Group 1407 Disorders of breast  610-612	Women	42
Lugo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	59
Lugo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Lugo	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	59
Lugo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	42
Lugo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Lugo	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	42
Lugo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	319
Lugo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Lugo	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	318
Lugo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.724
Lugo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Lugo	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.724
Lugo	Group 1501 Legally induced abortion  635	Both sexes	14
Lugo	Group 1501 Legally induced abortion  635	Men	..
Lugo	Group 1501 Legally induced abortion  635	Women	14
Lugo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	315
Lugo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Lugo	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	315
Lugo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.456
Lugo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Lugo	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.456
Lugo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	648
Lugo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Lugo	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	648
Lugo	Group 1505 Single spontaneous delivery  650	Both sexes	90
Lugo	Group 1505 Single spontaneous delivery  650	Men	..
Lugo	Group 1505 Single spontaneous delivery  650	Women	90
Lugo	Group 1506 Other deliveries  6695-6697	Both sexes	63
Lugo	Group 1506 Other deliveries  6695-6697	Men	..
Lugo	Group 1506 Other deliveries  6695-6697	Women	63
Lugo	Group 1507 Complications related to the puerperium  670-676	Both sexes	14
Lugo	Group 1507 Complications related to the puerperium  670-676	Men	..
Lugo	Group 1507 Complications related to the puerperium  670-676	Women	14
Lugo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	124
Lugo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Lugo	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	124
Lugo	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	371
Lugo	Group 1600 Some disorders originating in the perinatal period  760-779	Men	218
Lugo	Group 1600 Some disorders originating in the perinatal period  760-779	Women	153
Lugo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	97
Lugo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	50
Lugo	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	47
Lugo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	274
Lugo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	168
Lugo	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	106
Lugo	Grupo 1700 Congenital abnormalities  740-759	Both sexes	104
Lugo	Grupo 1700 Congenital abnormalities  740-759	Men	55
Lugo	Grupo 1700 Congenital abnormalities  740-759	Women	49
Lugo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.164
Lugo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.147
Lugo	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.017
Lugo	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	157
Lugo	Group 1801 Pain in throat and chest 7841, 7865	Men	106
Lugo	Group 1801 Pain in throat and chest 7841, 7865	Women	51
Lugo	Group 1802 Abdominal pain   7890	Both sexes	185
Lugo	Group 1802 Abdominal pain   7890	Men	75
Lugo	Group 1802 Abdominal pain   7890	Women	110
Lugo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	689
Lugo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	342
Lugo	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	347
Lugo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.133
Lugo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	624
Lugo	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	509
Lugo	Group 1900 Injuries and poisoning  800-999	Both sexes	3.800
Lugo	Group 1900 Injuries and poisoning  800-999	Men	1.945
Lugo	Group 1900 Injuries and poisoning  800-999	Women	1.855
Lugo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	253
Lugo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	145
Lugo	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	108
Lugo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	121
Lugo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	90
Lugo	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	31
Lugo	Group 1903 Radius and ulna fracture 813	Both sexes	154
Lugo	Group 1903 Radius and ulna fracture 813	Men	57
Lugo	Group 1903 Radius and ulna fracture 813	Women	97
Lugo	Group 1904 Femur fracture  820-821	Both sexes	640
Lugo	Group 1904 Femur fracture  820-821	Men	171
Lugo	Group 1904 Femur fracture  820-821	Women	469
Lugo	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	257
Lugo	Group 1905 Leg fracture, including the ankle 823-824	Men	132
Lugo	Group 1905 Leg fracture, including the ankle 823-824	Women	125
Lugo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.138
Lugo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	704
Lugo	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	434
Lugo	Group 1907 Burns  940-949	Both sexes	45
Lugo	Group 1907 Burns  940-949	Men	23
Lugo	Group 1907 Burns  940-949	Women	22
Lugo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	78
Lugo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	37
Lugo	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	41
Lugo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.013
Lugo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	535
Lugo	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	478
Lugo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	3
Lugo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Lugo	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Lugo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	98
Lugo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	48
Lugo	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	50
Lugo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	593
Lugo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	338
Lugo	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	255
Lugo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	41
Lugo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	23
Lugo	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	18
Lugo	Group 2102 Contraceptive management  V25	Both sexes	15
Lugo	Group 2102 Contraceptive management  V25	Men	..
Lugo	Group 2102 Contraceptive management  V25	Women	15
Lugo	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Lugo	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Lugo	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Lugo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	222
Lugo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	143
Lugo	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	79
Lugo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	315
Lugo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	172
Lugo	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	143
Ourense	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	38.373
Ourense	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	19.253
Ourense	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	19.120
Ourense	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	764
Ourense	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	431
Ourense	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	333
Ourense	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	165
Ourense	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	85
Ourense	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	80
Ourense	Group 0102 Imprecise intestinal infections 009	Both sexes	14
Ourense	Group 0102 Imprecise intestinal infections 009	Men	2
Ourense	Group 0102 Imprecise intestinal infections 009	Women	12
Ourense	Group 0103 Tuberculosis 010-018, 137	Both sexes	35
Ourense	Group 0103 Tuberculosis 010-018, 137	Men	28
Ourense	Group 0103 Tuberculosis 010-018, 137	Women	7
Ourense	Group 0104 Septicaemia  038	Both sexes	348
Ourense	Group 0104 Septicaemia  038	Men	182
Ourense	Group 0104 Septicaemia  038	Women	166
Ourense	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	13
Ourense	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	11
Ourense	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	2
Ourense	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	189
Ourense	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	123
Ourense	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	66
Ourense	Group 0200 Neoplasms  140-239	Both sexes	3.364
Ourense	Group 0200 Neoplasms  140-239	Men	1.891
Ourense	Group 0200 Neoplasms  140-239	Women	1.473
Ourense	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	457
Ourense	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	276
Ourense	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	181
Ourense	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	195
Ourense	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	166
Ourense	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	29
Ourense	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	31
Ourense	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	11
Ourense	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	20
Ourense	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	225
Ourense	Group 0204 Malignant neoplasm of breast  174-175	Men	2
Ourense	Group 0204 Malignant neoplasm of breast  174-175	Women	223
Ourense	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	79
Ourense	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Ourense	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	79
Ourense	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	22
Ourense	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Ourense	Group 0206 Malignant neoplasm of ovary  1830	Women	22
Ourense	Group 0207 Malignant neoplasm of prostate  185	Both sexes	130
Ourense	Group 0207 Malignant neoplasm of prostate  185	Men	130
Ourense	Group 0207 Malignant neoplasm of prostate  185	Women	..
Ourense	Group 0208 Malignant neoplasm of bladder  188	Both sexes	399
Ourense	Group 0208 Malignant neoplasm of bladder  188	Men	332
Ourense	Group 0208 Malignant neoplasm of bladder  188	Women	67
Ourense	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.212
Ourense	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	733
Ourense	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	479
Ourense	Group 0210 Carcinoma in situ  230-234	Both sexes	52
Ourense	Group 0210 Carcinoma in situ  230-234	Men	18
Ourense	Group 0210 Carcinoma in situ  230-234	Women	34
Ourense	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	61
Ourense	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	37
Ourense	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	24
Ourense	Grupo 0212 Leiomyoma of uterus  218	Both sexes	71
Ourense	Grupo 0212 Leiomyoma of uterus  218	Men	..
Ourense	Grupo 0212 Leiomyoma of uterus  218	Women	71
Ourense	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	430
Ourense	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	186
Ourense	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	244
Ourense	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	298
Ourense	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	151
Ourense	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	147
Ourense	Group 0301 Anaemias 280-285	Both sexes	225
Ourense	Group 0301 Anaemias 280-285	Men	105
Ourense	Group 0301 Anaemias 280-285	Women	120
Ourense	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	73
Ourense	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	46
Ourense	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	27
Ourense	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	507
Ourense	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	240
Ourense	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	267
Ourense	Group 0401 Diabetes mellitus  249-250	Both sexes	207
Ourense	Group 0401 Diabetes mellitus  249-250	Men	115
Ourense	Group 0401 Diabetes mellitus  249-250	Women	92
Ourense	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	300
Ourense	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	125
Ourense	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	175
Ourense	Group 0500 Mental disorders  290-319	Both sexes	567
Ourense	Group 0500 Mental disorders  290-319	Men	261
Ourense	Group 0500 Mental disorders  290-319	Women	306
Ourense	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	9
Ourense	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	6
Ourense	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	3
Ourense	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	37
Ourense	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	29
Ourense	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	8
Ourense	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	19
Ourense	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	14
Ourense	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	5
Ourense	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	168
Ourense	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	93
Ourense	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	75
Ourense	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	129
Ourense	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	41
Ourense	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	88
Ourense	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	205
Ourense	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	78
Ourense	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	127
Ourense	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	831
Ourense	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	395
Ourense	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	436
Ourense	Group 0601 Alzheimer's disease  3310	Both sexes	10
Ourense	Group 0601 Alzheimer's disease  3310	Men	..
Ourense	Group 0601 Alzheimer's disease  3310	Women	10
Ourense	Group 0602 Multiple sclerosis 340	Both sexes	89
Ourense	Group 0602 Multiple sclerosis 340	Men	24
Ourense	Group 0602 Multiple sclerosis 340	Women	65
Ourense	Group 0603 Epilepsy  345	Both sexes	103
Ourense	Group 0603 Epilepsy  345	Men	51
Ourense	Group 0603 Epilepsy  345	Women	52
Ourense	Group 0604 Transient cerebral ischemia 435	Both sexes	248
Ourense	Group 0604 Transient cerebral ischemia 435	Men	119
Ourense	Group 0604 Transient cerebral ischemia 435	Women	129
Ourense	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	381
Ourense	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	201
Ourense	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	180
Ourense	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	116
Ourense	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	68
Ourense	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	48
Ourense	Grupo 0701 Cataract  366	Both sexes	4
Ourense	Grupo 0701 Cataract  366	Men	3
Ourense	Grupo 0701 Cataract  366	Women	1
Ourense	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	112
Ourense	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	65
Ourense	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	47
Ourense	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	137
Ourense	Group 0800 Diseases of the ear and the mastoid  380-389	Men	73
Ourense	Group 0800 Diseases of the ear and the mastoid  380-389	Women	64
Ourense	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.127
Ourense	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.837
Ourense	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.290
Ourense	Group 0901 Hypertensive disease  401-405	Both sexes	234
Ourense	Group 0901 Hypertensive disease  401-405	Men	112
Ourense	Group 0901 Hypertensive disease  401-405	Women	122
Ourense	Group 0902 Angina pectoris  4111, 413	Both sexes	364
Ourense	Group 0902 Angina pectoris  4111, 413	Men	228
Ourense	Group 0902 Angina pectoris  4111, 413	Women	136
Ourense	Group 0903 Acute myocardial infarction  410	Both sexes	300
Ourense	Group 0903 Acute myocardial infarction  410	Men	197
Ourense	Group 0903 Acute myocardial infarction  410	Women	103
Ourense	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	206
Ourense	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	158
Ourense	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	48
Ourense	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	204
Ourense	Group 0905 Diseases of the lungs circulation 415-417	Men	86
Ourense	Group 0905 Diseases of the lungs circulation 415-417	Women	118
Ourense	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	658
Ourense	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	366
Ourense	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	292
Ourense	Grupo 0907 Heart failure  428	Both sexes	1.272
Ourense	Grupo 0907 Heart failure  428	Men	638
Ourense	Grupo 0907 Heart failure  428	Women	634
Ourense	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	948
Ourense	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	481
Ourense	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	467
Ourense	Grupo 0909 Atherosclerosis  440	Both sexes	171
Ourense	Grupo 0909 Atherosclerosis  440	Men	122
Ourense	Grupo 0909 Atherosclerosis  440	Women	49
Ourense	Group 0910 Varicose veins of lower extremities 454	Both sexes	63
Ourense	Group 0910 Varicose veins of lower extremities 454	Men	25
Ourense	Group 0910 Varicose veins of lower extremities 454	Women	38
Ourense	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	707
Ourense	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	424
Ourense	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	283
Ourense	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	5.747
Ourense	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	3.260
Ourense	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.487
Ourense	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	174
Ourense	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	91
Ourense	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	83
Ourense	Group 1002 Pneumonia 480-486	Both sexes	1.402
Ourense	Group 1002 Pneumonia 480-486	Men	869
Ourense	Group 1002 Pneumonia 480-486	Women	533
Ourense	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	209
Ourense	Group 1003 Acute bronchitis and bronchiolitis  466	Men	131
Ourense	Group 1003 Acute bronchitis and bronchiolitis  466	Women	78
Ourense	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	185
Ourense	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	94
Ourense	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	91
Ourense	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	312
Ourense	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	199
Ourense	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	113
Ourense	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	950
Ourense	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	672
Ourense	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	278
Ourense	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	211
Ourense	Group 1007 Asthma 4930-4931,4938-4939	Men	50
Ourense	Group 1007 Asthma 4930-4931,4938-4939	Women	161
Ourense	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.304
Ourense	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.154
Ourense	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.150
Ourense	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.836
Ourense	Group 1100 Diseases of the digestive system  520-579	Men	2.795
Ourense	Group 1100 Diseases of the digestive system  520-579	Women	2.041
Ourense	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	15
Ourense	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	8
Ourense	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	7
Ourense	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	56
Ourense	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	27
Ourense	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	29
Ourense	Group 1103 Diseases of the esophagus 530	Both sexes	68
Ourense	Group 1103 Diseases of the esophagus 530	Men	42
Ourense	Group 1103 Diseases of the esophagus 530	Women	26
Ourense	Group 1104 Peptic ulcer 531-534	Both sexes	61
Ourense	Group 1104 Peptic ulcer 531-534	Men	39
Ourense	Group 1104 Peptic ulcer 531-534	Women	22
Ourense	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	124
Ourense	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	60
Ourense	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	64
Ourense	Group 1106 Appendicitis  540-543	Both sexes	347
Ourense	Group 1106 Appendicitis  540-543	Men	201
Ourense	Group 1106 Appendicitis  540-543	Women	146
Ourense	Group 1107 Inguinal hernia  550	Both sexes	588
Ourense	Group 1107 Inguinal hernia  550	Men	544
Ourense	Group 1107 Inguinal hernia  550	Women	44
Ourense	Group 1108 Other abdominal hernia  551-553	Both sexes	345
Ourense	Group 1108 Other abdominal hernia  551-553	Men	161
Ourense	Group 1108 Other abdominal hernia  551-553	Women	184
Ourense	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	54
Ourense	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	29
Ourense	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	25
Ourense	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	265
Ourense	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	141
Ourense	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	124
Ourense	Group 1111 Intestinal obstruction without hernia 560	Both sexes	276
Ourense	Group 1111 Intestinal obstruction without hernia 560	Men	143
Ourense	Group 1111 Intestinal obstruction without hernia 560	Women	133
Ourense	Group 1112 Intestinal diverticulosis 562	Both sexes	218
Ourense	Group 1112 Intestinal diverticulosis 562	Men	91
Ourense	Group 1112 Intestinal diverticulosis 562	Women	127
Ourense	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	285
Ourense	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	167
Ourense	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	118
Ourense	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	167
Ourense	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	69
Ourense	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	98
Ourense	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	115
Ourense	Group 1115 Alcoholic hepatitis 5710-5713	Men	95
Ourense	Group 1115 Alcoholic hepatitis 5710-5713	Women	20
Ourense	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	213
Ourense	Group 1116 Other diseases of the liver 570,5714-573	Men	157
Ourense	Group 1116 Other diseases of the liver 570,5714-573	Women	56
Ourense	Group 1117 Cholelithiasis  574	Both sexes	876
Ourense	Group 1117 Cholelithiasis  574	Men	404
Ourense	Group 1117 Cholelithiasis  574	Women	472
Ourense	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	276
Ourense	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	145
Ourense	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	131
Ourense	Group 1119 Pancreatic diseases 577	Both sexes	295
Ourense	Group 1119 Pancreatic diseases 577	Men	167
Ourense	Group 1119 Pancreatic diseases 577	Women	128
Ourense	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	192
Ourense	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	105
Ourense	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	87
Ourense	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	504
Ourense	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	272
Ourense	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	232
Ourense	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	345
Ourense	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	204
Ourense	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	141
Ourense	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	16
Ourense	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	10
Ourense	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	6
Ourense	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	143
Ourense	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	58
Ourense	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	85
Ourense	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.783
Ourense	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.263
Ourense	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.520
Ourense	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Ourense	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Ourense	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Ourense	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Ourense	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Ourense	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Ourense	Group 1303 Internal derangement of knee 717	Both sexes	425
Ourense	Group 1303 Internal derangement of knee 717	Men	262
Ourense	Group 1303 Internal derangement of knee 717	Women	163
Ourense	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.194
Ourense	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	497
Ourense	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	697
Ourense	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	46
Ourense	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	19
Ourense	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	27
Ourense	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	89
Ourense	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	46
Ourense	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	43
Ourense	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	158
Ourense	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	79
Ourense	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	79
Ourense	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	33
Ourense	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	17
Ourense	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	16
Ourense	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	407
Ourense	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	217
Ourense	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	190
Ourense	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	431
Ourense	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	126
Ourense	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	305
Ourense	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.472
Ourense	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.179
Ourense	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.293
Ourense	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	187
Ourense	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	80
Ourense	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	107
Ourense	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	259
Ourense	Group 1402 Renal failure  5836-5837, 584-586	Men	164
Ourense	Group 1402 Renal failure  5836-5837, 584-586	Women	95
Ourense	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	259
Ourense	Group 1403 Urolithiasis  592, 594, 7880	Men	155
Ourense	Group 1403 Urolithiasis  592, 594, 7880	Women	104
Ourense	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	971
Ourense	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	428
Ourense	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	543
Ourense	Group 1405 Prostatic hyperplasia  600	Both sexes	167
Ourense	Group 1405 Prostatic hyperplasia  600	Men	167
Ourense	Group 1405 Prostatic hyperplasia  600	Women	..
Ourense	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	174
Ourense	Group 1406 Other diseases of the male genital organs    601-608	Men	174
Ourense	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Ourense	Group 1407 Disorders of breast  610-612	Both sexes	55
Ourense	Group 1407 Disorders of breast  610-612	Men	10
Ourense	Group 1407 Disorders of breast  610-612	Women	45
Ourense	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	44
Ourense	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Ourense	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	44
Ourense	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	43
Ourense	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Ourense	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	43
Ourense	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	313
Ourense	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	1
Ourense	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	312
Ourense	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	2.154
Ourense	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Ourense	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	2.154
Ourense	Group 1501 Legally induced abortion  635	Both sexes	2
Ourense	Group 1501 Legally induced abortion  635	Men	..
Ourense	Group 1501 Legally induced abortion  635	Women	2
Ourense	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	105
Ourense	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Ourense	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	105
Ourense	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.284
Ourense	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Ourense	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.284
Ourense	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	516
Ourense	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Ourense	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	516
Ourense	Group 1505 Single spontaneous delivery  650	Both sexes	81
Ourense	Group 1505 Single spontaneous delivery  650	Men	..
Ourense	Group 1505 Single spontaneous delivery  650	Women	81
Ourense	Group 1506 Other deliveries  6695-6697	Both sexes	15
Ourense	Group 1506 Other deliveries  6695-6697	Men	..
Ourense	Group 1506 Other deliveries  6695-6697	Women	15
Ourense	Group 1507 Complications related to the puerperium  670-676	Both sexes	9
Ourense	Group 1507 Complications related to the puerperium  670-676	Men	..
Ourense	Group 1507 Complications related to the puerperium  670-676	Women	9
Ourense	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	142
Ourense	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Ourense	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	142
Ourense	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	299
Ourense	Group 1600 Some disorders originating in the perinatal period  760-779	Men	162
Ourense	Group 1600 Some disorders originating in the perinatal period  760-779	Women	137
Ourense	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	79
Ourense	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	43
Ourense	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	36
Ourense	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	220
Ourense	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	119
Ourense	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	101
Ourense	Grupo 1700 Congenital abnormalities  740-759	Both sexes	145
Ourense	Grupo 1700 Congenital abnormalities  740-759	Men	83
Ourense	Grupo 1700 Congenital abnormalities  740-759	Women	62
Ourense	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	3.299
Ourense	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.728
Ourense	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.571
Ourense	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	257
Ourense	Group 1801 Pain in throat and chest 7841, 7865	Men	143
Ourense	Group 1801 Pain in throat and chest 7841, 7865	Women	114
Ourense	Group 1802 Abdominal pain   7890	Both sexes	269
Ourense	Group 1802 Abdominal pain   7890	Men	110
Ourense	Group 1802 Abdominal pain   7890	Women	159
Ourense	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.077
Ourense	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	516
Ourense	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	561
Ourense	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.696
Ourense	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	959
Ourense	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	737
Ourense	Group 1900 Injuries and poisoning  800-999	Both sexes	3.827
Ourense	Group 1900 Injuries and poisoning  800-999	Men	1.778
Ourense	Group 1900 Injuries and poisoning  800-999	Women	2.049
Ourense	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	295
Ourense	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	168
Ourense	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	127
Ourense	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	72
Ourense	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	46
Ourense	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	26
Ourense	Group 1903 Radius and ulna fracture 813	Both sexes	238
Ourense	Group 1903 Radius and ulna fracture 813	Men	100
Ourense	Group 1903 Radius and ulna fracture 813	Women	138
Ourense	Group 1904 Femur fracture  820-821	Both sexes	684
Ourense	Group 1904 Femur fracture  820-821	Men	166
Ourense	Group 1904 Femur fracture  820-821	Women	518
Ourense	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	266
Ourense	Group 1905 Leg fracture, including the ankle 823-824	Men	116
Ourense	Group 1905 Leg fracture, including the ankle 823-824	Women	150
Ourense	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.410
Ourense	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	780
Ourense	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	630
Ourense	Group 1907 Burns  940-949	Both sexes	11
Ourense	Group 1907 Burns  940-949	Men	5
Ourense	Group 1907 Burns  940-949	Women	6
Ourense	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	92
Ourense	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	43
Ourense	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	49
Ourense	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	684
Ourense	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	310
Ourense	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	374
Ourense	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	3
Ourense	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Ourense	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
Ourense	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	72
Ourense	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	42
Ourense	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	30
Ourense	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	596
Ourense	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	386
Ourense	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	210
Ourense	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	38
Ourense	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	20
Ourense	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	18
Ourense	Group 2102 Contraceptive management  V25	Both sexes	20
Ourense	Group 2102 Contraceptive management  V25	Men	1
Ourense	Group 2102 Contraceptive management  V25	Women	19
Ourense	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Ourense	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Ourense	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Ourense	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	312
Ourense	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	224
Ourense	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	88
Ourense	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	226
Ourense	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	141
Ourense	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	85
Pontevedra	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	95.723
Pontevedra	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	45.728
Pontevedra	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	49.995
Pontevedra	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.906
Pontevedra	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.014
Pontevedra	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	892
Pontevedra	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	313
Pontevedra	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	167
Pontevedra	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	146
Pontevedra	Group 0102 Imprecise intestinal infections 009	Both sexes	48
Pontevedra	Group 0102 Imprecise intestinal infections 009	Men	18
Pontevedra	Group 0102 Imprecise intestinal infections 009	Women	30
Pontevedra	Group 0103 Tuberculosis 010-018, 137	Both sexes	76
Pontevedra	Group 0103 Tuberculosis 010-018, 137	Men	53
Pontevedra	Group 0103 Tuberculosis 010-018, 137	Women	23
Pontevedra	Group 0104 Septicaemia  038	Both sexes	657
Pontevedra	Group 0104 Septicaemia  038	Men	305
Pontevedra	Group 0104 Septicaemia  038	Women	352
Pontevedra	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	101
Pontevedra	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	70
Pontevedra	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	31
Pontevedra	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	711
Pontevedra	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	401
Pontevedra	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	310
Pontevedra	Group 0200 Neoplasms  140-239	Both sexes	9.626
Pontevedra	Group 0200 Neoplasms  140-239	Men	5.077
Pontevedra	Group 0200 Neoplasms  140-239	Women	4.549
Pontevedra	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	886
Pontevedra	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	499
Pontevedra	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	387
Pontevedra	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	662
Pontevedra	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	538
Pontevedra	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	124
Pontevedra	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	153
Pontevedra	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	74
Pontevedra	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	79
Pontevedra	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	657
Pontevedra	Group 0204 Malignant neoplasm of breast  174-175	Men	6
Pontevedra	Group 0204 Malignant neoplasm of breast  174-175	Women	651
Pontevedra	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	168
Pontevedra	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Pontevedra	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	168
Pontevedra	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	74
Pontevedra	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Pontevedra	Group 0206 Malignant neoplasm of ovary  1830	Women	74
Pontevedra	Group 0207 Malignant neoplasm of prostate  185	Both sexes	700
Pontevedra	Group 0207 Malignant neoplasm of prostate  185	Men	700
Pontevedra	Group 0207 Malignant neoplasm of prostate  185	Women	..
Pontevedra	Group 0208 Malignant neoplasm of bladder  188	Both sexes	664
Pontevedra	Group 0208 Malignant neoplasm of bladder  188	Men	551
Pontevedra	Group 0208 Malignant neoplasm of bladder  188	Women	113
Pontevedra	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.813
Pontevedra	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.161
Pontevedra	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.652
Pontevedra	Group 0210 Carcinoma in situ  230-234	Both sexes	204
Pontevedra	Group 0210 Carcinoma in situ  230-234	Men	66
Pontevedra	Group 0210 Carcinoma in situ  230-234	Women	138
Pontevedra	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	68
Pontevedra	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	44
Pontevedra	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	24
Pontevedra	Grupo 0212 Leiomyoma of uterus  218	Both sexes	424
Pontevedra	Grupo 0212 Leiomyoma of uterus  218	Men	..
Pontevedra	Grupo 0212 Leiomyoma of uterus  218	Women	424
Pontevedra	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.153
Pontevedra	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	438
Pontevedra	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	715
Pontevedra	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	904
Pontevedra	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	468
Pontevedra	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	436
Pontevedra	Group 0301 Anaemias 280-285	Both sexes	584
Pontevedra	Group 0301 Anaemias 280-285	Men	290
Pontevedra	Group 0301 Anaemias 280-285	Women	294
Pontevedra	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	320
Pontevedra	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	178
Pontevedra	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	142
Pontevedra	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.765
Pontevedra	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	656
Pontevedra	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.109
Pontevedra	Group 0401 Diabetes mellitus  249-250	Both sexes	561
Pontevedra	Group 0401 Diabetes mellitus  249-250	Men	281
Pontevedra	Group 0401 Diabetes mellitus  249-250	Women	280
Pontevedra	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.204
Pontevedra	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	375
Pontevedra	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	829
Pontevedra	Group 0500 Mental disorders  290-319	Both sexes	2.051
Pontevedra	Group 0500 Mental disorders  290-319	Men	990
Pontevedra	Group 0500 Mental disorders  290-319	Women	1.061
Pontevedra	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	56
Pontevedra	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	17
Pontevedra	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	39
Pontevedra	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	121
Pontevedra	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	88
Pontevedra	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	33
Pontevedra	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	83
Pontevedra	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	58
Pontevedra	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	25
Pontevedra	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	564
Pontevedra	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	337
Pontevedra	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	227
Pontevedra	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	478
Pontevedra	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	158
Pontevedra	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	320
Pontevedra	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	749
Pontevedra	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	332
Pontevedra	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	417
Pontevedra	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.831
Pontevedra	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	872
Pontevedra	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	959
Pontevedra	Group 0601 Alzheimer's disease  3310	Both sexes	28
Pontevedra	Group 0601 Alzheimer's disease  3310	Men	9
Pontevedra	Group 0601 Alzheimer's disease  3310	Women	19
Pontevedra	Group 0602 Multiple sclerosis 340	Both sexes	92
Pontevedra	Group 0602 Multiple sclerosis 340	Men	25
Pontevedra	Group 0602 Multiple sclerosis 340	Women	67
Pontevedra	Group 0603 Epilepsy  345	Both sexes	275
Pontevedra	Group 0603 Epilepsy  345	Men	136
Pontevedra	Group 0603 Epilepsy  345	Women	139
Pontevedra	Group 0604 Transient cerebral ischemia 435	Both sexes	303
Pontevedra	Group 0604 Transient cerebral ischemia 435	Men	132
Pontevedra	Group 0604 Transient cerebral ischemia 435	Women	171
Pontevedra	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.133
Pontevedra	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	570
Pontevedra	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	563
Pontevedra	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	469
Pontevedra	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	231
Pontevedra	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	238
Pontevedra	Grupo 0701 Cataract  366	Both sexes	46
Pontevedra	Grupo 0701 Cataract  366	Men	21
Pontevedra	Grupo 0701 Cataract  366	Women	25
Pontevedra	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	423
Pontevedra	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	210
Pontevedra	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	213
Pontevedra	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	519
Pontevedra	Group 0800 Diseases of the ear and the mastoid  380-389	Men	249
Pontevedra	Group 0800 Diseases of the ear and the mastoid  380-389	Women	270
Pontevedra	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	12.647
Pontevedra	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.964
Pontevedra	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	5.683
Pontevedra	Group 0901 Hypertensive disease  401-405	Both sexes	875
Pontevedra	Group 0901 Hypertensive disease  401-405	Men	363
Pontevedra	Group 0901 Hypertensive disease  401-405	Women	512
Pontevedra	Group 0902 Angina pectoris  4111, 413	Both sexes	243
Pontevedra	Group 0902 Angina pectoris  4111, 413	Men	154
Pontevedra	Group 0902 Angina pectoris  4111, 413	Women	89
Pontevedra	Group 0903 Acute myocardial infarction  410	Both sexes	1.001
Pontevedra	Group 0903 Acute myocardial infarction  410	Men	748
Pontevedra	Group 0903 Acute myocardial infarction  410	Women	253
Pontevedra	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	836
Pontevedra	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	652
Pontevedra	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	184
Pontevedra	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	472
Pontevedra	Group 0905 Diseases of the lungs circulation 415-417	Men	206
Pontevedra	Group 0905 Diseases of the lungs circulation 415-417	Women	266
Pontevedra	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.511
Pontevedra	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	866
Pontevedra	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	645
Pontevedra	Grupo 0907 Heart failure  428	Both sexes	2.917
Pontevedra	Grupo 0907 Heart failure  428	Men	1.424
Pontevedra	Grupo 0907 Heart failure  428	Women	1.493
Pontevedra	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.933
Pontevedra	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	955
Pontevedra	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	978
Pontevedra	Grupo 0909 Atherosclerosis  440	Both sexes	483
Pontevedra	Grupo 0909 Atherosclerosis  440	Men	343
Pontevedra	Grupo 0909 Atherosclerosis  440	Women	140
Pontevedra	Group 0910 Varicose veins of lower extremities 454	Both sexes	508
Pontevedra	Group 0910 Varicose veins of lower extremities 454	Men	169
Pontevedra	Group 0910 Varicose veins of lower extremities 454	Women	339
Pontevedra	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.868
Pontevedra	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.084
Pontevedra	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	784
Pontevedra	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	13.462
Pontevedra	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.410
Pontevedra	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.052
Pontevedra	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	414
Pontevedra	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	222
Pontevedra	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	192
Pontevedra	Group 1002 Pneumonia 480-486	Both sexes	2.657
Pontevedra	Group 1002 Pneumonia 480-486	Men	1.488
Pontevedra	Group 1002 Pneumonia 480-486	Women	1.169
Pontevedra	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	653
Pontevedra	Group 1003 Acute bronchitis and bronchiolitis  466	Men	356
Pontevedra	Group 1003 Acute bronchitis and bronchiolitis  466	Women	297
Pontevedra	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	992
Pontevedra	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	522
Pontevedra	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	470
Pontevedra	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.111
Pontevedra	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	688
Pontevedra	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	423
Pontevedra	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.129
Pontevedra	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.467
Pontevedra	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	662
Pontevedra	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	411
Pontevedra	Group 1007 Asthma 4930-4931,4938-4939	Men	167
Pontevedra	Group 1007 Asthma 4930-4931,4938-4939	Women	244
Pontevedra	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.095
Pontevedra	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.500
Pontevedra	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.595
Pontevedra	Group 1100 Diseases of the digestive system  520-579	Both sexes	11.042
Pontevedra	Group 1100 Diseases of the digestive system  520-579	Men	6.254
Pontevedra	Group 1100 Diseases of the digestive system  520-579	Women	4.788
Pontevedra	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	198
Pontevedra	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	95
Pontevedra	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	103
Pontevedra	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	176
Pontevedra	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	101
Pontevedra	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	75
Pontevedra	Group 1103 Diseases of the esophagus 530	Both sexes	166
Pontevedra	Group 1103 Diseases of the esophagus 530	Men	97
Pontevedra	Group 1103 Diseases of the esophagus 530	Women	69
Pontevedra	Group 1104 Peptic ulcer 531-534	Both sexes	162
Pontevedra	Group 1104 Peptic ulcer 531-534	Men	110
Pontevedra	Group 1104 Peptic ulcer 531-534	Women	52
Pontevedra	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	243
Pontevedra	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	125
Pontevedra	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	118
Pontevedra	Group 1106 Appendicitis  540-543	Both sexes	1.079
Pontevedra	Group 1106 Appendicitis  540-543	Men	622
Pontevedra	Group 1106 Appendicitis  540-543	Women	457
Pontevedra	Group 1107 Inguinal hernia  550	Both sexes	1.267
Pontevedra	Group 1107 Inguinal hernia  550	Men	1.122
Pontevedra	Group 1107 Inguinal hernia  550	Women	145
Pontevedra	Group 1108 Other abdominal hernia  551-553	Both sexes	906
Pontevedra	Group 1108 Other abdominal hernia  551-553	Men	479
Pontevedra	Group 1108 Other abdominal hernia  551-553	Women	427
Pontevedra	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	261
Pontevedra	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	157
Pontevedra	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	104
Pontevedra	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	549
Pontevedra	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	252
Pontevedra	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	297
Pontevedra	Group 1111 Intestinal obstruction without hernia 560	Both sexes	485
Pontevedra	Group 1111 Intestinal obstruction without hernia 560	Men	249
Pontevedra	Group 1111 Intestinal obstruction without hernia 560	Women	236
Pontevedra	Group 1112 Intestinal diverticulosis 562	Both sexes	484
Pontevedra	Group 1112 Intestinal diverticulosis 562	Men	236
Pontevedra	Group 1112 Intestinal diverticulosis 562	Women	248
Pontevedra	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	719
Pontevedra	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	446
Pontevedra	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	273
Pontevedra	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	378
Pontevedra	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	170
Pontevedra	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	208
Pontevedra	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	272
Pontevedra	Group 1115 Alcoholic hepatitis 5710-5713	Men	215
Pontevedra	Group 1115 Alcoholic hepatitis 5710-5713	Women	57
Pontevedra	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	532
Pontevedra	Group 1116 Other diseases of the liver 570,5714-573	Men	336
Pontevedra	Group 1116 Other diseases of the liver 570,5714-573	Women	196
Pontevedra	Group 1117 Cholelithiasis  574	Both sexes	1.808
Pontevedra	Group 1117 Cholelithiasis  574	Men	723
Pontevedra	Group 1117 Cholelithiasis  574	Women	1.085
Pontevedra	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	379
Pontevedra	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	206
Pontevedra	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	173
Pontevedra	Group 1119 Pancreatic diseases 577	Both sexes	605
Pontevedra	Group 1119 Pancreatic diseases 577	Men	324
Pontevedra	Group 1119 Pancreatic diseases 577	Women	281
Pontevedra	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	373
Pontevedra	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	189
Pontevedra	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	184
Pontevedra	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.264
Pontevedra	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	662
Pontevedra	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	602
Pontevedra	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	817
Pontevedra	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	471
Pontevedra	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	346
Pontevedra	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	90
Pontevedra	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	39
Pontevedra	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	51
Pontevedra	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	357
Pontevedra	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	152
Pontevedra	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	205
Pontevedra	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	7.373
Pontevedra	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.648
Pontevedra	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.725
Pontevedra	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Pontevedra	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Pontevedra	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Pontevedra	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Pontevedra	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Pontevedra	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Pontevedra	Group 1303 Internal derangement of knee 717	Both sexes	1.455
Pontevedra	Group 1303 Internal derangement of knee 717	Men	957
Pontevedra	Group 1303 Internal derangement of knee 717	Women	498
Pontevedra	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.578
Pontevedra	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.073
Pontevedra	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.505
Pontevedra	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	123
Pontevedra	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	39
Pontevedra	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	84
Pontevedra	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	283
Pontevedra	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	148
Pontevedra	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	135
Pontevedra	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	699
Pontevedra	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	378
Pontevedra	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	321
Pontevedra	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	114
Pontevedra	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	47
Pontevedra	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	67
Pontevedra	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.067
Pontevedra	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	624
Pontevedra	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	443
Pontevedra	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.054
Pontevedra	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	382
Pontevedra	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	672
Pontevedra	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	6.150
Pontevedra	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.862
Pontevedra	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	3.288
Pontevedra	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	588
Pontevedra	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	196
Pontevedra	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	392
Pontevedra	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	425
Pontevedra	Group 1402 Renal failure  5836-5837, 584-586	Men	217
Pontevedra	Group 1402 Renal failure  5836-5837, 584-586	Women	208
Pontevedra	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	662
Pontevedra	Group 1403 Urolithiasis  592, 594, 7880	Men	375
Pontevedra	Group 1403 Urolithiasis  592, 594, 7880	Women	287
Pontevedra	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.893
Pontevedra	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	866
Pontevedra	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.027
Pontevedra	Group 1405 Prostatic hyperplasia  600	Both sexes	657
Pontevedra	Group 1405 Prostatic hyperplasia  600	Men	657
Pontevedra	Group 1405 Prostatic hyperplasia  600	Women	..
Pontevedra	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	510
Pontevedra	Group 1406 Other diseases of the male genital organs    601-608	Men	510
Pontevedra	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Pontevedra	Group 1407 Disorders of breast  610-612	Both sexes	237
Pontevedra	Group 1407 Disorders of breast  610-612	Men	18
Pontevedra	Group 1407 Disorders of breast  610-612	Women	219
Pontevedra	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	204
Pontevedra	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Pontevedra	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	204
Pontevedra	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	70
Pontevedra	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Pontevedra	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	70
Pontevedra	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	904
Pontevedra	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	23
Pontevedra	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	881
Pontevedra	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	9.010
Pontevedra	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Pontevedra	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	9.010
Pontevedra	Group 1501 Legally induced abortion  635	Both sexes	183
Pontevedra	Group 1501 Legally induced abortion  635	Men	..
Pontevedra	Group 1501 Legally induced abortion  635	Women	183
Pontevedra	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	971
Pontevedra	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Pontevedra	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	971
Pontevedra	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	5.134
Pontevedra	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Pontevedra	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	5.134
Pontevedra	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.522
Pontevedra	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Pontevedra	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.522
Pontevedra	Group 1505 Single spontaneous delivery  650	Both sexes	425
Pontevedra	Group 1505 Single spontaneous delivery  650	Men	..
Pontevedra	Group 1505 Single spontaneous delivery  650	Women	425
Pontevedra	Group 1506 Other deliveries  6695-6697	Both sexes	241
Pontevedra	Group 1506 Other deliveries  6695-6697	Men	..
Pontevedra	Group 1506 Other deliveries  6695-6697	Women	241
Pontevedra	Group 1507 Complications related to the puerperium  670-676	Both sexes	105
Pontevedra	Group 1507 Complications related to the puerperium  670-676	Men	..
Pontevedra	Group 1507 Complications related to the puerperium  670-676	Women	105
Pontevedra	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	429
Pontevedra	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Pontevedra	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	429
Pontevedra	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	981
Pontevedra	Group 1600 Some disorders originating in the perinatal period  760-779	Men	563
Pontevedra	Group 1600 Some disorders originating in the perinatal period  760-779	Women	418
Pontevedra	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	295
Pontevedra	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	170
Pontevedra	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	125
Pontevedra	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	686
Pontevedra	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	393
Pontevedra	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	293
Pontevedra	Grupo 1700 Congenital abnormalities  740-759	Both sexes	737
Pontevedra	Grupo 1700 Congenital abnormalities  740-759	Men	500
Pontevedra	Grupo 1700 Congenital abnormalities  740-759	Women	237
Pontevedra	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.611
Pontevedra	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.362
Pontevedra	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.249
Pontevedra	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	232
Pontevedra	Group 1801 Pain in throat and chest 7841, 7865	Men	131
Pontevedra	Group 1801 Pain in throat and chest 7841, 7865	Women	101
Pontevedra	Group 1802 Abdominal pain   7890	Both sexes	320
Pontevedra	Group 1802 Abdominal pain   7890	Men	106
Pontevedra	Group 1802 Abdominal pain   7890	Women	214
Pontevedra	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	10
Pontevedra	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	..
Pontevedra	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	10
Pontevedra	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.049
Pontevedra	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.125
Pontevedra	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	924
Pontevedra	Group 1900 Injuries and poisoning  800-999	Both sexes	9.691
Pontevedra	Group 1900 Injuries and poisoning  800-999	Men	5.090
Pontevedra	Group 1900 Injuries and poisoning  800-999	Women	4.601
Pontevedra	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	757
Pontevedra	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	429
Pontevedra	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	328
Pontevedra	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	333
Pontevedra	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	230
Pontevedra	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	103
Pontevedra	Group 1903 Radius and ulna fracture 813	Both sexes	518
Pontevedra	Group 1903 Radius and ulna fracture 813	Men	229
Pontevedra	Group 1903 Radius and ulna fracture 813	Women	289
Pontevedra	Group 1904 Femur fracture  820-821	Both sexes	1.108
Pontevedra	Group 1904 Femur fracture  820-821	Men	269
Pontevedra	Group 1904 Femur fracture  820-821	Women	839
Pontevedra	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	770
Pontevedra	Group 1905 Leg fracture, including the ankle 823-824	Men	397
Pontevedra	Group 1905 Leg fracture, including the ankle 823-824	Women	373
Pontevedra	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.302
Pontevedra	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.941
Pontevedra	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.361
Pontevedra	Group 1907 Burns  940-949	Both sexes	96
Pontevedra	Group 1907 Burns  940-949	Men	55
Pontevedra	Group 1907 Burns  940-949	Women	41
Pontevedra	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	237
Pontevedra	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	123
Pontevedra	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	114
Pontevedra	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	2.414
Pontevedra	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.332
Pontevedra	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.082
Pontevedra	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	2
Pontevedra	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	2
Pontevedra	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Pontevedra	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	154
Pontevedra	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	83
Pontevedra	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	71
Pontevedra	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.684
Pontevedra	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	856
Pontevedra	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	828
Pontevedra	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	70
Pontevedra	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	40
Pontevedra	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	30
Pontevedra	Group 2102 Contraceptive management  V25	Both sexes	79
Pontevedra	Group 2102 Contraceptive management  V25	Men	2
Pontevedra	Group 2102 Contraceptive management  V25	Women	77
Pontevedra	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Pontevedra	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Pontevedra	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Pontevedra	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	824
Pontevedra	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	548
Pontevedra	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	276
Pontevedra	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	711
Pontevedra	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	266
Pontevedra	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	445
MADRID, COMUNIDAD DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	692.090
MADRID, COMUNIDAD DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	317.375
MADRID, COMUNIDAD DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	374.715
MADRID, COMUNIDAD DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	15.651
MADRID, COMUNIDAD DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	8.423
MADRID, COMUNIDAD DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	7.229
MADRID, COMUNIDAD DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	2.374
MADRID, COMUNIDAD DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	1.177
MADRID, COMUNIDAD DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	1.197
MADRID, COMUNIDAD DE	Group 0102 Imprecise intestinal infections 009	Both sexes	856
MADRID, COMUNIDAD DE	Group 0102 Imprecise intestinal infections 009	Men	403
MADRID, COMUNIDAD DE	Group 0102 Imprecise intestinal infections 009	Women	453
MADRID, COMUNIDAD DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	481
MADRID, COMUNIDAD DE	Group 0103 Tuberculosis 010-018, 137	Men	276
MADRID, COMUNIDAD DE	Group 0103 Tuberculosis 010-018, 137	Women	205
MADRID, COMUNIDAD DE	Group 0104 Septicaemia  038	Both sexes	6.858
MADRID, COMUNIDAD DE	Group 0104 Septicaemia  038	Men	3.594
MADRID, COMUNIDAD DE	Group 0104 Septicaemia  038	Women	3.264
MADRID, COMUNIDAD DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	156
MADRID, COMUNIDAD DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	112
MADRID, COMUNIDAD DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	44
MADRID, COMUNIDAD DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	4.926
MADRID, COMUNIDAD DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	2.860
MADRID, COMUNIDAD DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	2.065
MADRID, COMUNIDAD DE	Group 0200 Neoplasms  140-239	Both sexes	69.724
MADRID, COMUNIDAD DE	Group 0200 Neoplasms  140-239	Men	34.676
MADRID, COMUNIDAD DE	Group 0200 Neoplasms  140-239	Women	35.048
MADRID, COMUNIDAD DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	5.914
MADRID, COMUNIDAD DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	3.391
MADRID, COMUNIDAD DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	2.524
MADRID, COMUNIDAD DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	4.639
MADRID, COMUNIDAD DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	3.510
MADRID, COMUNIDAD DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1.129
MADRID, COMUNIDAD DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	1.141
MADRID, COMUNIDAD DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	677
MADRID, COMUNIDAD DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	464
MADRID, COMUNIDAD DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	5.689
MADRID, COMUNIDAD DE	Group 0204 Malignant neoplasm of breast  174-175	Men	40
MADRID, COMUNIDAD DE	Group 0204 Malignant neoplasm of breast  174-175	Women	5.649
MADRID, COMUNIDAD DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	1.210
MADRID, COMUNIDAD DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
MADRID, COMUNIDAD DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	1.210
MADRID, COMUNIDAD DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	740
MADRID, COMUNIDAD DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
MADRID, COMUNIDAD DE	Group 0206 Malignant neoplasm of ovary  1830	Women	740
MADRID, COMUNIDAD DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	2.714
MADRID, COMUNIDAD DE	Group 0207 Malignant neoplasm of prostate  185	Men	2.714
MADRID, COMUNIDAD DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
MADRID, COMUNIDAD DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	6.094
MADRID, COMUNIDAD DE	Group 0208 Malignant neoplasm of bladder  188	Men	4.996
MADRID, COMUNIDAD DE	Group 0208 Malignant neoplasm of bladder  188	Women	1.098
MADRID, COMUNIDAD DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	25.877
MADRID, COMUNIDAD DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	14.361
MADRID, COMUNIDAD DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	11.516
MADRID, COMUNIDAD DE	Group 0210 Carcinoma in situ  230-234	Both sexes	1.068
MADRID, COMUNIDAD DE	Group 0210 Carcinoma in situ  230-234	Men	315
MADRID, COMUNIDAD DE	Group 0210 Carcinoma in situ  230-234	Women	753
MADRID, COMUNIDAD DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	954
MADRID, COMUNIDAD DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	580
MADRID, COMUNIDAD DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	374
MADRID, COMUNIDAD DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	3.663
MADRID, COMUNIDAD DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
MADRID, COMUNIDAD DE	Grupo 0212 Leiomyoma of uterus  218	Women	3.663
MADRID, COMUNIDAD DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	10.019
MADRID, COMUNIDAD DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	4.092
MADRID, COMUNIDAD DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	5.927
MADRID, COMUNIDAD DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	6.266
MADRID, COMUNIDAD DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	2.988
MADRID, COMUNIDAD DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	3.278
MADRID, COMUNIDAD DE	Group 0301 Anaemias 280-285	Both sexes	3.553
MADRID, COMUNIDAD DE	Group 0301 Anaemias 280-285	Men	1.650
MADRID, COMUNIDAD DE	Group 0301 Anaemias 280-285	Women	1.903
MADRID, COMUNIDAD DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	2.713
MADRID, COMUNIDAD DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	1.338
MADRID, COMUNIDAD DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	1.375
MADRID, COMUNIDAD DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	13.231
MADRID, COMUNIDAD DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	4.756
MADRID, COMUNIDAD DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	8.474
MADRID, COMUNIDAD DE	Group 0401 Diabetes mellitus  249-250	Both sexes	2.864
MADRID, COMUNIDAD DE	Group 0401 Diabetes mellitus  249-250	Men	1.699
MADRID, COMUNIDAD DE	Group 0401 Diabetes mellitus  249-250	Women	1.165
MADRID, COMUNIDAD DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	10.366
MADRID, COMUNIDAD DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	3.057
MADRID, COMUNIDAD DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	7.309
MADRID, COMUNIDAD DE	Group 0500 Mental disorders  290-319	Both sexes	17.371
MADRID, COMUNIDAD DE	Group 0500 Mental disorders  290-319	Men	8.530
MADRID, COMUNIDAD DE	Group 0500 Mental disorders  290-319	Women	8.841
MADRID, COMUNIDAD DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	318
MADRID, COMUNIDAD DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	139
MADRID, COMUNIDAD DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	179
MADRID, COMUNIDAD DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	1.738
MADRID, COMUNIDAD DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	1.195
MADRID, COMUNIDAD DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	543
MADRID, COMUNIDAD DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	1.308
MADRID, COMUNIDAD DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	940
MADRID, COMUNIDAD DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	368
MADRID, COMUNIDAD DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	4.390
MADRID, COMUNIDAD DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	2.545
MADRID, COMUNIDAD DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	1.845
MADRID, COMUNIDAD DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	4.129
MADRID, COMUNIDAD DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	1.486
MADRID, COMUNIDAD DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	2.643
MADRID, COMUNIDAD DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	5.488
MADRID, COMUNIDAD DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	2.225
MADRID, COMUNIDAD DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	3.263
MADRID, COMUNIDAD DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	18.510
MADRID, COMUNIDAD DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	9.881
MADRID, COMUNIDAD DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	8.629
MADRID, COMUNIDAD DE	Group 0601 Alzheimer's disease  3310	Both sexes	240
MADRID, COMUNIDAD DE	Group 0601 Alzheimer's disease  3310	Men	83
MADRID, COMUNIDAD DE	Group 0601 Alzheimer's disease  3310	Women	157
MADRID, COMUNIDAD DE	Group 0602 Multiple sclerosis 340	Both sexes	252
MADRID, COMUNIDAD DE	Group 0602 Multiple sclerosis 340	Men	94
MADRID, COMUNIDAD DE	Group 0602 Multiple sclerosis 340	Women	158
MADRID, COMUNIDAD DE	Group 0603 Epilepsy  345	Both sexes	3.242
MADRID, COMUNIDAD DE	Group 0603 Epilepsy  345	Men	1.692
MADRID, COMUNIDAD DE	Group 0603 Epilepsy  345	Women	1.550
MADRID, COMUNIDAD DE	Group 0604 Transient cerebral ischemia 435	Both sexes	2.202
MADRID, COMUNIDAD DE	Group 0604 Transient cerebral ischemia 435	Men	1.099
MADRID, COMUNIDAD DE	Group 0604 Transient cerebral ischemia 435	Women	1.103
MADRID, COMUNIDAD DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	12.574
MADRID, COMUNIDAD DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	6.913
MADRID, COMUNIDAD DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	5.660
MADRID, COMUNIDAD DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	4.233
MADRID, COMUNIDAD DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	2.181
MADRID, COMUNIDAD DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	2.052
MADRID, COMUNIDAD DE	Grupo 0701 Cataract  366	Both sexes	493
MADRID, COMUNIDAD DE	Grupo 0701 Cataract  366	Men	247
MADRID, COMUNIDAD DE	Grupo 0701 Cataract  366	Women	246
MADRID, COMUNIDAD DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	3.739
MADRID, COMUNIDAD DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	1.934
MADRID, COMUNIDAD DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	1.806
MADRID, COMUNIDAD DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	3.406
MADRID, COMUNIDAD DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	1.634
MADRID, COMUNIDAD DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	1.771
MADRID, COMUNIDAD DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	79.850
MADRID, COMUNIDAD DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	42.964
MADRID, COMUNIDAD DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	36.886
MADRID, COMUNIDAD DE	Group 0901 Hypertensive disease  401-405	Both sexes	4.345
MADRID, COMUNIDAD DE	Group 0901 Hypertensive disease  401-405	Men	1.758
MADRID, COMUNIDAD DE	Group 0901 Hypertensive disease  401-405	Women	2.587
MADRID, COMUNIDAD DE	Group 0902 Angina pectoris  4111, 413	Both sexes	2.053
MADRID, COMUNIDAD DE	Group 0902 Angina pectoris  4111, 413	Men	1.261
MADRID, COMUNIDAD DE	Group 0902 Angina pectoris  4111, 413	Women	792
MADRID, COMUNIDAD DE	Group 0903 Acute myocardial infarction  410	Both sexes	5.780
MADRID, COMUNIDAD DE	Group 0903 Acute myocardial infarction  410	Men	4.128
MADRID, COMUNIDAD DE	Group 0903 Acute myocardial infarction  410	Women	1.652
MADRID, COMUNIDAD DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	6.419
MADRID, COMUNIDAD DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	4.980
MADRID, COMUNIDAD DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	1.439
MADRID, COMUNIDAD DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	3.026
MADRID, COMUNIDAD DE	Group 0905 Diseases of the lungs circulation 415-417	Men	1.316
MADRID, COMUNIDAD DE	Group 0905 Diseases of the lungs circulation 415-417	Women	1.710
MADRID, COMUNIDAD DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	10.348
MADRID, COMUNIDAD DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	5.573
MADRID, COMUNIDAD DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	4.775
MADRID, COMUNIDAD DE	Grupo 0907 Heart failure  428	Both sexes	16.789
MADRID, COMUNIDAD DE	Grupo 0907 Heart failure  428	Men	7.210
MADRID, COMUNIDAD DE	Grupo 0907 Heart failure  428	Women	9.579
MADRID, COMUNIDAD DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	11.937
MADRID, COMUNIDAD DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	6.083
MADRID, COMUNIDAD DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	5.855
MADRID, COMUNIDAD DE	Grupo 0909 Atherosclerosis  440	Both sexes	2.296
MADRID, COMUNIDAD DE	Grupo 0909 Atherosclerosis  440	Men	1.706
MADRID, COMUNIDAD DE	Grupo 0909 Atherosclerosis  440	Women	590
MADRID, COMUNIDAD DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	2.291
MADRID, COMUNIDAD DE	Group 0910 Varicose veins of lower extremities 454	Men	846
MADRID, COMUNIDAD DE	Group 0910 Varicose veins of lower extremities 454	Women	1.445
MADRID, COMUNIDAD DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	14.565
MADRID, COMUNIDAD DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	8.103
MADRID, COMUNIDAD DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	6.462
MADRID, COMUNIDAD DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	78.445
MADRID, COMUNIDAD DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	43.300
MADRID, COMUNIDAD DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	35.145
MADRID, COMUNIDAD DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	3.279
MADRID, COMUNIDAD DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	1.742
MADRID, COMUNIDAD DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	1.537
MADRID, COMUNIDAD DE	Group 1002 Pneumonia 480-486	Both sexes	17.860
MADRID, COMUNIDAD DE	Group 1002 Pneumonia 480-486	Men	10.201
MADRID, COMUNIDAD DE	Group 1002 Pneumonia 480-486	Women	7.659
MADRID, COMUNIDAD DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	6.056
MADRID, COMUNIDAD DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	3.052
MADRID, COMUNIDAD DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	3.003
MADRID, COMUNIDAD DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	3.866
MADRID, COMUNIDAD DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	2.030
MADRID, COMUNIDAD DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1.837
MADRID, COMUNIDAD DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	6.479
MADRID, COMUNIDAD DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	3.906
MADRID, COMUNIDAD DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	2.573
MADRID, COMUNIDAD DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	12.831
MADRID, COMUNIDAD DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	9.252
MADRID, COMUNIDAD DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	3.579
MADRID, COMUNIDAD DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	3.572
MADRID, COMUNIDAD DE	Group 1007 Asthma 4930-4931,4938-4939	Men	1.236
MADRID, COMUNIDAD DE	Group 1007 Asthma 4930-4931,4938-4939	Women	2.336
MADRID, COMUNIDAD DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	24.501
MADRID, COMUNIDAD DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	11.880
MADRID, COMUNIDAD DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	12.621
MADRID, COMUNIDAD DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	82.434
MADRID, COMUNIDAD DE	Group 1100 Diseases of the digestive system  520-579	Men	44.851
MADRID, COMUNIDAD DE	Group 1100 Diseases of the digestive system  520-579	Women	37.583
MADRID, COMUNIDAD DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	2.388
MADRID, COMUNIDAD DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	1.038
MADRID, COMUNIDAD DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	1.350
MADRID, COMUNIDAD DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1.341
MADRID, COMUNIDAD DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	718
MADRID, COMUNIDAD DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	623
MADRID, COMUNIDAD DE	Group 1103 Diseases of the esophagus 530	Both sexes	1.979
MADRID, COMUNIDAD DE	Group 1103 Diseases of the esophagus 530	Men	1.138
MADRID, COMUNIDAD DE	Group 1103 Diseases of the esophagus 530	Women	840
MADRID, COMUNIDAD DE	Group 1104 Peptic ulcer 531-534	Both sexes	1.203
MADRID, COMUNIDAD DE	Group 1104 Peptic ulcer 531-534	Men	810
MADRID, COMUNIDAD DE	Group 1104 Peptic ulcer 531-534	Women	393
MADRID, COMUNIDAD DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	1.702
MADRID, COMUNIDAD DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	766
MADRID, COMUNIDAD DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	936
MADRID, COMUNIDAD DE	Group 1106 Appendicitis  540-543	Both sexes	7.085
MADRID, COMUNIDAD DE	Group 1106 Appendicitis  540-543	Men	3.953
MADRID, COMUNIDAD DE	Group 1106 Appendicitis  540-543	Women	3.131
MADRID, COMUNIDAD DE	Group 1107 Inguinal hernia  550	Both sexes	9.276
MADRID, COMUNIDAD DE	Group 1107 Inguinal hernia  550	Men	8.167
MADRID, COMUNIDAD DE	Group 1107 Inguinal hernia  550	Women	1.109
MADRID, COMUNIDAD DE	Group 1108 Other abdominal hernia  551-553	Both sexes	7.220
MADRID, COMUNIDAD DE	Group 1108 Other abdominal hernia  551-553	Men	3.454
MADRID, COMUNIDAD DE	Group 1108 Other abdominal hernia  551-553	Women	3.766
MADRID, COMUNIDAD DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	1.286
MADRID, COMUNIDAD DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	642
MADRID, COMUNIDAD DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	644
MADRID, COMUNIDAD DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	4.075
MADRID, COMUNIDAD DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	1.932
MADRID, COMUNIDAD DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	2.144
MADRID, COMUNIDAD DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	3.236
MADRID, COMUNIDAD DE	Group 1111 Intestinal obstruction without hernia 560	Men	1.554
MADRID, COMUNIDAD DE	Group 1111 Intestinal obstruction without hernia 560	Women	1.681
MADRID, COMUNIDAD DE	Group 1112 Intestinal diverticulosis 562	Both sexes	3.373
MADRID, COMUNIDAD DE	Group 1112 Intestinal diverticulosis 562	Men	1.631
MADRID, COMUNIDAD DE	Group 1112 Intestinal diverticulosis 562	Women	1.741
MADRID, COMUNIDAD DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	5.047
MADRID, COMUNIDAD DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	3.288
MADRID, COMUNIDAD DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	1.759
MADRID, COMUNIDAD DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	2.705
MADRID, COMUNIDAD DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	1.197
MADRID, COMUNIDAD DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	1.507
MADRID, COMUNIDAD DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	1.086
MADRID, COMUNIDAD DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	928
MADRID, COMUNIDAD DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	158
MADRID, COMUNIDAD DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	2.904
MADRID, COMUNIDAD DE	Group 1116 Other diseases of the liver 570,5714-573	Men	1.674
MADRID, COMUNIDAD DE	Group 1116 Other diseases of the liver 570,5714-573	Women	1.230
MADRID, COMUNIDAD DE	Group 1117 Cholelithiasis  574	Both sexes	15.235
MADRID, COMUNIDAD DE	Group 1117 Cholelithiasis  574	Men	6.110
MADRID, COMUNIDAD DE	Group 1117 Cholelithiasis  574	Women	9.124
MADRID, COMUNIDAD DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	4.055
MADRID, COMUNIDAD DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	2.054
MADRID, COMUNIDAD DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	2.001
MADRID, COMUNIDAD DE	Group 1119 Pancreatic diseases 577	Both sexes	4.230
MADRID, COMUNIDAD DE	Group 1119 Pancreatic diseases 577	Men	2.232
MADRID, COMUNIDAD DE	Group 1119 Pancreatic diseases 577	Women	1.998
MADRID, COMUNIDAD DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	3.007
MADRID, COMUNIDAD DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	1.562
MADRID, COMUNIDAD DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	1.445
MADRID, COMUNIDAD DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	6.373
MADRID, COMUNIDAD DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	3.356
MADRID, COMUNIDAD DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	3.017
MADRID, COMUNIDAD DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	3.529
MADRID, COMUNIDAD DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	2.080
MADRID, COMUNIDAD DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	1.449
MADRID, COMUNIDAD DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	380
MADRID, COMUNIDAD DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	196
MADRID, COMUNIDAD DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	184
MADRID, COMUNIDAD DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	2.464
MADRID, COMUNIDAD DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	1.080
MADRID, COMUNIDAD DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	1.383
MADRID, COMUNIDAD DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	59.968
MADRID, COMUNIDAD DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	28.563
MADRID, COMUNIDAD DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	31.405
MADRID, COMUNIDAD DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
MADRID, COMUNIDAD DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
MADRID, COMUNIDAD DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
MADRID, COMUNIDAD DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
MADRID, COMUNIDAD DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
MADRID, COMUNIDAD DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
MADRID, COMUNIDAD DE	Group 1303 Internal derangement of knee 717	Both sexes	9.932
MADRID, COMUNIDAD DE	Group 1303 Internal derangement of knee 717	Men	6.737
MADRID, COMUNIDAD DE	Group 1303 Internal derangement of knee 717	Women	3.194
MADRID, COMUNIDAD DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	18.892
MADRID, COMUNIDAD DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	7.863
MADRID, COMUNIDAD DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	11.029
MADRID, COMUNIDAD DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	941
MADRID, COMUNIDAD DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	315
MADRID, COMUNIDAD DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	626
MADRID, COMUNIDAD DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	3.539
MADRID, COMUNIDAD DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	1.615
MADRID, COMUNIDAD DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1.924
MADRID, COMUNIDAD DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	6.782
MADRID, COMUNIDAD DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	3.632
MADRID, COMUNIDAD DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	3.151
MADRID, COMUNIDAD DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	714
MADRID, COMUNIDAD DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	340
MADRID, COMUNIDAD DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	374
MADRID, COMUNIDAD DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	9.235
MADRID, COMUNIDAD DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	4.526
MADRID, COMUNIDAD DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	4.709
MADRID, COMUNIDAD DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	9.932
MADRID, COMUNIDAD DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	3.534
MADRID, COMUNIDAD DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	6.398
MADRID, COMUNIDAD DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	45.367
MADRID, COMUNIDAD DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	21.693
MADRID, COMUNIDAD DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	23.674
MADRID, COMUNIDAD DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	4.813
MADRID, COMUNIDAD DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	1.762
MADRID, COMUNIDAD DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	3.051
MADRID, COMUNIDAD DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	3.687
MADRID, COMUNIDAD DE	Group 1402 Renal failure  5836-5837, 584-586	Men	2.090
MADRID, COMUNIDAD DE	Group 1402 Renal failure  5836-5837, 584-586	Women	1.597
MADRID, COMUNIDAD DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	5.542
MADRID, COMUNIDAD DE	Group 1403 Urolithiasis  592, 594, 7880	Men	3.327
MADRID, COMUNIDAD DE	Group 1403 Urolithiasis  592, 594, 7880	Women	2.215
MADRID, COMUNIDAD DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	13.349
MADRID, COMUNIDAD DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	6.769
MADRID, COMUNIDAD DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	6.580
MADRID, COMUNIDAD DE	Group 1405 Prostatic hyperplasia  600	Both sexes	4.653
MADRID, COMUNIDAD DE	Group 1405 Prostatic hyperplasia  600	Men	4.653
MADRID, COMUNIDAD DE	Group 1405 Prostatic hyperplasia  600	Women	..
MADRID, COMUNIDAD DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	2.694
MADRID, COMUNIDAD DE	Group 1406 Other diseases of the male genital organs    601-608	Men	2.694
MADRID, COMUNIDAD DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
MADRID, COMUNIDAD DE	Group 1407 Disorders of breast  610-612	Both sexes	2.566
MADRID, COMUNIDAD DE	Group 1407 Disorders of breast  610-612	Men	274
MADRID, COMUNIDAD DE	Group 1407 Disorders of breast  610-612	Women	2.292
MADRID, COMUNIDAD DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	1.077
MADRID, COMUNIDAD DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
MADRID, COMUNIDAD DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	1.077
MADRID, COMUNIDAD DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	370
MADRID, COMUNIDAD DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
MADRID, COMUNIDAD DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	370
MADRID, COMUNIDAD DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	6.615
MADRID, COMUNIDAD DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	124
MADRID, COMUNIDAD DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	6.491
MADRID, COMUNIDAD DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	74.820
MADRID, COMUNIDAD DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
MADRID, COMUNIDAD DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	74.820
MADRID, COMUNIDAD DE	Group 1501 Legally induced abortion  635	Both sexes	135
MADRID, COMUNIDAD DE	Group 1501 Legally induced abortion  635	Men	..
MADRID, COMUNIDAD DE	Group 1501 Legally induced abortion  635	Women	135
MADRID, COMUNIDAD DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	2.720
MADRID, COMUNIDAD DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
MADRID, COMUNIDAD DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	2.720
MADRID, COMUNIDAD DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	48.264
MADRID, COMUNIDAD DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
MADRID, COMUNIDAD DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	48.264
MADRID, COMUNIDAD DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	11.034
MADRID, COMUNIDAD DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
MADRID, COMUNIDAD DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	11.034
MADRID, COMUNIDAD DE	Group 1505 Single spontaneous delivery  650	Both sexes	3.904
MADRID, COMUNIDAD DE	Group 1505 Single spontaneous delivery  650	Men	..
MADRID, COMUNIDAD DE	Group 1505 Single spontaneous delivery  650	Women	3.904
MADRID, COMUNIDAD DE	Group 1506 Other deliveries  6695-6697	Both sexes	2.451
MADRID, COMUNIDAD DE	Group 1506 Other deliveries  6695-6697	Men	..
MADRID, COMUNIDAD DE	Group 1506 Other deliveries  6695-6697	Women	2.451
MADRID, COMUNIDAD DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	584
MADRID, COMUNIDAD DE	Group 1507 Complications related to the puerperium  670-676	Men	..
MADRID, COMUNIDAD DE	Group 1507 Complications related to the puerperium  670-676	Women	584
MADRID, COMUNIDAD DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	5.729
MADRID, COMUNIDAD DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
MADRID, COMUNIDAD DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	5.729
MADRID, COMUNIDAD DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	11.470
MADRID, COMUNIDAD DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	6.329
MADRID, COMUNIDAD DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	5.141
MADRID, COMUNIDAD DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	2.401
MADRID, COMUNIDAD DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	1.246
MADRID, COMUNIDAD DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	1.154
MADRID, COMUNIDAD DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	9.070
MADRID, COMUNIDAD DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	5.082
MADRID, COMUNIDAD DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	3.987
MADRID, COMUNIDAD DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	7.541
MADRID, COMUNIDAD DE	Grupo 1700 Congenital abnormalities  740-759	Men	3.883
MADRID, COMUNIDAD DE	Grupo 1700 Congenital abnormalities  740-759	Women	3.658
MADRID, COMUNIDAD DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	24.633
MADRID, COMUNIDAD DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	13.277
MADRID, COMUNIDAD DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	11.356
MADRID, COMUNIDAD DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.665
MADRID, COMUNIDAD DE	Group 1801 Pain in throat and chest 7841, 7865	Men	1.496
MADRID, COMUNIDAD DE	Group 1801 Pain in throat and chest 7841, 7865	Women	1.169
MADRID, COMUNIDAD DE	Group 1802 Abdominal pain   7890	Both sexes	2.610
MADRID, COMUNIDAD DE	Group 1802 Abdominal pain   7890	Men	1.047
MADRID, COMUNIDAD DE	Group 1802 Abdominal pain   7890	Women	1.563
MADRID, COMUNIDAD DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	1.804
MADRID, COMUNIDAD DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1.077
MADRID, COMUNIDAD DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	726
MADRID, COMUNIDAD DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	17.555
MADRID, COMUNIDAD DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	9.657
MADRID, COMUNIDAD DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	7.897
MADRID, COMUNIDAD DE	Group 1900 Injuries and poisoning  800-999	Both sexes	53.926
MADRID, COMUNIDAD DE	Group 1900 Injuries and poisoning  800-999	Men	27.779
MADRID, COMUNIDAD DE	Group 1900 Injuries and poisoning  800-999	Women	26.147
MADRID, COMUNIDAD DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	2.433
MADRID, COMUNIDAD DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	1.415
MADRID, COMUNIDAD DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	1.018
MADRID, COMUNIDAD DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	1.403
MADRID, COMUNIDAD DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	1.003
MADRID, COMUNIDAD DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	400
MADRID, COMUNIDAD DE	Group 1903 Radius and ulna fracture 813	Both sexes	3.075
MADRID, COMUNIDAD DE	Group 1903 Radius and ulna fracture 813	Men	1.515
MADRID, COMUNIDAD DE	Group 1903 Radius and ulna fracture 813	Women	1.561
MADRID, COMUNIDAD DE	Group 1904 Femur fracture  820-821	Both sexes	7.217
MADRID, COMUNIDAD DE	Group 1904 Femur fracture  820-821	Men	1.944
MADRID, COMUNIDAD DE	Group 1904 Femur fracture  820-821	Women	5.273
MADRID, COMUNIDAD DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	3.654
MADRID, COMUNIDAD DE	Group 1905 Leg fracture, including the ankle 823-824	Men	1.952
MADRID, COMUNIDAD DE	Group 1905 Leg fracture, including the ankle 823-824	Women	1.703
MADRID, COMUNIDAD DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	13.851
MADRID, COMUNIDAD DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	8.377
MADRID, COMUNIDAD DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	5.473
MADRID, COMUNIDAD DE	Group 1907 Burns  940-949	Both sexes	487
MADRID, COMUNIDAD DE	Group 1907 Burns  940-949	Men	304
MADRID, COMUNIDAD DE	Group 1907 Burns  940-949	Women	183
MADRID, COMUNIDAD DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	1.524
MADRID, COMUNIDAD DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	699
MADRID, COMUNIDAD DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	825
MADRID, COMUNIDAD DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	18.318
MADRID, COMUNIDAD DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	9.525
MADRID, COMUNIDAD DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	8.793
MADRID, COMUNIDAD DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	115
MADRID, COMUNIDAD DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	70
MADRID, COMUNIDAD DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	45
MADRID, COMUNIDAD DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	1.848
MADRID, COMUNIDAD DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	974
MADRID, COMUNIDAD DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	874
MADRID, COMUNIDAD DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	18.871
MADRID, COMUNIDAD DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	8.311
MADRID, COMUNIDAD DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	10.560
MADRID, COMUNIDAD DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	928
MADRID, COMUNIDAD DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	506
MADRID, COMUNIDAD DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	422
MADRID, COMUNIDAD DE	Group 2102 Contraceptive management  V25	Both sexes	141
MADRID, COMUNIDAD DE	Group 2102 Contraceptive management  V25	Men	19
MADRID, COMUNIDAD DE	Group 2102 Contraceptive management  V25	Women	122
MADRID, COMUNIDAD DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
MADRID, COMUNIDAD DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
MADRID, COMUNIDAD DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
MADRID, COMUNIDAD DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	6.032
MADRID, COMUNIDAD DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	3.349
MADRID, COMUNIDAD DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	2.683
MADRID, COMUNIDAD DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	11.770
MADRID, COMUNIDAD DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	4.437
MADRID, COMUNIDAD DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	7.333
MURCIA, REGIËN DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	146.541
MURCIA, REGIËN DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	67.458
MURCIA, REGIËN DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	79.083
MURCIA, REGIËN DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	3.252
MURCIA, REGIËN DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.796
MURCIA, REGIËN DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.456
MURCIA, REGIËN DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	538
MURCIA, REGIËN DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	294
MURCIA, REGIËN DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	244
MURCIA, REGIËN DE	Group 0102 Imprecise intestinal infections 009	Both sexes	107
MURCIA, REGIËN DE	Group 0102 Imprecise intestinal infections 009	Men	52
MURCIA, REGIËN DE	Group 0102 Imprecise intestinal infections 009	Women	55
MURCIA, REGIËN DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	140
MURCIA, REGIËN DE	Group 0103 Tuberculosis 010-018, 137	Men	86
MURCIA, REGIËN DE	Group 0103 Tuberculosis 010-018, 137	Women	54
MURCIA, REGIËN DE	Group 0104 Septicaemia  038	Both sexes	1.375
MURCIA, REGIËN DE	Group 0104 Septicaemia  038	Men	711
MURCIA, REGIËN DE	Group 0104 Septicaemia  038	Women	664
MURCIA, REGIËN DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	90
MURCIA, REGIËN DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	72
MURCIA, REGIËN DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	18
MURCIA, REGIËN DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.002
MURCIA, REGIËN DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	581
MURCIA, REGIËN DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	421
MURCIA, REGIËN DE	Group 0200 Neoplasms  140-239	Both sexes	12.324
MURCIA, REGIËN DE	Group 0200 Neoplasms  140-239	Men	6.340
MURCIA, REGIËN DE	Group 0200 Neoplasms  140-239	Women	5.984
MURCIA, REGIËN DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.133
MURCIA, REGIËN DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	694
MURCIA, REGIËN DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	439
MURCIA, REGIËN DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	866
MURCIA, REGIËN DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	704
MURCIA, REGIËN DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	162
MURCIA, REGIËN DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	192
MURCIA, REGIËN DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	120
MURCIA, REGIËN DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	72
MURCIA, REGIËN DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	986
MURCIA, REGIËN DE	Group 0204 Malignant neoplasm of breast  174-175	Men	9
MURCIA, REGIËN DE	Group 0204 Malignant neoplasm of breast  174-175	Women	977
MURCIA, REGIËN DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	276
MURCIA, REGIËN DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
MURCIA, REGIËN DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	276
MURCIA, REGIËN DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	124
MURCIA, REGIËN DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
MURCIA, REGIËN DE	Group 0206 Malignant neoplasm of ovary  1830	Women	124
MURCIA, REGIËN DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	412
MURCIA, REGIËN DE	Group 0207 Malignant neoplasm of prostate  185	Men	412
MURCIA, REGIËN DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
MURCIA, REGIËN DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.121
MURCIA, REGIËN DE	Group 0208 Malignant neoplasm of bladder  188	Men	971
MURCIA, REGIËN DE	Group 0208 Malignant neoplasm of bladder  188	Women	150
MURCIA, REGIËN DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	4.207
MURCIA, REGIËN DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	2.408
MURCIA, REGIËN DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.799
MURCIA, REGIËN DE	Group 0210 Carcinoma in situ  230-234	Both sexes	212
MURCIA, REGIËN DE	Group 0210 Carcinoma in situ  230-234	Men	80
MURCIA, REGIËN DE	Group 0210 Carcinoma in situ  230-234	Women	132
MURCIA, REGIËN DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	134
MURCIA, REGIËN DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	73
MURCIA, REGIËN DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	61
MURCIA, REGIËN DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	723
MURCIA, REGIËN DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
MURCIA, REGIËN DE	Grupo 0212 Leiomyoma of uterus  218	Women	723
MURCIA, REGIËN DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.938
MURCIA, REGIËN DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	869
MURCIA, REGIËN DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.069
MURCIA, REGIËN DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.319
MURCIA, REGIËN DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	622
MURCIA, REGIËN DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	697
MURCIA, REGIËN DE	Group 0301 Anaemias 280-285	Both sexes	719
MURCIA, REGIËN DE	Group 0301 Anaemias 280-285	Men	354
MURCIA, REGIËN DE	Group 0301 Anaemias 280-285	Women	365
MURCIA, REGIËN DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	600
MURCIA, REGIËN DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	268
MURCIA, REGIËN DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	332
MURCIA, REGIËN DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	3.177
MURCIA, REGIËN DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.314
MURCIA, REGIËN DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.863
MURCIA, REGIËN DE	Group 0401 Diabetes mellitus  249-250	Both sexes	1.066
MURCIA, REGIËN DE	Group 0401 Diabetes mellitus  249-250	Men	667
MURCIA, REGIËN DE	Group 0401 Diabetes mellitus  249-250	Women	399
MURCIA, REGIËN DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.111
MURCIA, REGIËN DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	647
MURCIA, REGIËN DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.464
MURCIA, REGIËN DE	Group 0500 Mental disorders  290-319	Both sexes	3.464
MURCIA, REGIËN DE	Group 0500 Mental disorders  290-319	Men	1.990
MURCIA, REGIËN DE	Group 0500 Mental disorders  290-319	Women	1.474
MURCIA, REGIËN DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	115
MURCIA, REGIËN DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	54
MURCIA, REGIËN DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	61
MURCIA, REGIËN DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	213
MURCIA, REGIËN DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	171
MURCIA, REGIËN DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	42
MURCIA, REGIËN DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	259
MURCIA, REGIËN DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	199
MURCIA, REGIËN DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	60
MURCIA, REGIËN DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.003
MURCIA, REGIËN DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	661
MURCIA, REGIËN DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	342
MURCIA, REGIËN DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	706
MURCIA, REGIËN DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	333
MURCIA, REGIËN DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	374
MURCIA, REGIËN DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.167
MURCIA, REGIËN DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	572
MURCIA, REGIËN DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	595
MURCIA, REGIËN DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	3.487
MURCIA, REGIËN DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.802
MURCIA, REGIËN DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.685
MURCIA, REGIËN DE	Group 0601 Alzheimer's disease  3310	Both sexes	121
MURCIA, REGIËN DE	Group 0601 Alzheimer's disease  3310	Men	37
MURCIA, REGIËN DE	Group 0601 Alzheimer's disease  3310	Women	84
MURCIA, REGIËN DE	Group 0602 Multiple sclerosis 340	Both sexes	90
MURCIA, REGIËN DE	Group 0602 Multiple sclerosis 340	Men	27
MURCIA, REGIËN DE	Group 0602 Multiple sclerosis 340	Women	63
MURCIA, REGIËN DE	Group 0603 Epilepsy  345	Both sexes	777
MURCIA, REGIËN DE	Group 0603 Epilepsy  345	Men	431
MURCIA, REGIËN DE	Group 0603 Epilepsy  345	Women	346
MURCIA, REGIËN DE	Group 0604 Transient cerebral ischemia 435	Both sexes	650
MURCIA, REGIËN DE	Group 0604 Transient cerebral ischemia 435	Men	352
MURCIA, REGIËN DE	Group 0604 Transient cerebral ischemia 435	Women	298
MURCIA, REGIËN DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.849
MURCIA, REGIËN DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	955
MURCIA, REGIËN DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	894
MURCIA, REGIËN DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	450
MURCIA, REGIËN DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	241
MURCIA, REGIËN DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	209
MURCIA, REGIËN DE	Grupo 0701 Cataract  366	Both sexes	24
MURCIA, REGIËN DE	Grupo 0701 Cataract  366	Men	13
MURCIA, REGIËN DE	Grupo 0701 Cataract  366	Women	11
MURCIA, REGIËN DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	426
MURCIA, REGIËN DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	228
MURCIA, REGIËN DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	198
MURCIA, REGIËN DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	711
MURCIA, REGIËN DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	337
MURCIA, REGIËN DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	374
MURCIA, REGIËN DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	18.340
MURCIA, REGIËN DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	10.312
MURCIA, REGIËN DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	8.028
MURCIA, REGIËN DE	Group 0901 Hypertensive disease  401-405	Both sexes	773
MURCIA, REGIËN DE	Group 0901 Hypertensive disease  401-405	Men	331
MURCIA, REGIËN DE	Group 0901 Hypertensive disease  401-405	Women	442
MURCIA, REGIËN DE	Group 0902 Angina pectoris  4111, 413	Both sexes	1.074
MURCIA, REGIËN DE	Group 0902 Angina pectoris  4111, 413	Men	700
MURCIA, REGIËN DE	Group 0902 Angina pectoris  4111, 413	Women	374
MURCIA, REGIËN DE	Group 0903 Acute myocardial infarction  410	Both sexes	1.811
MURCIA, REGIËN DE	Group 0903 Acute myocardial infarction  410	Men	1.267
MURCIA, REGIËN DE	Group 0903 Acute myocardial infarction  410	Women	544
MURCIA, REGIËN DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.406
MURCIA, REGIËN DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.075
MURCIA, REGIËN DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	331
MURCIA, REGIËN DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	406
MURCIA, REGIËN DE	Group 0905 Diseases of the lungs circulation 415-417	Men	191
MURCIA, REGIËN DE	Group 0905 Diseases of the lungs circulation 415-417	Women	215
MURCIA, REGIËN DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.497
MURCIA, REGIËN DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.288
MURCIA, REGIËN DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.209
MURCIA, REGIËN DE	Grupo 0907 Heart failure  428	Both sexes	3.168
MURCIA, REGIËN DE	Grupo 0907 Heart failure  428	Men	1.416
MURCIA, REGIËN DE	Grupo 0907 Heart failure  428	Women	1.752
MURCIA, REGIËN DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	3.220
MURCIA, REGIËN DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.787
MURCIA, REGIËN DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.433
MURCIA, REGIËN DE	Grupo 0909 Atherosclerosis  440	Both sexes	280
MURCIA, REGIËN DE	Grupo 0909 Atherosclerosis  440	Men	227
MURCIA, REGIËN DE	Grupo 0909 Atherosclerosis  440	Women	53
MURCIA, REGIËN DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	609
MURCIA, REGIËN DE	Group 0910 Varicose veins of lower extremities 454	Men	199
MURCIA, REGIËN DE	Group 0910 Varicose veins of lower extremities 454	Women	410
MURCIA, REGIËN DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	3.096
MURCIA, REGIËN DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.831
MURCIA, REGIËN DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.265
MURCIA, REGIËN DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	16.041
MURCIA, REGIËN DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	9.115
MURCIA, REGIËN DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.926
MURCIA, REGIËN DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.003
MURCIA, REGIËN DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	509
MURCIA, REGIËN DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	494
MURCIA, REGIËN DE	Group 1002 Pneumonia 480-486	Both sexes	3.358
MURCIA, REGIËN DE	Group 1002 Pneumonia 480-486	Men	1.993
MURCIA, REGIËN DE	Group 1002 Pneumonia 480-486	Women	1.365
MURCIA, REGIËN DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.361
MURCIA, REGIËN DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	643
MURCIA, REGIËN DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	718
MURCIA, REGIËN DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	871
MURCIA, REGIËN DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	498
MURCIA, REGIËN DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	373
MURCIA, REGIËN DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.340
MURCIA, REGIËN DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	832
MURCIA, REGIËN DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	508
MURCIA, REGIËN DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.102
MURCIA, REGIËN DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.715
MURCIA, REGIËN DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	387
MURCIA, REGIËN DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	697
MURCIA, REGIËN DE	Group 1007 Asthma 4930-4931,4938-4939	Men	198
MURCIA, REGIËN DE	Group 1007 Asthma 4930-4931,4938-4939	Women	499
MURCIA, REGIËN DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	5.309
MURCIA, REGIËN DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	2.727
MURCIA, REGIËN DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	2.582
MURCIA, REGIËN DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	17.308
MURCIA, REGIËN DE	Group 1100 Diseases of the digestive system  520-579	Men	9.597
MURCIA, REGIËN DE	Group 1100 Diseases of the digestive system  520-579	Women	7.711
MURCIA, REGIËN DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	312
MURCIA, REGIËN DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	130
MURCIA, REGIËN DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	182
MURCIA, REGIËN DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	303
MURCIA, REGIËN DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	182
MURCIA, REGIËN DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	121
MURCIA, REGIËN DE	Group 1103 Diseases of the esophagus 530	Both sexes	314
MURCIA, REGIËN DE	Group 1103 Diseases of the esophagus 530	Men	197
MURCIA, REGIËN DE	Group 1103 Diseases of the esophagus 530	Women	117
MURCIA, REGIËN DE	Group 1104 Peptic ulcer 531-534	Both sexes	277
MURCIA, REGIËN DE	Group 1104 Peptic ulcer 531-534	Men	198
MURCIA, REGIËN DE	Group 1104 Peptic ulcer 531-534	Women	79
MURCIA, REGIËN DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	420
MURCIA, REGIËN DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	214
MURCIA, REGIËN DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	206
MURCIA, REGIËN DE	Group 1106 Appendicitis  540-543	Both sexes	1.534
MURCIA, REGIËN DE	Group 1106 Appendicitis  540-543	Men	896
MURCIA, REGIËN DE	Group 1106 Appendicitis  540-543	Women	638
MURCIA, REGIËN DE	Group 1107 Inguinal hernia  550	Both sexes	1.665
MURCIA, REGIËN DE	Group 1107 Inguinal hernia  550	Men	1.465
MURCIA, REGIËN DE	Group 1107 Inguinal hernia  550	Women	200
MURCIA, REGIËN DE	Group 1108 Other abdominal hernia  551-553	Both sexes	1.413
MURCIA, REGIËN DE	Group 1108 Other abdominal hernia  551-553	Men	714
MURCIA, REGIËN DE	Group 1108 Other abdominal hernia  551-553	Women	699
MURCIA, REGIËN DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	379
MURCIA, REGIËN DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	191
MURCIA, REGIËN DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	188
MURCIA, REGIËN DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.176
MURCIA, REGIËN DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	571
MURCIA, REGIËN DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	605
MURCIA, REGIËN DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	723
MURCIA, REGIËN DE	Group 1111 Intestinal obstruction without hernia 560	Men	363
MURCIA, REGIËN DE	Group 1111 Intestinal obstruction without hernia 560	Women	360
MURCIA, REGIËN DE	Group 1112 Intestinal diverticulosis 562	Both sexes	628
MURCIA, REGIËN DE	Group 1112 Intestinal diverticulosis 562	Men	342
MURCIA, REGIËN DE	Group 1112 Intestinal diverticulosis 562	Women	286
MURCIA, REGIËN DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.025
MURCIA, REGIËN DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	668
MURCIA, REGIËN DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	357
MURCIA, REGIËN DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	489
MURCIA, REGIËN DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	211
MURCIA, REGIËN DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	278
MURCIA, REGIËN DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	275
MURCIA, REGIËN DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	232
MURCIA, REGIËN DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	43
MURCIA, REGIËN DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	586
MURCIA, REGIËN DE	Group 1116 Other diseases of the liver 570,5714-573	Men	349
MURCIA, REGIËN DE	Group 1116 Other diseases of the liver 570,5714-573	Women	237
MURCIA, REGIËN DE	Group 1117 Cholelithiasis  574	Both sexes	3.366
MURCIA, REGIËN DE	Group 1117 Cholelithiasis  574	Men	1.326
MURCIA, REGIËN DE	Group 1117 Cholelithiasis  574	Women	2.040
MURCIA, REGIËN DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	782
MURCIA, REGIËN DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	442
MURCIA, REGIËN DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	340
MURCIA, REGIËN DE	Group 1119 Pancreatic diseases 577	Both sexes	882
MURCIA, REGIËN DE	Group 1119 Pancreatic diseases 577	Men	506
MURCIA, REGIËN DE	Group 1119 Pancreatic diseases 577	Women	376
MURCIA, REGIËN DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	759
MURCIA, REGIËN DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	400
MURCIA, REGIËN DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	359
MURCIA, REGIËN DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.628
MURCIA, REGIËN DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	888
MURCIA, REGIËN DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	740
MURCIA, REGIËN DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.066
MURCIA, REGIËN DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	629
MURCIA, REGIËN DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	437
MURCIA, REGIËN DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	64
MURCIA, REGIËN DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	26
MURCIA, REGIËN DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	38
MURCIA, REGIËN DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	498
MURCIA, REGIËN DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	233
MURCIA, REGIËN DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	265
MURCIA, REGIËN DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.774
MURCIA, REGIËN DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.619
MURCIA, REGIËN DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	5.155
MURCIA, REGIËN DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
MURCIA, REGIËN DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
MURCIA, REGIËN DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
MURCIA, REGIËN DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
MURCIA, REGIËN DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
MURCIA, REGIËN DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
MURCIA, REGIËN DE	Group 1303 Internal derangement of knee 717	Both sexes	1.222
MURCIA, REGIËN DE	Group 1303 Internal derangement of knee 717	Men	829
MURCIA, REGIËN DE	Group 1303 Internal derangement of knee 717	Women	393
MURCIA, REGIËN DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.522
MURCIA, REGIËN DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.459
MURCIA, REGIËN DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.063
MURCIA, REGIËN DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	205
MURCIA, REGIËN DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	69
MURCIA, REGIËN DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	136
MURCIA, REGIËN DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	370
MURCIA, REGIËN DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	183
MURCIA, REGIËN DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	187
MURCIA, REGIËN DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.260
MURCIA, REGIËN DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	685
MURCIA, REGIËN DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	575
MURCIA, REGIËN DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	300
MURCIA, REGIËN DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	127
MURCIA, REGIËN DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	173
MURCIA, REGIËN DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.416
MURCIA, REGIËN DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	690
MURCIA, REGIËN DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	726
MURCIA, REGIËN DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.479
MURCIA, REGIËN DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	577
MURCIA, REGIËN DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	902
MURCIA, REGIËN DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	10.388
MURCIA, REGIËN DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	4.793
MURCIA, REGIËN DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	5.595
MURCIA, REGIËN DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.221
MURCIA, REGIËN DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	413
MURCIA, REGIËN DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	808
MURCIA, REGIËN DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	902
MURCIA, REGIËN DE	Group 1402 Renal failure  5836-5837, 584-586	Men	539
MURCIA, REGIËN DE	Group 1402 Renal failure  5836-5837, 584-586	Women	363
MURCIA, REGIËN DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	1.625
MURCIA, REGIËN DE	Group 1403 Urolithiasis  592, 594, 7880	Men	953
MURCIA, REGIËN DE	Group 1403 Urolithiasis  592, 594, 7880	Women	672
MURCIA, REGIËN DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	3.053
MURCIA, REGIËN DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.416
MURCIA, REGIËN DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.637
MURCIA, REGIËN DE	Group 1405 Prostatic hyperplasia  600	Both sexes	692
MURCIA, REGIËN DE	Group 1405 Prostatic hyperplasia  600	Men	692
MURCIA, REGIËN DE	Group 1405 Prostatic hyperplasia  600	Women	..
MURCIA, REGIËN DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	719
MURCIA, REGIËN DE	Group 1406 Other diseases of the male genital organs    601-608	Men	719
MURCIA, REGIËN DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
MURCIA, REGIËN DE	Group 1407 Disorders of breast  610-612	Both sexes	605
MURCIA, REGIËN DE	Group 1407 Disorders of breast  610-612	Men	56
MURCIA, REGIËN DE	Group 1407 Disorders of breast  610-612	Women	549
MURCIA, REGIËN DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	274
MURCIA, REGIËN DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
MURCIA, REGIËN DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	274
MURCIA, REGIËN DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	99
MURCIA, REGIËN DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
MURCIA, REGIËN DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	99
MURCIA, REGIËN DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.198
MURCIA, REGIËN DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	5
MURCIA, REGIËN DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.193
MURCIA, REGIËN DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	19.051
MURCIA, REGIËN DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
MURCIA, REGIËN DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	19.051
MURCIA, REGIËN DE	Group 1501 Legally induced abortion  635	Both sexes	13
MURCIA, REGIËN DE	Group 1501 Legally induced abortion  635	Men	..
MURCIA, REGIËN DE	Group 1501 Legally induced abortion  635	Women	13
MURCIA, REGIËN DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	984
MURCIA, REGIËN DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
MURCIA, REGIËN DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	984
MURCIA, REGIËN DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.859
MURCIA, REGIËN DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
MURCIA, REGIËN DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.859
MURCIA, REGIËN DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	2.213
MURCIA, REGIËN DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
MURCIA, REGIËN DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	2.213
MURCIA, REGIËN DE	Group 1505 Single spontaneous delivery  650	Both sexes	619
MURCIA, REGIËN DE	Group 1505 Single spontaneous delivery  650	Men	..
MURCIA, REGIËN DE	Group 1505 Single spontaneous delivery  650	Women	619
MURCIA, REGIËN DE	Group 1506 Other deliveries  6695-6697	Both sexes	747
MURCIA, REGIËN DE	Group 1506 Other deliveries  6695-6697	Men	..
MURCIA, REGIËN DE	Group 1506 Other deliveries  6695-6697	Women	747
MURCIA, REGIËN DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	142
MURCIA, REGIËN DE	Group 1507 Complications related to the puerperium  670-676	Men	..
MURCIA, REGIËN DE	Group 1507 Complications related to the puerperium  670-676	Women	142
MURCIA, REGIËN DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.474
MURCIA, REGIËN DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
MURCIA, REGIËN DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.474
MURCIA, REGIËN DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.675
MURCIA, REGIËN DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	967
MURCIA, REGIËN DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	708
MURCIA, REGIËN DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	548
MURCIA, REGIËN DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	310
MURCIA, REGIËN DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	238
MURCIA, REGIËN DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.127
MURCIA, REGIËN DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	657
MURCIA, REGIËN DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	470
MURCIA, REGIËN DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.103
MURCIA, REGIËN DE	Grupo 1700 Congenital abnormalities  740-759	Men	620
MURCIA, REGIËN DE	Grupo 1700 Congenital abnormalities  740-759	Women	483
MURCIA, REGIËN DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	7.816
MURCIA, REGIËN DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	4.329
MURCIA, REGIËN DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	3.487
MURCIA, REGIËN DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.096
MURCIA, REGIËN DE	Group 1801 Pain in throat and chest 7841, 7865	Men	632
MURCIA, REGIËN DE	Group 1801 Pain in throat and chest 7841, 7865	Women	464
MURCIA, REGIËN DE	Group 1802 Abdominal pain   7890	Both sexes	672
MURCIA, REGIËN DE	Group 1802 Abdominal pain   7890	Men	270
MURCIA, REGIËN DE	Group 1802 Abdominal pain   7890	Women	402
MURCIA, REGIËN DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	582
MURCIA, REGIËN DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	313
MURCIA, REGIËN DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	269
MURCIA, REGIËN DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	5.466
MURCIA, REGIËN DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	3.114
MURCIA, REGIËN DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	2.352
MURCIA, REGIËN DE	Group 1900 Injuries and poisoning  800-999	Both sexes	12.345
MURCIA, REGIËN DE	Group 1900 Injuries and poisoning  800-999	Men	6.588
MURCIA, REGIËN DE	Group 1900 Injuries and poisoning  800-999	Women	5.757
MURCIA, REGIËN DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	629
MURCIA, REGIËN DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	358
MURCIA, REGIËN DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	271
MURCIA, REGIËN DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	368
MURCIA, REGIËN DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	261
MURCIA, REGIËN DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	107
MURCIA, REGIËN DE	Group 1903 Radius and ulna fracture 813	Both sexes	689
MURCIA, REGIËN DE	Group 1903 Radius and ulna fracture 813	Men	330
MURCIA, REGIËN DE	Group 1903 Radius and ulna fracture 813	Women	359
MURCIA, REGIËN DE	Group 1904 Femur fracture  820-821	Both sexes	1.765
MURCIA, REGIËN DE	Group 1904 Femur fracture  820-821	Men	523
MURCIA, REGIËN DE	Group 1904 Femur fracture  820-821	Women	1.242
MURCIA, REGIËN DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	840
MURCIA, REGIËN DE	Group 1905 Leg fracture, including the ankle 823-824	Men	439
MURCIA, REGIËN DE	Group 1905 Leg fracture, including the ankle 823-824	Women	401
MURCIA, REGIËN DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.813
MURCIA, REGIËN DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.383
MURCIA, REGIËN DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.430
MURCIA, REGIËN DE	Group 1907 Burns  940-949	Both sexes	117
MURCIA, REGIËN DE	Group 1907 Burns  940-949	Men	70
MURCIA, REGIËN DE	Group 1907 Burns  940-949	Women	47
MURCIA, REGIËN DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	411
MURCIA, REGIËN DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	191
MURCIA, REGIËN DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	220
MURCIA, REGIËN DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.277
MURCIA, REGIËN DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.792
MURCIA, REGIËN DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.485
MURCIA, REGIËN DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	17
MURCIA, REGIËN DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	12
MURCIA, REGIËN DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	5
MURCIA, REGIËN DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	419
MURCIA, REGIËN DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	229
MURCIA, REGIËN DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	190
MURCIA, REGIËN DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.888
MURCIA, REGIËN DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.188
MURCIA, REGIËN DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.700
MURCIA, REGIËN DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	71
MURCIA, REGIËN DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	37
MURCIA, REGIËN DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	34
MURCIA, REGIËN DE	Group 2102 Contraceptive management  V25	Both sexes	66
MURCIA, REGIËN DE	Group 2102 Contraceptive management  V25	Men	3
MURCIA, REGIËN DE	Group 2102 Contraceptive management  V25	Women	63
MURCIA, REGIËN DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
MURCIA, REGIËN DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
MURCIA, REGIËN DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
MURCIA, REGIËN DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	869
MURCIA, REGIËN DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	523
MURCIA, REGIËN DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	346
MURCIA, REGIËN DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.882
MURCIA, REGIËN DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	625
MURCIA, REGIËN DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.257
NAVARRA, COMUNIDAD FORAL DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	68.592
NAVARRA, COMUNIDAD FORAL DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	33.408
NAVARRA, COMUNIDAD FORAL DE	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	35.184
NAVARRA, COMUNIDAD FORAL DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.223
NAVARRA, COMUNIDAD FORAL DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	703
NAVARRA, COMUNIDAD FORAL DE	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	520
NAVARRA, COMUNIDAD FORAL DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	176
NAVARRA, COMUNIDAD FORAL DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	102
NAVARRA, COMUNIDAD FORAL DE	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	74
NAVARRA, COMUNIDAD FORAL DE	Group 0102 Imprecise intestinal infections 009	Both sexes	67
NAVARRA, COMUNIDAD FORAL DE	Group 0102 Imprecise intestinal infections 009	Men	31
NAVARRA, COMUNIDAD FORAL DE	Group 0102 Imprecise intestinal infections 009	Women	36
NAVARRA, COMUNIDAD FORAL DE	Group 0103 Tuberculosis 010-018, 137	Both sexes	60
NAVARRA, COMUNIDAD FORAL DE	Group 0103 Tuberculosis 010-018, 137	Men	35
NAVARRA, COMUNIDAD FORAL DE	Group 0103 Tuberculosis 010-018, 137	Women	25
NAVARRA, COMUNIDAD FORAL DE	Group 0104 Septicaemia  038	Both sexes	410
NAVARRA, COMUNIDAD FORAL DE	Group 0104 Septicaemia  038	Men	242
NAVARRA, COMUNIDAD FORAL DE	Group 0104 Septicaemia  038	Women	168
NAVARRA, COMUNIDAD FORAL DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	27
NAVARRA, COMUNIDAD FORAL DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	12
NAVARRA, COMUNIDAD FORAL DE	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	15
NAVARRA, COMUNIDAD FORAL DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	483
NAVARRA, COMUNIDAD FORAL DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	281
NAVARRA, COMUNIDAD FORAL DE	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	202
NAVARRA, COMUNIDAD FORAL DE	Group 0200 Neoplasms  140-239	Both sexes	8.144
NAVARRA, COMUNIDAD FORAL DE	Group 0200 Neoplasms  140-239	Men	4.394
NAVARRA, COMUNIDAD FORAL DE	Group 0200 Neoplasms  140-239	Women	3.750
NAVARRA, COMUNIDAD FORAL DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	875
NAVARRA, COMUNIDAD FORAL DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	580
NAVARRA, COMUNIDAD FORAL DE	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	295
NAVARRA, COMUNIDAD FORAL DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	615
NAVARRA, COMUNIDAD FORAL DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	472
NAVARRA, COMUNIDAD FORAL DE	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	143
NAVARRA, COMUNIDAD FORAL DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	133
NAVARRA, COMUNIDAD FORAL DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	76
NAVARRA, COMUNIDAD FORAL DE	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	57
NAVARRA, COMUNIDAD FORAL DE	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	596
NAVARRA, COMUNIDAD FORAL DE	Group 0204 Malignant neoplasm of breast  174-175	Men	5
NAVARRA, COMUNIDAD FORAL DE	Group 0204 Malignant neoplasm of breast  174-175	Women	591
NAVARRA, COMUNIDAD FORAL DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	163
NAVARRA, COMUNIDAD FORAL DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	163
NAVARRA, COMUNIDAD FORAL DE	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	71
NAVARRA, COMUNIDAD FORAL DE	Group 0206 Malignant neoplasm of ovary  1830	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 0206 Malignant neoplasm of ovary  1830	Women	71
NAVARRA, COMUNIDAD FORAL DE	Group 0207 Malignant neoplasm of prostate  185	Both sexes	302
NAVARRA, COMUNIDAD FORAL DE	Group 0207 Malignant neoplasm of prostate  185	Men	302
NAVARRA, COMUNIDAD FORAL DE	Group 0207 Malignant neoplasm of prostate  185	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 0208 Malignant neoplasm of bladder  188	Both sexes	597
NAVARRA, COMUNIDAD FORAL DE	Group 0208 Malignant neoplasm of bladder  188	Men	510
NAVARRA, COMUNIDAD FORAL DE	Group 0208 Malignant neoplasm of bladder  188	Women	87
NAVARRA, COMUNIDAD FORAL DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	3.131
NAVARRA, COMUNIDAD FORAL DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.846
NAVARRA, COMUNIDAD FORAL DE	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.285
NAVARRA, COMUNIDAD FORAL DE	Group 0210 Carcinoma in situ  230-234	Both sexes	172
NAVARRA, COMUNIDAD FORAL DE	Group 0210 Carcinoma in situ  230-234	Men	81
NAVARRA, COMUNIDAD FORAL DE	Group 0210 Carcinoma in situ  230-234	Women	91
NAVARRA, COMUNIDAD FORAL DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	97
NAVARRA, COMUNIDAD FORAL DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	58
NAVARRA, COMUNIDAD FORAL DE	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	39
NAVARRA, COMUNIDAD FORAL DE	Grupo 0212 Leiomyoma of uterus  218	Both sexes	306
NAVARRA, COMUNIDAD FORAL DE	Grupo 0212 Leiomyoma of uterus  218	Men	..
NAVARRA, COMUNIDAD FORAL DE	Grupo 0212 Leiomyoma of uterus  218	Women	306
NAVARRA, COMUNIDAD FORAL DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.086
NAVARRA, COMUNIDAD FORAL DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	464
NAVARRA, COMUNIDAD FORAL DE	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	622
NAVARRA, COMUNIDAD FORAL DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	654
NAVARRA, COMUNIDAD FORAL DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	363
NAVARRA, COMUNIDAD FORAL DE	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	291
NAVARRA, COMUNIDAD FORAL DE	Group 0301 Anaemias 280-285	Both sexes	410
NAVARRA, COMUNIDAD FORAL DE	Group 0301 Anaemias 280-285	Men	217
NAVARRA, COMUNIDAD FORAL DE	Group 0301 Anaemias 280-285	Women	193
NAVARRA, COMUNIDAD FORAL DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	244
NAVARRA, COMUNIDAD FORAL DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	146
NAVARRA, COMUNIDAD FORAL DE	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	98
NAVARRA, COMUNIDAD FORAL DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.275
NAVARRA, COMUNIDAD FORAL DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	578
NAVARRA, COMUNIDAD FORAL DE	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	697
NAVARRA, COMUNIDAD FORAL DE	Group 0401 Diabetes mellitus  249-250	Both sexes	418
NAVARRA, COMUNIDAD FORAL DE	Group 0401 Diabetes mellitus  249-250	Men	259
NAVARRA, COMUNIDAD FORAL DE	Group 0401 Diabetes mellitus  249-250	Women	159
NAVARRA, COMUNIDAD FORAL DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	857
NAVARRA, COMUNIDAD FORAL DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	319
NAVARRA, COMUNIDAD FORAL DE	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	538
NAVARRA, COMUNIDAD FORAL DE	Group 0500 Mental disorders  290-319	Both sexes	2.036
NAVARRA, COMUNIDAD FORAL DE	Group 0500 Mental disorders  290-319	Men	999
NAVARRA, COMUNIDAD FORAL DE	Group 0500 Mental disorders  290-319	Women	1.037
NAVARRA, COMUNIDAD FORAL DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	268
NAVARRA, COMUNIDAD FORAL DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	108
NAVARRA, COMUNIDAD FORAL DE	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	160
NAVARRA, COMUNIDAD FORAL DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	113
NAVARRA, COMUNIDAD FORAL DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	85
NAVARRA, COMUNIDAD FORAL DE	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	28
NAVARRA, COMUNIDAD FORAL DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	78
NAVARRA, COMUNIDAD FORAL DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	50
NAVARRA, COMUNIDAD FORAL DE	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	28
NAVARRA, COMUNIDAD FORAL DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	542
NAVARRA, COMUNIDAD FORAL DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	314
NAVARRA, COMUNIDAD FORAL DE	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	228
NAVARRA, COMUNIDAD FORAL DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	474
NAVARRA, COMUNIDAD FORAL DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	208
NAVARRA, COMUNIDAD FORAL DE	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	266
NAVARRA, COMUNIDAD FORAL DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	561
NAVARRA, COMUNIDAD FORAL DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	234
NAVARRA, COMUNIDAD FORAL DE	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	327
NAVARRA, COMUNIDAD FORAL DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.797
NAVARRA, COMUNIDAD FORAL DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	943
NAVARRA, COMUNIDAD FORAL DE	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	854
NAVARRA, COMUNIDAD FORAL DE	Group 0601 Alzheimer's disease  3310	Both sexes	40
NAVARRA, COMUNIDAD FORAL DE	Group 0601 Alzheimer's disease  3310	Men	16
NAVARRA, COMUNIDAD FORAL DE	Group 0601 Alzheimer's disease  3310	Women	24
NAVARRA, COMUNIDAD FORAL DE	Group 0602 Multiple sclerosis 340	Both sexes	23
NAVARRA, COMUNIDAD FORAL DE	Group 0602 Multiple sclerosis 340	Men	6
NAVARRA, COMUNIDAD FORAL DE	Group 0602 Multiple sclerosis 340	Women	17
NAVARRA, COMUNIDAD FORAL DE	Group 0603 Epilepsy  345	Both sexes	186
NAVARRA, COMUNIDAD FORAL DE	Group 0603 Epilepsy  345	Men	84
NAVARRA, COMUNIDAD FORAL DE	Group 0603 Epilepsy  345	Women	102
NAVARRA, COMUNIDAD FORAL DE	Group 0604 Transient cerebral ischemia 435	Both sexes	176
NAVARRA, COMUNIDAD FORAL DE	Group 0604 Transient cerebral ischemia 435	Men	103
NAVARRA, COMUNIDAD FORAL DE	Group 0604 Transient cerebral ischemia 435	Women	73
NAVARRA, COMUNIDAD FORAL DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.372
NAVARRA, COMUNIDAD FORAL DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	734
NAVARRA, COMUNIDAD FORAL DE	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	638
NAVARRA, COMUNIDAD FORAL DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	383
NAVARRA, COMUNIDAD FORAL DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	195
NAVARRA, COMUNIDAD FORAL DE	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	188
NAVARRA, COMUNIDAD FORAL DE	Grupo 0701 Cataract  366	Both sexes	28
NAVARRA, COMUNIDAD FORAL DE	Grupo 0701 Cataract  366	Men	16
NAVARRA, COMUNIDAD FORAL DE	Grupo 0701 Cataract  366	Women	12
NAVARRA, COMUNIDAD FORAL DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	355
NAVARRA, COMUNIDAD FORAL DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	179
NAVARRA, COMUNIDAD FORAL DE	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	176
NAVARRA, COMUNIDAD FORAL DE	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	471
NAVARRA, COMUNIDAD FORAL DE	Group 0800 Diseases of the ear and the mastoid  380-389	Men	245
NAVARRA, COMUNIDAD FORAL DE	Group 0800 Diseases of the ear and the mastoid  380-389	Women	226
NAVARRA, COMUNIDAD FORAL DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	7.913
NAVARRA, COMUNIDAD FORAL DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	4.612
NAVARRA, COMUNIDAD FORAL DE	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	3.301
NAVARRA, COMUNIDAD FORAL DE	Group 0901 Hypertensive disease  401-405	Both sexes	641
NAVARRA, COMUNIDAD FORAL DE	Group 0901 Hypertensive disease  401-405	Men	288
NAVARRA, COMUNIDAD FORAL DE	Group 0901 Hypertensive disease  401-405	Women	353
NAVARRA, COMUNIDAD FORAL DE	Group 0902 Angina pectoris  4111, 413	Both sexes	163
NAVARRA, COMUNIDAD FORAL DE	Group 0902 Angina pectoris  4111, 413	Men	109
NAVARRA, COMUNIDAD FORAL DE	Group 0902 Angina pectoris  4111, 413	Women	54
NAVARRA, COMUNIDAD FORAL DE	Group 0903 Acute myocardial infarction  410	Both sexes	600
NAVARRA, COMUNIDAD FORAL DE	Group 0903 Acute myocardial infarction  410	Men	446
NAVARRA, COMUNIDAD FORAL DE	Group 0903 Acute myocardial infarction  410	Women	154
NAVARRA, COMUNIDAD FORAL DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	553
NAVARRA, COMUNIDAD FORAL DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	448
NAVARRA, COMUNIDAD FORAL DE	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	105
NAVARRA, COMUNIDAD FORAL DE	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	368
NAVARRA, COMUNIDAD FORAL DE	Group 0905 Diseases of the lungs circulation 415-417	Men	157
NAVARRA, COMUNIDAD FORAL DE	Group 0905 Diseases of the lungs circulation 415-417	Women	211
NAVARRA, COMUNIDAD FORAL DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	987
NAVARRA, COMUNIDAD FORAL DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	581
NAVARRA, COMUNIDAD FORAL DE	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	406
NAVARRA, COMUNIDAD FORAL DE	Grupo 0907 Heart failure  428	Both sexes	1.296
NAVARRA, COMUNIDAD FORAL DE	Grupo 0907 Heart failure  428	Men	674
NAVARRA, COMUNIDAD FORAL DE	Grupo 0907 Heart failure  428	Women	622
NAVARRA, COMUNIDAD FORAL DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.401
NAVARRA, COMUNIDAD FORAL DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	734
NAVARRA, COMUNIDAD FORAL DE	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	667
NAVARRA, COMUNIDAD FORAL DE	Grupo 0909 Atherosclerosis  440	Both sexes	361
NAVARRA, COMUNIDAD FORAL DE	Grupo 0909 Atherosclerosis  440	Men	285
NAVARRA, COMUNIDAD FORAL DE	Grupo 0909 Atherosclerosis  440	Women	76
NAVARRA, COMUNIDAD FORAL DE	Group 0910 Varicose veins of lower extremities 454	Both sexes	124
NAVARRA, COMUNIDAD FORAL DE	Group 0910 Varicose veins of lower extremities 454	Men	54
NAVARRA, COMUNIDAD FORAL DE	Group 0910 Varicose veins of lower extremities 454	Women	70
NAVARRA, COMUNIDAD FORAL DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.419
NAVARRA, COMUNIDAD FORAL DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	836
NAVARRA, COMUNIDAD FORAL DE	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	583
NAVARRA, COMUNIDAD FORAL DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	7.771
NAVARRA, COMUNIDAD FORAL DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	4.350
NAVARRA, COMUNIDAD FORAL DE	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	3.421
NAVARRA, COMUNIDAD FORAL DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	425
NAVARRA, COMUNIDAD FORAL DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	212
NAVARRA, COMUNIDAD FORAL DE	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	213
NAVARRA, COMUNIDAD FORAL DE	Group 1002 Pneumonia 480-486	Both sexes	1.615
NAVARRA, COMUNIDAD FORAL DE	Group 1002 Pneumonia 480-486	Men	967
NAVARRA, COMUNIDAD FORAL DE	Group 1002 Pneumonia 480-486	Women	648
NAVARRA, COMUNIDAD FORAL DE	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	510
NAVARRA, COMUNIDAD FORAL DE	Group 1003 Acute bronchitis and bronchiolitis  466	Men	251
NAVARRA, COMUNIDAD FORAL DE	Group 1003 Acute bronchitis and bronchiolitis  466	Women	259
NAVARRA, COMUNIDAD FORAL DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	553
NAVARRA, COMUNIDAD FORAL DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	319
NAVARRA, COMUNIDAD FORAL DE	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	234
NAVARRA, COMUNIDAD FORAL DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	826
NAVARRA, COMUNIDAD FORAL DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	516
NAVARRA, COMUNIDAD FORAL DE	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	310
NAVARRA, COMUNIDAD FORAL DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.097
NAVARRA, COMUNIDAD FORAL DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	784
NAVARRA, COMUNIDAD FORAL DE	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	313
NAVARRA, COMUNIDAD FORAL DE	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	339
NAVARRA, COMUNIDAD FORAL DE	Group 1007 Asthma 4930-4931,4938-4939	Men	117
NAVARRA, COMUNIDAD FORAL DE	Group 1007 Asthma 4930-4931,4938-4939	Women	222
NAVARRA, COMUNIDAD FORAL DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	2.406
NAVARRA, COMUNIDAD FORAL DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.184
NAVARRA, COMUNIDAD FORAL DE	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.222
NAVARRA, COMUNIDAD FORAL DE	Group 1100 Diseases of the digestive system  520-579	Both sexes	8.539
NAVARRA, COMUNIDAD FORAL DE	Group 1100 Diseases of the digestive system  520-579	Men	4.921
NAVARRA, COMUNIDAD FORAL DE	Group 1100 Diseases of the digestive system  520-579	Women	3.618
NAVARRA, COMUNIDAD FORAL DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	146
NAVARRA, COMUNIDAD FORAL DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	68
NAVARRA, COMUNIDAD FORAL DE	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	78
NAVARRA, COMUNIDAD FORAL DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	132
NAVARRA, COMUNIDAD FORAL DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	77
NAVARRA, COMUNIDAD FORAL DE	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	55
NAVARRA, COMUNIDAD FORAL DE	Group 1103 Diseases of the esophagus 530	Both sexes	201
NAVARRA, COMUNIDAD FORAL DE	Group 1103 Diseases of the esophagus 530	Men	130
NAVARRA, COMUNIDAD FORAL DE	Group 1103 Diseases of the esophagus 530	Women	71
NAVARRA, COMUNIDAD FORAL DE	Group 1104 Peptic ulcer 531-534	Both sexes	155
NAVARRA, COMUNIDAD FORAL DE	Group 1104 Peptic ulcer 531-534	Men	108
NAVARRA, COMUNIDAD FORAL DE	Group 1104 Peptic ulcer 531-534	Women	47
NAVARRA, COMUNIDAD FORAL DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	252
NAVARRA, COMUNIDAD FORAL DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	137
NAVARRA, COMUNIDAD FORAL DE	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	115
NAVARRA, COMUNIDAD FORAL DE	Group 1106 Appendicitis  540-543	Both sexes	755
NAVARRA, COMUNIDAD FORAL DE	Group 1106 Appendicitis  540-543	Men	433
NAVARRA, COMUNIDAD FORAL DE	Group 1106 Appendicitis  540-543	Women	322
NAVARRA, COMUNIDAD FORAL DE	Group 1107 Inguinal hernia  550	Both sexes	787
NAVARRA, COMUNIDAD FORAL DE	Group 1107 Inguinal hernia  550	Men	698
NAVARRA, COMUNIDAD FORAL DE	Group 1107 Inguinal hernia  550	Women	89
NAVARRA, COMUNIDAD FORAL DE	Group 1108 Other abdominal hernia  551-553	Both sexes	703
NAVARRA, COMUNIDAD FORAL DE	Group 1108 Other abdominal hernia  551-553	Men	357
NAVARRA, COMUNIDAD FORAL DE	Group 1108 Other abdominal hernia  551-553	Women	346
NAVARRA, COMUNIDAD FORAL DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	179
NAVARRA, COMUNIDAD FORAL DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	88
NAVARRA, COMUNIDAD FORAL DE	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	91
NAVARRA, COMUNIDAD FORAL DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	358
NAVARRA, COMUNIDAD FORAL DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	177
NAVARRA, COMUNIDAD FORAL DE	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	181
NAVARRA, COMUNIDAD FORAL DE	Group 1111 Intestinal obstruction without hernia 560	Both sexes	374
NAVARRA, COMUNIDAD FORAL DE	Group 1111 Intestinal obstruction without hernia 560	Men	193
NAVARRA, COMUNIDAD FORAL DE	Group 1111 Intestinal obstruction without hernia 560	Women	181
NAVARRA, COMUNIDAD FORAL DE	Group 1112 Intestinal diverticulosis 562	Both sexes	342
NAVARRA, COMUNIDAD FORAL DE	Group 1112 Intestinal diverticulosis 562	Men	183
NAVARRA, COMUNIDAD FORAL DE	Group 1112 Intestinal diverticulosis 562	Women	159
NAVARRA, COMUNIDAD FORAL DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	516
NAVARRA, COMUNIDAD FORAL DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	346
NAVARRA, COMUNIDAD FORAL DE	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	170
NAVARRA, COMUNIDAD FORAL DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	377
NAVARRA, COMUNIDAD FORAL DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	173
NAVARRA, COMUNIDAD FORAL DE	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	204
NAVARRA, COMUNIDAD FORAL DE	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	206
NAVARRA, COMUNIDAD FORAL DE	Group 1115 Alcoholic hepatitis 5710-5713	Men	172
NAVARRA, COMUNIDAD FORAL DE	Group 1115 Alcoholic hepatitis 5710-5713	Women	34
NAVARRA, COMUNIDAD FORAL DE	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	286
NAVARRA, COMUNIDAD FORAL DE	Group 1116 Other diseases of the liver 570,5714-573	Men	181
NAVARRA, COMUNIDAD FORAL DE	Group 1116 Other diseases of the liver 570,5714-573	Women	105
NAVARRA, COMUNIDAD FORAL DE	Group 1117 Cholelithiasis  574	Both sexes	1.489
NAVARRA, COMUNIDAD FORAL DE	Group 1117 Cholelithiasis  574	Men	690
NAVARRA, COMUNIDAD FORAL DE	Group 1117 Cholelithiasis  574	Women	799
NAVARRA, COMUNIDAD FORAL DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	433
NAVARRA, COMUNIDAD FORAL DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	243
NAVARRA, COMUNIDAD FORAL DE	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	190
NAVARRA, COMUNIDAD FORAL DE	Group 1119 Pancreatic diseases 577	Both sexes	461
NAVARRA, COMUNIDAD FORAL DE	Group 1119 Pancreatic diseases 577	Men	275
NAVARRA, COMUNIDAD FORAL DE	Group 1119 Pancreatic diseases 577	Women	186
NAVARRA, COMUNIDAD FORAL DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	387
NAVARRA, COMUNIDAD FORAL DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	192
NAVARRA, COMUNIDAD FORAL DE	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	195
NAVARRA, COMUNIDAD FORAL DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	646
NAVARRA, COMUNIDAD FORAL DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	339
NAVARRA, COMUNIDAD FORAL DE	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	307
NAVARRA, COMUNIDAD FORAL DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	395
NAVARRA, COMUNIDAD FORAL DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	221
NAVARRA, COMUNIDAD FORAL DE	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	174
NAVARRA, COMUNIDAD FORAL DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	25
NAVARRA, COMUNIDAD FORAL DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	12
NAVARRA, COMUNIDAD FORAL DE	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
NAVARRA, COMUNIDAD FORAL DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	226
NAVARRA, COMUNIDAD FORAL DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	106
NAVARRA, COMUNIDAD FORAL DE	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	120
NAVARRA, COMUNIDAD FORAL DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	6.444
NAVARRA, COMUNIDAD FORAL DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.305
NAVARRA, COMUNIDAD FORAL DE	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.139
NAVARRA, COMUNIDAD FORAL DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
NAVARRA, COMUNIDAD FORAL DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
NAVARRA, COMUNIDAD FORAL DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1303 Internal derangement of knee 717	Both sexes	947
NAVARRA, COMUNIDAD FORAL DE	Group 1303 Internal derangement of knee 717	Men	668
NAVARRA, COMUNIDAD FORAL DE	Group 1303 Internal derangement of knee 717	Women	279
NAVARRA, COMUNIDAD FORAL DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.056
NAVARRA, COMUNIDAD FORAL DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.062
NAVARRA, COMUNIDAD FORAL DE	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	994
NAVARRA, COMUNIDAD FORAL DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	163
NAVARRA, COMUNIDAD FORAL DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	45
NAVARRA, COMUNIDAD FORAL DE	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	118
NAVARRA, COMUNIDAD FORAL DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	257
NAVARRA, COMUNIDAD FORAL DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	139
NAVARRA, COMUNIDAD FORAL DE	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	118
NAVARRA, COMUNIDAD FORAL DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	507
NAVARRA, COMUNIDAD FORAL DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	291
NAVARRA, COMUNIDAD FORAL DE	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	216
NAVARRA, COMUNIDAD FORAL DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	239
NAVARRA, COMUNIDAD FORAL DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	96
NAVARRA, COMUNIDAD FORAL DE	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	143
NAVARRA, COMUNIDAD FORAL DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.220
NAVARRA, COMUNIDAD FORAL DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	631
NAVARRA, COMUNIDAD FORAL DE	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	589
NAVARRA, COMUNIDAD FORAL DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.055
NAVARRA, COMUNIDAD FORAL DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	373
NAVARRA, COMUNIDAD FORAL DE	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	682
NAVARRA, COMUNIDAD FORAL DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	3.476
NAVARRA, COMUNIDAD FORAL DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.579
NAVARRA, COMUNIDAD FORAL DE	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.897
NAVARRA, COMUNIDAD FORAL DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	324
NAVARRA, COMUNIDAD FORAL DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	128
NAVARRA, COMUNIDAD FORAL DE	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	196
NAVARRA, COMUNIDAD FORAL DE	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	288
NAVARRA, COMUNIDAD FORAL DE	Group 1402 Renal failure  5836-5837, 584-586	Men	168
NAVARRA, COMUNIDAD FORAL DE	Group 1402 Renal failure  5836-5837, 584-586	Women	120
NAVARRA, COMUNIDAD FORAL DE	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	316
NAVARRA, COMUNIDAD FORAL DE	Group 1403 Urolithiasis  592, 594, 7880	Men	213
NAVARRA, COMUNIDAD FORAL DE	Group 1403 Urolithiasis  592, 594, 7880	Women	103
NAVARRA, COMUNIDAD FORAL DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.061
NAVARRA, COMUNIDAD FORAL DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	519
NAVARRA, COMUNIDAD FORAL DE	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	542
NAVARRA, COMUNIDAD FORAL DE	Group 1405 Prostatic hyperplasia  600	Both sexes	310
NAVARRA, COMUNIDAD FORAL DE	Group 1405 Prostatic hyperplasia  600	Men	310
NAVARRA, COMUNIDAD FORAL DE	Group 1405 Prostatic hyperplasia  600	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	212
NAVARRA, COMUNIDAD FORAL DE	Group 1406 Other diseases of the male genital organs    601-608	Men	212
NAVARRA, COMUNIDAD FORAL DE	Group 1406 Other diseases of the male genital organs    601-608	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 1407 Disorders of breast  610-612	Both sexes	201
NAVARRA, COMUNIDAD FORAL DE	Group 1407 Disorders of breast  610-612	Men	23
NAVARRA, COMUNIDAD FORAL DE	Group 1407 Disorders of breast  610-612	Women	178
NAVARRA, COMUNIDAD FORAL DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	98
NAVARRA, COMUNIDAD FORAL DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	98
NAVARRA, COMUNIDAD FORAL DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	37
NAVARRA, COMUNIDAD FORAL DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	37
NAVARRA, COMUNIDAD FORAL DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	629
NAVARRA, COMUNIDAD FORAL DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	6
NAVARRA, COMUNIDAD FORAL DE	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	623
NAVARRA, COMUNIDAD FORAL DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	6.869
NAVARRA, COMUNIDAD FORAL DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	6.869
NAVARRA, COMUNIDAD FORAL DE	Group 1501 Legally induced abortion  635	Both sexes	2
NAVARRA, COMUNIDAD FORAL DE	Group 1501 Legally induced abortion  635	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1501 Legally induced abortion  635	Women	2
NAVARRA, COMUNIDAD FORAL DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	441
NAVARRA, COMUNIDAD FORAL DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	441
NAVARRA, COMUNIDAD FORAL DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.131
NAVARRA, COMUNIDAD FORAL DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.131
NAVARRA, COMUNIDAD FORAL DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.419
NAVARRA, COMUNIDAD FORAL DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.419
NAVARRA, COMUNIDAD FORAL DE	Group 1505 Single spontaneous delivery  650	Both sexes	137
NAVARRA, COMUNIDAD FORAL DE	Group 1505 Single spontaneous delivery  650	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1505 Single spontaneous delivery  650	Women	137
NAVARRA, COMUNIDAD FORAL DE	Group 1506 Other deliveries  6695-6697	Both sexes	268
NAVARRA, COMUNIDAD FORAL DE	Group 1506 Other deliveries  6695-6697	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1506 Other deliveries  6695-6697	Women	268
NAVARRA, COMUNIDAD FORAL DE	Group 1507 Complications related to the puerperium  670-676	Both sexes	46
NAVARRA, COMUNIDAD FORAL DE	Group 1507 Complications related to the puerperium  670-676	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1507 Complications related to the puerperium  670-676	Women	46
NAVARRA, COMUNIDAD FORAL DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	425
NAVARRA, COMUNIDAD FORAL DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	425
NAVARRA, COMUNIDAD FORAL DE	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	622
NAVARRA, COMUNIDAD FORAL DE	Group 1600 Some disorders originating in the perinatal period  760-779	Men	335
NAVARRA, COMUNIDAD FORAL DE	Group 1600 Some disorders originating in the perinatal period  760-779	Women	287
NAVARRA, COMUNIDAD FORAL DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	174
NAVARRA, COMUNIDAD FORAL DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	87
NAVARRA, COMUNIDAD FORAL DE	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	87
NAVARRA, COMUNIDAD FORAL DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	448
NAVARRA, COMUNIDAD FORAL DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	248
NAVARRA, COMUNIDAD FORAL DE	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	200
NAVARRA, COMUNIDAD FORAL DE	Grupo 1700 Congenital abnormalities  740-759	Both sexes	534
NAVARRA, COMUNIDAD FORAL DE	Grupo 1700 Congenital abnormalities  740-759	Men	286
NAVARRA, COMUNIDAD FORAL DE	Grupo 1700 Congenital abnormalities  740-759	Women	248
NAVARRA, COMUNIDAD FORAL DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.397
NAVARRA, COMUNIDAD FORAL DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.282
NAVARRA, COMUNIDAD FORAL DE	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.115
NAVARRA, COMUNIDAD FORAL DE	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	133
NAVARRA, COMUNIDAD FORAL DE	Group 1801 Pain in throat and chest 7841, 7865	Men	74
NAVARRA, COMUNIDAD FORAL DE	Group 1801 Pain in throat and chest 7841, 7865	Women	59
NAVARRA, COMUNIDAD FORAL DE	Group 1802 Abdominal pain   7890	Both sexes	315
NAVARRA, COMUNIDAD FORAL DE	Group 1802 Abdominal pain   7890	Men	115
NAVARRA, COMUNIDAD FORAL DE	Group 1802 Abdominal pain   7890	Women	200
NAVARRA, COMUNIDAD FORAL DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	380
NAVARRA, COMUNIDAD FORAL DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	218
NAVARRA, COMUNIDAD FORAL DE	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	162
NAVARRA, COMUNIDAD FORAL DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.569
NAVARRA, COMUNIDAD FORAL DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	875
NAVARRA, COMUNIDAD FORAL DE	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	694
NAVARRA, COMUNIDAD FORAL DE	Group 1900 Injuries and poisoning  800-999	Both sexes	5.595
NAVARRA, COMUNIDAD FORAL DE	Group 1900 Injuries and poisoning  800-999	Men	2.978
NAVARRA, COMUNIDAD FORAL DE	Group 1900 Injuries and poisoning  800-999	Women	2.617
NAVARRA, COMUNIDAD FORAL DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	331
NAVARRA, COMUNIDAD FORAL DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	202
NAVARRA, COMUNIDAD FORAL DE	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	129
NAVARRA, COMUNIDAD FORAL DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	170
NAVARRA, COMUNIDAD FORAL DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	125
NAVARRA, COMUNIDAD FORAL DE	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	45
NAVARRA, COMUNIDAD FORAL DE	Group 1903 Radius and ulna fracture 813	Both sexes	392
NAVARRA, COMUNIDAD FORAL DE	Group 1903 Radius and ulna fracture 813	Men	182
NAVARRA, COMUNIDAD FORAL DE	Group 1903 Radius and ulna fracture 813	Women	210
NAVARRA, COMUNIDAD FORAL DE	Group 1904 Femur fracture  820-821	Both sexes	914
NAVARRA, COMUNIDAD FORAL DE	Group 1904 Femur fracture  820-821	Men	273
NAVARRA, COMUNIDAD FORAL DE	Group 1904 Femur fracture  820-821	Women	641
NAVARRA, COMUNIDAD FORAL DE	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	382
NAVARRA, COMUNIDAD FORAL DE	Group 1905 Leg fracture, including the ankle 823-824	Men	187
NAVARRA, COMUNIDAD FORAL DE	Group 1905 Leg fracture, including the ankle 823-824	Women	195
NAVARRA, COMUNIDAD FORAL DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.618
NAVARRA, COMUNIDAD FORAL DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.019
NAVARRA, COMUNIDAD FORAL DE	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	599
NAVARRA, COMUNIDAD FORAL DE	Group 1907 Burns  940-949	Both sexes	27
NAVARRA, COMUNIDAD FORAL DE	Group 1907 Burns  940-949	Men	16
NAVARRA, COMUNIDAD FORAL DE	Group 1907 Burns  940-949	Women	11
NAVARRA, COMUNIDAD FORAL DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	102
NAVARRA, COMUNIDAD FORAL DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	46
NAVARRA, COMUNIDAD FORAL DE	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	56
NAVARRA, COMUNIDAD FORAL DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.509
NAVARRA, COMUNIDAD FORAL DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	862
NAVARRA, COMUNIDAD FORAL DE	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	647
NAVARRA, COMUNIDAD FORAL DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	10
NAVARRA, COMUNIDAD FORAL DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	8
NAVARRA, COMUNIDAD FORAL DE	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	2
NAVARRA, COMUNIDAD FORAL DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	140
NAVARRA, COMUNIDAD FORAL DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	58
NAVARRA, COMUNIDAD FORAL DE	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	82
NAVARRA, COMUNIDAD FORAL DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	1.803
NAVARRA, COMUNIDAD FORAL DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.001
NAVARRA, COMUNIDAD FORAL DE	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	802
NAVARRA, COMUNIDAD FORAL DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	82
NAVARRA, COMUNIDAD FORAL DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	44
NAVARRA, COMUNIDAD FORAL DE	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	38
NAVARRA, COMUNIDAD FORAL DE	Group 2102 Contraceptive management  V25	Both sexes	20
NAVARRA, COMUNIDAD FORAL DE	Group 2102 Contraceptive management  V25	Men	3
NAVARRA, COMUNIDAD FORAL DE	Group 2102 Contraceptive management  V25	Women	17
NAVARRA, COMUNIDAD FORAL DE	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
NAVARRA, COMUNIDAD FORAL DE	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
NAVARRA, COMUNIDAD FORAL DE	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
NAVARRA, COMUNIDAD FORAL DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	923
NAVARRA, COMUNIDAD FORAL DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	577
NAVARRA, COMUNIDAD FORAL DE	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	346
NAVARRA, COMUNIDAD FORAL DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	778
NAVARRA, COMUNIDAD FORAL DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	377
NAVARRA, COMUNIDAD FORAL DE	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	401
PA═S VASCO	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	245.801
PA═S VASCO	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	122.094
PA═S VASCO	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	123.706
PA═S VASCO	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	4.549
PA═S VASCO	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	2.611
PA═S VASCO	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	1.938
PA═S VASCO	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	562
PA═S VASCO	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	295
PA═S VASCO	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	267
PA═S VASCO	Group 0102 Imprecise intestinal infections 009	Both sexes	266
PA═S VASCO	Group 0102 Imprecise intestinal infections 009	Men	142
PA═S VASCO	Group 0102 Imprecise intestinal infections 009	Women	123
PA═S VASCO	Group 0103 Tuberculosis 010-018, 137	Both sexes	187
PA═S VASCO	Group 0103 Tuberculosis 010-018, 137	Men	118
PA═S VASCO	Group 0103 Tuberculosis 010-018, 137	Women	69
PA═S VASCO	Group 0104 Septicaemia  038	Both sexes	1.942
PA═S VASCO	Group 0104 Septicaemia  038	Men	1.111
PA═S VASCO	Group 0104 Septicaemia  038	Women	831
PA═S VASCO	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	221
PA═S VASCO	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	145
PA═S VASCO	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	75
PA═S VASCO	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	1.371
PA═S VASCO	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	798
PA═S VASCO	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	573
PA═S VASCO	Group 0200 Neoplasms  140-239	Both sexes	24.210
PA═S VASCO	Group 0200 Neoplasms  140-239	Men	13.165
PA═S VASCO	Group 0200 Neoplasms  140-239	Women	11.045
PA═S VASCO	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	2.635
PA═S VASCO	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	1.621
PA═S VASCO	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	1.014
PA═S VASCO	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	1.715
PA═S VASCO	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	1.318
PA═S VASCO	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	397
PA═S VASCO	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	433
PA═S VASCO	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	224
PA═S VASCO	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	209
PA═S VASCO	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	1.650
PA═S VASCO	Group 0204 Malignant neoplasm of breast  174-175	Men	13
PA═S VASCO	Group 0204 Malignant neoplasm of breast  174-175	Women	1.637
PA═S VASCO	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	431
PA═S VASCO	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
PA═S VASCO	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	431
PA═S VASCO	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	234
PA═S VASCO	Group 0206 Malignant neoplasm of ovary  1830	Men	..
PA═S VASCO	Group 0206 Malignant neoplasm of ovary  1830	Women	234
PA═S VASCO	Group 0207 Malignant neoplasm of prostate  185	Both sexes	1.376
PA═S VASCO	Group 0207 Malignant neoplasm of prostate  185	Men	1.376
PA═S VASCO	Group 0207 Malignant neoplasm of prostate  185	Women	..
PA═S VASCO	Group 0208 Malignant neoplasm of bladder  188	Both sexes	2.125
PA═S VASCO	Group 0208 Malignant neoplasm of bladder  188	Men	1.733
PA═S VASCO	Group 0208 Malignant neoplasm of bladder  188	Women	392
PA═S VASCO	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	8.856
PA═S VASCO	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	5.242
PA═S VASCO	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	3.614
PA═S VASCO	Group 0210 Carcinoma in situ  230-234	Both sexes	335
PA═S VASCO	Group 0210 Carcinoma in situ  230-234	Men	88
PA═S VASCO	Group 0210 Carcinoma in situ  230-234	Women	247
PA═S VASCO	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	436
PA═S VASCO	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	280
PA═S VASCO	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	155
PA═S VASCO	Grupo 0212 Leiomyoma of uterus  218	Both sexes	945
PA═S VASCO	Grupo 0212 Leiomyoma of uterus  218	Men	..
PA═S VASCO	Grupo 0212 Leiomyoma of uterus  218	Women	945
PA═S VASCO	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	3.040
PA═S VASCO	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	1.270
PA═S VASCO	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	1.770
PA═S VASCO	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	2.704
PA═S VASCO	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	1.390
PA═S VASCO	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	1.314
PA═S VASCO	Group 0301 Anaemias 280-285	Both sexes	1.789
PA═S VASCO	Group 0301 Anaemias 280-285	Men	897
PA═S VASCO	Group 0301 Anaemias 280-285	Women	892
PA═S VASCO	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	915
PA═S VASCO	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	493
PA═S VASCO	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	422
PA═S VASCO	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	4.295
PA═S VASCO	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	1.716
PA═S VASCO	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	2.579
PA═S VASCO	Group 0401 Diabetes mellitus  249-250	Both sexes	1.402
PA═S VASCO	Group 0401 Diabetes mellitus  249-250	Men	827
PA═S VASCO	Group 0401 Diabetes mellitus  249-250	Women	575
PA═S VASCO	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	2.893
PA═S VASCO	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	889
PA═S VASCO	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	2.004
PA═S VASCO	Group 0500 Mental disorders  290-319	Both sexes	7.512
PA═S VASCO	Group 0500 Mental disorders  290-319	Men	4.052
PA═S VASCO	Group 0500 Mental disorders  290-319	Women	3.460
PA═S VASCO	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	139
PA═S VASCO	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	64
PA═S VASCO	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	75
PA═S VASCO	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	627
PA═S VASCO	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	466
PA═S VASCO	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	161
PA═S VASCO	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	513
PA═S VASCO	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	364
PA═S VASCO	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	149
PA═S VASCO	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	2.513
PA═S VASCO	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	1.581
PA═S VASCO	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	932
PA═S VASCO	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.818
PA═S VASCO	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	742
PA═S VASCO	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	1.076
PA═S VASCO	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.901
PA═S VASCO	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	834
PA═S VASCO	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	1.067
PA═S VASCO	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	5.542
PA═S VASCO	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	2.945
PA═S VASCO	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	2.597
PA═S VASCO	Group 0601 Alzheimer's disease  3310	Both sexes	110
PA═S VASCO	Group 0601 Alzheimer's disease  3310	Men	45
PA═S VASCO	Group 0601 Alzheimer's disease  3310	Women	65
PA═S VASCO	Group 0602 Multiple sclerosis 340	Both sexes	53
PA═S VASCO	Group 0602 Multiple sclerosis 340	Men	23
PA═S VASCO	Group 0602 Multiple sclerosis 340	Women	30
PA═S VASCO	Group 0603 Epilepsy  345	Both sexes	892
PA═S VASCO	Group 0603 Epilepsy  345	Men	468
PA═S VASCO	Group 0603 Epilepsy  345	Women	424
PA═S VASCO	Group 0604 Transient cerebral ischemia 435	Both sexes	780
PA═S VASCO	Group 0604 Transient cerebral ischemia 435	Men	391
PA═S VASCO	Group 0604 Transient cerebral ischemia 435	Women	389
PA═S VASCO	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	3.707
PA═S VASCO	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	2.018
PA═S VASCO	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	1.689
PA═S VASCO	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	769
PA═S VASCO	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	378
PA═S VASCO	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	391
PA═S VASCO	Grupo 0701 Cataract  366	Both sexes	71
PA═S VASCO	Grupo 0701 Cataract  366	Men	33
PA═S VASCO	Grupo 0701 Cataract  366	Women	38
PA═S VASCO	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	698
PA═S VASCO	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	345
PA═S VASCO	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	353
PA═S VASCO	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	1.233
PA═S VASCO	Group 0800 Diseases of the ear and the mastoid  380-389	Men	623
PA═S VASCO	Group 0800 Diseases of the ear and the mastoid  380-389	Women	610
PA═S VASCO	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	32.299
PA═S VASCO	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	18.449
PA═S VASCO	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	13.850
PA═S VASCO	Group 0901 Hypertensive disease  401-405	Both sexes	1.670
PA═S VASCO	Group 0901 Hypertensive disease  401-405	Men	753
PA═S VASCO	Group 0901 Hypertensive disease  401-405	Women	917
PA═S VASCO	Group 0902 Angina pectoris  4111, 413	Both sexes	730
PA═S VASCO	Group 0902 Angina pectoris  4111, 413	Men	451
PA═S VASCO	Group 0902 Angina pectoris  4111, 413	Women	279
PA═S VASCO	Group 0903 Acute myocardial infarction  410	Both sexes	1.957
PA═S VASCO	Group 0903 Acute myocardial infarction  410	Men	1.393
PA═S VASCO	Group 0903 Acute myocardial infarction  410	Women	563
PA═S VASCO	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	2.293
PA═S VASCO	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.776
PA═S VASCO	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	517
PA═S VASCO	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	1.143
PA═S VASCO	Group 0905 Diseases of the lungs circulation 415-417	Men	520
PA═S VASCO	Group 0905 Diseases of the lungs circulation 415-417	Women	623
PA═S VASCO	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	4.826
PA═S VASCO	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	2.729
PA═S VASCO	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	2.097
PA═S VASCO	Grupo 0907 Heart failure  428	Both sexes	6.278
PA═S VASCO	Grupo 0907 Heart failure  428	Men	3.244
PA═S VASCO	Grupo 0907 Heart failure  428	Women	3.034
PA═S VASCO	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	5.323
PA═S VASCO	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	2.857
PA═S VASCO	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	2.465
PA═S VASCO	Grupo 0909 Atherosclerosis  440	Both sexes	1.586
PA═S VASCO	Grupo 0909 Atherosclerosis  440	Men	1.205
PA═S VASCO	Grupo 0909 Atherosclerosis  440	Women	382
PA═S VASCO	Group 0910 Varicose veins of lower extremities 454	Both sexes	1.203
PA═S VASCO	Group 0910 Varicose veins of lower extremities 454	Men	459
PA═S VASCO	Group 0910 Varicose veins of lower extremities 454	Women	744
PA═S VASCO	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	5.291
PA═S VASCO	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	3.063
PA═S VASCO	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	2.228
PA═S VASCO	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	27.612
PA═S VASCO	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	15.911
PA═S VASCO	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	11.701
PA═S VASCO	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	1.238
PA═S VASCO	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	647
PA═S VASCO	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	590
PA═S VASCO	Group 1002 Pneumonia 480-486	Both sexes	5.755
PA═S VASCO	Group 1002 Pneumonia 480-486	Men	3.492
PA═S VASCO	Group 1002 Pneumonia 480-486	Women	2.263
PA═S VASCO	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	2.692
PA═S VASCO	Group 1003 Acute bronchitis and bronchiolitis  466	Men	1.228
PA═S VASCO	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.465
PA═S VASCO	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1.423
PA═S VASCO	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	751
PA═S VASCO	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	672
PA═S VASCO	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	2.265
PA═S VASCO	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	1.443
PA═S VASCO	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	822
PA═S VASCO	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	5.030
PA═S VASCO	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	3.780
PA═S VASCO	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	1.250
PA═S VASCO	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	1.748
PA═S VASCO	Group 1007 Asthma 4930-4931,4938-4939	Men	587
PA═S VASCO	Group 1007 Asthma 4930-4931,4938-4939	Women	1.160
PA═S VASCO	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	7.462
PA═S VASCO	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	3.983
PA═S VASCO	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	3.479
PA═S VASCO	Group 1100 Diseases of the digestive system  520-579	Both sexes	30.437
PA═S VASCO	Group 1100 Diseases of the digestive system  520-579	Men	17.489
PA═S VASCO	Group 1100 Diseases of the digestive system  520-579	Women	12.948
PA═S VASCO	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	425
PA═S VASCO	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	230
PA═S VASCO	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	194
PA═S VASCO	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	421
PA═S VASCO	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	241
PA═S VASCO	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	179
PA═S VASCO	Group 1103 Diseases of the esophagus 530	Both sexes	615
PA═S VASCO	Group 1103 Diseases of the esophagus 530	Men	399
PA═S VASCO	Group 1103 Diseases of the esophagus 530	Women	216
PA═S VASCO	Group 1104 Peptic ulcer 531-534	Both sexes	623
PA═S VASCO	Group 1104 Peptic ulcer 531-534	Men	445
PA═S VASCO	Group 1104 Peptic ulcer 531-534	Women	177
PA═S VASCO	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	594
PA═S VASCO	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	302
PA═S VASCO	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	293
PA═S VASCO	Group 1106 Appendicitis  540-543	Both sexes	2.534
PA═S VASCO	Group 1106 Appendicitis  540-543	Men	1.395
PA═S VASCO	Group 1106 Appendicitis  540-543	Women	1.139
PA═S VASCO	Group 1107 Inguinal hernia  550	Both sexes	3.794
PA═S VASCO	Group 1107 Inguinal hernia  550	Men	3.377
PA═S VASCO	Group 1107 Inguinal hernia  550	Women	417
PA═S VASCO	Group 1108 Other abdominal hernia  551-553	Both sexes	2.652
PA═S VASCO	Group 1108 Other abdominal hernia  551-553	Men	1.332
PA═S VASCO	Group 1108 Other abdominal hernia  551-553	Women	1.320
PA═S VASCO	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	607
PA═S VASCO	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	323
PA═S VASCO	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	285
PA═S VASCO	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	1.301
PA═S VASCO	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	616
PA═S VASCO	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	685
PA═S VASCO	Group 1111 Intestinal obstruction without hernia 560	Both sexes	1.724
PA═S VASCO	Group 1111 Intestinal obstruction without hernia 560	Men	906
PA═S VASCO	Group 1111 Intestinal obstruction without hernia 560	Women	818
PA═S VASCO	Group 1112 Intestinal diverticulosis 562	Both sexes	1.439
PA═S VASCO	Group 1112 Intestinal diverticulosis 562	Men	661
PA═S VASCO	Group 1112 Intestinal diverticulosis 562	Women	778
PA═S VASCO	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	2.065
PA═S VASCO	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	1.341
PA═S VASCO	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	724
PA═S VASCO	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	1.114
PA═S VASCO	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	482
PA═S VASCO	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	632
PA═S VASCO	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	547
PA═S VASCO	Group 1115 Alcoholic hepatitis 5710-5713	Men	440
PA═S VASCO	Group 1115 Alcoholic hepatitis 5710-5713	Women	107
PA═S VASCO	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	1.055
PA═S VASCO	Group 1116 Other diseases of the liver 570,5714-573	Men	652
PA═S VASCO	Group 1116 Other diseases of the liver 570,5714-573	Women	403
PA═S VASCO	Group 1117 Cholelithiasis  574	Both sexes	5.019
PA═S VASCO	Group 1117 Cholelithiasis  574	Men	2.136
PA═S VASCO	Group 1117 Cholelithiasis  574	Women	2.883
PA═S VASCO	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	1.320
PA═S VASCO	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	739
PA═S VASCO	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	581
PA═S VASCO	Group 1119 Pancreatic diseases 577	Both sexes	1.255
PA═S VASCO	Group 1119 Pancreatic diseases 577	Men	727
PA═S VASCO	Group 1119 Pancreatic diseases 577	Women	528
PA═S VASCO	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	1.332
PA═S VASCO	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	744
PA═S VASCO	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	587
PA═S VASCO	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	2.700
PA═S VASCO	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	1.481
PA═S VASCO	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	1.219
PA═S VASCO	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	1.889
PA═S VASCO	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	1.102
PA═S VASCO	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	786
PA═S VASCO	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	111
PA═S VASCO	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	59
PA═S VASCO	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	52
PA═S VASCO	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	700
PA═S VASCO	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	320
PA═S VASCO	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	381
PA═S VASCO	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	20.220
PA═S VASCO	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	10.128
PA═S VASCO	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	10.092
PA═S VASCO	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
PA═S VASCO	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
PA═S VASCO	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
PA═S VASCO	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
PA═S VASCO	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
PA═S VASCO	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
PA═S VASCO	Group 1303 Internal derangement of knee 717	Both sexes	3.158
PA═S VASCO	Group 1303 Internal derangement of knee 717	Men	2.161
PA═S VASCO	Group 1303 Internal derangement of knee 717	Women	997
PA═S VASCO	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	7.718
PA═S VASCO	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	3.600
PA═S VASCO	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	4.118
PA═S VASCO	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	278
PA═S VASCO	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	107
PA═S VASCO	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	170
PA═S VASCO	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	1.100
PA═S VASCO	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	538
PA═S VASCO	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	562
PA═S VASCO	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	1.452
PA═S VASCO	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	773
PA═S VASCO	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	678
PA═S VASCO	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	603
PA═S VASCO	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	269
PA═S VASCO	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	333
PA═S VASCO	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	2.957
PA═S VASCO	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	1.655
PA═S VASCO	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	1.302
PA═S VASCO	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	2.955
PA═S VASCO	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	1.024
PA═S VASCO	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	1.931
PA═S VASCO	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	16.110
PA═S VASCO	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	7.849
PA═S VASCO	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	8.261
PA═S VASCO	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	1.484
PA═S VASCO	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	540
PA═S VASCO	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	944
PA═S VASCO	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	1.292
PA═S VASCO	Group 1402 Renal failure  5836-5837, 584-586	Men	791
PA═S VASCO	Group 1402 Renal failure  5836-5837, 584-586	Women	501
PA═S VASCO	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	2.286
PA═S VASCO	Group 1403 Urolithiasis  592, 594, 7880	Men	1.384
PA═S VASCO	Group 1403 Urolithiasis  592, 594, 7880	Women	902
PA═S VASCO	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	4.620
PA═S VASCO	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	2.387
PA═S VASCO	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	2.233
PA═S VASCO	Group 1405 Prostatic hyperplasia  600	Both sexes	1.585
PA═S VASCO	Group 1405 Prostatic hyperplasia  600	Men	1.585
PA═S VASCO	Group 1405 Prostatic hyperplasia  600	Women	..
PA═S VASCO	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	991
PA═S VASCO	Group 1406 Other diseases of the male genital organs    601-608	Men	991
PA═S VASCO	Group 1406 Other diseases of the male genital organs    601-608	Women	..
PA═S VASCO	Group 1407 Disorders of breast  610-612	Both sexes	1.220
PA═S VASCO	Group 1407 Disorders of breast  610-612	Men	89
PA═S VASCO	Group 1407 Disorders of breast  610-612	Women	1.131
PA═S VASCO	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	391
PA═S VASCO	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
PA═S VASCO	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	391
PA═S VASCO	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	100
PA═S VASCO	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
PA═S VASCO	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	100
PA═S VASCO	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	2.140
PA═S VASCO	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	81
PA═S VASCO	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	2.059
PA═S VASCO	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	21.145
PA═S VASCO	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
PA═S VASCO	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	21.145
PA═S VASCO	Group 1501 Legally induced abortion  635	Both sexes	184
PA═S VASCO	Group 1501 Legally induced abortion  635	Men	..
PA═S VASCO	Group 1501 Legally induced abortion  635	Women	184
PA═S VASCO	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	538
PA═S VASCO	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
PA═S VASCO	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	538
PA═S VASCO	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	12.993
PA═S VASCO	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
PA═S VASCO	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	12.993
PA═S VASCO	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	3.581
PA═S VASCO	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
PA═S VASCO	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	3.581
PA═S VASCO	Group 1505 Single spontaneous delivery  650	Both sexes	1.866
PA═S VASCO	Group 1505 Single spontaneous delivery  650	Men	..
PA═S VASCO	Group 1505 Single spontaneous delivery  650	Women	1.866
PA═S VASCO	Group 1506 Other deliveries  6695-6697	Both sexes	394
PA═S VASCO	Group 1506 Other deliveries  6695-6697	Men	..
PA═S VASCO	Group 1506 Other deliveries  6695-6697	Women	394
PA═S VASCO	Group 1507 Complications related to the puerperium  670-676	Both sexes	160
PA═S VASCO	Group 1507 Complications related to the puerperium  670-676	Men	..
PA═S VASCO	Group 1507 Complications related to the puerperium  670-676	Women	160
PA═S VASCO	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	1.430
PA═S VASCO	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
PA═S VASCO	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	1.430
PA═S VASCO	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	2.381
PA═S VASCO	Group 1600 Some disorders originating in the perinatal period  760-779	Men	1.298
PA═S VASCO	Group 1600 Some disorders originating in the perinatal period  760-779	Women	1.083
PA═S VASCO	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	659
PA═S VASCO	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	333
PA═S VASCO	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	326
PA═S VASCO	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	1.722
PA═S VASCO	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	965
PA═S VASCO	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	758
PA═S VASCO	Grupo 1700 Congenital abnormalities  740-759	Both sexes	1.354
PA═S VASCO	Grupo 1700 Congenital abnormalities  740-759	Men	752
PA═S VASCO	Grupo 1700 Congenital abnormalities  740-759	Women	602
PA═S VASCO	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	13.691
PA═S VASCO	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	7.660
PA═S VASCO	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	6.031
PA═S VASCO	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2.632
PA═S VASCO	Group 1801 Pain in throat and chest 7841, 7865	Men	1.539
PA═S VASCO	Group 1801 Pain in throat and chest 7841, 7865	Women	1.094
PA═S VASCO	Group 1802 Abdominal pain   7890	Both sexes	1.489
PA═S VASCO	Group 1802 Abdominal pain   7890	Men	656
PA═S VASCO	Group 1802 Abdominal pain   7890	Women	833
PA═S VASCO	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	440
PA═S VASCO	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	230
PA═S VASCO	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	210
PA═S VASCO	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	9.130
PA═S VASCO	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	5.235
PA═S VASCO	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	3.895
PA═S VASCO	Group 1900 Injuries and poisoning  800-999	Both sexes	20.949
PA═S VASCO	Group 1900 Injuries and poisoning  800-999	Men	11.059
PA═S VASCO	Group 1900 Injuries and poisoning  800-999	Women	9.890
PA═S VASCO	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	1.182
PA═S VASCO	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	679
PA═S VASCO	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	503
PA═S VASCO	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	511
PA═S VASCO	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	352
PA═S VASCO	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	159
PA═S VASCO	Group 1903 Radius and ulna fracture 813	Both sexes	1.413
PA═S VASCO	Group 1903 Radius and ulna fracture 813	Men	587
PA═S VASCO	Group 1903 Radius and ulna fracture 813	Women	826
PA═S VASCO	Group 1904 Femur fracture  820-821	Both sexes	2.946
PA═S VASCO	Group 1904 Femur fracture  820-821	Men	782
PA═S VASCO	Group 1904 Femur fracture  820-821	Women	2.164
PA═S VASCO	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	1.433
PA═S VASCO	Group 1905 Leg fracture, including the ankle 823-824	Men	723
PA═S VASCO	Group 1905 Leg fracture, including the ankle 823-824	Women	710
PA═S VASCO	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	6.269
PA═S VASCO	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	3.936
PA═S VASCO	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	2.333
PA═S VASCO	Group 1907 Burns  940-949	Both sexes	132
PA═S VASCO	Group 1907 Burns  940-949	Men	93
PA═S VASCO	Group 1907 Burns  940-949	Women	39
PA═S VASCO	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	510
PA═S VASCO	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	218
PA═S VASCO	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	291
PA═S VASCO	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	5.728
PA═S VASCO	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	3.267
PA═S VASCO	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	2.461
PA═S VASCO	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	86
PA═S VASCO	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	52
PA═S VASCO	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	34
PA═S VASCO	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	738
PA═S VASCO	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	369
PA═S VASCO	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	370
PA═S VASCO	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	6.087
PA═S VASCO	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	3.139
PA═S VASCO	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	2.948
PA═S VASCO	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	254
PA═S VASCO	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	147
PA═S VASCO	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	106
PA═S VASCO	Group 2102 Contraceptive management  V25	Both sexes	82
PA═S VASCO	Group 2102 Contraceptive management  V25	Men	1
PA═S VASCO	Group 2102 Contraceptive management  V25	Women	81
PA═S VASCO	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
PA═S VASCO	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
PA═S VASCO	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
PA═S VASCO	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	1.772
PA═S VASCO	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	1.142
PA═S VASCO	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	629
PA═S VASCO	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	3.979
PA═S VASCO	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	1.848
PA═S VASCO	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	2.131
Araba/┴lava	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	36.481
Araba/┴lava	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.514
Araba/┴lava	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	17.967
Araba/┴lava	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	568
Araba/┴lava	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	331
Araba/┴lava	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	237
Araba/┴lava	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	77
Araba/┴lava	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	39
Araba/┴lava	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	38
Araba/┴lava	Group 0102 Imprecise intestinal infections 009	Both sexes	21
Araba/┴lava	Group 0102 Imprecise intestinal infections 009	Men	14
Araba/┴lava	Group 0102 Imprecise intestinal infections 009	Women	7
Araba/┴lava	Group 0103 Tuberculosis 010-018, 137	Both sexes	25
Araba/┴lava	Group 0103 Tuberculosis 010-018, 137	Men	10
Araba/┴lava	Group 0103 Tuberculosis 010-018, 137	Women	15
Araba/┴lava	Group 0104 Septicaemia  038	Both sexes	234
Araba/┴lava	Group 0104 Septicaemia  038	Men	143
Araba/┴lava	Group 0104 Septicaemia  038	Women	91
Araba/┴lava	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	18
Araba/┴lava	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	11
Araba/┴lava	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	7
Araba/┴lava	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	193
Araba/┴lava	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	114
Araba/┴lava	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	79
Araba/┴lava	Group 0200 Neoplasms  140-239	Both sexes	3.123
Araba/┴lava	Group 0200 Neoplasms  140-239	Men	1.782
Araba/┴lava	Group 0200 Neoplasms  140-239	Women	1.341
Araba/┴lava	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	313
Araba/┴lava	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	192
Araba/┴lava	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	121
Araba/┴lava	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	155
Araba/┴lava	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	136
Araba/┴lava	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	19
Araba/┴lava	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	26
Araba/┴lava	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	8
Araba/┴lava	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	18
Araba/┴lava	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	219
Araba/┴lava	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Araba/┴lava	Group 0204 Malignant neoplasm of breast  174-175	Women	219
Araba/┴lava	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	36
Araba/┴lava	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Araba/┴lava	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	36
Araba/┴lava	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	31
Araba/┴lava	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Araba/┴lava	Group 0206 Malignant neoplasm of ovary  1830	Women	31
Araba/┴lava	Group 0207 Malignant neoplasm of prostate  185	Both sexes	233
Araba/┴lava	Group 0207 Malignant neoplasm of prostate  185	Men	233
Araba/┴lava	Group 0207 Malignant neoplasm of prostate  185	Women	..
Araba/┴lava	Group 0208 Malignant neoplasm of bladder  188	Both sexes	362
Araba/┴lava	Group 0208 Malignant neoplasm of bladder  188	Men	307
Araba/┴lava	Group 0208 Malignant neoplasm of bladder  188	Women	55
Araba/┴lava	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.106
Araba/┴lava	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	631
Araba/┴lava	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	475
Araba/┴lava	Group 0210 Carcinoma in situ  230-234	Both sexes	35
Araba/┴lava	Group 0210 Carcinoma in situ  230-234	Men	18
Araba/┴lava	Group 0210 Carcinoma in situ  230-234	Women	17
Araba/┴lava	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	88
Araba/┴lava	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	58
Araba/┴lava	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	30
Araba/┴lava	Grupo 0212 Leiomyoma of uterus  218	Both sexes	92
Araba/┴lava	Grupo 0212 Leiomyoma of uterus  218	Men	..
Araba/┴lava	Grupo 0212 Leiomyoma of uterus  218	Women	92
Araba/┴lava	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	427
Araba/┴lava	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	199
Araba/┴lava	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	228
Araba/┴lava	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	496
Araba/┴lava	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	237
Araba/┴lava	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	259
Araba/┴lava	Group 0301 Anaemias 280-285	Both sexes	275
Araba/┴lava	Group 0301 Anaemias 280-285	Men	141
Araba/┴lava	Group 0301 Anaemias 280-285	Women	134
Araba/┴lava	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	221
Araba/┴lava	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	96
Araba/┴lava	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	125
Araba/┴lava	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	727
Araba/┴lava	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	283
Araba/┴lava	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	444
Araba/┴lava	Group 0401 Diabetes mellitus  249-250	Both sexes	237
Araba/┴lava	Group 0401 Diabetes mellitus  249-250	Men	142
Araba/┴lava	Group 0401 Diabetes mellitus  249-250	Women	95
Araba/┴lava	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	490
Araba/┴lava	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	141
Araba/┴lava	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	349
Araba/┴lava	Group 0500 Mental disorders  290-319	Both sexes	935
Araba/┴lava	Group 0500 Mental disorders  290-319	Men	520
Araba/┴lava	Group 0500 Mental disorders  290-319	Women	415
Araba/┴lava	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	17
Araba/┴lava	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	9
Araba/┴lava	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	8
Araba/┴lava	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	76
Araba/┴lava	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	57
Araba/┴lava	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	19
Araba/┴lava	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	42
Araba/┴lava	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	28
Araba/┴lava	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	14
Araba/┴lava	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	312
Araba/┴lava	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	220
Araba/┴lava	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	92
Araba/┴lava	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	205
Araba/┴lava	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	88
Araba/┴lava	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	117
Araba/┴lava	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	283
Araba/┴lava	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	118
Araba/┴lava	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	165
Araba/┴lava	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	941
Araba/┴lava	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	492
Araba/┴lava	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	449
Araba/┴lava	Group 0601 Alzheimer's disease  3310	Both sexes	27
Araba/┴lava	Group 0601 Alzheimer's disease  3310	Men	11
Araba/┴lava	Group 0601 Alzheimer's disease  3310	Women	16
Araba/┴lava	Group 0602 Multiple sclerosis 340	Both sexes	15
Araba/┴lava	Group 0602 Multiple sclerosis 340	Men	4
Araba/┴lava	Group 0602 Multiple sclerosis 340	Women	11
Araba/┴lava	Group 0603 Epilepsy  345	Both sexes	214
Araba/┴lava	Group 0603 Epilepsy  345	Men	117
Araba/┴lava	Group 0603 Epilepsy  345	Women	97
Araba/┴lava	Group 0604 Transient cerebral ischemia 435	Both sexes	136
Araba/┴lava	Group 0604 Transient cerebral ischemia 435	Men	72
Araba/┴lava	Group 0604 Transient cerebral ischemia 435	Women	64
Araba/┴lava	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	549
Araba/┴lava	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	288
Araba/┴lava	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	261
Araba/┴lava	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	101
Araba/┴lava	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	56
Araba/┴lava	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	45
Araba/┴lava	Grupo 0701 Cataract  366	Both sexes	8
Araba/┴lava	Grupo 0701 Cataract  366	Men	4
Araba/┴lava	Grupo 0701 Cataract  366	Women	4
Araba/┴lava	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	93
Araba/┴lava	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	52
Araba/┴lava	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	41
Araba/┴lava	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	174
Araba/┴lava	Group 0800 Diseases of the ear and the mastoid  380-389	Men	81
Araba/┴lava	Group 0800 Diseases of the ear and the mastoid  380-389	Women	93
Araba/┴lava	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	4.542
Araba/┴lava	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.615
Araba/┴lava	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	1.927
Araba/┴lava	Group 0901 Hypertensive disease  401-405	Both sexes	290
Araba/┴lava	Group 0901 Hypertensive disease  401-405	Men	133
Araba/┴lava	Group 0901 Hypertensive disease  401-405	Women	157
Araba/┴lava	Group 0902 Angina pectoris  4111, 413	Both sexes	120
Araba/┴lava	Group 0902 Angina pectoris  4111, 413	Men	83
Araba/┴lava	Group 0902 Angina pectoris  4111, 413	Women	37
Araba/┴lava	Group 0903 Acute myocardial infarction  410	Both sexes	374
Araba/┴lava	Group 0903 Acute myocardial infarction  410	Men	262
Araba/┴lava	Group 0903 Acute myocardial infarction  410	Women	112
Araba/┴lava	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	199
Araba/┴lava	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	155
Araba/┴lava	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	44
Araba/┴lava	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	179
Araba/┴lava	Group 0905 Diseases of the lungs circulation 415-417	Men	79
Araba/┴lava	Group 0905 Diseases of the lungs circulation 415-417	Women	100
Araba/┴lava	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	663
Araba/┴lava	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	378
Araba/┴lava	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	285
Araba/┴lava	Grupo 0907 Heart failure  428	Both sexes	793
Araba/┴lava	Grupo 0907 Heart failure  428	Men	425
Araba/┴lava	Grupo 0907 Heart failure  428	Women	368
Araba/┴lava	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	702
Araba/┴lava	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	411
Araba/┴lava	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	291
Araba/┴lava	Grupo 0909 Atherosclerosis  440	Both sexes	242
Araba/┴lava	Grupo 0909 Atherosclerosis  440	Men	193
Araba/┴lava	Grupo 0909 Atherosclerosis  440	Women	49
Araba/┴lava	Group 0910 Varicose veins of lower extremities 454	Both sexes	252
Araba/┴lava	Group 0910 Varicose veins of lower extremities 454	Men	84
Araba/┴lava	Group 0910 Varicose veins of lower extremities 454	Women	168
Araba/┴lava	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	728
Araba/┴lava	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	412
Araba/┴lava	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	316
Araba/┴lava	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	3.968
Araba/┴lava	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.354
Araba/┴lava	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	1.614
Araba/┴lava	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	163
Araba/┴lava	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	71
Araba/┴lava	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	92
Araba/┴lava	Group 1002 Pneumonia 480-486	Both sexes	886
Araba/┴lava	Group 1002 Pneumonia 480-486	Men	561
Araba/┴lava	Group 1002 Pneumonia 480-486	Women	325
Araba/┴lava	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	539
Araba/┴lava	Group 1003 Acute bronchitis and bronchiolitis  466	Men	272
Araba/┴lava	Group 1003 Acute bronchitis and bronchiolitis  466	Women	267
Araba/┴lava	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	155
Araba/┴lava	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	87
Araba/┴lava	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	68
Araba/┴lava	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	291
Araba/┴lava	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	193
Araba/┴lava	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	98
Araba/┴lava	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	744
Araba/┴lava	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	566
Araba/┴lava	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	178
Araba/┴lava	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	257
Araba/┴lava	Group 1007 Asthma 4930-4931,4938-4939	Men	78
Araba/┴lava	Group 1007 Asthma 4930-4931,4938-4939	Women	179
Araba/┴lava	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	933
Araba/┴lava	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	526
Araba/┴lava	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	407
Araba/┴lava	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.490
Araba/┴lava	Group 1100 Diseases of the digestive system  520-579	Men	2.612
Araba/┴lava	Group 1100 Diseases of the digestive system  520-579	Women	1.878
Araba/┴lava	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	76
Araba/┴lava	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	47
Araba/┴lava	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	29
Araba/┴lava	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	54
Araba/┴lava	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	29
Araba/┴lava	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	25
Araba/┴lava	Group 1103 Diseases of the esophagus 530	Both sexes	138
Araba/┴lava	Group 1103 Diseases of the esophagus 530	Men	94
Araba/┴lava	Group 1103 Diseases of the esophagus 530	Women	44
Araba/┴lava	Group 1104 Peptic ulcer 531-534	Both sexes	88
Araba/┴lava	Group 1104 Peptic ulcer 531-534	Men	59
Araba/┴lava	Group 1104 Peptic ulcer 531-534	Women	29
Araba/┴lava	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	115
Araba/┴lava	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	55
Araba/┴lava	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	60
Araba/┴lava	Group 1106 Appendicitis  540-543	Both sexes	287
Araba/┴lava	Group 1106 Appendicitis  540-543	Men	158
Araba/┴lava	Group 1106 Appendicitis  540-543	Women	129
Araba/┴lava	Group 1107 Inguinal hernia  550	Both sexes	551
Araba/┴lava	Group 1107 Inguinal hernia  550	Men	489
Araba/┴lava	Group 1107 Inguinal hernia  550	Women	62
Araba/┴lava	Group 1108 Other abdominal hernia  551-553	Both sexes	409
Araba/┴lava	Group 1108 Other abdominal hernia  551-553	Men	218
Araba/┴lava	Group 1108 Other abdominal hernia  551-553	Women	191
Araba/┴lava	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	94
Araba/┴lava	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	56
Araba/┴lava	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	38
Araba/┴lava	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	257
Araba/┴lava	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	126
Araba/┴lava	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	131
Araba/┴lava	Group 1111 Intestinal obstruction without hernia 560	Both sexes	292
Araba/┴lava	Group 1111 Intestinal obstruction without hernia 560	Men	156
Araba/┴lava	Group 1111 Intestinal obstruction without hernia 560	Women	136
Araba/┴lava	Group 1112 Intestinal diverticulosis 562	Both sexes	173
Araba/┴lava	Group 1112 Intestinal diverticulosis 562	Men	78
Araba/┴lava	Group 1112 Intestinal diverticulosis 562	Women	95
Araba/┴lava	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	269
Araba/┴lava	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	179
Araba/┴lava	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	90
Araba/┴lava	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	143
Araba/┴lava	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	56
Araba/┴lava	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	87
Araba/┴lava	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	70
Araba/┴lava	Group 1115 Alcoholic hepatitis 5710-5713	Men	55
Araba/┴lava	Group 1115 Alcoholic hepatitis 5710-5713	Women	15
Araba/┴lava	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	153
Araba/┴lava	Group 1116 Other diseases of the liver 570,5714-573	Men	90
Araba/┴lava	Group 1116 Other diseases of the liver 570,5714-573	Women	63
Araba/┴lava	Group 1117 Cholelithiasis  574	Both sexes	686
Araba/┴lava	Group 1117 Cholelithiasis  574	Men	309
Araba/┴lava	Group 1117 Cholelithiasis  574	Women	377
Araba/┴lava	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	206
Araba/┴lava	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	114
Araba/┴lava	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	92
Araba/┴lava	Group 1119 Pancreatic diseases 577	Both sexes	156
Araba/┴lava	Group 1119 Pancreatic diseases 577	Men	96
Araba/┴lava	Group 1119 Pancreatic diseases 577	Women	60
Araba/┴lava	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	273
Araba/┴lava	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	148
Araba/┴lava	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	125
Araba/┴lava	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	378
Araba/┴lava	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	206
Araba/┴lava	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	172
Araba/┴lava	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	291
Araba/┴lava	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	162
Araba/┴lava	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	129
Araba/┴lava	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	19
Araba/┴lava	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	9
Araba/┴lava	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	10
Araba/┴lava	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	68
Araba/┴lava	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	35
Araba/┴lava	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	33
Araba/┴lava	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	3.698
Araba/┴lava	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.956
Araba/┴lava	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.742
Araba/┴lava	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Araba/┴lava	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Araba/┴lava	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Araba/┴lava	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Araba/┴lava	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Araba/┴lava	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Araba/┴lava	Group 1303 Internal derangement of knee 717	Both sexes	639
Araba/┴lava	Group 1303 Internal derangement of knee 717	Men	466
Araba/┴lava	Group 1303 Internal derangement of knee 717	Women	173
Araba/┴lava	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	1.316
Araba/┴lava	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	691
Araba/┴lava	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	625
Araba/┴lava	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	27
Araba/┴lava	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	9
Araba/┴lava	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	18
Araba/┴lava	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	188
Araba/┴lava	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	87
Araba/┴lava	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	101
Araba/┴lava	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	233
Araba/┴lava	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	123
Araba/┴lava	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	110
Araba/┴lava	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	137
Araba/┴lava	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	52
Araba/┴lava	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	85
Araba/┴lava	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	568
Araba/┴lava	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	329
Araba/┴lava	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	239
Araba/┴lava	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	590
Araba/┴lava	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	199
Araba/┴lava	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	391
Araba/┴lava	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.576
Araba/┴lava	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.393
Araba/┴lava	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.183
Araba/┴lava	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	217
Araba/┴lava	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	75
Araba/┴lava	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	142
Araba/┴lava	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	194
Araba/┴lava	Group 1402 Renal failure  5836-5837, 584-586	Men	117
Araba/┴lava	Group 1402 Renal failure  5836-5837, 584-586	Women	77
Araba/┴lava	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	445
Araba/┴lava	Group 1403 Urolithiasis  592, 594, 7880	Men	287
Araba/┴lava	Group 1403 Urolithiasis  592, 594, 7880	Women	158
Araba/┴lava	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	815
Araba/┴lava	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	427
Araba/┴lava	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	388
Araba/┴lava	Group 1405 Prostatic hyperplasia  600	Both sexes	302
Araba/┴lava	Group 1405 Prostatic hyperplasia  600	Men	302
Araba/┴lava	Group 1405 Prostatic hyperplasia  600	Women	..
Araba/┴lava	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	171
Araba/┴lava	Group 1406 Other diseases of the male genital organs    601-608	Men	171
Araba/┴lava	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Araba/┴lava	Group 1407 Disorders of breast  610-612	Both sexes	111
Araba/┴lava	Group 1407 Disorders of breast  610-612	Men	11
Araba/┴lava	Group 1407 Disorders of breast  610-612	Women	100
Araba/┴lava	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	39
Araba/┴lava	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Araba/┴lava	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	39
Araba/┴lava	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	16
Araba/┴lava	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Araba/┴lava	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	16
Araba/┴lava	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	266
Araba/┴lava	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
Araba/┴lava	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	263
Araba/┴lava	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.100
Araba/┴lava	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Araba/┴lava	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.100
Araba/┴lava	Group 1501 Legally induced abortion  635	Both sexes	25
Araba/┴lava	Group 1501 Legally induced abortion  635	Men	..
Araba/┴lava	Group 1501 Legally induced abortion  635	Women	25
Araba/┴lava	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	50
Araba/┴lava	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Araba/┴lava	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	50
Araba/┴lava	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	2.102
Araba/┴lava	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Araba/┴lava	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	2.102
Araba/┴lava	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	592
Araba/┴lava	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Araba/┴lava	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	592
Araba/┴lava	Group 1505 Single spontaneous delivery  650	Both sexes	114
Araba/┴lava	Group 1505 Single spontaneous delivery  650	Men	..
Araba/┴lava	Group 1505 Single spontaneous delivery  650	Women	114
Araba/┴lava	Group 1506 Other deliveries  6695-6697	Both sexes	7
Araba/┴lava	Group 1506 Other deliveries  6695-6697	Men	..
Araba/┴lava	Group 1506 Other deliveries  6695-6697	Women	7
Araba/┴lava	Group 1507 Complications related to the puerperium  670-676	Both sexes	1
Araba/┴lava	Group 1507 Complications related to the puerperium  670-676	Men	..
Araba/┴lava	Group 1507 Complications related to the puerperium  670-676	Women	1
Araba/┴lava	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	209
Araba/┴lava	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Araba/┴lava	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	209
Araba/┴lava	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	377
Araba/┴lava	Group 1600 Some disorders originating in the perinatal period  760-779	Men	220
Araba/┴lava	Group 1600 Some disorders originating in the perinatal period  760-779	Women	157
Araba/┴lava	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	91
Araba/┴lava	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	48
Araba/┴lava	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	43
Araba/┴lava	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	286
Araba/┴lava	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	172
Araba/┴lava	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	114
Araba/┴lava	Grupo 1700 Congenital abnormalities  740-759	Both sexes	145
Araba/┴lava	Grupo 1700 Congenital abnormalities  740-759	Men	86
Araba/┴lava	Grupo 1700 Congenital abnormalities  740-759	Women	59
Araba/┴lava	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	2.361
Araba/┴lava	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	1.361
Araba/┴lava	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	1.000
Araba/┴lava	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	294
Araba/┴lava	Group 1801 Pain in throat and chest 7841, 7865	Men	177
Araba/┴lava	Group 1801 Pain in throat and chest 7841, 7865	Women	117
Araba/┴lava	Group 1802 Abdominal pain   7890	Both sexes	272
Araba/┴lava	Group 1802 Abdominal pain   7890	Men	109
Araba/┴lava	Group 1802 Abdominal pain   7890	Women	163
Araba/┴lava	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	4
Araba/┴lava	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	4
Araba/┴lava	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	..
Araba/┴lava	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.791
Araba/┴lava	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.071
Araba/┴lava	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	720
Araba/┴lava	Group 1900 Injuries and poisoning  800-999	Both sexes	3.080
Araba/┴lava	Group 1900 Injuries and poisoning  800-999	Men	1.531
Araba/┴lava	Group 1900 Injuries and poisoning  800-999	Women	1.549
Araba/┴lava	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	400
Araba/┴lava	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	222
Araba/┴lava	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	178
Araba/┴lava	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	80
Araba/┴lava	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	50
Araba/┴lava	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	30
Araba/┴lava	Group 1903 Radius and ulna fracture 813	Both sexes	179
Araba/┴lava	Group 1903 Radius and ulna fracture 813	Men	67
Araba/┴lava	Group 1903 Radius and ulna fracture 813	Women	112
Araba/┴lava	Group 1904 Femur fracture  820-821	Both sexes	362
Araba/┴lava	Group 1904 Femur fracture  820-821	Men	89
Araba/┴lava	Group 1904 Femur fracture  820-821	Women	273
Araba/┴lava	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	189
Araba/┴lava	Group 1905 Leg fracture, including the ankle 823-824	Men	94
Araba/┴lava	Group 1905 Leg fracture, including the ankle 823-824	Women	95
Araba/┴lava	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	738
Araba/┴lava	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	423
Araba/┴lava	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	315
Araba/┴lava	Group 1907 Burns  940-949	Both sexes	4
Araba/┴lava	Group 1907 Burns  940-949	Men	2
Araba/┴lava	Group 1907 Burns  940-949	Women	2
Araba/┴lava	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	161
Araba/┴lava	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	59
Araba/┴lava	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	102
Araba/┴lava	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	864
Araba/┴lava	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	472
Araba/┴lava	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	392
Araba/┴lava	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	9
Araba/┴lava	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	3
Araba/┴lava	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
Araba/┴lava	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	94
Araba/┴lava	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	50
Araba/┴lava	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	44
Araba/┴lava	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	701
Araba/┴lava	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	398
Araba/┴lava	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	303
Araba/┴lava	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	12
Araba/┴lava	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	7
Araba/┴lava	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	5
Araba/┴lava	Group 2102 Contraceptive management  V25	Both sexes	10
Araba/┴lava	Group 2102 Contraceptive management  V25	Men	..
Araba/┴lava	Group 2102 Contraceptive management  V25	Women	10
Araba/┴lava	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Araba/┴lava	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Araba/┴lava	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Araba/┴lava	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	194
Araba/┴lava	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	116
Araba/┴lava	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	78
Araba/┴lava	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	485
Araba/┴lava	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	275
Araba/┴lava	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	210
Bizkaia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	126.997
Bizkaia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	62.825
Bizkaia	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	64.171
Bizkaia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	2.275
Bizkaia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	1.323
Bizkaia	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	952
Bizkaia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	218
Bizkaia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	107
Bizkaia	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	111
Bizkaia	Group 0102 Imprecise intestinal infections 009	Both sexes	170
Bizkaia	Group 0102 Imprecise intestinal infections 009	Men	90
Bizkaia	Group 0102 Imprecise intestinal infections 009	Women	79
Bizkaia	Group 0103 Tuberculosis 010-018, 137	Both sexes	100
Bizkaia	Group 0103 Tuberculosis 010-018, 137	Men	66
Bizkaia	Group 0103 Tuberculosis 010-018, 137	Women	34
Bizkaia	Group 0104 Septicaemia  038	Both sexes	910
Bizkaia	Group 0104 Septicaemia  038	Men	532
Bizkaia	Group 0104 Septicaemia  038	Women	378
Bizkaia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	159
Bizkaia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	106
Bizkaia	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	52
Bizkaia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	718
Bizkaia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	420
Bizkaia	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	298
Bizkaia	Group 0200 Neoplasms  140-239	Both sexes	13.417
Bizkaia	Group 0200 Neoplasms  140-239	Men	7.205
Bizkaia	Group 0200 Neoplasms  140-239	Women	6.212
Bizkaia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	1.573
Bizkaia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	963
Bizkaia	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	610
Bizkaia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	981
Bizkaia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	766
Bizkaia	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	215
Bizkaia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	236
Bizkaia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	128
Bizkaia	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	108
Bizkaia	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	900
Bizkaia	Group 0204 Malignant neoplasm of breast  174-175	Men	10
Bizkaia	Group 0204 Malignant neoplasm of breast  174-175	Women	890
Bizkaia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	226
Bizkaia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Bizkaia	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	226
Bizkaia	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	126
Bizkaia	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Bizkaia	Group 0206 Malignant neoplasm of ovary  1830	Women	126
Bizkaia	Group 0207 Malignant neoplasm of prostate  185	Both sexes	595
Bizkaia	Group 0207 Malignant neoplasm of prostate  185	Men	595
Bizkaia	Group 0207 Malignant neoplasm of prostate  185	Women	..
Bizkaia	Group 0208 Malignant neoplasm of bladder  188	Both sexes	1.161
Bizkaia	Group 0208 Malignant neoplasm of bladder  188	Men	939
Bizkaia	Group 0208 Malignant neoplasm of bladder  188	Women	222
Bizkaia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	5.105
Bizkaia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	3.031
Bizkaia	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	2.074
Bizkaia	Group 0210 Carcinoma in situ  230-234	Both sexes	180
Bizkaia	Group 0210 Carcinoma in situ  230-234	Men	40
Bizkaia	Group 0210 Carcinoma in situ  230-234	Women	140
Bizkaia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	154
Bizkaia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	94
Bizkaia	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	59
Bizkaia	Grupo 0212 Leiomyoma of uterus  218	Both sexes	583
Bizkaia	Grupo 0212 Leiomyoma of uterus  218	Men	..
Bizkaia	Grupo 0212 Leiomyoma of uterus  218	Women	583
Bizkaia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.598
Bizkaia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	639
Bizkaia	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	959
Bizkaia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	1.376
Bizkaia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	726
Bizkaia	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	650
Bizkaia	Group 0301 Anaemias 280-285	Both sexes	901
Bizkaia	Group 0301 Anaemias 280-285	Men	463
Bizkaia	Group 0301 Anaemias 280-285	Women	438
Bizkaia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	475
Bizkaia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	263
Bizkaia	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	212
Bizkaia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	2.158
Bizkaia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	864
Bizkaia	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	1.294
Bizkaia	Group 0401 Diabetes mellitus  249-250	Both sexes	638
Bizkaia	Group 0401 Diabetes mellitus  249-250	Men	365
Bizkaia	Group 0401 Diabetes mellitus  249-250	Women	273
Bizkaia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	1.520
Bizkaia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	499
Bizkaia	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	1.021
Bizkaia	Group 0500 Mental disorders  290-319	Both sexes	4.547
Bizkaia	Group 0500 Mental disorders  290-319	Men	2.411
Bizkaia	Group 0500 Mental disorders  290-319	Women	2.136
Bizkaia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	49
Bizkaia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	22
Bizkaia	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	27
Bizkaia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	358
Bizkaia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	277
Bizkaia	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	81
Bizkaia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	346
Bizkaia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	244
Bizkaia	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	102
Bizkaia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	1.530
Bizkaia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	936
Bizkaia	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	594
Bizkaia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	1.229
Bizkaia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	497
Bizkaia	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	732
Bizkaia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	1.034
Bizkaia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	434
Bizkaia	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	600
Bizkaia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	2.922
Bizkaia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	1.578
Bizkaia	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	1.344
Bizkaia	Group 0601 Alzheimer's disease  3310	Both sexes	39
Bizkaia	Group 0601 Alzheimer's disease  3310	Men	20
Bizkaia	Group 0601 Alzheimer's disease  3310	Women	19
Bizkaia	Group 0602 Multiple sclerosis 340	Both sexes	22
Bizkaia	Group 0602 Multiple sclerosis 340	Men	14
Bizkaia	Group 0602 Multiple sclerosis 340	Women	8
Bizkaia	Group 0603 Epilepsy  345	Both sexes	397
Bizkaia	Group 0603 Epilepsy  345	Men	200
Bizkaia	Group 0603 Epilepsy  345	Women	197
Bizkaia	Group 0604 Transient cerebral ischemia 435	Both sexes	372
Bizkaia	Group 0604 Transient cerebral ischemia 435	Men	190
Bizkaia	Group 0604 Transient cerebral ischemia 435	Women	182
Bizkaia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	2.092
Bizkaia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	1.154
Bizkaia	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	938
Bizkaia	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	449
Bizkaia	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	216
Bizkaia	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	233
Bizkaia	Grupo 0701 Cataract  366	Both sexes	45
Bizkaia	Grupo 0701 Cataract  366	Men	19
Bizkaia	Grupo 0701 Cataract  366	Women	26
Bizkaia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	404
Bizkaia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	197
Bizkaia	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	207
Bizkaia	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	480
Bizkaia	Group 0800 Diseases of the ear and the mastoid  380-389	Men	249
Bizkaia	Group 0800 Diseases of the ear and the mastoid  380-389	Women	231
Bizkaia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	17.089
Bizkaia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	9.808
Bizkaia	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	7.281
Bizkaia	Group 0901 Hypertensive disease  401-405	Both sexes	928
Bizkaia	Group 0901 Hypertensive disease  401-405	Men	401
Bizkaia	Group 0901 Hypertensive disease  401-405	Women	527
Bizkaia	Group 0902 Angina pectoris  4111, 413	Both sexes	347
Bizkaia	Group 0902 Angina pectoris  4111, 413	Men	195
Bizkaia	Group 0902 Angina pectoris  4111, 413	Women	152
Bizkaia	Group 0903 Acute myocardial infarction  410	Both sexes	997
Bizkaia	Group 0903 Acute myocardial infarction  410	Men	702
Bizkaia	Group 0903 Acute myocardial infarction  410	Women	294
Bizkaia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	1.348
Bizkaia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	1.048
Bizkaia	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	300
Bizkaia	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	666
Bizkaia	Group 0905 Diseases of the lungs circulation 415-417	Men	306
Bizkaia	Group 0905 Diseases of the lungs circulation 415-417	Women	360
Bizkaia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	2.561
Bizkaia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	1.486
Bizkaia	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	1.075
Bizkaia	Grupo 0907 Heart failure  428	Both sexes	3.503
Bizkaia	Grupo 0907 Heart failure  428	Men	1.826
Bizkaia	Grupo 0907 Heart failure  428	Women	1.677
Bizkaia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	2.654
Bizkaia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.420
Bizkaia	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	1.233
Bizkaia	Grupo 0909 Atherosclerosis  440	Both sexes	760
Bizkaia	Grupo 0909 Atherosclerosis  440	Men	564
Bizkaia	Grupo 0909 Atherosclerosis  440	Women	197
Bizkaia	Group 0910 Varicose veins of lower extremities 454	Both sexes	428
Bizkaia	Group 0910 Varicose veins of lower extremities 454	Men	171
Bizkaia	Group 0910 Varicose veins of lower extremities 454	Women	257
Bizkaia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	2.898
Bizkaia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	1.690
Bizkaia	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	1.208
Bizkaia	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	13.977
Bizkaia	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	7.938
Bizkaia	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	6.039
Bizkaia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	613
Bizkaia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	322
Bizkaia	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	290
Bizkaia	Group 1002 Pneumonia 480-486	Both sexes	2.631
Bizkaia	Group 1002 Pneumonia 480-486	Men	1.567
Bizkaia	Group 1002 Pneumonia 480-486	Women	1.064
Bizkaia	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	1.815
Bizkaia	Group 1003 Acute bronchitis and bronchiolitis  466	Men	776
Bizkaia	Group 1003 Acute bronchitis and bronchiolitis  466	Women	1.040
Bizkaia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	651
Bizkaia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	332
Bizkaia	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	319
Bizkaia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	1.128
Bizkaia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	698
Bizkaia	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	430
Bizkaia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	2.696
Bizkaia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	2.026
Bizkaia	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	670
Bizkaia	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	996
Bizkaia	Group 1007 Asthma 4930-4931,4938-4939	Men	289
Bizkaia	Group 1007 Asthma 4930-4931,4938-4939	Women	706
Bizkaia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.448
Bizkaia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.928
Bizkaia	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.520
Bizkaia	Group 1100 Diseases of the digestive system  520-579	Both sexes	16.121
Bizkaia	Group 1100 Diseases of the digestive system  520-579	Men	9.254
Bizkaia	Group 1100 Diseases of the digestive system  520-579	Women	6.867
Bizkaia	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	179
Bizkaia	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	97
Bizkaia	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	81
Bizkaia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	190
Bizkaia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	107
Bizkaia	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	82
Bizkaia	Group 1103 Diseases of the esophagus 530	Both sexes	295
Bizkaia	Group 1103 Diseases of the esophagus 530	Men	199
Bizkaia	Group 1103 Diseases of the esophagus 530	Women	96
Bizkaia	Group 1104 Peptic ulcer 531-534	Both sexes	338
Bizkaia	Group 1104 Peptic ulcer 531-534	Men	241
Bizkaia	Group 1104 Peptic ulcer 531-534	Women	96
Bizkaia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	314
Bizkaia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	161
Bizkaia	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	154
Bizkaia	Group 1106 Appendicitis  540-543	Both sexes	1.381
Bizkaia	Group 1106 Appendicitis  540-543	Men	761
Bizkaia	Group 1106 Appendicitis  540-543	Women	620
Bizkaia	Group 1107 Inguinal hernia  550	Both sexes	2.168
Bizkaia	Group 1107 Inguinal hernia  550	Men	1.936
Bizkaia	Group 1107 Inguinal hernia  550	Women	232
Bizkaia	Group 1108 Other abdominal hernia  551-553	Both sexes	1.427
Bizkaia	Group 1108 Other abdominal hernia  551-553	Men	722
Bizkaia	Group 1108 Other abdominal hernia  551-553	Women	705
Bizkaia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	309
Bizkaia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	159
Bizkaia	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	151
Bizkaia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	528
Bizkaia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	252
Bizkaia	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	276
Bizkaia	Group 1111 Intestinal obstruction without hernia 560	Both sexes	806
Bizkaia	Group 1111 Intestinal obstruction without hernia 560	Men	404
Bizkaia	Group 1111 Intestinal obstruction without hernia 560	Women	402
Bizkaia	Group 1112 Intestinal diverticulosis 562	Both sexes	819
Bizkaia	Group 1112 Intestinal diverticulosis 562	Men	374
Bizkaia	Group 1112 Intestinal diverticulosis 562	Women	445
Bizkaia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	1.033
Bizkaia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	636
Bizkaia	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	397
Bizkaia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	654
Bizkaia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	289
Bizkaia	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	365
Bizkaia	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	294
Bizkaia	Group 1115 Alcoholic hepatitis 5710-5713	Men	235
Bizkaia	Group 1115 Alcoholic hepatitis 5710-5713	Women	59
Bizkaia	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	658
Bizkaia	Group 1116 Other diseases of the liver 570,5714-573	Men	419
Bizkaia	Group 1116 Other diseases of the liver 570,5714-573	Women	239
Bizkaia	Group 1117 Cholelithiasis  574	Both sexes	2.750
Bizkaia	Group 1117 Cholelithiasis  574	Men	1.142
Bizkaia	Group 1117 Cholelithiasis  574	Women	1.608
Bizkaia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	765
Bizkaia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	436
Bizkaia	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	329
Bizkaia	Group 1119 Pancreatic diseases 577	Both sexes	634
Bizkaia	Group 1119 Pancreatic diseases 577	Men	363
Bizkaia	Group 1119 Pancreatic diseases 577	Women	271
Bizkaia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	578
Bizkaia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	320
Bizkaia	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	257
Bizkaia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.204
Bizkaia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	672
Bizkaia	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	532
Bizkaia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	820
Bizkaia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	490
Bizkaia	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	329
Bizkaia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	55
Bizkaia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	29
Bizkaia	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	26
Bizkaia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	329
Bizkaia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	153
Bizkaia	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	177
Bizkaia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	9.362
Bizkaia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	4.493
Bizkaia	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	4.869
Bizkaia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Bizkaia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Bizkaia	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Bizkaia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Bizkaia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Bizkaia	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Bizkaia	Group 1303 Internal derangement of knee 717	Both sexes	1.072
Bizkaia	Group 1303 Internal derangement of knee 717	Men	703
Bizkaia	Group 1303 Internal derangement of knee 717	Women	369
Bizkaia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	3.982
Bizkaia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.745
Bizkaia	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	2.237
Bizkaia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	163
Bizkaia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	63
Bizkaia	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	99
Bizkaia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	424
Bizkaia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	215
Bizkaia	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	209
Bizkaia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	626
Bizkaia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	333
Bizkaia	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	292
Bizkaia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	216
Bizkaia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	111
Bizkaia	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	104
Bizkaia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	1.435
Bizkaia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	833
Bizkaia	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	602
Bizkaia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	1.445
Bizkaia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	489
Bizkaia	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	956
Bizkaia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	8.202
Bizkaia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	3.805
Bizkaia	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	4.397
Bizkaia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	865
Bizkaia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	302
Bizkaia	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	563
Bizkaia	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	748
Bizkaia	Group 1402 Renal failure  5836-5837, 584-586	Men	469
Bizkaia	Group 1402 Renal failure  5836-5837, 584-586	Women	279
Bizkaia	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	967
Bizkaia	Group 1403 Urolithiasis  592, 594, 7880	Men	541
Bizkaia	Group 1403 Urolithiasis  592, 594, 7880	Women	426
Bizkaia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	2.206
Bizkaia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	1.133
Bizkaia	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	1.073
Bizkaia	Group 1405 Prostatic hyperplasia  600	Both sexes	720
Bizkaia	Group 1405 Prostatic hyperplasia  600	Men	720
Bizkaia	Group 1405 Prostatic hyperplasia  600	Women	..
Bizkaia	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	559
Bizkaia	Group 1406 Other diseases of the male genital organs    601-608	Men	559
Bizkaia	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Bizkaia	Group 1407 Disorders of breast  610-612	Both sexes	769
Bizkaia	Group 1407 Disorders of breast  610-612	Men	46
Bizkaia	Group 1407 Disorders of breast  610-612	Women	723
Bizkaia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	234
Bizkaia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Bizkaia	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	234
Bizkaia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	40
Bizkaia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Bizkaia	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	40
Bizkaia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	1.093
Bizkaia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	34
Bizkaia	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	1.059
Bizkaia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	10.654
Bizkaia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Bizkaia	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	10.654
Bizkaia	Group 1501 Legally induced abortion  635	Both sexes	93
Bizkaia	Group 1501 Legally induced abortion  635	Men	..
Bizkaia	Group 1501 Legally induced abortion  635	Women	93
Bizkaia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	280
Bizkaia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Bizkaia	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	280
Bizkaia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	6.088
Bizkaia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Bizkaia	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	6.088
Bizkaia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.914
Bizkaia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Bizkaia	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.914
Bizkaia	Group 1505 Single spontaneous delivery  650	Both sexes	1.024
Bizkaia	Group 1505 Single spontaneous delivery  650	Men	..
Bizkaia	Group 1505 Single spontaneous delivery  650	Women	1.024
Bizkaia	Group 1506 Other deliveries  6695-6697	Both sexes	221
Bizkaia	Group 1506 Other deliveries  6695-6697	Men	..
Bizkaia	Group 1506 Other deliveries  6695-6697	Women	221
Bizkaia	Group 1507 Complications related to the puerperium  670-676	Both sexes	118
Bizkaia	Group 1507 Complications related to the puerperium  670-676	Men	..
Bizkaia	Group 1507 Complications related to the puerperium  670-676	Women	118
Bizkaia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	917
Bizkaia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Bizkaia	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	917
Bizkaia	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	1.128
Bizkaia	Group 1600 Some disorders originating in the perinatal period  760-779	Men	611
Bizkaia	Group 1600 Some disorders originating in the perinatal period  760-779	Women	517
Bizkaia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	361
Bizkaia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	184
Bizkaia	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	177
Bizkaia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	767
Bizkaia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	427
Bizkaia	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	341
Bizkaia	Grupo 1700 Congenital abnormalities  740-759	Both sexes	907
Bizkaia	Grupo 1700 Congenital abnormalities  740-759	Men	500
Bizkaia	Grupo 1700 Congenital abnormalities  740-759	Women	407
Bizkaia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	6.655
Bizkaia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	3.666
Bizkaia	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.989
Bizkaia	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	1.351
Bizkaia	Group 1801 Pain in throat and chest 7841, 7865	Men	772
Bizkaia	Group 1801 Pain in throat and chest 7841, 7865	Women	580
Bizkaia	Group 1802 Abdominal pain   7890	Both sexes	691
Bizkaia	Group 1802 Abdominal pain   7890	Men	305
Bizkaia	Group 1802 Abdominal pain   7890	Women	386
Bizkaia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	53
Bizkaia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	18
Bizkaia	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	35
Bizkaia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	4.560
Bizkaia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	2.571
Bizkaia	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.989
Bizkaia	Group 1900 Injuries and poisoning  800-999	Both sexes	11.258
Bizkaia	Group 1900 Injuries and poisoning  800-999	Men	6.077
Bizkaia	Group 1900 Injuries and poisoning  800-999	Women	5.181
Bizkaia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	373
Bizkaia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	203
Bizkaia	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	170
Bizkaia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	192
Bizkaia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	142
Bizkaia	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	50
Bizkaia	Group 1903 Radius and ulna fracture 813	Both sexes	791
Bizkaia	Group 1903 Radius and ulna fracture 813	Men	343
Bizkaia	Group 1903 Radius and ulna fracture 813	Women	448
Bizkaia	Group 1904 Femur fracture  820-821	Both sexes	1.621
Bizkaia	Group 1904 Femur fracture  820-821	Men	445
Bizkaia	Group 1904 Femur fracture  820-821	Women	1.176
Bizkaia	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	808
Bizkaia	Group 1905 Leg fracture, including the ankle 823-824	Men	421
Bizkaia	Group 1905 Leg fracture, including the ankle 823-824	Women	387
Bizkaia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	3.636
Bizkaia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	2.324
Bizkaia	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	1.312
Bizkaia	Group 1907 Burns  940-949	Both sexes	90
Bizkaia	Group 1907 Burns  940-949	Men	65
Bizkaia	Group 1907 Burns  940-949	Women	25
Bizkaia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	204
Bizkaia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	96
Bizkaia	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	107
Bizkaia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	3.171
Bizkaia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	1.837
Bizkaia	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	1.334
Bizkaia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	59
Bizkaia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	37
Bizkaia	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	22
Bizkaia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	312
Bizkaia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	163
Bizkaia	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	150
Bizkaia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.814
Bizkaia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.430
Bizkaia	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.384
Bizkaia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	180
Bizkaia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	102
Bizkaia	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	77
Bizkaia	Group 2102 Contraceptive management  V25	Both sexes	51
Bizkaia	Group 2102 Contraceptive management  V25	Men	1
Bizkaia	Group 2102 Contraceptive management  V25	Women	50
Bizkaia	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Bizkaia	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Bizkaia	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Bizkaia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	781
Bizkaia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	530
Bizkaia	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	250
Bizkaia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.802
Bizkaia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	796
Bizkaia	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	1.006
Gipuzkoa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	82.323
Gipuzkoa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	40.755
Gipuzkoa	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	41.568
Gipuzkoa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	1.706
Gipuzkoa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	957
Gipuzkoa	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	749
Gipuzkoa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	267
Gipuzkoa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	149
Gipuzkoa	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	118
Gipuzkoa	Group 0102 Imprecise intestinal infections 009	Both sexes	75
Gipuzkoa	Group 0102 Imprecise intestinal infections 009	Men	38
Gipuzkoa	Group 0102 Imprecise intestinal infections 009	Women	37
Gipuzkoa	Group 0103 Tuberculosis 010-018, 137	Both sexes	62
Gipuzkoa	Group 0103 Tuberculosis 010-018, 137	Men	42
Gipuzkoa	Group 0103 Tuberculosis 010-018, 137	Women	20
Gipuzkoa	Group 0104 Septicaemia  038	Both sexes	798
Gipuzkoa	Group 0104 Septicaemia  038	Men	436
Gipuzkoa	Group 0104 Septicaemia  038	Women	362
Gipuzkoa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	44
Gipuzkoa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	28
Gipuzkoa	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	16
Gipuzkoa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	460
Gipuzkoa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	264
Gipuzkoa	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	196
Gipuzkoa	Group 0200 Neoplasms  140-239	Both sexes	7.670
Gipuzkoa	Group 0200 Neoplasms  140-239	Men	4.178
Gipuzkoa	Group 0200 Neoplasms  140-239	Women	3.492
Gipuzkoa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	749
Gipuzkoa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	466
Gipuzkoa	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	283
Gipuzkoa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	579
Gipuzkoa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	416
Gipuzkoa	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	163
Gipuzkoa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	171
Gipuzkoa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	88
Gipuzkoa	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	83
Gipuzkoa	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	531
Gipuzkoa	Group 0204 Malignant neoplasm of breast  174-175	Men	3
Gipuzkoa	Group 0204 Malignant neoplasm of breast  174-175	Women	528
Gipuzkoa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	169
Gipuzkoa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Gipuzkoa	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	169
Gipuzkoa	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	77
Gipuzkoa	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Gipuzkoa	Group 0206 Malignant neoplasm of ovary  1830	Women	77
Gipuzkoa	Group 0207 Malignant neoplasm of prostate  185	Both sexes	548
Gipuzkoa	Group 0207 Malignant neoplasm of prostate  185	Men	548
Gipuzkoa	Group 0207 Malignant neoplasm of prostate  185	Women	..
Gipuzkoa	Group 0208 Malignant neoplasm of bladder  188	Both sexes	602
Gipuzkoa	Group 0208 Malignant neoplasm of bladder  188	Men	487
Gipuzkoa	Group 0208 Malignant neoplasm of bladder  188	Women	115
Gipuzkoa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	2.645
Gipuzkoa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	1.580
Gipuzkoa	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	1.065
Gipuzkoa	Group 0210 Carcinoma in situ  230-234	Both sexes	120
Gipuzkoa	Group 0210 Carcinoma in situ  230-234	Men	30
Gipuzkoa	Group 0210 Carcinoma in situ  230-234	Women	90
Gipuzkoa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	194
Gipuzkoa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	128
Gipuzkoa	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	66
Gipuzkoa	Grupo 0212 Leiomyoma of uterus  218	Both sexes	270
Gipuzkoa	Grupo 0212 Leiomyoma of uterus  218	Men	..
Gipuzkoa	Grupo 0212 Leiomyoma of uterus  218	Women	270
Gipuzkoa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	1.015
Gipuzkoa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	432
Gipuzkoa	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	583
Gipuzkoa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	832
Gipuzkoa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	427
Gipuzkoa	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	405
Gipuzkoa	Group 0301 Anaemias 280-285	Both sexes	613
Gipuzkoa	Group 0301 Anaemias 280-285	Men	293
Gipuzkoa	Group 0301 Anaemias 280-285	Women	320
Gipuzkoa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	219
Gipuzkoa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	134
Gipuzkoa	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	85
Gipuzkoa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	1.410
Gipuzkoa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	569
Gipuzkoa	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	841
Gipuzkoa	Group 0401 Diabetes mellitus  249-250	Both sexes	527
Gipuzkoa	Group 0401 Diabetes mellitus  249-250	Men	320
Gipuzkoa	Group 0401 Diabetes mellitus  249-250	Women	207
Gipuzkoa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	883
Gipuzkoa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	249
Gipuzkoa	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	634
Gipuzkoa	Group 0500 Mental disorders  290-319	Both sexes	2.030
Gipuzkoa	Group 0500 Mental disorders  290-319	Men	1.121
Gipuzkoa	Group 0500 Mental disorders  290-319	Women	909
Gipuzkoa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	73
Gipuzkoa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	33
Gipuzkoa	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	40
Gipuzkoa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	193
Gipuzkoa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	132
Gipuzkoa	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	61
Gipuzkoa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	125
Gipuzkoa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	92
Gipuzkoa	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	33
Gipuzkoa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	671
Gipuzkoa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	425
Gipuzkoa	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	246
Gipuzkoa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	384
Gipuzkoa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	157
Gipuzkoa	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	227
Gipuzkoa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	584
Gipuzkoa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	282
Gipuzkoa	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	302
Gipuzkoa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	1.679
Gipuzkoa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	875
Gipuzkoa	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	804
Gipuzkoa	Group 0601 Alzheimer's disease  3310	Both sexes	44
Gipuzkoa	Group 0601 Alzheimer's disease  3310	Men	14
Gipuzkoa	Group 0601 Alzheimer's disease  3310	Women	30
Gipuzkoa	Group 0602 Multiple sclerosis 340	Both sexes	16
Gipuzkoa	Group 0602 Multiple sclerosis 340	Men	5
Gipuzkoa	Group 0602 Multiple sclerosis 340	Women	11
Gipuzkoa	Group 0603 Epilepsy  345	Both sexes	281
Gipuzkoa	Group 0603 Epilepsy  345	Men	151
Gipuzkoa	Group 0603 Epilepsy  345	Women	130
Gipuzkoa	Group 0604 Transient cerebral ischemia 435	Both sexes	272
Gipuzkoa	Group 0604 Transient cerebral ischemia 435	Men	129
Gipuzkoa	Group 0604 Transient cerebral ischemia 435	Women	143
Gipuzkoa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	1.066
Gipuzkoa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	576
Gipuzkoa	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	490
Gipuzkoa	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	219
Gipuzkoa	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	106
Gipuzkoa	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	113
Gipuzkoa	Grupo 0701 Cataract  366	Both sexes	18
Gipuzkoa	Grupo 0701 Cataract  366	Men	10
Gipuzkoa	Grupo 0701 Cataract  366	Women	8
Gipuzkoa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	201
Gipuzkoa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	96
Gipuzkoa	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	105
Gipuzkoa	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	579
Gipuzkoa	Group 0800 Diseases of the ear and the mastoid  380-389	Men	293
Gipuzkoa	Group 0800 Diseases of the ear and the mastoid  380-389	Women	286
Gipuzkoa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	10.668
Gipuzkoa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	6.026
Gipuzkoa	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	4.642
Gipuzkoa	Group 0901 Hypertensive disease  401-405	Both sexes	452
Gipuzkoa	Group 0901 Hypertensive disease  401-405	Men	219
Gipuzkoa	Group 0901 Hypertensive disease  401-405	Women	233
Gipuzkoa	Group 0902 Angina pectoris  4111, 413	Both sexes	263
Gipuzkoa	Group 0902 Angina pectoris  4111, 413	Men	173
Gipuzkoa	Group 0902 Angina pectoris  4111, 413	Women	90
Gipuzkoa	Group 0903 Acute myocardial infarction  410	Both sexes	586
Gipuzkoa	Group 0903 Acute myocardial infarction  410	Men	429
Gipuzkoa	Group 0903 Acute myocardial infarction  410	Women	157
Gipuzkoa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	746
Gipuzkoa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	573
Gipuzkoa	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	173
Gipuzkoa	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	298
Gipuzkoa	Group 0905 Diseases of the lungs circulation 415-417	Men	135
Gipuzkoa	Group 0905 Diseases of the lungs circulation 415-417	Women	163
Gipuzkoa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	1.602
Gipuzkoa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	865
Gipuzkoa	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	737
Gipuzkoa	Grupo 0907 Heart failure  428	Both sexes	1.982
Gipuzkoa	Grupo 0907 Heart failure  428	Men	993
Gipuzkoa	Grupo 0907 Heart failure  428	Women	989
Gipuzkoa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	1.967
Gipuzkoa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	1.026
Gipuzkoa	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	941
Gipuzkoa	Grupo 0909 Atherosclerosis  440	Both sexes	584
Gipuzkoa	Grupo 0909 Atherosclerosis  440	Men	448
Gipuzkoa	Grupo 0909 Atherosclerosis  440	Women	136
Gipuzkoa	Group 0910 Varicose veins of lower extremities 454	Both sexes	523
Gipuzkoa	Group 0910 Varicose veins of lower extremities 454	Men	204
Gipuzkoa	Group 0910 Varicose veins of lower extremities 454	Women	319
Gipuzkoa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	1.665
Gipuzkoa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	961
Gipuzkoa	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	704
Gipuzkoa	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	9.667
Gipuzkoa	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	5.619
Gipuzkoa	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	4.048
Gipuzkoa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	462
Gipuzkoa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	254
Gipuzkoa	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	208
Gipuzkoa	Group 1002 Pneumonia 480-486	Both sexes	2.238
Gipuzkoa	Group 1002 Pneumonia 480-486	Men	1.364
Gipuzkoa	Group 1002 Pneumonia 480-486	Women	874
Gipuzkoa	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	338
Gipuzkoa	Group 1003 Acute bronchitis and bronchiolitis  466	Men	180
Gipuzkoa	Group 1003 Acute bronchitis and bronchiolitis  466	Women	158
Gipuzkoa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	617
Gipuzkoa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	332
Gipuzkoa	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	285
Gipuzkoa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	846
Gipuzkoa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	552
Gipuzkoa	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	294
Gipuzkoa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.590
Gipuzkoa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	1.188
Gipuzkoa	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	402
Gipuzkoa	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	495
Gipuzkoa	Group 1007 Asthma 4930-4931,4938-4939	Men	220
Gipuzkoa	Group 1007 Asthma 4930-4931,4938-4939	Women	275
Gipuzkoa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	3.081
Gipuzkoa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	1.529
Gipuzkoa	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	1.552
Gipuzkoa	Group 1100 Diseases of the digestive system  520-579	Both sexes	9.826
Gipuzkoa	Group 1100 Diseases of the digestive system  520-579	Men	5.623
Gipuzkoa	Group 1100 Diseases of the digestive system  520-579	Women	4.203
Gipuzkoa	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	170
Gipuzkoa	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	86
Gipuzkoa	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	84
Gipuzkoa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	177
Gipuzkoa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	105
Gipuzkoa	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	72
Gipuzkoa	Group 1103 Diseases of the esophagus 530	Both sexes	182
Gipuzkoa	Group 1103 Diseases of the esophagus 530	Men	106
Gipuzkoa	Group 1103 Diseases of the esophagus 530	Women	76
Gipuzkoa	Group 1104 Peptic ulcer 531-534	Both sexes	197
Gipuzkoa	Group 1104 Peptic ulcer 531-534	Men	145
Gipuzkoa	Group 1104 Peptic ulcer 531-534	Women	52
Gipuzkoa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	165
Gipuzkoa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	86
Gipuzkoa	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	79
Gipuzkoa	Group 1106 Appendicitis  540-543	Both sexes	866
Gipuzkoa	Group 1106 Appendicitis  540-543	Men	476
Gipuzkoa	Group 1106 Appendicitis  540-543	Women	390
Gipuzkoa	Group 1107 Inguinal hernia  550	Both sexes	1.075
Gipuzkoa	Group 1107 Inguinal hernia  550	Men	952
Gipuzkoa	Group 1107 Inguinal hernia  550	Women	123
Gipuzkoa	Group 1108 Other abdominal hernia  551-553	Both sexes	816
Gipuzkoa	Group 1108 Other abdominal hernia  551-553	Men	392
Gipuzkoa	Group 1108 Other abdominal hernia  551-553	Women	424
Gipuzkoa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	204
Gipuzkoa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	108
Gipuzkoa	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	96
Gipuzkoa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	516
Gipuzkoa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	238
Gipuzkoa	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	278
Gipuzkoa	Group 1111 Intestinal obstruction without hernia 560	Both sexes	626
Gipuzkoa	Group 1111 Intestinal obstruction without hernia 560	Men	346
Gipuzkoa	Group 1111 Intestinal obstruction without hernia 560	Women	280
Gipuzkoa	Group 1112 Intestinal diverticulosis 562	Both sexes	447
Gipuzkoa	Group 1112 Intestinal diverticulosis 562	Men	209
Gipuzkoa	Group 1112 Intestinal diverticulosis 562	Women	238
Gipuzkoa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	763
Gipuzkoa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	526
Gipuzkoa	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	237
Gipuzkoa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	317
Gipuzkoa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	137
Gipuzkoa	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	180
Gipuzkoa	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	183
Gipuzkoa	Group 1115 Alcoholic hepatitis 5710-5713	Men	150
Gipuzkoa	Group 1115 Alcoholic hepatitis 5710-5713	Women	33
Gipuzkoa	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	244
Gipuzkoa	Group 1116 Other diseases of the liver 570,5714-573	Men	143
Gipuzkoa	Group 1116 Other diseases of the liver 570,5714-573	Women	101
Gipuzkoa	Group 1117 Cholelithiasis  574	Both sexes	1.583
Gipuzkoa	Group 1117 Cholelithiasis  574	Men	685
Gipuzkoa	Group 1117 Cholelithiasis  574	Women	898
Gipuzkoa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	349
Gipuzkoa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	189
Gipuzkoa	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	160
Gipuzkoa	Group 1119 Pancreatic diseases 577	Both sexes	465
Gipuzkoa	Group 1119 Pancreatic diseases 577	Men	268
Gipuzkoa	Group 1119 Pancreatic diseases 577	Women	197
Gipuzkoa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	481
Gipuzkoa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	276
Gipuzkoa	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	205
Gipuzkoa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	1.118
Gipuzkoa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	603
Gipuzkoa	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	515
Gipuzkoa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	778
Gipuzkoa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	450
Gipuzkoa	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	328
Gipuzkoa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	37
Gipuzkoa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	21
Gipuzkoa	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	16
Gipuzkoa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	303
Gipuzkoa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	132
Gipuzkoa	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	171
Gipuzkoa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	7.160
Gipuzkoa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	3.679
Gipuzkoa	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	3.481
Gipuzkoa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Gipuzkoa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Gipuzkoa	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Gipuzkoa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Gipuzkoa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Gipuzkoa	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Gipuzkoa	Group 1303 Internal derangement of knee 717	Both sexes	1.447
Gipuzkoa	Group 1303 Internal derangement of knee 717	Men	992
Gipuzkoa	Group 1303 Internal derangement of knee 717	Women	455
Gipuzkoa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	2.420
Gipuzkoa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	1.164
Gipuzkoa	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	1.256
Gipuzkoa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	88
Gipuzkoa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	35
Gipuzkoa	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	53
Gipuzkoa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	488
Gipuzkoa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	236
Gipuzkoa	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	252
Gipuzkoa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	593
Gipuzkoa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	317
Gipuzkoa	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	276
Gipuzkoa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	250
Gipuzkoa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	106
Gipuzkoa	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	144
Gipuzkoa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	954
Gipuzkoa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	493
Gipuzkoa	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	461
Gipuzkoa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	920
Gipuzkoa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	336
Gipuzkoa	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	584
Gipuzkoa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	5.332
Gipuzkoa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	2.651
Gipuzkoa	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	2.681
Gipuzkoa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	402
Gipuzkoa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	163
Gipuzkoa	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	239
Gipuzkoa	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	350
Gipuzkoa	Group 1402 Renal failure  5836-5837, 584-586	Men	205
Gipuzkoa	Group 1402 Renal failure  5836-5837, 584-586	Women	145
Gipuzkoa	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	874
Gipuzkoa	Group 1403 Urolithiasis  592, 594, 7880	Men	556
Gipuzkoa	Group 1403 Urolithiasis  592, 594, 7880	Women	318
Gipuzkoa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	1.599
Gipuzkoa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	827
Gipuzkoa	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	772
Gipuzkoa	Group 1405 Prostatic hyperplasia  600	Both sexes	563
Gipuzkoa	Group 1405 Prostatic hyperplasia  600	Men	563
Gipuzkoa	Group 1405 Prostatic hyperplasia  600	Women	..
Gipuzkoa	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	261
Gipuzkoa	Group 1406 Other diseases of the male genital organs    601-608	Men	261
Gipuzkoa	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Gipuzkoa	Group 1407 Disorders of breast  610-612	Both sexes	340
Gipuzkoa	Group 1407 Disorders of breast  610-612	Men	32
Gipuzkoa	Group 1407 Disorders of breast  610-612	Women	308
Gipuzkoa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	118
Gipuzkoa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Gipuzkoa	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	118
Gipuzkoa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	44
Gipuzkoa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Gipuzkoa	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	44
Gipuzkoa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	781
Gipuzkoa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	44
Gipuzkoa	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	737
Gipuzkoa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	7.391
Gipuzkoa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Gipuzkoa	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	7.391
Gipuzkoa	Group 1501 Legally induced abortion  635	Both sexes	66
Gipuzkoa	Group 1501 Legally induced abortion  635	Men	..
Gipuzkoa	Group 1501 Legally induced abortion  635	Women	66
Gipuzkoa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	208
Gipuzkoa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Gipuzkoa	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	208
Gipuzkoa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	4.803
Gipuzkoa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Gipuzkoa	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	4.803
Gipuzkoa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	1.075
Gipuzkoa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Gipuzkoa	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	1.075
Gipuzkoa	Group 1505 Single spontaneous delivery  650	Both sexes	728
Gipuzkoa	Group 1505 Single spontaneous delivery  650	Men	..
Gipuzkoa	Group 1505 Single spontaneous delivery  650	Women	728
Gipuzkoa	Group 1506 Other deliveries  6695-6697	Both sexes	166
Gipuzkoa	Group 1506 Other deliveries  6695-6697	Men	..
Gipuzkoa	Group 1506 Other deliveries  6695-6697	Women	166
Gipuzkoa	Group 1507 Complications related to the puerperium  670-676	Both sexes	41
Gipuzkoa	Group 1507 Complications related to the puerperium  670-676	Men	..
Gipuzkoa	Group 1507 Complications related to the puerperium  670-676	Women	41
Gipuzkoa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	304
Gipuzkoa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Gipuzkoa	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	304
Gipuzkoa	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	876
Gipuzkoa	Group 1600 Some disorders originating in the perinatal period  760-779	Men	467
Gipuzkoa	Group 1600 Some disorders originating in the perinatal period  760-779	Women	409
Gipuzkoa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	207
Gipuzkoa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	101
Gipuzkoa	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	106
Gipuzkoa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	669
Gipuzkoa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	366
Gipuzkoa	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	303
Gipuzkoa	Grupo 1700 Congenital abnormalities  740-759	Both sexes	302
Gipuzkoa	Grupo 1700 Congenital abnormalities  740-759	Men	166
Gipuzkoa	Grupo 1700 Congenital abnormalities  740-759	Women	136
Gipuzkoa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	4.675
Gipuzkoa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	2.633
Gipuzkoa	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	2.042
Gipuzkoa	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	987
Gipuzkoa	Group 1801 Pain in throat and chest 7841, 7865	Men	590
Gipuzkoa	Group 1801 Pain in throat and chest 7841, 7865	Women	397
Gipuzkoa	Group 1802 Abdominal pain   7890	Both sexes	526
Gipuzkoa	Group 1802 Abdominal pain   7890	Men	242
Gipuzkoa	Group 1802 Abdominal pain   7890	Women	284
Gipuzkoa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	383
Gipuzkoa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	208
Gipuzkoa	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	175
Gipuzkoa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	2.779
Gipuzkoa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	1.593
Gipuzkoa	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	1.186
Gipuzkoa	Group 1900 Injuries and poisoning  800-999	Both sexes	6.611
Gipuzkoa	Group 1900 Injuries and poisoning  800-999	Men	3.451
Gipuzkoa	Group 1900 Injuries and poisoning  800-999	Women	3.160
Gipuzkoa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	409
Gipuzkoa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	254
Gipuzkoa	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	155
Gipuzkoa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	239
Gipuzkoa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	160
Gipuzkoa	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	79
Gipuzkoa	Group 1903 Radius and ulna fracture 813	Both sexes	443
Gipuzkoa	Group 1903 Radius and ulna fracture 813	Men	177
Gipuzkoa	Group 1903 Radius and ulna fracture 813	Women	266
Gipuzkoa	Group 1904 Femur fracture  820-821	Both sexes	963
Gipuzkoa	Group 1904 Femur fracture  820-821	Men	248
Gipuzkoa	Group 1904 Femur fracture  820-821	Women	715
Gipuzkoa	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	436
Gipuzkoa	Group 1905 Leg fracture, including the ankle 823-824	Men	208
Gipuzkoa	Group 1905 Leg fracture, including the ankle 823-824	Women	228
Gipuzkoa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	1.895
Gipuzkoa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	1.189
Gipuzkoa	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	706
Gipuzkoa	Group 1907 Burns  940-949	Both sexes	38
Gipuzkoa	Group 1907 Burns  940-949	Men	26
Gipuzkoa	Group 1907 Burns  940-949	Women	12
Gipuzkoa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	145
Gipuzkoa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	63
Gipuzkoa	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	82
Gipuzkoa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	1.693
Gipuzkoa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	958
Gipuzkoa	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	735
Gipuzkoa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	18
Gipuzkoa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	12
Gipuzkoa	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	6
Gipuzkoa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	332
Gipuzkoa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	156
Gipuzkoa	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	176
Gipuzkoa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	2.572
Gipuzkoa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	1.311
Gipuzkoa	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	1.261
Gipuzkoa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	62
Gipuzkoa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	38
Gipuzkoa	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	24
Gipuzkoa	Group 2102 Contraceptive management  V25	Both sexes	21
Gipuzkoa	Group 2102 Contraceptive management  V25	Men	..
Gipuzkoa	Group 2102 Contraceptive management  V25	Women	21
Gipuzkoa	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Gipuzkoa	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Gipuzkoa	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Gipuzkoa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	797
Gipuzkoa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	496
Gipuzkoa	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	301
Gipuzkoa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	1.692
Gipuzkoa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	777
Gipuzkoa	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	915
RIOJA, LA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	37.009
RIOJA, LA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	18.213
RIOJA, LA	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	18.796
RIOJA, LA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	757
RIOJA, LA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	463
RIOJA, LA	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	294
RIOJA, LA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	121
RIOJA, LA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	73
RIOJA, LA	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	48
RIOJA, LA	Group 0102 Imprecise intestinal infections 009	Both sexes	25
RIOJA, LA	Group 0102 Imprecise intestinal infections 009	Men	12
RIOJA, LA	Group 0102 Imprecise intestinal infections 009	Women	13
RIOJA, LA	Group 0103 Tuberculosis 010-018, 137	Both sexes	20
RIOJA, LA	Group 0103 Tuberculosis 010-018, 137	Men	12
RIOJA, LA	Group 0103 Tuberculosis 010-018, 137	Women	8
RIOJA, LA	Group 0104 Septicaemia  038	Both sexes	338
RIOJA, LA	Group 0104 Septicaemia  038	Men	210
RIOJA, LA	Group 0104 Septicaemia  038	Women	128
RIOJA, LA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	9
RIOJA, LA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	5
RIOJA, LA	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	4
RIOJA, LA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	244
RIOJA, LA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	151
RIOJA, LA	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	93
RIOJA, LA	Group 0200 Neoplasms  140-239	Both sexes	3.235
RIOJA, LA	Group 0200 Neoplasms  140-239	Men	1.789
RIOJA, LA	Group 0200 Neoplasms  140-239	Women	1.446
RIOJA, LA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	322
RIOJA, LA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	215
RIOJA, LA	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	107
RIOJA, LA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	194
RIOJA, LA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	149
RIOJA, LA	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	45
RIOJA, LA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	107
RIOJA, LA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	62
RIOJA, LA	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	45
RIOJA, LA	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	227
RIOJA, LA	Group 0204 Malignant neoplasm of breast  174-175	Men	5
RIOJA, LA	Group 0204 Malignant neoplasm of breast  174-175	Women	222
RIOJA, LA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	57
RIOJA, LA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
RIOJA, LA	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	57
RIOJA, LA	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	43
RIOJA, LA	Group 0206 Malignant neoplasm of ovary  1830	Men	..
RIOJA, LA	Group 0206 Malignant neoplasm of ovary  1830	Women	43
RIOJA, LA	Group 0207 Malignant neoplasm of prostate  185	Both sexes	104
RIOJA, LA	Group 0207 Malignant neoplasm of prostate  185	Men	104
RIOJA, LA	Group 0207 Malignant neoplasm of prostate  185	Women	..
RIOJA, LA	Group 0208 Malignant neoplasm of bladder  188	Both sexes	357
RIOJA, LA	Group 0208 Malignant neoplasm of bladder  188	Men	293
RIOJA, LA	Group 0208 Malignant neoplasm of bladder  188	Women	64
RIOJA, LA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	1.155
RIOJA, LA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	719
RIOJA, LA	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	436
RIOJA, LA	Group 0210 Carcinoma in situ  230-234	Both sexes	43
RIOJA, LA	Group 0210 Carcinoma in situ  230-234	Men	5
RIOJA, LA	Group 0210 Carcinoma in situ  230-234	Women	38
RIOJA, LA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	45
RIOJA, LA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	26
RIOJA, LA	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	19
RIOJA, LA	Grupo 0212 Leiomyoma of uterus  218	Both sexes	158
RIOJA, LA	Grupo 0212 Leiomyoma of uterus  218	Men	..
RIOJA, LA	Grupo 0212 Leiomyoma of uterus  218	Women	158
RIOJA, LA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	423
RIOJA, LA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	211
RIOJA, LA	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	212
RIOJA, LA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	700
RIOJA, LA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	396
RIOJA, LA	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	304
RIOJA, LA	Group 0301 Anaemias 280-285	Both sexes	493
RIOJA, LA	Group 0301 Anaemias 280-285	Men	266
RIOJA, LA	Group 0301 Anaemias 280-285	Women	227
RIOJA, LA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	207
RIOJA, LA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	130
RIOJA, LA	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	77
RIOJA, LA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	623
RIOJA, LA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	284
RIOJA, LA	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	339
RIOJA, LA	Group 0401 Diabetes mellitus  249-250	Both sexes	326
RIOJA, LA	Group 0401 Diabetes mellitus  249-250	Men	191
RIOJA, LA	Group 0401 Diabetes mellitus  249-250	Women	135
RIOJA, LA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	297
RIOJA, LA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	93
RIOJA, LA	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	204
RIOJA, LA	Group 0500 Mental disorders  290-319	Both sexes	684
RIOJA, LA	Group 0500 Mental disorders  290-319	Men	338
RIOJA, LA	Group 0500 Mental disorders  290-319	Women	346
RIOJA, LA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	36
RIOJA, LA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	18
RIOJA, LA	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	18
RIOJA, LA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	34
RIOJA, LA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	16
RIOJA, LA	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	18
RIOJA, LA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	33
RIOJA, LA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	24
RIOJA, LA	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	9
RIOJA, LA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	200
RIOJA, LA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	100
RIOJA, LA	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	100
RIOJA, LA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	138
RIOJA, LA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	58
RIOJA, LA	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	80
RIOJA, LA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	243
RIOJA, LA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	122
RIOJA, LA	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	121
RIOJA, LA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	655
RIOJA, LA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	310
RIOJA, LA	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	345
RIOJA, LA	Group 0601 Alzheimer's disease  3310	Both sexes	15
RIOJA, LA	Group 0601 Alzheimer's disease  3310	Men	3
RIOJA, LA	Group 0601 Alzheimer's disease  3310	Women	12
RIOJA, LA	Group 0602 Multiple sclerosis 340	Both sexes	11
RIOJA, LA	Group 0602 Multiple sclerosis 340	Men	2
RIOJA, LA	Group 0602 Multiple sclerosis 340	Women	9
RIOJA, LA	Group 0603 Epilepsy  345	Both sexes	119
RIOJA, LA	Group 0603 Epilepsy  345	Men	59
RIOJA, LA	Group 0603 Epilepsy  345	Women	60
RIOJA, LA	Group 0604 Transient cerebral ischemia 435	Both sexes	150
RIOJA, LA	Group 0604 Transient cerebral ischemia 435	Men	67
RIOJA, LA	Group 0604 Transient cerebral ischemia 435	Women	83
RIOJA, LA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	360
RIOJA, LA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	179
RIOJA, LA	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	181
RIOJA, LA	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	243
RIOJA, LA	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	121
RIOJA, LA	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	122
RIOJA, LA	Grupo 0701 Cataract  366	Both sexes	33
RIOJA, LA	Grupo 0701 Cataract  366	Men	19
RIOJA, LA	Grupo 0701 Cataract  366	Women	14
RIOJA, LA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	210
RIOJA, LA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	102
RIOJA, LA	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	108
RIOJA, LA	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	180
RIOJA, LA	Group 0800 Diseases of the ear and the mastoid  380-389	Men	81
RIOJA, LA	Group 0800 Diseases of the ear and the mastoid  380-389	Women	99
RIOJA, LA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	5.213
RIOJA, LA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	2.879
RIOJA, LA	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	2.334
RIOJA, LA	Group 0901 Hypertensive disease  401-405	Both sexes	384
RIOJA, LA	Group 0901 Hypertensive disease  401-405	Men	200
RIOJA, LA	Group 0901 Hypertensive disease  401-405	Women	184
RIOJA, LA	Group 0902 Angina pectoris  4111, 413	Both sexes	129
RIOJA, LA	Group 0902 Angina pectoris  4111, 413	Men	88
RIOJA, LA	Group 0902 Angina pectoris  4111, 413	Women	41
RIOJA, LA	Group 0903 Acute myocardial infarction  410	Both sexes	412
RIOJA, LA	Group 0903 Acute myocardial infarction  410	Men	281
RIOJA, LA	Group 0903 Acute myocardial infarction  410	Women	131
RIOJA, LA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	270
RIOJA, LA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	214
RIOJA, LA	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	56
RIOJA, LA	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	193
RIOJA, LA	Group 0905 Diseases of the lungs circulation 415-417	Men	77
RIOJA, LA	Group 0905 Diseases of the lungs circulation 415-417	Women	116
RIOJA, LA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	570
RIOJA, LA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	306
RIOJA, LA	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	264
RIOJA, LA	Grupo 0907 Heart failure  428	Both sexes	1.306
RIOJA, LA	Grupo 0907 Heart failure  428	Men	598
RIOJA, LA	Grupo 0907 Heart failure  428	Women	708
RIOJA, LA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	780
RIOJA, LA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	451
RIOJA, LA	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	329
RIOJA, LA	Grupo 0909 Atherosclerosis  440	Both sexes	152
RIOJA, LA	Grupo 0909 Atherosclerosis  440	Men	102
RIOJA, LA	Grupo 0909 Atherosclerosis  440	Women	50
RIOJA, LA	Group 0910 Varicose veins of lower extremities 454	Both sexes	296
RIOJA, LA	Group 0910 Varicose veins of lower extremities 454	Men	113
RIOJA, LA	Group 0910 Varicose veins of lower extremities 454	Women	183
RIOJA, LA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	721
RIOJA, LA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	449
RIOJA, LA	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	272
RIOJA, LA	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	4.881
RIOJA, LA	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	2.758
RIOJA, LA	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	2.123
RIOJA, LA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	247
RIOJA, LA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	127
RIOJA, LA	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	120
RIOJA, LA	Group 1002 Pneumonia 480-486	Both sexes	951
RIOJA, LA	Group 1002 Pneumonia 480-486	Men	558
RIOJA, LA	Group 1002 Pneumonia 480-486	Women	393
RIOJA, LA	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	164
RIOJA, LA	Group 1003 Acute bronchitis and bronchiolitis  466	Men	96
RIOJA, LA	Group 1003 Acute bronchitis and bronchiolitis  466	Women	68
RIOJA, LA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	257
RIOJA, LA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	134
RIOJA, LA	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	123
RIOJA, LA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	190
RIOJA, LA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	118
RIOJA, LA	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	72
RIOJA, LA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	1.038
RIOJA, LA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	819
RIOJA, LA	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	219
RIOJA, LA	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	206
RIOJA, LA	Group 1007 Asthma 4930-4931,4938-4939	Men	44
RIOJA, LA	Group 1007 Asthma 4930-4931,4938-4939	Women	162
RIOJA, LA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	1.828
RIOJA, LA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	862
RIOJA, LA	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	966
RIOJA, LA	Group 1100 Diseases of the digestive system  520-579	Both sexes	4.708
RIOJA, LA	Group 1100 Diseases of the digestive system  520-579	Men	2.688
RIOJA, LA	Group 1100 Diseases of the digestive system  520-579	Women	2.020
RIOJA, LA	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	34
RIOJA, LA	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	19
RIOJA, LA	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	15
RIOJA, LA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	72
RIOJA, LA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	32
RIOJA, LA	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	40
RIOJA, LA	Group 1103 Diseases of the esophagus 530	Both sexes	71
RIOJA, LA	Group 1103 Diseases of the esophagus 530	Men	43
RIOJA, LA	Group 1103 Diseases of the esophagus 530	Women	28
RIOJA, LA	Group 1104 Peptic ulcer 531-534	Both sexes	109
RIOJA, LA	Group 1104 Peptic ulcer 531-534	Men	74
RIOJA, LA	Group 1104 Peptic ulcer 531-534	Women	35
RIOJA, LA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	134
RIOJA, LA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	65
RIOJA, LA	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	69
RIOJA, LA	Group 1106 Appendicitis  540-543	Both sexes	320
RIOJA, LA	Group 1106 Appendicitis  540-543	Men	186
RIOJA, LA	Group 1106 Appendicitis  540-543	Women	134
RIOJA, LA	Group 1107 Inguinal hernia  550	Both sexes	518
RIOJA, LA	Group 1107 Inguinal hernia  550	Men	464
RIOJA, LA	Group 1107 Inguinal hernia  550	Women	54
RIOJA, LA	Group 1108 Other abdominal hernia  551-553	Both sexes	293
RIOJA, LA	Group 1108 Other abdominal hernia  551-553	Men	147
RIOJA, LA	Group 1108 Other abdominal hernia  551-553	Women	146
RIOJA, LA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	60
RIOJA, LA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	27
RIOJA, LA	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	33
RIOJA, LA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	404
RIOJA, LA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	201
RIOJA, LA	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	203
RIOJA, LA	Group 1111 Intestinal obstruction without hernia 560	Both sexes	306
RIOJA, LA	Group 1111 Intestinal obstruction without hernia 560	Men	163
RIOJA, LA	Group 1111 Intestinal obstruction without hernia 560	Women	143
RIOJA, LA	Group 1112 Intestinal diverticulosis 562	Both sexes	347
RIOJA, LA	Group 1112 Intestinal diverticulosis 562	Men	159
RIOJA, LA	Group 1112 Intestinal diverticulosis 562	Women	188
RIOJA, LA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	238
RIOJA, LA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	158
RIOJA, LA	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	80
RIOJA, LA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	133
RIOJA, LA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	69
RIOJA, LA	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	64
RIOJA, LA	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	53
RIOJA, LA	Group 1115 Alcoholic hepatitis 5710-5713	Men	42
RIOJA, LA	Group 1115 Alcoholic hepatitis 5710-5713	Women	11
RIOJA, LA	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	139
RIOJA, LA	Group 1116 Other diseases of the liver 570,5714-573	Men	78
RIOJA, LA	Group 1116 Other diseases of the liver 570,5714-573	Women	61
RIOJA, LA	Group 1117 Cholelithiasis  574	Both sexes	695
RIOJA, LA	Group 1117 Cholelithiasis  574	Men	327
RIOJA, LA	Group 1117 Cholelithiasis  574	Women	368
RIOJA, LA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	299
RIOJA, LA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	171
RIOJA, LA	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	128
RIOJA, LA	Group 1119 Pancreatic diseases 577	Both sexes	290
RIOJA, LA	Group 1119 Pancreatic diseases 577	Men	152
RIOJA, LA	Group 1119 Pancreatic diseases 577	Women	138
RIOJA, LA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	193
RIOJA, LA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	111
RIOJA, LA	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	82
RIOJA, LA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	449
RIOJA, LA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	226
RIOJA, LA	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	223
RIOJA, LA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	258
RIOJA, LA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	139
RIOJA, LA	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	119
RIOJA, LA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	22
RIOJA, LA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	9
RIOJA, LA	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	13
RIOJA, LA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	169
RIOJA, LA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	78
RIOJA, LA	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	91
RIOJA, LA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	2.753
RIOJA, LA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	1.421
RIOJA, LA	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	1.332
RIOJA, LA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
RIOJA, LA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
RIOJA, LA	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
RIOJA, LA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
RIOJA, LA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
RIOJA, LA	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
RIOJA, LA	Group 1303 Internal derangement of knee 717	Both sexes	530
RIOJA, LA	Group 1303 Internal derangement of knee 717	Men	380
RIOJA, LA	Group 1303 Internal derangement of knee 717	Women	150
RIOJA, LA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	883
RIOJA, LA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	446
RIOJA, LA	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	437
RIOJA, LA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	68
RIOJA, LA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	30
RIOJA, LA	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	38
RIOJA, LA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	46
RIOJA, LA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	27
RIOJA, LA	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	19
RIOJA, LA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	392
RIOJA, LA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	197
RIOJA, LA	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	195
RIOJA, LA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	71
RIOJA, LA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	32
RIOJA, LA	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	39
RIOJA, LA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	350
RIOJA, LA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	173
RIOJA, LA	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	177
RIOJA, LA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	413
RIOJA, LA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	136
RIOJA, LA	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	277
RIOJA, LA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	2.637
RIOJA, LA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	1.348
RIOJA, LA	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	1.289
RIOJA, LA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	272
RIOJA, LA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	74
RIOJA, LA	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	198
RIOJA, LA	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	168
RIOJA, LA	Group 1402 Renal failure  5836-5837, 584-586	Men	105
RIOJA, LA	Group 1402 Renal failure  5836-5837, 584-586	Women	63
RIOJA, LA	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	386
RIOJA, LA	Group 1403 Urolithiasis  592, 594, 7880	Men	229
RIOJA, LA	Group 1403 Urolithiasis  592, 594, 7880	Women	157
RIOJA, LA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	801
RIOJA, LA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	392
RIOJA, LA	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	409
RIOJA, LA	Group 1405 Prostatic hyperplasia  600	Both sexes	250
RIOJA, LA	Group 1405 Prostatic hyperplasia  600	Men	250
RIOJA, LA	Group 1405 Prostatic hyperplasia  600	Women	..
RIOJA, LA	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	265
RIOJA, LA	Group 1406 Other diseases of the male genital organs    601-608	Men	265
RIOJA, LA	Group 1406 Other diseases of the male genital organs    601-608	Women	..
RIOJA, LA	Group 1407 Disorders of breast  610-612	Both sexes	90
RIOJA, LA	Group 1407 Disorders of breast  610-612	Men	7
RIOJA, LA	Group 1407 Disorders of breast  610-612	Women	83
RIOJA, LA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	48
RIOJA, LA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
RIOJA, LA	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	48
RIOJA, LA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	32
RIOJA, LA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
RIOJA, LA	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	32
RIOJA, LA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	325
RIOJA, LA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	26
RIOJA, LA	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	299
RIOJA, LA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.251
RIOJA, LA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
RIOJA, LA	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.251
RIOJA, LA	Group 1501 Legally induced abortion  635	Both sexes	25
RIOJA, LA	Group 1501 Legally induced abortion  635	Men	..
RIOJA, LA	Group 1501 Legally induced abortion  635	Women	25
RIOJA, LA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	162
RIOJA, LA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
RIOJA, LA	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	162
RIOJA, LA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.891
RIOJA, LA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
RIOJA, LA	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.891
RIOJA, LA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	889
RIOJA, LA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
RIOJA, LA	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	889
RIOJA, LA	Group 1505 Single spontaneous delivery  650	Both sexes	96
RIOJA, LA	Group 1505 Single spontaneous delivery  650	Men	..
RIOJA, LA	Group 1505 Single spontaneous delivery  650	Women	96
RIOJA, LA	Group 1506 Other deliveries  6695-6697	Both sexes	4
RIOJA, LA	Group 1506 Other deliveries  6695-6697	Men	..
RIOJA, LA	Group 1506 Other deliveries  6695-6697	Women	4
RIOJA, LA	Group 1507 Complications related to the puerperium  670-676	Both sexes	19
RIOJA, LA	Group 1507 Complications related to the puerperium  670-676	Men	..
RIOJA, LA	Group 1507 Complications related to the puerperium  670-676	Women	19
RIOJA, LA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	165
RIOJA, LA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
RIOJA, LA	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	165
RIOJA, LA	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	239
RIOJA, LA	Group 1600 Some disorders originating in the perinatal period  760-779	Men	136
RIOJA, LA	Group 1600 Some disorders originating in the perinatal period  760-779	Women	103
RIOJA, LA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	104
RIOJA, LA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	60
RIOJA, LA	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	44
RIOJA, LA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	135
RIOJA, LA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	76
RIOJA, LA	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	59
RIOJA, LA	Grupo 1700 Congenital abnormalities  740-759	Both sexes	124
RIOJA, LA	Grupo 1700 Congenital abnormalities  740-759	Men	88
RIOJA, LA	Grupo 1700 Congenital abnormalities  740-759	Women	36
RIOJA, LA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	1.750
RIOJA, LA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	952
RIOJA, LA	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	798
RIOJA, LA	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	157
RIOJA, LA	Group 1801 Pain in throat and chest 7841, 7865	Men	94
RIOJA, LA	Group 1801 Pain in throat and chest 7841, 7865	Women	63
RIOJA, LA	Group 1802 Abdominal pain   7890	Both sexes	272
RIOJA, LA	Group 1802 Abdominal pain   7890	Men	126
RIOJA, LA	Group 1802 Abdominal pain   7890	Women	146
RIOJA, LA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	2
RIOJA, LA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
RIOJA, LA	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
RIOJA, LA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	1.319
RIOJA, LA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	731
RIOJA, LA	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	588
RIOJA, LA	Group 1900 Injuries and poisoning  800-999	Both sexes	2.934
RIOJA, LA	Group 1900 Injuries and poisoning  800-999	Men	1.449
RIOJA, LA	Group 1900 Injuries and poisoning  800-999	Women	1.485
RIOJA, LA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	384
RIOJA, LA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	197
RIOJA, LA	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	187
RIOJA, LA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	104
RIOJA, LA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	74
RIOJA, LA	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	30
RIOJA, LA	Group 1903 Radius and ulna fracture 813	Both sexes	112
RIOJA, LA	Group 1903 Radius and ulna fracture 813	Men	46
RIOJA, LA	Group 1903 Radius and ulna fracture 813	Women	66
RIOJA, LA	Group 1904 Femur fracture  820-821	Both sexes	486
RIOJA, LA	Group 1904 Femur fracture  820-821	Men	130
RIOJA, LA	Group 1904 Femur fracture  820-821	Women	356
RIOJA, LA	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	145
RIOJA, LA	Group 1905 Leg fracture, including the ankle 823-824	Men	74
RIOJA, LA	Group 1905 Leg fracture, including the ankle 823-824	Women	71
RIOJA, LA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	672
RIOJA, LA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	369
RIOJA, LA	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	303
RIOJA, LA	Group 1907 Burns  940-949	Both sexes	20
RIOJA, LA	Group 1907 Burns  940-949	Men	13
RIOJA, LA	Group 1907 Burns  940-949	Women	7
RIOJA, LA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	88
RIOJA, LA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	41
RIOJA, LA	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	47
RIOJA, LA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	828
RIOJA, LA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	456
RIOJA, LA	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	372
RIOJA, LA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1
RIOJA, LA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
RIOJA, LA	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	1
RIOJA, LA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	94
RIOJA, LA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	49
RIOJA, LA	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	45
RIOJA, LA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	993
RIOJA, LA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	486
RIOJA, LA	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	507
RIOJA, LA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	14
RIOJA, LA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	10
RIOJA, LA	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	4
RIOJA, LA	Group 2102 Contraceptive management  V25	Both sexes	6
RIOJA, LA	Group 2102 Contraceptive management  V25	Men	..
RIOJA, LA	Group 2102 Contraceptive management  V25	Women	6
RIOJA, LA	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
RIOJA, LA	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
RIOJA, LA	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
RIOJA, LA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	165
RIOJA, LA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	89
RIOJA, LA	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	76
RIOJA, LA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	808
RIOJA, LA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	387
RIOJA, LA	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	421
Ceuta	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	6.769
Ceuta	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	2.423
Ceuta	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	4.346
Ceuta	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	168
Ceuta	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	92
Ceuta	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	76
Ceuta	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	56
Ceuta	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	33
Ceuta	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	23
Ceuta	Group 0102 Imprecise intestinal infections 009	Both sexes	7
Ceuta	Group 0102 Imprecise intestinal infections 009	Men	3
Ceuta	Group 0102 Imprecise intestinal infections 009	Women	4
Ceuta	Group 0103 Tuberculosis 010-018, 137	Both sexes	19
Ceuta	Group 0103 Tuberculosis 010-018, 137	Men	14
Ceuta	Group 0103 Tuberculosis 010-018, 137	Women	5
Ceuta	Group 0104 Septicaemia  038	Both sexes	31
Ceuta	Group 0104 Septicaemia  038	Men	14
Ceuta	Group 0104 Septicaemia  038	Women	17
Ceuta	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	3
Ceuta	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	3
Ceuta	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	..
Ceuta	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	52
Ceuta	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	25
Ceuta	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	27
Ceuta	Group 0200 Neoplasms  140-239	Both sexes	345
Ceuta	Group 0200 Neoplasms  140-239	Men	145
Ceuta	Group 0200 Neoplasms  140-239	Women	200
Ceuta	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	46
Ceuta	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	21
Ceuta	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	25
Ceuta	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	38
Ceuta	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	31
Ceuta	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	7
Ceuta	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	2
Ceuta	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	2
Ceuta	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	..
Ceuta	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	34
Ceuta	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Ceuta	Group 0204 Malignant neoplasm of breast  174-175	Women	34
Ceuta	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	15
Ceuta	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Ceuta	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	15
Ceuta	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	7
Ceuta	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Ceuta	Group 0206 Malignant neoplasm of ovary  1830	Women	7
Ceuta	Group 0207 Malignant neoplasm of prostate  185	Both sexes	10
Ceuta	Group 0207 Malignant neoplasm of prostate  185	Men	10
Ceuta	Group 0207 Malignant neoplasm of prostate  185	Women	..
Ceuta	Group 0208 Malignant neoplasm of bladder  188	Both sexes	9
Ceuta	Group 0208 Malignant neoplasm of bladder  188	Men	6
Ceuta	Group 0208 Malignant neoplasm of bladder  188	Women	3
Ceuta	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	70
Ceuta	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	37
Ceuta	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	33
Ceuta	Group 0210 Carcinoma in situ  230-234	Both sexes	3
Ceuta	Group 0210 Carcinoma in situ  230-234	Men	1
Ceuta	Group 0210 Carcinoma in situ  230-234	Women	2
Ceuta	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	2
Ceuta	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	2
Ceuta	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	..
Ceuta	Grupo 0212 Leiomyoma of uterus  218	Both sexes	33
Ceuta	Grupo 0212 Leiomyoma of uterus  218	Men	..
Ceuta	Grupo 0212 Leiomyoma of uterus  218	Women	33
Ceuta	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	76
Ceuta	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	35
Ceuta	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	41
Ceuta	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	48
Ceuta	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	28
Ceuta	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	20
Ceuta	Group 0301 Anaemias 280-285	Both sexes	22
Ceuta	Group 0301 Anaemias 280-285	Men	13
Ceuta	Group 0301 Anaemias 280-285	Women	9
Ceuta	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	26
Ceuta	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	15
Ceuta	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	11
Ceuta	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	147
Ceuta	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	67
Ceuta	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	80
Ceuta	Group 0401 Diabetes mellitus  249-250	Both sexes	79
Ceuta	Group 0401 Diabetes mellitus  249-250	Men	47
Ceuta	Group 0401 Diabetes mellitus  249-250	Women	32
Ceuta	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	68
Ceuta	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	20
Ceuta	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	48
Ceuta	Group 0500 Mental disorders  290-319	Both sexes	116
Ceuta	Group 0500 Mental disorders  290-319	Men	63
Ceuta	Group 0500 Mental disorders  290-319	Women	53
Ceuta	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	1
Ceuta	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	..
Ceuta	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	1
Ceuta	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	4
Ceuta	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	4
Ceuta	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	..
Ceuta	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	3
Ceuta	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	3
Ceuta	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	..
Ceuta	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	34
Ceuta	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	23
Ceuta	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	11
Ceuta	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	26
Ceuta	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	14
Ceuta	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	12
Ceuta	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	48
Ceuta	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	19
Ceuta	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	29
Ceuta	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	173
Ceuta	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	77
Ceuta	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	96
Ceuta	Group 0601 Alzheimer's disease  3310	Both sexes	1
Ceuta	Group 0601 Alzheimer's disease  3310	Men	1
Ceuta	Group 0601 Alzheimer's disease  3310	Women	..
Ceuta	Group 0602 Multiple sclerosis 340	Both sexes	10
Ceuta	Group 0602 Multiple sclerosis 340	Men	5
Ceuta	Group 0602 Multiple sclerosis 340	Women	5
Ceuta	Group 0603 Epilepsy  345	Both sexes	44
Ceuta	Group 0603 Epilepsy  345	Men	26
Ceuta	Group 0603 Epilepsy  345	Women	18
Ceuta	Group 0604 Transient cerebral ischemia 435	Both sexes	27
Ceuta	Group 0604 Transient cerebral ischemia 435	Men	14
Ceuta	Group 0604 Transient cerebral ischemia 435	Women	13
Ceuta	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	91
Ceuta	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	31
Ceuta	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	60
Ceuta	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	81
Ceuta	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	38
Ceuta	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	43
Ceuta	Grupo 0701 Cataract  366	Both sexes	8
Ceuta	Grupo 0701 Cataract  366	Men	5
Ceuta	Grupo 0701 Cataract  366	Women	3
Ceuta	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	73
Ceuta	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	33
Ceuta	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	40
Ceuta	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	27
Ceuta	Group 0800 Diseases of the ear and the mastoid  380-389	Men	10
Ceuta	Group 0800 Diseases of the ear and the mastoid  380-389	Women	17
Ceuta	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	660
Ceuta	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	335
Ceuta	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	325
Ceuta	Group 0901 Hypertensive disease  401-405	Both sexes	55
Ceuta	Group 0901 Hypertensive disease  401-405	Men	21
Ceuta	Group 0901 Hypertensive disease  401-405	Women	34
Ceuta	Group 0902 Angina pectoris  4111, 413	Both sexes	69
Ceuta	Group 0902 Angina pectoris  4111, 413	Men	35
Ceuta	Group 0902 Angina pectoris  4111, 413	Women	34
Ceuta	Group 0903 Acute myocardial infarction  410	Both sexes	75
Ceuta	Group 0903 Acute myocardial infarction  410	Men	56
Ceuta	Group 0903 Acute myocardial infarction  410	Women	19
Ceuta	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	5
Ceuta	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	2
Ceuta	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	3
Ceuta	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	19
Ceuta	Group 0905 Diseases of the lungs circulation 415-417	Men	10
Ceuta	Group 0905 Diseases of the lungs circulation 415-417	Women	9
Ceuta	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	69
Ceuta	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	32
Ceuta	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	37
Ceuta	Grupo 0907 Heart failure  428	Both sexes	139
Ceuta	Grupo 0907 Heart failure  428	Men	64
Ceuta	Grupo 0907 Heart failure  428	Women	75
Ceuta	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	137
Ceuta	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	64
Ceuta	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	73
Ceuta	Grupo 0909 Atherosclerosis  440	Both sexes	3
Ceuta	Grupo 0909 Atherosclerosis  440	Men	2
Ceuta	Grupo 0909 Atherosclerosis  440	Women	1
Ceuta	Group 0910 Varicose veins of lower extremities 454	Both sexes	7
Ceuta	Group 0910 Varicose veins of lower extremities 454	Men	3
Ceuta	Group 0910 Varicose veins of lower extremities 454	Women	4
Ceuta	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	82
Ceuta	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	46
Ceuta	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	36
Ceuta	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	604
Ceuta	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	338
Ceuta	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	266
Ceuta	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	62
Ceuta	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	29
Ceuta	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	33
Ceuta	Group 1002 Pneumonia 480-486	Both sexes	177
Ceuta	Group 1002 Pneumonia 480-486	Men	89
Ceuta	Group 1002 Pneumonia 480-486	Women	88
Ceuta	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	66
Ceuta	Group 1003 Acute bronchitis and bronchiolitis  466	Men	31
Ceuta	Group 1003 Acute bronchitis and bronchiolitis  466	Women	35
Ceuta	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	7
Ceuta	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	4
Ceuta	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	3
Ceuta	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	34
Ceuta	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	21
Ceuta	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	13
Ceuta	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	84
Ceuta	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	68
Ceuta	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	16
Ceuta	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	7
Ceuta	Group 1007 Asthma 4930-4931,4938-4939	Men	4
Ceuta	Group 1007 Asthma 4930-4931,4938-4939	Women	3
Ceuta	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	167
Ceuta	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	92
Ceuta	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	75
Ceuta	Group 1100 Diseases of the digestive system  520-579	Both sexes	709
Ceuta	Group 1100 Diseases of the digestive system  520-579	Men	356
Ceuta	Group 1100 Diseases of the digestive system  520-579	Women	353
Ceuta	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	3
Ceuta	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	1
Ceuta	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	2
Ceuta	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	2
Ceuta	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	1
Ceuta	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	1
Ceuta	Group 1103 Diseases of the esophagus 530	Both sexes	3
Ceuta	Group 1103 Diseases of the esophagus 530	Men	2
Ceuta	Group 1103 Diseases of the esophagus 530	Women	1
Ceuta	Group 1104 Peptic ulcer 531-534	Both sexes	13
Ceuta	Group 1104 Peptic ulcer 531-534	Men	9
Ceuta	Group 1104 Peptic ulcer 531-534	Women	4
Ceuta	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	17
Ceuta	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	9
Ceuta	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	8
Ceuta	Group 1106 Appendicitis  540-543	Both sexes	91
Ceuta	Group 1106 Appendicitis  540-543	Men	54
Ceuta	Group 1106 Appendicitis  540-543	Women	37
Ceuta	Group 1107 Inguinal hernia  550	Both sexes	16
Ceuta	Group 1107 Inguinal hernia  550	Men	15
Ceuta	Group 1107 Inguinal hernia  550	Women	1
Ceuta	Group 1108 Other abdominal hernia  551-553	Both sexes	67
Ceuta	Group 1108 Other abdominal hernia  551-553	Men	19
Ceuta	Group 1108 Other abdominal hernia  551-553	Women	48
Ceuta	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	13
Ceuta	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	7
Ceuta	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	6
Ceuta	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	87
Ceuta	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	43
Ceuta	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	44
Ceuta	Group 1111 Intestinal obstruction without hernia 560	Both sexes	32
Ceuta	Group 1111 Intestinal obstruction without hernia 560	Men	15
Ceuta	Group 1111 Intestinal obstruction without hernia 560	Women	17
Ceuta	Group 1112 Intestinal diverticulosis 562	Both sexes	21
Ceuta	Group 1112 Intestinal diverticulosis 562	Men	10
Ceuta	Group 1112 Intestinal diverticulosis 562	Women	11
Ceuta	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	45
Ceuta	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	29
Ceuta	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	16
Ceuta	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	21
Ceuta	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	5
Ceuta	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	16
Ceuta	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	22
Ceuta	Group 1115 Alcoholic hepatitis 5710-5713	Men	21
Ceuta	Group 1115 Alcoholic hepatitis 5710-5713	Women	1
Ceuta	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	30
Ceuta	Group 1116 Other diseases of the liver 570,5714-573	Men	16
Ceuta	Group 1116 Other diseases of the liver 570,5714-573	Women	14
Ceuta	Group 1117 Cholelithiasis  574	Both sexes	132
Ceuta	Group 1117 Cholelithiasis  574	Men	51
Ceuta	Group 1117 Cholelithiasis  574	Women	81
Ceuta	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	34
Ceuta	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	14
Ceuta	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	20
Ceuta	Group 1119 Pancreatic diseases 577	Both sexes	37
Ceuta	Group 1119 Pancreatic diseases 577	Men	18
Ceuta	Group 1119 Pancreatic diseases 577	Women	19
Ceuta	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	23
Ceuta	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	17
Ceuta	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	6
Ceuta	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	78
Ceuta	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	30
Ceuta	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	48
Ceuta	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	54
Ceuta	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	21
Ceuta	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	33
Ceuta	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	3
Ceuta	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	1
Ceuta	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	2
Ceuta	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	21
Ceuta	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	8
Ceuta	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	13
Ceuta	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	161
Ceuta	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	73
Ceuta	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	88
Ceuta	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Ceuta	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Ceuta	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Ceuta	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Ceuta	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Ceuta	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Ceuta	Group 1303 Internal derangement of knee 717	Both sexes	7
Ceuta	Group 1303 Internal derangement of knee 717	Men	5
Ceuta	Group 1303 Internal derangement of knee 717	Women	2
Ceuta	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	50
Ceuta	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	26
Ceuta	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	24
Ceuta	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	7
Ceuta	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	5
Ceuta	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	2
Ceuta	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	4
Ceuta	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	3
Ceuta	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	1
Ceuta	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	19
Ceuta	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	6
Ceuta	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	13
Ceuta	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	6
Ceuta	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	1
Ceuta	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	5
Ceuta	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	34
Ceuta	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	14
Ceuta	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	20
Ceuta	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	34
Ceuta	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	13
Ceuta	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	21
Ceuta	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	334
Ceuta	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	142
Ceuta	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	192
Ceuta	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	22
Ceuta	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	8
Ceuta	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	14
Ceuta	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	25
Ceuta	Group 1402 Renal failure  5836-5837, 584-586	Men	12
Ceuta	Group 1402 Renal failure  5836-5837, 584-586	Women	13
Ceuta	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	46
Ceuta	Group 1403 Urolithiasis  592, 594, 7880	Men	28
Ceuta	Group 1403 Urolithiasis  592, 594, 7880	Women	18
Ceuta	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	83
Ceuta	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	40
Ceuta	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	43
Ceuta	Group 1405 Prostatic hyperplasia  600	Both sexes	35
Ceuta	Group 1405 Prostatic hyperplasia  600	Men	35
Ceuta	Group 1405 Prostatic hyperplasia  600	Women	..
Ceuta	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	19
Ceuta	Group 1406 Other diseases of the male genital organs    601-608	Men	19
Ceuta	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Ceuta	Group 1407 Disorders of breast  610-612	Both sexes	8
Ceuta	Group 1407 Disorders of breast  610-612	Men	..
Ceuta	Group 1407 Disorders of breast  610-612	Women	8
Ceuta	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	18
Ceuta	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Ceuta	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	18
Ceuta	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	21
Ceuta	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Ceuta	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	21
Ceuta	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	57
Ceuta	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	..
Ceuta	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	57
Ceuta	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	1.980
Ceuta	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Ceuta	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	1.980
Ceuta	Group 1501 Legally induced abortion  635	Both sexes	1
Ceuta	Group 1501 Legally induced abortion  635	Men	..
Ceuta	Group 1501 Legally induced abortion  635	Women	1
Ceuta	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	191
Ceuta	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Ceuta	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	191
Ceuta	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.252
Ceuta	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Ceuta	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.252
Ceuta	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	297
Ceuta	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Ceuta	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	297
Ceuta	Group 1505 Single spontaneous delivery  650	Both sexes	91
Ceuta	Group 1505 Single spontaneous delivery  650	Men	..
Ceuta	Group 1505 Single spontaneous delivery  650	Women	91
Ceuta	Group 1506 Other deliveries  6695-6697	Both sexes	12
Ceuta	Group 1506 Other deliveries  6695-6697	Men	..
Ceuta	Group 1506 Other deliveries  6695-6697	Women	12
Ceuta	Group 1507 Complications related to the puerperium  670-676	Both sexes	25
Ceuta	Group 1507 Complications related to the puerperium  670-676	Men	..
Ceuta	Group 1507 Complications related to the puerperium  670-676	Women	25
Ceuta	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	111
Ceuta	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Ceuta	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	111
Ceuta	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	150
Ceuta	Group 1600 Some disorders originating in the perinatal period  760-779	Men	80
Ceuta	Group 1600 Some disorders originating in the perinatal period  760-779	Women	70
Ceuta	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	45
Ceuta	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	21
Ceuta	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	24
Ceuta	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	105
Ceuta	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	59
Ceuta	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	46
Ceuta	Grupo 1700 Congenital abnormalities  740-759	Both sexes	30
Ceuta	Grupo 1700 Congenital abnormalities  740-759	Men	20
Ceuta	Grupo 1700 Congenital abnormalities  740-759	Women	10
Ceuta	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	399
Ceuta	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	206
Ceuta	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	193
Ceuta	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	32
Ceuta	Group 1801 Pain in throat and chest 7841, 7865	Men	21
Ceuta	Group 1801 Pain in throat and chest 7841, 7865	Women	11
Ceuta	Group 1802 Abdominal pain   7890	Both sexes	34
Ceuta	Group 1802 Abdominal pain   7890	Men	11
Ceuta	Group 1802 Abdominal pain   7890	Women	23
Ceuta	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	3
Ceuta	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	1
Ceuta	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	2
Ceuta	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	330
Ceuta	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	173
Ceuta	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	157
Ceuta	Group 1900 Injuries and poisoning  800-999	Both sexes	437
Ceuta	Group 1900 Injuries and poisoning  800-999	Men	254
Ceuta	Group 1900 Injuries and poisoning  800-999	Women	183
Ceuta	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	21
Ceuta	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	16
Ceuta	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	5
Ceuta	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	24
Ceuta	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	18
Ceuta	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	6
Ceuta	Group 1903 Radius and ulna fracture 813	Both sexes	35
Ceuta	Group 1903 Radius and ulna fracture 813	Men	21
Ceuta	Group 1903 Radius and ulna fracture 813	Women	14
Ceuta	Group 1904 Femur fracture  820-821	Both sexes	63
Ceuta	Group 1904 Femur fracture  820-821	Men	20
Ceuta	Group 1904 Femur fracture  820-821	Women	43
Ceuta	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	33
Ceuta	Group 1905 Leg fracture, including the ankle 823-824	Men	18
Ceuta	Group 1905 Leg fracture, including the ankle 823-824	Women	15
Ceuta	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	130
Ceuta	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	94
Ceuta	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	36
Ceuta	Group 1907 Burns  940-949	Both sexes	4
Ceuta	Group 1907 Burns  940-949	Men	3
Ceuta	Group 1907 Burns  940-949	Women	1
Ceuta	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	22
Ceuta	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	10
Ceuta	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	12
Ceuta	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	85
Ceuta	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	41
Ceuta	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	44
Ceuta	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	1
Ceuta	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	1
Ceuta	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Ceuta	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	19
Ceuta	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	12
Ceuta	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	7
Ceuta	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	122
Ceuta	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	69
Ceuta	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	53
Ceuta	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	1
Ceuta	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	1
Ceuta	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	..
Ceuta	Group 2102 Contraceptive management  V25	Both sexes	..
Ceuta	Group 2102 Contraceptive management  V25	Men	..
Ceuta	Group 2102 Contraceptive management  V25	Women	..
Ceuta	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Ceuta	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Ceuta	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Ceuta	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	80
Ceuta	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	38
Ceuta	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	42
Ceuta	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	41
Ceuta	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	30
Ceuta	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	11
Melilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Both sexes	7.213
Melilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Men	2.053
Melilla	Group 0000 All causes (see exceptions in methodology) 001-999 and V codes (only main diagnoses)	Women	5.160
Melilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Both sexes	149
Melilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Men	92
Melilla	Group 0100 Certain infectious and parasitic diseases  001-033, 0341-0992, 042-044, 0995-134, 1360, 1362-139	Women	57
Melilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Both sexes	45
Melilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Men	32
Melilla	Group 0101 Intestinal infectious diseases, except for diarrhea 001-008	Women	13
Melilla	Group 0102 Imprecise intestinal infections 009	Both sexes	1
Melilla	Group 0102 Imprecise intestinal infections 009	Men	..
Melilla	Group 0102 Imprecise intestinal infections 009	Women	1
Melilla	Group 0103 Tuberculosis 010-018, 137	Both sexes	22
Melilla	Group 0103 Tuberculosis 010-018, 137	Men	13
Melilla	Group 0103 Tuberculosis 010-018, 137	Women	9
Melilla	Group 0104 Septicaemia  038	Both sexes	7
Melilla	Group 0104 Septicaemia  038	Men	3
Melilla	Group 0104 Septicaemia  038	Women	4
Melilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Both sexes	10
Melilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Men	9
Melilla	Group 0105 Human immunodeficiency virus infection  (HIV) 042-044	Women	1
Melilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Both sexes	64
Melilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Men	35
Melilla	Grupo 0106 Other infectious and parasitic diseases  Rest of (001-139, excepto 0340, 0993-0994, 135, 1361)	Women	29
Melilla	Group 0200 Neoplasms  140-239	Both sexes	324
Melilla	Group 0200 Neoplasms  140-239	Men	146
Melilla	Group 0200 Neoplasms  140-239	Women	178
Melilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Both sexes	34
Melilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Men	20
Melilla	Group 0201 Malignant neoplasm of colon, rectum and anus  153-154	Women	14
Melilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Both sexes	23
Melilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Men	22
Melilla	Group 0202 Malignant neoplasm of trachea, bronchi and lungs  162	Women	1
Melilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Both sexes	3
Melilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Men	2
Melilla	Group 0203 Melanoma and other malignant neoplasms of skin  172-173	Women	1
Melilla	Group 0204 Malignant neoplasm of breast  174-175	Both sexes	28
Melilla	Group 0204 Malignant neoplasm of breast  174-175	Men	..
Melilla	Group 0204 Malignant neoplasm of breast  174-175	Women	28
Melilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Both sexes	9
Melilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Men	..
Melilla	Group 0205 Malignant neoplasm of uterus  179-180, 182	Women	9
Melilla	Group 0206 Malignant neoplasm of ovary  1830	Both sexes	2
Melilla	Group 0206 Malignant neoplasm of ovary  1830	Men	..
Melilla	Group 0206 Malignant neoplasm of ovary  1830	Women	2
Melilla	Group 0207 Malignant neoplasm of prostate  185	Both sexes	8
Melilla	Group 0207 Malignant neoplasm of prostate  185	Men	8
Melilla	Group 0207 Malignant neoplasm of prostate  185	Women	..
Melilla	Group 0208 Malignant neoplasm of bladder  188	Both sexes	34
Melilla	Group 0208 Malignant neoplasm of bladder  188	Men	24
Melilla	Group 0208 Malignant neoplasm of bladder  188	Women	10
Melilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Both sexes	89
Melilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Men	51
Melilla	Group 0209 Other malignant neoplasms. Rest of  (140-208), 2090-2093	Women	38
Melilla	Group 0210 Carcinoma in situ  230-234	Both sexes	7
Melilla	Group 0210 Carcinoma in situ  230-234	Men	..
Melilla	Group 0210 Carcinoma in situ  230-234	Women	7
Melilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Both sexes	10
Melilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Men	7
Melilla	Group 0211 Benign neoplasm of colon, rectum and anus 2113-2114	Women	3
Melilla	Grupo 0212 Leiomyoma of uterus  218	Both sexes	23
Melilla	Grupo 0212 Leiomyoma of uterus  218	Men	..
Melilla	Grupo 0212 Leiomyoma of uterus  218	Women	23
Melilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Both sexes	54
Melilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Men	12
Melilla	Grupo 0213 Other benign neoplasms and neoplasms of uncertain or unknown behaviour  Rest of (210-239), 2094-2099	Women	42
Melilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Both sexes	52
Melilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Men	17
Melilla	Group 0300 Blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 280-288, 2890, 2894-2899	Women	35
Melilla	Group 0301 Anaemias 280-285	Both sexes	20
Melilla	Group 0301 Anaemias 280-285	Men	7
Melilla	Group 0301 Anaemias 280-285	Women	13
Melilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Both sexes	32
Melilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Men	10
Melilla	Group 0302 Other blood and hematopoietic organ diseases, and disorders related to immunity 135, 2790-2793, 2798-2799, 286-288, 2890, 2894-2899	Women	22
Melilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Both sexes	149
Melilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Men	76
Melilla	Group 0400 Endocrine, nutritional and metabolic diseases 240-278	Women	73
Melilla	Group 0401 Diabetes mellitus  249-250	Both sexes	71
Melilla	Group 0401 Diabetes mellitus  249-250	Men	42
Melilla	Group 0401 Diabetes mellitus  249-250	Women	29
Melilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Both sexes	78
Melilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Men	34
Melilla	Group 0402 Other endocrine, nutritional and metabolic diseases Rest of (240-278)	Women	44
Melilla	Group 0500 Mental disorders  290-319	Both sexes	125
Melilla	Group 0500 Mental disorders  290-319	Men	97
Melilla	Group 0500 Mental disorders  290-319	Women	28
Melilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Both sexes	..
Melilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Men	..
Melilla	Group 0501 Dementia 2900-2902, 2904-2909, 2941	Women	..
Melilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Both sexes	8
Melilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Men	7
Melilla	Group 0502 Mental and behavioural disorders due to alcohol 291, 303, 3050	Women	1
Melilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Both sexes	29
Melilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Men	28
Melilla	0503 Mental and behavioural disorders due to use of other psychoactive substances 292,2940,304,3051-3059	Women	1
Melilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Both sexes	30
Melilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Men	26
Melilla	Group 0504 Schizophrenia, schizotypal and delusional disorders 295,2970-2973,2978-2979,2983-2989	Women	4
Melilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Both sexes	24
Melilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Men	14
Melilla	Group 0505 Mood or affective disorders 296, 2980, 3004, 3011, 311	Women	10
Melilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Both sexes	34
Melilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Men	22
Melilla	Group 0506 Other mental and behavioural disorders  Rest of (290-319)	Women	12
Melilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Both sexes	74
Melilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Men	39
Melilla	Group 0600 Inflammatory diseases of the nervous system 320-359, 435	Women	35
Melilla	Group 0601 Alzheimer's disease  3310	Both sexes	3
Melilla	Group 0601 Alzheimer's disease  3310	Men	2
Melilla	Group 0601 Alzheimer's disease  3310	Women	1
Melilla	Group 0602 Multiple sclerosis 340	Both sexes	4
Melilla	Group 0602 Multiple sclerosis 340	Men	1
Melilla	Group 0602 Multiple sclerosis 340	Women	3
Melilla	Group 0603 Epilepsy  345	Both sexes	22
Melilla	Group 0603 Epilepsy  345	Men	12
Melilla	Group 0603 Epilepsy  345	Women	10
Melilla	Group 0604 Transient cerebral ischemia 435	Both sexes	11
Melilla	Group 0604 Transient cerebral ischemia 435	Men	6
Melilla	Group 0604 Transient cerebral ischemia 435	Women	5
Melilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Both sexes	34
Melilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Men	18
Melilla	Group 0605 Other inflammatory diseases of the nervous system. Rest of (320-359)	Women	16
Melilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Both sexes	25
Melilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Men	10
Melilla	Grupo 0700 Diseases of the eye and adnexa  360-379	Women	15
Melilla	Grupo 0701 Cataract  366	Both sexes	3
Melilla	Grupo 0701 Cataract  366	Men	..
Melilla	Grupo 0701 Cataract  366	Women	3
Melilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Both sexes	22
Melilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Men	10
Melilla	Group 0702 Other diseases of the eye and adnexa  Rest of (360-379)	Women	12
Melilla	Group 0800 Diseases of the ear and the mastoid  380-389	Both sexes	7
Melilla	Group 0800 Diseases of the ear and the mastoid  380-389	Men	5
Melilla	Group 0800 Diseases of the ear and the mastoid  380-389	Women	2
Melilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Both sexes	573
Melilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Men	325
Melilla	Group 0900 Diseases of the circulatory system 2891-2893, 390-459 (except 435, 446 and 4590)	Women	248
Melilla	Group 0901 Hypertensive disease  401-405	Both sexes	9
Melilla	Group 0901 Hypertensive disease  401-405	Men	5
Melilla	Group 0901 Hypertensive disease  401-405	Women	4
Melilla	Group 0902 Angina pectoris  4111, 413	Both sexes	78
Melilla	Group 0902 Angina pectoris  4111, 413	Men	39
Melilla	Group 0902 Angina pectoris  4111, 413	Women	39
Melilla	Group 0903 Acute myocardial infarction  410	Both sexes	83
Melilla	Group 0903 Acute myocardial infarction  410	Men	52
Melilla	Group 0903 Acute myocardial infarction  410	Women	31
Melilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Both sexes	16
Melilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Men	12
Melilla	Group 0904 Other ischemic heart diseases 4110, 4118, 412, 414	Women	4
Melilla	Group 0905 Diseases of the lungs circulation 415-417	Both sexes	8
Melilla	Group 0905 Diseases of the lungs circulation 415-417	Men	4
Melilla	Group 0905 Diseases of the lungs circulation 415-417	Women	4
Melilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Both sexes	48
Melilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Men	31
Melilla	Group 0906 Heart conduction disorders and arrhytmias 426-427	Women	17
Melilla	Grupo 0907 Heart failure  428	Both sexes	149
Melilla	Grupo 0907 Heart failure  428	Men	75
Melilla	Grupo 0907 Heart failure  428	Women	74
Melilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Both sexes	113
Melilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Men	62
Melilla	Grupo 0908 Cerebrovascular diseases  430-434, 436-438	Women	51
Melilla	Grupo 0909 Atherosclerosis  440	Both sexes	3
Melilla	Grupo 0909 Atherosclerosis  440	Men	3
Melilla	Grupo 0909 Atherosclerosis  440	Women	..
Melilla	Group 0910 Varicose veins of lower extremities 454	Both sexes	6
Melilla	Group 0910 Varicose veins of lower extremities 454	Men	3
Melilla	Group 0910 Varicose veins of lower extremities 454	Women	3
Melilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Both sexes	60
Melilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Men	39
Melilla	Group 0911 Other diseases of the circulatory system  2891-2893 and Rest of (390-459, except for 435, 446 and 4590)	Women	21
Melilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Both sexes	490
Melilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Men	269
Melilla	Group 1000 Diseases of the respiratory system  0340, 460-519	Women	221
Melilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Both sexes	14
Melilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Men	7
Melilla	Group 1001 Acute upper respiratory infections and influenza 0340, 460-465,487-488	Women	7
Melilla	Group 1002 Pneumonia 480-486	Both sexes	146
Melilla	Group 1002 Pneumonia 480-486	Men	85
Melilla	Group 1002 Pneumonia 480-486	Women	61
Melilla	Group 1003 Acute bronchitis and bronchiolitis  466	Both sexes	80
Melilla	Group 1003 Acute bronchitis and bronchiolitis  466	Men	39
Melilla	Group 1003 Acute bronchitis and bronchiolitis  466	Women	41
Melilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Both sexes	1
Melilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Men	..
Melilla	Group 1004 Chronic disease of nucleos amygdala and adenoid 474	Women	1
Melilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Both sexes	11
Melilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Men	7
Melilla	Grupo 1005 Other diseases of the upper respiratory tract  470-473, 475-478	Women	4
Melilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Both sexes	42
Melilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Men	30
Melilla	Group 1006 Chronic obstructive lung disease and bronchiectasis 490-492, 4932, 494, 496	Women	12
Melilla	Group 1007 Asthma 4930-4931,4938-4939	Both sexes	22
Melilla	Group 1007 Asthma 4930-4931,4938-4939	Men	10
Melilla	Group 1007 Asthma 4930-4931,4938-4939	Women	12
Melilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Both sexes	174
Melilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Men	91
Melilla	Group 1008 Other diseases of the respiratory system Resto of (460-519)	Women	83
Melilla	Group 1100 Diseases of the digestive system  520-579	Both sexes	676
Melilla	Group 1100 Diseases of the digestive system  520-579	Men	325
Melilla	Group 1100 Diseases of the digestive system  520-579	Women	351
Melilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Both sexes	5
Melilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Men	4
Melilla	Group 1101 Disorders of the teeth and supporting structures 520-525	Women	1
Melilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Both sexes	1
Melilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Men	1
Melilla	Group 1102 Other diseases of the oral cavity, salivary glands and jaws 526-529	Women	..
Melilla	Group 1103 Diseases of the esophagus 530	Both sexes	7
Melilla	Group 1103 Diseases of the esophagus 530	Men	4
Melilla	Group 1103 Diseases of the esophagus 530	Women	3
Melilla	Group 1104 Peptic ulcer 531-534	Both sexes	18
Melilla	Group 1104 Peptic ulcer 531-534	Men	15
Melilla	Group 1104 Peptic ulcer 531-534	Women	3
Melilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Both sexes	13
Melilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Men	5
Melilla	Group 1105 Dyspepsia and other diseases of the stomach and duodenum 535-537	Women	8
Melilla	Group 1106 Appendicitis  540-543	Both sexes	85
Melilla	Group 1106 Appendicitis  540-543	Men	47
Melilla	Group 1106 Appendicitis  540-543	Women	38
Melilla	Group 1107 Inguinal hernia  550	Both sexes	53
Melilla	Group 1107 Inguinal hernia  550	Men	43
Melilla	Group 1107 Inguinal hernia  550	Women	10
Melilla	Group 1108 Other abdominal hernia  551-553	Both sexes	55
Melilla	Group 1108 Other abdominal hernia  551-553	Men	22
Melilla	Group 1108 Other abdominal hernia  551-553	Women	33
Melilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Both sexes	11
Melilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Men	4
Melilla	Group 1109 Crohn's disease and ulcerative colitis  555-556	Women	7
Melilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Both sexes	60
Melilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Men	32
Melilla	Group 1110 Other noninfective and unespecified gastroenteritis and colitis 558	Women	28
Melilla	Group 1111 Intestinal obstruction without hernia 560	Both sexes	26
Melilla	Group 1111 Intestinal obstruction without hernia 560	Men	8
Melilla	Group 1111 Intestinal obstruction without hernia 560	Women	18
Melilla	Group 1112 Intestinal diverticulosis 562	Both sexes	10
Melilla	Group 1112 Intestinal diverticulosis 562	Men	5
Melilla	Group 1112 Intestinal diverticulosis 562	Women	5
Melilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Both sexes	38
Melilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Men	22
Melilla	Group 1113 Diseases of the anus and rectum  565-566, 5690-5694	Women	16
Melilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Both sexes	12
Melilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Men	7
Melilla	Group 1114 Other diseases of the intestine 557,564,5695,5698-5699	Women	5
Melilla	Group 1115 Alcoholic hepatitis 5710-5713	Both sexes	9
Melilla	Group 1115 Alcoholic hepatitis 5710-5713	Men	7
Melilla	Group 1115 Alcoholic hepatitis 5710-5713	Women	2
Melilla	Group 1116 Other diseases of the liver 570,5714-573	Both sexes	31
Melilla	Group 1116 Other diseases of the liver 570,5714-573	Men	18
Melilla	Group 1116 Other diseases of the liver 570,5714-573	Women	13
Melilla	Group 1117 Cholelithiasis  574	Both sexes	134
Melilla	Group 1117 Cholelithiasis  574	Men	35
Melilla	Group 1117 Cholelithiasis  574	Women	99
Melilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Both sexes	29
Melilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Men	16
Melilla	Group 1118 Other diseases of the biliary vesicle and tract 575-576	Women	13
Melilla	Group 1119 Pancreatic diseases 577	Both sexes	50
Melilla	Group 1119 Pancreatic diseases 577	Men	15
Melilla	Group 1119 Pancreatic diseases 577	Women	35
Melilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Both sexes	29
Melilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Men	15
Melilla	Group 1120 Other diseases of the digestive system Rest of (520-579)	Women	14
Melilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Both sexes	41
Melilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Men	28
Melilla	Group 1200 Diseases of the skin and subcutaneous tissue 680-709	Women	13
Melilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Both sexes	34
Melilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Men	24
Melilla	Group 1201 Infections of the skin and the subcutaneous tissue 680-686	Women	10
Melilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Both sexes	..
Melilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Men	..
Melilla	Group 1202 Dermatitis, eczema and papulosquamous disorders 690-693, 6943, 696-6983, 6988-6989	Women	..
Melilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Both sexes	7
Melilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Men	4
Melilla	Group 1203 Other diseases of the skin and subcutaneous tissue Rest of (680-709)	Women	3
Melilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Both sexes	94
Melilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Men	36
Melilla	Group 1300 Diseases of the musculoskeletal system and connective tissue 0993,1361,2794-2795, 446, 710-739	Women	58
Melilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Both sexes	..
Melilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Men	..
Melilla	Group 1301 Coxarthrosis (osteoarthritis of the hip) Just specified on a 5 digits ICD level	Women	..
Melilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Both sexes	..
Melilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Men	..
Melilla	Group 1302 Gonarthrosis (osteoarthritis of the knee) Just specified on a 5 digits ICD level	Women	..
Melilla	Group 1303 Internal derangement of knee 717	Both sexes	5
Melilla	Group 1303 Internal derangement of knee 717	Men	5
Melilla	Group 1303 Internal derangement of knee 717	Women	..
Melilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Both sexes	36
Melilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Men	12
Melilla	Group 1304 Other arthropathies 0993, 711-716, 718-719, 7271, 7284	Women	24
Melilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Both sexes	4
Melilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Men	1
Melilla	Group 1305 Systemic disorders of the connective tissue 1361, 2794-2795, 446, 710, 725, 7285	Women	3
Melilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Both sexes	10
Melilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Men	4
Melilla	Grupo 1306 Deforming spinal diseases and spondyloarthropathies     720-721, 7230, 7235, 7240, 737	Women	6
Melilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Both sexes	11
Melilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Men	2
Melilla	Group 1307 Intervertebral disc disorders 7220-7227, 7229	Women	9
Melilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Both sexes	1
Melilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Men	..
Melilla	Group 1308 Dorsalgia 7231,7234,7236,7241,7243,7245	Women	1
Melilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Both sexes	8
Melilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Men	5
Melilla	Group 1309 Soft tissue disorders 726, 7270, 7272-7279, 7280-7283, 7286-7289, 729	Women	3
Melilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Both sexes	19
Melilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Men	7
Melilla	Group 1310 Other disorders of the musculoskeletal system and connective tissue  Rest of (710-739)	Women	12
Melilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Both sexes	374
Melilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Men	151
Melilla	Group 1400 Diseases of the genitourinary system  0994, 580-5996, 5998-629, 7880	Women	223
Melilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Both sexes	27
Melilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Men	8
Melilla	Group 1401 Glomerular and tubulointerstitial renal diseases 580-5834, 5838-5839, 5900-5902, 5908-5909, 591, 5933-5935, 5937, 5996	Women	19
Melilla	Group 1402 Renal failure  5836-5837, 584-586	Both sexes	36
Melilla	Group 1402 Renal failure  5836-5837, 584-586	Men	20
Melilla	Group 1402 Renal failure  5836-5837, 584-586	Women	16
Melilla	Group 1403 Urolithiasis  592, 594, 7880	Both sexes	44
Melilla	Group 1403 Urolithiasis  592, 594, 7880	Men	28
Melilla	Group 1403 Urolithiasis  592, 594, 7880	Women	16
Melilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Both sexes	104
Melilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Men	52
Melilla	Group 1404 Other diseases of the urinary system 0994, 587-589, 5903, 5930-5932, 5936, 5938-5939, 595-597, 5980-5981, 5988-5989, 5990-5995, 5998-5999, 6256	Women	52
Melilla	Group 1405 Prostatic hyperplasia  600	Both sexes	24
Melilla	Group 1405 Prostatic hyperplasia  600	Men	24
Melilla	Group 1405 Prostatic hyperplasia  600	Women	..
Melilla	Group 1406 Other diseases of the male genital organs    601-608	Both sexes	11
Melilla	Group 1406 Other diseases of the male genital organs    601-608	Men	11
Melilla	Group 1406 Other diseases of the male genital organs    601-608	Women	..
Melilla	Group 1407 Disorders of breast  610-612	Both sexes	13
Melilla	Group 1407 Disorders of breast  610-612	Men	5
Melilla	Group 1407 Disorders of breast  610-612	Women	8
Melilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Both sexes	9
Melilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Men	..
Melilla	Group 1408  Inflammatory disease of the female pelvic organs 614-616	Women	9
Melilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Both sexes	36
Melilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Men	..
Melilla	Group 1409 Menstruation disorders, menopause and other diseases of the female genital organs    6250-6255, 6257-627	Women	36
Melilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Both sexes	70
Melilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Men	3
Melilla	Group 1410 Other disorders of the genitourinary system  Rest of (580-629, except 5997)	Women	67
Melilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Both sexes	3.266
Melilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Men	..
Melilla	Group 1500 Complications of pregnancy, labour and postpartum period   630-679	Women	3.266
Melilla	Group 1501 Legally induced abortion  635	Both sexes	2
Melilla	Group 1501 Legally induced abortion  635	Men	..
Melilla	Group 1501 Legally induced abortion  635	Women	2
Melilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Both sexes	217
Melilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Men	..
Melilla	Group 1502 Other pregnancy with abortive outcome  630-634, 636-639	Women	217
Melilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Both sexes	1.533
Melilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Men	..
Melilla	Group 1503 Complications of pregnancy mainly during the antenatal period    640-646, 651-659	Women	1.533
Melilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Both sexes	823
Melilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Men	..
Melilla	Group 1504 Complications of pregnancy and during labour   660-668, 6690-6694, 6698-6699	Women	823
Melilla	Group 1505 Single spontaneous delivery  650	Both sexes	246
Melilla	Group 1505 Single spontaneous delivery  650	Men	..
Melilla	Group 1505 Single spontaneous delivery  650	Women	246
Melilla	Group 1506 Other deliveries  6695-6697	Both sexes	24
Melilla	Group 1506 Other deliveries  6695-6697	Men	..
Melilla	Group 1506 Other deliveries  6695-6697	Women	24
Melilla	Group 1507 Complications related to the puerperium  670-676	Both sexes	10
Melilla	Group 1507 Complications related to the puerperium  670-676	Men	..
Melilla	Group 1507 Complications related to the puerperium  670-676	Women	10
Melilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Both sexes	411
Melilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Men	..
Melilla	Group 1508 Other obstetric conditions not classified elsewhere   647-649, 677-679	Women	411
Melilla	Group 1600 Some disorders originating in the perinatal period  760-779	Both sexes	216
Melilla	Group 1600 Some disorders originating in the perinatal period  760-779	Men	117
Melilla	Group 1600 Some disorders originating in the perinatal period  760-779	Women	99
Melilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Both sexes	61
Melilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Men	30
Melilla	Group 1601 Disorders related with premature delivery and a low birth weight  765	Women	31
Melilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Both sexes	155
Melilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Men	87
Melilla	Group 1602 Other conditions originating in the perinatal period  Rest of (760-779)	Women	68
Melilla	Grupo 1700 Congenital abnormalities  740-759	Both sexes	49
Melilla	Grupo 1700 Congenital abnormalities  740-759	Men	28
Melilla	Grupo 1700 Congenital abnormalities  740-759	Women	21
Melilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Both sexes	134
Melilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Men	66
Melilla	Signs, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  780-799 (except 7880 and including 4590,5997)	Women	68
Melilla	Group 1801 Pain in throat and chest 7841, 7865	Both sexes	2
Melilla	Group 1801 Pain in throat and chest 7841, 7865	Men	2
Melilla	Group 1801 Pain in throat and chest 7841, 7865	Women	..
Melilla	Group 1802 Abdominal pain   7890	Both sexes	22
Melilla	Group 1802 Abdominal pain   7890	Men	9
Melilla	Group 1802 Abdominal pain   7890	Women	13
Melilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Both sexes	4
Melilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Men	3
Melilla	1803 Other unknown and unspecified causes of morbidity and mortality   7999	Women	1
Melilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Both sexes	106
Melilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Men	52
Melilla	Group 1804 Other igns, symptoms and abnormal clinical and laboratory findings , not classified elsewhere  Rest of (except 7880 and including 4590,5997)	Women	54
Melilla	Group 1900 Injuries and poisoning  800-999	Both sexes	366
Melilla	Group 1900 Injuries and poisoning  800-999	Men	219
Melilla	Group 1900 Injuries and poisoning  800-999	Women	147
Melilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Both sexes	21
Melilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Men	13
Melilla	Group 1901 Intracranial injury  8001-8004, 8006-8009, 8011-8014, 8016-8019, 8031-8034, 8036-8039, 8041-8044, 8046-8049, 850-854	Women	8
Melilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Both sexes	18
Melilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Men	15
Melilla	Group 1902 Other injuries to the head 8000, 8005, 8010, 8015, 802, 8030, 8035, 8040, 8045, 830, 870-873, 900, 910, 918, 920, 921, 925, 950-951	Women	3
Melilla	Group 1903 Radius and ulna fracture 813	Both sexes	20
Melilla	Group 1903 Radius and ulna fracture 813	Men	14
Melilla	Group 1903 Radius and ulna fracture 813	Women	6
Melilla	Group 1904 Femur fracture  820-821	Both sexes	74
Melilla	Group 1904 Femur fracture  820-821	Men	27
Melilla	Group 1904 Femur fracture  820-821	Women	47
Melilla	Group 1905 Leg fracture, including the ankle 823-824	Both sexes	47
Melilla	Group 1905 Leg fracture, including the ankle 823-824	Men	31
Melilla	Group 1905 Leg fracture, including the ankle 823-824	Women	16
Melilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Both sexes	98
Melilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Men	71
Melilla	Group 1906 Other injuries     805-812, 814-819, 822, 825-829, 831-848, 860-869, 874-897, 901-904, 911-917, 919, 922-924, 926-929, 952-959	Women	27
Melilla	Group 1907 Burns  940-949	Both sexes	16
Melilla	Group 1907 Burns  940-949	Men	13
Melilla	Group 1907 Burns  940-949	Women	3
Melilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Both sexes	7
Melilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Men	1
Melilla	Group 1908 poisonings due to drugs, medicines and biological substances  and toxic effects of non-medicinal substances with respect to their origin   960-989	Women	6
Melilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Both sexes	56
Melilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Men	28
Melilla	Group 1909 Complications of surgical and medical care not elsewhere classified  996-999	Women	28
Melilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Both sexes	..
Melilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Men	..
Melilla	Group 1910 Late effects of injuries, poisoning, toxic effects and other external causes   905-909	Women	..
Melilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Both sexes	9
Melilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Men	6
Melilla	Group 1911 Other and unspecified effects of external causes    930-939, 990-995	Women	3
Melilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Both sexes	29
Melilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Men	7
Melilla	Group 2100 Factors influencing health status and contact with health services  Codes V (only main diagnosis)	Women	22
Melilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Both sexes	3
Melilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Men	..
Melilla	Group 2101 Monitoring and assessment due to suspicion of diseases not founded V710-V712, V717-V719	Women	3
Melilla	Group 2102 Contraceptive management  V25	Both sexes	9
Melilla	Group 2102 Contraceptive management  V25	Men	..
Melilla	Group 2102 Contraceptive management  V25	Women	9
Melilla	Group 2103 Living newborns by type of delivery   V30-V39	Both sexes	..
Melilla	Group 2103 Living newborns by type of delivery   V30-V39	Men	..
Melilla	Group 2103 Living newborns by type of delivery   V30-V39	Women	..
Melilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Both sexes	6
Melilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Men	2
Melilla	Group 2104 Other medical care, including radiotherapy and chemotherapy sessions   V071, V58	Women	4
Melilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Both sexes	11
Melilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Men	5
Melilla	Group 2105 Other factors influencing health status and contact with health services Rest of codes V (only main diagnosis)	Women	6